Citrus Sinensis ID: 035992
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 613 | 2.2.26 [Sep-21-2011] | |||||||
| Q65X23 | 621 | Probable serine/threonine | yes | no | 0.907 | 0.895 | 0.544 | 1e-176 | |
| Q9STK6 | 516 | Probable serine/threonine | yes | no | 0.809 | 0.961 | 0.555 | 1e-174 | |
| A2YMV6 | 704 | Probable serine/threonine | N/A | no | 0.631 | 0.549 | 0.576 | 1e-140 | |
| Q0D598 | 704 | Probable serine/threonine | no | no | 0.631 | 0.549 | 0.576 | 1e-140 | |
| Q8S8Y9 | 568 | Serine/threonine-protein | no | no | 0.621 | 0.670 | 0.577 | 1e-136 | |
| Q9CAV6 | 700 | Serine/threonine-protein | no | no | 0.639 | 0.56 | 0.548 | 1e-133 | |
| Q2V338 | 492 | Probable serine/threonine | no | no | 0.629 | 0.784 | 0.553 | 1e-133 | |
| Q8S8Y8 | 567 | Probable serine/threonine | no | no | 0.646 | 0.698 | 0.533 | 1e-129 | |
| Q8LST2 | 557 | Probable serine/threonine | no | no | 0.631 | 0.694 | 0.552 | 1e-129 | |
| Q6EU49 | 612 | Probable serine/threonine | no | no | 0.626 | 0.627 | 0.548 | 1e-128 |
| >sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 619 bits (1596), Expect = e-176, Method: Compositional matrix adjust.
Identities = 350/643 (54%), Positives = 428/643 (66%), Gaps = 87/643 (13%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MP E D D++ EF E+DP+ARYGRY EVLG+GAFK VY+AFD+LEG+EVAWNQIK
Sbjct: 1 MPPTPPPELDLLDTEPEFAEVDPTARYGRYTEVLGKGAFKTVYKAFDQLEGLEVAWNQIK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V D+LRN++DLERL SEV LLKTLKHKNIIKFYNSW+D +N +INFITE+FTSGTLRQYR
Sbjct: 61 VGDILRNNDDLERLRSEVRLLKTLKHKNIIKFYNSWLDKKNNNINFITEVFTSGTLRQYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KHK VD+RALKKWSRQIL GL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA
Sbjct: 121 IKHKKVDVRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAT 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL ARSAHS+I EFMAPELY+EEYNELVDIYAFGMCLLELVTFEYPY EC+NAAQIY
Sbjct: 181 ILDNARSAHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIY 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSLRV 297
KKV+ G KP+SLAK+ D VR FIEKCIA+ S+RL A+ELL DPFL+ +D E + L+
Sbjct: 241 KKVSDGEKPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLR-DDGEKIFYPLQS 299
Query: 298 KTHY-----SAETSHQANLDKNA--------YGSSAE-----------------TGRDFT 327
T S+ +S D++A GS AE GR T
Sbjct: 300 NTKASDGAGSSNSSMGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQAAAGRIIT 359
Query: 328 VQGQRRDINTIFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTIS 387
V+ Q +D+NTIFLKLRI+DSTGH +NIHFPFD EADT+ +VA+EMV +L+LTDQDV+ I+
Sbjct: 360 VESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIA 419
Query: 388 AMIESEIRSHIPDW---EPKEIAGDRMYETVANLGICSPKTNDEASVMMSELNRSPSGLQ 444
MI++EIR+HIPDW E E GD + + S + +DE S + +E N + +G
Sbjct: 420 EMIDAEIRAHIPDWALEESVENQGDERAHSETD----SSEADDETSELRNEPNATHNGFV 475
Query: 445 METLPSGHKYWSDSPKETNRNSQGKSATSSRYSLSEHNERTPGTPDSYRDDDSPNSAASL 504
E LPSGHKYWSDSP+ RN + H+ P + + PN
Sbjct: 476 QEHLPSGHKYWSDSPR---RNIE-----------MSHSAVEP-----HIGGNMPNGI--- 513
Query: 505 EQLEDDHISDCVGNIG----------LKDGSGITNLQLDSTTHQLEDKCEILLNTESEGV 554
L+ + D V N+G + SG+ ++ ST+ Q D I +
Sbjct: 514 --LKKNDTDDTVSNLGTSVDLPNPSMIDRKSGVASV---STSPQSFDDEHIEAD------ 562
Query: 555 KHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKELSPEIHRK 597
V E+ LL +QQ E++ L+RKH+ I LK + PE HR+
Sbjct: 563 --VSERLVNLLAQQQEELNVLRRKHKADIEVILKGV-PEEHRE 602
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9STK6|WNK3_ARATH Probable serine/threonine-protein kinase WNK3 OS=Arabidopsis thaliana GN=WNK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 612 bits (1577), Expect = e-174, Method: Compositional matrix adjust.
Identities = 338/608 (55%), Positives = 403/608 (66%), Gaps = 112/608 (18%)
Query: 9 QDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS 68
QD ++S+ EFVEIDP+ RYGRYKEVLG+GAFK+VYRAFD+LEGIEVAWNQ+K+ D +S
Sbjct: 3 QDENNSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSS 62
Query: 69 EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL 128
EDL+RLYSEVHLLKTLKHK+IIKFY SW+D ++ IN ITE+FTSG LRQYRKKHK VDL
Sbjct: 63 EDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDL 122
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA 188
RALKKWSRQILEGL YLHSHDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL +ARSA
Sbjct: 123 RALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSA 182
Query: 189 HSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245
HSVI EFMAPELYEE+YN LVDIYAFGMCLLELVTFEYPY ECTNAAQIY+KVTSGIK
Sbjct: 183 HSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIK 242
Query: 246 PASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS--EDDESVGRSLRVKTHYSA 303
PA+L V D VRAFIEKCIA+VS+RL AKELL DPFL+ E+ E+V
Sbjct: 243 PAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCYKENTENV------------ 290
Query: 304 ETSHQANLDKNAYG-----SSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHFPF 358
+SH+ N N G S +E G TV+GQR+D+NTIFLKLRI+DS G RNIHFPF
Sbjct: 291 -SSHKEN-GYNGNGIVDKLSDSEVGL-LTVEGQRKDLNTIFLKLRITDSKGQIRNIHFPF 347
Query: 359 DTEADTAFAVASEMVEELNLT-DQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVAN 417
+ E DT+F+VA EMVEEL+LT DQD+STI+ MI++EI SHIPDW P + GD ++
Sbjct: 348 NIETDTSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDWTPSRLIGD---DSAVQ 404
Query: 418 LGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSSRYS 477
+ SP+T L ++ PSG K+WS SPK +S
Sbjct: 405 KCLSSPET-----------------LHLDRFPSGRKFWS-SPKAGAGDS----------- 435
Query: 478 LSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNLQLDSTTH 537
R+P P S N L G N ++
Sbjct: 436 ------RSPFAPRS--------------------------NSKLSSAQGPINQEVGVIVE 463
Query: 538 QLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKELSPEIHRK 597
+LE LL KQ+ E++E++R E +++FLKE PEI +
Sbjct: 464 KLES----------------------LLRKQREEIEEMQRDQERIVTEFLKEFPPEICEE 501
Query: 598 ILGMLKLK 605
L L++K
Sbjct: 502 ALVRLQVK 509
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 498 bits (1281), Expect = e-140, Method: Compositional matrix adjust.
Identities = 246/427 (57%), Positives = 304/427 (71%), Gaps = 40/427 (9%)
Query: 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
E+ E+DP+ RYGRY +VLG+GA K VYRAFDE +G+EVAWNQ+K+ D L++ EDLERLY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR 136
E+HLLKTLKH+NI+KFY SWVD +INFITE+FTSGTLRQYR+KH V++ A+K W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEF 194
QIL GL YLHSHDPP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL ++ + H V EF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 195 MAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254
MAPE+YEEEYNELVDIY+FGMC+LE+VTFEYPY ECT+ QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 255 NGVRAFIEKCIAEVSERLPAKELLGDPFLQSED--------DESVGRSLRVK--THYSAE 304
VR F+EKC+A S RL A+ELL DPFLQ +D D S+ LR H +
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVDDLVFCPGDGDYSLMNYLRQPYLEHAYSN 315
Query: 305 TSHQANL--------------------DKNAYGSSAETGR--------DFTVQGQRRDIN 336
S +N D A G G D T++G++ +
Sbjct: 316 VSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITIKGRKSEDG 375
Query: 337 TIFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRS 396
+IFL+LRI+D+ GH RNI+FPFD EADTA +VA+EMV EL++TD +V+ I+ MI+ E+ +
Sbjct: 376 SIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSA 435
Query: 397 HIPDWEP 403
+PDW P
Sbjct: 436 LVPDWRP 442
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1280), Expect = e-140, Method: Compositional matrix adjust.
Identities = 246/427 (57%), Positives = 304/427 (71%), Gaps = 40/427 (9%)
Query: 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
E+ E+DP+ RYGRY +VLG+GA K VYRAFDE +G+EVAWNQ+K+ D L++ EDLERLY
Sbjct: 16 EYAEVDPTGRYGRYNDVLGKGASKTVYRAFDEYQGMEVAWNQVKLHDFLQSPEDLERLYC 75
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR 136
E+HLLKTLKH+NI+KFY SWVD +INFITE+FTSGTLRQYR+KH V++ A+K W R
Sbjct: 76 EIHLLKTLKHRNIMKFYTSWVDVSRRNINFITEMFTSGTLRQYRQKHMRVNIWAVKHWCR 135
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEF 194
QIL GL YLHSHDPP+IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL ++ + H V EF
Sbjct: 136 QILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVHCVGTPEF 195
Query: 195 MAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254
MAPE+YEEEYNELVDIY+FGMC+LE+VTFEYPY ECT+ QIYKKV SG KP +L KV D
Sbjct: 196 MAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPEALYKVKD 255
Query: 255 NGVRAFIEKCIAEVSERLPAKELLGDPFLQSED--------DESVGRSLRVK--THYSAE 304
VR F+EKC+A S RL A+ELL DPFLQ +D D S+ LR H +
Sbjct: 256 PMVRQFVEKCLATASRRLSARELLKDPFLQVDDLVFCPGDGDYSLMNYLRQPYLEHAYSN 315
Query: 305 TSHQANL--------------------DKNAYGSSAETGR--------DFTVQGQRRDIN 336
S +N D A G G D T++G++ +
Sbjct: 316 VSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLGNVDITIKGRKSEDG 375
Query: 337 TIFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRS 396
+IFL+LRI+D+ GH RNI+FPFD EADTA +VA+EMV EL++TD +V+ I+ MI+ E+ +
Sbjct: 376 SIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTRIAEMIDGEVSA 435
Query: 397 HIPDWEP 403
+PDW P
Sbjct: 436 LVPDWRP 442
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1250), Expect = e-136, Method: Compositional matrix adjust.
Identities = 236/409 (57%), Positives = 301/409 (73%), Gaps = 28/409 (6%)
Query: 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE 77
FVEIDPS RYGRY E+LG+GA K VYRAFDE EGIEVAWNQ+K+ + RN E+LE+ + E
Sbjct: 14 FVEIDPSGRYGRYDEILGKGASKTVYRAFDEYEGIEVAWNQVKLRNFTRNPEELEKFFRE 73
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ 137
+HLLKTL H+NI+KFY SWVDT N INF+TE+FTSGTLRQYR +H+ V++RA+K+W +Q
Sbjct: 74 IHLLKTLNHQNIMKFYTSWVDTNNLSINFVTELFTSGTLRQYRLRHRRVNIRAVKQWCKQ 133
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFM 195
IL+GL YLHS PP+IHRDLKCDNIF+NGNQGEVKIGDLGLAAIL ++ + V EFM
Sbjct: 134 ILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHAVRCVGTPEFM 193
Query: 196 APELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
APE+Y+EEYNELVD+YAFGMC+LE+VTF+YPY ECT+ AQIYKKVTSG KP + V D
Sbjct: 194 APEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKKPEAFYLVKDP 253
Query: 256 GVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSA------------ 303
VR F+EKC+A V+ RL A ELL DPFLQ DD G +R +Y+
Sbjct: 254 EVREFVEKCLANVTCRLTALELLQDPFLQ--DDNMDGFVMRPIDYYNGYDETGVFLRHPL 311
Query: 304 ----------ETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRN 353
E+S +D + + E D +++G+R + IFL+LRISD+ G RN
Sbjct: 312 IDDPLYHDQFESSQICEID--LFANDDEDHVDISIKGKRNGDDGIFLRLRISDAEGRIRN 369
Query: 354 IHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWE 402
I+FPF+T DTA++VA EMV EL++T+QDV+ I+ MI++EI + +PDW+
Sbjct: 370 IYFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAALVPDWK 418
|
Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 475 bits (1223), Expect = e-133, Method: Compositional matrix adjust.
Identities = 254/463 (54%), Positives = 308/463 (66%), Gaps = 71/463 (15%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE 69
+PD S EFVE+DP+ RYGRY EVLG+GA K VYRAFDE EGIEVAWNQ+K+ D L++ E
Sbjct: 8 EPDYS--EFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 65
Query: 70 DLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR 129
DLERLY E+HLLKTLKHKNI+KFY SWVDT N +INF+TE+FTSGTLRQYR +HK V++R
Sbjct: 66 DLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIR 125
Query: 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH 189
A+K W RQIL GL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL ++ +AH
Sbjct: 126 AMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
Query: 190 SV--IEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247
V EFMAPE+YEE YNELVDIY+FGMC+LE+VTF+YPY ECT+ AQIYKKV SG KP
Sbjct: 186 CVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPD 245
Query: 248 SLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDE----------SVGRSLRV 297
+L KV D V+ FIEKC+A VS R+ A+ELL DPFL+ +D E SVG R
Sbjct: 246 ALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQ 305
Query: 298 KTH---YSAETSHQANLDK-------------------NAYGS-----------SAETGR 324
H Y S+ ++L++ N Y S AET
Sbjct: 306 PHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAETEE 365
Query: 325 DFTV-----------QGQRRDINT-IFLKLRISDSTGHF------------RNIHFPFDT 360
+ + +++ N I +K + D G F RNI+FPFD
Sbjct: 366 THGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPFDI 425
Query: 361 EADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEP 403
E DTA +VA+EMV EL++ D V+ I+ MI+ EI S +P W P
Sbjct: 426 ETDTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRP 468
|
Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2V338|WNK9_ARATH Probable serine/threonine-protein kinase WNK9 OS=Arabidopsis thaliana GN=WNK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1220), Expect = e-133, Method: Compositional matrix adjust.
Identities = 237/428 (55%), Positives = 301/428 (70%), Gaps = 42/428 (9%)
Query: 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLY 75
+E+VE+DP+ RYGRY EVLG+G+ K VYR FDE +GIEVAWNQ+K+ D L++ ++LERLY
Sbjct: 13 SEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQELERLY 72
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
E+HLLKTLKHK+I+KFY SWVDT+N +INF+TE+FTSGTLRQYR KHK V++RA+K W
Sbjct: 73 CEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAVKNWC 132
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IE 193
RQIL GL+YLH+HDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L + +AH V E
Sbjct: 133 RQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCVGTPE 192
Query: 194 FMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253
FMAPE+Y+EEYN+LVDIY+FGMC+LE+VTF+YPY EC++ AQIYK+V SG KP L KV
Sbjct: 193 FMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGLDKVK 252
Query: 254 DNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDD------------ESVGRSLRVKTH- 300
D VR FIEKC+A VS RL A ELL D FL ++ + G LR H
Sbjct: 253 DPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRRVESEKGLIDEAGTPLRHSYHI 312
Query: 301 -------YSAETSHQANLDKNAYGSSAET-------------------GRDFTVQGQRRD 334
YS +Q + + + S E D +++G+RRD
Sbjct: 313 PHYSNGYYSLYNQNQWDYNGDETVESHEIDLLEFQNDDDEEEEDKRFGSVDISIKGKRRD 372
Query: 335 I-NTIFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESE 393
+ +FL+L+ + G RNI+FPFD E DTA +VA EMVEEL + D+DV+ I+ MI+ E
Sbjct: 373 NGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELEMDDRDVTKIANMIDGE 432
Query: 394 IRSHIPDW 401
I S +P+W
Sbjct: 433 IASLVPNW 440
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 462 bits (1190), Expect = e-129, Method: Compositional matrix adjust.
Identities = 233/437 (53%), Positives = 303/437 (69%), Gaps = 41/437 (9%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
D ++ Q+P D E +E+DP+ RY RYKEV+G+GAFK VY+AFDE++GIEVAWNQ+++ D
Sbjct: 6 DASALQEP--PDPEVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDD 63
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
+L++ LERLYSEV LLK+LKH NII+FYNSW+D +N+ +N ITE+FTSG+LR YRKKH
Sbjct: 64 VLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKH 123
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+ V+++A+K W+RQIL GL YLH +PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++
Sbjct: 124 RKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVME 183
Query: 184 QARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
QA +A SVI EFMAPELY+E YNEL DIY+FGMC+LE+VTF+YPY EC N+AQIYKKV
Sbjct: 184 QA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKV 242
Query: 241 TSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQ---------------- 284
+SGIKPASL++V D V+ FIEKC+ SERL AKELL DPFLQ
Sbjct: 243 SSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLTMNNPLPLPDIV 302
Query: 285 -SEDDESVGRSL--------RVKTHYSAETSHQANLDKNAYGSS----------AETGRD 325
++ R L R S + +NL + + A+ G
Sbjct: 303 MPKEGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGSRCIEVRRAKRGNF 362
Query: 326 FTVQGQRRDINTIFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVST 385
F ++G+ D ++ L LRI D G RNIHF F E DTA V+SEMVE+L LTDQ+V+
Sbjct: 363 FVLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTF 422
Query: 386 ISAMIESEIRSHIPDWE 402
I+ +I+ + + IP W+
Sbjct: 423 IAELIDILLVNMIPTWK 439
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1186), Expect = e-129, Method: Compositional matrix adjust.
Identities = 235/425 (55%), Positives = 302/425 (71%), Gaps = 38/425 (8%)
Query: 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL 74
D E +EIDP+ RY RYKEV+G+GA K V++ FDE++GIEVAWNQ+++ DLL++ + LERL
Sbjct: 15 DPEVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRIDDLLQSPDCLERL 74
Query: 75 YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
YSEV LLK+LKHKNII+FYNSW+D +N+ +N ITE+FTSG+LRQYRKKH+ V+++A+K W
Sbjct: 75 YSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKKHRKVNMKAVKCW 134
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI-- 192
+RQIL GL YLHS DPP+IHRD+KCDNIF+NGN GEVKIGDLGLA ++ QA +A SVI
Sbjct: 135 ARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQA-NAKSVIGT 193
Query: 193 -EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251
EFMAPELY+E YNEL DIY+FGMC+LE+VTFEYPY EC N+AQIYKKV+SGIKPASL+K
Sbjct: 194 PEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIKPASLSK 253
Query: 252 VADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSE----------------DDESVG-RS 294
V D V FIEKC+ SERL A+ELL D FL + S G R
Sbjct: 254 VKDPEVMKFIEKCLLPASERLSAEELLLDSFLNVNGLVMNNPLPLPDIVMPKEGSFGERC 313
Query: 295 LRVKTHYSAET-SHQANLDK----------NAYGSS------AETGRDFTVQGQRRDINT 337
L + +A + NLD+ N G++ A+ G F ++G+ D N+
Sbjct: 314 LMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTNCIEVRRAKRGNFFVLKGEENDENS 373
Query: 338 IFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSH 397
+ L LRI D G RNIHF F E DTA V+SEMVE+L LTD++V I+ +I+ + +
Sbjct: 374 VSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFIAELIDVLLVNL 433
Query: 398 IPDWE 402
IP+W+
Sbjct: 434 IPNWK 438
|
May regulate flowering time by modulating the photoperiod pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 459 bits (1180), Expect = e-128, Method: Compositional matrix adjust.
Identities = 226/412 (54%), Positives = 299/412 (72%), Gaps = 28/412 (6%)
Query: 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL 74
DAE VE+DP+ RY RY EVLGRGA K VY+AFDE+EGIEVAW+Q+++ +++++ ++LERL
Sbjct: 12 DAECVEVDPTRRYIRYNEVLGRGAMKTVYKAFDEVEGIEVAWSQVEIDEVMQSPDNLERL 71
Query: 75 YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
YSEVHLLK+LKH+N++KFYN WVD + + IN ITE+FTSG+LRQYR+KH VDL+A+K W
Sbjct: 72 YSEVHLLKSLKHENVMKFYNYWVDDQKKTINVITELFTSGSLRQYRQKHPRVDLKAIKNW 131
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI-- 192
+RQ+L GL YLH+H PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++ R A SVI
Sbjct: 132 ARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPR-AKSVIGT 190
Query: 193 -EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251
EFMAPELY+E Y+ELVDIY+FGMC+LE+ T EYPY ECTNAAQI+KKV+ G+KPA+LAK
Sbjct: 191 PEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVKPAALAK 250
Query: 252 VADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDD---------ESVGRSLRVK---T 299
+ + + FI+KC+ SERL AKELL DPFL S++ S+ +S+ V
Sbjct: 251 ITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLVGTKFPSSLPKSVDVSLEAL 310
Query: 300 HYSAETSHQ---ANLDKNAYGSSAETGRDFT---------VQGQRRDINTIFLKLRISDS 347
H +T+ + +N G + +FT + G++ D N++ L LRI+D
Sbjct: 311 HMDVDTNESMCTSTCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNSVSLVLRIADL 370
Query: 348 TGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIP 399
GH RNIHF F ++DTA +VA+EMVE+L L D DV+ I+ I+ I + +P
Sbjct: 371 CGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNLVP 422
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 613 | ||||||
| 224121790 | 586 | predicted protein [Populus trichocarpa] | 0.942 | 0.986 | 0.681 | 0.0 | |
| 225456878 | 669 | PREDICTED: probable serine/threonine-pro | 0.980 | 0.898 | 0.668 | 0.0 | |
| 224133694 | 588 | predicted protein [Populus trichocarpa] | 0.944 | 0.984 | 0.678 | 0.0 | |
| 28874836 | 591 | ZIK1 protein [Medicago sativa] | 0.941 | 0.976 | 0.654 | 0.0 | |
| 255540491 | 614 | kinase, putative [Ricinus communis] gi|2 | 0.973 | 0.972 | 0.654 | 0.0 | |
| 449469727 | 601 | PREDICTED: probable serine/threonine-pro | 0.962 | 0.981 | 0.650 | 0.0 | |
| 357461755 | 591 | Serine/threonine protein kinase WNK2 [Me | 0.941 | 0.976 | 0.662 | 0.0 | |
| 297733694 | 487 | unnamed protein product [Vitis vinifera] | 0.771 | 0.971 | 0.764 | 0.0 | |
| 351724987 | 567 | with no lysine kinase 7 [Glycine max] gi | 0.889 | 0.961 | 0.618 | 0.0 | |
| 351724587 | 569 | with no lysine kinase [Glycine max] gi|2 | 0.895 | 0.964 | 0.607 | 0.0 |
| >gi|224121790|ref|XP_002318673.1| predicted protein [Populus trichocarpa] gi|222859346|gb|EEE96893.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/612 (68%), Positives = 469/612 (76%), Gaps = 34/612 (5%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MPQ+++SE DPDDSDAEFVEIDP+ RYGRYKEVLGRGAFKKVYRAFDE EGIEVAWNQ+K
Sbjct: 1 MPQESSSETDPDDSDAEFVEIDPTGRYGRYKEVLGRGAFKKVYRAFDEFEGIEVAWNQVK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNS DLERLYSEVHLL TLKHKNIIKFYNSW+DT+NE+INFITEIFTSGTLRQYR
Sbjct: 61 VADLLRNSVDLERLYSEVHLLNTLKHKNIIKFYNSWIDTKNENINFITEIFTSGTLRQYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+KHKHV LRALKKWSRQILEGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 121 QKHKHVGLRALKKWSRQILEGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QARSAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVT EYPYVECTNAAQIY
Sbjct: 181 ILQQARSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTVEYPYVECTNAAQIY 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS-EDDESVGRSLR 296
KKVTSGIKPASLAKV D V+AFIEKC A+VS+RLPAKELL DPFLQS E++ESVG S R
Sbjct: 241 KKVTSGIKPASLAKVKDPAVKAFIEKCTAKVSDRLPAKELLMDPFLQSDEENESVGHSFR 300
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
K H S +S Q ++++ A SSAE RDFTVQGQR+DINTIFLKLRI+DSTGH RNIHF
Sbjct: 301 PKAHSSGGSSDQIDVNEIAKDSSAEPIRDFTVQGQRKDINTIFLKLRIADSTGHIRNIHF 360
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVA 416
PFD E DTA AVASEMVEEL+LTDQDVSTI+AMI+SEIRSHIP W ++ + + VA
Sbjct: 361 PFDVEVDTAIAVASEMVEELDLTDQDVSTIAAMIDSEIRSHIPGWASHNVSPENL---VA 417
Query: 417 NLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSSRY 476
+T D++S + +E SP L +E LPSG KYWSDSPK+ + NS K R
Sbjct: 418 EDSEPPFETKDDSSPLSNESIPSPGSLVLERLPSGRKYWSDSPKDVDGNSPSKLG---RS 474
Query: 477 SLSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNLQLDSTT 536
+LS H PN+A S QLE + +SD N + +LQ
Sbjct: 475 NLSCHEPSL----------SCPNAARSNGQLEAESMSDDDDNSAKHGSNRSDDLQ----- 519
Query: 537 HQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKELSPEIHR 596
N S VK + EK + LLV QQ E++ELKRKH++AI D L E+SPEI +
Sbjct: 520 ---------YANRNSTSVKIIAEKLDKLLVMQQQELEELKRKHKVAILDLLNEVSPEIRQ 570
Query: 597 KILGMLKLKIPA 608
+L + KLKIP
Sbjct: 571 DVLNICKLKIPV 582
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456878|ref|XP_002277287.1| PREDICTED: probable serine/threonine-protein kinase WNK2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2002), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/633 (66%), Positives = 477/633 (75%), Gaps = 32/633 (5%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MPQ +SEQDPDD D EFVEIDP+ RYGRYKEVLG+GAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MPQVLSSEQDPDDPDTEFVEIDPTGRYGRYKEVLGKGAFKKVYRAFDELEGIEVAWNQVK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNSE+ ERLYSEVHLLKTLKHKNIIKFY SWVDT NE+INFITEIFTSGTLRQYR
Sbjct: 61 VADLLRNSEEFERLYSEVHLLKTLKHKNIIKFYISWVDTRNENINFITEIFTSGTLRQYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KKHKHVDLRALKKWSRQILEGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 121 KKHKHVDLRALKKWSRQILEGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QARSAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVEC NAAQIY
Sbjct: 181 ILRQARSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECANAAQIY 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS-EDDESVGRSLR 296
KKVTSGIKPASLAKV D VRAFI+KCIA VS+RL AKELL DPFLQS E++ SVGRSL+
Sbjct: 241 KKVTSGIKPASLAKVKDPRVRAFIDKCIANVSDRLSAKELLRDPFLQSDEENGSVGRSLQ 300
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
H+S H N ++ S E+ RDF VQGQRRD+NTIFLKLRI+DS GH RNIHF
Sbjct: 301 PHPHHSGSHDH-FNTGTSSKVSLPESSRDFKVQGQRRDVNTIFLKLRIADSKGHIRNIHF 359
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEP-KEIAGDRMYETV 415
PFD ADTA +VA EMVEEL+LTDQDVSTI+AMI+SEIRS I DW P +E+ GD + V
Sbjct: 360 PFDIGADTAISVAGEMVEELDLTDQDVSTIAAMIDSEIRSIISDWPPSREVFGDNLSTEV 419
Query: 416 ANLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSSR 475
A IC P++ +A +M+E S GL +E LPSG +YWSDSPK NS + A S+
Sbjct: 420 AISDICPPESEGDALPLMNESATSSCGLVLERLPSGRRYWSDSPKAVGGNSPIRPAFSNL 479
Query: 476 YS----------LSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGNIGLKDGS 525
S SE NE++ +P RD D N+AASL++ ED+ + ++ K+ S
Sbjct: 480 SSQVDSVTTEGRFSELNEQSLASP---RDGDKLNTAASLDKREDERVCGD-DDVEEKEAS 535
Query: 526 GITNLQL-DSTTHQLE-----------DKCEILLNTESEGVKHVVEKFEYLLVKQQNEVD 573
Q D +E C+IL TE K +VEK ++L VKQQ E+D
Sbjct: 536 ISAETQFSDQNDVAVELLGGYRAPSWGGNCKILRETELGDAKVIVEKLKHLFVKQQKELD 595
Query: 574 ELKRKHELAISDFLKELSPEIHRKILGMLKLKI 606
ELKRKHELAI D +KEL P+I K+ + LKI
Sbjct: 596 ELKRKHELAILDLVKELPPDIRNKVSSLCNLKI 628
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133694|ref|XP_002321638.1| predicted protein [Populus trichocarpa] gi|222868634|gb|EEF05765.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 774 bits (1998), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/615 (67%), Positives = 476/615 (77%), Gaps = 36/615 (5%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MP +++SE DPDDSDAEFVEIDPS RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MPHESSSEPDPDDSDAEFVEIDPSGRYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQVK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNS DLERL+SEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLR+YR
Sbjct: 61 VADLLRNSVDLERLFSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRKYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+KHKHVDLRALKKWS+QILEGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 121 QKHKHVDLRALKKWSKQILEGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QARSAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVT EYPYVEC+NAAQIY
Sbjct: 181 ILQQARSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTVEYPYVECSNAAQIY 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS-EDDESVGRSLR 296
KKVTSGIKPASLAKV D V+AFIEKCIA+VS+RLPAKELL DPFL+S E++ S G SLR
Sbjct: 241 KKVTSGIKPASLAKVKDPAVKAFIEKCIAKVSDRLPAKELLMDPFLRSDEENVSGGCSLR 300
Query: 297 VKTHYSAETSHQANLDKNA--YGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNI 354
K H S S Q +++++A S+AE+ RDF+VQGQR+DINTIFLKLRI+DSTGHFRNI
Sbjct: 301 PKAHSSGGISDQLDVNESAKDKDSAAESSRDFSVQGQRKDINTIFLKLRIADSTGHFRNI 360
Query: 355 HFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYET 414
HFPFD + DTA AVASEMVEEL++TDQDVSTI+AMI+SEIRSHIPDW+ ++ + +
Sbjct: 361 HFPFDVKVDTAIAVASEMVEELDVTDQDVSTIAAMIDSEIRSHIPDWDSNNVSPENL--- 417
Query: 415 VANLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSS 474
A +T D++S + +E + SP L +E L SGHKYW DSPK+ + +S K S
Sbjct: 418 AAEDSEPPSETKDDSSPLSNESSLSPGSLVLEKLSSGHKYWRDSPKDVDGDSPSKLGCS- 476
Query: 475 RYSLSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNLQLDS 534
+LS H P SPN A S QLE +SD DGSG
Sbjct: 477 --NLSFHRS-CPS---------SPNDAQSPGQLEAGSMSDG------DDGSGKNGSHRSD 518
Query: 535 TTHQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKELSPEI 594
H N S VK + EK E LLV QQ E++E+KRKH++AISD L E+SPEI
Sbjct: 519 NLH--------FANRNSTSVKIIAEKLENLLVMQQQELEEVKRKHKVAISDLLNEVSPEI 570
Query: 595 HRKILGMLKLKIPAF 609
+IL + KLKIP +
Sbjct: 571 CVEILNICKLKIPGY 585
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|28874836|emb|CAC84087.1| ZIK1 protein [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 763 bits (1969), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/617 (65%), Positives = 463/617 (75%), Gaps = 40/617 (6%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MP D+ +EQD DD D EF EIDP+ RYGRYKE+LG+GAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MPPDS-AEQD-DDPDTEFAEIDPTGRYGRYKEILGKGAFKKVYRAFDELEGIEVAWNQVK 58
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLRQYR
Sbjct: 59 VSDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRQYR 118
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KKHKHVDLRALKKWSRQILEGLSYLHSH+PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 119 KKHKHVDLRALKKWSRQILEGLSYLHSHNPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 178
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QA SAHSVI EFMAP LYEEEYNELVDIYAFGMCLLELVT EYPYVEC NAAQIY
Sbjct: 179 ILQQATSAHSVIGTPEFMAPXLYEEEYNELVDIYAFGMCLLELVTVEYPYVECANAAQIY 238
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSE-DDESVGRSLR 296
KKVTSGIKPASLAKV D V+AFIEKC A V+ERLPAK LL DPFLQS+ D +SVGRS R
Sbjct: 239 KKVTSGIKPASLAKVNDPEVKAFIEKCTAHVTERLPAKALLMDPFLQSDWDGDSVGRSSR 298
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
+T S ++ K+A +S ETGR+FTV+GQRRD+NTIFLKLRI+DS+GH RNIHF
Sbjct: 299 SRTQQSGNNFDNQSIGKSANDNSTETGREFTVEGQRRDVNTIFLKLRIADSSGHIRNIHF 358
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVA 416
PFD EADT+ +VASEMVEEL LTDQDVSTI+ I+SEIR HIP+W P E + +
Sbjct: 359 PFDIEADTSISVASEMVEELELTDQDVSTIAMTIDSEIRYHIPNWNPIETLDNSSCQDSG 418
Query: 417 NLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSS-R 475
+ + +T EAS M N SP L +E LPSG KYWSDSPK NS A S+
Sbjct: 419 H----TLETMPEASPMG---NESPGSLALEILPSGRKYWSDSPKGVGGNSPCLHAASNLS 471
Query: 476 YS---LSEHNERTPGTPDSYRDD--DSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNL 530
Y ++E + D DSP++ S+ SDC G G+++
Sbjct: 472 YEGDVIAEEGSLFANSTGKECDGTADSPSNEKSI-------TSDCSEATG-----GMSSQ 519
Query: 531 QLDSTTHQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKEL 590
+ S + L ++E+E + + K E LLV QQ+E+DELKRKH+LA+SDFL E
Sbjct: 520 EEISVS---------LKDSETEDINKIATKLETLLVMQQDELDELKRKHKLAVSDFLNEF 570
Query: 591 SPEIHRKILGMLKLKIP 607
SPEI ++L M L++P
Sbjct: 571 SPEISLQVLNMCNLQMP 587
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540491|ref|XP_002511310.1| kinase, putative [Ricinus communis] gi|223550425|gb|EEF51912.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 757 bits (1955), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/623 (65%), Positives = 471/623 (75%), Gaps = 26/623 (4%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
M Q+ SEQDPDDSD EFVEIDP+ RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MAQELQSEQDPDDSDTEFVEIDPTGRYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQVK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V +L+RN +DLERLYSEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLRQYR
Sbjct: 61 VAELVRNFDDLERLYSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRQYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 121 RKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QARSAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVTF+YPY EC NAAQI+
Sbjct: 181 ILQQARSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTFDYPYAECINAAQIF 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS-EDDESVGRSLR 296
KKVTSGIKPASLAKV D V+AFIEKCIA VS+RL AKELL DPFL+ E++E +G SLR
Sbjct: 241 KKVTSGIKPASLAKVTDPSVKAFIEKCIARVSDRLSAKELLMDPFLRPDEENEIIGHSLR 300
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
K+H+ + Q K A S E RDFTVQGQ +D+NTIFLKLRI+DSTGH RNIHF
Sbjct: 301 QKSHHPGGSPDQTISGKGAGDPSLEKSRDFTVQGQMKDVNTIFLKLRIADSTGHIRNIHF 360
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVA 416
PFD E DTA AVASEMVEEL+LTDQDVSTI+A+I+SEI+SHIPDW P++++ D M V
Sbjct: 361 PFDIEVDTAIAVASEMVEELDLTDQDVSTIAAIIDSEIQSHIPDWTPRKLSSDNMCPEVM 420
Query: 417 NLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSSRY 476
+ S +D S + +E S L +E LPSG KYWS SPK +S K S+
Sbjct: 421 DSETASEIKDD--SPLTNESTHSSGSLALERLPSGRKYWS-SPKAVGGSSPSKLGHSNSS 477
Query: 477 SLSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISD----------CVGNIGLKDGSG 526
S S++ + PN + SLEQ E +++S VG+ S
Sbjct: 478 SYEPSLS-------SHQAGNGPNVSCSLEQFEAENLSQNSREDEEASWPVGSQSRDRNSA 530
Query: 527 ITNLQLDSTTHQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDF 586
+ L+ T Q D +I ++ E + V +V+K E LLVKQQ E+D+LKR+HE AISD
Sbjct: 531 SVDQGLE-TGEQASDSSKISMDVEPD-VNILVQKLENLLVKQQKELDDLKRRHEEAISDL 588
Query: 587 LKELSPEIHRKILGMLKLKIPAF 609
L E+SPEI R++L KL +P +
Sbjct: 589 LNEVSPEISRQVLSFCKLSLPDY 611
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469727|ref|XP_004152570.1| PREDICTED: probable serine/threonine-protein kinase WNK2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 748 bits (1931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/616 (65%), Positives = 477/616 (77%), Gaps = 26/616 (4%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
M QD + +QD D+SD EFVEIDP+ RYGRYKE+LG+GAFK+VYRAFDELEGIEVAWNQ+K
Sbjct: 1 MSQDLSPDQDLDESDPEFVEIDPTGRYGRYKEILGKGAFKRVYRAFDELEGIEVAWNQVK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLRQYR
Sbjct: 61 VTDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRQYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KKHKHVD+RALKKWSRQILEGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 121 KKHKHVDVRALKKWSRQILEGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QARSAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPY+EC NAAQIY
Sbjct: 181 ILQQARSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYIECANAAQIY 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDD-ESVGRSLR 296
KKVTSGIKPASLAKV + GVRAFIEKCIA VS+RLPAK+LL DPFLQ++DD ES+ R LR
Sbjct: 241 KKVTSGIKPASLAKVTNLGVRAFIEKCIANVSDRLPAKDLLRDPFLQADDDHESISRHLR 300
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
KT E Q + D++ S AET RDF++ G+R+D+N IFLKLRI+DS G+FRNIHF
Sbjct: 301 SKTQ-PTEKKEQIDFDRSVDYSPAETSRDFSMHGERKDVNKIFLKLRIADSMGNFRNIHF 359
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVA 416
PFD EADTA +VASEMVEEL+L+DQDVSTIS MIE+EIRS+IPDW E +GD
Sbjct: 360 PFDIEADTAISVASEMVEELDLSDQDVSTISEMIETEIRSYIPDWISVEYSGD------- 412
Query: 417 NLGICSPKTN---DEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATS 473
N+G +P ++ E + S L+ L +E +PSG KYWSDSPK S K S
Sbjct: 413 NVGADAPVSDSSPSETRNVASPLSIESGNLALEVMPSGRKYWSDSPKGIGGCSPIKPGPS 472
Query: 474 SRYSLSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNLQLD 533
+LS +++ + +S+ D+ + AA ++ LE++ +S+ G DG +++
Sbjct: 473 ---NLSFASDQNVESSNSHIHGDNLDHAAIIKGLENELLSEG----GDHDGQDESSIHTS 525
Query: 534 STTHQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKELSPE 593
S TH E+ ES +K V EK E LL +QQ E+DEL++KH+L IS+ L +L+PE
Sbjct: 526 SETHHSEENN----YDESVDLKIVAEKLENLLTQQQKELDELRKKHKLDISELLTKLTPE 581
Query: 594 IHRKILGMLKLKIPAF 609
++K++ M +L+ P F
Sbjct: 582 SYQKVIEMCQLQHPDF 597
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461755|ref|XP_003601159.1| Serine/threonine protein kinase WNK2 [Medicago truncatula] gi|355490207|gb|AES71410.1| Serine/threonine protein kinase WNK2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/617 (66%), Positives = 467/617 (75%), Gaps = 40/617 (6%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MP D+ SEQD DD D EFVEIDP+ARYGRYKE+LG+GAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MPPDS-SEQD-DDPDTEFVEIDPTARYGRYKEILGKGAFKKVYRAFDELEGIEVAWNQVK 58
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLRQYR
Sbjct: 59 VSDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRQYR 118
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KKHKHVDLRALKKWSRQILEGLSYLHSH+PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 119 KKHKHVDLRALKKWSRQILEGLSYLHSHNPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 178
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QA SAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVT EYPYVECTNAAQIY
Sbjct: 179 ILQQATSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTVEYPYVECTNAAQIY 238
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSE-DDESVGRSLR 296
KKV SGIKPASLAKV D V+AFIEKC A VSERLPAK LL DPFLQS+ D +SVGRS R
Sbjct: 239 KKVISGIKPASLAKVNDPEVKAFIEKCTAHVSERLPAKALLMDPFLQSDWDGDSVGRSSR 298
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
+T +S ++ K+A +SAETGR+FTV+GQRRD+NTIFLKLRI+DS+GH RNIHF
Sbjct: 299 SRTQHSGNNFDNQSIGKSANDNSAETGREFTVEGQRRDVNTIFLKLRIADSSGHIRNIHF 358
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVA 416
PFD EADT+ +VASEMVEEL LTDQDVSTI+ I+SEIR HIP+W P E + +
Sbjct: 359 PFDIEADTSISVASEMVEELELTDQDVSTIAMTIDSEIRYHIPNWNPSETLDNSSCQESG 418
Query: 417 NLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSS-R 475
+ + +T EAS M N SP L +E LPSG KYWSDSPK NS A S+
Sbjct: 419 H----TLETMPEASPMG---NESPGSLALEILPSGRKYWSDSPKGVGGNSPCLHAASNLS 471
Query: 476 YS---LSEHNERTPGTPDSYRDD--DSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNL 530
Y ++E + D DSP + S+ SDC G G+++
Sbjct: 472 YEGDVIAEEGSLFANSVGKECDGTADSPFNEKSI-------TSDCSEATG-----GMSSQ 519
Query: 531 QLDSTTHQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKEL 590
+ S + L ++E+E + + K E LLV Q++E+DELKRKH+LA+SDFL E
Sbjct: 520 EEISAS---------LKDSETEDINKIATKLETLLVMQRDELDELKRKHKLAVSDFLNEF 570
Query: 591 SPEIHRKILGMLKLKIP 607
SPEI ++L M L++P
Sbjct: 571 SPEISLQVLNMCNLQMP 587
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297733694|emb|CBI14941.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/479 (76%), Positives = 399/479 (83%), Gaps = 6/479 (1%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MPQ +SEQDPDD D EFVEIDP+ RYGRYKEVLG+GAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MPQVLSSEQDPDDPDTEFVEIDPTGRYGRYKEVLGKGAFKKVYRAFDELEGIEVAWNQVK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNSE+ ERLYSEVHLLKTLKHKNIIKFY SWVDT NE+INFITEIFTSGTLRQYR
Sbjct: 61 VADLLRNSEEFERLYSEVHLLKTLKHKNIIKFYISWVDTRNENINFITEIFTSGTLRQYR 120
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KKHKHVDLRALKKWSRQILEGL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 121 KKHKHVDLRALKKWSRQILEGLLYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QARSAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVEC NAAQIY
Sbjct: 181 ILRQARSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECANAAQIY 240
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS-EDDESVGRSLR 296
KKVTSGIKPASLAKV D VRAFI+KCIA VS+RL AKELL DPFLQS E++ SVGRSL+
Sbjct: 241 KKVTSGIKPASLAKVKDPRVRAFIDKCIANVSDRLSAKELLRDPFLQSDEENGSVGRSLQ 300
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
H+S H N ++ S E+ RDF VQGQRRD+NTIFLKLRI+DS GH RNIHF
Sbjct: 301 PHPHHSGSHDH-FNTGTSSKVSLPESSRDFKVQGQRRDVNTIFLKLRIADSKGHIRNIHF 359
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEP-KEIAGDRMYETV 415
PFD ADTA +VA EMVEEL+LTDQDVSTI+AMI+SEIRS I DW P +E+ GD + V
Sbjct: 360 PFDIGADTAISVAGEMVEELDLTDQDVSTIAAMIDSEIRSIISDWPPSREVFGDNLSTEV 419
Query: 416 ANLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSS 474
A IC P++ +A +M+E S GL +E LPSG +YWSDSPK NS + A S+
Sbjct: 420 AISDICPPESEGDALPLMNESATSSCGLVLERLPSGRRYWSDSPKAVGGNSPIRPAFSN 478
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724987|ref|NP_001236053.1| with no lysine kinase 7 [Glycine max] gi|225348643|gb|ACN87283.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/619 (61%), Positives = 447/619 (72%), Gaps = 74/619 (11%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKV--YRAFDELEGIEVAWNQ 58
MP D+ SEQD DD D EFVEIDP+ RYGRYKEVLG+GAFKK+ YRAFDELEGIEVAWNQ
Sbjct: 1 MPPDS-SEQDLDDPDIEFVEIDPTGRYGRYKEVLGKGAFKKILIYRAFDELEGIEVAWNQ 59
Query: 59 IKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ 118
+KV DLLRNS+DLERLYSEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLRQ
Sbjct: 60 VKVADLLRNSDDLERLYSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRQ 119
Query: 119 YRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
YRKKHKHVDLRA+KKWSRQILEGL YLHSH+PPVIHRDLKCDNIFVNGNQGEVKIGDLGL
Sbjct: 120 YRKKHKHVDLRAVKKWSRQILEGLLYLHSHNPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 179
Query: 179 AAILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235
AAIL QA SAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVT EYPY+ECTNAAQ
Sbjct: 180 AAILQQANSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTVEYPYIECTNAAQ 239
Query: 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSE-DDESVGRS 294
IYKKVTSGIKPASLAKVAD V+AFIEKCIA+VSERL AK+LL DPFLQS+ D++SVGRS
Sbjct: 240 IYKKVTSGIKPASLAKVADLEVKAFIEKCIADVSERLSAKDLLIDPFLQSDYDNDSVGRS 299
Query: 295 LRVKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNI 354
R +TH+S SH + A +S ET R+FTV+ G+ RNI
Sbjct: 300 SRSQTHHSGNNSHNQAI---AEDNSVETSREFTVE-------------------GNIRNI 337
Query: 355 HFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYET 414
HFPFDTEADT+ +VASEMVEEL LTDQDV+TI+ MI+SEIR HIP W E D ++
Sbjct: 338 HFPFDTEADTSISVASEMVEELELTDQDVTTIAGMIDSEIRYHIPSWNFSETPVDFNHQD 397
Query: 415 VANLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATSS 474
+ + +T EAS M + +P L +E LPSG KYWSDSP+ NS + TS
Sbjct: 398 SS----YTSETRPEASPMKIDSVVAPGSLALEILPSGRKYWSDSPRGFGGNSPSRHMTSI 453
Query: 475 RYSLSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGNIGLKDGSGITNLQLDS 534
+ + N S D+ + N S + DCV DG+
Sbjct: 454 LSNEAGVN--------SEEDNPTANGGISAD--------DCV------DGT--------- 482
Query: 535 TTHQLEDKCEILLN------TESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLK 588
+E +C+ + + +E E + + K E LLVKQ+ E+DELKRKH+LA+SD L
Sbjct: 483 ----IEQECDEIADSPSSEKSEMEYINQITTKLENLLVKQREELDELKRKHKLAVSDLLM 538
Query: 589 ELSPEIHRKILGMLKLKIP 607
E+ PE+ +K+L + L++P
Sbjct: 539 EIPPEMCQKVLNICNLQMP 557
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351724587|ref|NP_001236039.1| with no lysine kinase [Glycine max] gi|225348635|gb|ACN87279.1| with no lysine kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/617 (60%), Positives = 436/617 (70%), Gaps = 68/617 (11%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
MP D+ SE D DD D EFVE+DP+ RYGRYKEVLG+GAFKKVYRAFDELEGIEVAWNQ+K
Sbjct: 1 MPPDS-SELDLDDPDIEFVEVDPTGRYGRYKEVLGKGAFKKVYRAFDELEGIEVAWNQVK 59
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
V DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT+NE+INFITEIFTSGTLRQYR
Sbjct: 60 VADLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTKNENINFITEIFTSGTLRQYR 119
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
KKHKHVDLRA+KKWSRQILEGL YLHSH+PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA
Sbjct: 120 KKHKHVDLRAVKKWSRQILEGLLYLHSHNPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 179
Query: 181 ILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
IL QA SAHSVI EFMAPELYEEEYNELVDIYAFGMCLLELVT EYPY+ECTNAAQIY
Sbjct: 180 ILQQANSAHSVIGTPEFMAPELYEEEYNELVDIYAFGMCLLELVTVEYPYIECTNAAQIY 239
Query: 238 KKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSE-DDESVGRSLR 296
KKVTSGIKPASLAKVAD V+AFIEKCIA+VSERL AK+LL DPFLQS+ D++SVG S
Sbjct: 240 KKVTSGIKPASLAKVADLEVKAFIEKCIADVSERLSAKDLLMDPFLQSDNDNDSVGNS-- 297
Query: 297 VKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHF 356
SH A E R+FTV+ G+ RNIHF
Sbjct: 298 ---------SHIA----------VEPSREFTVE-------------------GNIRNIHF 319
Query: 357 PFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVA 416
PFD EADT+ +VA EMVEEL LTDQDV+TI+ MI+SEIR HIP W E D ++ +
Sbjct: 320 PFDIEADTSISVAGEMVEELELTDQDVTTIARMIDSEIRYHIPSWNFSETPLDINHQDSS 379
Query: 417 NLGICSPKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSATS--- 473
C+ +T E S M ++ SP L +E LPSG +YWSDSP+ NS + TS
Sbjct: 380 ----CTSETRPETSPMKNDSIASPGSLALEILPSGRRYWSDSPRGVGGNSPSQHFTSILS 435
Query: 474 --SRYSLSEHNERTPGTPDSYRDDDSPNSAASLEQLEDDHISDCVGN-IGLKDGSGITNL 530
+ + E N T G D + + + E D I+D + I + G+
Sbjct: 436 NETGVNAEEGNLITNG------DISANDCVDGTAERECDEIADSPSSEISITSGATSEKS 489
Query: 531 QLDSTTHQLEDKCEILLNTESEGVKHVVEKFEYLLVKQQNEVDELKRKHELAISDFLKEL 590
+ L+D +E+E + + K E LLVKQ+ E+DELKRKH+LA+SD L E+
Sbjct: 490 SQKEISRSLKD-------SETEYINQITTKLENLLVKQREELDELKRKHKLAVSDLLMEI 542
Query: 591 SPEIHRKILGMLKLKIP 607
PE+ +K+L + L++P
Sbjct: 543 PPEMCQKVLNVCNLQMP 559
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 613 | ||||||
| TAIR|locus:504955638 | 516 | WNK3 "with no lysine (K) kinas | 0.721 | 0.856 | 0.660 | 2e-162 | |
| TAIR|locus:2028521 | 557 | WNK7 [Arabidopsis thaliana (ta | 0.453 | 0.499 | 0.665 | 5.7e-123 | |
| TAIR|locus:2182039 | 492 | WNK9 [Arabidopsis thaliana (ta | 0.451 | 0.563 | 0.682 | 8.2e-123 | |
| TAIR|locus:2093994 | 567 | WNK6 "with no lysine (K) kinas | 0.453 | 0.490 | 0.665 | 5.8e-122 | |
| TAIR|locus:2098242 | 549 | WNK5 "with no lysine (K) kinas | 0.641 | 0.715 | 0.557 | 2.7e-116 | |
| TAIR|locus:2165790 | 563 | WNK8 "with no lysine (K) kinas | 0.533 | 0.580 | 0.597 | 1.3e-113 | |
| TAIR|locus:2019404 | 524 | WNK10 "with no lysine (K) kina | 0.438 | 0.513 | 0.671 | 4e-112 | |
| TAIR|locus:2114845 | 700 | WNK1 "with no lysine (K) kinas | 0.623 | 0.545 | 0.580 | 2.9e-110 | |
| TAIR|locus:2161278 | 571 | WNK4 "with no lysine (K) kinas | 0.623 | 0.669 | 0.532 | 1.7e-107 | |
| TAIR|locus:2176135 | 314 | AT5G55560 [Arabidopsis thalian | 0.471 | 0.920 | 0.608 | 1.5e-92 |
| TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1494 (531.0 bits), Expect = 2.0e-162, Sum P(2) = 2.0e-162
Identities = 310/469 (66%), Positives = 361/469 (76%)
Query: 9 QDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS 68
QD ++S+ EFVEIDP+ RYGRYKEVLG+GAFK+VYRAFD+LEGIEVAWNQ+K+ D +S
Sbjct: 3 QDENNSEEEFVEIDPTGRYGRYKEVLGKGAFKEVYRAFDQLEGIEVAWNQVKLDDKFCSS 62
Query: 69 EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL 128
EDL+RLYSEVHLLKTLKHK+IIKFY SW+D ++ IN ITE+FTSG LRQYRKKHK VDL
Sbjct: 63 EDLDRLYSEVHLLKTLKHKSIIKFYTSWIDHQHMTINLITEVFTSGNLRQYRKKHKCVDL 122
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA 188
RALKKWSRQILEGL YLHSHDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAAIL +ARSA
Sbjct: 123 RALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARSA 182
Query: 189 HSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245
HSVI EFMAPELYEE+YN LVDIYAFGMCLLELVTFEYPY ECTNAAQIY+KVTSGIK
Sbjct: 183 HSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGIK 242
Query: 246 PASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAET 305
PA+L V D VRAFIEKCIA+VS+RL AKELL DPFL+ + + V +H E
Sbjct: 243 PAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFLKCYKENTEN----VSSH--KEN 296
Query: 306 SHQAN--LDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISDSTGHFRNIHFPFDTEAD 363
+ N +DK S +E G TV+GQR+D+NTIFLKLRI+DS G RNIHFPF+ E D
Sbjct: 297 GYNGNGIVDKL---SDSEVGL-LTVEGQRKDLNTIFLKLRITDSKGQIRNIHFPFNIETD 352
Query: 364 TAFAVASEMVEELNLTD-QDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVANLGICS 422
T+F+VA EMVEEL+LTD QD+STI+ MI++EI SHIPDW P + GD ++ + S
Sbjct: 353 TSFSVAIEMVEELDLTDDQDISTIAKMIDTEIHSHIPDWTPSRLIGD---DSAVQKCLSS 409
Query: 423 PKTNDEASVMMSELNRSPSGLQMETLPSGHKYWSDSPKETNRNSQGKSA 471
P+T L+R PSG + + P S SP NS+ SA
Sbjct: 410 PET--------LHLDRFPSGRKFWSSPKAGAGDSRSPFAPRSNSKLSSA 450
|
|
| TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1008 (359.9 bits), Expect = 5.7e-123, Sum P(3) = 5.7e-123
Identities = 189/284 (66%), Positives = 236/284 (83%)
Query: 3 QDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
+D ++ +P D E +EIDP+ RY RYKEV+G+GA K V++ FDE++GIEVAWNQ+++
Sbjct: 5 EDASAIVEPPDP--EVLEIDPTCRYIRYKEVIGKGASKTVFKGFDEVDGIEVAWNQVRID 62
Query: 63 DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK 122
DLL++ + LERLYSEV LLK+LKHKNII+FYNSW+D +N+ +N ITE+FTSG+LRQYRKK
Sbjct: 63 DLLQSPDCLERLYSEVRLLKSLKHKNIIRFYNSWIDDKNKTVNIITELFTSGSLRQYRKK 122
Query: 123 HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182
H+ V+++A+K W+RQIL GL YLHS DPP+IHRD+KCDNIF+NGN GEVKIGDLGLA ++
Sbjct: 123 HRKVNMKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVM 182
Query: 183 AQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
QA +A SVI EFMAPELY+E YNEL DIY+FGMC+LE+VTFEYPY EC N+AQIYKK
Sbjct: 183 EQA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKK 241
Query: 240 VTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFL 283
V+SGIKPASL+KV D V FIEKC+ SERL A+ELL D FL
Sbjct: 242 VSSGIKPASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL 285
|
|
| TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1028 (366.9 bits), Expect = 8.2e-123, Sum P(2) = 8.2e-123
Identities = 191/280 (68%), Positives = 234/280 (83%)
Query: 13 DSD-AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL 71
+SD +E+VE+DP+ RYGRY EVLG+G+ K VYR FDE +GIEVAWNQ+K+ D L++ ++L
Sbjct: 9 ESDYSEYVEVDPTGRYGRYNEVLGKGSSKTVYRGFDEYQGIEVAWNQVKLYDFLQSPQEL 68
Query: 72 ERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRAL 131
ERLY E+HLLKTLKHK+I+KFY SWVDT+N +INF+TE+FTSGTLRQYR KHK V++RA+
Sbjct: 69 ERLYCEIHLLKTLKHKSIMKFYASWVDTDNRNINFVTEMFTSGTLRQYRLKHKRVNIRAV 128
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
K W RQIL GL+YLH+HDPPVIHRDLKCDNIF+NGNQGEVKIGDLGLAA L + +AH V
Sbjct: 129 KNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHAAHCV 188
Query: 192 --IEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL 249
EFMAPE+Y+EEYN+LVDIY+FGMC+LE+VTF+YPY EC++ AQIYK+V SG KP L
Sbjct: 189 GTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKKPDGL 248
Query: 250 AKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDE 289
KV D VR FIEKC+A VS RL A ELL D FL ++ +
Sbjct: 249 DKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESD 288
|
|
| TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1020 (364.1 bits), Expect = 5.8e-122, Sum P(2) = 5.8e-122
Identities = 189/284 (66%), Positives = 237/284 (83%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
D ++ Q+P D E +E+DP+ RY RYKEV+G+GAFK VY+AFDE++GIEVAWNQ+++ D
Sbjct: 6 DASALQEPPDP--EVLEVDPTFRYIRYKEVIGKGAFKTVYKAFDEVDGIEVAWNQVRIDD 63
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
+L++ LERLYSEV LLK+LKH NII+FYNSW+D +N+ +N ITE+FTSG+LR YRKKH
Sbjct: 64 VLQSPNCLERLYSEVRLLKSLKHNNIIRFYNSWIDDKNKTVNIITELFTSGSLRHYRKKH 123
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+ V+++A+K W+RQIL GL YLH +PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++
Sbjct: 124 RKVNMKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVME 183
Query: 184 QARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
QA +A SVI EFMAPELY+E YNEL DIY+FGMC+LE+VTF+YPY EC N+AQIYKKV
Sbjct: 184 QA-NAKSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKV 242
Query: 241 TSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQ 284
+SGIKPASL++V D V+ FIEKC+ SERL AKELL DPFLQ
Sbjct: 243 SSGIKPASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQ 286
|
|
| TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
Identities = 223/400 (55%), Positives = 290/400 (72%)
Query: 12 DDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL 71
DDS A +VE DPS RYGR++EVLG+GA K VY+AFD++ G+EVAWNQ+K+ ++ R+ E L
Sbjct: 10 DDSIA-YVETDPSGRYGRFREVLGKGAMKTVYKAFDQVLGMEVAWNQVKLNEVFRSPEPL 68
Query: 72 ERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRAL 131
+RLYSEVHLLK L H++II++ SW+D NFITE+FTSGTLR+YR+K++ VD+RA+
Sbjct: 69 QRLYSEVHLLKNLNHESIIRYCTSWIDVNRRTFNFITELFTSGTLREYRRKYQKVDIRAI 128
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
K W+RQIL GL+YLH HDPPVIHRDLKCDNIFVNG+ G+VKIGDLGLAAIL +++AHSV
Sbjct: 129 KSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQNAHSV 188
Query: 192 I---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
I EFMAPELYEE+YNELVDIY+FGMC+LE++T EYPY ECTN AQIYKKVTSG P S
Sbjct: 189 IGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGKLPDS 248
Query: 249 LAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSHQ 308
+ + F+ KC+ VS RLPAKELL DPFL + D+ + R+ + +
Sbjct: 249 FHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLAPLFRLPQQLAIQNLAA 308
Query: 309 ANLDKNAYGSSAETGR--DFTVQGQRR-DINTIFLKLRISDSTGHFRNIHFPFDTEADTA 365
S+ + R D ++ G+ + +TIFL+++I D GH RNI FPF+ +DT
Sbjct: 309 NGTVVEHLPSTTDPTRTTDMSITGKMNSEDHTIFLQVQILDGDGHMRNIQFPFNILSDTP 368
Query: 366 FAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKE 405
VA EMV+EL +TD D I+AMIE+EI +P+W +
Sbjct: 369 LEVALEMVKELEITDWDPLEIAAMIENEISLLVPNWRAND 408
|
|
| TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 978 (349.3 bits), Expect = 1.3e-113, Sum P(2) = 1.3e-113
Identities = 203/340 (59%), Positives = 244/340 (71%)
Query: 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL 74
+A+F E DPS RY RY +VLGRGAFK VY+AFDE++GIEVAWN + + D+++ LERL
Sbjct: 16 EADFAEKDPSGRYIRYDDVLGRGAFKTVYKAFDEVDGIEVAWNLVSIEDVMQMPGQLERL 75
Query: 75 YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
YSEVHLLK LKH+NIIK + SWVD +N+ IN ITE+FTSG+LR YRKKH+ VD +A+K W
Sbjct: 76 YSEVHLLKALKHENIIKLFYSWVDEKNKTINMITELFTSGSLRVYRKKHRKVDPKAIKNW 135
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--ARSAHSVI 192
+RQIL+GL+YLHS +PPVIHRDLKCDNIFVNGN GEVKIGDLGLA +L Q ARS
Sbjct: 136 ARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTARSVIGTP 195
Query: 193 EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252
EFMAPELYEEEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKVTS IKP SL KV
Sbjct: 196 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKPQSLGKV 255
Query: 253 ADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSED--DESVGRSLRVKTHY--SAETSH- 307
D VR FIEKC+ S R A EL DPFL + D ++ S + Y + H
Sbjct: 256 DDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASSSTSSKYVRPPQLEHL 315
Query: 308 QANLDKNAYGSSAETGRDF----TVQGQRRDINTIFLKLR 343
++D N S + D+ T++ QR N F +LR
Sbjct: 316 PMDVDHNE-NKSVSSNEDYPWSQTIELQRIAENKEF-RLR 353
|
|
| TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 940 (336.0 bits), Expect = 4.0e-112, Sum P(3) = 4.0e-112
Identities = 182/271 (67%), Positives = 213/271 (78%)
Query: 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL 74
+A+FV+ DP+ RY RY +VLGRGAFK VY+AFDE+EGIEVAWN + + D+L+ L+RL
Sbjct: 3 EADFVQKDPTGRYIRYNDVLGRGAFKTVYKAFDEVEGIEVAWNLMSIEDVLQMPGQLDRL 62
Query: 75 YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
YSEVHLL +LKH NIIK + SWVD N+ IN ITE+FTSG+L YRKKH+ VD +A+ W
Sbjct: 63 YSEVHLLNSLKHDNIIKLFYSWVDDHNKSINMITELFTSGSLTLYRKKHRKVDPKAIMNW 122
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--ARSAHSVI 192
+RQIL+GL YLHS PPVIHRDLKCDNIFVNGN G+VKIGDLGLAA++ Q ARS
Sbjct: 123 ARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTARSVIGTP 182
Query: 193 EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252
EFMAPELYEEEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKVTSGIKP SL+KV
Sbjct: 183 EFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKPQSLSKV 242
Query: 253 ADNGVRAFIEKCIAEVSERLPAKELLGDPFL 283
D V+ FIEKC+ R A ELL D L
Sbjct: 243 DDPQVKQFIEKCLLPAPSRPTALELLKDQLL 273
|
|
| TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1089 (388.4 bits), Expect = 2.9e-110, P = 2.9e-110
Identities = 227/391 (58%), Positives = 277/391 (70%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE 69
+PD S EFVE+DP+ RYGRY EVLG+GA K VYRAFDE EGIEVAWNQ+K+ D L++ E
Sbjct: 8 EPDYS--EFVEVDPTGRYGRYNEVLGKGASKTVYRAFDEYEGIEVAWNQVKLYDFLQSPE 65
Query: 70 DLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR 129
DLERLY E+HLLKTLKHKNI+KFY SWVDT N +INF+TE+FTSGTLRQYR +HK V++R
Sbjct: 66 DLERLYCEIHLLKTLKHKNIMKFYTSWVDTANRNINFVTELFTSGTLRQYRLRHKRVNIR 125
Query: 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH 189
A+K W RQIL GL YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL ++ +AH
Sbjct: 126 AMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAAH 185
Query: 190 SV--IEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247
V EFMAPE+YEE YNELVDIY+FGMC+LE+VTF+YPY ECT+ AQIYKKV SG KP
Sbjct: 186 CVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKKPD 245
Query: 248 SLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSH 307
+L KV D V+ FIEKC+A VS R+ A+ELL DPFL+ +D E RS+ ++
Sbjct: 246 ALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLYRQ 305
Query: 308 QANL-DKNAYGS-SAETGRDFTVQGQRRDINTIFLKLRISDS-TGHFRNIHFPFDTEADT 364
+L D Y S S+ R ++ G N+ L + S+ H + A+T
Sbjct: 306 PHHLPDYYNYPSNSSSLNRQYS-NGNYPS-NSSSLNRQYSNGYNSHHEYQNGWAYNPAET 363
Query: 365 AFAVASEMVEELNLTDQDVSTISAMIESEIR 395
E+ E N DQ+ S ++ I+
Sbjct: 364 EETHGIELFESRNNDDQEEEKKSGNVDITIK 394
|
|
| TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 1.7e-107, P = 1.7e-107
Identities = 212/398 (53%), Positives = 278/398 (69%)
Query: 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLY 75
AE+VE DP+ RYGR+ E+LGRGA K VY+A DE GIEVAW+Q+K+ ++LR+S DL+RLY
Sbjct: 7 AEYVETDPTGRYGRFAEILGRGAMKTVYKAIDEKLGIEVAWSQVKLKEVLRSSVDLQRLY 66
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
SEVHLL TL HK+II+FY SW+D N +NFITE+FTSGTLRQY+ K+ +D+RA+K W+
Sbjct: 67 SEVHLLSTLNHKSIIRFYTSWIDVHNHTLNFITELFTSGTLRQYKNKYLRIDIRAIKSWA 126
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI--- 192
RQILEGL YLH HDPPVIHRDLKCDNIFVNG+ G+VKIGDLGLA +L SAHS+I
Sbjct: 127 RQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHSAHSIIGTP 186
Query: 193 EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252
EFMAPELYEE YNEL+D+Y+FGMC LE++T E+PY EC + AQIYKKV G P + +V
Sbjct: 187 EFMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGKLPGAFYRV 246
Query: 253 ADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSHQANLD 312
D + FI KC+ S+R+ AKELL DPFL S++ S V T S + + L+
Sbjct: 247 GDIEAQRFIGKCLVSASKRVSAKELLQDPFLASDE------SWMVYT--SGAGNPKPFLN 298
Query: 313 KNAYGS----SAETGRDFTVQGQR-RDINTIFLKLRISDSTGHFRNIHFPFDTEADTAFA 367
+N + E + ++ G+ + N I L+++I+ G N+ FPFD DT+
Sbjct: 299 ENEMDTLKLEDDELRTEMSIAGKLGAEDNKIDLEVQIAYDNGLANNVFFPFDIMNDTSID 358
Query: 368 VASEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPKE 405
VA EMV+EL + D + I+ MI+ I S + DW+ +E
Sbjct: 359 VAKEMVKELEIIDWEPVEIAKMIDGAISSLVSDWKYEE 396
|
|
| TAIR|locus:2176135 AT5G55560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 922 (329.6 bits), Expect = 1.5e-92, P = 1.5e-92
Identities = 180/296 (60%), Positives = 218/296 (73%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
D SE+D D FVE+DP+ RYGRY E+LG GA KKVYRAFD+ EGIEVAWNQ+K+
Sbjct: 9 DNESEKDKDSES--FVEVDPTGRYGRYGELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRC 66
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
+ ERLYSEV LLK LK+ NII Y W D N +NFITEI TSG LR+YRKKH
Sbjct: 67 FSDDPAMTERLYSEVRLLKNLKNSNIITLYKVWRDERNNTLNFITEICTSGNLREYRKKH 126
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+HV +RALKKWS+QIL+GL YLH+HDP +IHRDL C NIFVNGN G+VKIGDLGLAAI+
Sbjct: 127 RHVSMRALKKWSKQILKGLDYLHTHDPCIIHRDLNCSNIFVNGNIGQVKIGDLGLAAIVG 186
Query: 184 QARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
+ AHS++ EFMAPELYEE Y E+VDIY++GMC+LELV+ E PY EC + A+IYK+V
Sbjct: 187 KNHLAHSILGTPEFMAPELYEENYTEMVDIYSYGMCVLELVSLEIPYSECDSVAKIYKRV 246
Query: 241 TSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQS--EDDESVGRS 294
+ G+KP +L KV D +AFIEKCIA+ R A ELL DPF +DD+ G +
Sbjct: 247 SKGLKPEALNKVNDPEAKAFIEKCIAQPRARPSAAELLCDPFFDGILDDDDEDGEN 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q65X23 | WNK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5443 | 0.9070 | 0.8953 | yes | no |
| Q9STK6 | WNK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5559 | 0.8091 | 0.9612 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pm.C_LG_XII000307 | hypothetical protein (586 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 613 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-61 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-51 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-47 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-43 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-37 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-33 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-32 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-32 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-32 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-31 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-30 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-30 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-27 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-26 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-22 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-21 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-20 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-18 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-15 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 8e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-14 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 2e-61
Identities = 87/258 (33%), Positives = 131/258 (50%), Gaps = 14/258 (5%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E LG G+F KVY A D+ G VA IKVI + +D ER+ E+ +LK LKH NI++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVA---IKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
Y+ + D + + + E G L KK + + + RQIL L YLHS
Sbjct: 62 LYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG-- 117
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE-LYEEEYNEL 207
++HRDLK +NI ++ + G VK+ D GLA L + + E+MAPE L + Y +
Sbjct: 118 IVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176
Query: 208 VDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA-SLAKVADNGVRAFIEKCIA 266
VDI++ G+ L EL+T + P+ +++KK+ P + I K +
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236
Query: 267 -EVSERLPAKELLGDPFL 283
+ +RL A+E L PF
Sbjct: 237 KDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 4e-58
Identities = 94/265 (35%), Positives = 144/265 (54%), Gaps = 23/265 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTLKHKNII 90
E+LGRG+F VY A D+ G +A +K ++L +S E+LE L E+ +L +L+H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMA---VKSVELSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
++Y S D E +N E + G+L KK + ++K++RQILEGL+YLHS+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG- 121
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA---HSVI---EFMAPELYE-EE 203
++HRD+K NI V+ + G VK+ D G A L + SV +MAPE+ EE
Sbjct: 122 -IVHRDIKGANILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK----PASLAKVADNGVRA 259
Y DI++ G ++E+ T + P+ E N K+ S + P L++ A +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEA----KD 235
Query: 260 FIEKC-IAEVSERLPAKELLGDPFL 283
F+ KC + +R A ELL PFL
Sbjct: 236 FLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 6e-52
Identities = 71/194 (36%), Positives = 105/194 (54%), Gaps = 14/194 (7%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG G F VY A D+ G +VA IK+I +S LE L E+ +LK L H NI+K Y
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVA---IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLY 57
Query: 94 NSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPV 152
+ D H+ + E G+L+ ++ + + + QILEGL YLHS+ +
Sbjct: 58 GVFED--ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN--GI 113
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPELYEE--EYNE 206
IHRDLK +NI ++ + G+VK+ D GL+ +L +S I +MAPE+ Y+E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 207 LVDIYAFGMCLLEL 220
DI++ G+ L EL
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-51
Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 20/267 (7%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHK 87
LG G+F VY+A + G VA +K++ S+ + E+ +L+ L H
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVA---VKILKKRSEKSKKDQTARREIRILRRLSHP 58
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
NI++ +++ D +H+ + E G L Y + + KK + QIL GL YLHS
Sbjct: 59 NIVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHS 116
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-ARSAHSV---IEFMAPE--LYE 201
+ +IHRDLK +NI ++ N G VKI D GLA L + + S + +MAPE L
Sbjct: 117 NG--IIHRDLKPENILLDEN-GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK--KVTSGIKPASLAKVADNG--V 257
Y VD+++ G+ L EL+T + P+ Q+ ++ K +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEA 233
Query: 258 RAFIEKCIA-EVSERLPAKELLGDPFL 283
+ I+KC+ + S+R A+E+L P+
Sbjct: 234 KDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 2e-47
Identities = 80/260 (30%), Positives = 140/260 (53%), Gaps = 15/260 (5%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
E +G+G F +VY+A + G EVA IKVI L + E E++ +E+ +LK KH N
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVA---IKVIKL-ESKEKKEKIINEIQILKKCKHPN 58
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEGLSYLHS 147
I+K+Y S++ + + + E + G+L+ K + +++L+GL YLHS
Sbjct: 59 IVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE-LYEEE 203
+ +IHRD+K NI + + GEVK+ D GL+A L+ ++ ++++ +MAPE + +
Sbjct: 117 NG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP 173
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263
Y+ DI++ G+ +EL + PY E ++K T+G + + + F++K
Sbjct: 174 YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 264 C-IAEVSERLPAKELLGDPF 282
C +R A++LL PF
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-43
Identities = 89/298 (29%), Positives = 147/298 (49%), Gaps = 36/298 (12%)
Query: 3 QDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
+D SE DP + E +G GA +VY+A D G EVA IK +
Sbjct: 9 KDIVSEGDPRELYKNL-------------EKIGEGASGEVYKATDRATGKEVA---IKKM 52
Query: 63 DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL----RQ 118
L ++ E + +E+ ++K KH NI+ +Y+S++ + + + E G+L Q
Sbjct: 53 RL--RKQNKELIINEILIMKDCKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQ 108
Query: 119 YRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
+ + + R++L+GL YLHS VIHRD+K DNI ++ G VK+ D G
Sbjct: 109 NFVRMNEPQIAYV---CREVLQGLEYLHSQ--NVIHRDIKSDNILLS-KDGSVKLADFGF 162
Query: 179 AAILAQARSA-HSVI---EFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNA 233
AA L + +S +SV+ +MAPE+ + ++Y VDI++ G+ +E+ E PY+
Sbjct: 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222
Query: 234 AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
++ T GI P + + F+ KC+ + +R A+ELL PFL+ +
Sbjct: 223 RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKE 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-42
Identities = 80/269 (29%), Positives = 135/269 (50%), Gaps = 22/269 (8%)
Query: 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTL 84
+Y + +G+G+F KVY + +G +K IDL + ++ E +EV +LK L
Sbjct: 1 KY-EIIKQIGKGSFGKVYLVRRKSDGKLYV---LKEIDLSNMSEKEREDALNEVKILKKL 56
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY----RKKHKHVDLRALKKWSRQILE 140
H NIIK+Y S+ E + + E G L Q +K+ K + W Q+
Sbjct: 57 NHPNIIKYYESFE--EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL 114
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVI---EFMA 196
L YLHS ++HRD+K NIF+ N G VK+GD G++ +L+ A +V+ +++
Sbjct: 115 ALKYLHSRK--ILHRDIKPQNIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 197 PELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
PEL + + YN DI++ G L EL T ++P+ E N ++ K+ G P ++ +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKGQYPPIPSQYSSE 230
Query: 256 GVRAFIEKCI-AEVSERLPAKELLGDPFL 283
+R + + + ER ++L PF+
Sbjct: 231 -LRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 84/266 (31%), Positives = 135/266 (50%), Gaps = 29/266 (10%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+++GRGAF VY+ + G VA QI + + E L+ + E+ LLK LKH NI+
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIV 62
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
K+ S ++T + + I E +G+LRQ KK + + Q+L+GL+YLH
Sbjct: 63 KYIGS-IETSD-SLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG- 119
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-AQARSAHSVI---EFMAPELYEEE-YN 205
VIHRD+K NI + G VK+ D G+A L ++ SV+ +MAPE+ E +
Sbjct: 120 -VIHRDIKAANILTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT-------SGIKPASLAKVADNGVR 258
DI++ G ++EL+T PY + A +++ V GI P ++
Sbjct: 178 TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPE---------LK 228
Query: 259 AFIEKCIA-EVSERLPAKELLGDPFL 283
F+ +C + + R AK+LL P++
Sbjct: 229 DFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 2e-39
Identities = 73/255 (28%), Positives = 116/255 (45%), Gaps = 22/255 (8%)
Query: 31 KEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
+ LG GAF +VY+ + +EVA +K + + + +E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQILEGLSYL 145
N++K V TE E + + E G L Y +K++ + L L ++ QI G+ YL
Sbjct: 61 PNVVKLLG--VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYL 118
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-----ARSAHSVIEFMAPE-L 199
S IHRDL N V N VKI D GL+ L R I +MAPE L
Sbjct: 119 ESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 200 YEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258
E ++ D+++FG+ L E+ T E PY +N ++ + + +G + +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPE-LY 233
Query: 259 AFIEKCIAEVSERLP 273
+ +C AE E P
Sbjct: 234 DLMLQCWAEDPEDRP 248
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 74/260 (28%), Positives = 130/260 (50%), Gaps = 15/260 (5%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
VLG+G+ VY+ + G A +K I + + E ++L E+ L++ + ++K
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYA---LKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPV 152
Y ++ I+ + E G+L KK + L +RQIL+GL YLH +
Sbjct: 65 YGAFYK--EGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH-TKRHI 121
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----AQARSAHSVIEFMAPE-LYEEEYNEL 207
IHRD+K N+ +N ++GEVKI D G++ +L Q + + +M+PE + E Y+
Sbjct: 122 IHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 208 VDIYAFGMCLLELVTFEYPY--VECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265
DI++ G+ LLE ++P+ + ++ + + G P+ A+ R FI C+
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 266 -AEVSERLPAKELLGDPFLQ 284
+ +R A ELL PF++
Sbjct: 241 QKDPKKRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 74/256 (28%), Positives = 117/256 (45%), Gaps = 23/256 (8%)
Query: 31 KEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
+ LG GAF +VY+ + + +EVA +K + + + +E E +++ L H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVA---VKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL--RALKKWSRQILEGLSY 144
NI+K V TE E + + E G L Y +K++ +L L ++ QI G+ Y
Sbjct: 61 PNIVKLLG--VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-----ARSAHSVIEFMAPE- 198
L S IHRDL N V N VKI D GL+ L + I +MAPE
Sbjct: 119 LESK--NFIHRDLAARNCLVGENLV-VKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 199 LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257
L E ++ D+++FG+ L E+ T E PY +N A++ + + G + +
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPE-L 233
Query: 258 RAFIEKCIAEVSERLP 273
+ +C AE E P
Sbjct: 234 YKLMLQCWAEDPEDRP 249
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 79/259 (30%), Positives = 134/259 (51%), Gaps = 13/259 (5%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTLKHKNII 90
E+LG G+F VY + +G A ++ + D + E +++L E+ LL L+H NI+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
++ + + E +++ E+ G+L + KK+ ++ ++RQIL GL YLH +
Sbjct: 66 QYLGT--EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN- 122
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPELY--EEEYN 205
+HRD+K NI V+ N G VK+ D G+A + + A S +MAPE+ + Y
Sbjct: 123 -TVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYG 180
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265
DI++ G +LE+ T + P+ + A ++K S P ++D + FI KC+
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA-KDFILKCL 239
Query: 266 -AEVSERLPAKELLGDPFL 283
+ S R A ELL PF+
Sbjct: 240 QRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 24/229 (10%)
Query: 29 RYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
+ LG GAF +VY+ E +VA +K + + E+ E E ++K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVA---VKTLKEGASEEEREEFLEEASIMKKL 58
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLS 143
H NI++ V T+ E + +TE G L + +KH + L+ L + + QI +G+
Sbjct: 59 SHPNIVRLLG--VCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMA 196
YL S +HRDL N V VKI D GL + + I++MA
Sbjct: 117 YLESK--NFVHRDLAARNCLV-TENLVVKISDFGL-SRDIYEDDYYRKRGGGKLPIKWMA 172
Query: 197 PELYEE-EYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
PE ++ ++ D+++FG+ L E+ T E PY +N ++ + + G
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLELLEDG 220
|
Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 86/267 (32%), Positives = 136/267 (50%), Gaps = 29/267 (10%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
VLG+G + VY A D + +A +I R+S ++ L+ E+ L LKH+NI+++
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPE----RDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLR--ALKKWSRQILEGLSYLHSHD 149
S D+EN E G+L R K + + +++QILEGL YLH +
Sbjct: 71 LGS--DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILAQARSAHSVIEFMAPELYEE--- 202
++HRD+K DN+ VN G VKI D G LA I + +++MAPE+ ++
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNA-AQIYK----KVTSGIKPASLAKVADNGV 257
Y DI++ G ++E+ T + P++E A ++K K+ I P SL+ A
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI-PESLSAEA---- 241
Query: 258 RAFIEKCIA-EVSERLPAKELLGDPFL 283
+ FI +C + +R A +LL DPFL
Sbjct: 242 KNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 74/265 (27%), Positives = 134/265 (50%), Gaps = 18/265 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E +G+G+F V + + +G + W +I ++ ++ ++L SEV++L+ LKH NI++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVR 63
Query: 92 FYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
+Y+ +D N+ + + E G L ++ +K+ K+++ + + Q+L L H+
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 148 HDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVI---EFMAPE-L 199
P V+HRDLK NIF++ N VK+GD GLA IL S A + + +M+PE L
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 200 YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259
Y+E DI++ G + EL P+ N Q+ K+ G + + +
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFRRIPYRYSS-ELNE 240
Query: 260 FIEKCIA-EVSERLPAKELLGDPFL 283
I+ + + +R +ELL P +
Sbjct: 241 VIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 79/267 (29%), Positives = 140/267 (52%), Gaps = 22/267 (8%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER----LYSEVHLLKTL 84
R ++LG+GAF +VY +D G E+A +K + +S + ++ L E+ LLK L
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELA---VKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
+H+ I+++Y ++E ++ E G+++ K + + +K++RQILEG+ Y
Sbjct: 62 QHERIVQYYG--CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEY 119
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILAQ---ARSAHSVIEFMAP 197
LHS+ ++HRD+K NI + G VK+GD G L I + +S +M+P
Sbjct: 120 LHSNM--IVHRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 198 ELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
E+ E Y D+++ G ++E++T + P+ E A I+K T P + V+ +
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA 236
Query: 257 VRAFIEKCIAEVSERLP-AKELLGDPF 282
R F+ + E +++ P A+ELL F
Sbjct: 237 -RNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 80/265 (30%), Positives = 140/265 (52%), Gaps = 23/265 (8%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G G F KVY A + G +A +I++ D + ++ + E+ +L+ LKH N++K+Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT--IKEIADEMKVLELLKHPNLVKYY 65
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVI 153
V+ E + E + GTL + + + +D ++ ++ Q+LEGL+YLHSH ++
Sbjct: 66 G--VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IV 121
Query: 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAILA-QARSAHSVIE-------FMAPELY----E 201
HRD+K NIF++ N G +K+GD G A L + ++ +MAPE+
Sbjct: 122 HRDIKPANIFLDHN-GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--SLAKVADNGVRA 259
+ + DI++ G +LE+ T + P+ E N QI V +G KP +++ G
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD- 239
Query: 260 FIEKC-IAEVSERLPAKELLGDPFL 283
F+++C ++ +R A ELL PF+
Sbjct: 240 FLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 71/242 (29%), Positives = 131/242 (54%), Gaps = 16/242 (6%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G+G F VY+A L+G VA ++++ +++ +++ + E+ LLK L H N+IK+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 94 NSWVDTENEHINFITEIFTSGTLRQ----YRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
S++ EN +N + E+ +G L + ++K+ + + R + K+ Q+ L ++HS
Sbjct: 69 ASFI--ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-QARSAHSVIE---FMAPE-LYEEEY 204
++HRD+K N+F+ G VK+GDLGL + + +AHS++ +M+PE ++E Y
Sbjct: 127 --IMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 205 NELVDIYAFGMCLLELVTFEYP-YVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263
N DI++ G L E+ + P Y + N + KK+ P A +R + +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243
Query: 264 CI 265
CI
Sbjct: 244 CI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 92/275 (33%), Positives = 135/275 (49%), Gaps = 33/275 (12%)
Query: 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
Y R E++GRGA+ VYR G VA +K+I+L +D+ + EV LL L+
Sbjct: 3 YQRL-ELIGRGAYGAVYRGKHVPTGRVVA---LKIINLDTPDDDVSDIQREVALLSQLRQ 58
Query: 87 ---KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
NI K+Y S++ I I E G++R K + + + R++L L
Sbjct: 59 SQPPNITKYYGSYLKGPRLWI--IMEYAEGGSVRTLMKAGP-IAEKYISVIIREVLVALK 115
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----FMAPEL 199
Y+H VIHRD+K NI V N G VK+ D G+AA+L Q S S +MAPE+
Sbjct: 116 YIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV 172
Query: 200 YEE--EYNELVDIYAFGMCLLELVTFEYPY--VECTNAAQIYKKVTSGIKPASLAKVADN 255
E Y+ DI++ G+ + E+ T PY V+ A + K KP L DN
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----KPPRL---EDN 225
Query: 256 G----VRAFIEKCIAEV-SERLPAKELLGDPFLQS 285
G +R F+ C+ E ERL A+ELL ++++
Sbjct: 226 GYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 81/265 (30%), Positives = 138/265 (52%), Gaps = 13/265 (4%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLERLYSEVHLLKTLKHK 87
R ++LG+GAF +VY +D G E+A Q++ + S+++ L E+ LLK L+H+
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHE 64
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I+++Y D + + E G+++ K + + +K++RQILEG+SYLHS
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-------ARSAHSVIEFMAPELY 200
+ ++HRD+K NI + + G VK+GD G + L RS +M+PE+
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 201 E-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259
E Y D+++ G ++E++T + P+ E A I+K T P + ++++ R
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA-RD 240
Query: 260 FIEKCIAEVSERLPAKELLGDPFLQ 284
F+ E R A+ELL PF Q
Sbjct: 241 FLGCIFVEARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 3e-32
Identities = 68/264 (25%), Positives = 113/264 (42%), Gaps = 34/264 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGI-----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
+ LG GAF +VY+ +L+G EVA +K + + E+ + E ++K L H
Sbjct: 1 KKLGEGAFGEVYKG--KLKGKDGKTTEVA---VKTLKEDASEEERKDFLKEARVMKKLGH 55
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH---------VDLRALKKWSRQ 137
N+++ V TE E + + E G L Y +K + + L+ L ++ Q
Sbjct: 56 PNVVRLLG--VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA------AILAQARSAHSV 191
I +G+ YL S +HRDL N V + VKI D GL+ +
Sbjct: 114 IAKGMEYLASK--KFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLP 170
Query: 192 IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASL 249
I +MAPE L + + D+++FG+ L E+ T PY +N ++ + + G +
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGYRLPKP 229
Query: 250 AKVADNGVRAFIEKCIAEVSERLP 273
D + + C E P
Sbjct: 230 EYCPDE-LYELMLSCWQLDPEDRP 252
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 18/264 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED--LERLYSEVHLLKTLKHKNI 89
+ LG GAF Y+A D G +A Q+ + + ++ +E L E+ L+ L H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
I+ + E+ H N E G++ K+ + ++ Q+L GLSYLH +
Sbjct: 66 IRMLGATC--EDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH--E 121
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS--------VIEFMAPE-LY 200
+IHRD+K N+ ++ ++I D G AA LA + I FMAPE L
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPY--VECTNAAQIYKKVTSGIKPASLAKVADNGVR 258
E+Y D+++ G ++E+ T + P+ + +N + K+ S S+ + G+R
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241
Query: 259 AFIEKCI-AEVSERLPAKELLGDP 281
+C+ + +R P++ELL P
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 31/274 (11%)
Query: 30 YK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87
Y+ EV+G GA VY A +VA IK IDL + ++ L EV + H
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVA---IKRIDLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLR---QYRKKHKHVDLRALKKWSRQILEGLSY 144
N++K+Y S+V + + + + G+L + +D + +++L+GL Y
Sbjct: 60 NVVKYYTSFV--VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-----QARSAHSVIE---FMA 196
LHS+ IHRD+K NI + G G VKI D G++A LA + + + +MA
Sbjct: 118 LHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 197 PELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254
PE+ E+ Y+ DI++FG+ +EL T PY + + + + P SL AD
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN--DPPSLETGAD 232
Query: 255 NGV-----RAFIEKCI-AEVSERLPAKELLGDPF 282
R I C+ + S+R A+ELL F
Sbjct: 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 83/265 (31%), Positives = 136/265 (51%), Gaps = 13/265 (4%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLERLYSEVHLLKTLKHK 87
R ++LG+GAF +VY +D G E+A Q++ + S+++ L E+ LLK L H+
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I+++Y D ++ E G+++ K + + +K++RQILEG+SYLHS
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILAQARSAHSVI---EFMAPELY 200
+ ++HRD+K NI + + G VK+GD G L I SV +M+PE+
Sbjct: 125 N--MIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 201 E-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259
E Y DI++ G ++E++T + P+ E A I+K T P V+D+ R
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH-CRD 240
Query: 260 FIEKCIAEVSERLPAKELLGDPFLQ 284
F+++ E R A ELL F+
Sbjct: 241 FLKRIFVEAKLRPSADELLRHTFVH 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-30
Identities = 82/263 (31%), Positives = 136/263 (51%), Gaps = 13/263 (4%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLERLYSEVHLLKTLKHK 87
R ++LGRGAF +VY +D G E+A Q+ D S+++ L E+ LLK L+H
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I+++Y D E + ++ E G+++ K + + ++++RQIL+G+SYLHS
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILAQARSAHSVI---EFMAPELY 200
+ ++HRD+K NI + + G VK+GD G + I SV +M+PE+
Sbjct: 125 N--MIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 201 E-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259
E Y D+++ ++E++T + P+ E A I+K T KP V+D R
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSD-ACRD 240
Query: 260 FIEKCIAEVSERLPAKELLGDPF 282
F+++ E R A+ LL PF
Sbjct: 241 FLKQIFVEEKRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKH 86
E LG G + VY+A D+ G VA +K I R + E + S E+ LLK LKH
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVA---LKKI---RLDNEEEGIPSTALREISLLKELKH 57
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYL 145
NI+K + V + + E + L++Y K+ + +K Q+L GL+Y
Sbjct: 58 PNIVKLLD--VIHTERKLYLVFE-YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--LAQARSAHSVIE--FMAPELY- 200
HSH ++HRDLK NI +N + G +K+ D GLA + H V+ + APE+
Sbjct: 115 HSHR--ILHRDLKPQNILINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171
Query: 201 -EEEYNELVDIYAFGMCLLELVTFE 224
+ Y+ VDI++ G E++T +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 80/269 (29%), Positives = 142/269 (52%), Gaps = 26/269 (9%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-----LERLYSEVHLLKTLKHK 87
++G G+F VY + G +A Q+++ + +S+D L+ L E+ LLK L+H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
NI+++ S +D +H+N E G++ + + ++ + RQIL+GL+YLH+
Sbjct: 67 NIVQYLGSSLDA--DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL-----AAILAQARSAH------SVIEFMA 196
+IHRD+K NI V+ N+G +KI D G+ A L+ + SV +MA
Sbjct: 125 RG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF-WMA 180
Query: 197 PELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
PE+ ++ Y DI++ G ++E++T ++P+ +CT I+ K+ P + ++
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENASPEIPSNISSE 239
Query: 256 GVRAFIEKCIA-EVSERLPAKELLGDPFL 283
F+EK + ++R A ELL PFL
Sbjct: 240 A-IDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 78/255 (30%), Positives = 140/255 (54%), Gaps = 16/255 (6%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
R ++ +GRG F +VYRA L+G+ VA ++++ DL+ +++ E+ LLK L H N
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-DAKARADCIKEIDLLKQLNHPN 63
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSY 144
+IK+Y S+++ +NE +N + E+ +G L + ++K+ + + + + K+ Q+ L +
Sbjct: 64 VIKYYASFIE-DNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-AQARSAHSVI---EFMAPE-L 199
+HS V+HRD+K N+F+ G VK+GDLGL ++ +AHS++ +M+PE +
Sbjct: 122 MHSRR--VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 200 YEEEYNELVDIYAFGMCLLELVTFEYP-YVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258
+E YN DI++ G L E+ + P Y + N + KK+ P + +R
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238
Query: 259 AFIEKCIAEVSERLP 273
+ CI E+ P
Sbjct: 239 QLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 38/269 (14%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E +G+G+F +VY+A D+ VA IKVIDL +++E + E+ L + I K
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVA---IKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 92 FYNSWVDTENEHINFITEIFTSGT----LRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
+Y S++ I I E G+ L+ + ++ R++L GL YLH
Sbjct: 64 YYGSFLKGSKLWI--IMEYCGGGSCLDLLKPGKLDETYIAFIL-----REVLLGLEYLHE 116
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF------MAPELY- 200
IHRD+K NI ++ +G+VK+ D G++ L S + F MAPE+
Sbjct: 117 EG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIK 171
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK-KVTSGIKPASLAKVADNG--- 256
+ Y+E DI++ G+ +EL E P + ++ +V I + + N
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPL------SDLHPMRVLFLIPKNNPPSLEGNKFSK 225
Query: 257 -VRAFIEKC-IAEVSERLPAKELLGDPFL 283
+ F+ C + ER AKELL F+
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (292), Expect = 2e-28
Identities = 89/384 (23%), Positives = 149/384 (38%), Gaps = 43/384 (11%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKH 86
R LG G+F +VY A D VA +KV+ L S+++ER E+ +L +L H
Sbjct: 3 RILRKLGEGSFGEVYLARDR---KLVA---LKVLAKKLESKSKEVERFLREIQILASLNH 56
Query: 87 -KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH---VDLRALKKWSRQILEGL 142
NI+K Y+ + D + + E G+L KK + QIL L
Sbjct: 57 PPNIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV----------I 192
YLHS +IHRD+K +NI ++ + VK+ D GLA +L S S+
Sbjct: 115 EYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 193 EFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPY---VECTNAAQIYKKVTSGIK 245
+MAPE+ + DI++ G+ L EL+T P+ + +Q K +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT 232
Query: 246 PASLAKVADNG-------VRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGRSLRV 297
P+ + ++ + ++K +A + RL + L L + S +
Sbjct: 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLL 292
Query: 298 KTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQRRDINT--IFLKLRISDSTGHFRNIH 355
K SA A SS + + D N +S S + ++
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLL 352
Query: 356 FPFDTEADTAFAVASEMVEELNLT 379
+ ++ S +L+
Sbjct: 353 LSTASSKRSSLPKISARSSPSSLS 376
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 66/223 (29%), Positives = 116/223 (52%), Gaps = 15/223 (6%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+G+G+F V++ + + A QI + + N + E E +L L II
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYII 62
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR--QILEGLSYLHSH 148
++Y S++D +N + E +G L + K + L + W QIL GL++LHS
Sbjct: 63 RYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-AQARSAHSVI---EFMAPELYEEE- 203
++HRD+K N+F++ VKIGDLG+A +L A++++ +++PEL E++
Sbjct: 121 K--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246
YNE D++A G+ L E T ++P+ + N + K+ G+ P
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 79/268 (29%), Positives = 130/268 (48%), Gaps = 34/268 (12%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
E LG G++ VY+A + G VA IKV+ EDL+ + E+ +LK I+
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVA---IKVV---PVEEDLQEIIKEISILKQCDSPYIV 61
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRK-KHKHVDLRALKKWSRQILEGLSYLHSHD 149
K+Y S+ +N + + E +G++ K +K + + Q L+GL YLHS+
Sbjct: 62 KYYGSYF--KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-RSAHSVIE---FMAPELYEEE-Y 204
IHRD+K NI +N +G+ K+ D G++ L ++VI +MAPE+ +E Y
Sbjct: 120 --KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK---PASLAKVAD-----NG 256
N DI++ G+ +E+ + PY + I+ I P +L+ N
Sbjct: 177 NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPPTLSDPEKWSPEFN- 230
Query: 257 VRAFIEKC-IAEVSERLPAKELLGDPFL 283
F++KC + + ER A +LL PF+
Sbjct: 231 --DFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 71/250 (28%), Positives = 134/250 (53%), Gaps = 16/250 (6%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+GRG F +VYRA L+ VA ++++ +++ +++ + E+ LLK L H N+IK+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMM-DAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 94 NSWVDTENEHINFITEIFTSGTLRQ----YRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+S++ E+ +N + E+ +G L Q ++K+ + + R + K+ Q+ + ++HS
Sbjct: 69 DSFI--EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-AQARSAHSVI---EFMAPE-LYEEEY 204
V+HRD+K N+F+ G VK+GDLGL ++ +AHS++ +M+PE ++E Y
Sbjct: 127 --VMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 205 NELVDIYAFGMCLLELVTFEYP-YVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263
N DI++ G L E+ + P Y + N + +K+ P + +R +
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243
Query: 264 CIAEVSERLP 273
CI ++ P
Sbjct: 244 CIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 20/266 (7%)
Query: 32 EVLGRGAFKKVYRAF-DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
EVLG+GA+ VY ++ + I V ++ ++L ++ E+L EV LLK+LKH NI+
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
++ + +D + I+ E G++ + + K+++QIL+G++YLH++
Sbjct: 66 QYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----------RSAHSVIEFMAPELY 200
V+HRD+K +N+ + N G +K+ D G A LA +S H +MAPE+
Sbjct: 123 -VVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 201 EEE-YNELVDIYAFGMCLLELVTFEYPYVECTN-AAQIYKKVTSGIKPASLAKVADNGVR 258
E Y DI++ G + E+ T + P AA Y G+ P + +
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAID 240
Query: 259 AFIEKCIA-EVSERLPAKELLGDPFL 283
F+ C+ + ER A +LL FL
Sbjct: 241 -FVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 2e-26
Identities = 67/260 (25%), Positives = 124/260 (47%), Gaps = 22/260 (8%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLLKTLKHKNIIK 91
LG+G+F KV + G A +KV+ + +++E +E ++L + H I+K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYA---MKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ ++ E + + E G L + K + ++ +I+ L YLHS
Sbjct: 58 LHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG-- 113
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVI---EFMAPE-LYEEEYNE 206
+I+RDLK +NI ++ G +K+ D GLA L+ S ++ E++APE L + Y +
Sbjct: 114 IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 207 LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266
VD ++ G+ L E++T + P+ + +IY+K+ P + R I +
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQ 229
Query: 267 -EVSERL---PAKELLGDPF 282
+ ++RL A+E+ PF
Sbjct: 230 KDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 73/256 (28%), Positives = 133/256 (51%), Gaps = 15/256 (5%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
V+GRGAF V+ + + V QI V + ++ +E +LK L H NII++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER--LAAQNECQVLKLLSHPNIIEY 64
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
Y +++ E++ + + E GTL +Y ++ + +D + + QIL L ++H+
Sbjct: 65 YENFL--EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE---FMAPELYE-EEYNE 206
++HRDLK NI ++ ++ VKIGD G++ IL+ A++V+ +++PEL E + YN+
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180
Query: 207 LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266
DI+A G L EL + + + E N + K+ SG A ++ +R I +
Sbjct: 181 KSDIWALGCVLYELASLKRAF-EAANLPALVLKIMSG-TFAPISDRYSPDLRQLILSMLN 238
Query: 267 -EVSERLPAKELLGDP 281
+ S+R +++ P
Sbjct: 239 LDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 86/273 (31%), Positives = 139/273 (50%), Gaps = 25/273 (9%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP +Y RY E +G+GA V+ A D G EVA QI L+ E + +E+ ++
Sbjct: 16 DPKKKYTRY-EKIGQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVM 70
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
K LK+ NI+ F +S++ + + + E G+L + +D + R+ L+
Sbjct: 71 KELKNPNIVNFLDSFL--VGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAP 197
L +LH++ VIHRD+K DN+ + G G VK+ D G A + +S S + +MAP
Sbjct: 128 LEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 198 ELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI----KPASLAKV 252
E+ + Y VDI++ G+ +E+V E PY+ +Y T+G P L+ +
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244
Query: 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
R F+ +C+ +V +R AKELL PFL+
Sbjct: 245 ----FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 80/275 (29%), Positives = 125/275 (45%), Gaps = 23/275 (8%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG GAF KVY+A + G+ A K+I + + E+LE E+ +L KH NI+ Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAA---AKIIQI-ESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEGLSYLHSHDPPV 152
++ I + E G L + + ++ RQ+LE L++LHSH V
Sbjct: 69 EAYFYENKLWI--LIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--V 124
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPELYEEE----- 203
IHRDLK NI + G+VK+ D G++A +MAPE+ E
Sbjct: 125 IHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183
Query: 204 -YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA-DNGVRAFI 261
Y+ DI++ G+ L+EL E P+ E N ++ K+ P + F+
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHE-LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFL 242
Query: 262 EKCIA-EVSERLPAKELLGDPFLQSEDDESVGRSL 295
+ C+ + +R A ELL PF+ + D + L
Sbjct: 243 KSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDL 277
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 85/273 (31%), Positives = 138/273 (50%), Gaps = 25/273 (9%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP +Y R+ E +G+GA VY A D G EVA Q+ L+ E + +E+ ++
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDVATGQEVAIKQMN----LQQQPKKELIINEILVM 70
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ KH NI+ + +S++ + + + E G+L + +D + R+ L+
Sbjct: 71 RENKHPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAP 197
L +LHS+ VIHRD+K DNI + G G VK+ D G A + +S S + +MAP
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 198 ELY-EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI----KPASLAKV 252
E+ + Y VDI++ G+ +E+V E PY+ +Y T+G P L+ +
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244
Query: 253 ADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQ 284
R F+ +C+ +V +R AKELL PFL+
Sbjct: 245 ----FRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 70/261 (26%), Positives = 118/261 (45%), Gaps = 23/261 (8%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKTLKHKNIIK 91
LG+G++ VY+ + A +K +DL + ER + E+ +L ++ H NII
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYA---LKEVDL-GSMSQKEREDAVNEIRILASVNHPNIIS 63
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKK---WSR--QILEGLSYLH 146
+ +++D I + E G L + K K + + + W Q+L GL LH
Sbjct: 64 YKEAFLDGNKLCI--VMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQALH 120
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPELYEEE 203
++HRDLK NI + N VKIGDLG++ +L + A + I +MAPE+++
Sbjct: 121 EQK--ILHRDLKSANILLVAN-DLVKIGDLGISKVLKK-NMAKTQIGTPHYMAPEVWKGR 176
Query: 204 -YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262
Y+ DI++ G L E+ TF P+ E + + KV G P + +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 263 KCIAEVSERLPAKELLGDPFL 283
+ R ++L P +
Sbjct: 236 MLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 81/285 (28%), Positives = 139/285 (48%), Gaps = 35/285 (12%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP + + ++ G G+ V A D+ G +VA +K +DL R + E L++EV ++
Sbjct: 16 DPRSYLDNFVKI-GEGSTGIVCIATDKSTGRQVA---VKKMDL-RKQQRRELLFNEVVIM 70
Query: 82 KTLKHKNIIKFYNS-------WVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
+ +H NI++ Y+S WV E +T+I T H ++ +
Sbjct: 71 RDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVT----------HTRMNEEQIATV 120
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA----QARSAHS 190
+L+ LS+LH+ VIHRD+K D+I + + G VK+ D G A ++ + +S
Sbjct: 121 CLAVLKALSFLHAQG--VIHRDIKSDSILLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVG 177
Query: 191 VIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS- 248
+MAPE+ Y VDI++ G+ ++E+V E PY Q K++ + P
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLK 236
Query: 249 -LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291
L KV+ +R+F+++ + + ++R A ELL PFL S
Sbjct: 237 NLHKVSPR-LRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 78/269 (28%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+ +G G + VY+A D G VA IKVI L +D E + E+ +LK +H NI+
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVA---IKVI-KLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQ--YRKKHKHVDLRALKKW-----SRQILEGLSY 144
++ S++ +I + G Q Y V L + R+ L+GL+Y
Sbjct: 65 YFGSYL---RRDKLWIVMEYCGGGSLQDIY-----QVTRGPLSELQIAYVCRETLKGLAY 116
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA-HSVI---EFMAPELY 200
LH IHRD+K NI + G+VK+ D G++A L + S I +MAPE+
Sbjct: 117 LHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173
Query: 201 EEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA--D 254
E Y+ DI+A G+ +EL + P + ++ S P L
Sbjct: 174 AVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS 233
Query: 255 NGVRAFIEKCIAEVSERLP-AKELLGDPF 282
FI+KC+ + ++ P A +LL PF
Sbjct: 234 PVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 1e-24
Identities = 85/273 (31%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP +Y R+ E +G+GA VY A D G EVA Q+ L+ E + +E+ ++
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVM 70
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ K+ NI+ + +S++ + + + E G+L + +D + R+ L+
Sbjct: 71 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAP 197
L +LHS+ VIHRD+K DNI + G G VK+ D G A + +S S + +MAP
Sbjct: 128 LDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
Query: 198 ELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI----KPASLAKV 252
E+ + Y VDI++ G+ +E+V E PY+ +Y T+G P L+ V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244
Query: 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
R F+ +C+ +V R AKELL PFL+
Sbjct: 245 ----FRDFLNRCLEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/262 (30%), Positives = 133/262 (50%), Gaps = 23/262 (8%)
Query: 33 VLGRGAFKK--VYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL-YSEVHLLKTLKHKNI 89
VLG+GAF + +YR ++ V W K ++L R SE R +E+ +L L+H NI
Sbjct: 7 VLGKGAFGEATLYRRTED--DSLVVW---KEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQ--YRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I +YN ++D I E GTL R+K + + + + QI+ +SY+H
Sbjct: 62 IAYYNHFMDDNTLLIEM--EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVIE---FMAPELYE-E 202
++HRD+K NIF+ G +K+GD G++ IL S A +V+ +M+PEL +
Sbjct: 120 AG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV 176
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262
+YN DI+A G L EL+T + + + TN + K+ G + V + + + +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNY-TPVVSVYSSELISLVH 234
Query: 263 KCIAEVSERLP-AKELLGDPFL 283
+ + E+ P A E+L P L
Sbjct: 235 SLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 77/288 (26%), Positives = 132/288 (45%), Gaps = 52/288 (18%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID---LLR----NSEDLERLYSEVHLLKTL 84
+++G G+F V A ++ E A IK++D L++ +E+ EV L +
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYA---IKILDKRQLIKEKKVKYVKIEK---EV-LTRLN 59
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
H IIK Y ++ D EN + F+ E +G L QY +K+ +D + + ++ +IL L Y
Sbjct: 60 GHPGIIKLYYTFQDEEN--LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL---------------------- 182
LHS +IHRDLK +NI ++ + +KI D G A +L
Sbjct: 118 LHSKG--IIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 183 AQARSAHSV--IEFMAPELYEEEY-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
+ R A V E+++PEL E+ + D++A G + +++T + P+ +N ++K
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF-RGSNEYLTFQK 233
Query: 240 VTSGIKPASLAKVADNGVRAFIEK-CIAEVSERL----PAKELLGDPF 282
+ S + IEK + + +RL EL PF
Sbjct: 234 ILKL--EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 20/267 (7%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
Y LG G V + G +A +K I L N +++ E+ +L
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMA---VKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHS 147
I+ FY ++ + + I+ E G+L + K+ + R L K + +L+GL+YLH
Sbjct: 61 IVGFYGAFYN-NGD-ISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH- 117
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLG----LAAILAQARSAHSVIEFMAPE-LYEE 202
+IHRD+K NI VN ++G++K+ D G L LA+ S +MAPE +
Sbjct: 118 EKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTS--SYMAPERIQGN 174
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAA----QIYKKVTSGIKPASLAKVADNGVR 258
+Y+ DI++ G+ L+EL T +PY + ++ + + + P + +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234
Query: 259 AFIEKC-IAEVSERLPAKELLGDPFLQ 284
F+ C I + ER KELL PF++
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 73/271 (26%), Positives = 130/271 (47%), Gaps = 26/271 (9%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED------LERLYSEVHLLKTLK 85
E++G+G + +VY A + G +A Q+++ + D ++ L SE+ LK L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H NI+++ +T E+++ E G++ + + + + ++ ++ Q+LEGL+YL
Sbjct: 67 HLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARSAHSVIEFMAPE- 198
HS ++HRDLK DN+ V+ G KI D G++ Q S + +MAPE
Sbjct: 125 HSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 199 --LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK----KVTSGIKPASLAKV 252
Y + Y+ VDI++ G +LE+ P+ + A ++K + I P +
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241
Query: 253 ADNGVRAFIEKCIAEVSERLP-AKELLGDPF 282
+ F+ C + P A+ELL PF
Sbjct: 242 SPVA-LDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 59/248 (23%), Positives = 109/248 (43%), Gaps = 18/248 (7%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIK---VIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
LG G F +V + + A +K +++ + E ++SE +L+ H I+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE--TGQQ--EHIFSEKEILEECNHPFIV 56
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
K Y ++ D ++I + E G L + D + + ++ YLH+
Sbjct: 57 KLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG- 113
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPELYEEE-YNE 206
+I+RDLK +N+ ++ + G VK+ D G A L + + E++APE+ + Y+
Sbjct: 114 -IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDF 171
Query: 207 LVDIYAFGMCLLELVTFEYPYVEC-TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK-C 264
VD ++ G+ L EL+T P+ E + +IY + G D + I++
Sbjct: 172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLL 231
Query: 265 IAEVSERL 272
ERL
Sbjct: 232 RRNPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 25/273 (9%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP +Y R+ E +G+GA VY A D G EVA Q+ L+ E + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVM 71
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ K+ NI+ + +S++ + + + E G+L + +D + R+ L+
Sbjct: 72 RENKNPNIVNYLDSYL--VGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAP 197
L +LHS+ VIHRD+K DNI + G G VK+ D G A + +S S + +MAP
Sbjct: 129 LEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 198 ELY-EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI----KPASLAKV 252
E+ + Y VDI++ G+ +E++ E PY+ +Y T+G P L+ +
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
Query: 253 ADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQ 284
R F+ +C+ +V +R AKELL FL+
Sbjct: 246 ----FRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 71/219 (32%), Positives = 96/219 (43%), Gaps = 47/219 (21%)
Query: 30 YKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--------EVH 79
YK + LG G F VY A ++ G VA IK + ++ YS EV
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVA---IKKM--------KKKFYSWEECMNLREVK 49
Query: 80 LLKTLK-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL--RALKKWSR 136
L+ L H NI+K V EN+ + F+ E + G L Q K K ++
Sbjct: 50 SLRKLNEHPNIVKLKE--VFRENDELYFVFE-YMEGNLYQLMKDRKGKPFSESVIRSIIY 106
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM- 195
QIL+GL+++H H HRDLK +N+ V+G VKI D GL AR S +
Sbjct: 107 QILQGLAHIHKHG--FFHRDLKPENLLVSGP-EVVKIADFGL------AREIRSRPPYTD 157
Query: 196 --------APE--LYEEEYNELVDIYAFGMCLLELVTFE 224
APE L Y+ VDI+A G + EL T
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER-LYSEVHLLKTLK 85
RY++ LG G + VY+A D+ G VA +IK+ + + + E+ LL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA--LKKWSRQILEGLS 143
H NII + + N IN + E F L + K K + L +K + L GL
Sbjct: 61 HPNIIGLLDVFGHKSN--INLVFE-FMETDLEKVIKD-KSIVLTPADIKSYMLMTLRGLE 116
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--RSAHSVIEFM--APEL 199
YLHS+ ++HRDLK +N+ + + G +K+ D GLA + H V+ APEL
Sbjct: 117 YLHSNW--ILHRDLKPNNLLIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173
Query: 200 Y--EEEYNELVDIYAFGMCLLEL 220
Y VD+++ G EL
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 30 YKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED---LERLYSEVHLLKTL 84
Y+E+ +G GA+ VY+A D G VA +++V SE+ L L E+ LLK L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRV----PLSEEGIPLSTL-REIALLKQL 55
Query: 85 K---HKNIIKFYNSWVDTENEHINFITEIF--TSGTLRQYRKKH--KHVDLRALKKWSRQ 137
+ H NI++ + + +T +F L Y K + +K RQ
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQ 115
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM-- 195
+L G+ +LHSH ++HRDLK NI V + G+VKI D GLA I + + SV+ +
Sbjct: 116 LLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWY 172
Query: 196 -APE-LYEEEYNELVDIYAFGMCLLEL 220
APE L + Y VD+++ G EL
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-22
Identities = 81/302 (26%), Positives = 148/302 (49%), Gaps = 28/302 (9%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL--RN 67
DP+ ++ F + DP + +E+ G G+F VY A D VA IK + ++
Sbjct: 1 DPEIAEL-FSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVA---IKKMSYSGKQS 55
Query: 68 SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT----LRQYRKKH 123
+E + + EV L+ L+H N I++ ++ EH ++ + G+ L ++K
Sbjct: 56 NEKWQDIIKEVRFLQQLRHPNTIEYKGCYL---REHTAWLVMEYCLGSASDILEVHKKPL 112
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+ V++ A+ L+GL+YLHSH+ IHRD+K NI + G VK+ D G A++++
Sbjct: 113 QEVEIAAI---CHGALQGLAYLHSHE--RIHRDIKAGNILLTEP-GTVKLADFGSASLVS 166
Query: 184 QARSAHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
A S +MAPE+ E +Y+ VD+++ G+ +EL + P + +Y
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 240 VTSGIKPASLAKVA-DNGVRAFIEKCIAEV-SERLPAKELLGDPFLQSEDDESVGRSLRV 297
+ +L+ + R F++ C+ ++ +R ++ELL F+ E +V L
Sbjct: 227 AQN--DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQ 284
Query: 298 KT 299
+T
Sbjct: 285 RT 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 5e-22
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI-DLLRNSEDLERLYSEVHLLKTLK 85
RY+ + +G GA+ V A D+ G +VA IK I ++ + D +R+ E+ LL+ L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVA---IKKISNVFDDLIDAKRILREIKLLRHLR 57
Query: 86 HKNIIKFYNSWVDTENE---HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGL 142
H+NII + E + +TE+ + L + K + + ++ + QIL GL
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA---HSVIEFM---- 195
YLHS + VIHRDLK NI VN N ++KI D GL AR F+
Sbjct: 117 KYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGL------ARGVDPDEDEKGFLTEYV 167
Query: 196 ------APE--LYEEEYNELVDIYAFGMCLL-ELVT 222
APE L Y + +DI++ G C+ EL+T
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 6e-22
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 21/212 (9%)
Query: 26 RYGRYKEVLGRGAFKKVYRA----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
R+ ++ + LG G F KV + G +VA + ++ D ER E+ +L
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEIL 60
Query: 82 KTLKHKNIIKFYNSWVDTENEH-INFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQIL 139
+TL H+NI+K Y + + I E SG+LR Y ++H+ ++L+ L +S QI
Sbjct: 61 RTLDHENIVK-YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQIC 119
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------I 192
+G+ YL S IHRDL NI V ++ VKI D GLA +L + + + V I
Sbjct: 120 KGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTF 223
+ APE L +++ D+++FG+ L EL T+
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 8e-22
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 16/220 (7%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTLKHKNII 90
+ +G G+F K+Y A + + IK IDL + ++ E EV LL +KH NI+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCV---IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR--ALKKWSRQILEGLSYLHSH 148
F+ S+ EN + + E G L + + + V + W QI GL H H
Sbjct: 63 TFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK--HIH 118
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARSAHSVIEFMAPELYEEE- 203
D ++HRD+K NIF++ N K+GD G+A L A + +++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
YN DI++ G L EL T ++P+ E N Q+ K+ G
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL-YSEVHLLKTLKHKNIIKF 92
+G G + VY+A D+L G VA IK I L SE + + E+ LLK L H NIIK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVA---IKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPV 152
+ V + + E + + + + + + +K + Q+L+GL++ HSH +
Sbjct: 64 LD--VFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--I 119
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM----------APELY-- 200
+HRDLK +N+ +N G +K+ D GL ARS S + APEL
Sbjct: 120 LHRDLKPENLLINTE-GVLKLADFGL------ARSFGSPVRPYTHYVVTRWYRAPELLLG 172
Query: 201 EEEYNELVDIYAFGMCLLELVT 222
++ Y+ VDI++ G EL++
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 83/304 (27%), Positives = 149/304 (49%), Gaps = 32/304 (10%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL---- 65
DPD ++ F + DP + +E+ G G+F VY A D V +++ I +
Sbjct: 1 DPDVAEL-FFKDDPEKLFSDLREI-GHGSFGAVYFARD------VRNSEVVAIKKMSYSG 52
Query: 66 -RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT----LRQYR 120
+++E + + EV L+ L+H N I++ ++ EH ++ + G+ L ++
Sbjct: 53 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL---REHTAWLVMEYCLGSASDLLEVHK 109
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
K + V++ A+ + L+GL+YLHSH+ +IHRD+K NI ++ G VK+GD G A+
Sbjct: 110 KPLQEVEIAAV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSAS 163
Query: 181 ILAQARSAHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI 236
I+A A +MAPE+ E +Y+ VD+++ G+ +EL + P + +
Sbjct: 164 IMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 237 YKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKE-LLGDPFLQSEDDESVGRSL 295
Y + PA + R F++ C+ ++ + P E LL F+ E +V L
Sbjct: 224 Y-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 296 RVKT 299
+T
Sbjct: 283 IQRT 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 26/203 (12%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLY-SEVHLLKTLKHKNIIKF 92
+G G + +VY+A ++ G VA +K I + E E+ LL+ L+H NI++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 93 YNSWVDTENEHINFITEIFT------SGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
+ T I +F +G L +K + +Q+LEGL YLH
Sbjct: 64 KE--IVTSKG-KGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA---HSVIE--FMAPELY- 200
S+ ++HRD+K NI +N N G +K+ D GLA + SA + VI + PEL
Sbjct: 118 SNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 201 -EEEYNELVDIYAFGMCLLELVT 222
Y VD+++ G L EL
Sbjct: 175 GATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 67/212 (31%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 25 ARYGRYKEVLGRGAFKKV----YRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
R+ ++ + LG+G F V Y + G VA +++ + D ER E+ +
Sbjct: 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-STAEHLRDFER---EIEI 58
Query: 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQIL 139
LK+L+H NI+K+ ++ + E G+LR Y +KH+ +D R L ++ QI
Sbjct: 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE------ 193
+G+ YL S +HRDL NI V ++ VKIGD GL +L Q + + V E
Sbjct: 119 KGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 194 -FMAPE-LYEEEYNELVDIYAFGMCLLELVTF 223
+ APE L E +++ D+++FG+ L EL T+
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFTY 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 81/276 (29%), Positives = 133/276 (48%), Gaps = 34/276 (12%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
+Y+E+LG G VY+A+ L +A +KVI L E +++ SE+ +L
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILA---VKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
II FY ++ EN I+ TE G+L YRK +HV L + + +++GL+YL S
Sbjct: 61 IIGFYGAFF-VENR-ISICTEFMDGGSLDVYRKIPEHV----LGRIAVAVVKGLTYLWSL 114
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--ARSAHSVIEFMAPE-LYEEEYN 205
++HRD+K N+ VN +G+VK+ D G++ L A++ +MAPE + E+Y
Sbjct: 115 K--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYG 171
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA------ 259
D+++ G+ +EL +PY QI K S + L + D
Sbjct: 172 IHSDVWSLGISFMELALGRFPY------PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQF 225
Query: 260 ------FIEKCIAEV-SERLPAKELLGDPFLQSEDD 288
FI +C+ + ER + L+ PF+ +D
Sbjct: 226 SEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 69/224 (30%), Positives = 110/224 (49%), Gaps = 31/224 (13%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQ---IKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
LG G F +V+ EG+ WN + V L + D + +E ++K L+H +I
Sbjct: 14 LGAGQFGEVW------EGL---WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ Y V T E I +TE+ G+L +Y + + L L + Q+ G++YL +
Sbjct: 65 QLYA--VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ 122
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS-AHSVIEFMAPELYEEE 203
+ IHRDL N+ V G K+ D GLA ++ + AR A I++ APE
Sbjct: 123 N--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE--AAL 177
Query: 204 YNELV---DIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
YN D+++FG+ L E+VT+ PY TN A++ ++V G
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQG 220
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 71/209 (33%), Positives = 111/209 (53%), Gaps = 19/209 (9%)
Query: 26 RYGRYKEVLGRGAFKKV----YRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
RY + VLG G F KV Y ++ G VA +K +N+ ++ E+++L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
KTL H+NI+K+ + + + I E G+LR Y KHK ++L L +++QI EG
Sbjct: 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEG 119
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE-------F 194
++YLHS IHRDL N+ ++ N VKIGD GLA + + + V E +
Sbjct: 120 MAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 195 MAPE-LYEEEYNELVDIYAFGMCLLELVT 222
A E L E +++ D+++FG+ L EL+T
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 80/287 (27%), Positives = 136/287 (47%), Gaps = 39/287 (13%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP+ + EV+G G + KVY+A + G VA IK++D++ + E E + E ++L
Sbjct: 3 DPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVA---IKIMDIIEDEE--EEIKEEYNIL 56
Query: 82 KTL-KHKNIIKFYNSW---VDTENEH-INFITEIFTSGTLRQYRKKHKHVDLRALKKW-- 134
+ H NI FY ++ N+ + + E+ G++ K + R ++W
Sbjct: 57 RKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 135 --SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA-HSV 191
R+ L GL+YLH + VIHRD+K NI + N EVK+ D G++A L ++
Sbjct: 117 YILRETLRGLAYLHENK--VIHRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 192 I---EFMAPEL------YEEEYNELVDIYAFGMCLLELVTFEYPYVEC--TNAA-QIYKK 239
I +MAPE+ + Y+ D+++ G+ +EL + P + A +I +
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233
Query: 240 VTSGIKPASL--AKVADNGVRAFIEKCIAEVSERLP-AKELLGDPFL 283
+K K D FI +C+ + E+ P +ELL PF+
Sbjct: 234 PPPTLKSPENWSKKFND-----FISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-20
Identities = 81/294 (27%), Positives = 148/294 (50%), Gaps = 22/294 (7%)
Query: 7 SEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR 66
S +DP+ ++ F E DP + +E+ G G+F VY A D VA ++ +
Sbjct: 8 SLKDPEIAELFFKE-DPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGK-Q 64
Query: 67 NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT----LRQYRKK 122
++E + + EV L+ +KH N I++ ++ EH ++ + G+ L ++K
Sbjct: 65 SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL---REHTAWLVMEYCLGSASDLLEVHKKP 121
Query: 123 HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182
+ V++ A+ + L+GL+YLHSH+ +IHRD+K NI + G+VK+ D G A+I
Sbjct: 122 LQEVEIAAI---THGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIA 175
Query: 183 AQARSAHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK 238
+ A S +MAPE+ E +Y+ VD+++ G+ +EL + P + +Y
Sbjct: 176 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY- 234
Query: 239 KVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLP-AKELLGDPFLQSEDDESV 291
+ P + + R F++ C+ ++ + P ++ELL F+ E E+V
Sbjct: 235 HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 34 LGRGAFKKV----YRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89
LG G F KV Y + G +VA +K + DL++ E+ +L+ L H+NI
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENI 68
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSH 148
+K+ + I I E SG+L++Y ++K ++L+ K++ QI +G+ YL S
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMAPE-LY 200
+HRDL N+ V ++ +VKIGD GL + + ++V + + APE L
Sbjct: 129 Q--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 201 EEEYNELVDIYAFGMCLLELVTF 223
+ ++ D+++FG+ L EL+T+
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 23/221 (10%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
+VLG GAF VY+ EG I VA IKV+ + + + + E +++ ++
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVA---IKVLREETSPKANKEILDEAYVMASV 66
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLS 143
H ++++ + + + IT++ G L Y + HK ++ + L W QI +G+S
Sbjct: 67 DHPHVVRLLGICL---SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARSAHSVIEFMAP 197
YL ++HRDL N+ V Q VKI D GLA +L A I++MA
Sbjct: 124 YLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 198 E-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQI 236
E + Y D++++G+ + EL+TF PY E A +I
Sbjct: 181 ESILHRIYTHKSDVWSYGVTVWELMTFGAKPY-EGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 8e-20
Identities = 73/259 (28%), Positives = 131/259 (50%), Gaps = 20/259 (7%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G G+ V A ++ G +VA +K +DL R + E L++EV +++ H+N++ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVA---VKKMDL-RKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVI 153
NS++ + + + E G L H ++ + +L LSYLH+ VI
Sbjct: 86 NSYL--VGDELWVVMEFLEGGALTDI-VTHTRMNEEQIATVCLSVLRALSYLHNQG--VI 140
Query: 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----RSAHSVIEFMAPELYEE-EYNELV 208
HRD+K D+I + + G +K+ D G A +++ +S +MAPE+ Y V
Sbjct: 141 HRDIKSDSILLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 209 DIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKVADNGVRAFIE-KCI 265
DI++ G+ ++E++ E PY Q +++ + P KV+ + +R F++ +
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPRVKDSHKVS-SVLRGFLDLMLV 257
Query: 266 AEVSERLPAKELLGDPFLQ 284
E S+R A+ELL PFL+
Sbjct: 258 REPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 68/275 (24%), Positives = 131/275 (47%), Gaps = 23/275 (8%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG GA V + + G+ A +K I N + +++ E+ + K+ K I+K+Y
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFA---LKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 94 NSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+++D + I E G+L ++ +K+ + + L K + +L+GLSYLHS
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAHSVIEFMAPE-LYEEEYNE 206
+IHRD+K NI + +G+VK+ D G++ + + A + +MAPE + + Y+
Sbjct: 126 --IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSI 182
Query: 207 LVDIYAFGMCLLELVT--FEYPYVECTNAAQI-YKKVTSGIKPASLAKVADNGV------ 257
D+++ G+ LLE+ F +P I + L NG+
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242
Query: 258 RAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
+ FI++C + + R ++L P+++++ + V
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 1e-19
Identities = 77/260 (29%), Positives = 126/260 (48%), Gaps = 20/260 (7%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G G + VY+A + G E+A IKVI L ED + E+ ++K KH NI+ ++
Sbjct: 17 IGSGTYGDVYKARNVNTG-ELA--AIKVIKL-EPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVI 153
S++ + I E G+L+ + + SR+ L+GL YLHS +
Sbjct: 73 GSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK--M 128
Query: 154 HRDLKCDNIFVNGNQGEVKIGDLG----LAAILAQARSAHSVIEFMAPELYEEE----YN 205
HRD+K NI + N G VK+ D G + A +A+ +S +MAPE+ E YN
Sbjct: 129 HRDIKGANILLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA-KVA-DNGVRAFIEK 263
+L DI+A G+ +EL + P + ++ S +P L K+ N F++
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKM 247
Query: 264 CIAEVSERLP-AKELLGDPF 282
+ + ++ P A++LL PF
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 78/287 (27%), Positives = 140/287 (48%), Gaps = 22/287 (7%)
Query: 9 QDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS 68
+DP+ +D F + DP + E+ G G+F VY A + VA ++ N
Sbjct: 6 KDPEIADL-FYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN- 62
Query: 69 EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT----LRQYRKKHK 124
E + + EV L+ LKH N I++ ++ EH ++ + G+ L ++K +
Sbjct: 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYL---KEHTAWLVMEYCLGSASDLLEVHKKPLQ 119
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
V++ A+ + L+GL+YLHSH+ +IHRD+K NI + G+VK+ D G A+ +
Sbjct: 120 EVEIAAI---THGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSSP 173
Query: 185 ARSAHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
A S +MAPE+ E +Y+ VD+++ G+ +EL + P + +Y +
Sbjct: 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HI 232
Query: 241 TSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAK-ELLGDPFLQSE 286
P + + R F++ C+ ++ + PA ELL F++ +
Sbjct: 233 AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 67/224 (29%), Positives = 104/224 (46%), Gaps = 26/224 (11%)
Query: 32 EVLGRGAFKKVYRA-FDELEG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
+ LG G+F V R + G I VA +K L +D + E ++ +L H+N
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLK---EAAIMHSLDHEN 57
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLH 146
+I+ Y + + +TE+ G+L +K H + L ++ QI G+ YL
Sbjct: 58 LIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF--------MAPE 198
S IHRDL NI + + +VKIGD GL L Q H V+E APE
Sbjct: 115 SKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNED-HYVMEEHLKVPFAWCAPE 170
Query: 199 -LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKV 240
L ++ D++ FG+ L E+ T+ E P+ + +QI KK+
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 3e-19
Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 13/198 (6%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
RY ++ +G GAF V A D+L G VA K++ +R Y E+ LLK L+H
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
+NII + ++ + E I F+TE+ GT + ++ + ++ + QIL GL Y+H
Sbjct: 69 ENIISLSDIFI-SPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH 125
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH-SVIEFMAPE--LYEEE 203
S V+HRDLK NI +N N ++KI D GLA I + + S + APE L ++
Sbjct: 126 SAG--VVHRDLKPSNILINEN-CDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQK 182
Query: 204 YNELVDIYAFGMCLLELV 221
Y+ VDI++ G E++
Sbjct: 183 YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 29/272 (10%)
Query: 29 RY--KEVLGRGAFKKVYRAFD----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLK 82
RY ++ LG+G+F VY D E ++V +I V +L N + + E LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVL-KEIPVGEL--NPNETVQANQEAQLLS 57
Query: 83 TLKHKNIIKFYNSWVDTENEHINFITEIFTSG-----TLRQYRKKHKHVDLRALKKWSRQ 137
L H I+KF+ S++ E + ITE + G L + + K + + +W Q
Sbjct: 58 KLDHPAIVKFHASFL--ERDAFCIITE-YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARSAHSVIE 193
+L G+ Y+H ++HRDLK NIF+ N +KIGD G++ +L A +
Sbjct: 115 LLLGVHYMHQRR--ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFTGTPY 170
Query: 194 FMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252
+M+PE L + Y+ DI++ G L E+ + + E N + ++ G P SL +
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-SLPET 228
Query: 253 ADNGVRAFIEKCI-AEVSERLPAKELLGDPFL 283
+ + ++ + + S R A E+L +PF+
Sbjct: 229 YSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 9e-19
Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 18/268 (6%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP + + E +G+G+F +V++ D VA IK+IDL +++E + E+ +L
Sbjct: 1 DPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ K+Y S++ ++ + I E G+ + +D + R+IL+G
Sbjct: 57 SQCDSPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGP-LDETQIATILREILKG 113
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----FMAP 197
L YLHS IHRD+K N+ ++ GEVK+ D G+A L + + +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 198 ELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
E+ ++ Y+ DI++ G+ +EL E P+ E ++ + P +L
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--LIPKNNPPTLEGNYSKP 228
Query: 257 VRAFIEKCI-AEVSERLPAKELLGDPFL 283
++ F+E C+ E S R AKELL F+
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE---RLYSEVHLLKT 83
RY+ + +G GA+ +V AFD G +VA IK L R + R Y E+ LLK
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVA---IK--KLSRPFQSAIHAKRTYRELRLLKH 70
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFT---------SGTLRQYRKKHKHVDLRALKKW 134
+ H+N+I + V T + +++ + ++ + H+
Sbjct: 71 MDHENVIGLLD--VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVY--- 125
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE- 193
QIL GL Y+HS +IHRDLK NI VN + E+KI D GLA + +
Sbjct: 126 --QILRGLKYIHSAG--IIHRDLKPSNIAVNED-CELKILDFGLARHTDDEMTGYVATRW 180
Query: 194 FMAPE--LYEEEYNELVDIYAFGMCLLELVT 222
+ APE L YN+ VDI++ G + EL+T
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 67/265 (25%), Positives = 122/265 (46%), Gaps = 27/265 (10%)
Query: 33 VLGRGAFKKV----YRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
V+G+GAF KV R ++ ++ N+ K + + S + + +E +L+ L H
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYM-NKQKCV--EKGS--VRNVLNERRILQELNHPF 61
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
++ + S+ D EN + + ++ G LR + + +K W +I+ L YLHS
Sbjct: 62 LVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPELY-EEEY 204
+IHRD+K DNI ++ QG V I D +A + S +MAPE+ + Y
Sbjct: 120 G--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY 176
Query: 205 NELVDIYAFGMCLLELVTFEYPY---VECTNAAQIYKKVTSGIK-PASLAKVADNGVRAF 260
+ VD ++ G+ E + + PY K+ T+ + PA+ + A + +
Sbjct: 177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236
Query: 261 IEKCIAEVSERL--PAKELLGDPFL 283
+E+ + +RL K+L P+
Sbjct: 237 LER---DPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 75/272 (27%), Positives = 137/272 (50%), Gaps = 25/272 (9%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG GAF KVY+A ++ G+ A KVID ++ E+LE E+ +L + H NI+K
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA---AKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPV 152
+++ N I + E G + + + + ++ +Q LE L+YLH + +
Sbjct: 69 DAFYYENNLWI--LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH--ENKI 124
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAA----ILAQARSAHSVIEFMAPELY------EE 202
IHRDLK NI + G++K+ D G++A + + S +MAPE+ +
Sbjct: 125 IHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA--DNGVRAF 260
Y+ D+++ G+ L+E+ E P+ E N ++ K+ +P +LA+ + + + F
Sbjct: 184 PYDYKADVWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241
Query: 261 IEKCIAE-VSERLPAKELLGDPFLQSEDDESV 291
++KC+ + V R +LL PF+ ++ +
Sbjct: 242 LKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 5e-18
Identities = 67/274 (24%), Positives = 127/274 (46%), Gaps = 30/274 (10%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+ +GA+ +V+ A + G A IKVI + ++++ +E +L + ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYA---IKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
Y S+ +N + + E G L + +D + + +I+ L YLHS+
Sbjct: 58 LYYSFQGKKN--LYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG-- 113
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI------------EFMAPE- 198
+IHRDLK DNI ++ N G +K+ D GL+ + R + +++APE
Sbjct: 114 IIHRDLKPDNILIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IKPASLAKVADNGV 257
+ + +++ VD ++ G L E + P+ T +I++ + +G I+ +V+D
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILNGKIEWPEDVEVSDE-A 230
Query: 258 RAFIEKCI-AEVSERLPAK---ELLGDPFLQSED 287
I K + + +RL AK E+ PF + D
Sbjct: 231 IDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWN---QIKVIDLLRNSEDLERLYSEVHLLKTLK 85
+ + LG G F +V+ WN ++ V L + E E ++K L+
Sbjct: 9 KLERKLGAGQFGEVWMGT---------WNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR 59
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR--ALKKWSRQILEGLS 143
H +++ Y V +E E I +TE + G+L + K + LR L + QI EG++
Sbjct: 60 HDKLVQLYA--VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR-SAHSVIEFMAPE 198
YL S + IHRDL NI V G KI D GLA ++ AR A I++ APE
Sbjct: 118 YLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPE 174
Query: 199 --LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNA 233
Y + D+++FG+ L E+VT+ PY TN
Sbjct: 175 AANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 62/220 (28%), Positives = 110/220 (50%), Gaps = 23/220 (10%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
LG G F +V+ + VA IK++ D L +D + EV LK L+HK++I
Sbjct: 14 LGSGYFGEVWEGL-WKNRVRVA---IKILKSDDLLKQQDFQ---KEVQALKRLRHKHLIS 66
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRK--KHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ V + E + ITE+ G+L + + + + + + +L + Q+ EG++YL +
Sbjct: 67 LFA--VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-RSAHSV---IEFMAPE-LYEEEY 204
IHRDL NI V G K+ D GLA ++ + + ++ APE +
Sbjct: 125 --SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 205 NELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+ D+++FG+ L E+ T+ + PY N ++Y ++T+G
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAG 220
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 76/268 (28%), Positives = 133/268 (49%), Gaps = 17/268 (6%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP + Y ++ G G+ V A ++ G +VA +K++DL R + E L++EV ++
Sbjct: 18 DPRSLLENYIKI-GEGSTGIVCIAREKHSGRQVA---VKMMDL-RKQQRRELLFNEVVIM 72
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ +H+N+++ Y S++ E + + E G L + + ++ + +L+
Sbjct: 73 RDYQHQNVVEMYKSYL--VGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQA 129
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA----QARSAHSVIEFMAP 197
L YLHS VIHRD+K D+I + + G VK+ D G A ++ + +S +MAP
Sbjct: 130 LCYLHSQG--VIHRDIKSDSILLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 198 ELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
E+ Y VDI++ G+ ++E+V E PY + + + S A
Sbjct: 187 EVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV 246
Query: 257 VRAFIEKCIA-EVSERLPAKELLGDPFL 283
+R F+E+ + E ER A+ELL PFL
Sbjct: 247 LRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 76/267 (28%), Positives = 128/267 (47%), Gaps = 27/267 (10%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG GAF KVY+A ++ G A KVI+ ++ E+LE E+ +L T H I+K
Sbjct: 20 LGDGAFGKVYKAKNKETGALAA---AKVIET-KSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 94 NS--WVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ W I F + + + ++ + RQ+LE L YLHS
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVI---CRQMLEALQYLHSMK-- 130
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAA----ILAQARSAHSVIEFMAPE------LYE 201
+IHRDLK N+ + G++K+ D G++A L + S +MAPE + +
Sbjct: 131 IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV--RA 259
Y+ DI++ G+ L+E+ E P+ E N ++ K+ +P +L++ + + R
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKS-EPPTLSQPSKWSMEFRD 247
Query: 260 FIEKCIAEVSERLP-AKELLGDPFLQS 285
F++ + + E P A +LL PF+ S
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE--VHLLKTLKHK 87
+ V+G+G++ +V +G + IK ++L RN+ ER +E LL LKH
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYV---IKKLNL-RNASRRERKAAEQEAQLLSQLKHP 59
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL--RALKKWSRQILEGLSYL 145
NI+ + SW + E+ + + G L K+ K L + +W QI L YL
Sbjct: 60 NIVAYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYL 118
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-AQARSAHSVI---EFMAPELYE 201
H+ ++HRDLK N+F+ +K+GDLG+A +L Q A ++I +M+PEL+
Sbjct: 119 --HEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 202 EE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260
+ YN D++A G C+ E+ T ++ + + +Y+ + + P + K +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP--MPKDYSPELGEL 233
Query: 261 IEKCIAEVSERLPA-KELLGDPFL 283
I +++ E+ P+ K +L P++
Sbjct: 234 IATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 35 GRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRNSEDLERL----YSEVHLLKTLKHKN 88
GRG + +VY+A + +G E A + K + E + E+ LL+ LKH+N
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHEN 63
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQ-----YRKKHKHVDLRALKKWSRQILEGLS 143
++ +++ ++ + + + + L Q + K + +K QIL G+
Sbjct: 64 VVSLVEVFLEHADKSVYLLFD-YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAAI----LAQARSAHSV---IE 193
YLHS+ V+HRDLK NI V G +G VKIGDLGLA + L V I
Sbjct: 123 YLHSN--WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 194 FMAPELY--EEEYNELVDIYAFGMCLLELVTFE 224
+ APEL Y + +DI+A G EL+T E
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 66/233 (28%), Positives = 121/233 (51%), Gaps = 17/233 (7%)
Query: 59 IKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ 118
+K +DL R + E L++EV +++ +H+N+++ YNS++ + + + E G L
Sbjct: 50 VKKMDL-RKQQRRELLFNEVVIMRDYQHENVVEMYNSYL--VGDELWVVMEFLEGGALTD 106
Query: 119 YRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
H ++ + +L+ LS LH+ VIHRD+K D+I + + G VK+ D G
Sbjct: 107 I-VTHTRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGF 162
Query: 179 AAILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA 233
A +++ +S +MAPEL Y VDI++ G+ ++E+V E PY
Sbjct: 163 CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPP 221
Query: 234 AQIYKKVTSGIKP--ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283
+ K + + P +L KV+ + ++ F+++ + + ++R A ELL PFL
Sbjct: 222 LKAMKMIRDNLPPKLKNLHKVSPS-LKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 24/203 (11%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKHK 87
E +G G + VY+A D+L G VA +I++ +ED E + S E+ LLK L H
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRL-----ETED-EGVPSTAIREISLLKELNHP 58
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV--DLRALKKWSRQILEGLSYL 145
NI++ + V + + E F L++Y D +K + Q+L+G++Y
Sbjct: 59 NIVRLLD--VVHSENKLYLVFE-FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAPE--L 199
HSH V+HRDLK N+ ++ +G +K+ D GLA A R+ H V+ + APE L
Sbjct: 116 HSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172
Query: 200 YEEEYNELVDIYAFGMCLLELVT 222
+Y+ VDI++ G E+V
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 64/253 (25%), Positives = 107/253 (42%), Gaps = 45/253 (17%)
Query: 31 KEVLGRGAFKKVYRA-FDELEG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87
+G G F VY+ + E I VA +K + E+ E ++++ H
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVA---VKTCKNCTSPSVREKFLQEAYIMRQFDHP 67
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQILEGLSYLH 146
+I+K + + + E+ G LR Y + +K+ +DL +L +S Q+ L+YL
Sbjct: 68 HIVKLIGVITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEFMAPE-LY 200
S +HRD+ N+ V+ VK+GD GL+ L + I++MAPE +
Sbjct: 125 SKR--FVHRDIAARNVLVSSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESIN 181
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260
+ D++ FG+C+ E++ G+KP V +N V
Sbjct: 182 FRRFTSASDVWMFGVCMWEILML-------------------GVKP--FQGVKNNDVIGR 220
Query: 261 IEKCIAEVSERLP 273
IE ERLP
Sbjct: 221 IEN-----GERLP 228
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 15/221 (6%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
V+G G+F + + A +I+ L ++S +E E LL +KH NI+ F
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIR---LPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRK--KHKHVDLRALKKWSRQILEGLSYLHSHDP 150
S+ + H+ + E G L Q K + K + +W Q+ G+ H H+
Sbjct: 64 KESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ--HIHEK 119
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARSAHSVIEFMAPELYEE-EYN 205
V+HRD+K NIF+ N G+VK+GD G A +L A + ++ PE++E YN
Sbjct: 120 RVLHRDIKSKNIFLTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246
DI++ G L EL T ++P+ + I K KP
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 18/200 (9%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLKHKNII 90
E +G G + VY+A ++L G VA +K I L +E + E+ LLK L H NI+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVA---LKKIRLDTETEGVPSTAIREISLLKELNHPNIV 62
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRK--KHKHVDLRALKKWSRQILEGLSYLHSH 148
K + + TEN+ ++ F L+++ + L +K + Q+L+GL++ HSH
Sbjct: 63 KLLDV-IHTENKL--YLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAPE--LYEE 202
V+HRDLK N+ +N +G +K+ D GLA A R+ H V+ + APE L +
Sbjct: 120 R--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 203 EYNELVDIYAFGMCLLELVT 222
Y+ VDI++ G E+VT
Sbjct: 177 YYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 18/268 (6%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP + + E +G+G+F +VY+ D VA IK+IDL +++E + E+ +L
Sbjct: 1 DPEELFTKL-ERIGKGSFGEVYKGIDNRTKEVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
I ++Y S++ I I E G+ K ++ + R+IL+G
Sbjct: 57 SQCDSPYITRYYGSYLKGTKLWI--IMEYLGGGSALDLLKPGP-LEETYIATILREILKG 113
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----FMAP 197
L YLHS IHRD+K N+ ++ QG+VK+ D G+A L + + +MAP
Sbjct: 114 LDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 198 ELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
E+ ++ Y+ DI++ G+ +EL E P + ++ + P +L
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--LIPKNSPPTLEGQYSKP 228
Query: 257 VRAFIEKCIAEVSERLP-AKELLGDPFL 283
+ F+E C+ + P AKELL F+
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 17/224 (7%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G G + VY+A + G E+A +K+I L +D + E+ ++K KH NI+ ++
Sbjct: 17 VGSGTYGDVYKARNLHTG-ELA--AVKIIKL-EPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVI 153
S++ E I E G+L+ + + R+ L+GL+YLHS +
Sbjct: 73 GSYLSREKLWI--CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--M 128
Query: 154 HRDLKCDNIFVNGNQGEVKIGDLGLA----AILAQARSAHSVIEFMAPELYEEE----YN 205
HRD+K NI + N G+VK+ D G+A A +A+ +S +MAPE+ E YN
Sbjct: 129 HRDIKGANILLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL 249
+L DI+A G+ +EL + P + ++ S +P L
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKL 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 29 RYKE--VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED--LERLYSEVHLLKTL 84
RYK +G GA V++A D G VA +K + LR E + E+ L+
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVA---LKKV-ALRRLEGGIPNQALREIKALQAC 56
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
+H ++K + V + E S R + + + +K + R +L+G++Y
Sbjct: 57 QHPYVVKLLD--VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAY 114
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS---AHSVIE--FMAPEL 199
+H++ ++HRDLK N+ + G +KI D GLA + ++ +H V + APEL
Sbjct: 115 MHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 200 Y--EEEYNELVDIYAFGMCLLEL 220
+Y+ VD++A G EL
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 18/216 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E LG G + VY+ + G VA +K I L E+ L+K LKH+NI++
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVA---LKEIHLDAEEGTPSTAIREISLMKELKHENIVR 62
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH---VDLRALKKWSRQILEGLSYLHSH 148
++ + TEN+ + + E + L++Y H +D +K ++ Q+L+G+++ H +
Sbjct: 63 LHDV-IHTENK-LMLVFE-YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSV-IEFMAPE--LYEE 202
V+HRDLK N+ +N +GE+K+ D GLA I S V + + AP+ L
Sbjct: 120 R--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK 238
Y+ +DI++ G + E++T + N Q+ K
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK 212
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 65/229 (28%), Positives = 111/229 (48%), Gaps = 18/229 (7%)
Query: 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTL 84
+Y + K++ G G+F K + +G + IK I++ + S ++ E EV +L +
Sbjct: 1 KYVKVKKI-GEGSFGKAILVKSKEDGKQYV---IKEINISKMSPKEREESRKEVAVLSNM 56
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL--RALKKWSRQILEGL 142
KH NI+++ S+ EN ++ + + G L + + V + W QI L
Sbjct: 57 KHPNIVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARSAHSVIEFMAPE 198
H HD ++HRD+K NIF+ G +K+GD G+A +L AR+ +++PE
Sbjct: 115 K--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171
Query: 199 LYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246
+ E YN DI+A G L E+ T ++ + E N + K+ G P
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSYP 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 76/265 (28%), Positives = 121/265 (45%), Gaps = 30/265 (11%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER--LYSEVHLLKTLKHKNIIK 91
+G GA VY+ G A +KVI N ED R + E+ +L+ + H N++K
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYA---LKVI--YGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
++ + N I + E G+L + L +RQIL G++YLH
Sbjct: 137 CHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQ----FLADVARQILSGIAYLHRRH-- 188
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----RSAHSVIEFMAPELYEEEYNEL 207
++HRD+K N+ +N + VKI D G++ ILAQ S+ I +M+PE + N
Sbjct: 189 IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHG 247
Query: 208 V------DIYAFGMCLLE--LVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259
DI++ G+ +LE L F + + A + + P + A A R
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT-ASREFRH 306
Query: 260 FIEKCI-AEVSERLPAKELLGDPFL 283
FI C+ E ++R A +LL PF+
Sbjct: 307 FISCCLQREPAKRWSAMQLLQHPFI 331
|
Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 57/206 (27%), Positives = 106/206 (51%), Gaps = 20/206 (9%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERL-YSEVHLLKTL 84
+Y+ V+G GA+ V + ++ G VA + K + + ED+++ EV +L+ L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE---DDEDVKKTALREVKVLRQL 57
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
+H+NI+ ++ ++ F E L + A++ + Q+L+ ++Y
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVF--EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM------APE 198
HSH+ +IHRD+K +NI V+ + G +K+ D G A L +AR A + +++ APE
Sbjct: 116 CHSHN--IIHRDIKPENILVSES-GVLKLCDFGFARAL-RARPASPLTDYVATRWYRAPE 171
Query: 199 LY--EEEYNELVDIYAFGMCLLELVT 222
L + Y + VD++A G + EL+
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLD 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 68/258 (26%), Positives = 118/258 (45%), Gaps = 27/258 (10%)
Query: 33 VLGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KH 86
LG GAF KV A ++VA +K++ +S + E L SE+ ++ L H
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVA---VKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWSRQILEGLSY 144
+NI+ + T I ITE G L + RK+ + L L +S Q+ +G+++
Sbjct: 99 ENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEV-KIGDLGLAA-ILAQAR-----SAHSVIEFMAP 197
L S + IHRDL N+ + G++ KI D GLA I+ + +A +++MAP
Sbjct: 157 LASKN--CIHRDLAARNVLLT--HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 198 E-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
E ++ Y D++++G+ L E+ + PY ++ YK + G + A
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAE 272
Query: 256 GVRAFIEKCIAEVSERLP 273
+ ++ C + P
Sbjct: 273 -IYDIMKTCWDADPLKRP 289
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 18/268 (6%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP + + E +G+G+F +V++ D VA IK+IDL +++E + E+ +L
Sbjct: 1 DPEELFTKL-ERIGKGSFGEVFKGIDNRTQQVVA---IKIIDLEEAEDEIEDIQQEITVL 56
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ K+Y S++ + + I E G+ + D + ++IL+G
Sbjct: 57 SQCDSPYVTKYYGSYL--KGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKG 113
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----FMAP 197
L YLHS IHRD+K N+ ++ QG+VK+ D G+A L + + +MAP
Sbjct: 114 LDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 198 ELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
E+ ++ Y+ DI++ G+ +EL E P + ++ + P +L
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF--LIPKNNPPTLTGEFSKP 228
Query: 257 VRAFIEKCI-AEVSERLPAKELLGDPFL 283
+ FI+ C+ + S R AKELL F+
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 50/249 (20%)
Query: 30 YKEVLGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
K LG GAF KV+ E + VA +K +D ER E LL
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNF 65
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--------------RKKHKHVDLRA 130
+H+NI+KFY V TE + + E G L ++ + L
Sbjct: 66 QHENIVKFYG--VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS 190
L + + QI G+ YL S +HRDL N V G VKIGD G+ +R ++
Sbjct: 124 LLQIAVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGM------SRDVYT 174
Query: 191 V------------IEFMAPE--LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQ 235
I +M PE +Y + E D+++FG+ L E+ T+ + P+ +N
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 236 IYKKVTSGI 244
I + +T G
Sbjct: 234 I-ECITQGR 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 66/230 (28%), Positives = 112/230 (48%), Gaps = 18/230 (7%)
Query: 59 IKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ 118
IK+I SED E ++ L H+ +++ Y V T+ I +TE ++G L
Sbjct: 33 IKMIKEGSMSED--EFIEEAKVMMKLSHEKLVQLYG--VCTKQRPIYIVTEYMSNGCLLN 88
Query: 119 YRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177
Y ++H K L + + + EG++YL S IHRDL N V+ +QG VK+ D G
Sbjct: 89 YLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFG 145
Query: 178 LAAILAQARSAHSV-----IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVEC 230
L+ + SV + + PE L +++ D++AFG+ + E+ + + PY E
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY-ER 204
Query: 231 TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPA-KELLG 279
N ++ +KV+ G++ +A V A + C E +E P ++LL
Sbjct: 205 FNNSETVEKVSQGLR-LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 21/258 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIE-VAWNQIKV------IDLLRNSEDLERLYSEVHLLK-T 83
E LG GAF VY+ + G +A +I V D + + + SEV ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY----RKKHKHVDLRALKKWSRQIL 139
L+H NI+++Y +++ EN+ + + ++ L ++ ++K + + Q++
Sbjct: 66 LRHPNIVRYYKTFL--ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSVIEFMA 196
L YLH + ++HRDL +NI + G +V I D GLA ++ S I +
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIML-GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 197 PELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
PE+ + E Y E D++AFG L ++ T + P+ TN + K+ + +
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGMYSE 240
Query: 256 GVRAFIEKCIAEVSERLP 273
V I C+ +E P
Sbjct: 241 DVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 64/244 (26%), Positives = 101/244 (41%), Gaps = 47/244 (19%)
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS- 147
I+ FY ++ + I+ E G+L Q KK + L K S +L GL+YL
Sbjct: 61 IVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK 118
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--AQARSAHSVIEFMAPE-LYEEEY 204
H ++HRD+K NI VN GE+K+ D G++ L + A S +M+PE L Y
Sbjct: 119 HK--IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 175
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK----KVTSGIKPASLAKVADNGVRA- 259
DI++ G+ L+E+ YP + +A ++ V+ G S V+ + +
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYP-IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234
Query: 260 -------------------------------FIEKC-IAEVSERLPAKELLGDPFLQSED 287
F++KC ER KEL PF++ +
Sbjct: 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294
Query: 288 DESV 291
E V
Sbjct: 295 LEEV 298
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 23/165 (13%)
Query: 28 GRYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKT 83
Y+ + LG G F +VY+A G VA +I L+ N +D + + E+ +LK
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI----LMHNEKDGFPITALREIKILKK 63
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFT---------SGTLRQYRKKHKHVDLRALKKW 134
LKH N++ + V+ ++ ++ SG L K +K +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ---IKCY 120
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
Q+LEG++YLH + ++HRD+K NI ++ NQG +KI D GLA
Sbjct: 121 MLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLA 162
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 7e-16
Identities = 72/258 (27%), Positives = 119/258 (46%), Gaps = 30/258 (11%)
Query: 34 LGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
LG G F V+ + G I+VA IK+I SED E ++ L H N+++
Sbjct: 12 LGSGQFGVVHLG--KWRGKIDVA---IKMIREGAMSED--DFIEEAKVMMKLSHPNLVQL 64
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA-LKKWSRQILEGLSYLHSHDPP 151
Y V T+ I +TE +G L Y ++ K L + E + YL S+
Sbjct: 65 YG--VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG-- 120
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEFMAPELYE-EEYN 205
IHRDL N V G VK+ D GLA + + S +++ PE+++ ++
Sbjct: 121 FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179
Query: 206 ELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGI---KPASLAKVADNGVRAFI 261
D+++FG+ + E+ + + PY +N +++ + V++G +P K+A V +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLYRP----KLAPTEVYTIM 234
Query: 262 EKCIAEVSERLPA-KELL 278
C E E PA K+LL
Sbjct: 235 YSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 70/272 (25%), Positives = 129/272 (47%), Gaps = 31/272 (11%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNII 90
E++G G + +VY+ G A IKV+D+ + E E + E+++LK H +NI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTGDEE--EEIKQEINMLKKYSHHRNIA 66
Query: 91 KFYNSWVDTE----NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW----SRQILEGL 142
+Y +++ ++ + + E +G++ K K L+ ++W R+IL GL
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIAYICREILRGL 124
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE 198
S+LH H VIHRD+K N+ + N EVK+ D G++A L + + +MAPE
Sbjct: 125 SHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 181
Query: 199 LY------EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252
+ + Y+ D+++ G+ +E+ P + ++ + P +K
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLKSKK 240
Query: 253 ADNGVRAFIEKCIAEVSERLPAKE-LLGDPFL 283
++FIE C+ + + P E L+ PF+
Sbjct: 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 73/247 (29%), Positives = 116/247 (46%), Gaps = 22/247 (8%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL---ERLYSEVHLLKT 83
RY+ + +G GA+ V AFD G+ VA V L R + + +R Y E+ LLK
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVA-----VKKLSRPFQSIIHAKRTYRELRLLKH 72
Query: 84 LKHKNIIKFYNSWVDTEN-EHIN--FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILE 140
+KH+N+I + + + E N ++ L K K D ++ QIL
Sbjct: 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQILR 131
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE-FMAPEL 199
GL Y+HS D +IHRDLK N+ VN E+KI D GLA + + + APE+
Sbjct: 132 GLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 188
Query: 200 YEE--EYNELVDIYAFGMCLLELVTFE--YPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
YN+ VDI++ G + EL+T +P + + ++ ++ L K++
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248
Query: 256 GVRAFIE 262
R +I+
Sbjct: 249 SARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 63/232 (27%), Positives = 101/232 (43%), Gaps = 50/232 (21%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLL---RNSEDLERLYSEVHLLKTL-KH 86
+ LG GAF +V +A E G++ V + +L +DL L SE+ ++K + KH
Sbjct: 18 KPLGEGAFGQVVKA--EAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----------------KHVDLRA 130
KNII V T+ + + E G LR + + + + +
Sbjct: 76 KNIINLLG--VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS 190
L ++ Q+ G+ +L S IHRDL N+ V +KI D GLA R H
Sbjct: 134 LVSFAYQVARGMEFLASKK--CIHRDLAARNVLV-TEDHVMKIADFGLA------RDIHH 184
Query: 191 V------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF---EYP 226
+ +++MAPE L++ Y D+++FG+ L E+ T YP
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL-LKTLKHKNII 90
E LGRGA+ V + G +A +K I NS++ +RL ++ + ++++ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMA---VKRIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 91 KFYNS-------WVDTENEHINFITEIFTSGTLRQYRKKHKH---VDLRALKKWSRQILE 140
FY + W+ E+ + + Y+K + + L K + I++
Sbjct: 64 TFYGALFREGDVWI---------CMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVK 114
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----AQARSAHSVIEFMA 196
L YLHS VIHRD+K N+ +N G+VK+ D G++ L A+ A +MA
Sbjct: 115 ALEYLHSK-LSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCK-PYMA 171
Query: 197 PELYEEE-----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251
PE E Y+ D+++ G+ ++EL T +PY Q K+V P A+
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAE 231
Query: 252 VADNGVRAFIEKCIAEVS-ERLPAKELLGDPFLQSEDDESV 291
+ F+ KC+ + ER ELL PF + ++
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNT 272
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 32/213 (15%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
RY+ +G GA+ V A + G++VA IK I + +R E+ +L+ KH
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVA---IKKISPFEHQTFCQRTLREIKILRRFKH 62
Query: 87 KNIIKFYN----SWVDTENEHINFITEIFTSGTLRQYRKKH---KHVDLRALKKWSRQIL 139
+NII + ++ N+ + + E+ + + + +H H+ + + QIL
Sbjct: 63 ENIIGILDIIRPPSFESFND-VYIVQELMETDLYKLIKTQHLSNDHI-----QYFLYQIL 116
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS--VIEFM-- 195
GL Y+HS + V+HRDLK N+ +N N ++KI D GLA I H+ + E++
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTN-CDLKICDFGLARIADPE-HDHTGFLTEYVAT 172
Query: 196 ----APE--LYEEEYNELVDIYAFGMCLLELVT 222
APE L + Y + +DI++ G L E+++
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 29 RYKEVLGRGAFKKV----YRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
R VLGRG F KV Y+ EL I+ +K D++ E +E L E + +T
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKA----LKKGDIIARDE-VESLMCEKRIFETA 56
Query: 85 ---KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKK---WSRQI 138
+H ++ + + TE +H+ F+ E G L H H D+ + + ++ +
Sbjct: 57 NSERHPFLVNLF-ACFQTE-DHVCFVMEYAAGGDLMM----HIHTDVFSEPRAVFYAACV 110
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EF 194
+ GL YLH + +++RDLK DN+ ++ +G VKI D GL S EF
Sbjct: 111 VLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEF 167
Query: 195 MAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+APE L E Y VD + G+ + E++ E P+
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 69/282 (24%), Positives = 133/282 (47%), Gaps = 28/282 (9%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP+ + E +G+G + KVY+ ++ +G A +K++D + + + E + +E ++L
Sbjct: 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAA---VKILDPISDVD--EEIEAEYNIL 72
Query: 82 KTL-KHKNIIKFYNSWVDTEN---EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ 137
++L H N++KFY + + + + E+ G++ + K R +
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 138 ILEG--LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR----SAHSV 191
IL G L H H+ +IHRD+K +NI + +G VK+ D G++A L R ++
Sbjct: 133 ILYGALLGLQHLHNNRIIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGT 191
Query: 192 IEFMAPEL------YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245
+MAPE+ Y+ Y+ D+++ G+ +EL + P + ++K +
Sbjct: 192 PFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--P 249
Query: 246 PASLAKVAD--NGVRAFIEKCIAEVSERLPA-KELLGDPFLQ 284
P +L FI +C+ + E P+ LL PF++
Sbjct: 250 PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 49/232 (21%)
Query: 29 RYKEV---LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--------- 76
RY + LG G + KV +A+D L G VA ++K+I++ + +L
Sbjct: 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 77 -EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
E+ ++ +KH+NI+ + +V E + IN + +I + L++ + + +K
Sbjct: 69 RELKIMNEIKHENIMGLVDVYV--EGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL 125
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE-- 193
QIL GL+ LH +HRDL NIF+N ++G KI D GLA R +
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLA-----RRYGYPPYSDT 177
Query: 194 ---------------------FMAPELY--EEEYNELVDIYAFGMCLLELVT 222
+ APEL E+Y+ VD+++ G EL+T
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI-KVIDLLRNSEDLERLYSEVHLLKTLK 85
RYK E +G GA+ V A D G +VA +I D+ ++ R E+ +L+ K
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK---RTLRELKILRHFK 62
Query: 86 HKNIIKFYNSWVDTENE--HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
H NII + + + + ++ S L + + ++ + Q+L GL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM-------- 195
Y+HS + VIHRDLK N+ VN + E++IGD G+A L+ + + H FM
Sbjct: 122 YIHSAN--VIHRDLKPSNLLVNED-CELRIGDFGMARGLSSSPTEHK--YFMTEYVATRW 176
Query: 196 --APELY--EEEYNELVDIYAFGMCLLELV 221
APEL EY +D+++ G E++
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 35/220 (15%)
Query: 28 GRYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY ++ LG G+ V+ A D VA +I +L + + ++ E+ +++ L
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI----VLTDPQSVKHALREIKIIRRLD 60
Query: 86 HKNIIKFYNSWVDT---ENEHINFITEIFTSGTLRQYRKKHKHVDLRAL----------- 131
H NI+K Y + E + +TE+ + +++Y + DL +
Sbjct: 61 HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME----TDLANVLEQGPLSEEHA 116
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
+ + Q+L GL Y+HS + V+HRDLK N+F+N +KIGD GLA I+ S
Sbjct: 117 RLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 192 IE-------FMAPE--LYEEEYNELVDIYAFGMCLLELVT 222
+ + +P L Y + +D++A G E++T
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 25/204 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKHK 87
E +G G + VY+ ++ G VA +I++ SE+ E + S E+ LLK L+H
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRL-----ESEE-EGVPSTAIREISLLKELQHP 59
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYR---KKHKHVDLRALKKWSRQILEGLSY 144
NI+ + V + + I E F S L++Y K +++D +K + QIL+G+ +
Sbjct: 60 NIVCLQD--VLMQESRLYLIFE-FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAPE-- 198
HS V+HRDLK N+ ++ N+G +K+ D GLA A R H V+ + APE
Sbjct: 117 CHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVL 173
Query: 199 LYEEEYNELVDIYAFGMCLLELVT 222
L Y+ VDI++ G E+ T
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 34 LGRGAFKKVYR--AFDELEGIEVAWNQIKVIDLLRNSEDLER--LYSEVHLLKTLKHKNI 89
LG GAF +VY A D L G ++ V L + + D E+ E HL+ H NI
Sbjct: 3 LGSGAFGEVYEGTATDIL-GPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-------VDLRALKKWSRQILEGL 142
+K + E ++I I E+ G L Y + + + L+ L + +G
Sbjct: 62 VKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLAAIL-----AQARSAHSV-I 192
YL IHRDL N V+ + VKIGD GLA + + + +
Sbjct: 120 VYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+MAPE L + ++ D+++FG+ + E++T + PY N ++ + VT+G
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 31/272 (11%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNII 90
EV+G G + +VY+ G A IKV+D+ + E E + E+++LK H +NI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTEDEE--EEIKLEINMLKKYSHHRNIA 76
Query: 91 KFYNSWVDT----ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW----SRQILEGL 142
+Y +++ ++ + + E +G++ K K L+ + W R+IL GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALK--EDWIAYICREILRGL 134
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE 198
++LH+H VIHRD+K N+ + N EVK+ D G++A L + + +MAPE
Sbjct: 135 AHLHAHK--VIHRDIKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE 191
Query: 199 LY------EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252
+ + Y+ DI++ G+ +E+ P + ++ + P +K
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPPPKLKSKK 250
Query: 253 ADNGVRAFIEKC-IAEVSERLPAKELLGDPFL 283
FIE C + R ++LL PF+
Sbjct: 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 7e-15
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG G F +V+ + ++ V L + ++ E +L+KTL+H +++ Y
Sbjct: 14 LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPP 151
V T+ E I ITE G+L + K + V L L +S QI EG++Y+ +
Sbjct: 68 A--VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 123
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS-AHSVIEFMAPELYE-EEYN 205
IHRDL+ N+ V+ KI D GLA ++ AR A I++ APE +
Sbjct: 124 YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182
Query: 206 ELVDIYAFGMCLLELVTF-EYPYVECTNA 233
D+++FG+ L E+VT+ + PY +N+
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNS 211
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 64/227 (28%), Positives = 106/227 (46%), Gaps = 26/227 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
K LG G + +VY + + VA V L ++ ++E E ++K +KH N++
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 65
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA--LKKWSRQILEGLSYLHSH 148
+ V T ITE T G L Y ++ ++ A L + QI + YL
Sbjct: 66 QLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK 123
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARSAHSVIEFMAPE-LYE 201
+ IHRDL N V G VK+ D GL+ ++ A A A I++ APE L
Sbjct: 124 N--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 179
Query: 202 EEYNELVDIYAFGMCLLELVTF---EYPYVECTNAAQIYKKVTSGIK 245
+++ D++AFG+ L E+ T+ YP ++ + Q+Y+ + G +
Sbjct: 180 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKGYR 223
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 28/204 (13%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKTLKHKNI 89
+ LG G++ VY+ +L G VA +K I L E+ + E LLK LKH NI
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVA---LKEIRL--EHEEGAPFTAIREASLLKDLKHANI 65
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQILEGLSYLHSH 148
+ ++ + T+ + + + E + L+QY + + ++ + Q+L GL+Y H
Sbjct: 66 VTLHDI-IHTK-KTLTLVFE-YLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS------AHSVIE--FMAPE-- 198
V+HRDLK N+ ++ +GE+K+ D G LA+A+S ++ V+ + P+
Sbjct: 123 R--VLHRDLKPQNLLIS-ERGELKLADFG----LARAKSVPSKTYSNEVVTLWYRPPDVL 175
Query: 199 LYEEEYNELVDIYAFGMCLLELVT 222
L EY+ +D++ G E+ T
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 51/206 (24%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+G+G F V + G +VA +K +S + +E ++ TL+H N++
Sbjct: 11 GATIGKGEFGDVMLG--DYRGQKVAVKCLK-----DDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQY---RKKHKHVDLRALKKWSRQILEGLSYLHS 147
+ V + + +TE G+L Y R + + L ++ + EG+ YL
Sbjct: 64 QLLG--VVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEE 120
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV----IEFMAPE-LYEE 202
+ +HRDL N+ V+ K+ D GLA +A +++ APE L E+
Sbjct: 121 KN--FVHRDLAARNVLVS-EDLVAKVSDFGLA---KEASQGQDSGKLPVKWTAPEALREK 174
Query: 203 EYNELVDIYAFGMCLLELVTF-EYPY 227
+++ D+++FG+ L E+ +F PY
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 19/241 (7%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
EI PS + ++V+G G F +V+R ++ G + IK + + + SE
Sbjct: 1 EIHPS--HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEAS 58
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQI 138
++ H NII+ V T+ + ITE +G L +Y + H L R I
Sbjct: 59 IMGQFSHHNIIRLEG--VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGI 116
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------- 191
G+ YL D +HRDL NI VN + E K+ D GL+ +L
Sbjct: 117 AAGMKYLS--DMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173
Query: 192 IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIK-PAS 248
I + APE + ++ D+++FG+ + E+++F E PY + +N ++ K + G + PA
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRLPAP 232
Query: 249 L 249
+
Sbjct: 233 M 233
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 31/217 (14%)
Query: 34 LGRGAFKKVYRAF-----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
LG+G+F VY VA IK ++ + + +E ++K +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVA---IKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH----------VDLRALKKWSRQI 138
+++ V + + + E+ G L+ Y + + L+ + + +I
Sbjct: 71 VVRLLG--VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ------ARSAHSVI 192
+G++YL + +HRDL N V + VKIGD G+ + + +
Sbjct: 129 ADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPY 227
+MAPE L + + D+++FG+ L E+ T E PY
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 23/200 (11%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKHK 87
E +G G + V++A + VA ++++ D D E + S E+ LLK LKHK
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD------DDEGVPSSALREICLLKELKHK 59
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLH 146
NI++ Y+ V ++ + + E + L++Y + +D +K + Q+L+GL++ H
Sbjct: 60 NIVRLYD--VLHSDKKLTLVFE-YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH 116
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSV-IEFMAPE--LY 200
SH+ V+HRDLK N+ +N N GE+K+ D GLA I + SA V + + P+
Sbjct: 117 SHN--VLHRDLKPQNLLINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 201 EEEYNELVDIYAFGMCLLEL 220
+ Y+ +D+++ G EL
Sbjct: 174 AKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 72/276 (26%), Positives = 140/276 (50%), Gaps = 27/276 (9%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTL-KHKNI 89
VLG+G+F KV A EL+G + + +KV+ D++ +D+E +E +L KH +
Sbjct: 2 VLGKGSFGKVLLA--ELKGTDELY-AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ + S T+ + + F+ E G L + ++ D + ++ +I+ GL +LH
Sbjct: 59 TQLH-SCFQTK-DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAH--SVIEFMAPE-LYEEEY 204
+I+RDLK DN+ ++ +G +KI D G+ IL ++ +++APE L + Y
Sbjct: 117 --IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY 173
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIE 262
VD +A G+ L E++ + P+ E + ++++ + P L+K A + +++F+
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLT 232
Query: 263 KCIAEVSERLPA-----KELLGDPFLQSEDDESVGR 293
K +RL +++ G PF + D + + R
Sbjct: 233 K---NPEKRLGCLPTGEQDIKGHPFFREIDWDKLER 265
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 63/240 (26%), Positives = 112/240 (46%), Gaps = 36/240 (15%)
Query: 32 EVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87
+VLG GAF VY+ EG I VA IK + + + + + E +++ ++ +
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELREATSPKANKEILDEAYVMASVDNP 69
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLH 146
++ + + + + IT++ G L Y ++HK ++ + L W QI +G++YL
Sbjct: 70 HVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARSAHSVIEFMAPE-L 199
+ ++HRDL N+ V Q VKI D GLA +L A I++MA E +
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 200 YEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258
Y D++++G+ + EL+TF PY GI + ++ + + G R
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPY--------------DGIPASEISSILEKGER 229
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 16/203 (7%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLK-TLKHKNI 89
VLG+G+F KV A EL+G + IK + D++ +D+E E +L +H +
Sbjct: 2 VLGKGSFGKVMLA--ELKGTN-EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ EH+ F+ E G L + + D + ++ +I+ GL +LH
Sbjct: 59 THLFCTF--QTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----AQARSAHSVIEFMAPELYE-EEY 204
+I+RDLK DN+ ++ G +KI D G+ +A + +++APE+ + ++Y
Sbjct: 117 --IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY 173
Query: 205 NELVDIYAFGMCLLELVTFEYPY 227
NE VD ++FG+ L E++ + P+
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 56/249 (22%)
Query: 21 IDPSARYGRYKEVLGR----GAFKKVYRAFDELEGIEVAWNQIKV---IDLLRNS---ED 70
+DP + R + VLG+ G F +V RA E GI+ + V + +L+++ +D
Sbjct: 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRA--EAYGIDKSRPDQTVTVAVKMLKDNATDKD 60
Query: 71 LERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY---------- 119
L L SE+ L+K + KHKNII V T+ + I E G LR++
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLG--VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 120 ------RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173
+ + + + L + Q+ G+ YL S IHRDL N+ V + +KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKI 175
Query: 174 GDLGLAAILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLEL 220
D GLA R H + +++MAPE L++ Y D+++FG+ + E+
Sbjct: 176 ADFGLA------RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
Query: 221 VTF---EYP 226
T YP
Sbjct: 230 FTLGGSPYP 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (184), Expect = 6e-14
Identities = 69/255 (27%), Positives = 122/255 (47%), Gaps = 35/255 (13%)
Query: 22 DPSARYGRYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
D +R Y+ + +G G F +V+ + W I L + +L EV+
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVN 64
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL-RQYRKKHK---HVDLRALKKWS 135
+++ LKHKNI+++ + +++ N+ + + E +G L R +K +K ++ A+ +
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124
Query: 136 RQILEGLSYLHS-HDPP----VIHRDLKCDNIFV--------------NGNQGE--VKIG 174
RQ+L L+Y H+ D P V+HRDLK NIF+ N G KIG
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIG 184
Query: 175 DLGLAAILAQARSAHSVI---EFMAPELYEEE---YNELVDIYAFGMCLLELVTFEYPYV 228
D GL+ + AHS + + +PEL E Y++ D++A G + EL + + P+
Sbjct: 185 DFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 229 ECTNAAQIYKKVTSG 243
+ N +Q+ ++ G
Sbjct: 245 KANNFSQLISELKRG 259
|
Length = 1021 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 40/215 (18%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKTLKHKNII 90
+G G + +VY+A D+ G VA +++ L N ++ + + E+ +L+ L H+NI+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR----LDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 91 KFYNSWVD----------TENEHINF------ITEIFTSGTLRQYRKKHKHVDLRALKKW 134
D ++ F + + SG L + + H +K +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG-LVHFSEDH-------IKSF 121
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS---AHSV 191
+Q+LEGL+Y H + +HRD+KC NI +N N+G++K+ D GLA + S + V
Sbjct: 122 MKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 192 IE--FMAPELY--EEEYNELVDIYAFGMCLLELVT 222
I + PEL EE Y +D+++ G L EL T
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 41/212 (19%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKTLKHKNIIK 91
+G G + VYRA D G VA +++ + N D + S E+ LL L+H NI++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR----MDNERDGIPISSLREITLLLNLRHPNIVE 70
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRAL-------------KKWSRQI 138
V +H++ I + +Y ++ DL +L K Q+
Sbjct: 71 LKEVVV---GKHLDSIFLVM------EYCEQ----DLASLLDNMPTPFSESQVKCLMLQL 117
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSV-IEF 194
L GL YLH + +IHRDLK N+ + G +KI D GLA + A+ + V + +
Sbjct: 118 LRGLQYLHEN--FIIHRDLKVSNLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWY 174
Query: 195 MAPELY--EEEYNELVDIYAFGMCLLELVTFE 224
APEL Y +D++A G L EL+ +
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKHK 87
E +G G + KVY+A D+ G VA + R D E + E+ LL+ L
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKT------RLEMDEEGIPPTALREISLLQMLSES 60
Query: 88 NIIKFYNSWVDTENEHIN---FITEIFTSGTLRQY-----RKKHKHVDLRALKKWSRQIL 139
I E ++ ++ + L+++ R + + + +K + Q+L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL--AAILAQARSAHSVIE--FM 195
+G+++ H H V+HRDLK N+ V+ +G +KI DLGL A + H ++ +
Sbjct: 121 KGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR 178
Query: 196 APE--LYEEEYNELVDIYAFGMCLLELVT 222
APE L Y+ VDI++ G E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSR 207
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 61/207 (29%), Positives = 109/207 (52%), Gaps = 22/207 (10%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQ---IKVI--DLLRNSEDLERLYSEVHLLK-TLK 85
++LG+G+F KV+ A EL+G NQ IK + D++ +D+E E +L +
Sbjct: 1 KMLGKGSFGKVFLA--ELKGT----NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H + Y ++ E++ F+ E G L + + DL ++ +I+ GL +L
Sbjct: 55 HPFLTHLYCTF--QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFL 112
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAH--SVIEFMAPE-LY 200
HS +++RDLK DNI ++ G +KI D G+ +L A++ +++APE L
Sbjct: 113 HSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPY 227
++YN VD ++FG+ L E++ + P+
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G G F +V+ D + A + + +++R ++ + +++E +LK + H II+ +
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-QHVHNEKRVLKEVSHPFIIRLF 67
Query: 94 NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ--------ILEGLSYL 145
+ D + + E G L Y LR ++S I+ L YL
Sbjct: 68 WTEHD--QRFLYMLMEYVPGGELFSY--------LRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-QARSAHSVIEFMAPELYEEE- 203
HS + +++RDLK +NI ++ +G +K+ D G A L + + E++APE+ + +
Sbjct: 118 HSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKG 174
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+N+ VD +A G+ + E++ YP N IY+K+ +G
Sbjct: 175 HNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKTL 84
+Y+ V +G GA+ VY+A D G VA ++V + +ED L + EV LLK L
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV----QTNEDGLPLSTVREVALLKRL 56
Query: 85 K---HKNIIKFYNSWVDTENEHINFITEIF--TSGTLRQYRKK--HKHVDLRALKKWSRQ 137
+ H NI++ + + + +T +F LR Y K + +K RQ
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE---F 194
L GL +LH++ ++HRDLK +NI V + G+VK+ D GLA I + + V+ +
Sbjct: 117 FLRGLDFLHAN--CIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWY 173
Query: 195 MAPE-LYEEEYNELVDIYAFGMCLLEL 220
APE L + Y VD+++ G E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+GRGA+ V A + +VA K+ + N D +R E+ LL+ L H+N+I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIK--KIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 94 NSWVDTENEHIN--FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ E N +I L Q + + + + + Q+L GL Y+HS +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN-- 128
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM----------APELY- 200
V+HRDLK N+ +N N ++KI D GL AR+ +FM APEL
Sbjct: 129 VLHRDLKPSNLLLNAN-CDLKICDFGL------ARTTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 201 -EEEYNELVDIYAFGMCLLELVTFE--YPYVECTN 232
EY +D+++ G EL+ + +P + +
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH 216
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E +G+G F VY+ + EVA + + + E +LK H NI+K
Sbjct: 1 EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVK 56
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
V + + I + E+ G+L + RKK + ++ L + S G+ YL S +
Sbjct: 57 LIG--VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN- 113
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA------AILAQARSAHSVIEFMAPE-LYEEE 203
IHRDL N V G +KI D G++ I++ APE L
Sbjct: 114 -CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 204 YNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
Y D++++G+ L E + + PY +N Q +++ SG
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTRERIESG 211
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/269 (21%), Positives = 117/269 (43%), Gaps = 33/269 (12%)
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY 119
KV+ + S +++ E+ ++ + I+ FY ++++ EN +I E G+L +
Sbjct: 36 KVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-EN-NICMCMEFMDCGSLDRI 93
Query: 120 RKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
KK + + L K + ++EGL+YL++ H ++HRD+K NI VN +G++K+ D G+
Sbjct: 94 YKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGV 150
Query: 179 AAIL----AQARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNA 233
+ L A S +M+PE + +Y D+++ G+ ++EL ++P+
Sbjct: 151 SGELINSIADTFVGTST--YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI- 207
Query: 234 AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAK------ELLGDPFLQSED 287
+ G+ +++ + E RLP+ D L +
Sbjct: 208 -------------DDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDP 254
Query: 288 DESVGRSLRVKTHYSAETSHQANLDKNAY 316
E + +N+D A+
Sbjct: 255 TERPTPQQLCAMPPFIQALRASNVDLQAW 283
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 24/202 (11%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G GAF V+ D +G VA K+ ++ +N +R++ E+ +L KH N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK--KMPNVFQNLVSCKRVFRELKMLCFFKHDNVL--- 62
Query: 94 NSWVDT-ENEHINFITEIFTSGTLRQYRKKHK------HVDLRALKKWSRQILEGLSYLH 146
S +D + HI+ EI+ L Q HK + +K + QIL GL YLH
Sbjct: 63 -SALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE-----FMAPELY- 200
S ++HRD+K N+ VN N +KI D GLA + S H E + APE+
Sbjct: 121 SAG--ILHRDIKPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 201 -EEEYNELVDIYAFGMCLLELV 221
Y VDI++ G EL+
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 31/271 (11%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNIIKF 92
+GRGAF V + + G +A +K I + ++ +RL ++ ++++ I+KF
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMA---VKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 93 Y-------NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
Y + W+ E I+ + F Y + L K + ++ L+YL
Sbjct: 69 YGALFREGDCWICMELMDISL--DKFYK---YVYEVLKSVIPEEILGKIAVATVKALNYL 123
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----AQARSAHSVIEFMAPELYE 201
+ +IHRD+K NI ++ N G +K+ D G++ L A+ R A +MAPE +
Sbjct: 124 KE-ELKIIHRDVKPSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDA-GCRPYMAPERID 180
Query: 202 EE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG---IKPASLAKVAD 254
Y+ D+++ G+ L E+ T ++PY + + +V G I S +
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240
Query: 255 NGVRAFIEKC-IAEVSERLPAKELLGDPFLQ 284
FI C I + S+R KELL PF++
Sbjct: 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 20/199 (10%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS--EVHLLKTLKHKNI 89
E LG G++ VY+ + G VA +KVI + +E+ + E LLK LKH NI
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVA---LKVISM--KTEEGVPFTAIREASLLKGLKHANI 65
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSH 148
+ ++ + E + F+ E + L QY +H + ++ + Q+L GL+Y+H
Sbjct: 66 VLLHD--IIHTKETLTFVFE-YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSVIEFMAPE---LYEE 202
++HRDLK N+ ++ GE+K+ D GLA +I +Q S+ V + P L
Sbjct: 123 H--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT 179
Query: 203 EYNELVDIYAFGMCLLELV 221
+Y+ +DI+ G +E++
Sbjct: 180 DYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 77/301 (25%), Positives = 128/301 (42%), Gaps = 57/301 (18%)
Query: 22 DPSARYGRYKEVLGR----GAFKKVYRA----FDELEGIEVAWNQIKVIDLLRNSEDLER 73
DP + R K LG+ G F +V A D+ + E +K++ +DL
Sbjct: 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSD 66
Query: 74 LYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY------------- 119
L SE+ ++K + KHKNII + T++ + I E + G LR+Y
Sbjct: 67 LVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 120 ---RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176
R + + + L + Q+ G+ YL S IHRDL N+ V N +KI D
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADF 181
Query: 177 GLAAILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF 223
GLA R +++ +++MAPE L++ Y D+++FG+ + E+ T
Sbjct: 182 GLA------RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 224 ---EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPA-KELLG 279
YP + ++ K+ KPA+ N + + C + P K+L+
Sbjct: 236 GGSPYPGIPVEELFKLLKEGHRMDKPANCT----NELYMMMRDCWHAIPSHRPTFKQLVE 291
Query: 280 D 280
D
Sbjct: 292 D 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 24/223 (10%)
Query: 34 LGRGAF----KKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89
LG G F K VY E +EVA +K + ++ R E ++ L H I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKE-VEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCI 58
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ + E + + E+ G L +Y KK + + + LK+ + Q+ G++YL S
Sbjct: 59 VRLIGV---CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARSAHS-VIEFMAPE-LYE 201
+HRDL N+ + N+ + KI D G++ L +A +A +++ APE +
Sbjct: 116 --FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 202 EEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+++ D++++G+ L E ++ PY E A++ + SG
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIAMLESG 214
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 47/233 (20%)
Query: 33 VLGRGAFKKVYRAFD-ELEGI----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87
LG G F KV +A L+G VA +K++ +S +L L SE +LLK + H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVA---VKMLKENASSSELRDLLSEFNLLKQVNHP 63
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-------------------DL 128
++IK Y + +++ + I E G+LR + ++ + V D
Sbjct: 64 HVIKLYGAC--SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 129 RALK-----KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
RAL ++ QI G+ YL + ++HRDL N+ V + ++KI D GL+ +
Sbjct: 122 RALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDVY 178
Query: 184 Q-----ARSAHSV-IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF---EYP 226
+ RS + +++MA E L++ Y D+++FG+ L E+VT YP
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 65/252 (25%), Positives = 126/252 (50%), Gaps = 16/252 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+V+G+G+F KV A + E A ++ +L+ E+ + LLK +KH ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDP 150
+ S+ + + F+ + G L + ++ + ++ RA + ++ +I L YLHS +
Sbjct: 61 LHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRA-RFYAAEIASALGYLHSLN- 116
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYEEEYN 205
+++RDLK +NI ++ +QG + + D GL + S E++APE L+++ Y+
Sbjct: 117 -IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265
VD + G L E++ + P N A++Y + + KP L N R +E +
Sbjct: 175 RTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILN--KPLQLKPNITNSARHLLEGLL 231
Query: 266 -AEVSERLPAKE 276
+ ++RL AK+
Sbjct: 232 QKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 68/281 (24%), Positives = 137/281 (48%), Gaps = 28/281 (9%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DPS + E +G+G + KV++ ++ G + A +K++D + + + E + +E ++L
Sbjct: 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAA---VKILDPIHDID--EEIEAEYNIL 68
Query: 82 KTLK-HKNIIKFYNSWV--DTEN-EHINFITEIFTSGTL----RQYRKKHKHVDLRALKK 133
K L H N++KFY + D +N + + + E+ G++ + + K+ + ++ +
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR----SAH 189
+ L GL +LH + IHRD+K +NI + +G VK+ D G++A L R ++
Sbjct: 129 ILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 190 SVIEFMAPEL------YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+MAPE+ + Y+ D+++ G+ +EL + P + ++K +
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP 245
Query: 244 IKPASLAKVADNGVRAFIEKCIAEVSERLP-AKELLGDPFL 283
++ N FI KC+ + E+ P +LL F+
Sbjct: 246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 20/177 (11%)
Query: 129 RALKKWSRQILEGLSYL---HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--- 182
L K + I++ L YL H VIHRD+K NI ++ + G VK+ D G++ L
Sbjct: 114 DILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDAS-GNVKLCDFGISGRLVDS 168
Query: 183 -AQARSAHSVIEFMAPELYE-----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI 236
A+ RSA +MAPE + +Y+ D+++ G+ L+EL T ++PY C ++
Sbjct: 169 KAKTRSA-GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227
Query: 237 YKKVTSGIKPA-SLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
K+ P+ + +F++ C + +R +ELL PF++ + V
Sbjct: 228 LTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 66/223 (29%), Positives = 102/223 (45%), Gaps = 36/223 (16%)
Query: 21 IDP--SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEV 78
ID +Y + LG+GA+ V++A D VA K+ D RN+ D +R + E+
Sbjct: 1 IDKHILRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREI 57
Query: 79 HLLKTLK-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA--LKKWS 135
L+ L H NI+K N ++ I + E Y + H +RA L+
Sbjct: 58 MFLQELGDHPNIVKLLNVIKAENDKDIYLVFE---------YMETDLHAVIRANILEDVH 108
Query: 136 R-----QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS 190
+ Q+L+ L Y+HS + VIHRDLK NI +N + VK+ D GLA L++
Sbjct: 109 KRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSD-CRVKLADFGLARSLSELEENPE 165
Query: 191 VIE---------FMAPE--LYEEEYNELVDIYAFGMCLLELVT 222
+ APE L Y + VD+++ G L E++
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL 208
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 18/204 (8%)
Query: 29 RYKEVL--GRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLK 85
RY+++ G GA+ V A D G +VA IK + SE +R Y E+ LLK +K
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVA---IKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFT----SGTLRQYRKKHKHVDLRALKKWSRQILEG 141
H+N+I + V T + ++ + + GT KH+ + ++ Q+L+G
Sbjct: 73 HENVIGLLD--VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKG 130
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE-FMAPE-- 198
L Y+H+ +IHRDLK N+ VN E+KI D GLA + + V + APE
Sbjct: 131 LKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVI 187
Query: 199 LYEEEYNELVDIYAFGMCLLELVT 222
L Y + VDI++ G + E++T
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR 136
E+ +LK LKH N++ V ++ + E L + K + V +KK
Sbjct: 50 EIRMLKQLKHPNLVNLIE--VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIW 107
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS--VIE- 193
Q L+ +++ H H+ IHRD+K +NI + QG++K+ D G A IL ++ V
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 194 -FMAPELY--EEEYNELVDIYAFGMCLLELVT 222
+ APEL + +Y VD++A G EL+T
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-13
Identities = 72/262 (27%), Positives = 117/262 (44%), Gaps = 35/262 (13%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+ LG G F +V+ + ++ + L + S E +E +L+K L+H +++
Sbjct: 12 KKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVR 65
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR--ALKKWSRQILEGLSYLHSHD 149
Y V T+ E I ITE +G+L + K + + L L + QI EG++++ +
Sbjct: 66 LYA--VVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS-AHSVIEFMAPE-LYEEE 203
IHRDL+ NI V+ KI D GLA ++ AR A I++ APE +
Sbjct: 123 --YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 179
Query: 204 YNELVDIYAFGMCLLELVTF-EYPYVECTNAAQI------YKKVTSGIKPASLAKVADNG 256
+ D+++FG+ L E+VT+ PY TN I Y+ P L ++
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL---- 235
Query: 257 VRAFIEKCIAEVSERLPAKELL 278
+ C E E P E L
Sbjct: 236 ----MRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 49/157 (31%), Positives = 83/157 (52%), Gaps = 17/157 (10%)
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHI---NFITEIFTSGTLRQYRKKHKHVDLRALKK 133
E LL+ + H ++I+ ++ V + ++ ++++T T R + +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP-----LPIDQALI 161
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-- 191
+QILEGL YLH+ +IHRD+K +NIF+N + +V IGDLG A A + +
Sbjct: 162 IEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAG 218
Query: 192 -IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYP 226
+E APE L ++YN DI++ G+ L E++ YP
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 66/273 (24%), Positives = 127/273 (46%), Gaps = 23/273 (8%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
LG+G + VY+ G+ +A +K I L + ++ E+ +L I+ FY
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMA---MKEIRLELDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 94 NSWVDTENEHINFITEIFTSGTLRQY---RKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
++ + E +G+L + + + L++ + +++GL +L +
Sbjct: 66 GAF--FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL-KEEH 122
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--ARSAHSVIEFMAPELYEEE----- 203
+IHRD+K N+ VNGN G+VK+ D G++ L A++ +MAPE +
Sbjct: 123 NIIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 204 --YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRA 259
Y D+++ G+ +LE+ YPY T A I+ ++++ + P +L + +
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGDPPTLPSGYSDDAQD 240
Query: 260 FIEKCIAEVSERLPA-KELLGDPFLQSEDDESV 291
F+ KC+ ++ R P +LL P+L + V
Sbjct: 241 FVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADV 273
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKHK 87
E +G G + VY+A D + +A +I++ ED E + S E+ LLK ++H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRL-----EQED-EGVPSTAIREISLLKEMQHG 61
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV------DLRALKKWSRQILEG 141
NI++ + V + + + E L KKH + R +K + QIL G
Sbjct: 62 NIVRLQD--VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAP 197
++Y HSH V+HRDLK N+ ++ +K+ D GLA A R+ H V+ + AP
Sbjct: 115 IAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 198 E--LYEEEYNELVDIYAFGMCLLELVT 222
E L Y+ VDI++ G E+V
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 34 LGRGAFKKVYRAFDELEGIE-VAWNQIKVIDLLRNSEDLERLYS--EVHLLK---TLKHK 87
+G GA+ KV++A D G VA +++V + E+ L + EV +L+ T +H
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV----QTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 88 NIIKFYNSWVDTENEHINFITEIF--TSGTLRQYRKK--HKHVDLRALKKWSRQILEGLS 143
N+++ ++ + + +T +F L Y K V +K Q+L GL
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE---FMAPE-L 199
+LHSH V+HRDLK NI V + G++K+ D GLA I + + SV+ + APE L
Sbjct: 125 FLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181
Query: 200 YEEEYNELVDIYAFGMCLLEL 220
+ Y VD+++ G E+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E LG G++ VY+ ++ G VA +KVI L E LLK LKH NI+
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVA---LKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSH 148
++ + E + + E + L QY KH H + +K + Q+L GLSY+H
Sbjct: 68 LHD--IIHTKETLTLVFE-YVHTDLCQYMDKHPGGLHPE--NVKLFLFQLLRGLSYIHQR 122
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSVIEFMAPE---LYEE 202
++HRDLK N+ ++ + GE+K+ D GLA ++ + S V + P L
Sbjct: 123 --YILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 203 EYNELVDIYAFGMCLLELV 221
EY+ +D++ G +E++
Sbjct: 180 EYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 32 EVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87
+VLG GAF VY+ EG I VA IK+++ + E ++ ++ H
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLH 146
++++ + I +T++ G L Y +HK ++ + L W QI +G+ YL
Sbjct: 70 HLVRLLGVCLSPT---IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 126
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARSAHSVIEFMAPE-L 199
++HRDL N+ V + VKI D GLA +L A I++MA E +
Sbjct: 127 ERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 200 YEEEYNELVDIYAFGMCLLELVTF 223
+ ++ D++++G+ + EL+TF
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 68/237 (28%), Positives = 115/237 (48%), Gaps = 27/237 (11%)
Query: 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERL--Y 75
IDPS Y ++V+G G F +V R +L G I+VA +K S D +RL
Sbjct: 1 IDPS--YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-----GSSDKQRLDFL 53
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKW 134
+E ++ H NII+ V T++ + ITE +G+L ++ R+ + L
Sbjct: 54 TEASIMGQFDHPNIIRLEG--VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM 111
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--- 191
R I G+ YL + +HRDL NI VN + K+ D GL+ L + + ++
Sbjct: 112 LRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGG 168
Query: 192 ---IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
I + APE + ++ D+++FG+ + E++++ E PY + +N + K V G
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVIKAVEDG 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 41/241 (17%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWN---QIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
LG G F +V+ WN ++ V L + E E ++K L+H ++
Sbjct: 14 LGNGQFGEVWMG---------TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRK--KHKHVDLRALKKWSRQILEGLSYLHSH 148
+ Y E I +TE + G+L + K + + + L L + Q+ G++Y+
Sbjct: 65 QLYAV---VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS-AHSVIEFMAPE--LYE 201
+ IHRDL+ NI V G+ KI D GLA ++ AR A I++ APE LY
Sbjct: 122 N--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178
Query: 202 EEYNELVDIYAFGMCLLELVT---FEYPYVECTNAAQIYKKVTSGIK-------PASLAK 251
+ D+++FG+ L ELVT YP + N ++ ++V G + P SL +
Sbjct: 179 R-FTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQVERGYRMPCPQDCPISLHE 234
Query: 252 V 252
+
Sbjct: 235 L 235
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-12
Identities = 39/99 (39%), Positives = 58/99 (58%), Gaps = 8/99 (8%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA----H 189
++ QI+ GL +LH +I+RDLK +N+ ++ N G V+I DLGLA L +S
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 190 SVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPY 227
FMAPEL + EEY+ VD +A G+ L E++ P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 64/253 (25%), Positives = 124/253 (49%), Gaps = 20/253 (7%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVH-LLKTLKHKNI 89
V+G+G+F KV A + +G A +KV+ + ++ + + +E + LLK +KH +
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYA---VKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL 58
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ + S+ + + F+ + G L + ++ + + ++ +I L YLHS +
Sbjct: 59 VGLHYSFQTADK--LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN 116
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYEEEY 204
+I+RDLK +NI ++ +QG V + D GL + S E++APE L ++ Y
Sbjct: 117 --IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264
+ VD + G L E++ + P + A++Y + + KP L R +E
Sbjct: 174 DRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYDNILN--KPLRLKPNISVSARHLLEGL 230
Query: 265 I-AEVSERLPAKE 276
+ + ++RL AK+
Sbjct: 231 LQKDRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 70/248 (28%), Positives = 113/248 (45%), Gaps = 33/248 (13%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-----RLYSEVHLLKTLKH 86
E+LG+G F +V++ + + VA K EDL + SE +LK H
Sbjct: 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCK--------EDLPQELKIKFLSEARILKQYDH 51
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYL 145
NI+K V T+ + I + E+ G + RKK + + L K++ G++YL
Sbjct: 52 PNIVKLIG--VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-----AILAQARSAHSVIEFMAPE-L 199
S + IHRDL N V G +KI D G++ I + + I++ APE L
Sbjct: 110 ESKN--CIHRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 200 YEEEYNELVDIYAFGMCLLELVTFEY---PYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
Y+ D++++G+ L E TF PY TN Q ++V G + + K D+
Sbjct: 167 NYGRYSSESDVWSYGILLWE--TFSLGVCPYPGMTN-QQAREQVEKGYRMSCPQKCPDD- 222
Query: 257 VRAFIEKC 264
V +++C
Sbjct: 223 VYKVMQRC 230
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 56/206 (27%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWN---QIKVIDLLRNSEDLERLYSEVHLLKTLK 85
R + LG+G F +V+ WN ++ + L + E E ++K L+
Sbjct: 9 RLEVKLGQGCFGEVWMG---------TWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR 59
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLS 143
H+ +++ Y E I +TE + G+L + K K++ L L + QI G++
Sbjct: 60 HEKLVQLYAV---VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----AQARSAHSVIEFMAPE 198
Y+ + +HRDL+ NI V G K+ D GLA ++ + A I++ APE
Sbjct: 117 YVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
Query: 199 --LYEEEYNELVDIYAFGMCLLELVT 222
LY + D+++FG+ L EL T
Sbjct: 174 AALY-GRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTL 84
RY K+V G GA+ V A D+ G +VA IK + SE +R Y E+ LLK +
Sbjct: 16 RYTSLKQV-GSGAYGSVCSAIDKRTGEKVA---IKKLSRPFQSEIFAKRAYRELTLLKHM 71
Query: 85 KHKNIIKF---YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+H+N+I + S V + ++ + L++ D ++ Q+L G
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED--KVQYLVYQMLCG 129
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE-FMAPE-- 198
L Y+HS +IHRDLK N+ VN E+KI D GLA + + V + APE
Sbjct: 130 LKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVVTRWYRAPEVI 186
Query: 199 LYEEEYNELVDIYAFGMCLLELVT 222
L YN+ VDI++ G + E++T
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
RYK EV+G+G++ V A D G +VA +I D+ + D R+ E+ LL+ L+H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN--DVFEHVSDATRILREIKLLRLLRH 58
Query: 87 KNIIKFYNSWVDTENEHINFITEIF--TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
+I++ + + I +F L Q K + + + + Q+L L Y
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEFM------AP 197
+H+ + V HRDLK NI N + ++KI D GLA +A +++ AP
Sbjct: 119 IHTAN--VFHRDLKPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 198 EL---YEEEYNELVDIYAFGMCLLELVT 222
EL + +Y +DI++ G E++T
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLT 203
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 55/219 (25%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID---LLRNSEDLERLYSEVHLLKTLKHKN 88
+ LG G+F +V + G A +K++ +++ + +E + +E +L++++H
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYA---LKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPF 62
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
++ Y S+ D N + + E G L + +K + ++ Q++ L YLHS
Sbjct: 63 LVNLYGSFQDDSN--LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPELYEEE-Y 204
D +++RDLK +N+ + + G +KI D G A + +++ E++APE+ + Y
Sbjct: 121 D--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKG--RTYTLCGTPEYLAPEIILSKGY 175
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+ VD +A G+ + E++ P+ + N QIY+K+ G
Sbjct: 176 GKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEG 213
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 56/203 (27%), Positives = 104/203 (51%), Gaps = 14/203 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNI 89
+VLG+G+F KV A EL+G + + +K + D++ +D+E E +L
Sbjct: 1 KVLGKGSFGKVLLA--ELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ T+ EH+ F+ E G L + + DL ++ +I+ GL +LHS
Sbjct: 58 LTHLYCTFQTK-EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--ILAQARSAH--SVIEFMAPELYE-EEY 204
+I+RDLK DN+ ++ + G +KI D G+ + R++ +++APE+ + +Y
Sbjct: 117 --IIYRDLKLDNVMLDRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 205 NELVDIYAFGMCLLELVTFEYPY 227
VD ++FG+ L E++ + P+
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 41/207 (19%)
Query: 37 GAFKKVYRAFDELEGIEVAWNQIKV--------IDLLRNSEDLERLYSEVHLLKTLKHKN 88
G + VYRA D+ G VA ++K+ I LR E+++L L+H N
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR----------EINILLKLQHPN 65
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA-LKKWSRQILEGLSYLHS 147
I+ V + + I + E + L+ + K L++ +K Q+L G+++LH
Sbjct: 66 IVTVKEVVVGSNLDKIYMVME-YVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM----------AP 197
+ ++HRDLK N+ +N N+G +KI D GL AR S ++ AP
Sbjct: 125 N--WILHRDLKTSNLLLN-NRGILKICDFGL------AREYGSPLKPYTQLVVTLWYRAP 175
Query: 198 ELY--EEEYNELVDIYAFGMCLLELVT 222
EL +EY+ +D+++ G EL+T
Sbjct: 176 ELLLGAKEYSTAIDMWSVGCIFAELLT 202
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 68/243 (27%), Positives = 125/243 (51%), Gaps = 21/243 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLK-TLKHKN 88
+VLG+G+F KV A EL+G + + IKV+ D++ +D++ +E +L KH
Sbjct: 1 KVLGKGSFGKVMLA--ELKGTDEVY-AIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLR-QYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
+ + + + + F+ E G L Q ++ K + R+ + ++ ++ L +LH
Sbjct: 58 LTALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-RFYAAEVTLALMFLHR 114
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAH--SVIEFMAPE-LYEE 202
H VI+RDLK DNI ++ +G K+ D G+ IL + +++APE L E
Sbjct: 115 HG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAF 260
EY VD +A G+ + E++ + P+ E N +++ + + P L+K A + ++AF
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKAF 230
Query: 261 IEK 263
+ K
Sbjct: 231 MTK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 54/178 (30%), Positives = 87/178 (48%), Gaps = 15/178 (8%)
Query: 57 NQIKVIDLLRNSEDLERL----YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFT 112
QI I SED + + E+ +LK L+H+N++ V + + + E
Sbjct: 26 GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE--VFRRKKRLYLVFEFVD 83
Query: 113 SGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172
L K +D ++K+ QIL G+ + HSH+ +IHRD+K +NI V+ + G VK
Sbjct: 84 HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQS-GVVK 140
Query: 173 IGDLGLAAILAQARSAHS----VIEFMAPELY--EEEYNELVDIYAFGMCLLELVTFE 224
+ D G A LA ++ + APEL + +Y VDI+A G + E++T E
Sbjct: 141 LCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 28/201 (13%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWN---QIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
LG+G F +V+ WN ++ + L + E E ++K L+H ++
Sbjct: 14 LGQGCFGEVWMG---------TWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSH 148
Y E I +TE G+L + K+ K++ L L + QI +G++Y+
Sbjct: 65 PLYAV---VSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----AQARSAHSVIEFMAPE--LYE 201
+ IHRDL+ NI V N KI D GLA ++ + A I++ APE LY
Sbjct: 122 N--YIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY- 177
Query: 202 EEYNELVDIYAFGMCLLELVT 222
+ D+++FG+ L ELVT
Sbjct: 178 GRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 7/157 (4%)
Query: 73 RLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALK 132
++ E+ +L I+ FY ++ + I+ E G+L Q K+ K + L
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKEAKRIPEEILG 106
Query: 133 KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--AQARSAHS 190
K S +L GL+YL ++HRD+K NI VN ++GE+K+ D G++ L + A S
Sbjct: 107 KVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVG 164
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYP 226
+M+PE L Y+ DI++ G+ L+EL YP
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 37/256 (14%)
Query: 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL---ERLYSEVHLLK 82
RY V G GA+ V A+D +VA V L R + L R Y E+ LLK
Sbjct: 16 RYQNLTPV-GSGAYGSVCSAYDTRLRQKVA-----VKKLSRPFQSLIHARRTYRELRLLK 69
Query: 83 TLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR------ 136
+KH+N+I + V T I E++ L DL + K +
Sbjct: 70 HMKHENVIGLLD--VFTPATSIENFNEVYLVTNLMG-------ADLNNIVKCQKLSDEHV 120
Query: 137 -----QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
Q+L GL Y+HS +IHRDLK N+ VN E++I D GLA + +
Sbjct: 121 QFLIYQLLRGLKYIHS--AGIIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMTGYVA 177
Query: 192 IE-FMAPE--LYEEEYNELVDIYAFGMCLLELVTFE--YPYVECTNAAQIYKKVTSGIKP 246
+ APE L YN+ VDI++ G + EL+ + +P + + + +V P
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 247 ASLAKVADNGVRAFIE 262
L K++ R +I+
Sbjct: 238 EVLKKISSEHARKYIQ 253
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 59/217 (27%), Positives = 118/217 (54%), Gaps = 17/217 (7%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVH-LLKTLKHKN 88
+V+G+G+F KV A +L+G A +KV+ ++ N ++ + + +E + LLK +KH
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYA---VKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF 57
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
++ + S+ TE + F+ + G L + ++ + + ++ +I L YLHS
Sbjct: 58 LVGLHYSFQTTEK--LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI-LAQARSAHSVI---EFMAPE-LYEEE 203
+ +++RDLK +NI ++ +QG V + D GL +AQ+ + + E++APE + ++
Sbjct: 116 N--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
Y+ VD + G L E++ + P C + A++Y +
Sbjct: 173 YDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQ---IKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
LG G F +V+ A +N+ + V + S +E +E +++KTL+H ++
Sbjct: 14 LGAGQFGEVWMA---------TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSH 148
K + E I ITE G+L + K + L L +S QI EG++++
Sbjct: 65 KLHAV---VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS-AHSVIEFMAPE-LYEE 202
+ IHRDL+ NI V+ + KI D GLA ++ AR A I++ APE +
Sbjct: 122 N--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 203 EYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQI 236
+ D+++FG+ L+E+VT+ PY +N I
Sbjct: 179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 52/268 (19%)
Query: 22 DPSARYGRYKEVLGR----GAFKKVYRA----FDELEGIEVAWNQIKVIDLLRNSEDLER 73
DP R + VLG+ G F +V A D+ + V +K++ +DL
Sbjct: 10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSD 69
Query: 74 LYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-------- 124
L SE+ ++K + KHKNII + T++ + I E + G LR+Y + +
Sbjct: 70 LISEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127
Query: 125 --------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176
+ + L + Q+ G+ YL S IHRDL N+ V + +KI D
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 184
Query: 177 GLAAILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF 223
GLA R H + +++MAPE L++ Y D+++FG+ L E+ T
Sbjct: 185 GLA------RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
Query: 224 ---EYPYVECTNAAQIYKKVTSGIKPAS 248
YP V ++ K+ KP++
Sbjct: 239 GGSPYPGVPVEELFKLLKEGHRMDKPSN 266
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 29/269 (10%)
Query: 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
I PS + +G G F V+ + LE +VA IK I SE E E +
Sbjct: 1 IHPSEL--TLVQEIGSGQFGLVWLGY-WLEKRKVA---IKTIREGAMSE--EDFIEEAQV 52
Query: 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQIL 139
+ L H +++ Y V TE I + E G L Y R + L +
Sbjct: 53 MMKLSHPKLVQLYG--VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVC 110
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA--QARSAHSV---IEF 194
EG++YL S + VIHRDL N V NQ VK+ D G+ + Q S+ +++
Sbjct: 111 EGMAYLESSN--VIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKW 167
Query: 195 MAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG---IKPASL 249
+PE++ +Y+ D+++FG+ + E+ + + PY +N +++ + + +G KP
Sbjct: 168 SSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGFRLYKP--- 223
Query: 250 AKVADNGVRAFIEKCIAEVSERLPAKELL 278
++A V ++ C E E P+ LL
Sbjct: 224 -RLASQSVYELMQHCWKERPEDRPSFSLL 251
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 57/215 (26%), Positives = 106/215 (49%), Gaps = 9/215 (4%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
E LG G+F +V A + G A +K ++L+ + ++ + E +L L H I+
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSHPFIV 81
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
S+ D + F+ E G L + +K K + +++ YLHS D
Sbjct: 82 NMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD- 138
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILAQARSAHSVIEFMAPELYEEE-YNELV 208
+I+RDLK +N+ ++ N+G VK+ D G A + + + E++APE+ + + + + V
Sbjct: 139 -IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAV 196
Query: 209 DIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
D + G+ L E + P+ + T +IY+K+ +G
Sbjct: 197 DWWTMGVLLYEFIAGYPPFFDDT-PFRIYEKILAG 230
|
Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 18/197 (9%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-RLYSEVHLLKTLKHKNIIKF 92
LG G + V++ +L VA +I+ L + E EV LLK LKH NI+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEGLSYLHSHDPP 151
++ + TE + + E S L+QY ++ + +K + Q+L GLSY H
Sbjct: 69 HD-IIHTE-RCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-- 123
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSVIEFMAPE---LYEEEYN 205
++HRDLK N+ +N +GE+K+ D GLA ++ + S V + P L EY+
Sbjct: 124 ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 206 ELVDIYAFGMCLLELVT 222
+D++ G L E+ T
Sbjct: 183 TPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHI---NFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
L+K + N IK Y S V T H+ ++I + G L KK + +KK
Sbjct: 63 QLMK--DNPNFIKLYYS-VTTLKGHVLIMDYIKD----GDLFDLLKKEGKLSEAEVKKII 115
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM 195
RQ++E L+ LH H+ +IH D+K +N+ + + + + D GL I+ +++
Sbjct: 116 RQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYF 173
Query: 196 APE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVE 229
+PE + Y+ D +A G+ EL+T ++P+ E
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKE 208
|
Length = 267 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
RY+++ +G GA V AFD + GI VA K+ +N +R Y E+ LLK + H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVK--KLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 87 KNIIKFYNSWVDT----ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGL 142
KNII N + E + + + E+ + + H +D + Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI---HMELDHERMSYLLYQMLCGI 136
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAHSVIEFM-APE- 198
+LHS +IHRDLK NI V + +KI D GLA A + + V + APE
Sbjct: 137 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193
Query: 199 LYEEEYNELVDIYAFGMCLLELV 221
+ Y E VDI++ G + ELV
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 66/230 (28%), Positives = 101/230 (43%), Gaps = 31/230 (13%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVA-WNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87
R+ E LG AF K+Y+ L G++ A IK + + N + E L+ L H
Sbjct: 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQY---RKKHKHV--------------DLRA 130
NI+ V T+ + + + E G L ++ R H V D
Sbjct: 68 NIVCLLG--VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---- 186
+ QI G+ YL SH +H+DL NI + G Q VKI DLGL+ + A
Sbjct: 126 FLHIAIQIAAGMEYLSSHF--FVHKDLAARNILI-GEQLHVKISDLGLSREIYSADYYRV 182
Query: 187 SAHSV--IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEY-PYVECTN 232
S+ I +M PE + +++ DI++FG+ L E+ +F PY +N
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 69/240 (28%), Positives = 107/240 (44%), Gaps = 55/240 (22%)
Query: 34 LGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTLKHK 87
LG GAF KV+ A E + + VA +K + ++ +D +R E LL L+H+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQR---EAELLTVLQHQ 67
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH---------------KHVDLRALK 132
+I++FY V TE + + E G L ++ + H + L +
Sbjct: 68 HIVRFYG--VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 133 KWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
+ QI G+ YL S H +HRDL N V G VKIGD G+ +R +S
Sbjct: 126 AIASQIASGMVYLASLH---FVHRDLATRNCLV-GQGLVVKIGDFGM------SRDIYST 175
Query: 192 ------------IEFMAPE--LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQI 236
I +M PE LY + E DI++FG+ L E+ T+ + P+ + +N I
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 34 LGRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+GRG + VY+A D + E A QI+ + ++ E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSA------CREIALLRELKHPNVIA 62
Query: 92 FYNSWVDTENEHINFITE--------IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
++ + + + + I + KK + +K QIL+G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 144 YLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAI-------LAQARSAHSVIE 193
YLH++ V+HRDLK NI V G +G VKI D+G A + LA
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 194 FMAPELY--EEEYNELVDIYAFGMCLLELVTFEYPYVEC 230
+ APEL Y + +DI+A G EL+T E P C
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 7/157 (4%)
Query: 73 RLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALK 132
++ E+ +L I+ FY ++ + I+ E G+L Q KK + + L
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFY--SDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 106
Query: 133 KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--AQARSAHS 190
K S +++GL+YL ++HRD+K NI VN ++GE+K+ D G++ L + A S
Sbjct: 107 KVSIAVIKGLTYLREKH-KIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVG 164
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYP 226
+M+PE L Y+ DI++ G+ L+E+ YP
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 52/201 (25%), Positives = 97/201 (48%), Gaps = 17/201 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+ +G+G F V + G +VA IK N + +E ++ L+H N+++
Sbjct: 12 QTIGKGEFGDV--MLGDYRGNKVAVKCIK------NDATAQAFLAEASVMTQLRHSNLVQ 63
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHV-DLRALKKWSRQILEGLSYLHSHD 149
V+ E + +TE G+L Y R + + V L K+S + E + YL +++
Sbjct: 64 LLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-SAHSVIEFMAPE-LYEEEYNEL 207
+HRDL N+ V+ K+ D GL + + + +++ APE L E++++
Sbjct: 123 --FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 208 VDIYAFGMCLLELVTF-EYPY 227
D+++FG+ L E+ +F PY
Sbjct: 180 SDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 19/224 (8%)
Query: 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
ID S + +EV+G G F +V R +L G + IK + + SE +
Sbjct: 1 IDVS--CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 58
Query: 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQIL 139
+ H NII V T++ + ITE +G L + R+ + L R I
Sbjct: 59 MGQFDHPNIIHLEG--VVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIA 116
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------- 191
G+ YL + +HRDL NI VN N K+ D GL+ L S +
Sbjct: 117 AGMKYLS--EMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173
Query: 192 -IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTN 232
I + APE + ++ D++++G+ + E++++ E PY + +N
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 18/197 (9%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-RLYSEVHLLKTLKHKNIIKF 92
LG G + VY+ +L VA +I+ L + E EV LLK LKH NI+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQILEGLSYLHSHDPP 151
++ + TE + + + E + L+QY + +++ +K + Q+L GL+Y H
Sbjct: 70 HDI-IHTE-KSLTLVFE-YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK-- 124
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSVIEFMAPE---LYEEEYN 205
V+HRDLK N+ +N +GE+K+ D GLA +I + S V + P L +Y+
Sbjct: 125 VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 206 ELVDIYAFGMCLLELVT 222
+D++ G E+ T
Sbjct: 184 TQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 68/243 (27%), Positives = 111/243 (45%), Gaps = 25/243 (10%)
Query: 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSE 77
ID S + ++V+G G F +V +L G I VA +K + D SE
Sbjct: 1 IDASCI--KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF---LSE 55
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSR 136
++ H NII V T+++ + +TE +G+L + +KH + L R
Sbjct: 56 ASIMGQFDHPNIIHLEG--VVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-------ARSAH 189
I G+ YL D +HRDL NI VN N K+ D GL+ +L R
Sbjct: 114 GIASGMKYLS--DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 190 SVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIK-P 246
I + APE + ++ D++++G+ + E++++ E PY E +N I K + G + P
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI-KAIEEGYRLP 229
Query: 247 ASL 249
A +
Sbjct: 230 APM 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 62/273 (22%)
Query: 22 DPSARYGRYKEVLGR----GAFKKVYRAFDELEGIE---------VAWNQIKVIDLLRNS 68
DP R + LG+ G F +V A E GI+ VA +K++
Sbjct: 4 DPKWELSRTRLTLGKPLGEGCFGQVVMA--EAIGIDKDKPNKPVTVA---VKMLKDDATD 58
Query: 69 EDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-------- 119
+DL L SE+ ++K + KHKNII + T++ + + E + G LR+Y
Sbjct: 59 KDLSDLVSEMEMMKMIGKHKNIINLLGAC--TQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 120 --------RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171
+ + + + L + Q+ G+ YL S IHRDL N+ V +
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVM 173
Query: 172 KIGDLGLAAILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLL 218
KI D GLA R H++ +++MAPE L++ Y D+++FG+ L
Sbjct: 174 KIADFGLA------RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227
Query: 219 ELVTF---EYPYVECTNAAQIYKKVTSGIKPAS 248
E+ T YP + ++ K+ KPA+
Sbjct: 228 EIFTLGGSPYPGIPVEELFKLLKEGHRMDKPAN 260
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 29/222 (13%)
Query: 29 RYKEVLGRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRNSE-DLERLYSEVHLLKTLK 85
++L G F +++ DE G E V D SE + L E LL L
Sbjct: 9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD--HASEIQVTLLLQESCLLYGLS 66
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTS-GTLRQYRKKHKHVDL--------RALKKWSR 136
H+NI+ V E+ F+ + + G L+ + ++ + + + L +
Sbjct: 67 HQNILPI--LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV----- 191
QI G+SYLH VIH+D+ N ++ + +VKI D L+ L H +
Sbjct: 125 QIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLFPM-DYHCLGDNEN 180
Query: 192 --IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVE 229
+++MA E L +EY+ D+++FG+ L EL+T + PYVE
Sbjct: 181 RPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-RLYSEVHLLKTLKHKNII 90
E LG G + V++ +L VA +I+ L + E EV LLK LKH NI+
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIR----LEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEGLSYLHSHD 149
++ + ++ + + E + L+QY ++ + +K + QIL GL+Y H
Sbjct: 68 TLHD--IVHTDKSLTLVFE-YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK 124
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHSVIEFMAPE---LYEEE 203
V+HRDLK N+ +N +GE+K+ D GLA ++ + S V + P L E
Sbjct: 125 --VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 204 YNELVDIYAFGMCLLELVT 222
Y+ +D++ G E+ +
Sbjct: 182 YSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 44/203 (21%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKF 92
+G G F +V +A G A +K ++ E + L E+ L+ L H NI++
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--KHFKSLEQVNNL-REIQALRRLSPHPNILRL 63
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPV 152
D + + + E+ + + + + + +K + Q+L+ L ++H + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--I 121
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM---------APE--LYE 201
HRD+K +NI + +K+ D G R +S + APE L +
Sbjct: 122 FHRDIKPENILI--KDDILKLADFG------SCRGIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 202 EEYNELVDIYAFGMCLLELVTFE 224
Y +DI+A G E+++
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLF 196
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 63/219 (28%), Positives = 97/219 (44%), Gaps = 31/219 (14%)
Query: 34 LGRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+GRG + VY+A D + + A QI+ + ++ E+ LL+ LKH N+I
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSA------CREIALLRELKHPNVIS 62
Query: 92 FYNSWVDTENEHINFITE--------IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
++ + + + + I + KK + +K QIL+G+
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 144 YLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAI-------LAQARSAHSVIE 193
YLH++ V+HRDLK NI V G +G VKI D+G A + LA
Sbjct: 123 YLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 194 FMAPELY--EEEYNELVDIYAFGMCLLELVTFEYPYVEC 230
+ APEL Y + +DI+A G EL+T E P C
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHC 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 63/242 (26%), Positives = 119/242 (49%), Gaps = 19/242 (7%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLK-TLKHKN 88
VLG+G+F KV A + G A +KV+ D++ +D+E +E +L H
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYA---VKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ + Y + + + F+ E G L + +K + D + ++ +I L +LH
Sbjct: 58 LTQLYCCFQTPD--RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH-- 113
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAH--SVIEFMAPE-LYEEE 203
D +I+RDLK DN+ ++ ++G K+ D G+ I ++ +++APE L E
Sbjct: 114 DKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFI 261
Y VD +A G+ L E++ P+ E N +++ + + + P L++ A + ++AF+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFM 231
Query: 262 EK 263
K
Sbjct: 232 TK 233
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 63/239 (26%), Positives = 110/239 (46%), Gaps = 36/239 (15%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKV---IDLLRNSEDLER--LYSEVHLLKTLK 85
K LG GAF KV+ A E + Q K+ + L+++ D R + E LL L+
Sbjct: 10 KRELGEGAFGKVFLA----ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-------------KHVDLRALK 132
H++I+KFY V E + + + E G L ++ + H + +
Sbjct: 66 HEHIVKFYG--VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 133 KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR----SA 188
++QI G+ YL S +HRDL N V G VKIGD G++ +
Sbjct: 124 HIAQQIAAGMVYLASQH--FVHRDLATRNCLV-GENLLVKIGDFGMSRDVYSTDYYRVGG 180
Query: 189 HSV--IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
H++ I +M PE + ++ D+++ G+ L E+ T+ + P+ + +N ++ + +T G
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 29 RYKEVLGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT 83
R+ E LG GAF KVY+ + L VA IK + + + E L+
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVA---IKTLKENAEPKVQQEFRQEAELMSD 64
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKW-------- 134
L+H NI+ V T+ + + E G L ++ ++ H D+ A
Sbjct: 65 LQHPNIVCLLG--VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 135 -------SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185
+ QI G+ YL SH +HRDL N V G VKI D GL+ + A
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADY 179
Query: 186 -RSAHSV---IEFMAPE--LYEEEYNELVDIYAFGMCLLELVTF 223
R + +M PE LY + E DI++FG+ L E+ ++
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSY 222
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 40/209 (19%), Positives = 86/209 (41%), Gaps = 7/209 (3%)
Query: 36 RGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNS 95
+GAF VY A G A +K D++ ++ ++ + + K Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-- 63
Query: 96 WVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHR 155
+ +++ + E G K + K++ +++ G+ LH +IHR
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH--QRGIIHR 121
Query: 156 DLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYE-EEYNELVDIYAFG 214
D+K +N+ ++ G +K+ D GL+ + + +++APE +++ D ++ G
Sbjct: 122 DIKPENLLID-QTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLG 180
Query: 215 MCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+ E + F YP ++ + S
Sbjct: 181 CVIFEFL-FGYPPFHAETPDAVFDNILSR 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 59 IKVIDL-LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLR 117
+K I+L + EDL+ L E+ + L+H NI+ + S++ + + ++ + G+
Sbjct: 30 VKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE 87
Query: 118 QYRKKHKHVDLR--ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175
K H L A+ + +L L Y+HS IHR +K +I ++G+ G+V +
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSG 144
Query: 176 L-----------GLAAILAQARSAHSVIEFMAPELYEEE---YNELVDIYAFGMCLLELV 221
L + +S+ + +++PE+ ++ YNE DIY+ G+ EL
Sbjct: 145 LRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELA 204
Query: 222 TFEYPYVECTNAAQIYKKVTSGIKP 246
P+ + A Q+ + G P
Sbjct: 205 NGHVPFKD-MPATQMLLEKVRGTVP 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 33 VLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
VLG GAF VY+ +G I VA IKV+ + + + + E +++ +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVA---IKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHS 147
+ + + + + +T++ G L Y +++K + + L W QI +G+SYL
Sbjct: 71 VCRLLGICLTST---VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYL-- 125
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARSAHSVIEFMAPE-LY 200
+ ++HRDL N+ V + VKI D GLA +L A I++MA E +
Sbjct: 126 EEVRLVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 201 EEEYNELVDIYAFGMCLLELVTF 223
+ D++++G+ + EL+TF
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTF 207
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 66/256 (25%), Positives = 100/256 (39%), Gaps = 56/256 (21%)
Query: 29 RYKEVLGRGAFKKVYRA-------FDELEGIEVAWNQIKV---IDLLR---NSEDLERLY 75
+ E LG G F +V+ F E E V + +LR + E
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-----------K 124
EV +L L NI + V T + + I E +G L Q+ +KH K
Sbjct: 68 KEVKILSRLSDPNIARLLG--VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+ L + QI G+ YL S + +HRDL N V N +KI D G+
Sbjct: 126 SLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCLVGKNY-TIKIADFGM------ 176
Query: 185 ARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF--EYPYVE 229
+R+ +S I +MA E + ++ D++AFG+ L E++T E PY
Sbjct: 177 SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
Query: 230 CT------NAAQIYKK 239
T NA ++
Sbjct: 237 LTDQQVIENAGHFFRD 252
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 27/220 (12%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLKHKN 88
LGRG F +V+ A + +GIE + V+ E L S E+ + + L HKN
Sbjct: 12 TLGRGEFGEVFLA--KAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQY----RKKHKHVDLRALKKWSR-----QIL 139
+++ + E ++ I E G L+Q+ + K + + L + QI
Sbjct: 70 VVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-----RSAHSVIEF 194
G+ +L + +HRDL N V+ +Q EVK+ L L+ + + R+A + +
Sbjct: 128 LGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRW 184
Query: 195 MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTN 232
+APE + E++++ D+++FG+ + E+ T E P+ ++
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 63/243 (25%), Positives = 111/243 (45%), Gaps = 41/243 (16%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRN-----SEDLERLYSEVHLLKTL 84
K LG GAF KV+ A E + +++ V + L++ +D +R E LL L
Sbjct: 10 KRELGEGAFGKVFLA--ECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNL 64
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----------------KHVDL 128
+H++I+KFY D + + + E G L ++ + H + L
Sbjct: 65 QHEHIVKFYGVCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-- 186
+ + QI G+ YL S +HRDL N V G VKIGD G++ +
Sbjct: 123 SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYY 179
Query: 187 --SAHSV--IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKV 240
H++ I +M PE + ++ D+++FG+ L E+ T+ + P+ + +N ++ + +
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIECI 238
Query: 241 TSG 243
T G
Sbjct: 239 TQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 11/216 (5%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+V+G+G+F KV A + +G A ++ +L+ E + LLK LKH ++
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ S+ E + F+ + G L + ++ + + ++ ++ + YLHS +
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN-- 116
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYEEEYNE 206
+I+RDLK +NI ++ +QG V + D GL + S E++APE L +E Y+
Sbjct: 117 IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 207 LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS 242
VD + G L E++ + P + +Q+Y +
Sbjct: 176 TVDWWCLGAVLYEML-YGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 48/204 (23%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 33 VLGRGAFKKVY----RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
V+GRG++ KV + + + ++V + L+ + ED++ + +E H+ + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKE-----LVNDDEDIDWVQTEKHVFEQASNHP 56
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ +S TE+ + F+ E G L + ++ + + + +S +I L+YLH
Sbjct: 57 FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPELYE-EE 203
+I+RDLK DN+ ++ ++G +K+ D G+ + S ++APE+ E+
Sbjct: 116 G--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 204 YNELVDIYAFGMCLLELVTFEYPY 227
Y VD +A G+ + E++ P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE 193
++ QI+ GL H H +++RDLK +N+ ++ + G V+I DLGLA L +
Sbjct: 100 YAAQIICGL--EHLHQRRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAG 156
Query: 194 ---FMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+MAPE L E Y+ VD +A G L E++ P+
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 52/303 (17%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
V+GRGAF +V+ D+ G A ++ D+++ ++ + +E +L I+K
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKL 66
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR-QILEGLSYLHS-HDP 150
Y S+ D EH+ + E G L + ++ +R I E + L S H
Sbjct: 67 YYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFP----EETARFYIAELVLALDSVHKL 120
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA------------------------- 185
IHRD+K DNI + G +K+ D GL + +A
Sbjct: 121 GFIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 186 -----RSAHSVI---EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI 236
A+S + +++APE L Y D ++ G+ L E++ + +P +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML-YGFPPFYSDTLQET 238
Query: 237 YKKVTSGIKPASLAKVADNGVRA----FIEKCIAEVSERL-PAKELLGDPFLQSEDDESV 291
Y K+ + + SL D V I + + + +RL +E+ PF + D E++
Sbjct: 239 YNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWENL 296
Query: 292 GRS 294
+
Sbjct: 297 RET 299
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 53/218 (24%)
Query: 34 LGRGAFKKVYRAFD--ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNII 90
LG+GA+ V A + E VA K+ ++ +R E+ LL+ + HKNI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIK--KITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR------------QI 138
Y D + E++ L + DL + + + QI
Sbjct: 66 CLY----DMDIVFPGNFNELYLYEELMEA-------DLHQIIRSGQPLTDAHFQSFIYQI 114
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----F 194
L GL Y+HS + V+HRDLK N+ VN + E+KI D GL AR F
Sbjct: 115 LCGLKYIHSAN--VLHRDLKPGNLLVNAD-CELKICDFGL------ARGFSENPGENAGF 165
Query: 195 M----------APE--LYEEEYNELVDIYAFGMCLLEL 220
M APE L + Y + +D+++ G L EL
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 40/214 (18%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR---NSEDLERLYSEVHLLKT 83
RY+ + +G GA V A+D + G VA IK L R N +R Y E+ L+K
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVA---IK--KLSRPFQNVTHAKRAYRELVLMKL 71
Query: 84 LKHKNIIKFYNSWVD----TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQIL 139
+ HKNII N + E + + + E+ + L Q +D + Q+L
Sbjct: 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQV--IQMDLDHERMSYLLYQML 128
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM---- 195
G+ +LHS +IHRDLK NI V + +KI D GL AR+A + FM
Sbjct: 129 CGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL------ARTAGT--SFMMTPY 177
Query: 196 -------APE-LYEEEYNELVDIYAFGMCLLELV 221
APE + Y E VDI++ G + E++
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 64/276 (23%), Positives = 128/276 (46%), Gaps = 30/276 (10%)
Query: 33 VLGRGAFKKVY---RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89
VLG GA+ KV+ + G A +K +++ ++ E +E +L+ ++
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 90 IK--FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
+ Y DT+ ++ I + G L + + +H ++ + +I+ L +LH
Sbjct: 67 LVTLHYAFQTDTK---LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ 123
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-----QARSAHSVIEFMAPELY-- 200
+I+RD+K +NI ++ G V + D GL+ +A S IE+MAPE+
Sbjct: 124 LG--IIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 201 -EEEYNELVDIYAFGMCLLELVTFEYPYV---ECTNAAQIYKKV--TSGIKPASLAKVAD 254
+++ VD ++ G+ EL+T P+ E + ++I +++ + P +++ A
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240
Query: 255 NGVRAFIEKCIAEVSERL---PAKELLGDPFLQSED 287
+ ++ +EK + +RL A E+ PF Q D
Sbjct: 241 DFIQKLLEK---DPKKRLGANGADEIKNHPFFQGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-R 73
EF D ++Y + ++ G+G F +V++A + VA +K + + E
Sbjct: 2 QYEFPFCDEVSKYEKLAKI-GQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPIT 57
Query: 74 LYSEVHLLKTLKHKNIIKFY---NSWVDTENEHINFITEIFT------SGTLRQYRKKHK 124
E+ +L+ LKH+N++ + N + +F +G L K+
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN---KNV 114
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
L +KK + +L GL Y+H + ++HRD+K NI + + G +K+ D GLA +
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKD-GILKLADFGLARAFSL 171
Query: 185 A------RSAHSVIE--FMAPELY--EEEYNELVDIYAFGMCLLELVT 222
+ R + V+ + PEL E +Y +D++ G + E+ T
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 55/242 (22%), Positives = 109/242 (45%), Gaps = 34/242 (14%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
R ++LG G F V++ EG I VA IK I + + + + + +L
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVA---IKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLS 143
H I++ + +T++ G+L + ++H+ +D + L W QI +G+
Sbjct: 67 DHAYIVRLLGI---CPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAP 197
YL H ++HR+L NI + + V+I D G+A +L + I++MA
Sbjct: 124 YLEEHR--MVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180
Query: 198 E-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256
E + Y D++++G+ + E++++ A+ Y +G++P + + + G
Sbjct: 181 ESILFGRYTHQSDVWSYGVTVWEMMSY---------GAEPY----AGMRPHEVPDLLEKG 227
Query: 257 VR 258
R
Sbjct: 228 ER 229
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 30/235 (12%)
Query: 21 IDPSARYGRYKEVLGRGAFKKV----YRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
I+PS + + LG G F V +RA I+VA IK I+ SE E
Sbjct: 1 INPSEL--TFMKELGSGQFGVVHLGKWRA-----QIKVA---IKAINEGAMSE--EDFIE 48
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWS 135
E ++ L H +++ Y V T+ + + +TE +G L Y R++ + L
Sbjct: 49 EAKVMMKLSHPKLVQLYG--VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-----AQARSAHS 190
+ + EG+ YL + IHRDL N V+ + G VK+ D G+ + + A
Sbjct: 107 QDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKF 163
Query: 191 VIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243
+++ PE++ +Y+ D+++FG+ + E+ T + P+ + +N ++ + ++ G
Sbjct: 164 PVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 66/238 (27%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 28 GRYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY + +G+G +VY A+D + VA +I+ DL N +R E + L
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLI 60
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSG-TLRQYRKK-----------HKHVDLRALKK 133
H I+ Y+ D + + T + G TL+ K + + A
Sbjct: 61 HPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR------- 186
+I + Y+HS V+HRDLK DNI + G GEV I D G AAI +
Sbjct: 118 IFHKICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWG-AAIFKKLEEEDLLDI 173
Query: 187 ------SAHS----------VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+S ++MAPE L +E DIYA G+ L +++T +PY
Sbjct: 174 DVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 66/246 (26%), Positives = 113/246 (45%), Gaps = 38/246 (15%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE-DLERLYSEVHL 80
+ + +Y VLG GA V A +G A +KV+D+ SE D R +EV
Sbjct: 29 EQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFA---VKVVDMEGMSEADKNRAQAEVCC 84
Query: 81 LKTLKHKNIIKFYNSWV--DTENEH----INFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
L +I+K + + D N I + + +G LRQ ++++ K
Sbjct: 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQ--------EIKSRAKT 136
Query: 135 SRQILE---GLSYL-------HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+R E GL ++ H H +IHRD+K NI + N G VK+GD G + + A
Sbjct: 137 NRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAA 195
Query: 185 ------ARSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237
R+ ++APE++ + Y++ D+++ G+ L EL+T + P+ + N ++
Sbjct: 196 TVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVM 254
Query: 238 KKVTSG 243
K +G
Sbjct: 255 HKTLAG 260
|
Length = 496 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 4e-09
Identities = 47/201 (23%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
++LG+G F KV ++ G A +K +++ +++ +E +LK +H +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKK-EVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
S+ + + F+ E G L + + + + + +I+ L YLHS
Sbjct: 60 LKYSF--QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-- 115
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILAQARSAHSVIEFMAPELYEE-EYNE 206
+++RDLK +N+ ++ + G +KI D GL A ++ E++APE+ E+ +Y
Sbjct: 116 IVYRDLKLENLMLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 207 LVDIYAFGMCLLELVTFEYPY 227
VD + G+ + E++ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 12/153 (7%)
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
+E H+L+ + H +II+ ++ T N+ I + + L Y +++ + +
Sbjct: 132 TEAHILRAINHPSIIQLKGTF--TYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIE 188
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI---LAQAR--SAHS 190
R +L + YLH + +IHRD+K +NIF+N + G+V +GD G A + +
Sbjct: 189 RSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAG 245
Query: 191 VIEFMAPELYEEE-YNELVDIYAFGMCLLELVT 222
I APEL + Y VDI++ G+ L E+ T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 65/275 (23%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
+P ++GR AF G + + +L + SE+H L
Sbjct: 63 NPREHMYVLTTLVGRNP---TTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCL 119
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQ 137
H I+K ++ + ++ + I E + G L +Q K+H + Q
Sbjct: 120 AACDHFGIVKHFDDF--KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQ 177
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF--- 194
I+ L +HS ++HRDLK NIF+ G +K+GD G + + + S F
Sbjct: 178 IVLALDEVHSRK--MMHRDLKSANIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 195 ---MAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250
+APEL+E + Y++ D+++ G+ L EL+T P+ + + +I ++V G
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKYDPFPC 293
Query: 251 KVADNGVRAFIEKCIAE-VSERLPAKELLGDPFLQ 284
V+ G++A ++ +++ + R ++LL FL+
Sbjct: 294 PVSS-GMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDN 161
+ ++FI ++ G L + +H ++ ++ +I+ GL H H+ V++RDLK N
Sbjct: 70 DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE--HMHNRFVVYRDLKPAN 127
Query: 162 IFVNGNQGEVKIGDLGLAAILAQARSAHSVIE--FMAPELYEE--EYNELVDIYAFGMCL 217
I ++ + G V+I DLGLA ++ + SV +MAPE+ ++ Y+ D ++ G L
Sbjct: 128 ILLDEH-GHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186
Query: 218 LELVTFEYPYVE-CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERL--- 272
+L+ P+ + T ++T + L +R+ +E + +V+ RL
Sbjct: 187 FKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-ELPDSFSPELRSLLEGLLQRDVNRRLGCL 245
Query: 273 --PAKELLGDPFLQSEDDESV 291
A+E+ PF +S D + V
Sbjct: 246 GRGAQEVKEHPFFRSLDWQMV 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 8e-09
Identities = 58/267 (21%), Positives = 110/267 (41%), Gaps = 60/267 (22%)
Query: 3 QDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
+ + D DA A+ E L +R D+L A+ +I +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAH------FRVIDDL--PAGAFGKIFIC 167
Query: 63 DLLRNSEDLER-------------------------------LYSEVHLLKTLKHKNIIK 91
L ++E+ E L +E+ L L H+NI+K
Sbjct: 168 ALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227
Query: 92 FY-------NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
N+++ T+ + + ++ ++ + RA+ K Q+L + Y
Sbjct: 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAF--DWKDRPLLKQTRAIMK---QLLCAVEY 282
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS-----VIEFMAPE- 198
+H D +IHRD+K +NIF+N + G++ +GD G A + R A + +PE
Sbjct: 283 IH--DKKLIHRDIKLENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEI 339
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEY 225
L + Y E+ DI++ G+ LL++++ ++
Sbjct: 340 LAGDGYCEITDIWSCGLILLDMLSHDF 366
|
Length = 501 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 59/234 (25%), Positives = 104/234 (44%), Gaps = 32/234 (13%)
Query: 33 VLGRGAFKKVY------RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
LG GAF +VY R D +E ++VA +K + + +D E ++ H
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVE-LQVA---VKTLPESCSEQDESDFLMEALIMSKFNH 68
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGT----LRQYRKKHKH---VDLRALKKWSRQIL 139
+NI++ + I + E+ G LR+ R + + + ++ L +R +
Sbjct: 69 QNIVRLIGVSFERLPRFI--LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILAQAR------SAHSV 191
+G YL + IHRD+ N + G KI D G+A + +A A
Sbjct: 127 KGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP 184
Query: 192 IEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEY-PYVECTNAAQIYKKVTSG 243
I++M PE + + + D+++FG+ L E+ + Y PY TN ++ + VT G
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEFVTGG 237
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 31/220 (14%)
Query: 24 SARYGRYKEVLGRGAFKKVYRA--FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
+ + ++G G+F VY A D E ++ + +L++ + R E+ ++
Sbjct: 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSE-------KVAIKKVLQDPQYKNR---ELLIM 113
Query: 82 KTLKHKNIIKFYNSWVDTE-------NEHINFITEIFTSGT---LRQYRKKHKHVDLRAL 131
K L H NII F + TE N +N + E ++ Y + + + L +
Sbjct: 114 KNLNHINII-FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILAQARSAHS 190
K +S Q+ L+Y+HS + HRDLK N+ ++ N +K+ D G A +LA RS
Sbjct: 173 KLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 191 VIE--FMAPELY--EEEYNELVDIYAFGMCLLELVTFEYP 226
+ + APEL Y +D+++ G C++ + YP
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLG-CIIAEMILGYP 269
|
Length = 440 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 69/258 (26%), Positives = 105/258 (40%), Gaps = 54/258 (20%)
Query: 29 RYKEVLGRGAFKKVY----RAFDELEGIEVAWNQIK------VIDLLR---NSEDLERLY 75
+KE LG G F +V+ +L ++ +N K + +LR N
Sbjct: 8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVD-------- 127
EV +L LK NII+ VD + + ITE +G L Q+ H D
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 128 -----------LRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176
+L + QI G+ YL S + +HRDL N V N +KI D
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVGENL-TIKIADF 182
Query: 177 GLAAIL-------AQARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF--EYP 226
G++ L Q R+ I +MA E + ++ D++AFG+ L E++ E P
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLP-IRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 227 YVECT------NAAQIYK 238
Y E T NA + ++
Sbjct: 242 YGELTDEQVIENAGEFFR 259
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 52/205 (25%), Positives = 82/205 (40%), Gaps = 23/205 (11%)
Query: 51 GIEVAWNQIKV--IDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108
G EVA IK+ D R E L L H NI+ +S + +
Sbjct: 3 GHEVA---IKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGE-APPGLLFAVF 58
Query: 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168
E TLR+ + + Q+L+ L+ +H+ ++HRDLK NI V+
Sbjct: 59 EYVPGRTLREVLAADGALPAGETGRLMLQVLDALA--CAHNQGIVHRDLKPQNIMVSQTG 116
Query: 169 GE--VKIGDLGLAAIL--------AQARSAHSVI---EFMAPE-LYEEEYNELVDIYAFG 214
K+ D G+ +L A V+ + APE L E D+YA+G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 215 MCLLELVTFEYPYVECTNAAQIYKK 239
+ LE +T + V+ + A+I +
Sbjct: 177 LIFLECLTGQ-RVVQGASVAEILYQ 200
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 44/243 (18%)
Query: 30 YKEVLGRGAFKKVYRAFDELEGIE----------VAWNQ--IKVIDLLR---NSEDLERL 74
+KE LG G F +V+ E EG+E V+ NQ + + +LR N
Sbjct: 9 FKEKLGEGQFGEVHLC--EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 75 YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK---------- 124
E+ ++ LK NII+ + ++ + ITE +G L Q+ +H+
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCITSDP--LCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 125 -HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL- 182
+ L + QI G+ YL S + +HRDL N V G +KI D G++ L
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLY 181
Query: 183 ------AQARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF--EYPYVECTNA 233
Q R+ I +M+ E + ++ D++AFG+ L E++T E PY + ++
Sbjct: 182 SGDYYRIQGRAVLP-IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240
Query: 234 AQI 236
I
Sbjct: 241 QVI 243
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 61/263 (23%), Positives = 111/263 (42%), Gaps = 39/263 (14%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+G+G + +V+ A + G VA +K + LL ++ + +E +L T K + ++K
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVA---LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 92 FYNSWVDTENEHI--------NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
++ D E ++ +F T + G L + + + ++ E +
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE----------DHARFYMAEMFEAVD 115
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILAQARSAHSVIEFMAPE-LYE 201
LH IHRDLK +N F+ G +K+ D GL+ I+ A S ++MAPE L
Sbjct: 116 ALHELG--YIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRG 172
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY------KKVTSGIKPASLAKVADN 255
+ Y+ VD ++ G C+L +P + + + K+ +P +
Sbjct: 173 KGYDFTVDYWSLG-CMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ--RPVYDDPRFNL 229
Query: 256 GVRA--FIEKCIAEVSERLPAKE 276
A I K I + S R + E
Sbjct: 230 SDEAWDLITKLINDPSRRFGSLE 252
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 45/201 (22%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
++LG+G F KV ++ G A ++ +++ +++ +E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRK-EVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ ++ + F+ E G L + + + + + +I+ L YLHS D
Sbjct: 60 L--KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD-- 115
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILAQARSAHSVIEFMAPELYEE-EYNE 206
V++RD+K +N+ ++ G +KI D GL + A ++ E++APE+ E+ +Y
Sbjct: 116 VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 174
Query: 207 LVDIYAFGMCLLELVTFEYPY 227
VD + G+ + E++ P+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 9/131 (6%)
Query: 103 HINFITEIFTSGTLRQ--YRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160
H+ + + G L+ Y + +++ + +S QI G+ +LHS D +++RD+K +
Sbjct: 67 HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPE 124
Query: 161 NIFVNGNQGEVKIGDLGLAAILAQARSAHS---VIEFMAPE-LYEEEYNELVDIYAFGMC 216
N+ ++ +QG ++ DLGLA L ++ +MAPE L EE Y+ VD +A G
Sbjct: 125 NVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCS 183
Query: 217 LLELVTFEYPY 227
+ E+V P+
Sbjct: 184 IYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 53/202 (26%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
V+GRG++ KV EL+ + +KVI +L+ + ED++ + +E H+ +T + +
Sbjct: 2 VIGRGSYAKVLLV--ELKKTRRIY-AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL 58
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
+S TE+ + F+ E + G L + ++ + + + +S +I L++LH
Sbjct: 59 VGLHSCFQTESR-LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYEEEYN 205
+I+RDLK DN+ ++ +G +K+ D G+ + S ++APE L E+Y
Sbjct: 117 -IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 206 ELVDIYAFGMCLLELVTFEYPY 227
VD +A G+ + E++ P+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/126 (29%), Positives = 67/126 (53%), Gaps = 7/126 (5%)
Query: 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165
FI ++ G L + +H + ++ ++ +I+ GL H H+ V++RDLK NI ++
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD 131
Query: 166 GNQGEVKIGDLGLAAILAQARSAHSVIE--FMAPELYEE--EYNELVDIYAFGMCLLELV 221
G V+I DLGLA ++ + SV +MAPE+ ++ Y+ D ++ G L +L+
Sbjct: 132 -EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
Query: 222 TFEYPY 227
P+
Sbjct: 191 RGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENE--HINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
E+ L+ + NI+K Y +D ++ ++ I E T G LR+ K K + K
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSF---KTK 124
Query: 135 SRQILE---GLSYLHSHD--PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH 189
++ GL L+ + P +++L + V N ++KI GL IL+ +
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTEN-YKLKIICHGLEKILSSPPFKN 180
Query: 190 SVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+ FM Y+ EY DIY+ G+ L E+ T + P+ E +IY + +
Sbjct: 181 --VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-ENLTTKEIYDLIINK 237
Query: 244 IKPASLAKVADNGVRAFIEKCIAEVSERLP 273
L ++ +E C + S + P
Sbjct: 238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRP 267
|
Length = 283 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
VLG+G+F KV A E +G + + IK++ D++ +D+E E +L +
Sbjct: 7 VLGKGSFGKVMLA--ERKGTDELY-AIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 91 KFYNSWVDTENEHINFITEIFTSGTL----RQYRK-KHKHVDLRALKKWSRQILEGLSYL 145
+S T + + F+ E G L +Q K K H A +I GL +L
Sbjct: 64 TQLHSCFQTM-DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYA-----AEIAIGLFFL 117
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--IL--AQARSAHSVIEFMAPE--L 199
HS +I+RDLK DN+ ++ +G +KI D G+ I R+ +++APE
Sbjct: 118 HSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA 174
Query: 200 YEEEYNELVDIYAFGMCLLELVTFEYPY 227
Y + Y + VD +AFG+ L E++ + P+
Sbjct: 175 Y-QPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY K + G GA V A+D + VA K+ +N +R Y E+ L+K +
Sbjct: 18 RYQNLKPI-GSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 86 HKNIIKFYNSWVDT----ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
HKNII N + E + + + E+ + + + + H + L Q+L G
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCG 131
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--RSAHSVIEFM-APE 198
+ +LHS +IHRDLK NI V + +KI D GLA + + + V + APE
Sbjct: 132 IKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 188
Query: 199 -LYEEEYNELVDIYAFGMCLLELV 221
+ Y E VDI++ G + E+V
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 22/222 (9%)
Query: 13 DSDAEFVEIDPSA-----RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN 67
D++ VEI S RY K + G GA V A+D + VA K+ +N
Sbjct: 7 DNNFYSVEIGDSTFTVLKRYQNLKPI-GSGAQGIVCAAYDAILERNVAIK--KLSRPFQN 63
Query: 68 SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT----ENEHINFITEIFTSGTLRQYRKKH 123
+R Y E+ L+K + HKNII N + E + + + E+ + + + +
Sbjct: 64 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 123
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
H + L Q+L G+ +LHS +IHRDLK NI V + +KI D GLA
Sbjct: 124 DHERMSYL---LYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGLARTAG 177
Query: 184 QARSAHSVI---EFMAPE-LYEEEYNELVDIYAFGMCLLELV 221
+ + + APE + Y E VDI++ G + E++
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 32/259 (12%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHK 87
++++V+G G F +V RA + +G+++ IK++ + D E+ +L L H
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMN-AAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63
Query: 88 NIIKFYNSWVDTENEHINFIT-EIFTSGTLRQYRKKHKHVDL----------------RA 130
NII + EN +I E G L + +K + ++ +
Sbjct: 64 NIINLLGA---CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARS 187
L +++ + G+ YL + IHRDL N+ V G KI D GL+ + +
Sbjct: 121 LLQFASDVATGMQYLS--EKQFIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVKKTM 177
Query: 188 AHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIK 245
+ +MA E L Y D+++FG+ L E+V+ PY T A++Y+K+ G +
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYR 236
Query: 246 PASLAKVADNGVRAFIEKC 264
+ D+ V + +C
Sbjct: 237 -MEKPRNCDDEVYELMRQC 254
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 33 VLGRGAFKKVY----RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
V+GRG++ KV + D++ ++V + L+ + ED++ + +E H+ +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKE-----LVHDDEDIDWVQTEKHVFEQASSNP 56
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ +S T + + + E G L + ++ + + + ++ +I L++LH
Sbjct: 57 FLVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPELYE-EE 203
+I+RDLK DN+ ++ + G +K+ D G+ S ++APE+ EE
Sbjct: 116 G--IIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 204 YNELVDIYAFGMCLLELVTFEYPY 227
Y VD +A G+ + E++ P+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 48/203 (23%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNI 89
++LG+G F KV ++ G A +K++ +++ +++ +E +L+ +H +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYA---MKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
S+ ++ + F+ E G L + + + + + +I+ L YLHS D
Sbjct: 58 TALKYSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILAQARSAHSVIEFMAPELYEE-EY 204
V++RDLK +N+ ++ + G +KI D GL + A ++ E++APE+ E+ +Y
Sbjct: 116 --VVYRDLKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 205 NELVDIYAFGMCLLELVTFEYPY 227
VD + G+ + E++ P+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 38/144 (26%), Positives = 72/144 (50%), Gaps = 9/144 (6%)
Query: 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDN 161
E + + G L + ++ DL + ++ ++L L LH + VI+RDLK +N
Sbjct: 66 EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPEN 123
Query: 162 IFVNGNQGEVKIGDLGLAAI-LAQARSAHSVI---EFMAPELYE-EEYNELVDIYAFGMC 216
I ++ QG + + D GL + + ++ E++APEL Y + VD + G+
Sbjct: 124 ILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182
Query: 217 LLELVTFEYPYVECTNAAQIYKKV 240
L E++T P+ + N ++Y+K+
Sbjct: 183 LYEMLTGLPPFYD-ENVNEMYRKI 205
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 17/154 (11%)
Query: 76 SEVHLLKTLKHKNIIKFYN--SWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKK 133
E+ +LKT+ H+ II + W T + + + L Y + + L
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKST----VCMVMPKYKC-DLFTYVDRSGPLPLEQAIT 189
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA------QARS 187
R++LE L+YLH +IHRD+K +NIF++ +GD G A L Q
Sbjct: 190 IQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 188 AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLEL 220
+E +PEL + Y DI++ G+ L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 10/92 (10%)
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA------ 188
+RQ+L + Y+H +IHRD+K +N+ VNG + ++ +GD G A + S
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322
Query: 189 HSVIEFMAPE-LYEEEYNELVDIYAFGMCLLE 219
++ APE L + Y VDI++ G+ + E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 33 VLGRGAFKKVY----RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
VLG+G+F KV + DEL I++ + + D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALSGKPP 61
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQY-----RKKHKHVDLRALKKWSRQILEGLS 143
+ +S T + + F+ E G L R K H ++ +I GL
Sbjct: 62 FLTQLHSCFQTM-DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-----YAAEIAIGLF 115
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA--IL--AQARSAHSVIEFMAPEL 199
+LHS +I+RDLK DN+ ++ ++G +KI D G+ + ++ +++APE+
Sbjct: 116 FLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
Query: 200 YE-EEYNELVDIYAFGMCLLELVTFEYPY 227
+ Y + VD +AFG+ L E++ + P+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAILAQAR------ 186
+S Q+ G+ +L S + +HRDL N+ + +G+ VKI D GLA + +
Sbjct: 244 FSYQVANGMEFLASKN--CVHRDLAARNVLIC--EGKLVKICDFGLARDIMRDSNYISKG 299
Query: 187 SAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGI 244
S +++MAPE ++ Y L D+++FG+ L E+ T PY E Q Y + G
Sbjct: 300 STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY 359
Query: 245 KPASLAKVADNGVRAFIEKCIAEVSERLP 273
+ A A +D + ++KC E E P
Sbjct: 360 RMAKPAHASDE-IYEIMQKCWEEKFEIRP 387
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 60/244 (24%), Positives = 96/244 (39%), Gaps = 43/244 (17%)
Query: 29 RYKEVLGRGAFKKVY--RAFDELEGIE---VAWNQIKVIDLLRNSEDLERLYSEVHLLKT 83
Y +G+GAF +V+ RA L VA +K D +R E L+
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAALMAE 64
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--------KHVDLRALK--- 132
H NI+K V + + + E G L ++ + H A K
Sbjct: 65 FDHPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 133 -----------KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL--- 178
++Q+ G++YL + +HRDL N V N VKI D GL
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENM-VVKIADFGLSRN 179
Query: 179 --AAILAQARSAHSV-IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEY-PYVECTNA 233
+A +A ++ I +M PE ++ Y D++A+G+ L E+ ++ PY +
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239
Query: 234 AQIY 237
IY
Sbjct: 240 EVIY 243
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 31/229 (13%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93
+G G F KV + G+ A +K + ++ EV + L H N+++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 94 NSWVDTENEHINFITEIFTSGTLRQY-RKKHKHV----DLRALKKWSRQILEGLSYLHSH 148
+ E+ + E G L+ Y R V L++ + ++ GL +LH
Sbjct: 62 GQCI--ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--------IEFMAPELY 200
D IH DL N + + VKIGD GLA L Q + + + ++APEL
Sbjct: 120 D--FIHSDLALRNCQLTADL-SVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 201 EEEYNELV--------DIYAFGMCLLELVTF-EYPYVECTNAAQIYKKV 240
E +L+ +I++ G+ + EL T + PY + ++ Q+ K+V
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-EQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/276 (21%), Positives = 132/276 (47%), Gaps = 27/276 (9%)
Query: 32 EVLGRGAFKKVY---RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
+VLG GA+ KV+ + G A ++ L++ ++ +E +E ++L+ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ + TE + ++ I + + G + + + + ++ +S +I+ L +LH
Sbjct: 66 FLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILAQAR----SAHSVIEFMAPELYEEE 203
+++RD+K +NI ++ ++G V + D GL+ L++ + S IE+MAPE+ +
Sbjct: 125 G--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 204 --YNELVDIYAFGMCLLELVTFEYPYV---ECTNAAQIYKKV--TSGIKPASLAKVADNG 256
+ + VD ++ G+ + EL+T P+ E +++ +++ P+ + A +
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241
Query: 257 VRAFIEKCIAEVSERL-----PAKELLGDPFLQSED 287
+ + K + +RL A E+ PF + D
Sbjct: 242 LHKLLRK---DPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 31/235 (13%)
Query: 32 EVLGRGAFKKVYRAF---DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
++LG G F V D+ ++VA +K+ ++E SE +K H N
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPN 62
Query: 89 IIKFYNSWVDTENEHIN------FITEIFTSGTLRQY------RKKHKHVDLRALKKWSR 136
++K V E + I G L + + + L+ L K+
Sbjct: 63 VMKLIG--VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARSAHS 190
I G+ YL + + IHRDL N + + V + D GL+ + Q R A
Sbjct: 121 DIALGMEYLSNRN--FIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
++++A E L + Y D++AFG+ + E+ T + PY N +IY + G
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHG 231
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 46/207 (22%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED----LERLYSEVHLLKTLKHKNI 89
LG G F V + +++ E + + +L+N + + L E ++++ L + I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSE----KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI 58
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ E E + E+ G L ++ +K+KHV + + + Q+ G+ YL +
Sbjct: 59 VRMIGI---CEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMAPE-LYE 201
+HRDL N+ + Q KI D GL+ L + + +++ APE +
Sbjct: 116 --FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 202 EEYNELVDIYAFGMCLLELVTF-EYPY 227
+++ D+++FG+ + E ++ + PY
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 38/145 (26%), Positives = 75/145 (51%), Gaps = 12/145 (8%)
Query: 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165
+T+ + G L + +K K + +++ L +LH +D +++RDLK +NI ++
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD 130
Query: 166 GNQGEVKIGDLGLA-AILAQARSAHS---VIEFMAPELYEEE--YNELVDIYAFGMCLLE 219
G + + D GL+ A L ++ ++ E++APE+ +E Y + VD ++ G+ + E
Sbjct: 131 AT-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
Query: 220 LVTFEYP-YVECTNAAQIYKKVTSG 243
+ P Y E T Q+Y+ + G
Sbjct: 190 MCCGWSPFYAEDTQ--QMYRNIAFG 212
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 8e-07
Identities = 51/204 (25%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 33 VLGRGAFKKVY----RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
VLG+G+F KV + DEL I++ + + D +D+E E +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-----DDVECTMVEKRVLALQDKPP 61
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ +S T + + F+ E G L + ++ ++ +I GL +LH
Sbjct: 62 FLTQLHSCFQTV-DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----AQARSAHSVIEFMAPELYE-EE 203
+I+RDLK DN+ ++ ++G +KI D G+ R+ +++APE+ +
Sbjct: 121 G--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP 177
Query: 204 YNELVDIYAFGMCLLELVTFEYPY 227
Y + VD +A+G+ L E++ + P+
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 52/229 (22%), Positives = 111/229 (48%), Gaps = 18/229 (7%)
Query: 32 EVLGRGAFKKVY---RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
+VLG GA+ KV+ + G A +K +++ ++ E +E +L+ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ + T+ + ++ I + G L + + + + ++ +S +I+ L +LH
Sbjct: 66 FLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGL-----AAILAQARSAHSVIEFMAPELY--- 200
+I+RD+K +NI ++ N G V + D GL + +A S IE+MAP++
Sbjct: 125 G--IIYRDIKLENILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPYV---ECTNAAQIYKKVTSGIKP 246
+ +++ VD ++ G+ + EL+T P+ E + A+I +++ P
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 60/256 (23%), Positives = 107/256 (41%), Gaps = 32/256 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNII 90
+V+G G F +V +A + +G+ + IK + + +D E+ +L L H NII
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 91 KFYNSWVDTENEHINFIT-EIFTSGTLRQYRKKHKHVDL----------------RALKK 133
+ E+ ++ E G L + +K + ++ + L
Sbjct: 60 NLLGA---CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQARSAHS 190
++ + G+ YL IHRDL NI V N KI D GL+ + +
Sbjct: 117 FAADVARGMDYLS--QKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRL 173
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPAS 248
+ +MA E L Y D++++G+ L E+V+ PY T A++Y+K+ G +
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQGYR-LE 231
Query: 249 LAKVADNGVRAFIEKC 264
D+ V + +C
Sbjct: 232 KPLNCDDEVYDLMRQC 247
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 9e-07
Identities = 61/253 (24%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIE----VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
+VLG+G + KV++ ++ G + A +K ++RN +D +E ++L+ +KH
Sbjct: 1 LKVLGKGGYGKVFQV-RKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
I+ ++ + I E + G L + ++ + +I L +LH
Sbjct: 60 PFIVDLIYAF--QTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLH 117
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILAQARSAHS---VIEFMAPE-LYE 201
+I+RDLK +NI ++ QG VK+ D GL + + H+ IE+MAPE L
Sbjct: 118 QQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR 174
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRA 259
+ + VD ++ G + +++T P+ N + K+ G P L A + ++
Sbjct: 175 SGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPYLTPEARDLLKK 233
Query: 260 FIEKCIAEVSERL 272
+++ S RL
Sbjct: 234 LLKR---NPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 48/202 (23%), Positives = 96/202 (47%), Gaps = 16/202 (7%)
Query: 32 EVLGRGAFKKVYRA-FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
V+G+G F VY + +G ++ +K ++ + + E++E+ E ++K H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHC-AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ +E + + G LR + R + + ++ L + Q+ +G+ YL S
Sbjct: 60 SLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--------AQARSAHSVIEFMAPE-LY 200
+HRDL N ++ + VK+ D GLA + A +++MA E L
Sbjct: 119 --FVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 201 EEEYNELVDIYAFGMCLLELVT 222
+++ D+++FG+ L EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 30/216 (13%)
Query: 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLY--SEVHLLKTLKHKNIIK 91
+G G F KV + G A Q+ V +L ++ E++ E ++L+H N+++
Sbjct: 3 IGNGWFGKVILG-EVNSGYTPA--QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-----DLRALKKWSRQILEGLSYLH 146
TE + E G L+ Y + + D L++ + +I GL +LH
Sbjct: 60 CLGQC--TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI------LAQARSAHSVIEFMAPELY 200
++ IH DL N + + VKIGD GL+ + ++APEL
Sbjct: 118 KNN--FIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174
Query: 201 EEEYNELV--------DIYAFGMCLLELVTF-EYPY 227
+E + L+ ++++ G+ + EL PY
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 45/165 (27%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
EFV + P + RGAF KVY + A +K D++ N + ++ +
Sbjct: 5 EFVIVKP----------ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQA 53
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR 136
E L K I+ Y S N + + E G ++ + + D K+
Sbjct: 54 ERDALALSKSPFIVHLYYSLQSANN--VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS 111
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
++ L YLH H +IHRDLK DN+ ++ N+G +K+ D GL+ +
Sbjct: 112 EVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 27/232 (11%)
Query: 33 VLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89
+LG+G F V A + E +VA +K D+ +S D+E E +K H N+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIF-SSSDIEEFLREAACMKEFDHPNV 63
Query: 90 IKFYNSWVDTENEH----INFITEIFTSGTLRQYRKKHK------HVDLRALKKWSRQIL 139
IK + + + I G L + + + L+ L ++ I
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARSAHSVIE 193
G+ YL S + IHRDL N +N N V + D GL+ + Q ++ ++
Sbjct: 124 SGMEYLSSKN--FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVK 180
Query: 194 FMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
++A E L + Y D++AFG+ + E++T + PY N ++IY + G
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKG 231
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHS 190
++ +I GL LH +++RDLK +NI ++ + G ++I DLGLA + + R
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163
Query: 191 VIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPY 227
+ +MAPE+ + E Y D + G + E++ + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAILAQAR--- 186
L ++ Q+ G+ +L S + +HRDL N+ + QG+ VKI D GLA +
Sbjct: 239 LLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA--QGKIVKICDFGLARDIMHDSNYV 294
Query: 187 ---SAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVT 241
S +++MAPE +++ Y L D++++G+ L E+ + PY + Y K+
Sbjct: 295 SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354
Query: 242 SGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGD 280
SG + A A V + KC E+ P+ L D
Sbjct: 355 SGYRMAK-PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 65/274 (23%), Positives = 115/274 (41%), Gaps = 42/274 (15%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHK 87
++++V+G G F +V +A + +G+ + IK + + +D E+ +L L H
Sbjct: 10 KFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 88 NIIKFYNSWVDTENEHINFI---TEIFTSGTLRQYRKKHKHVDL---------------- 128
NII + EH ++ E G L + +K + ++
Sbjct: 69 NIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---AILAQA 185
+ L ++ + G+ YL IHRDL NI V G KI D GL+ + +
Sbjct: 124 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKK 180
Query: 186 RSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+ +MA E L Y D++++G+ L E+V+ PY T A++Y+K+ G
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKLPQG 239
Query: 244 I---KPASLAKVADNGVRAFIEKCIAEVSERLPA 274
KP + D+ V + +C E P+
Sbjct: 240 YRLEKPLN----CDDEVYDLMRQCWREKPYERPS 269
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 36/112 (32%), Positives = 58/112 (51%), Gaps = 13/112 (11%)
Query: 128 LRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----- 182
L L +S Q+ G+ +L S IHRDL NI ++ N VKI D GLA +
Sbjct: 172 LEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPD 228
Query: 183 -AQARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF---EYPYVE 229
+ A +++MAPE ++++ Y D+++FG+ L E+ + YP V+
Sbjct: 229 YVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 30/98 (30%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH---S 190
++ +I GL LH +++RDLK +NI ++ + G ++I DLGLA + + ++
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163
Query: 191 VIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPY 227
+ +MAPE+ + E Y D +A G L E++ + P+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 53/205 (25%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS----EDLERLYSEVHLLKTLKHK 87
+VLG+G+F KV+ ++ G + Q+ + +L+ + D R E +L + H
Sbjct: 2 KVLGQGSFGKVF-LVRKITGPDA--GQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHP 58
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I+K + ++ TE + + I + G L K +K + ++ L +LHS
Sbjct: 59 FIVKLHYAF-QTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 116
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA-ILAQARSAHS---VIEFMAPELYEEE 203
+I+RDLK +NI ++ +G +K+ D GL+ + + A+S +E+MAPE+
Sbjct: 117 LG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173
Query: 204 -YNELVDIYAFGMCLLELVTFEYPY 227
+ + D ++FG+ + E++T P+
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPF 198
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHS 190
++ +IL GL LH + ++RDLK +NI ++ + G ++I DLGLA + + R
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+ +MAPE L + Y D + G + E++ + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 35/106 (33%), Positives = 57/106 (53%), Gaps = 13/106 (12%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARS 187
+S Q+ G+ +L S IHRDL NI ++ N VKI D GLA + + S
Sbjct: 179 YSFQVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGS 235
Query: 188 AHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF---EYPYVE 229
A +++MAPE ++++ Y D+++FG+ L E+ + YP V+
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
V+G GA+ V + + VA + K D N E E E+ +L+TLK +NI++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPV 152
++ ++ F E L + V ++ + Q+++ + + H +D +
Sbjct: 66 KEAFRRRGKLYLVF--EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--I 121
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYEE-------EYN 205
+HRD+K +N+ ++ N +K+ D G A L++ +A+ E++A Y Y
Sbjct: 122 VHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYT-EYVATRWYRSPELLLGAPYG 179
Query: 206 ELVDIYAFGMCLLEL 220
+ VD+++ G L EL
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 31/255 (12%)
Query: 32 EVLGRGAFKKVYRA-FDELEGI-EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89
+ LG G F V ++ + I +VA +K+ R+ ++E SE +K H N+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRS--EMEDFLSEAVCMKEFDHPNV 62
Query: 90 IKFYN-SWVDTENEHIN---FITEIFTSGTLRQYRKKHK------HVDLRALKKWSRQIL 139
++ E+E I G L + + ++ + L K+ I
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARSAHSVIE 193
G+ YL S IHRDL N +N N V + D GL+ + Q R A ++
Sbjct: 123 SGMEYLSSKS--FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 194 FMAPE-LYEEEYNELVDIYAFGMCLLELVT---FEYPYVECTNAAQIYKKVTSGIKPASL 249
++A E L + Y D+++FG+ + E+ T YP VE ++IY + G +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE---NSEIYDYLRQGNRLKQP 236
Query: 250 AKVADNGVRAFIEKC 264
D G+ + + C
Sbjct: 237 PDCLD-GLYSLMSSC 250
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 56/250 (22%), Positives = 106/250 (42%), Gaps = 49/250 (19%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+V+GRGAF +V + G A ++ D+L E + + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEK-EQVAHIRAERDILVEADGAWVVK 65
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ S+ D N ++ I E G + K + A + + + + + +H
Sbjct: 66 MFYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG-- 121
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS------------------------ 187
IHRD+K DN+ ++ +G VK+ D GL L +A
Sbjct: 122 FIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 188 ------------AHSVI---EFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECT 231
A+S + +++APE++ + YN+L D ++ G+ + E++ P+ C+
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF--CS 238
Query: 232 NAAQ-IYKKV 240
Q Y+KV
Sbjct: 239 ETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 31/73 (42%), Positives = 37/73 (50%), Gaps = 13/73 (17%)
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI--E 193
RQIL L LHS ++HRD+K NI + G KI DLG AA L R + I E
Sbjct: 262 RQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADL---RVGINYIPKE 316
Query: 194 FM------APELY 200
F+ APE Y
Sbjct: 317 FLLDPRYAAPEQY 329
|
Length = 566 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 56/250 (22%), Positives = 105/250 (42%), Gaps = 49/250 (19%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+V+GRGAF +V + G A ++ D+L E + + +E +L ++K
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-EQVGHIRAERDILVEADSLWVVK 65
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
+ S+ D N ++ I E G + K + + + + + + +H
Sbjct: 66 MFYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG-- 121
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA-------HSV------------- 191
IHRD+K DN+ ++ ++G VK+ D GL L +A HS+
Sbjct: 122 FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 192 -------------------IEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECT 231
+++APE++ + YN+L D ++ G+ + E++ P+ C+
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF--CS 238
Query: 232 NAAQ-IYKKV 240
Q YKKV
Sbjct: 239 ETPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 40/156 (25%), Positives = 78/156 (50%), Gaps = 20/156 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID----LLRNSEDLERLYSEVHLLKTLKHK 87
++LG+G +V+ L+G + +KV+D + RN ++R+ +E +L TL H
Sbjct: 7 KLLGKGDVGRVFLV--RLKGTGKLF-ALKVLDKKEMIKRNK--VKRVLTEQEILATLDHP 61
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSG----TLRQYRKKHKHVDLRALKKWSRQILEGLS 143
+ Y S TE ++ + + + G L Q R+ K + + ++ ++L L
Sbjct: 62 FLPTLYAS-FQTE-TYLCLVMD-YCPGGELFRLLQ-RQPGKCLSEEVARFYAAEVLLALE 117
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
YLH +++RDLK +NI ++ + G + + D L+
Sbjct: 118 YLHLLG--IVYRDLKPENILLHES-GHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 56/271 (20%), Positives = 119/271 (43%), Gaps = 52/271 (19%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER-----LYSEVHLLKTLKH 86
+V+GRGAF +V A +L+ + ++ + +L E L+R E +L +
Sbjct: 7 KVIGRGAFGEV--AVVKLKNAD----KVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
+ I + ++ D N ++ + + + G L L L K+ ++ E ++ +
Sbjct: 61 QWITTLHYAFQDENNLYL--VMDYYVGGDL-----------LTLLSKFEDRLPEDMARFY 107
Query: 147 ----------SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---- 192
H +HRD+K DNI ++ N G +++ D G L + + S +
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGT 166
Query: 193 -EFMAPELYEE------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245
++++PE+ + +Y D ++ G+C+ E++ E P+ + + Y K+ + +
Sbjct: 167 PDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKE 225
Query: 246 ----PASLAKVADNGVRAFIEKCIAEVSERL 272
PA + V+++ + I + I RL
Sbjct: 226 RFQFPAQVTDVSEDA-KDLIRRLICSREHRL 255
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 45/213 (21%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+V+GRGAF +V + + ++ + LL E ++R S + ++I+
Sbjct: 49 KVIGRGAFGEVQLVRHK------SSQKVYAMKLLSKFEMIKRSDSAFFW----EERDIMA 98
Query: 92 FYNS-WVDT------ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
F NS WV +++++ + E G L + V + K ++ +++ L
Sbjct: 99 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDA 157
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH-----SVIEFMAPEL 199
+HS +IHRD+K DN+ ++ G +K+ D G + + ++++PE+
Sbjct: 158 IHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 200 YEEE-----YNELVDIYAFGMCLLELVTFEYPY 227
+ + Y D ++ G+ L E++ + P+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARS 187
+S Q+ +G+ +L S IHRDL NI ++ N VKI D GLA + +
Sbjct: 184 YSFQVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD 240
Query: 188 AHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF---EYPYVE 229
A +++MAPE +++ Y D+++FG+ L E+ + YP V+
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 31/228 (13%)
Query: 34 LGRG--AFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNII 90
+GRG VY A G V +++ DL E L+ L +EV L +H NI+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVT---VRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQIL----EGLSYLH 146
+ V T + I+ G+ K + + + IL GL+YLH
Sbjct: 63 TSWT--VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS--EALIGNILFGALRGLNYLH 118
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG-LAAILAQARSAHSVIEF----------M 195
+ IHR++K +I ++G+ G V + L L +++ + A V +F +
Sbjct: 119 QNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWL 175
Query: 196 APELYEEE---YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
+PEL ++ YN DIY+ G+ EL T P+ + + +K+
Sbjct: 176 SPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 27/98 (27%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHS 190
++ ++ GL L +++RDLK +NI ++ ++G ++I DLGLA + + R
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+ +MAPE + E+Y D + G + E++ + P+
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 50/202 (24%), Positives = 86/202 (42%), Gaps = 29/202 (14%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92
V+ RG Y+ G++ +I ++ + +SE + + L+H NI+K
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD--------MGKLQHPNIVKL 748
Query: 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ------ILEGLSYLH 146
+E ++ + G K V LR L W R+ I + L +LH
Sbjct: 749 IGL---CRSEKGAYLIHEYIEG------KNLSEV-LRNLS-WERRRKIAIGIAKALRFLH 797
Query: 147 SH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYE-EEY 204
P V+ +L + I ++G + E + L L +L ++APE E ++
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDG-KDEPHL-RLSLPGLLCTDTKCFISSAYVAPETRETKDI 855
Query: 205 NELVDIYAFGMCLLELVTFEYP 226
E DIY FG+ L+EL+T + P
Sbjct: 856 TEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 39/142 (27%), Positives = 65/142 (45%), Gaps = 34/142 (23%)
Query: 114 GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173
L Q + ++ L L++ + +I G++++H H+ +H DL N F+ + VK+
Sbjct: 84 SYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDL-TVKV 140
Query: 174 GDLGLAAILAQARSAHSVIE----------FMAPELYEEEYNELV--------DIYAFGM 215
GD G+ +R IE ++APEL E + L+ +++A G+
Sbjct: 141 GDYGIGP----SRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGV 196
Query: 216 CLLELVTFEYPYVECTNAAQIY 237
L EL FE NAAQ Y
Sbjct: 197 TLWEL--FE-------NAAQPY 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 145 LHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI-----EFMAPE 198
+HS H +HRD+K +N+ ++ G +K+ D G AA L + +S + +++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173
Query: 199 LYEE-------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---GIKPAS 248
+ Y D ++ G+ E++ P+ E +A+ Y + + +K
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMNFQRFLKFPE 232
Query: 249 LAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSED 287
KV+ + I+ + ERL + L PF D
Sbjct: 233 DPKVSSD-FLDLIQSLLCGQKERLGYEGLCCHPFFSKID 270
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 38/164 (23%), Positives = 58/164 (35%), Gaps = 29/164 (17%)
Query: 134 WS--RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--AQARSAH 189
W+ Q L L LH L + + + G A Q+R
Sbjct: 20 WAVCLQCLGALRELHRQAKS--GNILLTWDGLLKLD---------GSVAFKTPEQSRPDP 68
Query: 190 SVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
FMAPE+ + Y E DIY+ G+ L E + +E PY E + I + + +G+ PA
Sbjct: 69 Y---FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGM-PAD 124
Query: 249 LAKVADNG--------VRAFIEKCIAEVS-ERLPAKELLGDPFL 283
+ N F+ C + + R A L
Sbjct: 125 DPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 23/100 (23%)
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI--------LAQARSAHSVIE 193
L YLH++ ++HRDLK DN+ + + G +K+ D GL+ I L + E
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 194 FM-----------APE-LYEEEYNELVDIYAFGMCLLELV 221
F+ APE + + Y + VD +A G+ L E +
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 22/53 (41%), Positives = 32/53 (60%), Gaps = 3/53 (5%)
Query: 127 DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
D+ +K RQ+L GL LH ++HRD+K +N+ V + G+VKI D G A
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVD-GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 47/215 (21%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+V+GRGAF +V A +++ E +I + +L E L+R +E + + +N++
Sbjct: 7 KVIGRGAFGEV--AVVKMKHTE----RIYAMKILNKWEMLKR--AETACFR--EERNVLV 56
Query: 92 FYN-SWVDT------ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
+ W+ T + ++ + + + G L K + + ++ I E +
Sbjct: 57 NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF--YIAEMVLA 114
Query: 145 LHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI-----EFMAPE 198
+HS H +HRD+K DN+ ++ N G +++ D G + Q + S + ++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 199 LYEE------EYNELVDIYAFGMCLLELVTFEYPY 227
+ + +Y D ++ G+C+ E++ E P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.004
Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 9/119 (7%)
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
+ + E EV +L+ L K + + + E TL +
Sbjct: 28 INPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE----- 82
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPV-IHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
V + + Q+ E L+ LH V H DL NI V+ + + I D A
Sbjct: 83 --VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI-LGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 613 | |||
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.67 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.19 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.6 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.52 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.49 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.29 | |
| PF12202 | 38 | OSR1_C: Oxidative-stress-responsive kinase 1 C ter | 98.27 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.21 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.05 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.88 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.82 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.71 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.58 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.47 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.41 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.32 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.31 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.31 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.24 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.13 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.03 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.23 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.19 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.02 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.78 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.69 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.62 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.24 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 95.19 | |
| PLN02236 | 344 | choline kinase | 94.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.31 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.16 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 93.99 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.36 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.05 | |
| PTZ00384 | 383 | choline kinase; Provisional | 92.84 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.34 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 88.99 | |
| PF06631 | 47 | DUF1154: Protein of unknown function (DUF1154); In | 87.34 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 87.19 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 86.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.63 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-84 Score=699.09 Aligned_cols=394 Identities=62% Similarity=1.020 Sum_probs=350.1
Q ss_pred CCCCCCcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcc
Q 035992 11 PDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90 (613)
Q Consensus 11 ~~~~~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 90 (613)
.+++..++++++|+|||+||.++||+|+|.+||+|+|..+|.+|||++++..++.+++...++|+.|+++|+.|+|||||
T Consensus 25 ~e~~~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIi 104 (632)
T KOG0584|consen 25 SEPDESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNII 104 (632)
T ss_pred hccccccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCcee
Confidence 44677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc
Q 035992 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE 170 (613)
Q Consensus 91 kl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~ 170 (613)
+||++|++..+.++.||+|+|++|+|+.|++++++++.+.++.|++||++||.|||++.||||||||||+||||+|+.|.
T Consensus 105 rfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~ 184 (632)
T KOG0584|consen 105 RFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE 184 (632)
T ss_pred eeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeccchhHHHhhhc--cCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc
Q 035992 171 VKIGDLGLAAILAQAR--SAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248 (613)
Q Consensus 171 VKL~DFGla~~l~~~~--~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~ 248 (613)
|||+|+|||+.+.... ...|||+|||||+|++.|++.+|||||||||+||+|+.|||.+|.++++||+++++|++|..
T Consensus 185 VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 185 VKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred eeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 9999999999987654 45699999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccHHHHHHHHHHhhcccCCCCHHHHhcCCCCCCCCc---------cc-cccc--ccccc-----c-CCcccccccc
Q 035992 249 LAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDD---------ES-VGRS--LRVKT-----H-YSAETSHQAN 310 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~dP~~Rpta~eLL~HPff~~~~~---------~~-~~~~--~~~~~-----~-~~~~~~~~~~ 310 (613)
|.++.+++++.||.+||...++|+|+.|||+||||+.+.. .. .... ++... + .........+
T Consensus 265 l~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~ 344 (632)
T KOG0584|consen 265 LSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDEDGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYN 344 (632)
T ss_pred hhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhccccccccccchhhcccccccccccccchhhcCCcccccccceee
Confidence 9999999999999999998999999999999999998632 00 0000 00000 0 0000000111
Q ss_pred CCccccCC----------CC----------CCCCCeeeeccccCCc-ceEEEEEEecCCCCeeeeEecccCCCCCHHHHH
Q 035992 311 LDKNAYGS----------SA----------ETGRDFTVQGQRRDIN-TIFLKLRISDSTGHFRNIHFPFDTEADTAFAVA 369 (613)
Q Consensus 311 ~~~~~~~~----------~~----------~~~~~~~v~g~~~d~~-~i~L~lri~~~~~~~~~i~F~F~~~~Dta~~Va 369 (613)
+..+.... .. .....++++|.+.+.. .++|.|||++..|..|||+|||++..|||.+||
T Consensus 345 ~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va 424 (632)
T KOG0584|consen 345 LNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVA 424 (632)
T ss_pred cCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHH
Confidence 11111000 01 1236788999998777 999999999999999999999999999999999
Q ss_pred HHHHHhhCCCCccHHHHHHHHHHHHHhhCCCCCCC
Q 035992 370 SEMVEELNLTDQDVSTISAMIESEIRSHIPDWEPK 404 (613)
Q Consensus 370 ~Emv~~~~l~~~d~~~ia~~i~~~i~~~~~~~~~~ 404 (613)
.|||+++.++++++..||+||+.+|.+|+|.|+..
T Consensus 425 ~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~ 459 (632)
T KOG0584|consen 425 HEMVEELEITDQPVVNIAEMIDGEISALVPNWKAS 459 (632)
T ss_pred HHHHhhcCCcccchhhHHHHHhchhhhcCCccCCC
Confidence 99999999999999999999999999999999873
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=429.64 Aligned_cols=251 Identities=30% Similarity=0.489 Sum_probs=226.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
..+||+|+.|+||+++|+.|++.+|+|+|. ..-++...+++.+|+++++.++|||||++|+.|+.... .+.++|||
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~---~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI~mEY 159 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVIL---LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISICMEY 159 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeec---ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEeehhh
Confidence 488999999999999999999999988874 33457788999999999999999999999999987654 79999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--hcc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--ARS 187 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--~~~ 187 (613)
|.+|+|..++++.++++|..+..++.+|++||.|||. ++ ||||||||+|||+| ..|+|||||||.+..+.. ..+
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~t 236 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIANT 236 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhccc
Confidence 9999999999999999999999999999999999995 77 99999999999999 579999999999998865 357
Q ss_pred CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCC----CCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 188 AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVE----CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~----~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
+.||..|||||.+.+ .|+.++||||||+.++||++|++||.. ..+..+++..|..+..|......+++++++||.
T Consensus 237 fvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~ 316 (364)
T KOG0581|consen 237 FVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVS 316 (364)
T ss_pred ccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 789999999998876 599999999999999999999999966 346788888899887665555569999999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 263 KCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
+||+ +|.+|+++.||+.|||+++...
T Consensus 317 ~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 317 CCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999 9999999999999999997643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=425.14 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=227.1
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh---HHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS---EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~---~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
...||-+.+.||+|+||.|-+|+.+.+|+.||+|++.+....... .....+.+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec--
Confidence 445677889999999999999999999999999999876654322 234456899999999999999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEeccch
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGL 178 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DFGl 178 (613)
....|+||||+.||+|++.+-.++.+.+..-+.+++|++.||.|||++| |+||||||+|||++.+ +-.+||+|||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccch
Confidence 4567999999999999999999999999999999999999999999999 9999999999999732 35789999999
Q ss_pred hHHHhh---hccCcccccccCccccccc----cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC--cc
Q 035992 179 AAILAQ---ARSAHSVIEFMAPELYEEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--SL 249 (613)
Q Consensus 179 a~~l~~---~~~~~gt~~YmAPEvl~~~----ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l 249 (613)
|++... .++.+||+.|.|||++... |..++|||||||++|-+++|.+||++......+++.|.+|..+. ..
T Consensus 326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 998854 3578999999999988642 45699999999999999999999988777777889999887543 34
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..++.++++||.+||. ||++|||+.|+|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 55679999999999999 999999999999999999754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=434.73 Aligned_cols=258 Identities=31% Similarity=0.505 Sum_probs=233.5
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
+-.||..++|...++||+|||++||.+.+..+|+.||+|+|.+.. .......+++.+||++.++|+|||||++|++|.+
T Consensus 11 ~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED 89 (592)
T KOG0575|consen 11 VIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED 89 (592)
T ss_pred eeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec
Confidence 445888888899999999999999999999999999999998654 4556888999999999999999999999999965
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
..++|||+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++ |||||||..|+|++ +..+|||+||||
T Consensus 90 --s~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGL 164 (592)
T KOG0575|consen 90 --SNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGL 164 (592)
T ss_pred --CCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccce
Confidence 5689999999999999999999999999999999999999999999999 99999999999999 456999999999
Q ss_pred hHHHhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 179 AAILAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 179 a~~l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
|+.+.. ..+.+||+.|+|||++.. +++..+||||+||+||.||+|++||.. .+..+.|.+|.... -.+|...
T Consensus 165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~--Y~~P~~l 241 (592)
T KOG0575|consen 165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNE--YSMPSHL 241 (592)
T ss_pred eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcC--ccccccc
Confidence 998874 347799999999998764 599999999999999999999999954 67888898888663 2355678
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+.++++||.++|+ +|.+|||+.++|.|+||..
T Consensus 242 s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 242 SAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 9999999999999 9999999999999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=420.01 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=229.7
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
-....++..-|.+.++||.|..++||+|+++.++..||||.+. +.+...+++.+.+|++.|+.++||||++++.+|+
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~in---LEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIIN---LEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEee---hhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 3445677788899999999999999999999999999977765 4455677999999999999999999999999998
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
. +..+|+||.||.+|++.++++.. ..++|..|+.+++++++||.|||.+| .||||||+.||||+ .+|.|||+|
T Consensus 95 v--~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLad 169 (516)
T KOG0582|consen 95 V--DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLAD 169 (516)
T ss_pred e--cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcC
Confidence 6 45899999999999999999875 45999999999999999999999999 99999999999998 679999999
Q ss_pred cchhHHHhhh--------ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 176 LGLAAILAQA--------RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 176 FGla~~l~~~--------~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
||.+..+... .++.++++|||||++.+ +|+.|+|||||||+++||++|..||........+..++....
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p 249 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP 249 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence 9988655321 35578889999998543 599999999999999999999999999998888888777654
Q ss_pred C-------CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 K-------PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ~-------p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
. +....+.++..++.||..||+ ||.+||||.+||+|+||+...
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3 223345567899999999999 999999999999999999874
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=410.92 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=231.5
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-+.+.++||+|+||+||+++.+.+++.+|+|++++...... .+.++...|..+|..++||.||+++.+|.+ ...+|+
T Consensus 26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt--~~kLyl 102 (357)
T KOG0598|consen 26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQT--EEKLYL 102 (357)
T ss_pred heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEeccc--CCeEEE
Confidence 35677999999999999999999999999999998776554 678889999999999999999999999965 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
|++|+.||.|+.++++.+.|+|..++.|+.+|+.||.|||++| ||||||||+|||++ .+|+|+|+|||+++....
T Consensus 103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCC
Confidence 9999999999999999999999999999999999999999999 99999999999998 789999999999985432
Q ss_pred --hccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 --ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
..+.+||+.|||||++. .+|+..+|+||||+++|||++|.+||.. .+...++++|..+.. ..++...+.+++++|
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~-~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKL-PLPPGYLSEEARDLL 257 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcC-CCCCccCCHHHHHHH
Confidence 34678999999999765 5699999999999999999999999965 778888999998863 245667899999999
Q ss_pred HHHhh-cccCCC----CHHHHhcCCCCCCCCcccc
Q 035992 262 EKCIA-EVSERL----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 262 ~~cL~-dP~~Rp----ta~eLL~HPff~~~~~~~~ 291 (613)
+++|+ +|.+|. ++.++.+||||...+|..+
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 99999 999996 5899999999999988654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=390.56 Aligned_cols=253 Identities=25% Similarity=0.476 Sum_probs=230.1
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
..+.||.|+||.|.+++++.+|..+|+|++++.++.+ ..+.++..+|..+|+.+.||++++++++|.+ ...+|+|||
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVk-lKQveH~~nEk~vL~~v~~PFlv~l~~t~~d--~~~lymvme 124 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVK-LKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD--NSNLYMVME 124 (355)
T ss_pred heeeeccCccceEEEEEEccCCceeehhhcCHHHHHH-HHHHHHHhhHHHHHhhccCceeEEEEEeecc--CCeEEEEEe
Confidence 3489999999999999999999999999998766543 5778899999999999999999999999865 678999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-ccC
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-RSA 188 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~ 188 (613)
|..||.|+.++++.++|++..++.++.||+.||+|||+++ |++|||||+|||++ ..|.+||+|||+|+.+... -+.
T Consensus 125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~rT~Tl 201 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGRTWTL 201 (355)
T ss_pred ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCcEEEe
Confidence 9999999999999999999999999999999999999999 99999999999998 6799999999999887653 467
Q ss_pred cccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-
Q 035992 189 HSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA- 266 (613)
Q Consensus 189 ~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~- 266 (613)
+||+.|+|||++. .+|+.++|+|||||++|||+.|.+||.. .++.++|++|..+. ..+|..+++++++||.++|+
T Consensus 202 CGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~--v~fP~~fs~~~kdLl~~LL~v 278 (355)
T KOG0616|consen 202 CGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGK--VKFPSYFSSDAKDLLKKLLQV 278 (355)
T ss_pred cCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCc--ccCCcccCHHHHHHHHHHHhh
Confidence 9999999999776 5699999999999999999999999976 66799999999985 35678889999999999999
Q ss_pred cccCCC-----CHHHHhcCCCCCCCCcccc
Q 035992 267 EVSERL-----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 267 dP~~Rp-----ta~eLL~HPff~~~~~~~~ 291 (613)
|-++|. ...++..||||+..+|..+
T Consensus 279 D~t~R~gnlknG~~dIk~H~wF~~v~W~~i 308 (355)
T KOG0616|consen 279 DLTKRFGNLKNGVEDIKNHPWFKGVDWEAI 308 (355)
T ss_pred hhHhhhcCcCCCccccccCcccccccHHHH
Confidence 999984 4789999999999988654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=409.97 Aligned_cols=280 Identities=20% Similarity=0.359 Sum_probs=240.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+.+.++||+||||.||+|+.+.||..+|+|++++..+.+ ..+++.++.|..+|...++|+||++|.+|.+ ..++|+|
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~-~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD--~~~LYLi 219 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLK-KNQVEHVRAERDILAEVDSPWVVKLYYSFQD--KEYLYLI 219 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHh-hhhHHHHHHHHHHhhhcCCCcEEEEEEEecC--CCeeEEE
Confidence 345689999999999999999999999999999876554 5788999999999999999999999999965 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||++||++..+|.+.+.|++..++.++.+++.||+.||++| +|||||||+|+||+ ..|++||+||||+..+..
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhh
Confidence 999999999999999999999999999999999999999999 99999999999998 789999999999854310
Q ss_pred ------------------------------------------------hccCcccccccCcccccc-ccCccchhhhhhH
Q 035992 185 ------------------------------------------------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGM 215 (613)
Q Consensus 185 ------------------------------------------------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGv 215 (613)
.....|||.|||||++.+ +|+..+|+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 012356788999998765 5999999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc--ccccHHHHHHHHHHhhcccCCCC---HHHHhcCCCCCCCCccc
Q 035992 216 CLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA--KVADNGVRAFIEKCIAEVSERLP---AKELLGDPFLQSEDDES 290 (613)
Q Consensus 216 iL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~l~~lI~~cL~dP~~Rpt---a~eLL~HPff~~~~~~~ 290 (613)
|+||||.|.+||.. .++.+.+.+|........++ ...+.++++||.+||.+|.+|+. +.||.+||||+..+|..
T Consensus 377 ImyEmLvGyPPF~s-~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCS-ETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHhCCCCCCC-CCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcch
Confidence 99999999999965 67888888988775333333 34579999999999999999986 89999999999999876
Q ss_pred c---cccccccccCCccccccccCCcc
Q 035992 291 V---GRSLRVKTHYSAETSHQANLDKN 314 (613)
Q Consensus 291 ~---~~~~~~~~~~~~~~~~~~~~~~~ 314 (613)
+ .++..|......+++.+.++++.
T Consensus 456 l~~~~apfvP~v~~~~DT~yFddF~e~ 482 (550)
T KOG0605|consen 456 LREMPAPFVPQVNSELDTQYFDDFPEE 482 (550)
T ss_pred hhcCCCCCCCCCCCcccccccccCccc
Confidence 5 45566666667777777665543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=394.33 Aligned_cols=252 Identities=26% Similarity=0.471 Sum_probs=221.0
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
-+.+.||+|+||+||+|+++.++..||||.|.+.++ +...++.+..||.+|+.++|||||.+++++.. .+.+|+||
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~--~~~i~lVM 88 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIED--DDFIYLVM 88 (429)
T ss_pred eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEec--CCeEEEEE
Confidence 456779999999999999999999999999876544 56788889999999999999999999997654 56899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--C---CcEEEeccchhHHHh
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--Q---GEVKIGDLGLAAILA 183 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~---g~VKL~DFGla~~l~ 183 (613)
|||.||+|.+|+++++.+++..++.++.||+.||++||+++ ||||||||.|||++.. . -.+||+|||+|+.+.
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999 9999999999999743 1 358999999999987
Q ss_pred hh---ccCcccccccCcccc-ccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-CCCcccccccHHHH
Q 035992 184 QA---RSAHSVIEFMAPELY-EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-KPASLAKVADNGVR 258 (613)
Q Consensus 184 ~~---~~~~gt~~YmAPEvl-~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-~p~~l~~~~s~~l~ 258 (613)
.. .+.+|++-|||||++ .++|+-|+|+||+|+++|+|++|+.||.. .+..+++..+..+. ..+.++...+....
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~ 245 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLR 245 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchh
Confidence 54 467899999999988 56799999999999999999999999966 45666666776664 34456666777888
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+++...|+ ++.+|.+..+-+.|+|+....
T Consensus 246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 246 ELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 88888888 999999999999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=410.37 Aligned_cols=256 Identities=29% Similarity=0.533 Sum_probs=230.5
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
.||..+|..+ +.||+|+.|.||.|....+++.||+|++.+.. ....+-+.+|+.+|+..+|+|||.|+++|...
T Consensus 269 ~dP~~~y~~~-~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~----Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~- 342 (550)
T KOG0578|consen 269 GDPRSKYTDF-KKIGQGATGGVYVARKISTKQEVAIKRMDLRK----QPKKELLLNEILVMRDLHHPNIVNFLDSYLVG- 342 (550)
T ss_pred CChhhhhcch-hhhccccccceeeeeeccCCceEEEEEEEecc----CCchhhhHHHHHHHHhccchHHHHHHHHhccc-
Confidence 6888888655 89999999999999999999999999988654 34456789999999999999999999998764
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+|+||||+.||+|.+.+.... ++|.+|+.+++++++||+|||.++ |||||||.+|||+. .+|.|||+|||++.
T Consensus 343 -deLWVVMEym~ggsLTDvVt~~~-~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFca 417 (550)
T KOG0578|consen 343 -DELWVVMEYMEGGSLTDVVTKTR-MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCA 417 (550)
T ss_pred -ceeEEEEeecCCCchhhhhhccc-ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeee
Confidence 67999999999999999887754 999999999999999999999999 99999999999997 77899999999998
Q ss_pred HHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 181 ILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 181 ~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.+... .+..||+.|||||++.. .|++++||||||++++||+-|++||........+|..-.+|......+...++
T Consensus 418 qi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~ 497 (550)
T KOG0578|consen 418 QISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSP 497 (550)
T ss_pred ccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCH
Confidence 77543 35678999999998875 59999999999999999999999998877777888888888877778888999
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+++|+.+||+ |+.+|++|.|||.||||+...
T Consensus 498 ~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 498 ELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred HHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 99999999999 999999999999999997654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=394.01 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=216.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
++..+.||+|+||+||++.++.+|..+|+|.+...+ . ...+.+.+|+.+|++++|||||++++.........++++
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~-~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---S-PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeeccc---c-hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 466799999999999999999999999999887642 2 227789999999999999999999996322222479999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 108 TEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
|||+++|+|.+++.+.+ .+++..++.+.+||++||+|||++| ||||||||+|||++...+.+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999987 7999999999999999999999998 999999999999984368999999999987652
Q ss_pred -----hccCcccccccCccccccccC--ccchhhhhhHHHHHHHhcCCCCCC-CCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 185 -----ARSAHSVIEFMAPELYEEEYN--ELVDIYAFGMCLLELVTFEYPYVE-CTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 185 -----~~~~~gt~~YmAPEvl~~~ys--~ksDIWSLGviL~EmltG~~Pf~~-~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.....||+.|||||++...+. .++|||||||+++||+||..||.+ ......++........| .++...+.+
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~ 251 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDE 251 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHH
Confidence 224678899999998885533 499999999999999999999987 44455555555555444 777889999
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+++||.+|+. +|.+||||.+||.|||.+...
T Consensus 252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999 999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=402.45 Aligned_cols=258 Identities=27% Similarity=0.463 Sum_probs=226.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~ 105 (613)
-+.|++.||.|+|++||+|.++.+++.||||++.+.-+.+ ...+..+..|..+|.+| .||.|+++|..|.+ ...+|
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iik-e~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sLY 150 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIK-EKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESLY 150 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHh-hcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccceE
Confidence 3578899999999999999999999999999987654433 35567788899999999 89999999999966 45799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||+||+++|+|.+++++.+.|++...+.++.||+.||+|||++| ||||||||+|||++ .+|++||+|||.|+.+...
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999 99999999999999 6789999999999887421
Q ss_pred -----------------ccCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 186 -----------------RSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 186 -----------------~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
..+.||..|.+||++... .+..+|||+|||++|.|+.|.+||.. .+.-.++++|..-. -
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~--y 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALD--Y 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhc--c
Confidence 235678899999998765 78899999999999999999999966 56667777877542 2
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcccccc
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGR 293 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~~~~~ 293 (613)
.|+..+++.+++||+++|. +|.+|+|+.+|.+||||.+.+|..+-.
T Consensus 305 ~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~ 351 (604)
T KOG0592|consen 305 EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQ 351 (604)
T ss_pred cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhh
Confidence 3566677999999999998 999999999999999999998876533
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=399.46 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=221.4
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh-HHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTEN 101 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~-~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~ 101 (613)
.++| ++.+.||+|+||+|+.|.+..+|..||+|++.+....... ...+.+.+|+.+++.+. ||||+++++++.. .
T Consensus 16 ~g~y-~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--~ 92 (370)
T KOG0583|consen 16 IGKY-ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--P 92 (370)
T ss_pred cCce-eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec--C
Confidence 3454 8889999999999999999999999999976654322122 34567778999999999 9999999998754 3
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++||||+.||+|.+++.+.+++.|..++.+++||+.|++|||++| |+||||||+|||++.+.+++||+|||++..
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 459999999999999999999999999999999999999999999999 999999999999995548999999999998
Q ss_pred Hh----hhccCcccccccCcccccc-c-cC-ccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc-
Q 035992 182 LA----QARSAHSVIEFMAPELYEE-E-YN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA- 253 (613)
Q Consensus 182 l~----~~~~~~gt~~YmAPEvl~~-~-ys-~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~- 253 (613)
.. ...+.+|++.|+|||++.+ . |+ .++||||+|++||.|++|.+||.+ .+...++.+|..+.. .++...
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~--~~p~~~~ 247 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEF--KIPSYLL 247 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCc--cCCCCcC
Confidence 72 3457889999999998875 4 64 789999999999999999999977 666777778887743 345555
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++++.+|++||. +|.+|+++.+++.||||+..
T Consensus 248 S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 248 SPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE 281 (370)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence 9999999999999 99999999999999999973
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=380.59 Aligned_cols=250 Identities=30% Similarity=0.475 Sum_probs=219.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.++||+|+||+||++.+..+|..||+|.|+... -+....+.+..|+.+|++|+|||||++|+.-+..++.-+++
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~--md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM--MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh--ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 3577899999999999999999999999999988433 24677888999999999999999999999444555666999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCC--EEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 107 ITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPP--VIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~--IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+||||..|+|.++++. ++.++|..+++++.|++.||+.+|+.-+. |+||||||.|||++ ..|.|||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHh
Confidence 9999999999998764 45799999999999999999999994444 99999999999998 67899999999999
Q ss_pred HHhhh----ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 181 ILAQA----RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 181 ~l~~~----~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.+... ....||+.||+||++. .+|+.++||||+||++|||+.-+.||.+ .+-.++.++|.+|..|+.+...++.
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~ 255 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYST 255 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhh
Confidence 98654 3567999999999775 5699999999999999999999999977 5889999999999877777789999
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+++.+|..|+. ||..||+. +|+++.
T Consensus 256 ~l~~li~~ci~vd~~~RP~t-----~~~v~d 281 (375)
T KOG0591|consen 256 DLRELINMCIAVDPEQRPDT-----VPYVQD 281 (375)
T ss_pred HHHHHHHHHccCCcccCCCc-----chHHHH
Confidence 99999999999 99999986 555544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=400.07 Aligned_cols=255 Identities=24% Similarity=0.433 Sum_probs=228.5
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-+++++.||.|+.|.|.+|+|..||+.+|||+|.+... -.......+.+||-+|+.+.|||++.+|+.| .++..+|+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~-~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~lyl 89 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSE-LSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHLYL 89 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccc-cccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceEEE
Confidence 35999999999999999999999999999999876532 2345667889999999999999999999988 45778999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|.||+.||.|++|+.++|++++..++++++||+.|+.|||..+ |+||||||+|+|++. .+++||+|||+|..-...
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~-~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDV-KNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhc-ccCEeeeccceeecccCCc
Confidence 9999999999999999999999999999999999999999999 999999999999984 456999999999875443
Q ss_pred --ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 --RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.+.||.++|.|||++.+. | +.++||||+|||||.|+||+.||. ..|...++.++..|... ++..++.++++||
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdNir~LLlKV~~G~f~--MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDNIRVLLLKVQRGVFE--MPSNISSEAQDLL 243 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-CccHHHHHHHHHcCccc--CCCcCCHHHHHHH
Confidence 367899999999987764 5 578999999999999999999996 58899999999999754 5688899999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCCCccc
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSEDDES 290 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~~~~~ 290 (613)
.+||. ||.+|+|.+|+++|||+.+.....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 99999 999999999999999999875433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=401.09 Aligned_cols=272 Identities=24% Similarity=0.408 Sum_probs=236.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~ 105 (613)
-+++.++||+|.||+|++|..+.+++.+|||++|+.....+ ++++.++.|.+|+.... ||.++.+|.+|.. ..++|
T Consensus 369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~-d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~l~ 445 (694)
T KOG0694|consen 369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR-DEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEHLF 445 (694)
T ss_pred ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc-ccHHHHHHHHHHHHHhccCCeEeeccccccc--CCeEE
Confidence 46788999999999999999999999999999998776654 77888999999998885 9999999999954 56899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh--
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-- 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~-- 183 (613)
|||||+.||++ ..+++.+.|++..++.|+..|+.||+|||++| |||||||.+|||++ ..|++||+|||+++..-
T Consensus 446 fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 446 FVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred EEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCC
Confidence 99999999994 34455578999999999999999999999999 99999999999998 67999999999998542
Q ss_pred --hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 184 --QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 184 --~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
...+++||+.|||||++.+ .|+.++|+|||||+||||++|+.||.+ .+.++++..|... ...+|..++.++..+
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d--~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVND--EVRYPRFLSKEAIAI 598 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--CCCCCCcccHHHHHH
Confidence 3457899999999998875 599999999999999999999999965 6788888888865 345677789999999
Q ss_pred HHHHhh-cccCCCC-----HHHHhcCCCCCCCCccc-----ccccccccccCCcccccc
Q 035992 261 IEKCIA-EVSERLP-----AKELLGDPFLQSEDDES-----VGRSLRVKTHYSAETSHQ 308 (613)
Q Consensus 261 I~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~-----~~~~~~~~~~~~~~~~~~ 308 (613)
++++|. +|.+|+. +.+|..||||+.++|.. +.++.+|+...+.+.+.+
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snF 657 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNF 657 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhccc
Confidence 999998 9999996 58999999999998744 455666677666666654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=367.70 Aligned_cols=254 Identities=23% Similarity=0.389 Sum_probs=218.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+.+|+.+++.++||||+++++++.+ ...+++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 79 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--QRFLYML 79 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--CCeEEEE
Confidence 3677999999999999999999999999998875332 123455678899999999999999999997744 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-c
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-R 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~ 186 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++..+... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCCcc
Confidence 999999999999999999999999999999999999999998 99999999999998 6789999999999876442 2
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|+|||++.+ .++.++|||||||++|+|++|..||.. .+...+++.+..+.. .++...+..+++||.+||
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 233 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLL 233 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHc
Confidence 3457889999998765 489999999999999999999999966 456667777776642 345566889999999999
Q ss_pred h-cccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 266 A-EVSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
+ +|.+|++ +.+++.||||+..++..
T Consensus 234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 234 VVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred CCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 9 9999995 99999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=373.93 Aligned_cols=254 Identities=24% Similarity=0.411 Sum_probs=220.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+++.++||||++++++|.. +..+++|
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 96 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRVYFL 96 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEEEEE
Confidence 47789999999999999999999999999998754322 23456778999999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-c
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-R 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~ 186 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++...... .
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCCcc
Confidence 999999999999999999999999999999999999999998 99999999999998 6789999999998765432 2
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|+|||++.. .++.++|||||||++|+|++|..||.+ .+...+++.+..+.. .++...+..+++||.+||
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L 250 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLL 250 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHh
Confidence 3467889999998765 489999999999999999999999965 456677777777643 345567889999999999
Q ss_pred h-cccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 266 A-EVSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
+ +|.+|++ +++|+.||||+..++..
T Consensus 251 ~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 251 QTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred hcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 9 9999997 79999999999875543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=390.63 Aligned_cols=258 Identities=29% Similarity=0.509 Sum_probs=228.2
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
..++|...|.++ ++||+|+||.||+|++..+++.||+|++. +.....+++.+.+|+.+|..++++||.++|++|+.
T Consensus 7 ~~~~~~~~~~~~-~~IgrGsfG~Vyk~~d~~t~k~vAiKii~---Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~ 82 (467)
T KOG0201|consen 7 LKIDPELLYTKL-ELIGRGSFGEVYKAIDNKTKKVVAIKIID---LEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK 82 (467)
T ss_pred hcCCcccccccc-hhccccccceeeeeeeccccceEEEEEec---hhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee
Confidence 345777788555 99999999999999999999999977765 45567788999999999999999999999999976
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
+..+|++||||.||++.+.++..+.+++..+..++++++.||.|||+++ .+|||||+.|||+. ..|.|||+|||+
T Consensus 83 --g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~DfgV 157 (467)
T KOG0201|consen 83 --GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFGV 157 (467)
T ss_pred --cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecce
Confidence 4579999999999999999999888899999999999999999999999 99999999999998 459999999999
Q ss_pred hHHHhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 179 AAILAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 179 a~~l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
+..+.. ..++.||+.|||||++.+ +|+.++||||||+++|||++|.+||.++..+..++ +.-...|+.+...+
T Consensus 158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf--lIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF--LIPKSAPPRLDGDF 235 (467)
T ss_pred eeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE--eccCCCCCcccccc
Confidence 976653 256789999999998876 69999999999999999999999999887744433 22334567777789
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
++.+++||..||. +|..||+|.+||+|+|++...
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999999999999 999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.62 Aligned_cols=250 Identities=22% Similarity=0.409 Sum_probs=214.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
++||+|+||+||+|.+..+|+.||+|+++.... ........+.+|+.+++.++||||++++++|.. +..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 479999999999999999999999999875332 234556778899999999999999999998754 56899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hcc
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS 187 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~~ 187 (613)
.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccc
Confidence 99999999999899999999999999999999999998 99999999999998 578999999999875322 123
Q ss_pred CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh
Q 035992 188 AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~ 266 (613)
..+++.|||||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+. ..++...+..+++||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 457889999998765 589999999999999999999999965 45556666665543 23456678999999999999
Q ss_pred -cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 267 -EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 267 -dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
+|.+|| ++.+|++||||+..++..
T Consensus 232 ~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~ 261 (323)
T cd05571 232 KDPKQRLGGGPEDAKEIMEHRFFASINWQD 261 (323)
T ss_pred CCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 999999 899999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.97 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=215.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.+..+|+.||+|+++..... .......+.+|+.+|+.++||||++++++|.. +..+++|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--ENYLYLI 79 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCeEEEE
Confidence 46779999999999999999999999999998754322 23456778899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceecccccc
Confidence 999999999999999889999999999999999999999998 99999999999998 6789999999998654211
Q ss_pred ----------------------------------------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcC
Q 035992 186 ----------------------------------------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFE 224 (613)
Q Consensus 186 ----------------------------------------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~ 224 (613)
....||+.|||||++.. .|+.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 01347889999998754 5899999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHcCCCCCcccc--cccHHHHHHHHHHhhcccCCCC---HHHHhcCCCCCCCCccc
Q 035992 225 YPYVECTNAAQIYKKVTSGIKPASLAK--VADNGVRAFIEKCIAEVSERLP---AKELLGDPFLQSEDDES 290 (613)
Q Consensus 225 ~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~l~~lI~~cL~dP~~Rpt---a~eLL~HPff~~~~~~~ 290 (613)
.||... +....+..+........++. ..++.+++||.+||.+|.+|++ +.+++.||||+..++..
T Consensus 237 ~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~ 306 (364)
T cd05599 237 PPFCSD-NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH 306 (364)
T ss_pred CCCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 999764 44555566655433222222 4688999999999999999998 99999999999876643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=371.61 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=223.0
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
+-+|+.+.||.|.-|+||+|....++..+|+|++.+..+.. ...+.+...|.+||+.++||.++.+|..|. ...++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe--t~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-RKKLKRAQTEREILSLLDHPFLPTLYASFE--TDKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-hhHHHHHHHHHHHHHhcCCCccchhhheee--ccceeE
Confidence 34566789999999999999999999999999988665443 566788899999999999999999999984 467899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++||||+||+|..+++++ +.|++..++.++.+|+.||+|||-+| ||+|||||+||||. ++|+|.|+||.|+..+.
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCC
Confidence 999999999999998876 57999999999999999999999999 99999999999997 78999999999975431
Q ss_pred h-----------------------------------h-------------------------ccCcccccccCcccccc-
Q 035992 184 Q-----------------------------------A-------------------------RSAHSVIEFMAPELYEE- 202 (613)
Q Consensus 184 ~-----------------------------------~-------------------------~~~~gt~~YmAPEvl~~- 202 (613)
. . ..+.||-+|+|||++.+
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 0 01234557999999876
Q ss_pred ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCC----HHHH
Q 035992 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLP----AKEL 277 (613)
Q Consensus 203 ~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpt----a~eL 277 (613)
+.+.++|||+|||++|||+.|..||.+..+.+.+.+.+.+....+.-+ ..+..+++||+++|. ||.+|+. |.||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 589999999999999999999999999888888887777655433322 567889999999998 9999998 9999
Q ss_pred hcCCCCCCCCcccc
Q 035992 278 LGDPFLQSEDDESV 291 (613)
Q Consensus 278 L~HPff~~~~~~~~ 291 (613)
.+||||++.+|.-+
T Consensus 390 K~HpFF~gVnWaLi 403 (459)
T KOG0610|consen 390 KRHPFFEGVNWALI 403 (459)
T ss_pred hcCccccCCChhhe
Confidence 99999999999744
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=361.58 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=207.3
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
+|.++ -++|+|+||+||+++++.||+.||||.+.-. ..++...+-.++||.+|++|+|+|+|.++++| ...+.++
T Consensus 3 kYE~L-gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklh 77 (396)
T KOG0593|consen 3 KYEKL-GKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLH 77 (396)
T ss_pred HHhhh-hccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeE
Confidence 34333 6789999999999999999999999887632 23445556678999999999999999999988 4567899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+|+|||...-|..+-.....++.+.++.+++|++.|+.|||+++ +|||||||+||||+ .+|.+||||||+|+.+...
T Consensus 78 LVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 78 LVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred EEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCC
Confidence 99999988555554444567999999999999999999999999 99999999999998 6789999999999998743
Q ss_pred ccC----cccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-----------------
Q 035992 186 RSA----HSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS----------------- 242 (613)
Q Consensus 186 ~~~----~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~----------------- 242 (613)
... ..|-+|.|||++-+ +|+..+||||+||++.||++|++-|.+..+.+++|.....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 222 23458999997754 6999999999999999999999999999999998865431
Q ss_pred --CC------CCCccc---ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 243 --GI------KPASLA---KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 243 --g~------~p~~l~---~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
|. .+..+. ...+.-+.+|+.+||. ||.+|++.+|||.||||..
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~ 289 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG 289 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence 11 011111 1235578899999999 9999999999999999954
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=373.99 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=214.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++..... .......+..|+.+++.++||||++++++|.+ ...+|+|
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~~~~~lv 79 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--KLNLYLI 79 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCeEEEE
Confidence 36779999999999999999999999999998754322 23456778899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCccccccccc
Confidence 999999999999999899999999999999999999999998 99999999999998 5789999999998654211
Q ss_pred -------------------------------------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCC
Q 035992 186 -------------------------------------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPY 227 (613)
Q Consensus 186 -------------------------------------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf 227 (613)
....||+.|||||++.+ .|+.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 12357889999998754 5899999999999999999999999
Q ss_pred CCCCcHHHHHHHHHcCCCCCcccc--cccHHHHHHHHHHhhc---ccCCCCHHHHhcCCCCCCCCcccc
Q 035992 228 VECTNAAQIYKKVTSGIKPASLAK--VADNGVRAFIEKCIAE---VSERLPAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 228 ~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~l~~lI~~cL~d---P~~Rpta~eLL~HPff~~~~~~~~ 291 (613)
.. .+....+.++........++. ..+.++++||.+++.+ +..||++.||++||||+..++..+
T Consensus 237 ~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~ 304 (363)
T cd05628 237 CS-ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHI 304 (363)
T ss_pred CC-CCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHH
Confidence 65 455666777765432222222 3578999999997664 345789999999999999877554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=370.07 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=215.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|+.||+|+++.... ........+..|+.+++.++||||++++++|.. ...+++|
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~~lv 79 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--DEYLYLA 79 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--CCEEEEE
Confidence 4778999999999999999999999999999875432 223456678899999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-hc
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-AR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-~~ 186 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~~~~ 156 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVTYAN 156 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCcccccccC
Confidence 999999999999999899999999999999999999999998 99999999999998 678999999999976543 23
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc------ccccHHHHH
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA------KVADNGVRA 259 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~------~~~s~~l~~ 259 (613)
...+++.|+|||++.+ .|+.++|||||||++|||++|..||.. .+....+..+.........+ ...+.++.+
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~ 235 (333)
T cd05600 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWD 235 (333)
T ss_pred CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHH
Confidence 4567889999998764 589999999999999999999999965 45555555555432111111 245789999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCCCccc
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~~ 290 (613)
||.+||. +|.+||++.++++||||....+..
T Consensus 236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~ 267 (333)
T cd05600 236 LITKLINDPSRRFGSLEDIKNHPFFKEVDWNE 267 (333)
T ss_pred HHHHHhhChhhhcCCHHHHHhCcccCCCCHHH
Confidence 9999999 788999999999999999875543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=384.75 Aligned_cols=246 Identities=28% Similarity=0.491 Sum_probs=219.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+-+.||+|+||+||+|+.+.+.+.||+|.+.+. .+...++..+.+|+++++.++|||||.++++|. ...++|+|+|
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~--gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE--t~~~~~vVte 81 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS--GRNEKELKNLRQEVRILRSLKHPNIVEMLESFE--TSAHLWVVTE 81 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhc--CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc--ccceEEEEeh
Confidence 348999999999999999999999999987654 356778999999999999999999999999884 4678999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR--- 186 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 186 (613)
|+.| +|+.++...+.++|+.++.++.|++.||.|||+++ |+|||+||.|||+. ..|.+|+||||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vl 157 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVL 157 (808)
T ss_pred hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCceee
Confidence 9988 99999999999999999999999999999999999 99999999999997 67899999999999887643
Q ss_pred -cCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 187 -SAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 187 -~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
...||+-|||||++++. |+..+|.|||||++|||++|++||.. ....++.+.|... |..++...+..+..|++.+
T Consensus 158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gL 234 (808)
T KOG0597|consen 158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQGL 234 (808)
T ss_pred eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHHHH
Confidence 45788999999988764 99999999999999999999999965 4555666666654 3344557899999999999
Q ss_pred hh-cccCCCCHHHHhcCCCCCCC
Q 035992 265 IA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|. ||.+|++..+|+.|||.++.
T Consensus 235 L~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 235 LIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred hhcChhhcccHHHHhcChHHhhh
Confidence 98 99999999999999999874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=373.74 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=210.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|+||+||+|.+..+++.||+|+++..... .......+.+|+.+++.++||||++++++|.+ ...+++|
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~~~~lv 79 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CCEEEEE
Confidence 46779999999999999999999999999998754332 33556789999999999999999999998864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++..+..
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 80 MDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccc
Confidence 999999999999999999999999999999999999999998 99999999999998 578999999998753210
Q ss_pred ------------------------------------------------hccCcccccccCcccccc-ccCccchhhhhhH
Q 035992 185 ------------------------------------------------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGM 215 (613)
Q Consensus 185 ------------------------------------------------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGv 215 (613)
.....|++.|||||++.+ .|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 012357889999998764 5899999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc--cccccHHHHHHHHHHhh---cccCCCCHHHHhcCCCCCCCCcc
Q 035992 216 CLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL--AKVADNGVRAFIEKCIA---EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 216 iL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s~~l~~lI~~cL~---dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
++|||++|..||........ ...+........+ ....++++++||.+||. ++..|+++.+++.||||+...+.
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET-QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH-HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChh
Confidence 99999999999976544333 3344432211122 22468899999999654 55669999999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=373.42 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=213.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|++.+... ......+.+.+|+.+++.++||||++++++|.+ ...+|+|
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv 79 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--AQYLYLI 79 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCeeEEE
Confidence 3678999999999999999999999999998875432 223456788999999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeecccccccccccc
Confidence 999999999999999899999999999999999999999998 99999999999997 6789999999998532110
Q ss_pred -------------------------------------------------ccCcccccccCcccccc-ccCccchhhhhhH
Q 035992 186 -------------------------------------------------RSAHSVIEFMAPELYEE-EYNELVDIYAFGM 215 (613)
Q Consensus 186 -------------------------------------------------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGv 215 (613)
....|++.|+|||++.. .|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 01347789999998754 5999999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccc--cccHHHHHHHHHHhhcccCC---CCHHHHhcCCCCCCCCccc
Q 035992 216 CLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK--VADNGVRAFIEKCIAEVSER---LPAKELLGDPFLQSEDDES 290 (613)
Q Consensus 216 iL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~l~~lI~~cL~dP~~R---pta~eLL~HPff~~~~~~~ 290 (613)
++|||++|..||... +....+..+........++. ..+.++++||.+||.+|.+| +++.+++.||||+..++..
T Consensus 237 il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~ 315 (377)
T cd05629 237 IMFECLIGWPPFCSE-NSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDT 315 (377)
T ss_pred hhhhhhcCCCCCCCC-CHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence 999999999999664 44555666655432222332 46789999999999866654 5999999999999876543
Q ss_pred c
Q 035992 291 V 291 (613)
Q Consensus 291 ~ 291 (613)
+
T Consensus 316 ~ 316 (377)
T cd05629 316 I 316 (377)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=368.77 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=216.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++..... .......+..|+.++..++||||++++++|.+ +..+++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 79 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQD--EEHLYLV 79 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheec--CCeEEEE
Confidence 36789999999999999999999999999998754322 23456778899999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCc
Confidence 999999999999998889999999999999999999999988 99999999999998 67899999999987654322
Q ss_pred --------------------------------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH
Q 035992 187 --------------------------------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA 233 (613)
Q Consensus 187 --------------------------------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~ 233 (613)
...+++.|+|||++.+ .++.++|||||||++|||++|..||.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~ 235 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-L 235 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-H
Confidence 2346779999998765 58999999999999999999999997644 5
Q ss_pred HHHHHHHHcCCCCCccc--ccccHHHHHHHHHHhhcccCCCC-HHHHhcCCCCCCCCccc
Q 035992 234 AQIYKKVTSGIKPASLA--KVADNGVRAFIEKCIAEVSERLP-AKELLGDPFLQSEDDES 290 (613)
Q Consensus 234 ~~i~~~I~~g~~p~~l~--~~~s~~l~~lI~~cL~dP~~Rpt-a~eLL~HPff~~~~~~~ 290 (613)
...+..+........++ ..+++.+++||.+||.+|.+|++ +.++++||||+...+..
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 55566666522222222 23589999999999999999999 99999999999876543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=373.89 Aligned_cols=241 Identities=33% Similarity=0.563 Sum_probs=203.5
Q ss_pred eeeecccCceEEEEEEEcCCCcE-EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIE-VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~-VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
.+.||+|+||+||+|... |.. ||+|.+..... .....+.|.+|+.+|.+++|||||+|++++.... ..+++|||
T Consensus 46 ~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~~iVtE 120 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSLCIVTE 120 (362)
T ss_pred hhhcccCCceeEEEEEeC--CceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-CceEEEEE
Confidence 466999999999999664 555 99888875443 2233789999999999999999999999875432 26899999
Q ss_pred ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC-cEEEeccchhHHHhh--
Q 035992 110 IFTSGTLRQYRKK--HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG-EVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 110 ~~~gGsL~~~l~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g-~VKL~DFGla~~l~~-- 184 (613)
|+.+|+|..++.+ .+.++...+..|+.||++||+|||++++ ||||||||+|||++ ..+ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeecccc
Confidence 9999999999988 6889999999999999999999999986 99999999999998 454 999999999987653
Q ss_pred -h-ccCcccccccCccccccc---cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 -A-RSAHSVIEFMAPELYEEE---YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 -~-~~~~gt~~YmAPEvl~~~---ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
. ....||..|||||++.+. |+.|+|||||||++|||+||+.||.+.......+..+..+..| .++..+++.+..
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp-~~p~~~~~~l~~ 277 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP-PIPKECPPHLSS 277 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC-CCCccCCHHHHH
Confidence 2 225788899999999853 9999999999999999999999998887744444444555544 555568999999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+|.+||. +|.+||+..+++.
T Consensus 278 l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 278 LMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHhCCCCCCcCCCHHHHHH
Confidence 9999999 9999999988864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=371.28 Aligned_cols=255 Identities=21% Similarity=0.315 Sum_probs=211.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.++||+|+||+||+|.+..+++.||+|++..... ........+.+|+.+++.++||||++++++|.+ +..+++|
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 3667999999999999999999999999998875332 223556788999999999999999999999864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+..
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 80 MDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCcccccccc
Confidence 999999999999998889999999999999999999999998 99999999999998 678999999999743210
Q ss_pred ------------------------------------------------hccCcccccccCcccccc-ccCccchhhhhhH
Q 035992 185 ------------------------------------------------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGM 215 (613)
Q Consensus 185 ------------------------------------------------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGv 215 (613)
.....|++.|||||++.+ .|+.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 012357789999998754 5999999999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc--cccccHHHHHHHHHHhhcccCCCC---HHHHhcCCCCCCCCcc
Q 035992 216 CLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL--AKVADNGVRAFIEKCIAEVSERLP---AKELLGDPFLQSEDDE 289 (613)
Q Consensus 216 iL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~~~~s~~l~~lI~~cL~dP~~Rpt---a~eLL~HPff~~~~~~ 289 (613)
++|||++|..||..... ......+........+ ....++++.++|.+|+.+|.+|++ +.+++.||||+..++.
T Consensus 237 il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP-LETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred HHHHHHhCCCCCCCCCH-HHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 99999999999976443 4444444443222222 234688999999998889999997 9999999999987553
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.56 Aligned_cols=257 Identities=23% Similarity=0.401 Sum_probs=215.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||+||+|.++.+|+.||+|+++..... .......+..|+.++..++||||++++++|.+ ...+++|
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~~~~~lv 79 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQD--KRNLYLI 79 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEE
Confidence 46779999999999999999999999999988754322 23556788899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccccc
Confidence 999999999999999899999999999999999999999998 99999999999998 6789999999998644211
Q ss_pred -------------------------------------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCC
Q 035992 186 -------------------------------------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPY 227 (613)
Q Consensus 186 -------------------------------------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf 227 (613)
....|++.|||||++.+ .|+.++|||||||++|||++|..||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 12357789999998754 5999999999999999999999999
Q ss_pred CCCCcHHHHHHHHHcCCCCCcccc--cccHHHHHHHHHHhhcccCCC---CHHHHhcCCCCCCCCcccc
Q 035992 228 VECTNAAQIYKKVTSGIKPASLAK--VADNGVRAFIEKCIAEVSERL---PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 228 ~~~~~~~~i~~~I~~g~~p~~l~~--~~s~~l~~lI~~cL~dP~~Rp---ta~eLL~HPff~~~~~~~~ 291 (613)
.. .+....+.++........++. ..+..+++||.+|+.+|.+|+ ++.++++||||+..++..+
T Consensus 237 ~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~ 304 (360)
T cd05627 237 CS-ETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHI 304 (360)
T ss_pred CC-CCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHH
Confidence 65 455566666665432222222 367899999999877999988 4899999999999877554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.30 Aligned_cols=246 Identities=23% Similarity=0.402 Sum_probs=211.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||+|+||+||+|.+..+++.||+|+++.... ........+..|+.+++.++||||++++++|.. ...+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 7999999999999999999999998874332 234566788899999999999999999998754 5689999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hccCc
Q 035992 114 GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARSAH 189 (613)
Q Consensus 114 GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~~~~ 189 (613)
|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... .....
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCcccccc
Confidence 999999999889999999999999999999999998 99999999999998 678999999999875322 12345
Q ss_pred ccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-c
Q 035992 190 SVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-E 267 (613)
Q Consensus 190 gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-d 267 (613)
+++.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...+++.+..+ +..++...++.+++||.+||. +
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~d 231 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRD 231 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCC
Confidence 7889999998765 489999999999999999999999976 4555666666655 334556788999999999999 9
Q ss_pred ccCCC---CHHHHhcCCCCCCCCc
Q 035992 268 VSERL---PAKELLGDPFLQSEDD 288 (613)
Q Consensus 268 P~~Rp---ta~eLL~HPff~~~~~ 288 (613)
|.+|| ++.++|.||||....+
T Consensus 232 p~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 232 PTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred HHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99997 5899999999998644
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=367.20 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=217.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCC-cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg-~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|.+.+.||+|+||.||+|.+..++ ..||+|.+..... ......+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~l 108 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESYLYL 108 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCEEEE
Confidence 467799999999999999877665 6899998875432 233456778999999999999999999998854 468999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||||+.+|+|.+++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCCCc
Confidence 9999999999999999999999999999999999999999998 99999999999997 6789999999999765432
Q ss_pred ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 186 RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
....+++.|||||++.+ .++.++|||||||++|||++|..||.. .+...+++.+..+.. .++...+..++++|++|
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~ 262 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKL 262 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence 23467889999998765 489999999999999999999999965 556667777777643 34566788999999999
Q ss_pred hh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 265 IA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 265 L~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
|+ +|.+|+ +++++++||||+..++..
T Consensus 263 l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 263 LSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred cccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 99 999995 899999999999876643
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.78 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=210.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|++...... .......+.+|+.+|+.++||||+++++.|.. +..+++|
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 79 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--KDNLYFV 79 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--CCEEEEE
Confidence 47789999999999999999999999999988654322 22445678899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..+..
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCcccccccc
Confidence 999999999999999899999999999999999999999998 99999999999998 678999999999742210
Q ss_pred --------------------------------------------hccCcccccccCcccccc-ccCccchhhhhhHHHHH
Q 035992 185 --------------------------------------------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLE 219 (613)
Q Consensus 185 --------------------------------------------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~E 219 (613)
.....|++.|||||++.+ .++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 012357789999998765 58999999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccccHHHHHHHHHHhhcccCCC---CHHHHhcCCCCCCCCc
Q 035992 220 LVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVADNGVRAFIEKCIAEVSERL---PAKELLGDPFLQSEDD 288 (613)
Q Consensus 220 mltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~l~~lI~~cL~dP~~Rp---ta~eLL~HPff~~~~~ 288 (613)
|++|..||.... .......+........ .....++.+.++|.+|+.+|.+|+ ++.++++||||+..+.
T Consensus 237 ll~G~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 237 MLVGQPPFLADT-PAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred hhhCCCCCCCCC-HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 999999997644 3344444443322111 123468899999999888999999 9999999999998654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.46 Aligned_cols=249 Identities=20% Similarity=0.405 Sum_probs=212.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
++||+|+||+||+|.+..+|..||+|+++.... ........+..|+.+++.++||||++++++|.. +..+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEEEeCC
Confidence 479999999999999999999999998875322 234556778899999999999999999998854 45899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----cc
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----RS 187 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~~ 187 (613)
.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||++...... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCcccc
Confidence 99999999998889999999999999999999999998 99999999999998 6789999999998753221 23
Q ss_pred CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh
Q 035992 188 AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~ 266 (613)
..+++.|||||++.+ .++.++|||||||++|||++|..||.. .+...++..+.... ..++..+++.++++|.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLAGLLK 231 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcc
Confidence 457789999998764 589999999999999999999999965 34455555555432 23455678999999999999
Q ss_pred -cccCCC-----CHHHHhcCCCCCCCCcc
Q 035992 267 -EVSERL-----PAKELLGDPFLQSEDDE 289 (613)
Q Consensus 267 -dP~~Rp-----ta~eLL~HPff~~~~~~ 289 (613)
+|.+|+ ++.++++||||....+.
T Consensus 232 ~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 232 KDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred CCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999998 89999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=362.85 Aligned_cols=249 Identities=21% Similarity=0.408 Sum_probs=212.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
++||+|+||+||+|.+..+|+.||+|+++.... ........+.+|+.+++.++||||++++++|.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 479999999999999999999999999875332 234556788899999999999999999998754 56899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hcc
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARS 187 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~~ 187 (613)
.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..... ...
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCccccccc
Confidence 99999999998889999999999999999999999998 99999999999998 678999999999875322 123
Q ss_pred CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh
Q 035992 188 AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~ 266 (613)
..+++.|+|||++.+ .++.++|||||||++|+|++|..||... +...+.+.+..+. ..++...+..+.+||.+||.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~ 231 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILMED--IKFPRTLSADAKSLLSGLLI 231 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcC
Confidence 457889999998764 5899999999999999999999999663 4455555555432 23556678999999999999
Q ss_pred -cccCCC-----CHHHHhcCCCCCCCCcc
Q 035992 267 -EVSERL-----PAKELLGDPFLQSEDDE 289 (613)
Q Consensus 267 -dP~~Rp-----ta~eLL~HPff~~~~~~ 289 (613)
+|.+|+ ++.++++||||...++.
T Consensus 232 ~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 232 KDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred CCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 999997 89999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.48 Aligned_cols=257 Identities=20% Similarity=0.315 Sum_probs=216.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|+||+||+|.++.+|+.||+|+++.... ........+..|+.+++.++||||++++++|.. ...+++|
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQD--KDNLYLV 79 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCeEEEE
Confidence 4778999999999999999999999999999875432 233456778899999999999999999998754 5679999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..|.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCC
Confidence 9999999999999887 78999999999999999999999998 99999999999998 67899999999997654321
Q ss_pred -----cCcccccccCccccc-------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc--cc
Q 035992 187 -----SAHSVIEFMAPELYE-------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA--KV 252 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~-------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~ 252 (613)
...+++.|+|||++. ..++.++|||||||++|||++|..||.... ....+..+........++ ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-HHHHHHHHHcCCCccCCCCCCC
Confidence 235778999999874 347889999999999999999999997644 445556665543322222 24
Q ss_pred ccHHHHHHHHHHhhcccCCCCHHHHhcCCCCCCCCcccc
Q 035992 253 ADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 253 ~s~~l~~lI~~cL~dP~~Rpta~eLL~HPff~~~~~~~~ 291 (613)
.+..+++||.+||.+|.+||++.+++.||||+..++..+
T Consensus 236 ~~~~~~~li~~ll~~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 236 VSSDFLDLIQSLLCGQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred CCHHHHHHHHHHccChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 688999999999999999999999999999998766544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=353.25 Aligned_cols=256 Identities=18% Similarity=0.335 Sum_probs=211.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|+..+.||+|+||+||+|.+..+|+.||+|.+...... .......+.+|+.+++.++|+||++++++|.. +..++++
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CCeEEEE
Confidence 46779999999999999999999999999988754332 22334567889999999999999999998754 4579999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++ +++.+||+|||++......
T Consensus 79 ~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 79 LTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCC
Confidence 9999999999887643 46899999999999999999999998 99999999999998 5689999999998765322
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH---HHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA---AQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~---~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
....++..|||||++.+ .|+.++|||||||++|+|++|..||...... ..+...+... +..++...+..+.
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~ 233 (285)
T cd05631 156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED--QEEYSEKFSEDAK 233 (285)
T ss_pred CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc--cccCCccCCHHHH
Confidence 23457789999998764 5899999999999999999999999764332 2233333222 2334556788999
Q ss_pred HHHHHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 259 AFIEKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
+||.+||+ +|.+||+ ++++++||||+..++..+
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 99999999 9999997 899999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.08 Aligned_cols=255 Identities=31% Similarity=0.417 Sum_probs=209.7
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENE 102 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~ 102 (613)
..|| .+.+.||.|+||.||+|..+.+|..||||.+|..- .. -+.-.-++|++.|++|+ |||||++++.+.+.+.
T Consensus 9 m~RY-~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~- 83 (538)
T KOG0661|consen 9 MDRY-TVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR- 83 (538)
T ss_pred HHHH-HHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-cc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-
Confidence 4466 56699999999999999999999999999887432 22 12222368999999998 9999999998866443
Q ss_pred EEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+|||||||.. +|.++++. .+.|++..++.|++||++||+|+|.+| ++|||+||+|||+.+. ..|||+|||+|+.
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~-~~iKiaDFGLARe 159 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGN-DVIKIADFGLARE 159 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEeccc-ceeEecccccccc
Confidence 99999999987 77777764 467999999999999999999999999 9999999999999854 4899999999987
Q ss_pred Hhhhc---cCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-C------------
Q 035992 182 LAQAR---SAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-G------------ 243 (613)
Q Consensus 182 l~~~~---~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g------------ 243 (613)
+.... ....|-+|.|||++- +.|+.++|+|++||+++|+.+-++-|.+....+++++...- |
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 76532 234556899999663 45999999999999999999999999998888888865430 0
Q ss_pred -------CCC----C---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 244 -------IKP----A---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 244 -------~~p----~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..| . .+-..++.++.++|.+||. ||.+||||.|+|+||||+...
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 011 1 1112367899999999999 999999999999999999763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=369.27 Aligned_cols=250 Identities=27% Similarity=0.357 Sum_probs=210.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
.+.||+|+||.||+|++..+|+.||+|.|..... .+.......+||.||++|+||||+++.+..+......+|+|+||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~--~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE--KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccC--CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 3889999999999999999999999998886442 34556677899999999999999999998766656799999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc--
Q 035992 111 FTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-- 187 (613)
Q Consensus 111 ~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 187 (613)
|.. +|.-++... -+|++.+|+.+++||+.||+|||++| |+|||||++||||| +.|.+||+|||||.++.....
T Consensus 200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcc
Confidence 987 888877774 47999999999999999999999999 99999999999998 889999999999998765432
Q ss_pred ---CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-----------CC-----
Q 035992 188 ---AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-----------KP----- 246 (613)
Q Consensus 188 ---~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-----------~p----- 246 (613)
..-|.+|.|||++-+ .|+.++|+||.||||.||++|++.|.+.+..+|+-..+.-.- .|
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 234569999997654 599999999999999999999999988887777654433110 00
Q ss_pred --C--------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 --A--------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 --~--------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
. ...+.++....+|+..+|. ||.+|.||.+.|+++||...
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 0 0023357788899999999 99999999999999999543
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=380.24 Aligned_cols=249 Identities=32% Similarity=0.560 Sum_probs=223.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
=+||+|.||+||.|++..++..+|||.|.. ++....+-+..||.+-++|+|.|||+|++++ .+++++-+.||-+
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpe----kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqV 654 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPE----KDSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQV 654 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccc----ccchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecC
Confidence 489999999999999999999999988764 4467788899999999999999999999986 5577899999999
Q ss_pred CCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----
Q 035992 112 TSGTLRQYRKKH-KHV--DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ---- 184 (613)
Q Consensus 112 ~gGsL~~~l~~~-~~l--se~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~---- 184 (613)
+||+|..+++.. |++ +|.++..+.+||++||.|||.+. |||||||-+||||+.-.|.+||+|||.++.+..
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 999999998876 667 89999999999999999999999 999999999999998889999999999998764
Q ss_pred hccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 ARSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
..++.||..|||||++.+ +|+.++|||||||++.||+||++||.+..++....-++---...+.++...+.+++.||
T Consensus 733 TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Fi 812 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFI 812 (1226)
T ss_pred ccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence 346778899999999975 49999999999999999999999998887777666666655566678888999999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+|+. +|.+||+|.+||.+||++..++
T Consensus 813 lrcFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 813 LRCFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HHHcCCCcccCccHHHhccCcccccCCC
Confidence 99999 9999999999999999998744
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=359.71 Aligned_cols=249 Identities=21% Similarity=0.400 Sum_probs=211.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
++||+|+||+||+|.+..+|..||+|+++.... ........+..|+.+++.++||||++++++|.. +..+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 479999999999999999999999999875432 234556778899999999999999999998754 56899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
.+|+|..++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccc
Confidence 999999999988899999999999999999999997 67 99999999999998 678999999999864321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|||||++.+ .|+.++|||||||++|+|++|..||.. .+...+...+.... ..++...++++.+||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~~~~~~~li~~~L 231 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLSGLL 231 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHh
Confidence 3457889999998764 589999999999999999999999966 44555666655442 2345667899999999999
Q ss_pred h-cccCCC-----CHHHHhcCCCCCCCCcc
Q 035992 266 A-EVSERL-----PAKELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rp-----ta~eLL~HPff~~~~~~ 289 (613)
+ +|.+|+ ++.++++||||....+.
T Consensus 232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 232 KKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred hcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9 999997 89999999999987543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.89 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=219.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.++||+|+|+.||++.+..+|+.+|+|.|....+.. ...+.+.+|+.|-+.|+||||+++.++. ......|+|+
T Consensus 14 ~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~--~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~ylvF 89 (355)
T KOG0033|consen 14 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA--RDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYLVF 89 (355)
T ss_pred hHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--ccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEEEE
Confidence 55699999999999999999999999998887655543 3778899999999999999999999976 4456899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHHHhhhc
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~l~~~~ 186 (613)
|++.|++|..-+-..-.++|..+-.+++||+.+|.|+|.++ |||||+||.|+++.+ +..-|||+|||+|..+....
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~ 167 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE 167 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCcc
Confidence 99999999876666677899999999999999999999999 999999999999963 34569999999998877433
Q ss_pred ---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHHHH
Q 035992 187 ---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRAF 260 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~~l 260 (613)
.+.||+.|||||++.. .|+..+|||+.|++||-|+.|.+||++ .+...+|+.|..|.. +.......+++++++
T Consensus 168 ~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L 246 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL 246 (355)
T ss_pred ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence 4567899999998875 599999999999999999999999976 567889999998853 333455679999999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|++||. ||.+|+|+.|.|+|||+...
T Consensus 247 vrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 247 IRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHhccChhhhccHHHHhCCchhcch
Confidence 999999 99999999999999999864
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=358.07 Aligned_cols=250 Identities=20% Similarity=0.379 Sum_probs=209.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+++.||+|+++... .........+..|+.+++.+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~-~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~ 77 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKEL-VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEF 77 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeC
Confidence 47999999999999999999999999987533 23345567788999999998 79999999998854 4589999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..... ..
T Consensus 78 ~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 78 VSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccc
Confidence 999999999998899999999999999999999999998 99999999999998 578999999999864221 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC--------CcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC--------TNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
...++..|+|||++.+ .++.++|||||||++|+|++|..||... .....+++.+.... ..++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~ 232 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHH
Confidence 3457789999998765 5899999999999999999999999521 12233455555443 23455678899
Q ss_pred HHHHHHHhh-cccCCCC------HHHHhcCCCCCCCCcc
Q 035992 258 RAFIEKCIA-EVSERLP------AKELLGDPFLQSEDDE 289 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpt------a~eLL~HPff~~~~~~ 289 (613)
.++|.+||+ +|.+|++ +.++++||||....+.
T Consensus 233 ~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 233 SSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999999 9999987 7899999999887653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.33 Aligned_cols=263 Identities=24% Similarity=0.436 Sum_probs=224.8
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
-+...|+.-| .+.++||+|+||.||+|.|+++|+.+|||++.+ ..+++.+..||.+|++++.|++|+||++++
T Consensus 26 sL~K~PEEVF-Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV------~sDLQEIIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 26 ALNKPPEEVF-DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV------DTDLQEIIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred hhcCChHHHH-HHHHHhcCCcchHHHHHHHhccCcEEEEEecCc------cchHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence 3444555555 556899999999999999999999999998875 467889999999999999999999999876
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRK-KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
. +..+|+|||||..|+..+.++ +++.+++..+..+++.-++||+|||... -||||||..|||++ ..|..||+||
T Consensus 99 K--~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADF 173 (502)
T KOG0574|consen 99 K--HSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADF 173 (502)
T ss_pred c--CCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhc
Confidence 4 456999999999999999875 5678999999999999999999999987 89999999999999 6799999999
Q ss_pred chhHHHhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 177 GLAAILAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 177 Gla~~l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
|.|..+.. ..+..||+.|||||++++ +|+.++||||||++.+||..|++||.+...+..++-.-+.......-+.
T Consensus 174 GVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 174 GVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPE 253 (502)
T ss_pred cccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChH
Confidence 99987654 346678999999999876 6999999999999999999999999887766555433232222222356
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCccccc
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVG 292 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~~~~ 292 (613)
.++.++.+||++||. +|.+|.||.+|++|||+++.....+.
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~I~ 295 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCDIM 295 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcccHH
Confidence 789999999999998 99999999999999999988765543
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=359.41 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=212.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.++.+++.||+|+++.... ......+.+..|+.+++.+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey 77 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEF 77 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcC
Confidence 479999999999999999999999998875332 2234566778898888876 69999999998854 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 78 VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCccc
Confidence 999999999999899999999999999999999999998 99999999999998 678999999999865321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|||||++.+ .|+.++|||||||++|+|++|..||.. .+...+++.+..+.. .++...+.++++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L 231 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFM 231 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence 3457889999998765 489999999999999999999999965 556667777766532 345567899999999999
Q ss_pred h-cccCCCCH------HHHhcCCCCCCCCccc
Q 035992 266 A-EVSERLPA------KELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rpta------~eLL~HPff~~~~~~~ 290 (613)
+ +|.+|+++ +++++||||+...+..
T Consensus 232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~ 263 (320)
T cd05590 232 TKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263 (320)
T ss_pred ccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 9 99999998 9999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=356.36 Aligned_cols=254 Identities=26% Similarity=0.419 Sum_probs=204.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---CEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN---EHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~~l 104 (613)
|++.++||+|+||.||+|.+..+|..||+|.++... .......++.+|+.+++.++||||+++++++..... ..+
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh--ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 478899999999999999999999999999876321 223445678899999999999999999998764332 358
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+||||+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCcccccccc
Confidence 99999995 689999998889999999999999999999999998 99999999999998 678999999999875432
Q ss_pred h-------ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHH--------------HHH
Q 035992 185 A-------RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY--------------KKV 240 (613)
Q Consensus 185 ~-------~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~--------------~~I 240 (613)
. ....++..|+|||++.+ .++.++|||||||++|||++|++||........+. ..+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 1 12356778999998753 58999999999999999999999996644322211 011
Q ss_pred Hc-----------CCCCCccc---ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 241 TS-----------GIKPASLA---KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 241 ~~-----------g~~p~~l~---~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.. ...+..+. ...++.+.++|.+||. +|.+||++.|+|+||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 00 00111111 1346788999999999 999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=358.59 Aligned_cols=255 Identities=21% Similarity=0.360 Sum_probs=213.1
Q ss_pred eeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|.+. .+|..||+|+++...........+.+..|+.+++.+ +||||++++++|.. ...
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~ 79 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EAK 79 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CCE
Confidence 477899999999999999764 578999999987654444445567788999999999 59999999998754 567
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCcccc
Confidence 9999999999999999998889999999999999999999999998 99999999999998 56899999999987643
Q ss_pred hh-----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCC---CcHHHHHHHHHcCCCCCcccccc
Q 035992 184 QA-----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVEC---TNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 184 ~~-----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~---~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
.. ....++..|||||++.+ .++.++|||||||++|||++|..||... .....+...+.... ..++...
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 234 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFI 234 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCC
Confidence 21 13457889999998764 3788999999999999999999999532 23444555554432 2345567
Q ss_pred cHHHHHHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCcc
Q 035992 254 DNGVRAFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDE 289 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~ 289 (613)
+..+++||.+||+ +|.+|| +++++++||||+...+.
T Consensus 235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 8999999999999 999999 78999999999986543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=354.77 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=214.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC-CcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK-NIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.+..+++.||+|+++.... ......+.+..|+.++..+.|+ +|++++++|.. ...+|+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 4778999999999999999999999999998875332 2345567788999999999765 57888887754 457999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
||||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCC
Confidence 9999999999999999899999999999999999999999998 99999999999998 578999999999864321
Q ss_pred --hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 --ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.....+++.|+|||++.+ .++.++|||||||++|+|+||..||.. .+...++..+.... ..++...+..+.++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li 232 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSIC 232 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHH
Confidence 123457889999998765 489999999999999999999999965 45566677776553 234566789999999
Q ss_pred HHHhh-cccCCCCH-----HHHhcCCCCCCCCcc
Q 035992 262 EKCIA-EVSERLPA-----KELLGDPFLQSEDDE 289 (613)
Q Consensus 262 ~~cL~-dP~~Rpta-----~eLL~HPff~~~~~~ 289 (613)
.+||. +|.+|+++ .++++||||+..++.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 233 KGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999 99999976 899999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=358.60 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=208.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHH-HHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+|+.||+|++....... ......+..|.. +++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 47999999999999999999999999987543322 233445555554 5678999999999998754 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccc
Confidence 999999999999899999999999999999999999998 99999999999998 678999999999865322 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|||||++.+ .++.++|||||||++|+|++|..||.. .+..+++..+..+.. .++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKPL--RLKPNISVSARHLLEGLL 231 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 3457789999998765 589999999999999999999999965 556677777766532 334456899999999999
Q ss_pred h-cccCCCCH----HHHhcCCCCCCCCcc
Q 035992 266 A-EVSERLPA----KELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rpta----~eLL~HPff~~~~~~ 289 (613)
+ +|.+||++ .+++.||||....+.
T Consensus 232 ~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 232 QKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred hcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 9 99999987 699999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.82 Aligned_cols=249 Identities=20% Similarity=0.335 Sum_probs=203.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+++.||+|+++... ......+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRTLKQENIVELKEAFRR--RGKLYLV 78 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccc--ccccchhhHHHHHHHHHhCCCccccchhhhEec--CCEEEEE
Confidence 377899999999999999999999999999887542 223445678899999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|||+.++.+..+......+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++..+....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCccccccccc
Confidence 999999888777666678999999999999999999999998 99999999999998 67899999999998754321
Q ss_pred ----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCC---------------
Q 035992 187 ----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIK--------------- 245 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~--------------- 245 (613)
...++..|+|||++.+ .++.++|||||||++|||++|+.||........+...... +..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 2346778999997754 5899999999999999999999999765544333221110 000
Q ss_pred ----CC---------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 246 ----PA---------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 246 ----p~---------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+. ......+..+.+||.+||+ +|.+|||++++|+||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 0112357789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=378.00 Aligned_cols=267 Identities=28% Similarity=0.471 Sum_probs=233.3
Q ss_pred CCCCCc-ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcc
Q 035992 12 DDSDAE-FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90 (613)
Q Consensus 12 ~~~~~~-~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 90 (613)
|++.++ |.--||+.+|..+ +.||.|+||.||-|++..+.+.||||.+...-. .+.+..+.+..|+.+|+++.|||+|
T Consensus 12 DPeiA~LF~k~DPEklf~dL-rEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPnti 89 (948)
T KOG0577|consen 12 DPEIADLFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTI 89 (948)
T ss_pred CchHHHHHccCCHHHHHHHH-HHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcc
Confidence 344443 7777899999766 889999999999999999999999888775432 4456678899999999999999999
Q ss_pred eeeeeeecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 91 kl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
.|.++|.. ..+.|+|||||-| +..+++.-+ +++.+..|+.|+.+.+.||.|||+++ .||||||+.|||++ +.|
T Consensus 90 eYkgCyLr--e~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g 163 (948)
T KOG0577|consen 90 EYKGCYLR--EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPG 163 (948)
T ss_pred cccceeec--cchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCC
Confidence 99999875 4579999999965 788877654 57999999999999999999999999 99999999999998 789
Q ss_pred cEEEeccchhHHHhhhccCcccccccCcccc----ccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC
Q 035992 170 EVKIGDLGLAAILAQARSAHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~~~~~gt~~YmAPEvl----~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~ 245 (613)
.|||+|||.|.+......+.||+.|||||++ ++.|+-++|||||||+.+||.-.++|+.+.+.+..+|. |.+.-.
T Consensus 164 ~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-IAQNes 242 (948)
T KOG0577|consen 164 LVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNES 242 (948)
T ss_pred eeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-HHhcCC
Confidence 9999999999999999999999999999965 35799999999999999999999999988777777774 455555
Q ss_pred CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 246 PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 246 p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
|......++..|+.||..||+ -|.+|||.++||+|+|.....
T Consensus 243 PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 655567899999999999999 799999999999999997643
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.95 Aligned_cols=256 Identities=23% Similarity=0.415 Sum_probs=215.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC----------hHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN----------SEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~----------~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
|++.+.||+|.||.|-+|++..+++.||+|++.+..+.+. -..+++.++||.+|++|+|||||+++++.-
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 4667899999999999999999999999999987554321 123468999999999999999999999877
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
+.....+|+|+|||..|.+...-.....+++.+++.+++.++.||+|||.+| ||||||||+|+||+ ..|+|||+|||
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDFG 255 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDFG 255 (576)
T ss_pred CcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeeccc
Confidence 7777899999999999988654333334999999999999999999999999 99999999999998 56999999999
Q ss_pred hhHHHhh---------hccCcccccccCcccccc---c--cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC
Q 035992 178 LAAILAQ---------ARSAHSVIEFMAPELYEE---E--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 178 la~~l~~---------~~~~~gt~~YmAPEvl~~---~--ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g 243 (613)
.+..... .....||+.|||||.+.+ . .+.+.||||+||+||.|+.|++||.+ .....++.+|...
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~ 334 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVND 334 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcC
Confidence 9875521 224689999999997754 2 36789999999999999999999966 5667788888876
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.....-.+.....++++|.+||. ||.+|+++.++..|||....-
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 43322233468899999999998 999999999999999998753
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=357.37 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=211.6
Q ss_pred eeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++||+|+||+||+|.+. .+++.||+|+++.............+..|+.+|+.++||||++++++|.. +..+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 68999999999999864 57899999998865544444556678899999999999999999998854 45799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ---- 184 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~---- 184 (613)
||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~ 156 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTV 156 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCc
Confidence 99999999999999999999999999999999999999998 99999999999998 678999999999864321
Q ss_pred hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 185 ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
.....+++.|+|||++.+ .++.++|||||||++|||++|..||.. .+....+..+..+.. .++...++.+++||.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 233 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILKGKL--NLPPYLTPEARDLLKK 233 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 123457789999998765 488999999999999999999999966 444555566665532 3455678899999999
Q ss_pred Hhh-cccCCC-----CHHHHhcCCCCCCCCc
Q 035992 264 CIA-EVSERL-----PAKELLGDPFLQSEDD 288 (613)
Q Consensus 264 cL~-dP~~Rp-----ta~eLL~HPff~~~~~ 288 (613)
||+ +|.+|| ++.+++.||||....+
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 999 999999 8999999999987654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.25 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=212.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+|+.||+|+++.... ......+.+..|+.++..+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~ 77 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEY 77 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeC
Confidence 479999999999999999999999999875332 2345566778899999876 79999999998854 5579999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 78 VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCcccc
Confidence 999999999999899999999999999999999999998 99999999999998 678999999999865322 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. .++...+.++.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L 231 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFM 231 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 3357789999998765 589999999999999999999999965 456666677766532 234557889999999999
Q ss_pred h-cccCCC-------CHHHHhcCCCCCCCCccc
Q 035992 266 A-EVSERL-------PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rp-------ta~eLL~HPff~~~~~~~ 290 (613)
. +|.+|+ ++.++++||||...++..
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~ 264 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHH
Confidence 9 999999 899999999998876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=363.39 Aligned_cols=255 Identities=18% Similarity=0.335 Sum_probs=213.1
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.++||+|+||+||+|.+..++..||+|+++..... .....+.+..|+.+++.++||||++++++|.+ +..+++
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~--~~~~~l 120 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQD--DKYLYM 120 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCEEEE
Confidence 347779999999999999999999999999998753322 23445567889999999999999999998754 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||||+.+|+|.+++.+. .+++..+..++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCC
Confidence 99999999999988764 6899999999999999999999998 99999999999998 6789999999998765432
Q ss_pred ----ccCcccccccCcccccc-----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccc--ccc
Q 035992 186 ----RSAHSVIEFMAPELYEE-----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK--VAD 254 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s 254 (613)
....+++.|||||++.. .++.++|||||||++|||++|..||.. .+....+..+........++. ..+
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 23457889999998743 378999999999999999999999966 445566777766543333333 468
Q ss_pred HHHHHHHHHHhh-cccC--CCCHHHHhcCCCCCCCCcc
Q 035992 255 NGVRAFIEKCIA-EVSE--RLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~--Rpta~eLL~HPff~~~~~~ 289 (613)
..+++||.+||+ +|.+ |+++.++++||||+...+.
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999999999998 7776 9999999999999986543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=364.64 Aligned_cols=255 Identities=29% Similarity=0.448 Sum_probs=221.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~ 103 (613)
..+|.+.+.||+|.||.||+|.++.+|+.+|+|.+++.... .....+.+.+|+.+|+++. |||||.+++.|.+ ...
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~-~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~--~~~ 110 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLR-GKEDREDVRREVAILQQLSGHPNIVQLKDAFED--PDS 110 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcc-ccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc--CCe
Confidence 34568889999999999999999999999999999876543 3346788999999999998 9999999999865 458
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC---CCcEEEeccchhH
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAA 180 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~---~g~VKL~DFGla~ 180 (613)
+++|||++.||.|++.+.+. ++++..+..+++||+.++.|||+.| |+||||||+|+|+... .+.+|++|||++.
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999998887 5999999999999999999999998 9999999999999743 3579999999999
Q ss_pred HHhh---hccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCccccccc
Q 035992 181 ILAQ---ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVAD 254 (613)
Q Consensus 181 ~l~~---~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s 254 (613)
.... ....+|++.|+|||++. ..|+..+||||+|+++|.|++|..||...+. ......|..+.. +......++
T Consensus 188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~-~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE-FEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh-hHHHHHHHcCCCCCCCCCccccC
Confidence 8775 34567899999999988 6799999999999999999999999977544 444556666643 333445569
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..+++||.+||. +|.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999998 99999999999999999875
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.45 Aligned_cols=252 Identities=26% Similarity=0.412 Sum_probs=208.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|..||+|+++.. ......+.+.+|+.+|+.++||||++++++|.. +..+++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEE
Confidence 36679999999999999999999999998887642 234556789999999999999999999998865 4579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..+..++.|++.||.|||+.+ +|+||||||+|||++ .++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-~ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 159 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH-QIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA 159 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEcCCCChhhEEEc-CCCcEEEccCccccccccccc
Confidence 999999999999999889999999999999999999999853 399999999999998 6689999999998765332
Q ss_pred ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHH-------------------------
Q 035992 186 RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK------------------------- 239 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~------------------------- 239 (613)
....++..|+|||++.+ .++.++|||||||++|||++|+.||.... ...+...
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccccCCccccCcccccccc
Confidence 23457789999998765 48999999999999999999999995432 2222211
Q ss_pred ---------------------HHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 240 ---------------------VTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 240 ---------------------I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+.....+.......+.++++||.+||+ +|.+|||+.+|++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 111111222223467889999999999 999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.55 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=200.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV 81 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence 3667999999999999999999999999998864332 2223456789999999999999999998754 4579999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+. ++|.+++.++ +.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPS 157 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccCCC
Confidence 99996 5777776654 67999999999999999999999998 99999999999998 6789999999998654321
Q ss_pred ---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC----------------
Q 035992 186 ---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---------------- 244 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---------------- 244 (613)
....+++.|+|||++.+ .++.++|||||||++|+|++|..||.+..+.......+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 22345678999998753 488999999999999999999999977655544433332100
Q ss_pred -C--------CCcccc-----cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 -K--------PASLAK-----VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 -~--------p~~l~~-----~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
. +..+.. ..+..+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 0 000000 124678999999999 999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=352.43 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=208.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+++.||+|+++..... .....+.+..|..++..+ +||||++++++|.. +..+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~ 77 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEY 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 4799999999999999999999999998754322 234455566777777654 89999999998754 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 78 LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875422 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|||||++.+ .|+.++|||||||++|||++|..||.. .+..+++..+.... ..++...+..+.+||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l 231 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLF 231 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHc
Confidence 3457889999998765 489999999999999999999999966 45566666666543 2345667889999999999
Q ss_pred h-cccCCCCH-HHHhcCCCCCCCCcc
Q 035992 266 A-EVSERLPA-KELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rpta-~eLL~HPff~~~~~~ 289 (613)
. +|.+||++ .+++.||||....+.
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 232 ERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred cCCHHHcCCChHHHHcCcccCCCCHH
Confidence 9 99999986 589999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=372.67 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=201.9
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC---
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT--- 99 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~--- 99 (613)
+.++| ++.++||+|+||+||+|.+..+++.||+|.+.... ....+|+.+|+.++||||++++++|...
T Consensus 64 ~~~~y-~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~ 134 (440)
T PTZ00036 64 PNKSY-KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFK 134 (440)
T ss_pred cCCeE-EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence 44555 88899999999999999999999999999775321 2234799999999999999999877532
Q ss_pred ---CCCEEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 100 ---ENEHINFITEIFTSGTLRQYRK----KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 100 ---~~~~l~lV~E~~~gGsL~~~l~----~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
....+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+|
T Consensus 135 ~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred cCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCcee
Confidence 22357899999986 6666554 3567999999999999999999999998 999999999999985556799
Q ss_pred EeccchhHHHhhhc---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-
Q 035992 173 IGDLGLAAILAQAR---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP- 246 (613)
Q Consensus 173 L~DFGla~~l~~~~---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p- 246 (613)
|+|||++..+.... ...+++.|||||++.+ .|+.++|||||||++|||++|.+||.+......+.+.+.....|
T Consensus 212 L~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 212 LCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred eeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99999998764322 3356778999997653 58999999999999999999999998766555554433211000
Q ss_pred -------------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 -------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 -------------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..++...+.++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 01223356789999999999 999999999999999998653
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.23 Aligned_cols=247 Identities=25% Similarity=0.391 Sum_probs=198.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||.|+||+||+|.+..++..||+|+++.... ......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHT--ERCLTLV 81 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEEE
Confidence 4667999999999999999999999999998864321 2234567789999999999999999998754 4579999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+ +|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPT 157 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccCCC
Confidence 999975 8998887654 5899999999999999999999998 99999999999998 6789999999998654321
Q ss_pred ---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCC--------------
Q 035992 186 ---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIK-------------- 245 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~-------------- 245 (613)
....+++.|+|||++.+ .++.++|||||||++|+|+||.+||......+.+...+.. +..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12345678999997753 4899999999999999999999999765443333221110 000
Q ss_pred -----CC-------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 246 -----PA-------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 246 -----p~-------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+. ......+.++++||.+||+ +|.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 0012346789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=360.00 Aligned_cols=254 Identities=18% Similarity=0.351 Sum_probs=210.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.++||+|+||.||+|.+..+++.||+|++++.... .......+..|+.+++.++||||++++++|.. +..+|+
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~~~~~l 120 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLYM 120 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEE
Confidence 347889999999999999999999999999988753322 23445668899999999999999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||||+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..+...
T Consensus 121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecccCC
Confidence 99999999999998764 5899999999999999999999998 99999999999998 6789999999999765432
Q ss_pred ----ccCcccccccCcccccc-----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccc--ccc
Q 035992 186 ----RSAHSVIEFMAPELYEE-----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK--VAD 254 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~--~~s 254 (613)
....+++.|||||++.. .++.++|||||||++|+|++|..||.. .+....+..+........++. ..+
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCC
Confidence 23457889999998753 278899999999999999999999966 444556666665433222332 458
Q ss_pred HHHHHHHHHHhhc-c--cCCCCHHHHhcCCCCCCCCc
Q 035992 255 NGVRAFIEKCIAE-V--SERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 255 ~~l~~lI~~cL~d-P--~~Rpta~eLL~HPff~~~~~ 288 (613)
..++++|.+||.+ + ..|+++.++++||||+...+
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 8999999999983 3 34889999999999998643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=354.96 Aligned_cols=250 Identities=20% Similarity=0.383 Sum_probs=209.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+++.||+|++++... ........+..|+.++..+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 77 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEY 77 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHh-cchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeC
Confidence 479999999999999999999999999875432 3345667788999998877 89999999998855 4589999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 78 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccc
Confidence 999999999998889999999999999999999999998 99999999999998 678999999999875321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC--------CcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC--------TNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
...++..|+|||++.+ .++.++|||||||++|+|++|..||... .....+++.+.... ..++...+..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~ 232 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKA 232 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHH
Confidence 3457889999998765 5899999999999999999999999421 12233445554432 23556678899
Q ss_pred HHHHHHHhh-cccCCCC------HHHHhcCCCCCCCCcc
Q 035992 258 RAFIEKCIA-EVSERLP------AKELLGDPFLQSEDDE 289 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpt------a~eLL~HPff~~~~~~ 289 (613)
.++|.+||+ +|.+|++ +.++++||||+..++.
T Consensus 233 ~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999999 9999998 5899999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=352.40 Aligned_cols=251 Identities=24% Similarity=0.412 Sum_probs=209.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHH---HhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL---KTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iL---k~L~HpNIVkl~~~fv~~~~~~l 104 (613)
|++.++||+|+||+||+|.+..+|+.||+|+++..... .....+.+.+|+.++ +.++||||++++++|.. ...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~ 77 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDII-ARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHV 77 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEE
Confidence 47789999999999999999999999999998754322 234556777777665 46689999999998854 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+||||+.+|+|..++.+ +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 78 ~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 78 CFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCC
Confidence 999999999999988765 57999999999999999999999998 99999999999998 678999999999864322
Q ss_pred ----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.....+++.|||||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..+.. .++...+..+.+
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ 230 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG-DDEEEVFDSIVNDEV--RYPRFLSREAIS 230 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHH
Confidence 123457789999998765 589999999999999999999999965 445566666665432 244567889999
Q ss_pred HHHHHhh-cccCCC-----CHHHHhcCCCCCCCCc
Q 035992 260 FIEKCIA-EVSERL-----PAKELLGDPFLQSEDD 288 (613)
Q Consensus 260 lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~ 288 (613)
||.+||+ +|.+|| ++.++++||||+...+
T Consensus 231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 9999999 999999 6999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=350.59 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=214.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.+..+++.||+|+++.... ......+.+..|..++..+ +|++|++++++|.. ...+++
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 4678999999999999999999999999998875332 2334556677888888877 58899999998754 468999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
||||+.+|+|..++.+.+.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCC
Confidence 9999999999999999889999999999999999999999998 99999999999998 678999999999864321
Q ss_pred --hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 --ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.....+++.|||||++.. .|+.++|||||||++|||+||..||.. .+...++..+..... .++...+.++.++|
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 232 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAIC 232 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHH
Confidence 223457889999998765 589999999999999999999999965 455666667665532 34566789999999
Q ss_pred HHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 262 EKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 262 ~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
.+||+ +|.+|++ ..+++.||||+..++...
T Consensus 233 ~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred HHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 99999 9999998 489999999998776443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=352.55 Aligned_cols=257 Identities=18% Similarity=0.335 Sum_probs=210.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+++.||+|++.+... ......+.+..|+.+++.++|+||++++++|.. +..+|+|
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 79 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQD--ENNLYLV 79 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--CCeEEEE
Confidence 4678999999999999999999999999999874332 223455678899999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|.+++.+ ...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCC
Confidence 999999999999977 467999999999999999999999998 99999999999997 67899999999986543321
Q ss_pred -----cCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc---ccc
Q 035992 187 -----SAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL---AKV 252 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~ 252 (613)
...+++.|||||++. ..++.++|||||||++|+|++|..||.. .+..+.+..+........+ ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCC
Confidence 235788999999875 2478899999999999999999999965 3445555566543221111 223
Q ss_pred ccHHHHHHHHHHhhc---ccCCCCHHHHhcCCCCCCCCcccc
Q 035992 253 ADNGVRAFIEKCIAE---VSERLPAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 253 ~s~~l~~lI~~cL~d---P~~Rpta~eLL~HPff~~~~~~~~ 291 (613)
.+..+++||.+||.. +..|+++.++++||||...++...
T Consensus 236 ~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~ 277 (331)
T cd05597 236 VSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI 277 (331)
T ss_pred CCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence 688999999999863 344789999999999998766443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=353.91 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=207.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHH-HHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEV-HLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei-~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
+.||+|+||+||+|.+..+++.||+|++........ .....+..|. .+++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKK-KEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhh-hHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEEEEeC
Confidence 479999999999999999999999999875433222 2233444444 45788999999999998754 5679999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcc
Confidence 999999999999889999999999999999999999998 99999999999998 678999999999875322 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|||||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+.... ..+....+..++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLL 231 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhCC--cCCCCCCCHHHHHHHHHHc
Confidence 3457889999998765 489999999999999999999999975 45556666665543 2344567889999999999
Q ss_pred h-cccCCCCHH----HHhcCCCCCCCCccc
Q 035992 266 A-EVSERLPAK----ELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rpta~----eLL~HPff~~~~~~~ 290 (613)
+ +|.+|+++. ++++|+||...++..
T Consensus 232 ~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 232 QKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred ccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 9 999999865 899999998876644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.41 Aligned_cols=249 Identities=25% Similarity=0.429 Sum_probs=209.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||.||+|.++.+|..||+|+++..... .......+..|+.++..+ +||||++++++|.. ...+|+||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~ 77 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEF 77 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECC
Confidence 4799999999999999999999999998753321 224456677788888764 89999999998854 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 78 LNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCcee
Confidence 999999999998889999999999999999999999998 99999999999998 568999999999864321 22
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...++..|+|||++.+ .|+.++|||||||++|||++|..||.. .+...+++.+..+. ..++...+..++++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLF 231 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHc
Confidence 3457889999998765 589999999999999999999999965 45566666665543 2345567889999999999
Q ss_pred h-cccCCCCH-HHHhcCCCCCCCCcc
Q 035992 266 A-EVSERLPA-KELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rpta-~eLL~HPff~~~~~~ 289 (613)
. +|.+|+++ .++++||||+..++.
T Consensus 232 ~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 232 ERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred cCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 9 99999997 589999999987543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=352.63 Aligned_cols=248 Identities=26% Similarity=0.407 Sum_probs=206.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHH-HHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.++.+|+.||+|++...... .......+..|.. +++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEEEEcC
Confidence 4799999999999999999999999988754322 2334455566655 5677999999999998754 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcc
Confidence 999999999999899999999999999999999999998 99999999999998 678999999999865321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...++..|||||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. .+....+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~ll 231 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKPL--VLRPGASLTAWSILEELL 231 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCCc--cCCCCCCHHHHHHHHHHh
Confidence 3457789999998765 489999999999999999999999965 455666666665432 233456888999999999
Q ss_pred h-cccCCCCH----HHHhcCCCCCCCCc
Q 035992 266 A-EVSERLPA----KELLGDPFLQSEDD 288 (613)
Q Consensus 266 ~-dP~~Rpta----~eLL~HPff~~~~~ 288 (613)
. +|.+||++ .++++||||....+
T Consensus 232 ~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 232 EKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred ccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 8 99999976 59999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=352.31 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=207.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHH-HHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+|+.||+|++....... ......+..|+. +++.++||||++++++|.. ...+++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEEEEcC
Confidence 47999999999999999999999999887543322 233445555554 6788999999999998754 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccc
Confidence 999999999988889999999999999999999999998 99999999999998 678999999999875321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|+|||++.+ .++.++|||||||++|||++|..||.. .+..+++..+.... ..++...+..+.++|.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHKP--LQLPGGKTVAACDLLVGLL 231 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHc
Confidence 3456789999998765 589999999999999999999999966 45666777776553 3445567889999999999
Q ss_pred h-cccCCCCH----HHHhcCCCCCCCCcc
Q 035992 266 A-EVSERLPA----KELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rpta----~eLL~HPff~~~~~~ 289 (613)
+ +|.+|+++ .++++||||...++.
T Consensus 232 ~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 232 HKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred cCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 9 99999975 599999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=351.54 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=208.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh-CCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT-LKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
+.||+|+||+||+|.+..+++.||+|+++.... ...........|..+++. ++||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey 77 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEY 77 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeC
Confidence 479999999999999999999999998875322 122345566778888876 499999999998854 4579999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..... ..
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 78 LNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCcee
Confidence 999999999998888999999999999999999999998 99999999999998 568999999999864321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...++..|||||++.+ .|+.++|||||||++|||++|..||.. .+...+++.+..+. ..++...+..+++||.+||
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l 231 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLF 231 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHh
Confidence 3457789999998765 589999999999999999999999966 44566666665443 2345567889999999999
Q ss_pred h-cccCCCCHH-HHhcCCCCCCCCcc
Q 035992 266 A-EVSERLPAK-ELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rpta~-eLL~HPff~~~~~~ 289 (613)
+ +|.+|+++. +++.||||+..++.
T Consensus 232 ~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 232 VREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred ccCHhhcCCChHHHHcCcccCCCCHH
Confidence 9 999999996 99999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=344.42 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=204.8
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||+|+||+||+|.+..+|+.||+|.+..... ......+.+..|+.+++.++||||++++++|.. ...+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRL-KKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHH-hhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 7999999999999999999999998875332 223345677889999999999999999998754 4679999999999
Q ss_pred CCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---
Q 035992 114 GTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR--- 186 (613)
Q Consensus 114 GsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 186 (613)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.++|+|||++..+....
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKT 154 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccc
Confidence 999987743 356999999999999999999999998 99999999999997 57899999999987654322
Q ss_pred -cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 187 -SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 187 -~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
...+++.|+|||++.+ .++.++||||||+++|+|++|+.||..... ...+...+... +..++...+..+++++
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 232 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPDKFSPASKSFC 232 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcccCCHHHHHHH
Confidence 2356779999998764 589999999999999999999999965332 22233333322 2344556788999999
Q ss_pred HHHhh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 262 EKCIA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 262 ~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
.+||+ +|.+|| +++++++||||+...+..
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 99998 999999 889999999999866544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=335.72 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=207.0
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
||.+ .++||+|.||+||+|++..+|+.||||.|+..+.. ..-.....+||.+|+.++|+||+.+.++|- ....+.
T Consensus 3 rY~~-~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k--dGi~~talREIK~Lqel~h~nIi~LiD~F~--~~~~l~ 77 (318)
T KOG0659|consen 3 RYEK-LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK--DGINRTALREIKLLQELKHPNIIELIDVFP--HKSNLS 77 (318)
T ss_pred hhhh-hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc--cCccHHHHHHHHHHHHccCcchhhhhhhcc--CCCceE
Confidence 5544 48999999999999999999999999999876432 222345789999999999999999999984 456799
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 106 FITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+|+||+.. +|...++.. ..++...++.|+.++++||+|||++. |+||||||.|+|++ .+|.+||+|||+|+.+..
T Consensus 78 lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGS 153 (318)
T ss_pred EEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCC
Confidence 99999987 888777654 57999999999999999999999999 99999999999998 678999999999998765
Q ss_pred hccC----cccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--CCCC----------
Q 035992 185 ARSA----HSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS--GIKP---------- 246 (613)
Q Consensus 185 ~~~~----~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~--g~~p---------- 246 (613)
.... .-|-+|.|||++-+ .|+..+|+||.||++.||+-|.+-|.+.++.+|+...+.. ...+
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 4322 23458999997643 5999999999999999999988778777777777544331 0101
Q ss_pred ----------Cc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 ----------AS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 ----------~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+. +....+.++.+|+.+||. +|.+|+++.|+|+|+||...
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 00 122346778999999999 99999999999999999874
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=353.90 Aligned_cols=248 Identities=23% Similarity=0.456 Sum_probs=221.1
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||+|.||+|-+|.....|+.||||.|++.+ .++..++-++.+||+||..|+||||+.+|++| ++...+.+||
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdk-IkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvivM 132 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDK-IKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVIVM 132 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhh-cccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEEEE
Confidence 66799999999999999999999999999988644 46778899999999999999999999999988 4566899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 185 (613)
||..+|.|.+|+.+.+.+++..++.|++||+.|+.|||.++ ++|||||.+|||++ .++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhccccHH
Confidence 99999999999999999999999999999999999999999 99999999999998 5689999999999988654
Q ss_pred ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 186 RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
.+++|++-|.+||++++. | ++.+|.||||++||.|+.|..||.+ .+-..+.+.|..|... ....+..+.-||++
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYr---EP~~PSdA~gLIRw 285 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYR---EPETPSDASGLIRW 285 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhccccc---CCCCCchHHHHHHH
Confidence 478899999999999875 4 6789999999999999999999965 5666777788877532 22335678899999
Q ss_pred Hhh-cccCCCCHHHHhcCCCCCCC
Q 035992 264 CIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||. +|.+|.|+.++-.|-|+.-.
T Consensus 286 mLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred HHhcCcccchhHHHHhhhheeecc
Confidence 998 99999999999999998644
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=351.09 Aligned_cols=249 Identities=22% Similarity=0.395 Sum_probs=211.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+++.||+|++++... ........+..|+.+++.+ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~ 77 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEY 77 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcC
Confidence 479999999999999999999999999875432 2334566778899999888 69999999998754 4589999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 78 VNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCccc
Confidence 999999999999889999999999999999999999998 99999999999998 678999999999864321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...++..|+|||++.+ .++.++|||||||++|+|++|..||.. .+...++..+..... .++...+..+++||.+||
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l 231 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFL 231 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHc
Confidence 2346789999998765 589999999999999999999999965 455666666665532 345567899999999999
Q ss_pred h-cccCCCCH-----HHHhcCCCCCCCCcc
Q 035992 266 A-EVSERLPA-----KELLGDPFLQSEDDE 289 (613)
Q Consensus 266 ~-dP~~Rpta-----~eLL~HPff~~~~~~ 289 (613)
. +|.+||++ .+++.||||+..++.
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9 99999999 999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=351.68 Aligned_cols=251 Identities=19% Similarity=0.351 Sum_probs=211.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|.+..+++.||+|+++... .......+.+..|+.++.++ +||||++++++|.. ...+++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKEL-VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEY 77 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeC
Confidence 47999999999999999999999999987533 23345667788999999888 69999999998754 4579999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 78 VNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCcee
Confidence 999999999998889999999999999999999999998 99999999999998 568999999999875321 12
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC------CcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC------TNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~------~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
...+++.|+|||++.+ .|+.++|||||||++|+|++|..||... .....+++.+... +..++...+..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~ 232 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASH 232 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHH
Confidence 3457889999998764 5899999999999999999999999532 2334455555543 33456677899999
Q ss_pred HHHHHhh-cccCCCC------HHHHhcCCCCCCCCccc
Q 035992 260 FIEKCIA-EVSERLP------AKELLGDPFLQSEDDES 290 (613)
Q Consensus 260 lI~~cL~-dP~~Rpt------a~eLL~HPff~~~~~~~ 290 (613)
+|.+||. +|.+|++ +.+++.||||+..++..
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 9999999 9999998 57999999999887643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.21 Aligned_cols=259 Identities=17% Similarity=0.326 Sum_probs=214.0
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
.-...-|++.+.||+|+||+||+|.++.+++.||+|++.+.... .......+.+|+.+++.++||||++++++|.. +
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~--~ 115 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD--D 115 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--C
Confidence 33334557889999999999999999999999999988753322 23445668899999999999999999998854 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++||||+.+|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMK 191 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeE
Confidence 6899999999999999998764 5899999999999999999999998 99999999999998 678999999999876
Q ss_pred Hhhh-----ccCcccccccCcccccc-----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc-
Q 035992 182 LAQA-----RSAHSVIEFMAPELYEE-----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA- 250 (613)
Q Consensus 182 l~~~-----~~~~gt~~YmAPEvl~~-----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~- 250 (613)
+... ....+++.|||||++.. .++.++|||||||++|||++|..||.. .+....+..+........++
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCC
Confidence 5432 23457889999998753 278999999999999999999999965 55666777777654332222
Q ss_pred -ccccHHHHHHHHHHhhcccC---CCCHHHHhcCCCCCCCCc
Q 035992 251 -KVADNGVRAFIEKCIAEVSE---RLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 251 -~~~s~~l~~lI~~cL~dP~~---Rpta~eLL~HPff~~~~~ 288 (613)
...+..++++|.+||.+|.. |+++.++++||||+...+
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 35788999999999985443 789999999999988643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=351.69 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=208.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC---E
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE---H 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~---~ 103 (613)
.++-.+++|+|+||.||+|....+++.||||.+-.....+ .+|+++|+.++|||||++..+|....+. +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3456699999999999999999999999999876544333 3699999999999999999988765544 6
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 104 INFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+++||||++. +|.++++. +..++.-.++.+.+||++||.|||+.+ |+||||||.|+|+|.+.|.+||||||.|
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcc
Confidence 7889999976 88877764 578999999999999999999999988 9999999999999988899999999999
Q ss_pred HHHhhhccCccc---ccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-C----------
Q 035992 180 AILAQARSAHSV---IEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-G---------- 243 (613)
Q Consensus 180 ~~l~~~~~~~gt---~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g---------- 243 (613)
+.+......... -.|.|||++-+ .|+.+.||||.||++.||+-|++-|.+.....|+...+.- |
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 988765543332 36999997643 5999999999999999999999999887776666544320 0
Q ss_pred -----------CCCC----cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 244 -----------IKPA----SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 244 -----------~~p~----~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.++. .+.+..++++.+|+.++|+ +|.+|.++.|++.||||.....
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 0111 1344568899999999999 9999999999999999987643
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=350.55 Aligned_cols=248 Identities=23% Similarity=0.360 Sum_probs=209.1
Q ss_pred eeecccCceEEEEEEE---cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFD---ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~---~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+.||+|+||+||++.+ ..+|+.||+|+++.... .......+..|+.++++++||||++++++|.. +..+|+||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 77 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKLYLIL 77 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEEEEEE
Confidence 6799999999999976 45789999998875432 22344567889999999999999999998854 56899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 185 (613)
||+.+|+|.+++.+...+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 78 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCc
Confidence 99999999999998889999999999999999999999998 99999999999998 6789999999998765332
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
....+++.|+|||++.. .++.++|||||||++|||++|..||... +....+..+..... .++...++.++++|.+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~ 231 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK-DRKETMTMILKAKL--GMPQFLSPEAQSLLRA 231 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence 23456789999998764 5889999999999999999999999664 44555555554432 3455678899999999
Q ss_pred Hhh-cccCCCC-----HHHHhcCCCCCCCCcc
Q 035992 264 CIA-EVSERLP-----AKELLGDPFLQSEDDE 289 (613)
Q Consensus 264 cL~-dP~~Rpt-----a~eLL~HPff~~~~~~ 289 (613)
||+ +|.+||+ +.+++.||||+...+.
T Consensus 232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 232 LFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred HhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 999 9999999 7889999999987543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=349.07 Aligned_cols=257 Identities=17% Similarity=0.312 Sum_probs=210.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+++.||+|+++.... ........+..|+.++..++|+||++++++|.. ...+|+|
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~~~~~lv 79 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQD--ENYLYLV 79 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCEEEEE
Confidence 4778999999999999999999999999998875332 223445668889999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|.+++.+ .+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCC
Confidence 999999999999987 467999999999999999999999998 99999999999998 67899999999987654321
Q ss_pred -----cCcccccccCcccccc------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc---cc
Q 035992 187 -----SAHSVIEFMAPELYEE------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA---KV 252 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~~------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~---~~ 252 (613)
...+++.|||||++.. .++.++|||||||++|+|++|..||.. .+....+..+........++ ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCcccc
Confidence 2457889999998753 478899999999999999999999966 44455566665543222222 23
Q ss_pred ccHHHHHHHHHHhhcccC---CCCHHHHhcCCCCCCCCcccc
Q 035992 253 ADNGVRAFIEKCIAEVSE---RLPAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 253 ~s~~l~~lI~~cL~dP~~---Rpta~eLL~HPff~~~~~~~~ 291 (613)
.+..++++|.+||..+.+ |++++++++||||+..++...
T Consensus 236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~ 277 (331)
T cd05624 236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENI 277 (331)
T ss_pred CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHH
Confidence 578999999999984333 568999999999998766544
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=388.58 Aligned_cols=274 Identities=19% Similarity=0.334 Sum_probs=236.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.++||+|+||.|..++++.+++.||+|.+.+-...+ ..+...|..|..+|...+.+.|+.++-.|.+ +.++|+|
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlK-r~~tA~F~EERDimv~~ns~Wiv~LhyAFQD--~~~LYlV 153 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLK-RAETACFREERDIMVFGNSEWIVQLHYAFQD--ERYLYLV 153 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhh-chhHHHHHHHhHHHHcCCcHHHHHHHHHhcC--ccceEEE
Confidence 455699999999999999999999999999887644433 2455678899999999999999999998855 6789999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|+|++||+|..++.++.++++..++.|+..|+.||..||+.| +|||||||+|||++ ..|+|||+|||.+-.+..
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCc
Confidence 999999999999999999999999999999999999999999 99999999999998 789999999999987763
Q ss_pred --hccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc--cccc
Q 035992 185 --ARSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA--KVAD 254 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s 254 (613)
.....|||.|++||++. +.|+..+|+||+||++|||+.|..||+. ......|.+|++-.....|| ..++
T Consensus 231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccC
Confidence 34678999999999874 3499999999999999999999999976 56777888888765444444 4489
Q ss_pred HHHHHHHHHHhhcccCCCC---HHHHhcCCCCCCCCcccccc---cccccccCCcccccc
Q 035992 255 NGVRAFIEKCIAEVSERLP---AKELLGDPFLQSEDDESVGR---SLRVKTHYSAETSHQ 308 (613)
Q Consensus 255 ~~l~~lI~~cL~dP~~Rpt---a~eLL~HPff~~~~~~~~~~---~~~~~~~~~~~~~~~ 308 (613)
.++++||.++|.+|..|++ +.++..||||.+++|..+.. +..|...++.+++++
T Consensus 310 eeakdLI~~ll~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnF 369 (1317)
T KOG0612|consen 310 EEAKDLIEALLCDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNF 369 (1317)
T ss_pred HHHHHHHHHHhcChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCccccc
Confidence 9999999999999999998 99999999999999976644 444445555556655
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=331.56 Aligned_cols=250 Identities=30% Similarity=0.523 Sum_probs=211.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
+.+.+.||+|++|.||+|.+..+++.||+|.+....... .......+.+|+.++++++||||+++++++.. ...+++
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 81 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETLSI 81 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeEEE
Confidence 366799999999999999999999999999887543221 22345678899999999999999999998854 458999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
++||+.+++|.+++.+.+.+++..++.++.|++.||.|||+++ ++||||+|+||+++ .++.++|+|||++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccccc
Confidence 9999999999999999889999999999999999999999998 99999999999998 6789999999998754321
Q ss_pred ------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 ------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
....++..|+|||++.+ .++.++||||||+++|+|++|+.||.......... .+........++...+..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHH
Confidence 12335568999998765 48899999999999999999999997755554444 33333334456667889999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
++|.+||. +|.+||++.++++||||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999 99999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=346.99 Aligned_cols=253 Identities=30% Similarity=0.424 Sum_probs=209.3
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec---CCCCEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD---TENEHIN 105 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~---~~~~~l~ 105 (613)
...+.||+|+||.|..|.++.+|+.||+|.+. +..++....++.++|+.+|+.++|+||+.+++.+.. ..-..+|
T Consensus 25 ~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~--~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 25 VLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL--NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred cccccccCcceeeEEEEEEcCCCCEeehhhhh--hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 34689999999999999999999999988654 345667888999999999999999999999998765 2345799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+|+|+|. -+|.+.++.++.+++..+..+++||++||.|+|+.+ |+||||||.|+|++ .+..+||+|||+|+.....
T Consensus 103 iV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 103 LVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKF 178 (359)
T ss_pred EehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceeecccc
Confidence 9999994 489999999888999999999999999999999999 99999999999999 5678999999999987531
Q ss_pred ------ccCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHH--------------HH--
Q 035992 186 ------RSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK--------------VT-- 241 (613)
Q Consensus 186 ------~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~--------------I~-- 241 (613)
.....|-+|.|||++. ..|+.++||||+|||+.||++|++-|.+.....|+... |.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 1122345899999764 46999999999999999999999999775544444221 11
Q ss_pred -------c-CCCC-Cc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 242 -------S-GIKP-AS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 242 -------~-g~~p-~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+ ...| .. +.+..++.+.+|+++||. ||.+|+|++|.|.||||..-.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 0 1111 11 223568899999999999 999999999999999998753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=358.13 Aligned_cols=252 Identities=26% Similarity=0.436 Sum_probs=220.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|-|++|.+|+|.-+|+.||+|+|.+.++ +.....++++|+..|+.++|||||++|++. .....+|+|
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLi 95 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLI 95 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEE
Confidence 3678999999999999999999999999999887664 334557899999999999999999999963 445679999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
+|+-.+|+|++||.++ ..+.|..++.|+.||+.|+.|||+.. +|||||||+||.+....|-|||.|||++..+...
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999999887 57999999999999999999999999 9999999999988878999999999999877654
Q ss_pred --ccCcccccccCcccccc-ccC-ccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 --RSAHSVIEFMAPELYEE-EYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~ys-~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.+.+|...|-|||++-+ .|+ +++||||||||||.|++|++||.+..+.+.+ .+|+.... ..+...+.++++||
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-TmImDCKY--tvPshvS~eCrdLI 250 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-TMIMDCKY--TVPSHVSKECRDLI 250 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-hhhhcccc--cCchhhhHHHHHHH
Confidence 36678889999997654 575 7899999999999999999999887666555 45665542 34677899999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
..||. +|.+|.+.++|..|+|++..+.
T Consensus 251 ~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 251 QSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHhcCchhhccHHHHhccccccCCCC
Confidence 99999 9999999999999999999764
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=346.84 Aligned_cols=253 Identities=21% Similarity=0.336 Sum_probs=212.9
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV 107 (613)
++.++||+|+||+||+|.++.+|+.||+|+++.... ......+.+..|+.+++.+. |++|++++++|.. ...+|+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv 79 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYFV 79 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEEE
Confidence 667999999999999999999999999998875332 23345667888999998886 5677888887754 4579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.+|+|..++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCc
Confidence 999999999999999899999999999999999999999998 99999999999998 678999999999875422
Q ss_pred -hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 185 -ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 185 -~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
.....+++.|||||++.. .++.++|||||||++|+|++|..||.. .+...+++.+..... .++...+..+.+++.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICK 233 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHH
Confidence 123457889999998764 489999999999999999999999966 455666666665432 345567889999999
Q ss_pred HHhh-cccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 263 KCIA-EVSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 263 ~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
+||+ +|.+|++ .+++++||||+..++..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~ 267 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHH
Confidence 9999 9999997 57999999999876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=347.39 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=207.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|..+|+|.++.. ........+.+|+++++.++||||++++++|.. +..+++|
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence 36779999999999999999999999998877642 234556778999999999999999999999865 4589999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++ + ++||||||+|||++ ..+.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhc
Confidence 99999999999999988999999999999999999999974 5 99999999999998 5689999999999765432
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHH--------------------------
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY-------------------------- 237 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~-------------------------- 237 (613)
....++..|+|||++.+ .++.++|||||||++|+|++|..||..... ..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (333)
T cd06650 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRPPGRP 237 (333)
T ss_pred cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCCccch
Confidence 23457789999998765 488999999999999999999999964322 1111
Q ss_pred ------------------HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 238 ------------------KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 238 ------------------~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..+.....+.......+.++++||.+||+ +|.+|||+.||+.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 238 LSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 11122222222223457889999999999 999999999999999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=346.92 Aligned_cols=257 Identities=18% Similarity=0.330 Sum_probs=210.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||++.++.+++.||+|++.+.... .......+..|+.++..++|+||++++++|.. ...+++|
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 79 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQD--ENNLYLV 79 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CCEEEEE
Confidence 46789999999999999999999999999988653322 23345568889999999999999999998754 4689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+|+|.+++.+ .+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCC
Confidence 999999999999987 467999999999999999999999998 99999999999998 6789999999998654321
Q ss_pred ----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc---ccc
Q 035992 186 ----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL---AKV 252 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~ 252 (613)
....+++.|||||++. ..|+.++|||||||++|||++|+.||.. .+....+.++........+ ...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCcccc
Confidence 1245788999999874 3488999999999999999999999976 4455566666654322222 234
Q ss_pred ccHHHHHHHHHHhh-c--ccCCCCHHHHhcCCCCCCCCcccc
Q 035992 253 ADNGVRAFIEKCIA-E--VSERLPAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-d--P~~Rpta~eLL~HPff~~~~~~~~ 291 (613)
.+..+++||.+||. + +..|+++.++++||||+..++..+
T Consensus 236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~ 277 (332)
T cd05623 236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNI 277 (332)
T ss_pred CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHH
Confidence 68899999999996 3 344789999999999998766443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=338.66 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=196.0
Q ss_pred eeEeeeecccCceEEEEEEEcC-CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCCcceeeeeeec---CC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL-EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVD---TE 100 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~-tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~---~~ 100 (613)
|++.+.||+|+||+||+|.+.. +|..||+|.++..... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC--CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3778999999999999999864 5688999988754321 22234455677777665 69999999998753 23
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...++++|||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccc
Confidence 456899999996 5899988764 45899999999999999999999998 99999999999998 578999999999
Q ss_pred hHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CC-----
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PA----- 247 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~----- 247 (613)
+...... ....+++.|+|||++.+ .++.++|||||||++|||++|..||........+.+.+..... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 157 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 8765432 23356779999998754 5899999999999999999999999775554443332221100 00
Q ss_pred -----------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 248 -----------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 248 -----------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+....+..+++||.+||+ +|.+|||+.++|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0112357788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.18 Aligned_cols=257 Identities=26% Similarity=0.448 Sum_probs=217.9
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
.+|.-.+ .+.-.||-|+||.||+|.++.++...|.|+|.. +..+.++.++-||.||..|+||+||++|+.|+..
T Consensus 28 lnP~d~W-eIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e- 101 (1187)
T KOG0579|consen 28 LNPRDHW-EIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE- 101 (1187)
T ss_pred CCHHHHH-HHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-
Confidence 3454444 344678999999999999999999889887663 4578899999999999999999999999987653
Q ss_pred CCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+.+|++.|||.||-....+-. ...+++.+|..+++|++.||.|||+++ |||||||+.|||++ -+|.|+|+|||++
T Consensus 102 -nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVS 177 (1187)
T KOG0579|consen 102 -NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVS 177 (1187)
T ss_pred -CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeeccccc
Confidence 469999999999999876544 567999999999999999999999999 99999999999998 6799999999998
Q ss_pred HHHh----hhccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc
Q 035992 180 AILA----QARSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL 249 (613)
Q Consensus 180 ~~l~----~~~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l 249 (613)
.... ....+.||+.|||||++. ..|+.++||||||++|+||+.+.+|..+...+..+++...+......-
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlq 257 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ 257 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccC
Confidence 6543 345788999999999753 359999999999999999999999998866555555444444433445
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..++..+++|+.+||. +|..||++.+||+||||++..
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 67889999999999998 999999999999999999653
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=339.30 Aligned_cols=255 Identities=20% Similarity=0.362 Sum_probs=208.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.+..++..||+|++..... ........+.+|+.+++.++||||++++++|.. +..+++|
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDALCLV 78 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhh-hhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CCeEEEE
Confidence 3667999999999999999999999999998864332 222334567789999999999999999998754 4579999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|..++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +.+.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCC
Confidence 9999999999887654 46999999999999999999999998 99999999999998 5689999999998765332
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH---HHHHHHHcCCCCCcccccccHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAA---QIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~---~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
....++..|+|||++.+ .++.++||||||+++|||++|..||....... .+...+... +..++...+..++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 233 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED--QEEYSEKFSEAAR 233 (285)
T ss_pred CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc--ccccCcccCHHHH
Confidence 22356779999998764 58899999999999999999999997643322 222223222 2334456788999
Q ss_pred HHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 259 AFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
+||.+||. +|.+|| ++++|+.||||...++..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 99999999 999999 899999999999865543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.44 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=212.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL-RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|.+..+|..||+|.+...... ......+.+.+|+.+++.++||||++++++|.+.....+++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 47789999999999999999999999999987643221 22345678899999999999999999999887655668899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
+|||+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ ++|+||||+||+++ ..+.++|+|||++..+..
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCcccccccccc
Confidence 9999999999999998888999999999999999999999998 99999999999998 678999999999875532
Q ss_pred -----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 185 -----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 185 -----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
.....++..|+|||.+.+ .++.++||||||+++|+|++|+.||........+.+ +.........+...+..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPTNPVLPPHVSDHCR 239 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHH-HhcCCCCCCCchhhCHHHH
Confidence 112345668999998754 588999999999999999999999977655555443 3333333344556778899
Q ss_pred HHHHHHhhcccCCCCHHHHhcCCCCC
Q 035992 259 AFIEKCIAEVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 259 ~lI~~cL~dP~~Rpta~eLL~HPff~ 284 (613)
++|.+||.+|.+||++++++.|||+.
T Consensus 240 ~~i~~~l~~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 240 DFLKRIFVEAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHhcChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=333.91 Aligned_cols=249 Identities=31% Similarity=0.547 Sum_probs=204.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+++.||+|++..... ..........|+.+++.++||||+++++++.. ...++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v 76 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIV 76 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhccccccccccccccccccc--ccccccc
Confidence 5889999999999999999999999999998875432 12223344569999999999999999998865 5678999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH----h
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----A 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l----~ 183 (613)
||++.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||||+||+++ +++.++|+|||.+... .
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-ccccccccccccccccccccc
Confidence 999999999999998889999999999999999999999998 99999999999998 7789999999998642 1
Q ss_pred hhccCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcCCCCCccc--ccccHHH
Q 035992 184 QARSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSGIKPASLA--KVADNGV 257 (613)
Q Consensus 184 ~~~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~--~~~s~~l 257 (613)
......++..|+|||++. ..++.++||||||+++|+|++|..||.... +.............+.... ......+
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEEL 233 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHH
Confidence 223445677999999887 458999999999999999999999997752 2222332222221111111 1123789
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.++|.+||+ +|.+||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 234 RDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 999999999 99999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=349.57 Aligned_cols=247 Identities=21% Similarity=0.367 Sum_probs=206.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
||+|+||+||+|.+..+|+.||+|++...... .......+..|..++..+ +||||++++.+|.. ...+|+||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~ 77 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDY 77 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcC
Confidence 79999999999999999999999988753322 223445556677777665 69999999998754 4679999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----hc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----AR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~----~~ 186 (613)
+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..... ..
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 78 MSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred CCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCcc
Confidence 999999999999899999999999999999999999998 99999999999998 678999999999865322 22
Q ss_pred cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 187 SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
...++..|||||++.+ .++.++|||||||++|+|++|..||.. .+..++++.+..+.... .....+..+++||.+|
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~ 232 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGL 232 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHH
Confidence 3457889999998753 489999999999999999999999965 55666777776654321 1234688999999999
Q ss_pred hh-cccCCC----CHHHHhcCCCCCCCCc
Q 035992 265 IA-EVSERL----PAKELLGDPFLQSEDD 288 (613)
Q Consensus 265 L~-dP~~Rp----ta~eLL~HPff~~~~~ 288 (613)
|. +|.+|| ++.+++.||||....+
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~~~~ 261 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFADIDW 261 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccCCCH
Confidence 99 999998 6999999999987654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.77 Aligned_cols=250 Identities=29% Similarity=0.500 Sum_probs=220.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
-+.+++|+|+||.+++++++.++..+++|.|..... .....+...+|+.+++++.|||||.++++|+.. +..++|+|
T Consensus 7 e~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~-~~~l~Ivm 83 (426)
T KOG0589|consen 7 EVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEED-GQLLCIVM 83 (426)
T ss_pred hhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcC-CceEEEEE
Confidence 556999999999999999999999999998886553 334445788999999999999999999999753 44599999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 109 EIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
+||.||+|.+.+.+. ..|+++.+..|+.||+.|+.|||++. |+|||||+.|||++ .++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhcCCch
Confidence 999999999998765 46999999999999999999999988 99999999999998 4568899999999998764
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.+..||+.||.||++.+ .|+.|+||||||||+|||++-+.+|.. .+...+..+|..+. -..++..++.+++.+|
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGL-YSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhcc-CCCCCccccHHHHHHH
Confidence 35678999999999976 599999999999999999999999955 77888888888876 3346778899999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..||. +|..||++.+||.+|.++..
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999 99999999999999988753
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=349.05 Aligned_cols=245 Identities=28% Similarity=0.458 Sum_probs=200.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||+|+||+||+|.+..+|+.||+|++... ........+.+|+.+++.++|+||++++++|.. +..+++||
T Consensus 77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 151 (353)
T PLN00034 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDH--NGEIQVLL 151 (353)
T ss_pred hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--CCeEEEEE
Confidence 4558999999999999999999999999987532 234556778999999999999999999998743 56899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 185 (613)
||+.+|+|... ...++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..+...
T Consensus 152 e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 152 EFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred ecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceeccccccc
Confidence 99999998643 34678889999999999999999998 99999999999998 6789999999999765432
Q ss_pred -ccCcccccccCcccccc-----c-cCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcCCCCCcccccccHH
Q 035992 186 -RSAHSVIEFMAPELYEE-----E-YNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-----~-ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
....++..|+|||++.. . ++.++|||||||++|||++|+.||.... +...+...+.... +...+...+..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 303 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ-PPEAPATASRE 303 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC-CCCCCCccCHH
Confidence 23457789999998742 2 3568999999999999999999996322 2222333333322 23344567889
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++||.+||. +|.+||++.|+|+||||...
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999 99999999999999999875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=344.12 Aligned_cols=269 Identities=21% Similarity=0.404 Sum_probs=231.3
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.|.++||+|.||+|-+++.+.+|+.+|+|++++.-. -..+++.+-+.|-++|+..+||.+..+..+|.. +..+||||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevi-iakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt--~drlCFVM 247 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVI-IAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT--QDRLCFVM 247 (516)
T ss_pred hHHHHhcCCccceEEEEeecccCceeehhhhhhhhe-eehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc--CceEEEEE
Confidence 345899999999999999999999999999886443 345778888899999999999999999888854 56899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH----hh
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----AQ 184 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l----~~ 184 (613)
||..||.|+-++.+.+.|++...+.+...|+.||.|||+++ ||+||||.+|+|++ .+|++||+|||+++.- ..
T Consensus 248 eyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 248 EYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred EEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccce
Confidence 99999999999999999999999999999999999999999 99999999999998 7899999999998743 23
Q ss_pred hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 185 ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
.++++||++|+|||+++. .|+.++|+|.+|++||||++|+.||+. .+-+.++..|... ...++...+++++.++..
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsG 401 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLLSG 401 (516)
T ss_pred eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHHHH
Confidence 467899999999999986 499999999999999999999999976 4556666666654 234677889999999999
Q ss_pred Hhh-cccCCCC-----HHHHhcCCCCCCCCccc-----ccccccccccCCcccc
Q 035992 264 CIA-EVSERLP-----AKELLGDPFLQSEDDES-----VGRSLRVKTHYSAETS 306 (613)
Q Consensus 264 cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~-----~~~~~~~~~~~~~~~~ 306 (613)
+|. +|.+|+. |+|+..|+||...+|.. +.++..|...+..++.
T Consensus 402 LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVtSetDTr 455 (516)
T KOG0690|consen 402 LLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVTSETDTR 455 (516)
T ss_pred HhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcccccchh
Confidence 998 9999996 89999999999998854 3445555544444333
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.53 Aligned_cols=252 Identities=33% Similarity=0.553 Sum_probs=211.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL-RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|.+.++||+|+||.||+|.+..+|..||+|.++..... ........+.+|+.+++.++||||+++++++.......+++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 35679999999999999999999999999987754321 22345677899999999999999999999887655678999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
++||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++..+...
T Consensus 84 ~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCcccccccc
Confidence 9999999999999998888999999999999999999999988 99999999999998 5679999999998755321
Q ss_pred ------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 ------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
....++..|+|||.+.+ .++.++|||||||++|||++|+.||........+....... ..+.++...++.++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 239 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP-TNPQLPSHISEHAR 239 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCC-CCCCCchhcCHHHH
Confidence 12345668999998764 48899999999999999999999998765555555444333 33455666788999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+||. ||. +|.+||+++|++.||||+
T Consensus 240 ~li~-~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 240 DFLG-CIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HhcCChhhCcCHHHHhcCcccc
Confidence 9994 555 999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.19 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=215.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHH----HHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED----LERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~----~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.+.||+|..++|-++.++.+|+++|+|++.........+. .+.-.+|+.+|+++ .||+|+++.++| +.+..++
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es~sF~F 99 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ESDAFVF 99 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cCcchhh
Confidence 4899999999999999999999999999887664443333 34457799999998 599999999987 4467899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+|+++|+.|.|++|+...-.++++..+++++|++.|++|||.++ |+||||||+|||++ ++.++||+|||+|+.+...
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999 99999999999998 5679999999999988654
Q ss_pred ---ccCcccccccCccccc-------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccc
Q 035992 186 ---RSAHSVIEFMAPELYE-------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVA 253 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~-------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~ 253 (613)
...+||++|+|||.+. .+|+..+|+|++|++||.|+.|.+||.... ...++..|.+|..... -+...
T Consensus 177 ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-QmlMLR~ImeGkyqF~speWadi 255 (411)
T KOG0599|consen 177 EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-QMLMLRMIMEGKYQFRSPEWADI 255 (411)
T ss_pred hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-HHHHHHHHHhcccccCCcchhhc
Confidence 3578999999999764 258999999999999999999999997633 3344567777764322 23456
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..++++|.+||+ ||.+|.|++|+|.||||...
T Consensus 256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 256 SATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred cccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 8889999999999 99999999999999999754
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=332.80 Aligned_cols=253 Identities=25% Similarity=0.496 Sum_probs=208.4
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT 99 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~ 99 (613)
.+|+|+| ++.+.||+|+||+||+|.+..+++.||+|.+.... .....+..|+.+++.+ +||||++++++|...
T Consensus 2 ~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 2 RDPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred CChhhhh-hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 4788898 66799999999999999999999999999876432 2345678899999998 799999999998654
Q ss_pred C----CCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 100 E----NEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 100 ~----~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
. ...++++|||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.++|
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l 152 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKL 152 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEE
Confidence 3 24689999999999999998864 46899999999999999999999998 99999999999998 6679999
Q ss_pred eccchhHHHhhh----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC
Q 035992 174 GDLGLAAILAQA----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 174 ~DFGla~~l~~~----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g 243 (613)
+|||++...... ....++..|+|||++. ..|+.++|||||||++|||++|..||.......... .+...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-~~~~~ 231 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRN 231 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhcC
Confidence 999998754321 2335667899999874 248889999999999999999999997654433333 33333
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+......++..+++||.+||. +|.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 22333334567899999999999 99999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=348.14 Aligned_cols=252 Identities=29% Similarity=0.414 Sum_probs=199.7
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--- 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 101 (613)
.+| ++.+.||+|+||+||+|.+..+|..||+|+++... ........+.+|+.+++.++||||++++++|.....
T Consensus 21 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 21 KRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hce-EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc--cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 455 67799999999999999999999999999886432 234556778899999999999999999998754322
Q ss_pred -CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 -EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 -~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++||||+.+ +|.+++. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++.
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCcc
Confidence 357999999976 5666554 35899999999999999999999998 99999999999998 57899999999987
Q ss_pred HHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--------------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-------------- 242 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-------------- 242 (613)
..... ....++..|+|||++.+ .|+.++|||||||++|+|++|..||........+...+..
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 54322 22356778999998765 5899999999999999999999999765433222111100
Q ss_pred -------C-C-CC----------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 243 -------G-I-KP----------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 243 -------g-~-~p----------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
. . .+ .......+..+++||.+||. +|.+|||+.|+|.||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0 0 00 00112345788999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=334.33 Aligned_cols=250 Identities=27% Similarity=0.385 Sum_probs=196.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCCcceeeeeeecC---CC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVDT---EN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~~---~~ 101 (613)
|++.+.||+|+||+||+|.++.+|+.||+|.++..... ......+.+|+.+++.+ +||||++++++|... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 36779999999999999999999999999988753221 11223345677766655 799999999987542 23
Q ss_pred CEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 102 EHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
..++++|||+.+ +|..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCcc
Confidence 568999999975 888888764 35899999999999999999999998 99999999999998 6789999999999
Q ss_pred HHHhhhc---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC------CC---
Q 035992 180 AILAQAR---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI------KP--- 246 (613)
Q Consensus 180 ~~l~~~~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~------~p--- 246 (613)
....... ...++..|+|||++.+ .++.++|||||||++|+|++|.+||........+.+.+.... .+
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 8664321 2345678999997754 589999999999999999999999976544433322221100 00
Q ss_pred ---------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 ---------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 ---------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+....+..++++|.+||+ ||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01112356788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=336.87 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=208.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
..|++|+||.||+|+++.|++.||+|.++... .+. ..--.-++||.+|.+++|||||.+-.+.+..+-+.+|+|||||
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~ 159 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV 159 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeeccccc-ccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence 78999999999999999999999999887433 111 1223357899999999999999999998887778899999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc---
Q 035992 112 TSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS--- 187 (613)
Q Consensus 112 ~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~--- 187 (613)
.. +|..++.+-+ +|.+.+++.++.|+++||+|||.+. |+|||||++|+|++ +.|.+||+|||+|+.+.....
T Consensus 160 Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T 235 (419)
T KOG0663|consen 160 EH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPYT 235 (419)
T ss_pred Hh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccCc
Confidence 87 8999887765 8999999999999999999999999 99999999999998 789999999999998876532
Q ss_pred -CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CC-----CC------------
Q 035992 188 -AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GI-----KP------------ 246 (613)
Q Consensus 188 -~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~-----~p------------ 246 (613)
..-|.+|.|||++-+ .|+.++|+||+|||+.||+++++-|.+....+|+.+.+.- |. .|
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 234569999997643 5999999999999999999999999888888887655431 10 00
Q ss_pred --C--------ccccc-ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 --A--------SLAKV-ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 --~--------~l~~~-~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
. .|... .+....+|+..+|. ||.+|.||.|.|+|.||...
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 0 01111 34778899999999 99999999999999999874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=344.20 Aligned_cols=248 Identities=27% Similarity=0.415 Sum_probs=201.3
Q ss_pred CCCcceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSW 96 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 96 (613)
|..|| ++.++||+|+||+||+|.+ ..++..||+|+++.. ........+.+|+.+|+.+ +||||++++++|
T Consensus 5 ~~~~~-~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 5 PRDRL-RLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred chhHc-eeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 34455 7889999999999999975 345678998887632 2344567789999999999 899999999987
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKH----------------------------------------------------- 123 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~----------------------------------------------------- 123 (613)
.. .+..++++|||+.+|+|.+++...
T Consensus 81 ~~-~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (338)
T cd05102 81 TK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP 159 (338)
T ss_pred cC-CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence 54 345689999999999999998753
Q ss_pred ---------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh------ccC
Q 035992 124 ---------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA------RSA 188 (613)
Q Consensus 124 ---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~------~~~ 188 (613)
..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+... ...
T Consensus 160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 236 (338)
T cd05102 160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236 (338)
T ss_pred chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCC
Confidence 24778899999999999999999998 99999999999998 5689999999999764321 122
Q ss_pred cccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh
Q 035992 189 HSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266 (613)
Q Consensus 189 ~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~ 266 (613)
.++..|||||++.. .|+.++|||||||++|||++ |..||........+...+..+..+ ..+...++.+.++|.+||.
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~ 315 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQ 315 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcc
Confidence 33468999997754 58999999999999999997 999997655555555555555433 3455678899999999999
Q ss_pred -cccCCCCHHHHhc
Q 035992 267 -EVSERLPAKELLG 279 (613)
Q Consensus 267 -dP~~Rpta~eLL~ 279 (613)
+|.+|||+.+|++
T Consensus 316 ~dp~~RPs~~el~~ 329 (338)
T cd05102 316 GDPKERPTFSALVE 329 (338)
T ss_pred CChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.76 Aligned_cols=249 Identities=20% Similarity=0.343 Sum_probs=201.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||+|+||+||++.++.+|+.||+|.+...... .......+..|+.+++.++||||++++++|.. +..+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLK-KKSGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhh-cchhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 79999999999999999999999988643322 22233455679999999999999999998754 5689999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---cC
Q 035992 114 GTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---SA 188 (613)
Q Consensus 114 GsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~~ 188 (613)
++|..++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++ +.+.++|+|||++....... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeecc
Confidence 99998886543 5899999999999999999999998 99999999999998 67899999999987654322 24
Q ss_pred cccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 189 HSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 189 ~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
.++..|+|||++.. .++.++|||||||++|||++|..||..... ...+.........+ .....++.+++++|.+|
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHH
Confidence 56779999998754 489999999999999999999999965332 23344444333222 12235688999999999
Q ss_pred hh-cccCCCCH----HHHhcCCCCCCCCcc
Q 035992 265 IA-EVSERLPA----KELLGDPFLQSEDDE 289 (613)
Q Consensus 265 L~-dP~~Rpta----~eLL~HPff~~~~~~ 289 (613)
|+ +|.+||++ .+++.||||+..++.
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 99 99999999 678899999886553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.84 Aligned_cols=243 Identities=25% Similarity=0.369 Sum_probs=195.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+|+.++||||++++++|.. +...+++
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv 161 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLI 161 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEE
Confidence 478899999999999999999999999988532 2346789999999999999999998854 5578999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
+|++. ++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.....
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccccccc
Confidence 99985 689999988888999999999999999999999998 99999999999998 668999999999865322
Q ss_pred --hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc------HHHHHHHHHc--CCCC-------
Q 035992 185 --ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN------AAQIYKKVTS--GIKP------- 246 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~------~~~i~~~I~~--g~~p------- 246 (613)
.....+|+.|+|||++.+ .|+.++|||||||++|||++|..||..... .......+.. +..|
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 123457889999998764 589999999999999999999988754221 1111111110 1000
Q ss_pred -------------------Cc---cc--ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 -------------------AS---LA--KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 -------------------~~---l~--~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.. +. ...+.++.+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00 00 1135678999999999 99999999999999999874
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=326.59 Aligned_cols=250 Identities=30% Similarity=0.483 Sum_probs=208.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecc--ccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL--LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~--~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|++.+.||+|+||+||+|.+ .+|..+|+|.++.... .........+.+|+.+++.++|+||++++++|.. ...++
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~ 78 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTIS 78 (265)
T ss_pred ccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeEE
Confidence 36778999999999999976 4788999998875321 1223445678999999999999999999998754 46899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+++||+.+++|.+++.+.+.+++..+..++.||+.||+|||+++ ++|+||+|+||+++ ..+.++|+|||++......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhc
Confidence 99999999999999998888999999999999999999999998 99999999999998 6789999999999865321
Q ss_pred ----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 186 ----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 186 ----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
....++..|+|||.+.. .++.++|+||||+++|+|++|..||...................+.++...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS 235 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence 12345668999998765 4889999999999999999999999765554444433332122234556678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+.+||.+||. +|.+||++.+++.||||
T Consensus 236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 236 AAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999998 99999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=358.95 Aligned_cols=250 Identities=20% Similarity=0.296 Sum_probs=194.8
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC------CCcceeeeeeecCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH------KNIIKFYNSWVDTE 100 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H------pNIVkl~~~fv~~~ 100 (613)
.|++.++||+|+||+||+|.+..+++.||+|+++... .....+..|+.+++.+.| +++++++++|.. .
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~-~ 203 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN-E 203 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc-C
Confidence 3478899999999999999999999999999886421 223445667777777654 458888888754 3
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCC-----------
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQ----------- 168 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~----------- 168 (613)
...+++||+++ +++|.+++.+++.+++..++.++.||+.||+|||+ .+ ||||||||+|||++...
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccccccccccc
Confidence 45788999987 77899999888899999999999999999999997 47 99999999999997332
Q ss_pred ----CcEEEeccchhHHHhh-hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc
Q 035992 169 ----GEVKIGDLGLAAILAQ-ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS 242 (613)
Q Consensus 169 ----g~VKL~DFGla~~l~~-~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~ 242 (613)
+.+||+|||++..... .....++..|||||++.+ .|+.++|||||||++|||++|+.||....+...+. .+..
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~ 359 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH-LMEK 359 (467)
T ss_pred CCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHH
Confidence 1499999998764332 224567889999998765 59999999999999999999999997654433322 1111
Q ss_pred --CCCCCcc--------------------------------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCC
Q 035992 243 --GIKPASL--------------------------------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDP 281 (613)
Q Consensus 243 --g~~p~~l--------------------------------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HP 281 (613)
+..|..+ ....++.+.+||.+||+ ||.+|||++|+|+||
T Consensus 360 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp 439 (467)
T PTZ00284 360 TLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHP 439 (467)
T ss_pred HcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCc
Confidence 1111000 01124567899999999 999999999999999
Q ss_pred CCCCC
Q 035992 282 FLQSE 286 (613)
Q Consensus 282 ff~~~ 286 (613)
||+..
T Consensus 440 ~~~~~ 444 (467)
T PTZ00284 440 YVLKY 444 (467)
T ss_pred ccccc
Confidence 99874
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=361.43 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=215.7
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
.+.+|| ++.++||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++..++|+||++++..|.....
T Consensus 29 ~~~~rY-~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 29 EQAKKY-WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred ccCCCE-EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 344566 788999999999999999999999999998875432 34567788999999999999999999887754322
Q ss_pred ------CEEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcE
Q 035992 102 ------EHINFITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171 (613)
Q Consensus 102 ------~~l~lV~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~V 171 (613)
..+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCE
Confidence 2478999999999999988653 46999999999999999999999998 99999999999998 56899
Q ss_pred EEeccchhHHHhh------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 172 KIGDLGLAAILAQ------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 172 KL~DFGla~~l~~------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
||+|||++..+.. .....+++.|||||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~ 261 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGR 261 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC
Confidence 9999999876532 123457889999998865 489999999999999999999999965 45566666666654
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
.+ .++...++.+.++|.+||. +|.+||++.++++|||++.
T Consensus 262 ~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 262 YD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 43 3455678999999999999 9999999999999999875
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=326.04 Aligned_cols=253 Identities=27% Similarity=0.511 Sum_probs=207.9
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT 99 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~ 99 (613)
.+|.++| ++.+.||+|+||+||+|.++.+++.+++|++.... ...+.+.+|+.+++++ +|+||++++++|...
T Consensus 2 ~~~~~~y-~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 2 PDPTGIF-ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred CCchhhe-eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-----hhHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 3577787 77899999999999999999999999998876432 3456788999999999 799999999998754
Q ss_pred C----CCEEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcE
Q 035992 100 E----NEHINFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171 (613)
Q Consensus 100 ~----~~~l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~V 171 (613)
. ...++++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++ .++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~ 152 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEV 152 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeE
Confidence 3 4568999999999999998765 357999999999999999999999998 99999999999998 56899
Q ss_pred EEeccchhHHHhh----hccCcccccccCcccccc------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH
Q 035992 172 KIGDLGLAAILAQ----ARSAHSVIEFMAPELYEE------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 172 KL~DFGla~~l~~----~~~~~gt~~YmAPEvl~~------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~ 241 (613)
+|+|||++..... .....++..|+|||++.. .++.++||||||+++|+|++|..||........+.+ +.
T Consensus 153 ~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~ 231 (275)
T cd06608 153 KLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-IP 231 (275)
T ss_pred EECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHH-hh
Confidence 9999999865432 123446678999997642 367899999999999999999999976544444443 33
Q ss_pred cCCCCC-cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 242 SGIKPA-SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 242 ~g~~p~-~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+..+. ..+..++..+++||.+||. +|.+|||+.+++.|||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 232 RNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 333222 1223367889999999998 99999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=330.16 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=219.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+.+++.||+|-||.||+|+.+.++..||+|++-+....+ ......+.+|+++-..|+||||+++|++|.+ ...+|++
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~-~~v~~qlrREiEIqs~L~hpnilrlY~~fhd--~~riyLi 100 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK-TQVEHQLRREIEIQSHLRHPNILRLYGYFHD--SKRIYLI 100 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-hcchhhhhheeEeecccCCccHHhhhhheec--cceeEEE
Confidence 355699999999999999999999999999987655433 3445678999999999999999999999976 5679999
Q ss_pred EeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh--
Q 035992 108 TEIFTSGTLRQYRK--KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-- 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~--~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~-- 183 (613)
+||...|+|...+. +.+++++...+.+++|++.||.|+|..+ ||||||||+|+|+. ..|.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCC
Confidence 99999999999998 6678999999999999999999999998 99999999999997 67899999999986543
Q ss_pred hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 184 QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 184 ~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
...+.+||..|.+||+.++ .++..+|+|++|++.||++.|.+||.... ....|++|..-. ..++..++.+++++|.
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~--~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD--LKFPSTISGGAADLIS 254 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc--ccCCcccChhHHHHHH
Confidence 3346789999999998876 49999999999999999999999996644 788888888653 2345778999999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCCCC
Q 035992 263 KCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+||. +|.+|++..|++.|||+..
T Consensus 255 ~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 255 RLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHhccCccccccHHHHhhhHHHHh
Confidence 9999 9999999999999999864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.83 Aligned_cols=255 Identities=22% Similarity=0.420 Sum_probs=217.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+++.||+|+++.... ......+.+.+|++++++++||||+++++++.. ...+++|
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 79 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--DSNLYLV 79 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCeEEEE
Confidence 4778999999999999999999999999998874332 233456788999999999999999999998854 5679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-c
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-R 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~ 186 (613)
|||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++...... .
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~ 156 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGRTY 156 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCCCC
Confidence 999999999999999899999999999999999999999998 99999999999998 5689999999998766443 2
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|+|||.+.. .++.++||||||+++|+|++|..||.... ....++.+..+.. .++...+..++++|.+||
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 233 (290)
T cd05580 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILEGKV--RFPSFFSPDAKDLIRNLL 233 (290)
T ss_pred CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCc--cCCccCCHHHHHHHHHHc
Confidence 3356778999997754 47889999999999999999999996644 5556666665532 345556899999999999
Q ss_pred h-cccCCC-----CHHHHhcCCCCCCCCcccc
Q 035992 266 A-EVSERL-----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 266 ~-dP~~Rp-----ta~eLL~HPff~~~~~~~~ 291 (613)
. +|.+|+ ++++|++||||+...+...
T Consensus 234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 234 QVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred cCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 8 999999 8999999999998766443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=332.95 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=212.1
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
.+|...| ++.+.||+|+||.||+|.+..++..||+|.+... .....+.+..|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~y-~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 80 (292)
T cd06644 8 LDPNEVW-EIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYW-- 80 (292)
T ss_pred cCcchhh-hhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--
Confidence 3566666 7889999999999999999999999999887642 45667888999999999999999999998754
Q ss_pred CCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
...+++||||+.+++|..++.+ ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~ 157 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVS 157 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccc
Confidence 4579999999999999987754 467899999999999999999999998 99999999999997 5789999999988
Q ss_pred HHHhhh----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-Cc
Q 035992 180 AILAQA----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-AS 248 (613)
Q Consensus 180 ~~l~~~----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-~~ 248 (613)
...... ....++..|+|||++. ..++.++|||||||++|+|++|..||.... ....+.++.....+ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLS 236 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHhcCCCccCC
Confidence 654321 1234566899999773 236889999999999999999999996644 34444444444332 22
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+..++..+.++|.+||. +|.+||++.++++||||.....
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 344567889999999999 9999999999999999987654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=326.60 Aligned_cols=253 Identities=28% Similarity=0.491 Sum_probs=208.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|+..+.||+|+||.||+|.+..+++.||+|+++....... ....+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 79 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DSHFN 79 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CCeEE
Confidence 3566899999999999999999999999998875432211 2346788999999999999999999998754 56789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+|+||+.+++|.+++.+.+.+++..+..|+.||+.||.|||+++ ++|+||+|+||+++.+...++|+|||++..+...
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999999998889999999999999999999999998 9999999999999855457999999998766432
Q ss_pred c--------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc--HHHHHHHHHcCCCCCccccccc
Q 035992 186 R--------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 186 ~--------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s 254 (613)
. ...++..|+|||++.+ .++.++|+||||+++|+|++|..||..... .......+........++...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence 1 1235668999997754 588999999999999999999999964332 2222223333333445566678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+.+.++|.+||. +|.+||++.+|++||||+
T Consensus 238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999998 999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.42 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=211.5
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCC-CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELE-GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~t-g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
+|...-|++.+.||+|+||+||+|.+..+ +..||+|.+.. ........+.+|+.+|+.++||||++++++|..
T Consensus 63 ~~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~----~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-- 136 (478)
T PTZ00267 63 NPREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML----NDERQAAYARSELHCLAACDHFGIVKHFDDFKS-- 136 (478)
T ss_pred CCcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc----CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--
Confidence 34445578889999999999999998888 78888876542 234555678889999999999999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 101 NEHINFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
...+++||||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DF 213 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDF 213 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeC
Confidence 4689999999999999987753 456999999999999999999999998 99999999999998 6789999999
Q ss_pred chhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc
Q 035992 177 GLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL 249 (613)
Q Consensus 177 Gla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l 249 (613)
|++..+... ....|++.|||||++.+ .++.++|||||||++|||++|..||.. .+...++..+..+..+ .+
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~-~~~~~~~~~~~~~~~~-~~ 291 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG-PSQREIMQQVLYGKYD-PF 291 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC-CC
Confidence 999765432 23457889999998765 489999999999999999999999965 4455556666555433 23
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+..++..+++||.+||. +|.+||++.+++.|||++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 45578899999999999 9999999999999999964
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.65 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=189.3
Q ss_pred eeeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.++||+|+||+||+|.++ .+++.||+|.++... ....+.+|+.+|+.++||||++++++|....+..++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence 468999999999999865 477899998875322 123467899999999999999999998777777899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe---CCCCcEEEecc
Q 035992 109 EIFTSGTLRQYRKKH---------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN---GNQGEVKIGDL 176 (613)
Q Consensus 109 E~~~gGsL~~~l~~~---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~---~~~g~VKL~DF 176 (613)
||+.+ +|..++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 80 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99864 888876532 25899999999999999999999998 99999999999994 24578999999
Q ss_pred chhHHHhhh-------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCc---------HHHHHH
Q 035992 177 GLAAILAQA-------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTN---------AAQIYK 238 (613)
Q Consensus 177 Gla~~l~~~-------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---------~~~i~~ 238 (613)
|++...... ....+++.|||||++.+ .|+.++|||||||++|+|++|.+||..... ..++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 999765432 12355778999997754 489999999999999999999999954321 111111
Q ss_pred HHHcCCCC------------C-----------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 239 KVTSGIKP------------A-----------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 239 ~I~~g~~p------------~-----------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
.+.....| . ......+..+.+||.+||+ ||.+|||++|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 316 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 11000000 0 0001124568899999999 9999999999999999
Q ss_pred C
Q 035992 283 L 283 (613)
Q Consensus 283 f 283 (613)
|
T Consensus 317 f 317 (317)
T cd07868 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=321.22 Aligned_cols=249 Identities=28% Similarity=0.492 Sum_probs=214.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||.|+||+||+|.+..+|..||+|.++.... .....+++..|+.+++.++||||+++++++....+..++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 3667999999999999999999999999998775432 34566788999999999999999999998877677789999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhh-----cCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLH-----SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLH-----s~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
|||+.+++|.+++.+ ...+++..++.++.||+.||.||| +.+ ++|+||||+||+++ +.+.+||+|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecccc
Confidence 999999999999876 367999999999999999999999 776 99999999999998 678999999999
Q ss_pred hHHHhhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 179 AAILAQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 179 a~~l~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
+....... ...++..|+|||.+.. .++.++|+||||+++|+|++|..||... +...+.+.+..+..+ .++...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 234 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR-NQLQLASKIKEGKFR-RIPYRY 234 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCc-CHHHHHHHHhcCCCC-CCcccc
Confidence 98765432 2346678999998764 4889999999999999999999999664 456666777766543 455667
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+..+.+++.+||. +|.+||++.++++|||+
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 8899999999998 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=333.10 Aligned_cols=259 Identities=29% Similarity=0.494 Sum_probs=215.9
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
+...+|..+| ++.+.||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.+.||||+++++.|.
T Consensus 13 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~ 87 (296)
T cd06654 13 VSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYL 87 (296)
T ss_pred cccCCcccce-eeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC----cchHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3445777787 56699999999999999999999999998876433 233567889999999999999999999886
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
. +...++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||
T Consensus 88 ~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg 161 (296)
T cd06654 88 V--GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFG 161 (296)
T ss_pred e--CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccc
Confidence 5 4589999999999999999865 46899999999999999999999998 99999999999997 67899999999
Q ss_pred hhHHHhhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 178 LAAILAQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 178 la~~l~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
++....... ...+++.|+|||.+.. .++.++|||||||++|+|++|..||........++.....+..+...+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06654 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (296)
T ss_pred cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccc
Confidence 987654321 2356678999998765 48899999999999999999999997655545555444444333334456
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+..+.++|.+||. +|.+||++.+++.||||....
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 77889999999999 999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=332.54 Aligned_cols=241 Identities=20% Similarity=0.309 Sum_probs=204.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec--CCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD--TENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~--~~~~~l~lV~E 109 (613)
..||+|+++.||+|.. +|+.||+|.++.... ......+.+.+|+.+|++++||||+++++++.+ .....++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5799999999999976 799999998875432 233446788899999999999999999999876 44567899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-cc
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-RS 187 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~ 187 (613)
|+.+|+|.+++.+.+.+++.....++.|++.||.|||+. + ++||||||+|||++ +++.+||+|||++..+... ..
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~~~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFK 179 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhcccccc
Confidence 999999999999988999999999999999999999984 6 88999999999998 6789999999999876542 23
Q ss_pred CcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 188 AHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
..++..|+|||++.+ .|+.++|||||||++|||++|..||... +..+++..+..+.....++...+..+++||.+|
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 456779999998864 6899999999999999999999999764 456666666554444445556789999999999
Q ss_pred hh-cccCCCCHHHHhc
Q 035992 265 IA-EVSERLPAKELLG 279 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~ 279 (613)
|+ +|.+|||+.+++.
T Consensus 259 l~~dp~~Rps~~ell~ 274 (283)
T PHA02988 259 TSHDSIKRPNIKEILY 274 (283)
T ss_pred hcCCcccCcCHHHHHH
Confidence 99 9999999999985
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.13 Aligned_cols=253 Identities=19% Similarity=0.359 Sum_probs=206.1
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+..++||+|+||+||+|.+..+++.||+|.+..... ........+..|+.+++.++|+||+++++++.. +..++++|
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence 556899999999999999999999999998764332 223444567889999999999999999998754 45899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 109 EIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ ..+.++|+|||++......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCc
Confidence 999999999988654 35999999999999999999999998 99999999999998 5678999999998754332
Q ss_pred --ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH--HHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 --RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAA--QIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~--~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
....++..|+|||++.+ .++.++||||||+++|+|++|..||....... .....+.... +..++...++.+++|
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHH
Confidence 22356789999998764 48999999999999999999999997543211 1122222111 223445678899999
Q ss_pred HHHHhh-cccCCCC-----HHHHhcCCCCCCCCc
Q 035992 261 IEKCIA-EVSERLP-----AKELLGDPFLQSEDD 288 (613)
Q Consensus 261 I~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~ 288 (613)
|.+||+ +|.+||| +.|+++||||+...+
T Consensus 236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred HHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 999999 9999999 999999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.71 Aligned_cols=245 Identities=28% Similarity=0.484 Sum_probs=204.3
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++.. ...++++|
T Consensus 12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv~ 85 (267)
T cd06645 12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP----GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWICM 85 (267)
T ss_pred HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEEE
Confidence 56689999999999999999999999999876432 2345667889999999999999999998765 46789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 185 (613)
||+.+++|.+++...+.+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++..+...
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCcccc
Confidence 99999999999998899999999999999999999999998 99999999999998 5679999999998654321
Q ss_pred -ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc--ccccHHHH
Q 035992 186 -RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA--KVADNGVR 258 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~~l~ 258 (613)
....++..|+|||++. ..++.++|+|||||++|+|++|..||........+.........+..+. ..++..++
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 2335677899999763 3488999999999999999999999976554444433333332222222 13567899
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
+||.+||. +|.+||++.+|+.|||
T Consensus 243 ~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.11 Aligned_cols=253 Identities=27% Similarity=0.382 Sum_probs=200.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
.|| ++.+.||+|+||+||+|.+..+++.||+|.++... ........+.+|+.+++.++||||++++++|....
T Consensus 17 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hce-eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 466 67799999999999999999999999999876432 23455677889999999999999999999875432
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...++++|||+.+ +|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccc
Confidence 2457999999976 66666653 5899999999999999999999998 99999999999998 67899999999997
Q ss_pred HHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-----------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK----------- 245 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~----------- 245 (613)
..... ....++..|+|||++.+ .|+.++|||||||++|+|++|..||............+..-..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence 65432 23456779999998765 5899999999999999999999999764433322211110000
Q ss_pred -----------------C-----------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 246 -----------------P-----------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 246 -----------------p-----------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+ .......+..+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 0 00112235678999999999 99999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=343.31 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=200.9
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC---
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE--- 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~--- 100 (613)
..+| ++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+++.++||||++++++|....
T Consensus 23 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 23 LKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred hcce-eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc--cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 3455 67799999999999999999999999999876422 23455677889999999999999999999875432
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 -NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 -~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
...+++||||+.+ +|..++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a 173 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA 173 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCc
Confidence 2468999999975 67776654 4889999999999999999999998 99999999999998 5789999999999
Q ss_pred HHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC----------
Q 035992 180 AILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK---------- 245 (613)
Q Consensus 180 ~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~---------- 245 (613)
...... ....++..|+|||++.+ .++.++|||||||++|+|++|..||........ +.++.....
T Consensus 174 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 174 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred cccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHhh
Confidence 765432 23356779999998765 589999999999999999999999976444333 222221100
Q ss_pred -----------C-------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 246 -----------P-------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 246 -----------p-------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
| .......+..+++||.+||+ ||.+|||+.++|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 0 00011234678999999999 9999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.14 Aligned_cols=254 Identities=30% Similarity=0.509 Sum_probs=212.6
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
+|..+| .+.+.||.|+||+||+|.+..++..||+|+++.. .....+.+..|+.++++++||||++++++|.. +
T Consensus 2 ~~~~~~-~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (280)
T cd06611 2 NPNDIW-EIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFY--E 74 (280)
T ss_pred CchhHH-HHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--C
Confidence 566666 6779999999999999999999999999987643 34566788899999999999999999998864 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++||||+.+++|..++.+. +.+++..++.++.|++.||.|||+++ |+|+||||+||+++ ..+.++|+|||++.
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~ 151 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSA 151 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccch
Confidence 5799999999999999998764 57999999999999999999999998 99999999999997 57899999999987
Q ss_pred HHhhhc----cCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-Ccc
Q 035992 181 ILAQAR----SAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-ASL 249 (613)
Q Consensus 181 ~l~~~~----~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l 249 (613)
...... ...++..|+|||++. ..++.++|+||||+++|+|++|..||.... .......+..+..+ ...
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~ 230 (280)
T cd06611 152 KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-PMRVLLKILKSEPPTLDQ 230 (280)
T ss_pred hhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-HHHHHHHHhcCCCCCcCC
Confidence 654321 234667899999764 236789999999999999999999997644 34444455544332 223
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..++..+.+||.+||+ +|.+||++.++++||||...
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 44578899999999998 99999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.94 Aligned_cols=250 Identities=28% Similarity=0.496 Sum_probs=209.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
|..+| .+.+.||.|+||.||+|.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 1 ~~~~~-~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 73 (262)
T cd06613 1 PQEDY-ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP----GDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RD 73 (262)
T ss_pred Cccce-EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc----hhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CC
Confidence 44555 67799999999999999999999999999887432 2356788999999999999999999998755 55
Q ss_pred EEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.++++|||+.+++|..++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++ +++.+||+|||++..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~ 150 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQ 150 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchh
Confidence 799999999999999998876 78999999999999999999999998 99999999999998 678999999999876
Q ss_pred Hhhhc----cCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccc
Q 035992 182 LAQAR----SAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAK 251 (613)
Q Consensus 182 l~~~~----~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~ 251 (613)
..... ...++..|+|||.+.. .++.++|+||||+++|+|++|..||..................+.. ...
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKE 230 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchh
Confidence 65322 2345668999997753 5788999999999999999999999876655554443333222222 223
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
..+..+.+||.+||. +|.+||++.+++.|+|
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 456789999999998 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=320.15 Aligned_cols=247 Identities=28% Similarity=0.511 Sum_probs=210.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|+||.||+|.+..+|..|++|.+..... .......+.+|+.+++.++||||+++++++.. ...++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEE
Confidence 3567999999999999999999999999998775432 24566788999999999999999999998864 4689999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..+...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCc
Confidence 9999999999998774 57999999999999999999999988 99999999999998 5689999999998765432
Q ss_pred c----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 R----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
. ...++..|+|||++.+ .++.++|+||||+++|+|++|..||... +.......+..+..+. ++...+..+.++
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08529 155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFPP-VSQMYSQQLAQL 232 (256)
T ss_pred cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2 2345678999998765 4889999999999999999999999654 4555566666665443 344678899999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||+ +|.+||++.+++.|||+
T Consensus 233 i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 233 IDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHccCCcccCcCHHHHhhCCCC
Confidence 999998 99999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=328.48 Aligned_cols=252 Identities=26% Similarity=0.488 Sum_probs=207.9
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecC-
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT- 99 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~- 99 (613)
+|.++| ++.+.||.|+||+||+|.+..+++.+|+|++... ......+..|+.+++++ +|+||++++++|+..
T Consensus 13 ~~~~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 13 DPAGIF-ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred Chhhhh-hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 466666 6779999999999999999999999999886532 24456788899999998 799999999988643
Q ss_pred ---CCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 100 ---ENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 100 ---~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
....++++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ +.+.++|+
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~ 163 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLV 163 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEe
Confidence 246789999999999999998764 45899999999999999999999998 99999999999998 67899999
Q ss_pred ccchhHHHhhh----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 175 DLGLAAILAQA----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 175 DFGla~~l~~~----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
|||++...... ....++..|+|||.+. ..++.++||||||+++|||++|..||........+.. +....
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~ 242 (282)
T cd06636 164 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-IPRNP 242 (282)
T ss_pred eCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-HhhCC
Confidence 99998765432 2334667899999764 3488899999999999999999999976554444432 33333
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+......++..+.+||.+||. +|.+||++.|||+||||
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 3333344578899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=338.33 Aligned_cols=250 Identities=22% Similarity=0.403 Sum_probs=200.4
Q ss_pred Eeeeeccc--CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 30 YKEVLGRG--AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 30 ~~e~LG~G--afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+.++||+| +|++||++.++.+|+.||+|.++.... .....+.+..|+.+++.++||||++++++|.. +..+++|
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~~~lv 77 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNELWVV 77 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCEEEEE
Confidence 45789999 789999999999999999998764322 23455678889999999999999999999865 4578999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|.+++..+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.++++||+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccc
Confidence 9999999999998764 45999999999999999999999998 99999999999998 5679999999875433211
Q ss_pred -----------ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC----
Q 035992 186 -----------RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA---- 247 (613)
Q Consensus 186 -----------~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~---- 247 (613)
....++..|+|||++.. .|+.++|||||||++|||++|..||............+. +..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~ 233 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN-GTVPCLLDT 233 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc-CCccccccc
Confidence 11234457999998764 488999999999999999999999976544333332222 11110
Q ss_pred ----------------------------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 248 ----------------------------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 248 ----------------------------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
......++.+.+||.+||+ +|.+|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112346789999999999 99999999999999999865
Q ss_pred C
Q 035992 287 D 287 (613)
Q Consensus 287 ~ 287 (613)
.
T Consensus 314 ~ 314 (327)
T cd08227 314 K 314 (327)
T ss_pred c
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=376.14 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=215.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..++..||+|+++.... .......+..|+.+|+.|+||||++++++|+......+|+|
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 4788999999999999999999999999998875432 34556788999999999999999999999987777789999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCC-----CCEEecCCCCCcEEEeCC-----------
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHD-----PPVIHRDLKCDNIFVNGN----------- 167 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~-----~~IIHrDLKp~NILl~~~----------- 167 (613)
|||+.+|+|.+++.. .+.+++..++.|+.||+.||.|||+.+ .+||||||||+||||+..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 999999999998875 367999999999999999999999854 349999999999999621
Q ss_pred -----CCcEEEeccchhHHHhhh---ccCcccccccCccccc---cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH
Q 035992 168 -----QGEVKIGDLGLAAILAQA---RSAHSVIEFMAPELYE---EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI 236 (613)
Q Consensus 168 -----~g~VKL~DFGla~~l~~~---~~~~gt~~YmAPEvl~---~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i 236 (613)
.+.+||+|||++..+... ....+++.|+|||++. ..++.++|||||||+||||+||..||.......++
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ql 252 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL 252 (1021)
T ss_pred cccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHH
Confidence 235899999999765432 2345788999999874 24889999999999999999999999877777777
Q ss_pred HHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 237 YKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 237 ~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...+..+... .....+..+.+||.+||. +|.+||++.|+|.||||+..
T Consensus 253 i~~lk~~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 253 ISELKRGPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHhcCCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 7666655322 223457899999999999 99999999999999999865
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=346.68 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=203.7
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---CEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN---EHIN 105 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~~l~ 105 (613)
.+.+.||+|+||+||+|.+..+|+.||+|.+... ........++.+|+.+++.++||||+++++++..... ..++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV--FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEecccc--ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4568999999999999999999999999987532 1233456778999999999999999999998764331 2689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+||||+. ++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccC
Confidence 9999986 589888888889999999999999999999999998 99999999999998 6789999999998754322
Q ss_pred c-----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc----------------
Q 035992 186 R-----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---------------- 242 (613)
Q Consensus 186 ~-----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---------------- 242 (613)
. ...++..|+|||++.+ .|+.++|||||||++|||++|+.||....... ....+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHhhHH
Confidence 1 2234668999998764 37899999999999999999999997644333 2222211
Q ss_pred --------CCCCC------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 243 --------GIKPA------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 243 --------g~~p~------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
...+. .+....+.++.+||.+||+ +|.+|||+.|+|.||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11111 1122347789999999999 999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.03 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=199.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.+.||+|+||+||+|.++.++..||+|.++.... ......+.+|+.+++.++||||+++++++.. +..+++||
T Consensus 9 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 83 (309)
T cd07872 9 IKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLVF 83 (309)
T ss_pred EEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEEE
Confidence 777999999999999999999999999998875432 2223456789999999999999999998754 45799999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 109 EIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++......
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCCCcc
Confidence 99975 788877654 45899999999999999999999998 99999999999998 5689999999998754322
Q ss_pred --ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc---CC--------------
Q 035992 186 --RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---GI-------------- 244 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---g~-------------- 244 (613)
....++..|+|||++.+ .++.++|||||||++|+|+||..||......+.+ ..+.. ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-HLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhhcchhhh
Confidence 12345678999997753 4889999999999999999999999765433322 11111 00
Q ss_pred ----CCC-------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ----KPA-------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ----~p~-------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+. ......+.++++||.+||+ +|.+|||+.|+|.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 000 0112357789999999999 999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=324.51 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=212.4
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||.|+||+||+|.+..+++.||+|++..... ......+.+.+|+.+++.++||||+++++++.+ +..++++|||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHI-VETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcc-hhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 7999999999999999999999998875432 223456789999999999999999999998754 4578999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---ccCcc
Q 035992 114 GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHS 190 (613)
Q Consensus 114 GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~---~~~~g 190 (613)
++|.+++.+...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++...... ....+
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~ 154 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCG 154 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccC
Confidence 999999998888999999999999999999999988 99999999999998 5789999999999876543 22345
Q ss_pred cccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC-cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-c
Q 035992 191 VIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT-NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-E 267 (613)
Q Consensus 191 t~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-d 267 (613)
+..|+|||.+.. .++.++|+||||+++|+|++|..||.... +...++..+..+.....++...+..+++||.+||. +
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 234 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN 234 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence 678999997754 58899999999999999999999996644 35566666665444445555568899999999998 9
Q ss_pred ccCCCC-----HHHHhcCCCCCCCCc
Q 035992 268 VSERLP-----AKELLGDPFLQSEDD 288 (613)
Q Consensus 268 P~~Rpt-----a~eLL~HPff~~~~~ 288 (613)
|.+||+ ++|+++||||+..+|
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCCCC
Confidence 999999 999999999987654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.97 Aligned_cols=248 Identities=25% Similarity=0.487 Sum_probs=208.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|++|.||+|.++.+++.||+|.+.... ......+.+.+|+.++++++|+|++++++.|.. ....++++
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv 78 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN--ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIV 78 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh--cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEE
Confidence 478899999999999999999999999998876432 233456678899999999999999999997643 34578999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+++++|.+++... ..+++.+++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++..+...
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEeccc
Confidence 9999999999998763 45899999999999999999999998 99999999999998 6789999999998765332
Q ss_pred ----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 ----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
....+++.|+|||++.. .++.++||||||+++|+|++|+.||... +.......+..+..+ ..+...++.+.+|
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 233 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGEL 233 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHH
Confidence 22345678999998765 4889999999999999999999999654 444444455555443 3445678999999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||+ +|.+||++.++++||||
T Consensus 234 i~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 234 IATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHhccCcccCCCHHHHhcCCCC
Confidence 999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=327.25 Aligned_cols=254 Identities=27% Similarity=0.467 Sum_probs=206.8
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
....|...| ++.+.||+|+||.||+|.+..+|+.||+|+++... ......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 3 LRRNPQHDY-ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP----GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred cccCchhhc-chhheeecCCCeEEEEEEECCCCeEEEEEEEecCc----cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 445556666 77899999999999999999999999999876422 2344567889999999999999999998865
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++||||+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ |+||||||+||+++ ..+.++|+|||+
T Consensus 78 --~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~ 152 (267)
T cd06646 78 --REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGV 152 (267)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCcc
Confidence 4578999999999999999988888999999999999999999999998 99999999999997 677899999999
Q ss_pred hHHHhhh----ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc-
Q 035992 179 AAILAQA----RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL- 249 (613)
Q Consensus 179 a~~l~~~----~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l- 249 (613)
+..+... ....++..|+|||.+. ..++.++|||||||++|||++|..||..................+..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06646 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232 (267)
T ss_pred ceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCc
Confidence 8765422 1234566899999763 337889999999999999999999996654333322221222222222
Q ss_pred -cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 250 -AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 250 -~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
...++..+.+||.+||. +|.+||+++++|+|+|
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 12357899999999999 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=332.67 Aligned_cols=258 Identities=20% Similarity=0.325 Sum_probs=211.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+++.||+|.+..... ........+..|+.+++.++||||+++++.+.. ...++++
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 79 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPTLYASFQT--ETYLCLV 79 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-chHHHHHHHHHHHHHHHhCCCCCchhheeeeec--CCEEEEE
Confidence 4677999999999999999999999999998875432 223466788999999999999999999998744 5689999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhccccc
Confidence 9999999999998764 56999999999999999999999998 99999999999998 5689999999998754221
Q ss_pred c---------------------------------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC
Q 035992 186 R---------------------------------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT 231 (613)
Q Consensus 186 ~---------------------------------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~ 231 (613)
. ...++..|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1 1235667999997754 48889999999999999999999997655
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCC----HHHHhcCCCCCCCCccccc
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLP----AKELLGDPFLQSEDDESVG 292 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpt----a~eLL~HPff~~~~~~~~~ 292 (613)
....+. .+.............+..++++|.+||. +|.+||+ ++++|.||||++.++..+.
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~ 301 (316)
T cd05574 237 RDETFS-NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIR 301 (316)
T ss_pred hHHHHH-HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcc
Confidence 444443 3333322211222268899999999998 9999999 9999999999987765443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.53 Aligned_cols=247 Identities=24% Similarity=0.445 Sum_probs=199.4
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||+|+||+||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||++++++|.+ ...+++++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHS--DKKLTLVF 78 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhcc--CCceEEEE
Confidence 667999999999999999999999999998875321 22234567789999999999999999998854 45799999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 109 EIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
||+.+ +|..++.+ .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++.......
T Consensus 79 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 79 EYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred ecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCC
Confidence 99975 78777765 567999999999999999999999998 99999999999998 56899999999987654321
Q ss_pred ---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC---------------
Q 035992 187 ---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--------------- 246 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--------------- 246 (613)
...++..|+|||++.+ .++.++||||||+++|+|+||..||....+....+..+.....+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 2234568999997754 37899999999999999999999976555554444433221100
Q ss_pred ---C---------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 ---A---------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 ---~---------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. ......+..+++||.+||+ +|.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112357889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=323.81 Aligned_cols=249 Identities=28% Similarity=0.487 Sum_probs=211.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++||||+++++.+.. ...+++++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 78 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYN--NGDISICM 78 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeec--CCEEEEEE
Confidence 55689999999999999999999999999876532 23556778899999999999999999998865 46899999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 109 EIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||+.+++|.+++... ..+++..+..++.|++.||+|||+ .+ ++|+||||+||+++ +.+.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHH
Confidence 999999999999876 789999999999999999999999 87 99999999999998 5789999999998766432
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC----CcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC----TNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~----~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
....++..|+|||.+.+ .++.++||||||+++|+|++|..||... .......+.+.....+......++..+++
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (265)
T cd06605 156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQD 235 (265)
T ss_pred hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHH
Confidence 12456678999997754 4889999999999999999999999654 23444555555554444333347889999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
||.+||. +|.+||++.+++.||||+.
T Consensus 236 li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 236 FVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 9999998 9999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=323.66 Aligned_cols=248 Identities=30% Similarity=0.554 Sum_probs=208.0
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC-----hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN-----SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~-----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+...||+|+||.||+|.+..++..||+|.+........ ....+.+.+|+.++++++||||+++++++.. ...
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 80 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--ADH 80 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCc
Confidence 567899999999999999999999999998875432211 2234678899999999999999999998765 457
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
.+++|||+.+++|..++.+.+.+++..+..++.|++.||+|||+++ ++||||+|+||+++ +.+.++|+|||++..+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLE 157 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcccc
Confidence 8899999999999999999889999999999999999999999998 99999999999997 67899999999987664
Q ss_pred hhc----------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 184 QAR----------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 184 ~~~----------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
... ...++..|+|||.+.+ .++.++|+||||+++|+|++|..||........+. .+..... +.++..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~-~~~~~~ 235 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-KIGENAS-PEIPSN 235 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHH-HHhccCC-CcCCcc
Confidence 211 1235668999998764 48889999999999999999999998765544443 3333322 234556
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+..+.++|.+||+ +|.+||++.++++||||
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred cCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 78899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.46 Aligned_cols=249 Identities=27% Similarity=0.480 Sum_probs=205.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.++||+|+||+||+|.+..+++.||+|.+... ........+.+|+.++++++||||++++++|.. ....+++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD---ITVELQKQIMSELEILYKCDSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC---CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--CCEEEEE
Confidence 46779999999999999999999999999987642 234556678999999999999999999998865 4578899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+++|..+ ..+++..+..++.||+.||.|||+++ |+|+||||+|||++ .++.++|+|||++..+...
T Consensus 78 ~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~ 150 (279)
T cd06619 78 TEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIA 150 (279)
T ss_pred EecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccc
Confidence 999999999765 35789999999999999999999998 99999999999998 6789999999998755432
Q ss_pred ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc------HHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN------AAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~------~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
....++..|+|||++.+ .++.++|+||||+++|+|++|..||..... .....+.+.....+.......+++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 23456779999998764 589999999999999999999999954221 22333333333333323345678899
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
+||.+||+ +|.+||++.+++.||||+..+.
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 99999999 9999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=321.69 Aligned_cols=252 Identities=30% Similarity=0.524 Sum_probs=213.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecc-ccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||.||+|.+..+|..||+|.+..... .........+.+|+.+++.++|+||+++++++.+.....+++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 4788999999999999999999999999998754321 123456678899999999999999999999987666678899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
++||+.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcccccccccccc
Confidence 9999999999999998888999999999999999999999998 99999999999998 5679999999998765321
Q ss_pred ------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 ------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
....++..|+|||.+.+ .++.++|+||||+++|+|++|+.||........+.+... ...+..++...+..+.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~ 239 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-QPTKPMLPDGVSDACR 239 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-CCCCCCCCcccCHHHH
Confidence 12345678999998765 488999999999999999999999987655555554333 3334456677889999
Q ss_pred HHHHHHhhcccCCCCHHHHhcCCCC
Q 035992 259 AFIEKCIAEVSERLPAKELLGDPFL 283 (613)
Q Consensus 259 ~lI~~cL~dP~~Rpta~eLL~HPff 283 (613)
+||.+||+++..||++.+++.|||.
T Consensus 240 ~~i~~~l~~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 240 DFLKQIFVEEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHhcCcccCccHHHHhcCCCC
Confidence 9999999988999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.89 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=200.3
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
.|| ++.+.||+|+||+||+|.+..++..||+|.++... ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 15 ERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF--QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhh-hhheecccCCCeEEEEEEECCCCCEEEEEEeCchh--hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 455 56799999999999999999999999999876432 12234566789999999999999999999875332
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...++++++++ +++|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccce
Confidence 23578899987 7789887754 57999999999999999999999998 99999999999998 67899999999997
Q ss_pred HHhhh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC--CCC---------
Q 035992 181 ILAQA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKP--------- 246 (613)
Q Consensus 181 ~l~~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g--~~p--------- 246 (613)
..... ....++..|+|||++.+ .++.++|||||||++|+|++|..||........+ ..+... ..+
T Consensus 167 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred ecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhcch
Confidence 65432 23456779999998754 4899999999999999999999999654333222 222110 000
Q ss_pred ---------------Cc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 ---------------AS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 ---------------~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.. .....++.+.+||.+||. +|.+|||+.|+|.||||...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 00 011235668899999999 99999999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=326.99 Aligned_cols=250 Identities=26% Similarity=0.462 Sum_probs=206.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..++..+|+|.+... .....+.+.+|+.+++.++||||++++++|.. ....+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEE
Confidence 46678899999999999999999999998876532 34567788899999999999999999998865 4578999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
+||+.+++|..++.+ .+.+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 81 IEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccccc
Confidence 999999999988765 467999999999999999999999998 99999999999997 5689999999998654321
Q ss_pred ---ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-CCcccccccH
Q 035992 186 ---RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADN 255 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~ 255 (613)
....++..|+|||++. ..++.++|||||||++|+|++|..||....... ....+..... ....+..++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCCCCCCccccCH
Confidence 2234667899999863 237789999999999999999999997654433 3333433322 2223445788
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+++||.+||. +|.+||++.++++||||....
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 99999999998 999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.92 Aligned_cols=253 Identities=26% Similarity=0.486 Sum_probs=205.5
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTE 100 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 100 (613)
++.++| .+.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++++ +||||++++++|...+
T Consensus 19 ~~~~~y-~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 19 DPTDTW-EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred CCCCCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 456677 6779999999999999999999999999887532 12345677899999999 8999999999886533
Q ss_pred ---CCEEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 101 ---NEHINFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 101 ---~~~l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
...+++||||+.+|+|.+++.. ...+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEE
Confidence 2468999999999999998753 467999999999999999999999998 99999999999998 5788999
Q ss_pred eccchhHHHhhhc----cCcccccccCcccccc------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC
Q 035992 174 GDLGLAAILAQAR----SAHSVIEFMAPELYEE------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 174 ~DFGla~~l~~~~----~~~gt~~YmAPEvl~~------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g 243 (613)
+|||++..+.... ...++..|+|||.+.. .++.++|||||||++|+|++|..||........+. .+..+
T Consensus 170 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~ 248 (291)
T cd06639 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF-KIPRN 248 (291)
T ss_pred eecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH-HHhcC
Confidence 9999987654322 2345678999998743 26789999999999999999999997654444443 33333
Q ss_pred CCC-CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 244 IKP-ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 244 ~~p-~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
..+ ...+......+.++|.+||+ +|.+||++.+++.||||+
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 222 12233456789999999999 999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.03 Aligned_cols=250 Identities=27% Similarity=0.428 Sum_probs=205.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|..+|+|.++.. ........+.+|++++++++||||++++++|.. +..++++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEE
Confidence 47789999999999999999999999998877632 234556778899999999999999999998865 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
|||+.+++|.+++.+.+.+++..+..++.||+.||.|||+ ++ ++||||||+|||++ .++.+||+|||++.....
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccccc
Confidence 9999999999999998999999999999999999999997 46 99999999999998 578999999999875533
Q ss_pred hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH----------------------
Q 035992 185 ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT---------------------- 241 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~---------------------- 241 (613)
.....++..|+|||.+.+ .++.++||||||+++|+|++|..||.... .......+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 223456679999998764 48899999999999999999999995432 222222111
Q ss_pred --------------cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 --------------SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 --------------~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
....|......++.++++||.+||. +|.+||++.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111122367789999999998 99999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=320.43 Aligned_cols=249 Identities=29% Similarity=0.505 Sum_probs=205.9
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
|+.+| .+.+.||+|+||.||+|.+..++..+|+|.++.. ...+.+.+|+.+++.++||||++++++|.. ..
T Consensus 1 ~~~~y-~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 71 (256)
T cd06612 1 PEEVF-DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFK--NT 71 (256)
T ss_pred Ccccc-hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CC
Confidence 34455 6779999999999999999999999998887632 226789999999999999999999998865 46
Q ss_pred EEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+|+++||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++ +++.++|+|||++..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~ 148 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQ 148 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchh
Confidence 79999999999999999876 457899999999999999999999998 99999999999998 578999999999987
Q ss_pred Hhhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 182 LAQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 182 l~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
..... ...++..|+|||++.+ .++.++||||||+++|+|++|..||......................+..++..
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPE 228 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHH
Confidence 65432 2335668999998765 488999999999999999999999976444333322211111122233456788
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+.+||.+||+ +|.+||++.++|.||||
T Consensus 229 ~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 9999999998 99999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.41 Aligned_cols=254 Identities=30% Similarity=0.526 Sum_probs=211.8
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
|..+| ++.+.||.|+||+||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|.. ..
T Consensus 17 ~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 89 (296)
T cd06655 17 PKKKY-TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLV--GD 89 (296)
T ss_pred CcceE-EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEec--Cc
Confidence 45555 67799999999999999999999999999876432 2345678899999999999999999998854 55
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++|+||+.+++|..++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++..+
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~ 165 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQI 165 (296)
T ss_pred eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhc
Confidence 899999999999999988764 6899999999999999999999998 99999999999997 6789999999998765
Q ss_pred hhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 183 AQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 183 ~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.... ...++..|+|||.+.. .++.++|||||||++|+|++|..||........+.........+...+...++.+
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06655 166 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245 (296)
T ss_pred ccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence 4322 2345668999998765 4889999999999999999999999775554444433333333333455678899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
++||.+||. +|.+||++.+++.||||+...
T Consensus 246 ~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 999999998 999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=322.93 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=210.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||.|+||.||+|.+..++..||+|++..... ......+.+.+|++++++++||||++++++|. .+..+++|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQ--DEENMYLV 78 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhc--CCCeEEEE
Confidence 4678999999999999999999999999998875332 22345678999999999999999999999874 45689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
+||+.+++|..++.+...+++..+..|+.||+.||.|||+++ ++|+||+|+||+++ +++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCcc
Confidence 999999999999988888999999999999999999999998 99999999999998 6789999999998765443
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc--HHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
....++..|+|||.+.. .++.++|+||||+++|+|++|..||..... ...+.+.... ....++...+..+.++|
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAI 233 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHH
Confidence 23445668999998764 479999999999999999999999976554 4444443332 23344556789999999
Q ss_pred HHHhh-cccCCCCH--HHHhcCCCC
Q 035992 262 EKCIA-EVSERLPA--KELLGDPFL 283 (613)
Q Consensus 262 ~~cL~-dP~~Rpta--~eLL~HPff 283 (613)
.+||. +|.+||++ +|+++||||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99999 99999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=322.85 Aligned_cols=250 Identities=19% Similarity=0.343 Sum_probs=205.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHH-HhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL-KTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iL-k~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
+.||.|+||.||+|.+..+|+.||+|.++...... ......+..|..++ ...+|+||++++++|.. +..+++++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEY 78 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEec
Confidence 57999999999999999999999999876543221 22233445555544 45589999999998854 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccCcc
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS 190 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~g 190 (613)
+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ +.+.++|+|||++..........+
T Consensus 79 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~ 155 (260)
T cd05611 79 LNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKFVG 155 (260)
T ss_pred cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccccccCCC
Confidence 999999999998889999999999999999999999998 99999999999998 578999999999876554445567
Q ss_pred cccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC--CCCcccccccHHHHHHHHHHhh-
Q 035992 191 VIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASLAKVADNGVRAFIEKCIA- 266 (613)
Q Consensus 191 t~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~--~p~~l~~~~s~~l~~lI~~cL~- 266 (613)
+..|+|||.+.+. ++.++||||||+++|+|++|..||... +...++..+..+. .+......++..+.++|.+||+
T Consensus 156 ~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 7789999987654 789999999999999999999999654 4455555555443 2333444578999999999998
Q ss_pred cccCCCC---HHHHhcCCCCCCCCc
Q 035992 267 EVSERLP---AKELLGDPFLQSEDD 288 (613)
Q Consensus 267 dP~~Rpt---a~eLL~HPff~~~~~ 288 (613)
+|.+||+ ++|++.||||+..+|
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhcCCC
Confidence 9999995 579999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=319.38 Aligned_cols=247 Identities=30% Similarity=0.467 Sum_probs=205.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||.|+||+||+|.+..++..+|+|++.... .......+.+|+.+++.++|+||+++++.+.. ....+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK---CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC---cchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEE
Confidence 477899999999999999999999999988876432 23367789999999999999999999998754 5679999
Q ss_pred EeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 108 TEIFTSGTLRQYRKKH---KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||++.+++|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||+|+||+++ +++.++|+|||++..+..
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLAD 154 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhcc
Confidence 9999999999999764 46999999999999999999999998 99999999999998 568999999999987654
Q ss_pred hcc--------CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc----c
Q 035992 185 ARS--------AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL----A 250 (613)
Q Consensus 185 ~~~--------~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l----~ 250 (613)
... ..++..|+|||.+.. .++.++|+||||+++|+|++|..||....... .+..+.....+... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPSLETGADY 233 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCCCcCCcccc
Confidence 322 235668999997754 48899999999999999999999997654443 34444433222111 1
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
...+..+.+||.+||. +|.+||++.+|+.||||
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 234 KKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 2457889999999999 99999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=332.77 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=213.6
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
...++.++| ++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|..
T Consensus 13 ~~~~~~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 13 SVGDPKKKY-TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred ccCChhhhc-eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345677777 66799999999999999999999999999876432 2344678899999999999999999998854
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
+..+++||||+.+++|.+++.+ ..+++..+..++.|++.||.|||+.+ ++||||||+|||++ .++.++|+|||+
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~ 161 (297)
T cd06656 88 --GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGF 161 (297)
T ss_pred --CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCcc
Confidence 5689999999999999999866 46899999999999999999999998 99999999999997 678999999999
Q ss_pred hHHHhhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 179 AAILAQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 179 a~~l~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
+....... ...+++.|+|||.+.+ .++.++|+||||+++|+|++|..||........++.....+..+...+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcccc
Confidence 87543321 2345668999998765 488999999999999999999999976544444433333333333345567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..+++||.+||. +|.+||++.++++||||+...
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 7889999999999 999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.51 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=200.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|..||+|.++.... .......+.+|+.+++.++||||+++++++.. +..+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEE
Confidence 4677999999999999999999999999998765321 22334667889999999999999999998864 4578999
Q ss_pred EeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 108 TEIFTSGTLRQYRKKH---KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|||+. ++|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.++|+|||++.....
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 78 FEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGI 153 (285)
T ss_pred EecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCC
Confidence 99997 5888887643 56999999999999999999999998 99999999999998 678999999999875432
Q ss_pred h----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC------------
Q 035992 185 A----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP------------ 246 (613)
Q Consensus 185 ~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p------------ 246 (613)
. ....+++.|+|||++.+ .++.++||||||+++|+|+||..||........+...+.....+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 2 12234668999997754 47889999999999999999999997655544443322111000
Q ss_pred --------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 --------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 --------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.......+.++++||.+||. +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00112357889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.77 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=201.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||.|+||.||+|.+..+++.||+|.++.... ......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~--~~~~~lv 82 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 82 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEec--CCeEEEE
Confidence 3677999999999999999999999999998875432 2233456789999999999999999998854 4579999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+. ++|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPT 158 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCC
Confidence 99997 5888887654 56899999999999999999999998 99999999999998 66899999999987643221
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC----------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---------------- 244 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---------------- 244 (613)
...++..|+|||++.+ .++.++||||||+++|+|++|..||.......++ ..+....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL-HFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCChhhchhhhcccc
Confidence 2234668999997754 4788999999999999999999999765433322 2221100
Q ss_pred -----CCC-------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 -----KPA-------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 -----~p~-------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+. ......++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 0112457789999999999 999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=330.31 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=203.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC-cceeeeeeecCC----CCEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN-IIKFYNSWVDTE----NEHINF 106 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~----~~~l~l 106 (613)
++||+|+||+||+|+++.+|+.||+|++...... ...-....+|+.+|+.|+|+| |+.+++++.... ...+++
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 5699999999999999999999999988754321 123345689999999999999 999999875533 237999
Q ss_pred EEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 107 ITEIFTSGTLRQYRKKHK----HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~----~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
|+||+.. +|..|+.... .++...++.+++||+.||+|||+++ |+||||||.||||+ +.|.+||+|||+|...
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARAF 170 (323)
T ss_pred EEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHHh
Confidence 9999966 9999998765 6888999999999999999999999 99999999999998 5899999999999876
Q ss_pred hhhc----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-C-C----------
Q 035992 183 AQAR----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-G-I---------- 244 (613)
Q Consensus 183 ~~~~----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g-~---------- 244 (613)
.-.. ....|..|.|||++-+ .|+..+||||+|||++||++++.-|.+..+..++...... | .
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~ 250 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS 250 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence 5322 2345668999997643 4999999999999999999999999887777776554431 0 0
Q ss_pred ----C--------CCcccc---cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ----K--------PASLAK---VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ----~--------p~~l~~---~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+ +..+.. ..++...+++.+||+ +|.+|.||+..|.||||+...
T Consensus 251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 0 111111 123578899999999 999999999999999999863
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=314.63 Aligned_cols=251 Identities=35% Similarity=0.582 Sum_probs=216.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|++|.||+|.+..++..|++|++..... .....+.+.+|+.++++++||||+++++.+.......++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 3667999999999999999999999999998875432 24667889999999999999999999998865433689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
+||+.+++|.+++.+...+++..+..++.|++.||.|||+++ ++|+||+|+||+++ ..+.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEecccccc
Confidence 999999999999998889999999999999999999999988 99999999999998 56899999999987665432
Q ss_pred -----cCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 187 -----SAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
...++..|+|||.+... ++.++||||||+++|+|++|..||....+.......+..+.....++...+..+++|
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 23456689999987654 899999999999999999999999776655555555554444455666778999999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||. +|.+||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.04 Aligned_cols=249 Identities=30% Similarity=0.516 Sum_probs=210.1
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc-cChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL-RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~-~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+..++||+|+||+||+|.+..++..|++|.+...... ......+.+..|+.+++.++|+||+++++++.. ...++++
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 80 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--EDNLYIF 80 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec--CCeEEEE
Confidence 5679999999999999999999999999988764422 234456789999999999999999999998754 4679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
+||+.+++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceecccccc
Confidence 999999999999999888999999999999999999999998 99999999999998 5789999999998765432
Q ss_pred -ccCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....++..|+|||.+.. . ++.++|+||||+++|+|++|..||........... +........++...+..+++||.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~ 236 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELPPIPDHLSDEAKDFIL 236 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH-HHhcccCCCcCCCcCHHHHHHHH
Confidence 23446678999997653 3 78999999999999999999999977654444433 33322333455567899999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCC
Q 035992 263 KCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff 283 (613)
+||+ +|.+||++.+++.|||+
T Consensus 237 ~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 237 KCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHhhcCcccCcCHHHHhcCCCC
Confidence 9998 99999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.92 Aligned_cols=253 Identities=20% Similarity=0.364 Sum_probs=206.8
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+..++||+|+||+||+|.+..+++.||+|.+..... ........+.+|+.+|+.++|+||++++++|.. +..++++|
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRI-KKRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDALCLVL 79 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhh-hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCEEEEEE
Confidence 455889999999999999999999999998865332 223345567889999999999999999998754 45899999
Q ss_pred eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 109 EIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||+.+++|..++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++ +.+.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCC
Confidence 999999999887653 46999999999999999999999998 99999999999998 5679999999998654321
Q ss_pred --ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH---HHHHHHcCCCCCcccccccHHHHH
Q 035992 186 --RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ---IYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~---i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
....++..|+|||.+. ..++.++|+||||+++|+|++|..||........ +...+..+ ...++...+..+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET--EEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc--ccccCccCCHHHHH
Confidence 2345678999999875 4589999999999999999999999976443322 22222222 12334556788999
Q ss_pred HHHHHhh-cccCCCC-----HHHHhcCCCCCCCCcc
Q 035992 260 FIEKCIA-EVSERLP-----AKELLGDPFLQSEDDE 289 (613)
Q Consensus 260 lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~ 289 (613)
|+.+||+ +|.+||+ +.+++.|+||+...+.
T Consensus 235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 9999999 9999999 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.87 Aligned_cols=244 Identities=30% Similarity=0.516 Sum_probs=202.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
..||+|+||+||+|.+..++..||+|.+... .....+.+.+|+.+++.++|+||+++++++.. +..+++++||+
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 87 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NGFFKIFMEQV 87 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CCEEEEEEecC
Confidence 6899999999999999999999998877642 23556788999999999999999999998754 46899999999
Q ss_pred CCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---
Q 035992 112 TSGTLRQYRKKH-KHV--DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 112 ~gGsL~~~l~~~-~~l--se~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 185 (613)
.+++|.+++... ..+ ++..+..++.||+.||.|||+++ |+||||||+||+++...+.++|+|||++......
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 999999998765 455 88999999999999999999998 9999999999999855679999999998765321
Q ss_pred -ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
....++..|+|||.+.. .++.++||||||+++|+|++|..||............+........++...+..+++||
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 245 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFI 245 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHH
Confidence 12345678999998753 37899999999999999999999997654433332222221223345566788999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+||. +|.+|||+.+++.||||
T Consensus 246 ~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 246 LRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHcCCCchhCCCHHHHHhCCCC
Confidence 99998 99999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.15 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=211.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|+||.||+|.+..+++.||+|.++.... ........+.+|+.+++.++||||+++++++.. +..++++
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 79 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFET--KRHLCMV 79 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--CCEEEEE
Confidence 4677999999999999999999999999998764322 223455678899999999999999999998753 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.|++|.+++...+.+++..+..++.|++.||.|||+++ ++||||||+||+++ ..+.++|+|||++.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCcc
Confidence 999999999999998889999999999999999999999998 99999999999997 678999999998763110
Q ss_pred ----------------hccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-
Q 035992 185 ----------------ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP- 246 (613)
Q Consensus 185 ----------------~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p- 246 (613)
.....++..|+|||.+. ..++.++|+||||+++|||++|..||.+. ...+++..+..+..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCC
Confidence 00123456899999765 45899999999999999999999999764 455666665544322
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCC---HHHHhcCCCCCCCCccc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLP---AKELLGDPFLQSEDDES 290 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpt---a~eLL~HPff~~~~~~~ 290 (613)
+......+..++++|.+||+ +|.+||+ +.++|.||||...++..
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 22223568889999999999 9999998 89999999998876544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.52 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=214.3
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
+...+|..+| +..+.||+|+||+||+|.+..+|+.||+|++.... .......+.+.+|+.+++.++||||++++++|.
T Consensus 8 ~~~~~~~~~y-~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 8 FSKDDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred hcCCCcchhh-hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 3445777786 66799999999999999999999999999876433 223455677899999999999999999999886
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
. ....++||||+. |++.+++.. .+.+++..+..++.||+.||.|||+++ ++||||+|+||+++ .++.++|+||
T Consensus 86 ~--~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~df 159 (307)
T cd06607 86 R--EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADF 159 (307)
T ss_pred e--CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeec
Confidence 5 457899999997 567666654 467999999999999999999999998 99999999999998 6789999999
Q ss_pred chhHHHhhhccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 177 GLAAILAQARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 177 Gla~~l~~~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
|++..........++..|+|||++. +.++.++||||||+++|||++|..||........++ .+.....+......
T Consensus 160 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 238 (307)
T cd06607 160 GSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLSSND 238 (307)
T ss_pred CcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCCCCCCchh
Confidence 9987765555556677899999763 348899999999999999999999997654444443 33333333333445
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
++..++++|.+||. +|.+||++.+++.||||....
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 67899999999998 999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.65 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=203.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.++.+|+.||+|.++.... .....+.+.+|+.+++.++||||++++++|.. ...++++
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 3677999999999999999999999999998764321 22334567889999999999999999998854 4578999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|||+.+++|..++.+...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++..+....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCcc
Confidence 999999999988887788999999999999999999999998 99999999999998 66899999999998764432
Q ss_pred ---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC------------------
Q 035992 187 ---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG------------------ 243 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g------------------ 243 (613)
...++..|+|||.+.+ .++.++||||||+++|+|++|..||.+..+.+.++......
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 2235568999998754 47899999999999999999999997766555443322100
Q ss_pred -C-CCC--------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 244 -I-KPA--------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 244 -~-~p~--------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. .+. ......+..+.+||.+||+ +|.+||++.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 000 0012346789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=324.39 Aligned_cols=252 Identities=25% Similarity=0.483 Sum_probs=204.5
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeec--
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVD-- 98 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~-- 98 (613)
++..+| .+.+.||+|+||+||+|.+..++..+|+|+++.. ......+..|+.+++.+ +||||+++++++..
T Consensus 15 ~~~~~~-~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 15 DPSDTW-EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred Ccccce-eeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 466677 6779999999999999999999999998876532 12235677899999999 69999999998753
Q ss_pred -CCCCEEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 99 -TENEHINFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 99 -~~~~~l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
..+..++++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++||||||+||+++ ..+.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEE
Confidence 234579999999999999988753 356899999999999999999999998 99999999999998 5678999
Q ss_pred eccchhHHHhhh----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC
Q 035992 174 GDLGLAAILAQA----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 174 ~DFGla~~l~~~----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g 243 (613)
+|||++..+... ....++..|+|||++. ..++.++|||||||++|+|++|..||........+.. +...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~-~~~~ 244 (286)
T cd06638 166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRN 244 (286)
T ss_pred ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh-cccc
Confidence 999998765432 2234667899999764 3478899999999999999999999977554444332 2222
Q ss_pred C-CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 244 I-KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 244 ~-~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. .....+..++..+.++|.+||+ +|.+||++.++++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2 2222344567889999999998 99999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.19 Aligned_cols=276 Identities=21% Similarity=0.374 Sum_probs=244.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
-.||-|+||.|=++.-......+|+|++++.... +..+.+++..|.++|..++.|.||++|..|- +.+++|++||-|
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIV-dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr--d~kyvYmLmEaC 502 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIV-DTKQQEHVFSERNIMMECRSDFIVRLYRTFR--DSKYVYMLMEAC 502 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhcc-chhHHHHHHhHHHHHHhcCchHHHHHHHHhc--cchhhhhhHHhh
Confidence 6799999999999977666666999999877654 4577889999999999999999999999984 467999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---cC
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---SA 188 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~~ 188 (613)
-||.|+..++..+.|++.+.+.++..+++|++|||++| ||+|||||+|.+++ +.|.+||.|||+|+.+.... ++
T Consensus 503 lGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTF 579 (732)
T KOG0614|consen 503 LGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTF 579 (732)
T ss_pred cCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeee
Confidence 99999999999999999999999999999999999999 99999999999998 78999999999999987654 67
Q ss_pred cccccccCccc-cccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-
Q 035992 189 HSVIEFMAPEL-YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA- 266 (613)
Q Consensus 189 ~gt~~YmAPEv-l~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~- 266 (613)
+||++|.|||+ ++.+.+.++|.||||+++|||++|.+||++ .++...|+.|..|+....+|+.+...+.++|+++..
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~ 658 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRD 658 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhc
Confidence 89999999995 567799999999999999999999999966 788999999999999989999999999999999776
Q ss_pred cccCCCC-----HHHHhcCCCCCCCCccc-----ccccccccccCCccccccccCCcc
Q 035992 267 EVSERLP-----AKELLGDPFLQSEDDES-----VGRSLRVKTHYSAETSHQANLDKN 314 (613)
Q Consensus 267 dP~~Rpt-----a~eLL~HPff~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 314 (613)
+|.+|+. +.+|.+|-||.+.+|+. +.++..+....+.+.+.+.+++..
T Consensus 659 ~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p~d 716 (732)
T KOG0614|consen 659 NPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFPPD 716 (732)
T ss_pred CcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCCcc
Confidence 9999997 89999999999988754 455556666667777766655433
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=326.11 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=198.3
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHH---HHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL---LKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 33 ~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~i---Lk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+||+|+||.||+|.+..+|..+|+|.+........ .....+..|..+ +...+||||+.++++|.. ....++|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILD 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEe
Confidence 48999999999999999999999998875433222 222333444433 344579999999998754 457899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--cc
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--RS 187 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 187 (613)
|+.+|+|..++..++.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++...... ..
T Consensus 78 ~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~ 154 (279)
T cd05633 78 LMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (279)
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccC
Confidence 9999999999998889999999999999999999999998 99999999999998 6689999999998654322 23
Q ss_pred CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCc--HHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 188 AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
..++..|+|||.+.. .++.++|||||||++|+|++|..||..... ...+.. ... ..+..++...+..++++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~li~~ 232 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTL-TVNVELPDSFSPELKSLLEG 232 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH-Hhh-cCCcCCccccCHHHHHHHHH
Confidence 357789999998753 488999999999999999999999965332 222221 111 12334556678999999999
Q ss_pred Hhh-cccCCC-----CHHHHhcCCCCCCCCc
Q 035992 264 CIA-EVSERL-----PAKELLGDPFLQSEDD 288 (613)
Q Consensus 264 cL~-dP~~Rp-----ta~eLL~HPff~~~~~ 288 (613)
||. +|.+|+ +++++++||||+..++
T Consensus 233 ~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 233 LLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 999 999999 6999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=316.14 Aligned_cols=247 Identities=32% Similarity=0.572 Sum_probs=209.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+..|+.+++.++|+||+++++.+. ....+++++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 677999999999999999999999999998875432 2457788999999999999999999999764 356799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc-
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS- 187 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~- 187 (613)
||+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ ++|+||+|+||+++ +.+.+||+|||++........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCc
Confidence 99999999999998888999999999999999999999998 99999999999998 578999999999887643221
Q ss_pred -------CcccccccCcccccc-c---cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc--cc
Q 035992 188 -------AHSVIEFMAPELYEE-E---YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV--AD 254 (613)
Q Consensus 188 -------~~gt~~YmAPEvl~~-~---ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~--~s 254 (613)
..++..|+|||++.. . ++.++||||||+++|+|++|..||....+...+...+..+..+ .++.. .+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP-PIPDSLQLS 234 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCC-CCCcccccC
Confidence 234568999998753 2 7889999999999999999999997665555554445544322 23333 48
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+.+||.+||+ +|.+||++.+++.|||+
T Consensus 235 ~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 235 PEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 889999999998 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.57 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=188.2
Q ss_pred eeeecccCceEEEEEEEcC--CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDEL--EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~--tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
..+||+|+||+||+|.+.. ++..||+|.++... ....+.+|+.+++.++||||++++++|....+..++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 3789999999999998654 66889988775322 223567899999999999999999998877777899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe---CCCCcEEEecc
Q 035992 109 EIFTSGTLRQYRKKH---------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN---GNQGEVKIGDL 176 (613)
Q Consensus 109 E~~~gGsL~~~l~~~---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~---~~~g~VKL~DF 176 (613)
||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+||
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 99875 777776422 24899999999999999999999998 99999999999994 24578999999
Q ss_pred chhHHHhhh-------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCc---------HHHHHH
Q 035992 177 GLAAILAQA-------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTN---------AAQIYK 238 (613)
Q Consensus 177 Gla~~l~~~-------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---------~~~i~~ 238 (613)
|++...... ....++..|+|||++.+ .++.++|||||||++|||+||.+||..... ..++..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 999765432 12345678999998754 488999999999999999999999954221 111111
Q ss_pred HHHc-CC---------------------------CC-------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 239 KVTS-GI---------------------------KP-------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 239 ~I~~-g~---------------------------~p-------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
.+.. +. .. .......+..+.++|.+||+ ||.+|||+.|+|+|||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 0000 00 00 00011234568899999999 9999999999999999
Q ss_pred C
Q 035992 283 L 283 (613)
Q Consensus 283 f 283 (613)
|
T Consensus 317 f 317 (317)
T cd07867 317 F 317 (317)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.25 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=210.7
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.+.||.|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||++++++|.. ...+++++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--GSKLWIIM 78 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--CCeEEEEE
Confidence 56689999999999999999999999999876432 23455678899999999999999999998865 46899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--- 185 (613)
||+.+++|.+++... .+++..++.++.||+.||.|||+++ ++||||+|+||+++ +++.++|+|||++..+...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccccc
Confidence 999999999998875 8999999999999999999999998 99999999999998 5789999999998766432
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
....++..|+|||.+.+ .++.++||||||+++|+|+||..||.... .......+..+..+.......+..+.++|.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence 22345567999997764 48999999999999999999999996543 4444445555543332222278899999999
Q ss_pred Hhh-cccCCCCHHHHhcCCCCCCCCcc
Q 035992 264 CIA-EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
||. +|.+||+++++++||||+.....
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 998 99999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.64 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=201.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHH-HHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL-LKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
+++.+.||+|+||.||+|.+..+|+.||+|.++... .......+..|+.+ ++.++||||+++++++.. +..+++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~l 77 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWI 77 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCC---CcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEE
Confidence 467799999999999999999999999999876432 12233445556554 677799999999998854 456999
Q ss_pred EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 107 ITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+|||+. |+|.+++.. ...+++..++.++.||+.||+|||++ + ++||||||+||+++ .++.+||+|||++..
T Consensus 78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~ 153 (283)
T cd06617 78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGY 153 (283)
T ss_pred Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecccccc
Confidence 999996 578777654 34689999999999999999999987 6 99999999999998 578999999999876
Q ss_pred Hhhhc---cCcccccccCccccc-----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 182 LAQAR---SAHSVIEFMAPELYE-----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 182 l~~~~---~~~gt~~YmAPEvl~-----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
+.... ...++..|+|||.+. ..++.++|+||||+++|+|++|..||.........+..+..+..+......+
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred cccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 54321 234567899999774 3478899999999999999999999965444333333444443333333456
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
+.++.+||.+||. +|.+||++.+++.||||+....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 8899999999998 9999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=316.64 Aligned_cols=251 Identities=29% Similarity=0.502 Sum_probs=214.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+.+.+.||+|++|.||+|.+..+|+.||+|.+.... .......+.+|+..++.++|+||++++++|.. ...++++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG---DEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCc---chHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEE
Confidence 356799999999999999999999999988876432 22556789999999999999999999998865 4689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+++|.+++.+...+++..+..++.||+.||.|||+ ++ ++||||+|+||+++ .++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCC
Confidence 9999999999999988899999999999999999999999 88 99999999999998 57899999999988664432
Q ss_pred ----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 ----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
...++..|+|||.+.. .++.++|+||||+++|+|++|..||.... ...+..+.+.....+......++..+.+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 155 DQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred CcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 2235568999998765 48889999999999999999999997764 5556666666554443322227889999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+|.+||. +|.+||++.+++.||||+..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999998 99999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=322.68 Aligned_cols=249 Identities=24% Similarity=0.404 Sum_probs=200.0
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHH---HHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE---VHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 33 ~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~E---i~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+||+|+||+||+|.+..+|+.||+|.+........ ........| +.+++...||||++++++|.. ...+++|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILD 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEe
Confidence 48999999999999999999999998875432211 111223333 345555689999999998754 457999999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--cc
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--RS 187 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~ 187 (613)
|+.||+|..++.+.+.+++..++.|+.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++..+... ..
T Consensus 78 ~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~ 154 (278)
T cd05606 78 LMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHA 154 (278)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcC
Confidence 9999999999998889999999999999999999999998 99999999999998 5689999999998754322 23
Q ss_pred CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 188 AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
..++..|+|||.+.+ .++.++||||||+++|+|++|..||.... ....+...+.. .+..++...+..+.++|.+
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRSLLEG 232 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCCCcCCHHHHHHHHH
Confidence 456779999998763 48899999999999999999999997643 22233222222 2233455668999999999
Q ss_pred Hhh-cccCCC-----CHHHHhcCCCCCCCCcc
Q 035992 264 CIA-EVSERL-----PAKELLGDPFLQSEDDE 289 (613)
Q Consensus 264 cL~-dP~~Rp-----ta~eLL~HPff~~~~~~ 289 (613)
||. +|.+|+ ++.++++||||+...+.
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 999 999999 99999999999987653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.33 Aligned_cols=248 Identities=24% Similarity=0.408 Sum_probs=207.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||.|+||+||+|.+..+|+.+|+|++..... ......+.+.+|+.+++.++||||+++++.+. .+..+++++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCC
Confidence 6899999999999999999999998765432 22356678899999999999999999999774 35689999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-------
Q 035992 114 GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR------- 186 (613)
Q Consensus 114 GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~------- 186 (613)
++|..++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccc
Confidence 999999998889999999999999999999999998 99999999999998 67899999999987653321
Q ss_pred -----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 187 -----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
...++..|+|||.+.. .++.++||||||+++|+|++|..||... .....+..+..+..+.......+..+.+|
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILNGKIEWPEDVEVSDEAIDL 233 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCcCCCccccCCHHHHHH
Confidence 2234558999997654 4888999999999999999999999654 45555666665443322122248899999
Q ss_pred HHHHhh-cccCCCCH---HHHhcCCCCCCCCc
Q 035992 261 IEKCIA-EVSERLPA---KELLGDPFLQSEDD 288 (613)
Q Consensus 261 I~~cL~-dP~~Rpta---~eLL~HPff~~~~~ 288 (613)
|.+||+ +|.+|||+ .++|+||||+..+|
T Consensus 234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 999999 99999999 99999999987653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=336.82 Aligned_cols=242 Identities=25% Similarity=0.385 Sum_probs=190.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..++..||+|+.... ....|+.+++.++||||++++++|.. ....++|
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----------~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 135 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----------TTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMV 135 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----------ccHHHHHHHHhCCCCCCcChhheEEe--CCeeEEE
Confidence 57889999999999999999999999998864321 23468999999999999999998865 4578899
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||++. ++|.+++.+ .+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++......
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccCc
Confidence 99995 577777754 467999999999999999999999998 99999999999998 5679999999998754321
Q ss_pred --ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc----------HHHHHHHHHc-CCCCCccc-
Q 035992 186 --RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN----------AAQIYKKVTS-GIKPASLA- 250 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~----------~~~i~~~I~~-g~~p~~l~- 250 (613)
....++..|+|||++.+ .|+.++|||||||++|||+++..|+..... ...+...+.. +..|..++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 291 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR 291 (357)
T ss_pred ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCC
Confidence 23457789999998764 589999999999999999986655533211 1112221111 11111111
Q ss_pred -----------------------------ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 251 -----------------------------KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 251 -----------------------------~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
...+..+.+||.+||+ +|.+|||+.|+|+||||+.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 292 DPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 1235567789999999 9999999999999999985
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.39 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=210.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||.|+||.||.+.+..++..+++|.+..... .......+.+|+.++++++|+||++++++|.. ...++++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEE
Confidence 3677999999999999999999999999998765432 34556778899999999999999999999865 4679999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++.+. ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++ +++.+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcccc
Confidence 9999999999999775 56899999999999999999999998 99999999999998 5689999999998765432
Q ss_pred c----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 R----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
. ...++..|+|||++.+ .++.++||||||+++|+|++|..||.. .+.......+..+..+. .....+..+.++
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISL 232 (256)
T ss_pred cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHH
Confidence 2 3446778999997754 488899999999999999999999965 45555565666554433 235568899999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||. +|.+||++.++++|||+
T Consensus 233 i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 233 VHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHcccCcccCCCHHHHhhCcCC
Confidence 999998 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=313.52 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=208.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++.+.. ...+++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEec--CCEEEEE
Confidence 3678999999999999999999999999998875432 34556789999999999999999999998753 5679999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++|+||+|+||+++.+.+.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999999764 35899999999999999999999998 9999999999999855667899999999766432
Q ss_pred c---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 R---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 ~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
. ...++..|+|||.+.. .++.++||||||+++|+|++|..||..... ......+..+..+ .++...+..++++|
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li 233 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTFA-PISDRYSPDLRQLI 233 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhcCCC-CCCCCcCHHHHHHH
Confidence 2 2345668999998765 478899999999999999999999966443 4444455444332 33445788999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+||. +|.+|||+.|++.||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99998 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=348.51 Aligned_cols=231 Identities=31% Similarity=0.484 Sum_probs=199.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
+-||+|+.|.||+|+ ..++.||+|.|+-. -..+|.-|++|+||||+.|.++| .....+|||||||
T Consensus 130 eWlGSGaQGAVF~Gr--l~netVAVKKV~el-----------kETdIKHLRkLkH~NII~FkGVC--tqsPcyCIiMEfC 194 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR--LHNETVAVKKVREL-----------KETDIKHLRKLKHPNIITFKGVC--TQSPCYCIIMEFC 194 (904)
T ss_pred hhhccCcccceeeee--ccCceehhHHHhhh-----------hhhhHHHHHhccCcceeeEeeee--cCCceeEEeeecc
Confidence 679999999999995 46889997765521 13478899999999999999966 5677899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---ccC
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSA 188 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~---~~~ 188 (613)
..|.|...++....+....+..|..+|+.|+.|||.+. |||||||.-||||.. +..|||+|||.++.+... ..+
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISY-DDVVKISDFGTSKELSDKSTKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeec-cceEEeccccchHhhhhhhhhhhh
Confidence 99999999999999999999999999999999999998 999999999999984 458999999999877543 356
Q ss_pred cccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-
Q 035992 189 HSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA- 266 (613)
Q Consensus 189 ~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~- 266 (613)
.||..|||||++.++ .++|+|||||||+||||+||+.||.+... ..|..-+-+.......+..++..++-||++||+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds-sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS-SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch-heeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 788999999998765 89999999999999999999999976443 333334444445555677889999999999999
Q ss_pred cccCCCCHHHHhcCC
Q 035992 267 EVSERLPAKELLGDP 281 (613)
Q Consensus 267 dP~~Rpta~eLL~HP 281 (613)
.|..||++.++|.|-
T Consensus 351 KpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 351 KPRNRPSFRQILLHL 365 (904)
T ss_pred CCCCCccHHHHHHHH
Confidence 999999999999984
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=345.59 Aligned_cols=264 Identities=28% Similarity=0.460 Sum_probs=207.3
Q ss_pred CCCCcccccCCCCcceeE--eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-C---
Q 035992 13 DSDAEFVEIDPSARYGRY--KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-H--- 86 (613)
Q Consensus 13 ~~~~~~v~~dp~gRy~r~--~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-H--- 86 (613)
+.+.+|..+--+.-.+|| .++||+|+||.|.+|.+..|++.||||++|. ......+...|+.+|..|+ |
T Consensus 171 ~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-----~k~f~~Q~~~Ei~iL~~ln~~d~~ 245 (586)
T KOG0667|consen 171 DEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-----KKRFLRQAQIEIRILELLNKHDPD 245 (586)
T ss_pred CCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc-----ChHHHHHHHHHHHHHHHHhccCCC
Confidence 344444444444444455 7999999999999999999999999999874 3455666778999999996 4
Q ss_pred --CCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcE
Q 035992 87 --KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI 162 (613)
Q Consensus 87 --pNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NI 162 (613)
-|+|+++++|.. ..++|+|+|++.. +|.++++.+ ..|+...++.+++||+.||.+||+++ |||+||||+||
T Consensus 246 ~~~n~Vrm~d~F~f--r~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENI 320 (586)
T KOG0667|consen 246 DKYNIVRMLDYFYF--RNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENI 320 (586)
T ss_pred CCeeEEEeeecccc--ccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhhe
Confidence 389999999976 5689999999854 999999876 46999999999999999999999998 99999999999
Q ss_pred EEe-CCCCcEEEeccchhHHHhhhcc-CcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHH
Q 035992 163 FVN-GNQGEVKIGDLGLAAILAQARS-AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239 (613)
Q Consensus 163 Ll~-~~~g~VKL~DFGla~~l~~~~~-~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~ 239 (613)
||. .....|||+|||.|+.....-. ..-+-.|.|||++- ..|+.+.||||||||+.||++|.+-|.+....+++...
T Consensus 321 LL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I 400 (586)
T KOG0667|consen 321 LLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARI 400 (586)
T ss_pred eeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHH
Confidence 996 2334799999999998765322 11122799999765 56999999999999999999998888776665555433
Q ss_pred HH-cCC----------------------------------------------------CC-------CcccccccHHHHH
Q 035992 240 VT-SGI----------------------------------------------------KP-------ASLAKVADNGVRA 259 (613)
Q Consensus 240 I~-~g~----------------------------------------------------~p-------~~l~~~~s~~l~~ 259 (613)
+. .|. .| ..+.......+.+
T Consensus 401 ~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~d 480 (586)
T KOG0667|consen 401 IEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFID 480 (586)
T ss_pred HHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHH
Confidence 22 000 00 0001122356789
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||. ||.+|+|+.+.|+||||...
T Consensus 481 flk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 481 FLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred HHHHHhccCchhcCCHHHHhcCcccccc
Confidence 9999999 99999999999999999864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.26 Aligned_cols=250 Identities=24% Similarity=0.501 Sum_probs=206.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+.+.+.||+|+||+||+|.+..+|..||+|.++.. ........+.+|+.++++++||||+++++++.. ...+++|
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEE
Confidence 36679999999999999999999999999987642 234556788999999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKKH---KHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~---~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|||+.+++|..++.+. ..+++..+..++.||+.||.|||+ ++ ++||||||+||+++ ..+.+||+|||++..+.
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCccccc
Confidence 9999999999998774 479999999999999999999996 46 99999999999998 57899999999987653
Q ss_pred hh--ccCcccccccCcccccc-------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHH---HHHHcCCCCCcccc
Q 035992 184 QA--RSAHSVIEFMAPELYEE-------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY---KKVTSGIKPASLAK 251 (613)
Q Consensus 184 ~~--~~~~gt~~YmAPEvl~~-------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~---~~I~~g~~p~~l~~ 251 (613)
.. ....++..|+|||.+.. .++.++|||||||++|+|++|..||..... ...+ ..+..+. +..++.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~-~~~~~~ 232 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQLSAIVDGD-PPTLPS 232 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHHHHHHhhcC-CCCCCc
Confidence 32 22345668999998743 257899999999999999999999965332 2222 2333343 334455
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.++..+++||.+||+ +|.+||++.+++.||||....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 588999999999998 999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=340.37 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=196.4
Q ss_pred eeEeeeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|++.+.||+|+||+||+|... .++..||+|.+... ....+|+.+|+.++||||++++++|.. ...++
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~ 162 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRW--KSTVC 162 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEee--CCEEE
Confidence 578899999999999999754 45678888876532 134579999999999999999998754 45799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
++||++. ++|.+++...+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.++|+|||++..+...
T Consensus 163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCcc
Confidence 9999986 689899988889999999999999999999999998 99999999999998 6789999999999765432
Q ss_pred c------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHH--------------
Q 035992 186 R------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVT-------------- 241 (613)
Q Consensus 186 ~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~-------------- 241 (613)
. ...+++.|+|||++.. .|+.++|||||||++|||++|..||..... ..++...+.
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 2357789999998864 589999999999999999999999965432 111211111
Q ss_pred -----------cCCCC-Cccc-----ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 242 -----------SGIKP-ASLA-----KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 242 -----------~g~~p-~~l~-----~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
....+ ..++ ...+.++++||.+||. +|.+||++.|+|.||||....+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 00000 0011 1245678899999999 9999999999999999987654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=320.67 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=200.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||.|+||+||+|.++.+|+.||+|.++... ........+.+|+.++++++||||+++++++.. ...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc--cccccchHHHHHHHHHHhcCCCCCcchhhhccc--CCcEEEE
Confidence 467799999999999999999999999999876432 122334578899999999999999999998753 5678999
Q ss_pred EeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKK--HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+. ++|..++.. ...+++..++.++.||+.||+|||+++ ++||||+|+||+++ .++.+||+|||++..+...
T Consensus 78 ~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 78 FEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVP 153 (284)
T ss_pred eeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccC
Confidence 99996 589888865 356899999999999999999999998 99999999999998 6789999999998765432
Q ss_pred c----cCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC------------
Q 035992 186 R----SAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA------------ 247 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~------------ 247 (613)
. ...++..|+|||.+.+ . ++.++||||||+++|+|+||..||........+.+.+.....+.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence 1 1234568999997754 2 68899999999999999999999976555444443332111110
Q ss_pred --------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 248 --------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 248 --------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
......+..++++|.+||+ +|.+|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112357788999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=344.03 Aligned_cols=240 Identities=27% Similarity=0.443 Sum_probs=200.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
+..++.+.||+|-||.||.|.... ...||+|.++... ...+.+.+|+++|++|+|+|||++|+++. ....++
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~--~~~piy 277 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-----MSPEAFLREAQIMKKLRHEKLVKLYGVCT--KQEPIY 277 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-----cChhHHHHHHHHHHhCcccCeEEEEEEEe--cCCceE
Confidence 445677999999999999997642 2389999888542 22356779999999999999999999764 344799
Q ss_pred EEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKK--HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
||||||..|+|.+|++. ++.+....+..|+.||++|++||++++ +|||||.+.||||+ ++..+||+|||+|+...
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccC
Confidence 99999999999999997 567999999999999999999999999 99999999999998 67799999999999544
Q ss_pred hhcc-----CcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 QARS-----AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~~~~-----~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.... ..-.+.|+|||.+. +.|+.++|||||||+||||+| |+.||.+.+ ..++.+.+.+|...+. |..+++.
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-n~ev~~~le~GyRlp~-P~~CP~~ 432 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-NEEVLELLERGYRLPR-PEGCPDE 432 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-HHHHHHHHhccCcCCC-CCCCCHH
Confidence 3221 11123799999776 569999999999999999999 889997655 4566678888876543 4568999
Q ss_pred HHHHHHHHhh-cccCCCCHHHHh
Q 035992 257 VRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
+.+++..||. +|.+|||++.|.
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHH
Confidence 9999999999 999999988765
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=320.81 Aligned_cols=251 Identities=22% Similarity=0.412 Sum_probs=207.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||+||+|.+..+|..||+|++... ........+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 81 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLN--ENNICMC 81 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEec--CCEEEEE
Confidence 46679999999999999999999999999887643 234456788999999999999999999999865 3689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+++|..++.+.+.+++..+..++.|++.||.|||+ ++ ++||||||+||+++ +.+.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhc
Confidence 9999999999999988889999999999999999999997 46 99999999999998 6789999999998655322
Q ss_pred -ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcH----------HHHHHHHHcCCCCCcccccc
Q 035992 186 -RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNA----------AQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~----------~~i~~~I~~g~~p~~l~~~~ 253 (613)
....++..|+|||++. ..++.++|||||||++|+|++|..||...... ..+...+.....+.......
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhc
Confidence 2345677999999765 45889999999999999999999999654331 12233333332222222336
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..+.+||.+||+ +|.+||++.|+++||||...
T Consensus 239 ~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 7789999999999 99999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=318.15 Aligned_cols=249 Identities=22% Similarity=0.379 Sum_probs=202.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|..||+|++..... .......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEE
Confidence 3778999999999999999999999999998875432 23445678899999999999999999998855 5689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+ +++|.+++.. .+.+++..++.++.||+.||+|||+++ ++|+||||+||+++ ..+.++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCCC
Confidence 9999 9999998865 467999999999999999999999998 99999999999998 57899999999988764432
Q ss_pred -----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-------------
Q 035992 187 -----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP------------- 246 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p------------- 246 (613)
...++..|+|||.+.+ .++.++||||||+++|+|++|.+||....+...+...+.....+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence 2345678999997743 37899999999999999999988886654443332222210000
Q ss_pred --------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 247 --------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 247 --------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
.......+..+.+||.+||. +|.+||+++++|.||||.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00112346889999999999 999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=320.19 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=204.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||+|+||+||+|.+..+|+.||+|++..... ........+..|+.+++.++||||++++++|.. ...+++||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRL-KKRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhh-hhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 6999999999999999999999998865332 223345567789999999999999999998754 4679999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---cC
Q 035992 114 GTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---SA 188 (613)
Q Consensus 114 GsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---~~ 188 (613)
++|.+++.+.+ .+++..+..++.|++.||.|||+++ ++||||+|+||+++ +++.++|+|||++....... ..
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccc
Confidence 99999998766 7999999999999999999999998 99999999999998 67899999999987664321 23
Q ss_pred cccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 189 HSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 189 ~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
.++..|+|||.+.+ .++.++||||||+++|+|++|..||..... ...+...+.. .+...+...++.++++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHH
Confidence 44568999998754 488999999999999999999999965432 2233332222 23344556789999999999
Q ss_pred hh-cccCCC-----CHHHHhcCCCCCCCCcc
Q 035992 265 IA-EVSERL-----PAKELLGDPFLQSEDDE 289 (613)
Q Consensus 265 L~-dP~~Rp-----ta~eLL~HPff~~~~~~ 289 (613)
|+ +|.+|| ++.+|+.||||...++.
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCChh
Confidence 98 999999 89999999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=316.78 Aligned_cols=251 Identities=27% Similarity=0.480 Sum_probs=205.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc------ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR------NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~------~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
|.+.+.||.|+||.||+|.+..+|+.||+|.++...... .....+.+..|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 80 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT--E 80 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--C
Confidence 366799999999999999999999999999886532211 11234578889999999999999999998754 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||+|+||+++ .++.++|+|||++..
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~ 157 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKK 157 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeecccccc
Confidence 678999999999999999999889999999999999999999999998 99999999999998 678999999999875
Q ss_pred Hhhh------ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---CCCcc
Q 035992 182 LAQA------RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASL 249 (613)
Q Consensus 182 l~~~------~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---~p~~l 249 (613)
.... ....++..|+|||.+.. .++.++|+||||+++|+|++|..||........+.+...... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV 237 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence 4321 12245668999997753 378899999999999999999999976555444443322222 12223
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
...++..+++||.+||. +|.+||++.++|.||||
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 33467899999999999 99999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=337.86 Aligned_cols=257 Identities=27% Similarity=0.405 Sum_probs=208.0
Q ss_pred CCcccccCCCCc-----------ceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHH
Q 035992 15 DAEFVEIDPSAR-----------YGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEV 78 (613)
Q Consensus 15 ~~~~v~~dp~gR-----------y~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei 78 (613)
...|+.+||+.- -+++.++||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+
T Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei 89 (375)
T cd05104 13 GNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSEL 89 (375)
T ss_pred CceEEEecCCCCCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHH
Confidence 355677777654 257789999999999999964 4567789998876322 234567788999
Q ss_pred HHHHhC-CCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC---------------------------------
Q 035992 79 HLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK--------------------------------- 124 (613)
Q Consensus 79 ~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~--------------------------------- 124 (613)
.+|+.+ +||||++++++|.. ....++||||+++|+|.+++....
T Consensus 90 ~il~~l~~HpnIv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 167 (375)
T cd05104 90 KVLSYLGNHINIVNLLGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNE 167 (375)
T ss_pred HHHHHhcCCcceeeeeeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhh
Confidence 999999 89999999998854 457899999999999999886532
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcE
Q 035992 125 ------------------------------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI 162 (613)
Q Consensus 125 ------------------------------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NI 162 (613)
.+++..+..|+.||+.||.|||+++ |+||||||+||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Ni 245 (375)
T cd05104 168 YMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNI 245 (375)
T ss_pred hhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhE
Confidence 4788899999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHH
Q 035992 163 FVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAA 234 (613)
Q Consensus 163 Ll~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~ 234 (613)
|++ ..+.+||+|||++....... ...++..|||||++.+ .++.++|||||||++|||++ |..||.......
T Consensus 246 ll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~ 324 (375)
T cd05104 246 LLT-HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324 (375)
T ss_pred EEE-CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence 998 56789999999987654321 1223347999998754 58999999999999999998 899997766666
Q ss_pred HHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 235 ~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+++.+..+..+. .+...+.+++++|.+||+ +|.+||++.++++.
T Consensus 325 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 325 KFYKMIKEGYRML-SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHhCccCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 6777777665432 344567899999999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=312.06 Aligned_cols=247 Identities=23% Similarity=0.455 Sum_probs=207.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||++.+..+|+.||+|.+..... .......+.+|+.++++++||||++++++|.. ....++|
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CCeEEEE
Confidence 3778999999999999999999999999998775332 23455678999999999999999999998743 5689999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+||+.+++|.+++.... .+++..+..|+.|++.||.|||+++ ++|+||+|+||+++ .++.++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcc
Confidence 99999999999987643 5899999999999999999999998 99999999999998 5679999999998755332
Q ss_pred ----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 ----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+. .+...+..+.++
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYPP-VSSHYSYDLRNL 232 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCCC-CcccCCHHHHHH
Confidence 12345678999998754 4788999999999999999999999764 4445555555554432 345568899999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||+ +|.+||++.++++||||
T Consensus 233 i~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 233 VSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHhhCChhhCcCHHHHhhCcCC
Confidence 999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=319.23 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=207.3
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+..+.||.|++|.||+|.+..+++.+|+|.+.... .......+.+|+++++.++||||++++++|.......++++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 56689999999999999999999999998876432 235567789999999999999999999998776677899999
Q ss_pred eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 109 EIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 109 E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+.+ ++|+||+|+||+++ +.+.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccccc
Confidence 99999999887653 356899999999999999999999998 99999999999998 567899999999875433
Q ss_pred h--ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC----CcHHHHHHHHHcCCCCCc---cc--cc
Q 035992 185 A--RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC----TNAAQIYKKVTSGIKPAS---LA--KV 252 (613)
Q Consensus 185 ~--~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~----~~~~~i~~~I~~g~~p~~---l~--~~ 252 (613)
. ....++..|+|||.+.. .++.++||||||+++|+|++|..||... .....+...+.....+.. .. ..
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd06621 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237 (287)
T ss_pred cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCc
Confidence 2 12345668999997754 5899999999999999999999999654 233444444444222211 11 23
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+++.+++||.+||. +|.+|||+.|++.||||+...
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 238 WSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred hHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 46789999999998 999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=320.88 Aligned_cols=262 Identities=23% Similarity=0.448 Sum_probs=218.2
Q ss_pred CcccccCCCCcce------eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCC
Q 035992 16 AEFVEIDPSARYG------RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKN 88 (613)
Q Consensus 16 ~~~v~~dp~gRy~------r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpN 88 (613)
..|++++...||- .....||.|+-|+|++++.+.+|...|+|++.+. .+.++..+++..+.++...+ .|+
T Consensus 76 tg~lti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpy 152 (391)
T KOG0983|consen 76 TGYLTIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPY 152 (391)
T ss_pred ceeEEecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCe
Confidence 4566666555551 1236799999999999999999999999998754 46788999999999887775 999
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
||+.|++|+.. ..+++.||.|.. -+..++++ .++++|..+-.+...+++||.||..+. +|||||+||+|||++ +
T Consensus 153 IV~c~GyFi~n--~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e 227 (391)
T KOG0983|consen 153 IVQCFGYFITN--TDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-E 227 (391)
T ss_pred eeeeeeEEeeC--chHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-c
Confidence 99999999864 457788898853 34444443 467999999999999999999997654 599999999999998 7
Q ss_pred CCcEEEeccchhHHHhhhc---cCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHH
Q 035992 168 QGEVKIGDLGLAAILAQAR---SAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240 (613)
Q Consensus 168 ~g~VKL~DFGla~~l~~~~---~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I 240 (613)
.|+|||||||++.++.... ...|.+.|||||.+.. .|+.++||||||++++||+||.+||..|....+.+.+|
T Consensus 228 ~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv 307 (391)
T KOG0983|consen 228 RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV 307 (391)
T ss_pred CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH
Confidence 8999999999998875533 3456779999998753 49999999999999999999999999999888888888
Q ss_pred HcCCCCCcccc--cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 241 TSGIKPASLAK--VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 241 ~~g~~p~~l~~--~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+... +.++. .+++.+.+|+..||+ |+.+||...+||+|||+..-
T Consensus 308 ln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 308 LNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 88544 44432 379999999999999 99999999999999999764
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=318.60 Aligned_cols=262 Identities=30% Similarity=0.531 Sum_probs=215.1
Q ss_pred cccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeee
Q 035992 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSW 96 (613)
Q Consensus 17 ~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 96 (613)
++++.+-....|...+.||+|+||.||+|.+..++..||+|+++.... ..+.+..|+.+++.++|+||++++++|
T Consensus 10 ~~~~~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~ 84 (286)
T cd06614 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSY 84 (286)
T ss_pred hhcCCCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEE
Confidence 334444444555777999999999999999999999999998764321 556788999999999999999999988
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
... ..+++++||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|
T Consensus 85 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d 159 (286)
T cd06614 85 LVG--DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLAD 159 (286)
T ss_pred EEC--CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECc
Confidence 653 68999999999999999999877 8999999999999999999999988 99999999999998 678999999
Q ss_pred cchhHHHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 176 LGLAAILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 176 FGla~~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
||++...... ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...............+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd06614 160 FGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP 239 (286)
T ss_pred cchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcch
Confidence 9998765432 22345668999997764 489999999999999999999999976544433333333332222223
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
..++..+++||.+||+ +|.+||++.+++.||||....+
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 3367899999999999 9999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.06 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=203.8
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.+.||+|+||.||+|.+..+|+.||+|.++...... .......+..|+.+++.++|+||++++++|.. ...+++|
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 80 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNINLV 80 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEEEE
Confidence 56689999999999999999999999999987654321 12334567789999999999999999998865 5689999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+ +|+|..++.+.. .+++..++.++.||++||.|||+++ ++|+||||+|||++ .++.++|+|||++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCCC
Confidence 9999 899999998876 8999999999999999999999998 99999999999998 57899999999997664422
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-CC-------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-KP------------- 246 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-~p------------- 246 (613)
...++..|+|||.+.+ .++.++|||||||++|+|++|.+||....+... +.++.... .+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccccc
Confidence 1234567999997743 478999999999999999999877765444333 22322110 00
Q ss_pred ------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 ------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 ------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.......+..+.+||.+||. +|.+|||+.|++.||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 00112346789999999999 999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=324.06 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=201.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|+.||+|.++.... .......+.+|+.++++++|+||+++++++.......+++|
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE--RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC--CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 3677999999999999999999999999998875432 11222345679999999999999999999876665679999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+ +|..++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ +.+.+||+|||++.......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCCcc
Confidence 999975 78888775 367999999999999999999999998 99999999999998 67899999999987664321
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-C-------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-P------------- 246 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p------------- 246 (613)
...++..|+|||++.+ .++.++||||||+++|+|++|..||....... .+..+..... +
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhhcccc
Confidence 1223457999998753 48899999999999999999999997654443 3333322100 0
Q ss_pred -------Cc-c------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 -------AS-L------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 -------~~-l------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.. + ....++.+.+||.+||+ +|.+|||+.+++.||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 00 0 01247888999999999 99999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=346.16 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=194.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|++++|+||+++++++.. +...+++
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv 238 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLV 238 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEE
Confidence 4788999999999999999999999999885321 235679999999999999999998754 4578899
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|+++. ++|..++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..+...
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceeccccc
Confidence 99995 6888887654 57999999999999999999999998 99999999999998 5679999999999765322
Q ss_pred -----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC-------cHHHHHHHHHcCCCC-Cc---
Q 035992 186 -----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT-------NAAQIYKKVTSGIKP-AS--- 248 (613)
Q Consensus 186 -----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~-------~~~~i~~~I~~g~~p-~~--- 248 (613)
....++..|||||++.+ .++.++|||||||++|||++|..|+.... ...++.+.+...... ..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 12357889999998765 48999999999999999999887653321 133444444332110 00
Q ss_pred --------------------------cc--ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 249 --------------------------LA--KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 249 --------------------------l~--~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+. ...+..+.+||.+||+ ||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 1235678999999999 9999999999999999974
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=321.02 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=201.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||.|+||.||+|.+..++..+|+|.++..... ......+.+|+.++++++||||+++++++.......+++|
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc--ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 45679999999999999999999999999998754322 2233456789999999999999999999877655789999
Q ss_pred EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+ +|.+++.... .+++..++.++.||+.||+|||+++ ++|+||||+|||++ +.+.++|+|||++.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCc
Confidence 999975 8988887654 5999999999999999999999998 99999999999998 66899999999987654431
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC---------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--------------- 245 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--------------- 245 (613)
...++..|+|||.+.+ .++.++||||||+++|+|++|..||........+ .++.....
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhccch
Confidence 2234567999998754 3688999999999999999999999765543332 22211000
Q ss_pred --------------CCccccc-ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 246 --------------PASLAKV-ADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 246 --------------p~~l~~~-~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
...++.. .+..++++|.+||+ +|.+|||+.|+|.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0112222 47889999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.05 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=206.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||.||+|.+..++..||+|.++.... ........+.+|+.+++.++||||++++++|.. ...++++
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v 80 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNIV 80 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEEE
Confidence 4778999999999999999999999999998765332 234566778999999999999999999998865 4578999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceecc
Confidence 999999999988753 345899999999999999999999998 99999999999997 57899999999987654
Q ss_pred hh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC-cHHHHHHHHHcCCCCCcccccccHHH
Q 035992 184 QA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT-NAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 184 ~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.. ....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||.... +...+...+.....+.......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 32 23456678999997754 58899999999999999999999995433 34556666666555555555677889
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+++|.+||. +|.+||++.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999 99999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.11 Aligned_cols=236 Identities=24% Similarity=0.376 Sum_probs=193.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEeccC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFT 112 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~~~ 112 (613)
||+|+||.||++.++.++..+|+|.++...... .|+.....+ +||||++++++|.. ...+++||||++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e~~~ 92 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMDYIK 92 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEEcCC
Confidence 699999999999999999999998876432211 122222222 79999999998865 458999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccCcccc
Q 035992 113 SGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI 192 (613)
Q Consensus 113 gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~gt~ 192 (613)
+++|.+++.+.+.+++..++.++.||++||.|||+.+ ++||||||+||+++.+.+.++|+|||++..........++.
T Consensus 93 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 170 (267)
T PHA03390 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTL 170 (267)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCC
Confidence 9999999998889999999999999999999999998 99999999999998543489999999988766555556788
Q ss_pred cccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH----HHHHHHHcCCCCCcccccccHHHHHHHHHHhh-
Q 035992 193 EFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAA----QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA- 266 (613)
Q Consensus 193 ~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~----~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~- 266 (613)
.|+|||++.+ .++.++||||||+++|+|++|..||....... .+.... ..+....+..++.+.+||.+||+
T Consensus 171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~ 247 (267)
T PHA03390 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQSMLKY 247 (267)
T ss_pred cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCCcccccCHHHHHHHHHHhcc
Confidence 9999998764 58999999999999999999999997543221 222222 22334455788999999999999
Q ss_pred cccCCCC-HHHHhcCCCCCC
Q 035992 267 EVSERLP-AKELLGDPFLQS 285 (613)
Q Consensus 267 dP~~Rpt-a~eLL~HPff~~ 285 (613)
+|.+|++ ++++|+||||.+
T Consensus 248 ~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 248 NINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ChhhCCchHHHHhcCCcccC
Confidence 9999996 699999999973
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=317.63 Aligned_cols=249 Identities=26% Similarity=0.438 Sum_probs=204.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+.+|+++++.++|+||++++++|.. +..++++
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv 78 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE--DDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLV 78 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc--ccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEE
Confidence 377899999999999999999999999998876432 233455788999999999999999999998865 5679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|||+.++.+..+..+...+++..+..++.||+.||.|||.++ ++||||+|+||+++ +++.+||+|||++.......
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 79 FEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCcc
Confidence 999999888877777778999999999999999999999998 99999999999998 57899999999987765432
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc------------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS------------------ 242 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~------------------ 242 (613)
...++..|+|||++.. .++.++||||||+++|+|++|..||........+......
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 2234567999997653 5789999999999999999999999765554443322110
Q ss_pred -CCC------C----CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 243 -GIK------P----ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 243 -g~~------p----~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+.. + ..++...+..+++||.+||. +|.+||+++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000 0 01223347889999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=316.68 Aligned_cols=254 Identities=27% Similarity=0.513 Sum_probs=209.6
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
|+..+|..+ +.||+|++|.||+|.+..++..+|+|.++.. .....+.+.+|+.+++.++||||++++++|.. .
T Consensus 16 ~~~~~~~~~-~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~ 88 (285)
T cd06648 16 DPRSYLDNF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--G 88 (285)
T ss_pred cchHhhhcc-eEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEc--C
Confidence 444455443 8999999999999999999999999987532 23445668899999999999999999998764 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
...++++||+.+++|.+++.. +.+++..+..++.||+.||+|||+++ ++||||+|+||+++ .++.++|+|||++..
T Consensus 89 ~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~ 164 (285)
T cd06648 89 DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQ 164 (285)
T ss_pred CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchh
Confidence 578999999999999999888 67999999999999999999999998 99999999999998 678999999998875
Q ss_pred Hhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc-ccccccH
Q 035992 182 LAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-LAKVADN 255 (613)
Q Consensus 182 l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~-l~~~~s~ 255 (613)
.... ....++..|+|||.+.+ .++.++||||||+++|+|++|..||... +....+..+..+..+.. .....+.
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 165 VSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred hccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHhcCCCCCcccccCCH
Confidence 5332 12346678999998765 4889999999999999999999999663 44455555555532221 1223678
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+.+||.+||. +|.+||++.+++.||||+...
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 99999999999 999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=318.34 Aligned_cols=253 Identities=26% Similarity=0.485 Sum_probs=210.1
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
|.+.| ...+.||.|+||.||+|.+..++..||+|+++... .......+.+|+.+++.+.||||+++++++.. +.
T Consensus 2 ~~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06640 2 PEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GT 75 (277)
T ss_pred hHHhh-hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc---cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CC
Confidence 44555 34588999999999999999999999999876432 34566789999999999999999999998865 56
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++||||+.+|+|.+++.. +.+++..+..++.|++.||+|||+++ ++|+||+|+||+++ ..+.++|+|||++...
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQL 151 (277)
T ss_pred EEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceec
Confidence 89999999999999999875 56899999999999999999999998 99999999999998 6789999999998665
Q ss_pred hhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 183 AQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 183 ~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.... ...++..|+|||.+.. .++.++|+||||+++|||++|..||..... ......+..+. ++.+....+..+
T Consensus 152 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~ 229 (277)
T cd06640 152 TDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-MRVLFLIPKNN-PPTLTGEFSKPF 229 (277)
T ss_pred cCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-HhHhhhhhcCC-CCCCchhhhHHH
Confidence 4322 2235568999998754 488999999999999999999999976543 33333333332 334555677889
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+||.+||+ +|.+||++.+++.||||....
T Consensus 230 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 230 KEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 999999998 999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.42 Aligned_cols=259 Identities=27% Similarity=0.433 Sum_probs=207.5
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChH----------HHHHHHHHHHHHHhCCCCCcce
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE----------DLERLYSEVHLLKTLKHKNIIK 91 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~----------~~~~l~~Ei~iLk~L~HpNIVk 91 (613)
+...||..+.+.||+|+||+||+|.+..+|+.||+|+++......... ....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 457799888899999999999999999999999999887543222110 1125778999999999999999
Q ss_pred eeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcE
Q 035992 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171 (613)
Q Consensus 92 l~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~V 171 (613)
++++|.. ...++++|||+. |+|.+++.....+++..+..++.||+.||.|||+++ ++||||+|+||+++ ..+.+
T Consensus 85 ~~~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~ 158 (335)
T PTZ00024 85 LVDVYVE--GDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGIC 158 (335)
T ss_pred eeEEEec--CCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCE
Confidence 9998854 457999999997 599999988888999999999999999999999998 99999999999998 67899
Q ss_pred EEeccchhHHHhhh------------------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCC
Q 035992 172 KIGDLGLAAILAQA------------------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECT 231 (613)
Q Consensus 172 KL~DFGla~~l~~~------------------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~ 231 (613)
+|+|||++...... ....++..|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999998765410 01123557999997754 37899999999999999999999997655
Q ss_pred cHHHHHHHHHcCC---C--------------------CCc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 232 NAAQIYKKVTSGI---K--------------------PAS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 232 ~~~~i~~~I~~g~---~--------------------p~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+...+ ..+.... . +.. .....+..+.+||.+||. +|.+||+++++|.||||+
T Consensus 239 ~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~ 317 (335)
T PTZ00024 239 EIDQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317 (335)
T ss_pred HHHHH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccC
Confidence 44333 2222100 0 000 012346788999999999 999999999999999998
Q ss_pred CCC
Q 035992 285 SED 287 (613)
Q Consensus 285 ~~~ 287 (613)
...
T Consensus 318 ~~~ 320 (335)
T PTZ00024 318 SDP 320 (335)
T ss_pred CCC
Confidence 653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.26 Aligned_cols=243 Identities=20% Similarity=0.344 Sum_probs=199.9
Q ss_pred ceeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
-+++.++||+|+||.||+|.++ ..+..||+|.++.. ........+.+|+.+++.++||||+++++++.. +..
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR--GNT 80 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec--CCC
Confidence 3588899999999999999765 45678998877642 234556778999999999999999999998754 567
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++||||+.+|+|.+++.+. +.+++..+..++.||+.||+|||+++ ++||||||+|||++ .++.++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcccccc
Confidence 99999999999999999875 57899999999999999999999998 99999999999998 5689999999987543
Q ss_pred hhhc-----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 183 AQAR-----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 183 ~~~~-----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.... ...++..|+|||.+. ..++.++|||||||++|||++ |..||... ....+.+.+..+..++ .+..++.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 235 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRLP-APRNCPN 235 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCCC-CCCCCCH
Confidence 2211 122345799999775 458999999999999999775 99999764 4445566666664433 4556788
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+.+++.+||+ +|.+||++.+|++
T Consensus 236 ~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 236 LLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.42 Aligned_cols=246 Identities=27% Similarity=0.504 Sum_probs=203.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
...||+|+||.||++.+..++..||+|.+... .....+.+.+|+.+++.++||||+++++.+.. ....+++|||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e~ 100 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVMEF 100 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEeC
Confidence 47799999999999999999999999987542 23456678899999999999999999998754 4578999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----c
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----R 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 186 (613)
+.+++|..++.. +.+++..+..++.||+.||.|||+++ ++||||||+||+++ +++.++|+|||++...... .
T Consensus 101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCc
Confidence 999999998855 56899999999999999999999998 99999999999998 5689999999998754322 1
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC-cccccccHHHHHHHHHH
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA-SLAKVADNGVRAFIEKC 264 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~l~~lI~~c 264 (613)
...++..|+|||.+.. .++.++||||||+++|||++|..||.... ....+..+.....+. ......+..+++||.+|
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 2345678999998765 58899999999999999999999997643 334444444332221 12234678899999999
Q ss_pred hh-cccCCCCHHHHhcCCCCCCCC
Q 035992 265 IA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
|. +|.+|||+++++.||||+...
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccC
Confidence 98 999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.05 Aligned_cols=257 Identities=30% Similarity=0.517 Sum_probs=209.8
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
-++.++| ++.+.||+|+||+||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||++++++|..
T Consensus 15 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-- 87 (293)
T cd06647 15 GDPKKKY-TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLV-- 87 (293)
T ss_pred cCchhhc-eeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeee--
Confidence 4555666 66799999999999999999999999999875322 2345678899999999999999999998865
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
....|+|+||+.+++|.+++.+. .+++..+..++.|++.||.|||+++ ++||||||+||+++ ..+.++|+|||++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~ 163 (293)
T cd06647 88 GDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCA 163 (293)
T ss_pred CCcEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCccee
Confidence 45789999999999999998764 5889999999999999999999998 99999999999998 56899999999886
Q ss_pred HHhhhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 181 ILAQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 181 ~l~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
...... ...+++.|+|||.+.. .++.++|+||||+++|+|++|..||........+......+......+...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSA 243 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCH
Confidence 554321 2245668999997754 58899999999999999999999997655444433222222222223344677
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+++||.+||. +|.+||++.+++.||||+....
T Consensus 244 ~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 89999999998 9999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.09 Aligned_cols=245 Identities=27% Similarity=0.387 Sum_probs=192.7
Q ss_pred CCcceeEeeeecccCceEEEEEEEcC----------------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDEL----------------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~----------------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp 87 (613)
.++| ++.++||+|+||.||+|.+.. ++..||+|+++.. ........+.+|+.+|++++||
T Consensus 4 ~~~~-~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 4 RGHL-LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred hhhC-eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHHHHHHHHHHhhcCCC
Confidence 3455 788999999999999997532 3457998877632 2345567789999999999999
Q ss_pred CcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHhhhhhcC
Q 035992 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-------------------HVDLRALKKWSRQILEGLSYLHSH 148 (613)
Q Consensus 88 NIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~-------------------~lse~~i~~i~~QIl~gL~yLHs~ 148 (613)
||++++++|.. ...++++|||+.+|+|.+++.... .+++..+..++.||+.||.|||++
T Consensus 80 niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 80 NIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 99999998865 356899999999999999986532 367788999999999999999999
Q ss_pred CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHH
Q 035992 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELV 221 (613)
Q Consensus 149 ~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Eml 221 (613)
+ |+||||||+|||++ ..+.+||+|||++..+.... ...++..|||||++. +.++.++||||||+++|||+
T Consensus 158 ~--ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 N--FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred C--ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 8 99999999999998 56899999999987653321 223356899999765 45899999999999999998
Q ss_pred h--cCCCCCCCCcHHHHHHHHHc----C--CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 222 T--FEYPYVECTNAAQIYKKVTS----G--IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 222 t--G~~Pf~~~~~~~~i~~~I~~----g--~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
+ +..||...... ++...+.. . ......+..++..+.+||.+||. +|.+|||+.+|.
T Consensus 235 ~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 235 MLCKEQPYGELTDE-QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred HccCCCCCCcCCHH-HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 7 56788765433 33322211 1 11112233567889999999999 999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.42 Aligned_cols=256 Identities=26% Similarity=0.400 Sum_probs=203.6
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
++.+|| ++.+.||.|+||+||+|.++.+|..||+|.+...+ ....+.+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~y-~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~ 76 (342)
T cd07854 2 DLGSRY-MDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGS 76 (342)
T ss_pred CcCcce-EEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccc
Confidence 456777 67899999999999999999999999999876543 2455778899999999999999999987644321
Q ss_pred ------------CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 102 ------------EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 102 ------------~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
..++++|||+. ++|..++.. +.+++..++.++.||+.||.|||+++ ++||||||+||+++..++
T Consensus 77 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~ 152 (342)
T cd07854 77 DLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCc
Confidence 35789999997 589888764 56999999999999999999999998 999999999999986667
Q ss_pred cEEEeccchhHHHhhhc-------cCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHH
Q 035992 170 EVKIGDLGLAAILAQAR-------SAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~~-------~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I 240 (613)
.+||+|||++..+.... ...++..|+|||.+. ..++.++|||||||++|+|++|..||............+
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 89999999987653211 123456899999764 348889999999999999999999997655433332222
Q ss_pred HcC-----------------------CCC----CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 241 TSG-----------------------IKP----ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 241 ~~g-----------------------~~p----~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
... ..+ ..+....+.++.+||.+||+ +|.+|||+.++|.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 110 000 00112357789999999999 99999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.31 Aligned_cols=279 Identities=20% Similarity=0.331 Sum_probs=234.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
+.||-|+||.|.++....|...+|+|.+.+.+++. ..++.....|..||..-+.+.||++|-+|.+ ...+||||+|+
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-rnQvaHVKAERDILAEADn~WVVrLyySFQD--kdnLYFVMdYI 711 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-RNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFVMDYI 711 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHh-hhhhhhhhhhhhhHhhcCCcceEEEEEEecc--CCceEEEEecc
Confidence 78999999999999999999999999988777654 4677889999999999999999999999965 56799999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh--------
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-------- 183 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~-------- 183 (613)
+||++..++.+-+.|.|..++.++.++..|+++.|..| +|||||||+||||+ .+|+|||.||||++-+.
T Consensus 712 PGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred CCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccc
Confidence 99999999999999999999999999999999999998 99999999999998 78999999999986431
Q ss_pred --------------------------------------hhccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcC
Q 035992 184 --------------------------------------QARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFE 224 (613)
Q Consensus 184 --------------------------------------~~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~ 224 (613)
......||..|+|||++. .+|+..+|+||.|||||||+.|+
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~ 868 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ 868 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence 011234677899999876 56999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHHHHHHHHhhcccCCCC---HHHHhcCCCCCCCCcccc---ccccc
Q 035992 225 YPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRAFIEKCIAEVSERLP---AKELLGDPFLQSEDDESV---GRSLR 296 (613)
Q Consensus 225 ~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~~lI~~cL~dP~~Rpt---a~eLL~HPff~~~~~~~~---~~~~~ 296 (613)
.||...+..+..++.+. ... .......+++++.++|.+++..++.|+. +.++..||||+.+++.++ ..+.+
T Consensus 869 ~pf~~~tp~~tq~kv~n-w~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYI 947 (1034)
T KOG0608|consen 869 PPFLADTPGETQYKVIN-WRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYI 947 (1034)
T ss_pred CCccCCCCCcceeeeee-hhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcC
Confidence 99988766665554332 221 1223345789999999999888888885 788999999999987554 45677
Q ss_pred ccccCCccccccccCCccccC
Q 035992 297 VKTHYSAETSHQANLDKNAYG 317 (613)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~ 317 (613)
++..++.+++.++..+.+...
T Consensus 948 P~ItHptDTSNFdpvdpeklw 968 (1034)
T KOG0608|consen 948 PRITHPTDTSNFDPVDPEKLW 968 (1034)
T ss_pred ccccCCCccccCCcCCccccc
Confidence 788888888888777665443
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.33 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=198.1
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCC---CEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTEN---EHI 104 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~---~~l 104 (613)
++.+.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.+++.+. ||||+++++++..... ..+
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM--DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc--cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 67799999999999999999999999999876432 12223456788999999995 6999999998765332 248
Q ss_pred EEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 105 NFITEIFTSGTLRQYRKKH-----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+++|||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++.+.+.+||+|||++
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccc
Confidence 999999986 788887543 35899999999999999999999998 9999999999999854789999999998
Q ss_pred HHHhhh----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-------
Q 035992 180 AILAQA----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP------- 246 (613)
Q Consensus 180 ~~l~~~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p------- 246 (613)
..+... ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||........+...+..-..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 754321 11234568999997753 47899999999999999999999997755555443322110000
Q ss_pred ---------------C---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 247 ---------------A---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 247 ---------------~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
. ......+..+.+||.+||. +|.+||++.+++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 0112357889999999999 999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=354.31 Aligned_cols=244 Identities=24% Similarity=0.391 Sum_probs=201.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeee-ecC---C-
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSW-VDT---E- 100 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~f-v~~---~- 100 (613)
-.++.++|-+|||+.||+|.+...|..||+|.+... +...++.+.+||.+|+.|+ |+|||.|+++. ... .
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 347789999999999999999999899998876543 5788899999999999997 99999999942 211 1
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+.++||||.||.|-+++... ..|++.+|.+|+.|+++|+.+||...|||||||||-+||||+ .+|+.||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccc
Confidence 25688999999999999998743 569999999999999999999999999999999999999998 678999999998
Q ss_pred hHHH-------------hhhccCcccccccCccccc---c-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH
Q 035992 179 AAIL-------------AQARSAHSVIEFMAPELYE---E-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 179 a~~l-------------~~~~~~~gt~~YmAPEvl~---~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~ 241 (613)
++-. ...-...+|+.|.|||++. + ..++|+|||+|||+||-|+.+..||.+.... .|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEE
Confidence 8632 1122456788999999764 3 4899999999999999999999999653221 234
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+.........++..+++||+.||+ +|.+||++.+++.+
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 4433222234678899999999999 99999999888654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=309.44 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=205.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++|+||+++++.+.. ...++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheecc--CCeEEEE
Confidence 3677999999999999999999999999998765432 22345678899999999999999999998744 5689999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+||+.+++|.+++.+.. .+++..+..|+.||+.||.|||+++ ++|+||||+||+++.+...++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999999987654 4799999999999999999999998 9999999999999855456799999999876542
Q ss_pred c----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 R----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
. ...+++.|+|||.+.. .++.++|+||||+++|+|++|..||.... .......+..+..+ ......+..++++
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQGYFA-PISPNFSRDLRSL 233 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcccCC-CCCCCCCHHHHHH
Confidence 2 2345668999997754 58899999999999999999999996544 34444444444333 2334567889999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||. +|.+|||+.++++||||
T Consensus 234 i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 234 ISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHhccChhhCcCHHHHhhCCCC
Confidence 999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=303.17 Aligned_cols=245 Identities=31% Similarity=0.556 Sum_probs=205.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||+|++|.||+|.+..++..+++|.+..... .....+.+|+.+++.++|+||+++++++.. ....+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l~ 75 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KDELWIV 75 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEE
Confidence 4677999999999999999999999999888764322 466788999999999999999999998755 4678999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
+||+.+++|.+++... +.+++..+..++.|++.||.|||.++ ++||||+|+||+++ +.+.++|+|||.+......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccc
Confidence 9999999999998876 68999999999999999999999988 99999999999998 5789999999998876543
Q ss_pred --ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc-cccccHHHHHHH
Q 035992 186 --RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL-AKVADNGVRAFI 261 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l-~~~~s~~l~~lI 261 (613)
....++..|+|||.+.. .++.++|+||||+++|+|++|..||........+..... ...+... ...++..+.+||
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i 231 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL 231 (253)
T ss_pred cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence 23456678999998764 478899999999999999999999976544444433332 2222221 222378899999
Q ss_pred HHHhh-cccCCCCHHHHhcCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPf 282 (613)
.+||+ +|.+|||+.+++.|||
T Consensus 232 ~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 232 KKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHccCChhhCCCHHHHhcCCC
Confidence 99999 9999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=314.61 Aligned_cols=247 Identities=22% Similarity=0.334 Sum_probs=196.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||.||+|.+..++..||+|.++... .. .......+|+.+++++. |+||+++++++.+.....+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~--~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF--KS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhcc--CC-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence 467899999999999999999999999999876432 11 22234457899999885 999999999987765578999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||||+.+ +|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++. +.+||+|||++..+...
T Consensus 78 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 78 VFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD--DILKLADFGSCRGIYSK 152 (282)
T ss_pred EEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC--CCeEEEecccccccccC
Confidence 9999975 77777765 457999999999999999999999998 999999999999984 89999999999766432
Q ss_pred c---cCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC--C--------------
Q 035992 186 R---SAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--I-------------- 244 (613)
Q Consensus 186 ~---~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g--~-------------- 244 (613)
. ...++..|+|||.+. +.++.++|||||||++|||++|..||......+ ....+... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 223566899999653 347889999999999999999999996644322 22222110 0
Q ss_pred ----CCC-------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 245 ----KPA-------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 245 ----~p~-------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+. .+....+..+++||.+||. +|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000 0112357899999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=304.95 Aligned_cols=247 Identities=29% Similarity=0.514 Sum_probs=210.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..++..||+|.+..... .......+..|+++++.++|||++++++.+.. ...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~~~~lv 77 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEE--KGKLCIV 77 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEec--CCEEEEE
Confidence 3677999999999999999999999999998765332 34666788999999999999999999998865 3689999
Q ss_pred EeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+|++.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++ +.+.++|+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecc
Confidence 9999999999998764 77999999999999999999999998 99999999999998 56899999999987654
Q ss_pred hhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 184 QAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 184 ~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
... ...+++.|+|||.+.. .++.++|+||||+++|+|++|..||... +...+...+.... ...++...+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~ 232 (258)
T cd08215 155 STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSELR 232 (258)
T ss_pred cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHHHH
Confidence 432 2345668999997654 4889999999999999999999999654 4556666665543 3344557788999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
++|.+||. +|.+||++.++|.||||
T Consensus 233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 233 NLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 99999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.41 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=206.2
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
+++.....||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.+++.++||||++++++|.. +..++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~ 94 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELW 94 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEE
Confidence 44445578999999999999999999999999876432 2334668899999999999999999998754 46799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+++||+.+++|..++.. ..+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||++......
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccc
Confidence 99999999999987765 56899999999999999999999998 99999999999998 6789999999998755432
Q ss_pred ----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-CcccccccHHHHH
Q 035992 186 ----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-ASLAKVADNGVRA 259 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~~l~~ 259 (613)
....++..|+|||++.+ .++.++|||||||++|||++|..||.... .......+.....+ .......+..+.+
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 249 (297)
T cd06659 171 VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNAHKISPVLRD 249 (297)
T ss_pred cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCCCccccCCCCHHHHH
Confidence 22346678999998764 58899999999999999999999997544 33444444433221 1223346788999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
||.+||+ +|.+||++.+++.||||.+..
T Consensus 250 ~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 250 FLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 9999999 999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.43 Aligned_cols=248 Identities=24% Similarity=0.429 Sum_probs=198.6
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEEE
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
..+.||+|+||+||++.+..+|+.||+|.+.... .......+..|+.++.++. ||||+++++++.. ....+++|
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~~ 82 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWICM 82 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc---ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEEE
Confidence 3478999999999999999999999999876433 2355677889999999996 9999999998765 45678899
Q ss_pred eccCCCCHHHH---H--HhCCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 109 EIFTSGTLRQY---R--KKHKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 109 E~~~gGsL~~~---l--~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
||+.. ++.++ + ...+.+++..+..++.|++.||+|||+. + ++||||||+||+++ ..+.++|+|||++..+
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQL 158 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHh
Confidence 99864 55443 2 2346799999999999999999999975 6 99999999999998 5689999999999766
Q ss_pred hhh---ccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc---ccc
Q 035992 183 AQA---RSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL---AKV 252 (613)
Q Consensus 183 ~~~---~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~ 252 (613)
... ....++..|+|||++.. .++.++|||||||++|+|++|..||............+..+..+... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence 432 22346678999998754 48899999999999999999999997655333333333333322211 123
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+..+.+||.+||+ +|.+|||+.+++.||||+..
T Consensus 239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 67889999999999 99999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=313.56 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=199.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||.|++|+||+|.+..+|..||+|+++.... ......+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 76 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLV 76 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEE
Confidence 3677999999999999999999999999998875432 2334567789999999999999999999865 4568999
Q ss_pred EeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 108 TEIFTSGTLRQYRKKH---KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|||+.+ +|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ +++.++|+|||++.....
T Consensus 77 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 77 FEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGI 152 (284)
T ss_pred EecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcC
Confidence 999985 888887654 36899999999999999999999998 99999999999998 678999999999976543
Q ss_pred h----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC------------
Q 035992 185 A----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP------------ 246 (613)
Q Consensus 185 ~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p------------ 246 (613)
. ....++..|+|||.+.+ .++.++||||||+++|+|++|..||......+...+.+.....|
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc
Confidence 2 12334668999997644 47889999999999999999999997755444333222111000
Q ss_pred --------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 --------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 --------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+....+..++++|.+||+ +|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00112346788999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=315.02 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=202.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCC-----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG-----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg-----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+++.+.||+|+||.||+|.+...+ ..||+|.++.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 81 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK--EQ 81 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC--CC
Confidence 367799999999999999876655 67888876532 234556778999999999999999999998754 45
Q ss_pred EEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC
Q 035992 103 HINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~ 166 (613)
..+++|||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~- 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG- 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-
Confidence 789999999999999999765 45888999999999999999999998 99999999999998
Q ss_pred CCCcEEEeccchhHHHhhh------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHH
Q 035992 167 NQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYK 238 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~ 238 (613)
+++.++|+|||++...... ....+++.|||||.+. ..++.++|||||||++|||++ |..||.+. ...++..
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~-~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF-SNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHH
Confidence 6789999999998754321 1223456899999765 458999999999999999998 99999764 4566777
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+..+..+. .+..++..+.+++.+||+ +|.+||++.+++++
T Consensus 238 ~i~~~~~~~-~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcCC-CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777665443 445678999999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=316.57 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=195.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|..||+|.++.... ......+.+|+.+++.++|+||+++++++.. +...++|
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv 81 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTFV 81 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEEE
Confidence 4778999999999999999999999999998864321 2223456789999999999999999998754 4578999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+. ++|..++.. ...+++..++.++.||+.||.|||+++ |+|+||||+|||++ .++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPS 157 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCCCC
Confidence 99996 577666554 456889999999999999999999998 99999999999997 6789999999998754321
Q ss_pred ---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC----------------
Q 035992 186 ---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---------------- 244 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---------------- 244 (613)
....++..|+|||.+.+ .++.++||||||+++|+|++|..||....+.......+....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 12235668999998754 478899999999999999999999976554433333321100
Q ss_pred -C--------CCccc-----ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 245 -K--------PASLA-----KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 245 -~--------p~~l~-----~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. +..+. ...+..+.+++.+||. +|.+|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00000 0125688999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=315.30 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=196.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.. +...++|
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 81 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE---EGAPFTAIREASLLKDLKHANIVTLHDIIHT--KKTLTLV 81 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc---cCCchhHHHHHHHHhhCCCcceeeEEEEEec--CCeEEEE
Confidence 4677999999999999999999999999998875321 1222346689999999999999999998753 5689999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+ +|.+++.+. ..+++..++.++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPS 157 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCCCC
Confidence 999985 899988764 46899999999999999999999998 99999999999998 5689999999998654321
Q ss_pred ---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---C------------
Q 035992 186 ---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---K------------ 245 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---~------------ 245 (613)
....++..|+|||++.+ .++.++||||||+++|+|++|..||............+.... .
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 11234568999997753 488999999999999999999999976553333322221100 0
Q ss_pred ----------CCcc---ccccc--HHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 246 ----------PASL---AKVAD--NGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 246 ----------p~~l---~~~~s--~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+..+ ....+ ..+.++|.+||+ +|.+|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 01123 778899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=315.73 Aligned_cols=256 Identities=21% Similarity=0.366 Sum_probs=210.7
Q ss_pred eeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||.|+||.||+|.+. .+|..||+|+++...........+++..|+.+++.+ +|+||++++++|.. +..
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~~ 79 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DTK 79 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CCe
Confidence 467899999999999999875 488999999987544433445567788999999999 59999999998754 467
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++||||+.+++|.+++...+.+++..+..++.||+.||.|||+++ ++||||+|+|||++ .++.+||+|||++....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecc
Confidence 8999999999999999998888999999999999999999999998 99999999999998 57899999999987653
Q ss_pred hhc-----cCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCC---cHHHHHHHHHcCCCCCccccc
Q 035992 184 QAR-----SAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECT---NAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 184 ~~~-----~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~ 252 (613)
... ...++..|+|||.+.. .++.++||||||+++|+|++|..||.... ....+...+..... .++..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQE 234 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCcc
Confidence 321 2345678999998753 47889999999999999999999995322 22333344433322 23456
Q ss_pred ccHHHHHHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 253 ADNGVRAFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
.+..+.+++.+||+ +|.+|+ ++.+++.||||+...++.
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 78899999999999 999997 799999999999887644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=320.12 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=213.2
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
...++..+| ...+.||+|+||+||+|.+..+|..||+|.+..... ........+..|+.+++.++|||++++++++.+
T Consensus 15 ~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 92 (313)
T cd06633 15 YKDDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK 92 (313)
T ss_pred ccCCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 456666676 345789999999999999999999999998764332 234556778899999999999999999998865
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 99 TENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
....|++|||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||
T Consensus 93 --~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg 166 (313)
T cd06633 93 --EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFG 166 (313)
T ss_pred --CCEEEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecC
Confidence 4578999999964 67766654 467999999999999999999999998 99999999999997 56899999999
Q ss_pred hhHHHhhhccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 178 LAAILAQARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 178 la~~l~~~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
++..........++..|+|||++. +.++.++||||||+++|+|++|..||........++.. .....+......+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (313)
T cd06633 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNDSPTLQSNEW 245 (313)
T ss_pred CCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HhcCCCCCCcccc
Confidence 987654444556777899999863 34888999999999999999999999776555555443 3333343344456
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..+++||.+||+ +|.+||++.+++.||||+...
T Consensus 246 ~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 246 TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 7789999999999 999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=313.93 Aligned_cols=241 Identities=29% Similarity=0.555 Sum_probs=196.0
Q ss_pred eEeeeecccCceEEEEEEEc----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDE----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
.+.+.||.|+||.||+|... ..+..|++|.++. .......+.+.+|++.+++++||||+++++++.. ...+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP---SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST---TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc---ccccccceeeeecccccccccccccccccccccc--cccc
Confidence 45789999999999999887 4567889887642 3345568899999999999999999999999873 3458
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
++||||+.+|+|.+++... ..+++..+..|+.||+.||.|||+++ ++|++|+++|||++ .++.+||+|||++...
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEET
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccc-cccccccccccccccc
Confidence 9999999999999999987 78999999999999999999999998 99999999999999 5679999999999766
Q ss_pred hh------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 183 AQ------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 183 ~~------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.. .........|+|||.+.. .++.++||||||+++|||++ |..||.+. +...+...+..+..+. .+..++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 231 (259)
T PF07714_consen 154 SEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRLP-IPDNCP 231 (259)
T ss_dssp TTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEETT-SBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccce-eccchh
Confidence 21 112234458999998765 48999999999999999999 78999775 6667777776665433 455678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+.++|.+||. +|.+||++.+|++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 899999999998 9999999999974
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.43 Aligned_cols=243 Identities=28% Similarity=0.441 Sum_probs=197.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCC-----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG-----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg-----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 101 (613)
+.+.++||+|+||.||+|.+...| ..||+|.++... .......+.+|+.+++.+ +|+||++++++|.. .
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~ 114 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIVNLLGACTH--G 114 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--C
Confidence 467899999999999999865443 579988876432 344567789999999999 89999999998854 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhC----------------------------------------------------------
Q 035992 102 EHINFITEIFTSGTLRQYRKKH---------------------------------------------------------- 123 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~---------------------------------------------------------- 123 (613)
..+++||||+.+|+|.+++.+.
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 5789999999999999988643
Q ss_pred ------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-----
Q 035992 124 ------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR----- 186 (613)
Q Consensus 124 ------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----- 186 (613)
..+++..++.++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++..+....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeec
Confidence 24788899999999999999999998 99999999999998 67899999999987653321
Q ss_pred -cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 187 -SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 187 -~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
...++..|||||++. ..|+.++|||||||++|||++ |..||........++..+..+..+ ..+...++++.++|.+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 350 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM-SRPDFAPPEIYSIMKM 350 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc-cCCCCCCHHHHHHHHH
Confidence 112334799999775 459999999999999999997 999997755545555555544332 3444568899999999
Q ss_pred Hhh-cccCCCCHHHHhc
Q 035992 264 CIA-EVSERLPAKELLG 279 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~ 279 (613)
||+ +|.+||++.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=316.47 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=200.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.++||+|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||++++++|. ....+++||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 79 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLVF 79 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEEE
Confidence 677999999999999999999999999998764322 2234566888999999999999999999874 356899999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc--
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 186 (613)
||+.+++|..+......+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++..+....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccc
Confidence 99999999988877777999999999999999999999998 99999999999998 57899999999987654322
Q ss_pred --cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-------------------C
Q 035992 187 --SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-------------------G 243 (613)
Q Consensus 187 --~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-------------------g 243 (613)
...++..|+|||++.+ .++.++||||||+++|||++|..||............... +
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 1234568999997753 3788999999999999999999999654433322221110 0
Q ss_pred C-CCC--------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 244 I-KPA--------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 244 ~-~p~--------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. .+. .....++..+.+||.+||. +|.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 000 0012346789999999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.87 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=212.2
Q ss_pred eeEe-eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEE
Q 035992 28 GRYK-EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~-e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~ 105 (613)
|++. ++||+|+|+.|..+....+|.++|+|+|.+. ......++.+|++++.+++ |+||+.++++|.+ +..+|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FY 152 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFY 152 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEE
Confidence 4443 8899999999999999999999998887653 2456789999999999995 9999999998854 56799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC--CcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~--g~VKL~DFGla~~l~ 183 (613)
+|||-|.||.|...|.++++|+|..+..+++.|+.||.|||.+| |.||||||+|||....+ .-||||||.+..-..
T Consensus 153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccc
Confidence 99999999999999999999999999999999999999999999 99999999999996332 247999999986543
Q ss_pred hh-----------ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCC--------------c
Q 035992 184 QA-----------RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECT--------------N 232 (613)
Q Consensus 184 ~~-----------~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~--------------~ 232 (613)
.. .+..|+.+|||||+.. ..|+.+.|.|||||++|-|++|.+||.+.- -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 21 1234555899999653 248999999999999999999999995421 1
Q ss_pred HHHHHHHHHcCCC--CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 233 AAQIYKKVTSGIK--PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 233 ~~~i~~~I~~g~~--p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
...+++.|..|.. |..-+..++.+.+++|+.+|. ++.+|.++.++++|||++....
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 3456777888763 444455678999999999998 9999999999999999998643
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=307.01 Aligned_cols=243 Identities=27% Similarity=0.437 Sum_probs=205.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||.|+||.||++.+..+++.+|+|.++... .....+.+..|+.+++.++||||++++++|.. ...++++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 76 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DGHLYIV 76 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEE
Confidence 367899999999999999999999999999876432 34556788899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+++|+|.+++... ..+++..++.|+.||+.||.|||+++ ++|+||||+||+++ ..+.++|+|||++..+...
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeeccc
Confidence 9999999999988653 45899999999999999999999998 99999999999997 6789999999998765432
Q ss_pred c----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 R----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
. ...++..|+|||++.. .++.++|+||||+++|+|++|..||.. .+.......+..+..+ .++...+..+++|
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 231 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSL 231 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHH
Confidence 1 2345668999998765 488999999999999999999999965 4455555666655433 2345678889999
Q ss_pred HHHHhh-cccCCCCHHHHhcC
Q 035992 261 IEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~H 280 (613)
|.+||+ +|.+||++.+++.-
T Consensus 232 i~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 232 IKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHhCCcccCCCHHHHhhc
Confidence 999999 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.95 Aligned_cols=247 Identities=32% Similarity=0.527 Sum_probs=210.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.++++++|||++++++++.. ...++++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYII 77 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEE
Confidence 3677999999999999999999999999998875432 23567889999999999999999999998754 4679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|||+.+++|.+++.+.+.+++..+..++.|++.||.|||+++ ++||||+|+||+++ ..+.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCcc
Confidence 999999999999998889999999999999999999999998 99999999999998 57899999999998665432
Q ss_pred ---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 187 ---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
...++..|+|||.+.. .++.++||||||+++|+|++|..||..........+ +..... ..++...+..++++|.
T Consensus 155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~i~ 232 (254)
T cd06627 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFR-IVQDDH-PPLPEGISPELKDFLM 232 (254)
T ss_pred cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HhccCC-CCCCCCCCHHHHHHHH
Confidence 2345668999997654 478899999999999999999999976554444433 333322 2355667889999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCC
Q 035992 263 KCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff 283 (613)
+||. +|.+||++.+++.||||
T Consensus 233 ~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 233 QCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHhCChhhCcCHHHHhcCCCC
Confidence 9998 99999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.82 Aligned_cols=249 Identities=32% Similarity=0.514 Sum_probs=205.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK---HKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~l 104 (613)
|++.+.||+|+||.||+|.+..+|..||+|.++.. ........+.+|+.+++.++ |||+++++++|.. +...
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~ 77 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD---TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRL 77 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC---CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEE
Confidence 46678999999999999999999999999887642 23345667889999999996 9999999998754 5578
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+++|||+.+++|.+++.. +.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ ..+.++|+|||++..+..
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 78 WIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCC
Confidence 999999999999999876 47999999999999999999999998 99999999999998 578999999999876543
Q ss_pred hc----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccc-cccHHH
Q 035992 185 AR----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK-VADNGV 257 (613)
Q Consensus 185 ~~----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~-~~s~~l 257 (613)
.. ...++..|+|||.+.. .++.++|+||||+++|+|++|..||....... ....+... .++.+.. ..+.++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~ 231 (277)
T cd06917 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-AMMLIPKS-KPPRLEDNGYSKLL 231 (277)
T ss_pred CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-hhhccccC-CCCCCCcccCCHHH
Confidence 22 2345668999997754 37889999999999999999999996644332 22222222 2233333 377899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+||.+||+ +|.+||++.+++.||||+...
T Consensus 232 ~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 232 REFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 999999998 999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=314.04 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=198.6
Q ss_pred CCcceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
.+||+++.+.||+|+||+||++. ...++..||+|.++... .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 36899999999999999998764 34578899998876432 234556788999999999999999999988766
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
....++++|||+.+|+|.+++.+. .+++..++.++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~ 154 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLA 154 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccc
Confidence 666799999999999999999774 5999999999999999999999998 99999999999998 5689999999998
Q ss_pred HHHhhhc-------cCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHH--------------HHH
Q 035992 180 AILAQAR-------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAA--------------QIY 237 (613)
Q Consensus 180 ~~l~~~~-------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~--------------~i~ 237 (613)
..+.... ...++..|+|||.+. ..++.++||||||+++|||+||..||....... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 7654321 122345799999775 458999999999999999999999985433211 111
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+.. ...+...+..+.+++.+||+ +|++||++++++.
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111211 12244567899999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.68 Aligned_cols=239 Identities=31% Similarity=0.503 Sum_probs=206.4
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||+|.||+||+|++- ..||||++++... .++..+.|++|+.++++-+|.||+-|.+++... .+.||+
T Consensus 395 ~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p---~~AIiT 466 (678)
T KOG0193|consen 395 LLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP---PLAIIT 466 (678)
T ss_pred hccceeccccccceeecccc---cceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC---ceeeee
Confidence 56799999999999999875 4699999887654 567899999999999999999999999987532 358999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 109 EIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 109 E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
.+|.|.+|..++.-. .+|+....+.|++||++|+.|||.++ |||||||..|||+. +++.|||+|||++..-..
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeecc
Confidence 999999999988644 57999999999999999999999999 99999999999997 668999999999975432
Q ss_pred ---hccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc---ccccc
Q 035992 185 ---ARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL---AKVAD 254 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~~~~s 254 (613)
.....+.+.|||||++. ..|++.+||||||+++|||+||..||. ..+.+++...+..|...+.+ ...+.
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCH
Confidence 22445667899999775 249999999999999999999999998 78999999899999544333 34466
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.++++|+..||. ++.+||.+.+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 799999999999 9999999999885
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=318.99 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=196.3
Q ss_pred eEeeeecccCceEEEEEEEcC--CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDEL--EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~--tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
++.+.||+|+||.||+|.+.. ++..||+|.++.... ........+.+|+.+++.++||||++++++|.+.....+++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 677899999999999999988 899999998875321 22233466788999999999999999999998765578999
Q ss_pred EEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC---CCCcEEEeccch
Q 035992 107 ITEIFTSGTLRQYRKKH-----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGL 178 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~-----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~---~~g~VKL~DFGl 178 (613)
||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ ++||||||+||+++. ..+.+||+|||+
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 9999975 676665432 36899999999999999999999998 999999999999983 168999999999
Q ss_pred hHHHhhhc-------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH--------HHHHHHH
Q 035992 179 AAILAQAR-------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAA--------QIYKKVT 241 (613)
Q Consensus 179 a~~l~~~~-------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~--------~i~~~I~ 241 (613)
+..+.... ...++..|+|||++.+ .++.++||||||+++|+|++|..||....... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 88654321 2234568999997654 48899999999999999999999996433211 0000000
Q ss_pred c------------------------CCCCCccc-----------ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 242 S------------------------GIKPASLA-----------KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 242 ~------------------------g~~p~~l~-----------~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. ......++ ...+..+.++|.+||+ +|.+|||+.|++.||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 00000000 1456789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=315.64 Aligned_cols=252 Identities=23% Similarity=0.382 Sum_probs=201.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|++|+||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 79 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHS--EKRLYLV 79 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEec--CCeEEEE
Confidence 3677999999999999999999999999988764322 22344667889999999999999999998864 4689999
Q ss_pred EeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+. ++|..++..... +++..++.++.||+.||+|||+++ ++||||+|+||+++...+.+||+|||++......
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99996 578877765443 688999999999999999999998 9999999999999855668999999999765322
Q ss_pred ----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-------------
Q 035992 186 ----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP------------- 246 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p------------- 246 (613)
....++..|+|||.+.+ .++.++||||||+++|+|+||..||........+.+.+..-..+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 12234568999997754 47889999999999999999999997655554444332210000
Q ss_pred ----------Cc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 ----------AS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 ----------~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.. .....+..+.++|.+||+ +|.+||++.+++.||||...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 112357789999999998 99999999999999999864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.92 Aligned_cols=246 Identities=28% Similarity=0.501 Sum_probs=206.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|+.||+|.++.... ......+.+.+|+.++++++|+||++++++|.. ....+++
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~lv 80 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNIV 80 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEEE
Confidence 3788999999999999999999999999998875443 234557789999999999999999999999865 4578999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|||+.+|+|..++.+ ...+++..+..|+.||+.||.|||+++ ++||||+|+||+++ ..+.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeecc
Confidence 999999999998864 345899999999999999999999998 99999999999998 56899999999987654
Q ss_pred hhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC-cHHHHHHHHHcCCCCCcccccccHHH
Q 035992 184 QAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT-NAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 184 ~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
... ...++..|+|||.+.+ .++.++||||||+++|+|++|..||.... +...+...+..+..++......+..+
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 321 2345668999997654 58999999999999999999999995433 44455666666655544444678899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+++|.+||. +|.+||++.+|++
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHcCCCcccCCCHHHHHH
Confidence 999999998 9999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=306.09 Aligned_cols=239 Identities=26% Similarity=0.441 Sum_probs=203.5
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+.||+|+||.||+|.+... +..||+|.++... .....+.+.+|+.+++.++|+||+++++++.. ...++++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA---SEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeecccc---chhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEE
Confidence 4799999999999999866 8999988876432 22357889999999999999999999998754 66899999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 109 EIFTSGTLRQYRKKH---------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 109 E~~~gGsL~~~l~~~---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.++|+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccc
Confidence 999999999999885 78999999999999999999999998 99999999999998 5689999999999
Q ss_pred HHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 180 AILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 180 ~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
...... ....++..|+|||.+.. .++.++||||||+++|+|++ |..||... ...++...+..+... ..+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~ 230 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPE 230 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCc
Confidence 876542 23345668999997764 58999999999999999999 59999664 566677777765433 3445
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+..+.++|.+||. +|.+||++.+++.+
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 231 YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 568999999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.14 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=199.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.+.||.|++|+||+|.+..+|..||+|.+..... .......+.+|+.+++.++||||+++++++.. ....+++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheecc--CCeEEEEE
Confidence 567899999999999999999999999998775322 22334567889999999999999999998754 46899999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 109 EIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
||+. ++|.+++.... .+++..+..++.||+.||+|||+++ ++||||+|+||+++ .++.++|+|||++..+....
T Consensus 78 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 78 EFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPV 153 (283)
T ss_pred eccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCc
Confidence 9995 68999988766 7999999999999999999999998 99999999999998 57899999999987543221
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC---------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--------------- 245 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--------------- 245 (613)
...++..|+|||++.+ .++.++||||||+++|+|++|..||.......++.+.+.....
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 1234568999997653 3788999999999999999999999765544443332211000
Q ss_pred -----------CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 246 -----------PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 246 -----------p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
........+..+.++|.+||+ +|.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001123456789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=326.05 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=200.9
Q ss_pred CCCcceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSW 96 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 96 (613)
|..|| ++.++||+|+||.||+|.+. .+++.||+|+++.. ........+..|+.+++++ +|+||+++++++
T Consensus 5 ~~~~~-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 5 PRDRL-KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG---ATASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred CHHHh-hhhcccccCcCceEEeccccccccccccceeeeeeccCC---CCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 34455 88899999999999999743 34578998877632 2334566788999999999 899999999987
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKH----------------------------------------------------- 123 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~----------------------------------------------------- 123 (613)
... +..++++|||+.+|+|.+++...
T Consensus 81 ~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 81 TKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 643 45788999999999999988642
Q ss_pred --------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh------ccCc
Q 035992 124 --------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA------RSAH 189 (613)
Q Consensus 124 --------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~------~~~~ 189 (613)
..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.++|+|||++..+... ....
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~ 236 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDAR 236 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCC
Confidence 25789999999999999999999998 99999999999998 5689999999999875321 1223
Q ss_pred ccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-
Q 035992 190 SVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA- 266 (613)
Q Consensus 190 gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~- 266 (613)
++..|||||++. ..++.++|||||||++|||++ |..||......+.+...+..+..+ ..+...++.+.+++.+||+
T Consensus 237 ~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~ 315 (337)
T cd05054 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHN 315 (337)
T ss_pred CCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccC
Confidence 345799999765 459999999999999999998 999997644444454555544333 3345677899999999999
Q ss_pred cccCCCCHHHHhcC
Q 035992 267 EVSERLPAKELLGD 280 (613)
Q Consensus 267 dP~~Rpta~eLL~H 280 (613)
+|.+||++.+|++|
T Consensus 316 ~p~~RPs~~ell~~ 329 (337)
T cd05054 316 NPEDRPTFSELVEI 329 (337)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=315.64 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=198.8
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
+-..+.-++| ++.+.||+|+||+||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 81 (310)
T cd07865 5 FPFCDEVSKY-EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICR 81 (310)
T ss_pred Ccccchhhhe-EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEe
Confidence 3344555566 677999999999999999999999999998764321 1222345568999999999999999999875
Q ss_pred cCC------CCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc
Q 035992 98 DTE------NEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE 170 (613)
Q Consensus 98 ~~~------~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~ 170 (613)
... ....+++|||+.+ +|.+++.+. ..+++..++.++.||+.||.|||+++ ++|+||||+||+++ ..+.
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~ 157 (310)
T cd07865 82 TKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGI 157 (310)
T ss_pred cccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCc
Confidence 432 2467999999965 787777654 47999999999999999999999998 99999999999998 6789
Q ss_pred EEEeccchhHHHhhhc--------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH--HH
Q 035992 171 VKIGDLGLAAILAQAR--------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI--YK 238 (613)
Q Consensus 171 VKL~DFGla~~l~~~~--------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i--~~ 238 (613)
+||+|||++..+.... ...++..|+|||.+.+ .++.++||||||+++|+|++|..||......... ..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~ 237 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999997654321 1234557999997654 3788999999999999999999999654332221 11
Q ss_pred HHHcCCCCCc---------------------------ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 239 KVTSGIKPAS---------------------------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 239 ~I~~g~~p~~---------------------------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.+.....+.. .....+..+++||.+||. +|.+|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 1111100000 011235678899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=312.11 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=203.9
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
-|.|+ +.|| |+.+.||.|||+-||++.+..++..+|+|.|... +.++.+..++|++..++++|||+++++++.+
T Consensus 15 tv~In-~~Ry-ri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l 88 (302)
T KOG2345|consen 15 TVIIN-NKRY-RIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQL 88 (302)
T ss_pred cEEEc-CceE-EEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence 34444 4555 9999999999999999999999999998887642 3578889999999999999999999999865
Q ss_pred cCC---CCEEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc
Q 035992 98 DTE---NEHINFITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE 170 (613)
Q Consensus 98 ~~~---~~~l~lV~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~ 170 (613)
... ....|++++|+..|+|.+.+.+. ..++|.++..|+.+|++||++||+..+|++||||||.|||+. +.+.
T Consensus 89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~ 167 (302)
T KOG2345|consen 89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGL 167 (302)
T ss_pred HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCc
Confidence 432 35799999999999999987643 379999999999999999999999999999999999999997 5789
Q ss_pred EEEeccchhHHHh-------------hhccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCc-
Q 035992 171 VKIGDLGLAAILA-------------QARSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTN- 232 (613)
Q Consensus 171 VKL~DFGla~~l~-------------~~~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~- 232 (613)
++|.|||.++... .......|..|.|||++.- ..++++|||||||++|+|+.|..||...-.
T Consensus 168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~ 247 (302)
T KOG2345|consen 168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ 247 (302)
T ss_pred eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc
Confidence 9999999986542 1112345668999998863 368999999999999999999999932100
Q ss_pred HHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 233 ~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
...+.-.+.++.....-...++..+.++|+.||+ ||.+||++.+|+.+
T Consensus 248 GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0000001122211111122378999999999999 99999999999864
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=325.74 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=199.3
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
.+| +..+.||+|+||+||+|.+..+|..||+|.+.... ........+.+|+.+++.++||||++++++|....
T Consensus 16 ~~y-~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 16 KRY-QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF--QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred cce-EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc--cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 455 66799999999999999999999999999875322 23445567889999999999999999999875432
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
....++||||+.+ +|.+++... +++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccce
Confidence 2357999999964 888887654 899999999999999999999998 99999999999998 56899999999997
Q ss_pred HHhhhc---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-C---------
Q 035992 181 ILAQAR---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-P--------- 246 (613)
Q Consensus 181 ~l~~~~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p--------- 246 (613)
...... ...++..|+|||.+.+ .++.++|||||||++|+|++|..||....... .+..+..... |
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHHhh
Confidence 654322 2345668999997754 58999999999999999999999996544322 2222211000 0
Q ss_pred ---------------Ccc----------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 247 ---------------ASL----------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 247 ---------------~~l----------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..+ ....+..+++||.+||+ +|.+|||+.|+|.||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 000 11345678999999999 9999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=311.77 Aligned_cols=247 Identities=28% Similarity=0.456 Sum_probs=207.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
|.+.+.||+|+||.||+|.+..+|+.||+|++..... ........+..|+.+++++. ||||++++++|.. ...+++
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~l 79 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLYF 79 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEEE
Confidence 3677999999999999999999999999998765332 23344577889999999998 9999999998743 567999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
+||++.+++|.+++.+.+.+++..++.|+.||+.||.|||+++ ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCcc
Confidence 9999999999999999889999999999999999999999998 99999999999997 67899999999987654322
Q ss_pred ------------------------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH
Q 035992 187 ------------------------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 187 ------------------------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~ 241 (613)
...++..|+|||.+.. .++.++|+||||+++++|++|..||.... ....++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~ 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH
Confidence 1234568999997654 48889999999999999999999997644 344444544
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCH----HHHhcCCCC
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPA----KELLGDPFL 283 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta----~eLL~HPff 283 (613)
... ..++...++.+.+||.+||+ +|.+||++ .++++||||
T Consensus 236 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 KLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 332 22344568899999999998 99999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.91 Aligned_cols=255 Identities=27% Similarity=0.384 Sum_probs=203.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--- 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 101 (613)
.+| ++.+.||+|+||+||+|.+..+|..||+|.++... ........+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~y-~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 5 TKY-VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cce-eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 344 67789999999999999999999999999876432 223345667889999999999999999998754322
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++++||+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++..
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccc
Confidence 35899999996 689999998889999999999999999999999998 99999999999998 568999999999876
Q ss_pred Hhhh----ccCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc---C---------
Q 035992 182 LAQA----RSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---G--------- 243 (613)
Q Consensus 182 l~~~----~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---g--------- 243 (613)
.... ....++..|+|||.+. ..++.++||||||+++|+|++|..||..... ...+..+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhc
Confidence 5432 1224566899999765 3488999999999999999999999965322 111111110 0
Q ss_pred ---------------CCC--CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 244 ---------------IKP--ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 244 ---------------~~p--~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..+ .......++.+.+||.+||+ +|.+|||++++++||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000 01123467889999999999 999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.21 Aligned_cols=256 Identities=25% Similarity=0.384 Sum_probs=204.7
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC--CCCE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT--ENEH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~--~~~~ 103 (613)
+.|.+.+.||+|+||.||+|.+..+|..||+|.+.... ........+.+|+.+|+.++||||++++++|... ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF--DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc--ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 33467799999999999999999999999999876432 1234456778899999999999999999977533 3357
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .+|.+||+|||++....
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeec
Confidence 899999995 589999988888999999999999999999999998 99999999999998 67899999999987653
Q ss_pred hhc--------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH-cCC--------
Q 035992 184 QAR--------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT-SGI-------- 244 (613)
Q Consensus 184 ~~~--------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~-~g~-------- 244 (613)
... ...++..|+|||.+.. .++.++||||||+++|+|++|..||.......++...+. .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 321 2245668999998754 488999999999999999999999966443322211111 000
Q ss_pred ----------------CCC---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ----------------KPA---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ----------------~p~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+. .+....+..+.+||.+||+ +|.+||++.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 000 0113357889999999999 999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=332.99 Aligned_cols=260 Identities=21% Similarity=0.387 Sum_probs=219.4
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
+..++|.-++||+|+||.||-++...||+.+|+|.+.+... +....-...+.|.++|.+++.+.||.+-..|.. ...
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi-Kkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT--kd~ 259 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI-KKRKGETMALNEKQILEKVSSPFIVSLAYAFET--KDA 259 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH-HHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC--CCc
Confidence 34456667999999999999999999999999887764332 223344556789999999999999998777743 567
Q ss_pred EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+++|+.+|+||+|.-+|-+.+ .|++..+..++.+|+.||++||..+ ||+|||||+|||++ +.|+|.|+|+|+|..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAve 336 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVE 336 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEe
Confidence 999999999999999998876 8999999999999999999999998 99999999999998 789999999999987
Q ss_pred Hhhhc---cCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHcCCCCCccccccc
Q 035992 182 LAQAR---SAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 182 l~~~~---~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s 254 (613)
+.... ...||.+|||||++.++ |+..+|+|||||++|||+.|+.||..... .+++-+.+.. .+..++..++
T Consensus 337 i~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS 414 (591)
T KOG0986|consen 337 IPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFS 414 (591)
T ss_pred cCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccC
Confidence 75533 34789999999988754 99999999999999999999999965332 2233333433 3556778899
Q ss_pred HHHHHHHHHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 255 NGVRAFIEKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
++++++.+.+|+ +|.+|+. +.++.+||||+..+|..+
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 999999999998 9999985 789999999999988654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=321.59 Aligned_cols=255 Identities=26% Similarity=0.411 Sum_probs=199.7
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC---
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE--- 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~--- 100 (613)
..+| ++.++||+|+||+||+|.+..+|+.||+|+++.. ........+..|+.+++.++||||+++++++....
T Consensus 4 ~~~y-~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (336)
T cd07849 4 GPRY-QNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF---EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFES 79 (336)
T ss_pred ccce-EEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc---ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccc
Confidence 3454 7789999999999999999999999999987632 22345567888999999999999999998764332
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+++++||+.+ +|..++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~ 154 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLAR 154 (336)
T ss_pred cceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECccccee
Confidence 2468999999965 88877754 57999999999999999999999998 99999999999998 67899999999987
Q ss_pred HHhhhc-------cCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHH------------
Q 035992 181 ILAQAR-------SAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK------------ 239 (613)
Q Consensus 181 ~l~~~~-------~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~------------ 239 (613)
...... ...++..|+|||.+. ..++.++||||||+++|+|++|+.||........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 653321 124566899999764 34889999999999999999999999654322211110
Q ss_pred --HHcC---------C--CCCc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 240 --VTSG---------I--KPAS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 240 --I~~g---------~--~p~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+... . .... +....+..+.+||.+||+ +|.+|||+.+++.||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000 0 0000 112346789999999999 999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.06 Aligned_cols=240 Identities=26% Similarity=0.414 Sum_probs=202.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+.+.+.||+|+||+||+|.+..++..||+|.++. +......+.+|+.+++.++||||+++++++.. ...++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFYII 80 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecC-----CchHHHHHHHHHHHHHhCCCCChhheEEEEcC--CCCcEEE
Confidence 5778999999999999999999999999887653 23445678899999999999999999998754 4578999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccc
Confidence 9999999999998764 35899999999999999999999998 99999999999997 6789999999998766432
Q ss_pred cc-----CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 RS-----AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ~~-----~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
.. ...+..|+|||.+.. .++.++||||||+++|||++ |..||.. .+....+..+..+..+ ..+...+..+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVY 235 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHH
Confidence 21 122457999997754 58899999999999999998 8999965 4566677777766443 34556789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhc
Q 035992 259 AFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++|.+||+ +|.+||++.++++
T Consensus 236 ~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 236 ELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHHHHccCCcccCCCHHHHHH
Confidence 99999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.40 Aligned_cols=262 Identities=26% Similarity=0.446 Sum_probs=215.0
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
|...+|...| ...+.||+|+||+||+|.+..+|..||+|.+..... ........+..|+.+++.++|||++++++++.
T Consensus 18 ~~~~~~~~~f-~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 18 FFKEDPEKLF-TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred hcCCCchhhh-hhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 4556666665 667899999999999999999999999998764332 23455677899999999999999999999876
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
. ....++||||+.| +|.+++.. ...+++..+..++.||+.||.|||+++ |+||||+|+||+++ .++.++|+||
T Consensus 96 ~--~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~df 169 (317)
T cd06635 96 R--EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADF 169 (317)
T ss_pred e--CCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecC
Confidence 5 4578999999975 77776654 567999999999999999999999998 99999999999997 5789999999
Q ss_pred chhHHHhhhccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 177 GLAAILAQARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 177 Gla~~l~~~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
|++..........++..|+|||.+. +.++.++||||||+++|+|++|..||........+.. +..+..+......
T Consensus 170 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (317)
T cd06635 170 GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPTLQSNE 248 (317)
T ss_pred CCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHhccCCCCCCcc
Confidence 9987665555566778899999763 3588999999999999999999999977554444443 4433333334456
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
++..++++|.+||+ +|.+||++.+++.|+|+.....
T Consensus 249 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 249 WSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 77889999999999 9999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.89 Aligned_cols=247 Identities=27% Similarity=0.475 Sum_probs=205.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+..+.||+|+||.||+|.+..++..||+|.++... .....+.+.+|+.+++.++||||++++++|.. +..+++||
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIM 81 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEE
Confidence 44588999999999999999999999988776332 23456788999999999999999999998754 55789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc--
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 186 (613)
||+.+++|.+++.. +.+++..++.++.||+.||.|||+++ ++|+||+|+||+++ +++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcchh
Confidence 99999999998865 56899999999999999999999998 99999999999998 67899999999987654321
Q ss_pred --cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 187 --SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 187 --~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
...++..|+|||.+.. .++.++|+||||+++|||++|..||..... ......+..+. +..+....+..+.++|.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ 235 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP-MRVLFLIPKNS-PPTLEGQYSKPFKEFVEA 235 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccch-hhHHhhhhcCC-CCCCCcccCHHHHHHHHH
Confidence 2345668999998765 488999999999999999999999965433 33333333332 333445567889999999
Q ss_pred Hhh-cccCCCCHHHHhcCCCCCCC
Q 035992 264 CIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||+ +|.+||++.+++.||||...
T Consensus 236 ~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 236 CLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HccCCcccCcCHHHHHHhHHHHHH
Confidence 999 99999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=317.31 Aligned_cols=264 Identities=21% Similarity=0.345 Sum_probs=217.3
Q ss_pred CCCCcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcce
Q 035992 13 DSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIK 91 (613)
Q Consensus 13 ~~~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVk 91 (613)
+++..|-+...+.-|.--.++||-|-.|.|..++++.||+.+|+|++. +....++|+++--.. .|||||.
T Consensus 49 ~~~m~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---------Ds~KARrEVeLHw~~s~h~~iV~ 119 (400)
T KOG0604|consen 49 ESDMDFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---------DSPKARREVELHWMASGHPHIVS 119 (400)
T ss_pred hhhcchhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---------cCHHHHhHhhhhhhhcCCCceEE
Confidence 455566665566666444599999999999999999999999987654 223456777765554 6999999
Q ss_pred eeeeeecC--CCCEEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-
Q 035992 92 FYNSWVDT--ENEHINFITEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG- 166 (613)
Q Consensus 92 l~~~fv~~--~~~~l~lV~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~- 166 (613)
+++.|... ..+++.+|||.|.||.|+..++.++. |+|.++..|++||+.|+.|||+++ |.||||||+|+|..+
T Consensus 120 IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t 197 (400)
T KOG0604|consen 120 IIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTT 197 (400)
T ss_pred eehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecC
Confidence 99977432 35678899999999999999998876 999999999999999999999999 999999999999963
Q ss_pred -CCCcEEEeccchhHHHhh---hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHH
Q 035992 167 -NQGEVKIGDLGLAAILAQ---ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYK 238 (613)
Q Consensus 167 -~~g~VKL~DFGla~~l~~---~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~ 238 (613)
.+..+||+|||+|+.-.. ..+.+.|+.|.|||++.. +|+...|+||+||+||-|++|.+||+.... ...+..
T Consensus 198 ~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~ 277 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKR 277 (400)
T ss_pred CCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHh
Confidence 455789999999987653 235667889999999874 599999999999999999999999976543 223556
Q ss_pred HHHcCC--CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 239 KVTSGI--KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 239 ~I~~g~--~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+|..|. .|..-+...+..++++|+++|. +|++|+|+.+++.|||+....
T Consensus 278 rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 278 RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 777775 3444455678999999999999 999999999999999998753
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=321.13 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=199.6
Q ss_pred eeeccc--CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRG--AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~G--afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+.||+| +||+||+|.+..+|+.||+|+++... ......+.+.+|+.+++.++||||++++++|.. +..+++++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e 79 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN--CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISP 79 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEe
Confidence 567777 99999999999999999999876432 234556788999999999999999999999865 457899999
Q ss_pred ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 110 IFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 110 ~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|+.+++|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+|||++ ..+.++++||+.+.......
T Consensus 80 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 80 FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred cccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCc
Confidence 99999999998875 35899999999999999999999998 99999999999998 56899999998765432211
Q ss_pred ----------cCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--------
Q 035992 187 ----------SAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-------- 245 (613)
Q Consensus 187 ----------~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-------- 245 (613)
...++..|||||++.+ .++.++|||||||++|+|++|..||........+...+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccccc
Confidence 1122346999998754 3789999999999999999999999776554444333321100
Q ss_pred ------------------------------------CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 246 ------------------------------------PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 246 ------------------------------------p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
........+..+.+||.+||+ +|.+|||+.++|+||||.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 001122356788999999999 9999999999999999987543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=308.55 Aligned_cols=246 Identities=29% Similarity=0.514 Sum_probs=204.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||+|.+..+|..+|+|.+..... ........+.+|+.+++.++||||++++++|.. +..++++
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 80 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIV 80 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEEE
Confidence 3667999999999999999999999999998775442 233456788899999999999999999998865 4578999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhccc
Confidence 999999999998864 356899999999999999999999998 99999999999998 56799999999987664
Q ss_pred hhc----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC-cHHHHHHHHHcCCCCCcccccccHHH
Q 035992 184 QAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT-NAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 184 ~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
... ...++..|+|||.+.. .++.++|+||||+++|+|++|..||.... +...+.+.+.....+.......+..+
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 322 2345668999998754 58889999999999999999999996533 23445555555544444455678899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+++|.+||. +|.+|||+.++++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHhcCCCcccCCCHHHHHH
Confidence 999999998 9999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.79 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=201.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.+.||.|+||.||+|.+..+|+.+|+|.++... ........+.+|+.+++.++|||++++++++.......+++|+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 56789999999999999999999999999887543 2234456688899999999999999999988654346899999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 109 EIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
||+.+ +|..++.+. ..+++..++.++.||+.||+|||+++ ++|+||+|+||+++ +++.++|+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCc
Confidence 99975 888888765 67999999999999999999999998 99999999999998 67899999999987665432
Q ss_pred ----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-CC-------------
Q 035992 187 ----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-KP------------- 246 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-~p------------- 246 (613)
...++..|+|||.+.+ .++.++||||||+++|+|++|..||........+ ..+.... .+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL-EKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchhhccccccchh
Confidence 2234567999997653 4789999999999999999999999765543333 2222110 00
Q ss_pred ---------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 ---------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 ---------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+....+..+.++|.+||. +|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00112237789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=317.71 Aligned_cols=260 Identities=27% Similarity=0.460 Sum_probs=213.4
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
+...+|..+| ...+.||+|+||+||+|.++.++..||+|.+..... ........+.+|+.+++.++|+|++++++++.
T Consensus 8 ~~~~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 8 FFKDDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred hhcCCcHHHH-HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccc-cChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 4445666676 345889999999999999999999999998764322 23345567889999999999999999999886
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
. ....++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+++ ++||||+|+||+++ .++.++|+||
T Consensus 86 ~--~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~df 159 (308)
T cd06634 86 R--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 159 (308)
T ss_pred c--CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCc
Confidence 5 457899999997 577776654 456899999999999999999999998 99999999999998 5689999999
Q ss_pred chhHHHhhhccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 177 GLAAILAQARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 177 Gla~~l~~~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
|++..........++..|+|||.+. +.++.++|||||||++|+|++|..||........++. +..+..+......
T Consensus 160 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (308)
T cd06634 160 GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-IAQNESPALQSGH 238 (308)
T ss_pred ccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH-HhhcCCCCcCccc
Confidence 9987766555556778999999763 3478899999999999999999999976544444443 3334444444556
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+..+++||.+||. +|.+||++.+++.|||+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 78899999999998 99999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=318.00 Aligned_cols=242 Identities=25% Similarity=0.445 Sum_probs=198.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcE----EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIE----VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~----VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|.+..+|.. ||+|.++. .......+++..|+.+++.++||||+++++++.. ..
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~---~~ 82 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 82 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC---CC
Confidence 47789999999999999998776664 78777653 2234566788999999999999999999998764 24
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++++|+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccc
Confidence 67899999999999999875 46899999999999999999999998 99999999999997 5679999999999876
Q ss_pred hhhcc------CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 183 AQARS------AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 183 ~~~~~------~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
..... ...+..|||||.+.+ .++.++||||||+++|||++ |..||.+. ...++...+..+..++ .+..++
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~ 237 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP-QPPICT 237 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhCCCCCC-CCCCCC
Confidence 53221 122457999997754 58999999999999999998 99999653 4455555555544332 344567
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+..+|.+||. +|.+||++.+++.+
T Consensus 238 ~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 238 IDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 889999999998 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=370.97 Aligned_cols=248 Identities=30% Similarity=0.487 Sum_probs=220.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
...||.|.||.||.|.+..+|+..|+|-+++-... ......+.+|..++..++|||+|++|+.=+ +...++|.|||
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv--HRekv~IFMEy 1315 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEV--HREKVYIFMEY 1315 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceee--cHHHHHHHHHH
Confidence 57999999999999999999999999988865432 345566788999999999999999999544 45678899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-----
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----- 185 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 185 (613)
|.+|+|.+.+...+..+|...+.+..|++.|+.|||++| ||||||||.|||++ ..|.+|++|||.|..+...
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhcCC
Confidence 999999999999999999999999999999999999999 99999999999998 6789999999999766432
Q ss_pred ---ccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
+...||+.|||||++.+ +...++|||||||+++||+||+.||.+..+.-+|.-++..|.+|... ...+.+-+
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P-~~ls~~g~ 1471 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP-ERLSSEGR 1471 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc-hhhhHhHH
Confidence 24578999999998864 46779999999999999999999999999999999999999887544 44899999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+||+.||. ||.+|.++.|||.|.|-+..
T Consensus 1472 dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1472 DFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 99999998 99999999999999997654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.46 Aligned_cols=245 Identities=22% Similarity=0.367 Sum_probs=199.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCc--EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----CC
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGI--EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE----NE 102 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~--~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~~ 102 (613)
.+.++||+|+||.||+|.+..++. .||+|.++... ......+.+..|+.+++.++||||+++++++.... ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 356899999999999999887775 68888776432 24566788899999999999999999999764322 23
Q ss_pred EEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 103 HINFITEIFTSGTLRQYRKK------HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
..+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCC
Confidence 57899999999999988742 234899999999999999999999988 99999999999997 6789999999
Q ss_pred chhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCc
Q 035992 177 GLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPAS 248 (613)
Q Consensus 177 Gla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 248 (613)
|++..+.... ...++..|+|||.+.. .++.++||||||+++|||++ |..||.. .....++..+..+..+.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~- 234 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK- 234 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-
Confidence 9998754321 1233457999998764 48999999999999999999 8899965 44566777777665432
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+...+..+.++|.+||+ +|.+|||+.+|+++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 235 QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 334567889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.94 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=195.7
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
++| ++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 8 ~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 8 RDY-EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC--CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 355 778999999999999999999999999998765332 1122345678999999999999999999876543
Q ss_pred --CCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 101 --NEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 101 --~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
...++++|+|+.+ +|..++.. ...+++..++.++.||++||.|||+++ ++||||||+||+++ +++.++|+|||
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg 160 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFG 160 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCc
Confidence 2368999999876 66666654 457999999999999999999999998 99999999999998 67899999999
Q ss_pred hhHHHhhhcc---------------CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHH
Q 035992 178 LAAILAQARS---------------AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240 (613)
Q Consensus 178 la~~l~~~~~---------------~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I 240 (613)
++........ ..++..|+|||.+.+ .++.++||||||+++|+|++|..||........ ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~ 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLI 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 9976543211 123457999997653 488999999999999999999999966444332 2222
Q ss_pred HcC---CCC----------------------Ccc---cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 241 TSG---IKP----------------------ASL---AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 241 ~~g---~~p----------------------~~l---~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
... ..+ ..+ .......+.+||.+||+ +|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 210 000 000 01234678899999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.13 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=199.7
Q ss_pred eEeeeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC----
Q 035992 29 RYKEVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN---- 101 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---- 101 (613)
++.++||+|+||+||+|.+..+ +..||+|.++... ........+.+|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI--HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5779999999999999987654 4789999876422 234567789999999999999999999997654322
Q ss_pred CEEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 102 EHINFITEIFTSGTLRQYRKKH------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
...++++||+.+|+|..++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECC
Confidence 3478999999999999988543 36899999999999999999999998 99999999999998 567999999
Q ss_pred cchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 176 LGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 176 FGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
||++....... ....+..|+|||.+.. .++.++||||||+++|||++ |..||... ...++++.+..+..+
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~- 234 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL- 234 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-
Confidence 99987654321 1123457999998754 48999999999999999999 88999664 445566666665433
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+...+..+.++|.+||+ +|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3455678899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=305.71 Aligned_cols=237 Identities=22% Similarity=0.359 Sum_probs=197.9
Q ss_pred eecccCceEEEEEEE--cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 33 VLGRGAFKKVYRAFD--ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 33 ~LG~GafGtVYka~~--~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
.||+|+||+||+|.+ ..++..+|+|+++... ......+.+..|+.+++.++||||+++++++. ....+++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~ 76 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE---AESWMLVMEL 76 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc---CCCcEEEEec
Confidence 589999999999964 5678899998876332 23455678899999999999999999999763 3457899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc----
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---- 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 186 (613)
+.+|+|.+++.+.+.+++..+..++.||+.||+|||+++ ++||||||.||+++ .++.+||+|||++..+....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 77 AELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeee
Confidence 999999999998888999999999999999999999998 99999999999998 56799999999997654321
Q ss_pred ---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 187 ---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
...++..|+|||.+.. .++.++||||||+++|||++ |..||.. .+...+...+..+..+ ..+...+..+.++|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li 231 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLM 231 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHH
Confidence 1122358999998764 48889999999999999998 9999965 4456667777776543 34556789999999
Q ss_pred HHHhh-cccCCCCHHHHhc
Q 035992 262 EKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~ 279 (613)
.+||+ +|.+||++.+|..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 99999 9999999988754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=302.82 Aligned_cols=241 Identities=26% Similarity=0.438 Sum_probs=206.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||.|+||.||++.+..+++.+|+|++..... ........+..|+.+++.++||||+++++.+. .+..++++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQ--TEEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHee--cCCeeEEEEecCCC
Confidence 7999999999999999999999998875432 33456778899999999999999999999874 46689999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----ccCc
Q 035992 114 GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----RSAH 189 (613)
Q Consensus 114 GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~~~~ 189 (613)
++|.+++.+.+.+++..+..++.||+.||.|||+++ ++|+||+|+||+++ ..+.++|+|||++...... ....
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCc
Confidence 999999999888999999999999999999999988 99999999999998 6789999999998765442 2334
Q ss_pred ccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-c
Q 035992 190 SVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-E 267 (613)
Q Consensus 190 gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-d 267 (613)
++..|+|||...+ .++.++|+||||+++|+|++|..||.. .+...++..+.... ..++...+..+.+||.+||. +
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~ 231 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEKILKDP--LRFPEFLSPEARDLISGLLQKD 231 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcCC
Confidence 5668999997754 478899999999999999999999965 44456666666532 33555668899999999998 9
Q ss_pred ccCCCCH---HHHhcCCCC
Q 035992 268 VSERLPA---KELLGDPFL 283 (613)
Q Consensus 268 P~~Rpta---~eLL~HPff 283 (613)
|.+||++ .++++||||
T Consensus 232 p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 232 PTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HhhCCCcccHHHHHhCCCC
Confidence 9999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.28 Aligned_cols=238 Identities=21% Similarity=0.402 Sum_probs=195.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
+.||+|+||+||+|.+..+|..||+|.+... ...+....+.+|+.+++.++||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeec
Confidence 4799999999999999999999998876522 234556778999999999999999999998754 45789999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc---
Q 035992 112 TSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS--- 187 (613)
Q Consensus 112 ~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~--- 187 (613)
.+++|.+++.+. ..+++..++.++.|++.||.|||+++ ++||||||+|||++ .++.+||+|||++........
T Consensus 76 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 76 QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred cCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCccccccccccc
Confidence 999999998765 46899999999999999999999998 99999999999998 667999999999875432211
Q ss_pred ---CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 188 ---AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 188 ---~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
......|+|||.+.. .++.++||||||+++|||++ |..||.... .......+..+..+ ..+...+..+.+|+.
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~ 230 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS-NQQTREAIEQGVRL-PCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC-HHHHHHHHHcCCCC-CCcccCCHHHHHHHH
Confidence 111246999998754 48899999999999999998 889996543 34444455444332 345567889999999
Q ss_pred HHhh-cccCCCCHHHHhc
Q 035992 263 KCIA-EVSERLPAKELLG 279 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~ 279 (613)
+||+ +|.+||++.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.16 Aligned_cols=242 Identities=25% Similarity=0.391 Sum_probs=200.0
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+.+.+.||+|+||.||+|.+. .++..||+|.++.. ...+..+.+.+|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 81 (280)
T cd05049 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GD 81 (280)
T ss_pred hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CC
Confidence 466799999999999999874 34688998877632 233456789999999999999999999998865 45
Q ss_pred EEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 103 HINFITEIFTSGTLRQYRKKHK--------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~--------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
.++++|||+.+++|.+++...+ .+++..+..++.||+.||.|||+++ ++||||||+||+++ .+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CC
Confidence 7999999999999999997653 4789999999999999999999998 99999999999998 56
Q ss_pred CcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHH
Q 035992 169 GEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKV 240 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I 240 (613)
+.++|+|||++...... ....+++.|+|||++.. .++.++||||||+++|||++ |..||.... .......+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-~~~~~~~~ 237 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-NEEVIECI 237 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHH
Confidence 89999999998754221 12223468999998764 58999999999999999998 999997644 45556666
Q ss_pred HcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 241 TSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 241 ~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+. .+...+..++++|.+||+ +|.+||++.|++.
T Consensus 238 ~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQ-RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6665433 345678899999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=300.72 Aligned_cols=247 Identities=25% Similarity=0.449 Sum_probs=209.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||.||++.+..+++.+|+|.++.... .......+.+|+.+++.++|+||++++++|.. ....+++
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIV 77 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEE
Confidence 3677999999999999999999999999998775432 24556778899999999999999999998865 4689999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|||+.+++|..++.+ ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++ ..+.+||+|||++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLK 154 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhhc
Confidence 999999999998876 356899999999999999999999998 99999999999998 57899999999998765
Q ss_pred hhc--cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 184 QAR--SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 184 ~~~--~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
... ...++..|+|||.+.+ .++.++|+||||+++|+|++|..||... +...+...+..+..+. .+...+.+++++
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 232 (256)
T cd08530 155 KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYPP-IPPIYSQDLQNF 232 (256)
T ss_pred cCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCC-CchhhCHHHHHH
Confidence 431 2345668999997754 4888999999999999999999999664 4555555565554443 344678899999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff 283 (613)
|.+||. +|.+||++.++++||++
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999998 99999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.47 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=200.4
Q ss_pred CcceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
+.-+++.+.||+|+||+||++.+ ..++..+|+|.+... .......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 78 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVE- 78 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 34567889999999999999975 335567887776532 34556778999999999999999999998754
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHK-------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~-------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~ 166 (613)
...++++|||+.+++|.+++...+ .+++..+..++.||+.||+|||+++ ++||||||+|||++
T Consensus 79 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~- 154 (288)
T cd05093 79 -GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG- 154 (288)
T ss_pred -CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-
Confidence 457899999999999999997654 4899999999999999999999998 99999999999998
Q ss_pred CCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHH
Q 035992 167 NQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYK 238 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~ 238 (613)
..+.+||+|||++...... ....++..|+|||++.. .++.++||||||+++|+|++ |..||... ....+..
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~ 233 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIE 233 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence 6789999999998755321 12223457999998764 58999999999999999998 89999664 4455666
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+..+ ..+...+..+.+|+.+||+ +|.+|||+.+++.
T Consensus 234 ~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 77766543 2344578899999999999 9999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=331.22 Aligned_cols=255 Identities=24% Similarity=0.411 Sum_probs=206.0
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTE 100 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~ 100 (613)
.-.||.|...+.||+||.+.||++.....+.+++ |.+ .....+...+.-+.+||.+|.+|+ |.+||++|+|-+.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyal-kkv--~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-- 431 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYAL-KKV--VLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-- 431 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhh-hHH--HHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--
Confidence 4457888888999999999999998665554444 433 234457788899999999999995 9999999998654
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCH-HHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDL-RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse-~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
++++|+|||+-. -+|..++++.+...+ -.++.+..||+.++.++|.+| |||.||||.|+|+- .|.+||+|||+|
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA 506 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIA 506 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechh
Confidence 678999999764 489999988765433 689999999999999999999 99999999999985 589999999999
Q ss_pred HHHhhhc------cCcccccccCcccccc------------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH
Q 035992 180 AILAQAR------SAHSVIEFMAPELYEE------------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 180 ~~l~~~~------~~~gt~~YmAPEvl~~------------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~ 241 (613)
..+.... ...||+.||+||.+.. +.+.++||||||||||+|+.|++||....+.-.-+..|+
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 8876532 4578999999996531 156789999999999999999999977665444445555
Q ss_pred cCCCCCcccccccHH-HHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 SGIKPASLAKVADNG-VRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~-l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.......++...... +.++++.||. ||.+||++.+||+|||++..
T Consensus 587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 443333444444443 9999999999 99999999999999999863
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.85 Aligned_cols=247 Identities=28% Similarity=0.485 Sum_probs=206.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+..+.||.|+||.||+|.+..++..||+|++... ........+.+|+.+++.++||||++++++|.. +..+++||
T Consensus 7 ~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 7 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhheeEeecCCeEEEEEEECCCCcEEEEEEeccc---cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEE
Confidence 5668899999999999999999999998876532 223455778899999999999999999998854 45799999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc--
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-- 186 (613)
||+.+++|..++.+ +.+++..+..++.|++.||.|||+++ ++|+||+|+||+++ +++.++|+|||++..+....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhh
Confidence 99999999999875 46899999999999999999999998 99999999999998 67899999999986543321
Q ss_pred --cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 187 --SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 187 --~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
...++..|+|||.+.. .++.++|+|||||++|+|++|..||... ........+..+. ++.+....+..+.++|.+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~ 235 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEA 235 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCC-CCCCCcccCHHHHHHHHH
Confidence 2345668999998754 4788999999999999999999999653 3444444444433 334555678899999999
Q ss_pred Hhh-cccCCCCHHHHhcCCCCCCC
Q 035992 264 CIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||+ +|.+||++.++++||||...
T Consensus 236 ~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 236 CLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred HccCChhhCcCHHHHHhCHHHhhh
Confidence 998 99999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=308.99 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=201.1
Q ss_pred cceeEeeeecccCceEEEEEEEcC-----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~-----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
|| ++.++||+|+||.||+|.++. .+..||+|.++.. ........+.+|+.+++.++||||+++++++..
T Consensus 7 ~~-~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (288)
T cd05061 7 KI-TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES---ASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-- 80 (288)
T ss_pred Hc-eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 44 677999999999999997652 3568998876532 223444567889999999999999999998754
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK----------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE 170 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~----------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~ 170 (613)
....+++|||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ |+||||||+||+++ .++.
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~ 157 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFT 157 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCc
Confidence 457899999999999999997532 3466788999999999999999998 99999999999998 5689
Q ss_pred EEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHc
Q 035992 171 VKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTS 242 (613)
Q Consensus 171 VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~ 242 (613)
++|+|||++..+... ....++..|+|||.+.. .++.++|||||||++|||++ |..||.. .....++..+..
T Consensus 158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~ 236 (288)
T cd05061 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMD 236 (288)
T ss_pred EEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHc
Confidence 999999998754321 11233457999997754 58999999999999999998 7889965 445556666655
Q ss_pred CCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc------CCCCCCCCc
Q 035992 243 GIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG------DPFLQSEDD 288 (613)
Q Consensus 243 g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~------HPff~~~~~ 288 (613)
+..+ ..+...++.++++|.+||+ +|.+||++.++++ ||||+..+|
T Consensus 237 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 237 GGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 5333 2334557899999999999 9999999999986 999987653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.59 Aligned_cols=243 Identities=23% Similarity=0.408 Sum_probs=195.2
Q ss_pred CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHH
Q 035992 38 AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLR 117 (613)
Q Consensus 38 afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~ 117 (613)
++|.||.+++..+|+.||+|.++... ......+.+..|+.+++.++||||++++++|.. ....+++|||+.+|+|.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCE 87 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHH
Confidence 45666777777799999999887532 244667889999999999999999999998865 45789999999999999
Q ss_pred HHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----------
Q 035992 118 QYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---------- 185 (613)
Q Consensus 118 ~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~---------- 185 (613)
+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+||+++ .++.+||+|||.+..+...
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccc
Confidence 998864 46899999999999999999999998 99999999999998 6689999999988644321
Q ss_pred -ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC----------------
Q 035992 186 -RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK---------------- 245 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~---------------- 245 (613)
....++..|+|||++.. .|+.++|||||||++|||++|..||........+..++.....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 11234457999998754 4889999999999999999999999876655555444432110
Q ss_pred ---------------CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 246 ---------------PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 246 ---------------p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+.......+..+.+||.+||+ +|.+|||+.++|+||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112235678899999999 999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.09 Aligned_cols=237 Identities=23% Similarity=0.421 Sum_probs=196.8
Q ss_pred eeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++||+|+||.||+|....++ ..+|+|.++.... ....+.+..|+.+++.++||||+++++++. ....+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK---GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc---CCceEEEE
Confidence 47999999999999876655 7899888764332 245677899999999999999999999764 34579999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccC
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA 188 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 188 (613)
||+.+|+|.+++.+.+.+++..+..|+.|++.||.|||.++ ++||||||+|||++ .++.+||+|||++..+......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred EeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcc
Confidence 99999999999999889999999999999999999999998 99999999999998 6789999999998766432211
Q ss_pred -------cccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 189 -------HSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 189 -------~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.++..|+|||.+.. .++.++||||||+++|+|++ |..||.... ..++...+..+.. ...+...+..+++
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~l~~ 229 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-GAEVIAMLESGER-LPRPEECPQEIYS 229 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHHcCCc-CCCCCCCCHHHHH
Confidence 12346999997764 48999999999999999998 999996644 4556666665543 2344567789999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+|.+||. +|.+||++.+|++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 9999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.98 Aligned_cols=254 Identities=29% Similarity=0.413 Sum_probs=206.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC---CCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---NEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---~~~l 104 (613)
|++.+.||+|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.... ...+
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 377899999999999999999999999999876432 22455678899999999999999999999876542 2468
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+++|+|+. ++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.++|+|||++.....
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeecc
Confidence 99999998 489999988889999999999999999999999998 99999999999998 568999999999986654
Q ss_pred hc-------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-CC-------
Q 035992 185 AR-------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PA------- 247 (613)
Q Consensus 185 ~~-------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p~------- 247 (613)
.. ...++..|+|||++.+ .++.++|+||||+++|+|++|..||..... ...++.+..... +.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhhc
Confidence 32 2234567999998754 488999999999999999999999976443 333333332110 00
Q ss_pred ---------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 248 ---------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 248 ---------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
......+..+.+||.+||+ +|.+||++.+++.||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0112246788999999999 9999999999999999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.30 Aligned_cols=244 Identities=25% Similarity=0.364 Sum_probs=200.0
Q ss_pred ceeEeeeecccCceEEEEEEEc----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDE----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
.+++.+.||+|+||+||+|... .++..||+|.++.. ........+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 3578899999999999999853 45678998877632 234556788899999999999999999998754 45
Q ss_pred EEEEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 103 HINFITEIFTSGTLRQYRKKH-----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
..|++|||+.+++|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~ 158 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc
Confidence 789999999999999998532 24788999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~ 237 (613)
+++.+||+|||++....... ...++..|+|||.+. ..++.++||||||+++|||++ |..||.. .....+.
T Consensus 159 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~-~~~~~~~ 236 (283)
T cd05090 159 -EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG-FSNQEVI 236 (283)
T ss_pred -CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC-CCHHHHH
Confidence 56789999999997653321 223345799999775 458999999999999999998 9999965 3455666
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+.....+ ..+...+..+.++|.+||+ +|.+||++.+|+++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 666665433 3455678899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.38 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=207.9
Q ss_pred eeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|.+. .++..||+|+++...........+.+..|+.++.++ +||||+++++.|.. +..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~~ 79 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DTK 79 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CCE
Confidence 467799999999999999864 467899999887554433445567788999999999 69999999998743 567
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++||||+.+|+|.+++.+.+.+++..++.++.|++.||.|||+.+ ++||||||+||+++ .++.++|+|||++..+.
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccc
Confidence 8999999999999999988888999999999999999999999988 99999999999998 56899999999987654
Q ss_pred hhc-----cCcccccccCccccccc---cCccchhhhhhHHHHHHHhcCCCCCCCC---cHHHHHHHHHcCCCCCccccc
Q 035992 184 QAR-----SAHSVIEFMAPELYEEE---YNELVDIYAFGMCLLELVTFEYPYVECT---NAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 184 ~~~-----~~~gt~~YmAPEvl~~~---ys~ksDIWSLGviL~EmltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~ 252 (613)
... ...++..|+|||.+.+. ++.++||||||+++|+|++|..||.... ....+.+.+..... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKT 234 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcc
Confidence 322 12456689999987542 6889999999999999999999995322 22333334433322 23445
Q ss_pred ccHHHHHHHHHHhh-cccCCCC---HHHHhcCCCCCCCCcc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLP---AKELLGDPFLQSEDDE 289 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpt---a~eLL~HPff~~~~~~ 289 (613)
.+..++++|.+||+ +|.+||| +.++|+||||+...+.
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 77899999999999 9999998 6788999999987664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=307.39 Aligned_cols=246 Identities=22% Similarity=0.366 Sum_probs=199.4
Q ss_pred cceeEeeeecccCceEEEEEEEcC-----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~-----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
..+.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+..|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 80 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-- 80 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--
Confidence 445778999999999999999987 7788998876532 233445678899999999999999999998755
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcE
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK-------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEV 171 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~-------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~V 171 (613)
....+++|||+.+++|.+++.+.+ .+++..+..++.||+.||+|||+++ ++||||||+||+++.+ ...+
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcce
Confidence 346789999999999999997654 4899999999999999999999998 9999999999999732 2368
Q ss_pred EEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcC
Q 035992 172 KIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 172 KL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g 243 (613)
||+|||++..+.... .......|+|||++. ..++.++|||||||++|||++ |..||.... ...+...+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-NQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcC
Confidence 999999997653211 112235799999875 459999999999999999997 999997644 34455555544
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+ .++...+..+.+|+.+||+ +|.+||++.++++|
T Consensus 238 ~~~-~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 GRL-DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 332 3445567899999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=302.23 Aligned_cols=239 Identities=23% Similarity=0.402 Sum_probs=195.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||.||+|..+ .+..+|+|.++... ...+.+..|+.+++.++||||+++++++.. ...++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~iv 77 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ--QKPLYIV 77 (256)
T ss_pred cEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEcc--CCCEEEE
Confidence 467799999999999999775 45678988765322 223568889999999999999999998743 5578999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|.+++... +.+++..++.++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCc
Confidence 9999999999998754 56899999999999999999999998 99999999999998 56799999999987653221
Q ss_pred -----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 -----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
...++..|+|||++.. .++.++||||||+++|+|++ |+.||... +..++...+..+..+ ..+...+..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK-SNYEVVEMISRGFRL-YRPKLASMTVYE 232 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCHHHHH
Confidence 1123347999998764 58899999999999999999 89999654 445566666665433 234556788999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+|.+||+ +|.+||++.+++.
T Consensus 233 li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 233 VMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 9999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.97 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=220.2
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.--+|.+...||+|.|++|.+|++..+|..||||.+.+... +....+.+.+|+++|+.|+|||||++|.+.. ....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~--t~~~ 129 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIE--TEAT 129 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeee--ecce
Confidence 33456788999999999999999999999999998776543 4556677999999999999999999999754 3568
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+|+||||+.+|.+++|+.+++++.+..++.++.|++.|++|||+++ |+|||||++|||++. ..++||+|||++..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~-~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDE-NMNIKIADFGFSTFFD 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhccccc-ccceeeeccccceeec
Confidence 9999999999999999999999999999999999999999999999 999999999999984 5589999999998876
Q ss_pred h---hccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 184 Q---ARSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 184 ~---~~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
. ..+.+|++.|.|||++.+. | ++.+|+||+|+++|-|+.|..||.+ .+...+...+..+... ++...+.+++
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~r--Ip~~ms~dce 283 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKYR--IPFYMSCDCE 283 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC-cccccccchheeeeec--ccceeechhH
Confidence 4 3467889999999998764 4 6789999999999999999999955 5555565566655432 3445688999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
++|+++|. +|.+|++.+++.+|.|.....
T Consensus 284 ~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 284 DLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred HHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 99999998 999999999999999997643
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.88 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=203.3
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.+.||+|+||.||+|.+..+|..+|+|.+... .........+.+|+.+++++ +||||++++++|...+...+++|
T Consensus 10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA--FRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccc--cCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 5679999999999999999999999999987532 12334556788899999999 99999999998876666689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
|||+. ++|..++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+....
T Consensus 88 ~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 88 FEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccccccc
Confidence 99997 5999988776 7899999999999999999999998 99999999999998 67899999999998654322
Q ss_pred --------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC------------
Q 035992 187 --------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI------------ 244 (613)
Q Consensus 187 --------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~------------ 244 (613)
...++..|+|||.+.+ .++.++||||||+++|+|++|+.||............+....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 1235668999997643 478899999999999999999999976544433222111110
Q ss_pred ----------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 245 ----------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 245 ----------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.........+..+.+||.+||+ +|.+|||+.+++.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0011122357889999999999 99999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=305.21 Aligned_cols=240 Identities=22% Similarity=0.343 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFDEL--EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~--tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+.||+|+||+||+|.... ....+|+|.+. ..........+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~---~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELR---ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecC---ccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEEEEE
Confidence 368999999999996432 33456655543 22334556678899999999999999999998754 457899999
Q ss_pred ccCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 110 IFTSGTLRQYRKKHK-----HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~-----~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+.+|+|.+++.+.. ..++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~ 152 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYP 152 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEecccccccccc
Confidence 999999999987653 2467888999999999999999998 99999999999998 578999999999864322
Q ss_pred h------ccCcccccccCccccc--------cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCC---C
Q 035992 185 A------RSAHSVIEFMAPELYE--------EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIK---P 246 (613)
Q Consensus 185 ~------~~~~gt~~YmAPEvl~--------~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~---p 246 (613)
. ....++..|+|||++. ..++.++|||||||++|||++ |..||....+...+...+..+.. .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05042 153 EDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232 (269)
T ss_pred chheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC
Confidence 1 1223345799999764 246789999999999999999 78899776555555444444322 2
Q ss_pred CcccccccHHHHHHHHHHhhcccCCCCHHHHhc
Q 035992 247 ASLAKVADNGVRAFIEKCIAEVSERLPAKELLG 279 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~dP~~Rpta~eLL~ 279 (613)
+.+....+..+..++..|+.+|.+||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~ 265 (269)
T cd05042 233 PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265 (269)
T ss_pred CcccccCCHHHHHHHHHHhcCcccccCHHHHHH
Confidence 234446788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=306.21 Aligned_cols=243 Identities=21% Similarity=0.389 Sum_probs=196.2
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+++.+.||+|+||+||+|.+. .++..||+|.++.. ........+.+|+.+++.++||||+++++++. .+.
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~ 82 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QGQ 82 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCC
Confidence 578899999999999999864 34578998876432 22344567889999999999999999999874 355
Q ss_pred EEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 103 HINFITEIFTSGTLRQYRKKHK----------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~----------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
..++||||+.+|+|.+++.+.+ .++...+..++.|++.||.|||+++ ++||||||+||+++ .++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEE
Confidence 7899999999999999987632 3577889999999999999999988 99999999999998 578999
Q ss_pred EeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCC
Q 035992 173 IGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 173 L~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
|+|||++..+.... ...+++.|||||.+.. .++.++||||||+++|||++ |..||... +.......+..+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~ 238 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVMEGG 238 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCC
Confidence 99999987543211 1233568999998764 58999999999999999999 78899664 4455555555543
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+ .++...+..++++|.+||+ +|.+|||+.|++++
T Consensus 239 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 239 LL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 3345567889999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.57 Aligned_cols=238 Identities=28% Similarity=0.446 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEEcC-CC--cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDEL-EG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~-tg--~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++||+|++|+||+|.+.. .+ ..||+|.++.... ....+.+.+|+.++++++||||+++++.+.. ..++++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCccc---HHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEE
Confidence 478999999999998865 33 3689888765332 1667789999999999999999999998765 6789999
Q ss_pred eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 109 EIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
||+.+|+|.+++.+.. .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..+....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccc
Confidence 9999999999998764 6899999999999999999999998 99999999999998 55899999999998764321
Q ss_pred -------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 187 -------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 187 -------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
...++..|+|||.+.. .++.++|||||||++|+|++ |..||.... ..++.+.+.........+...+..+
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS-GSQILKKIDKEGERLERPEACPQDI 230 (257)
T ss_pred cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCCcCCCCccCCHHH
Confidence 1234457999998764 58999999999999999999 999996544 4445555543222223344567899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+++.+||+ +|.+||++.+++.
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=311.85 Aligned_cols=244 Identities=24% Similarity=0.413 Sum_probs=196.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEE--EEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEV--AWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~V--AiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 103 (613)
.+.+.+.||+|+||+||+|.+..++..+ |+|.++ ..........+.+|+.++.++ +||||+++++++.. ...
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~---~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~ 82 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 82 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEec---ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCC
Confidence 3577899999999999999998888655 554433 222345567888999999999 89999999998744 457
Q ss_pred EEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 104 INFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
++++|||+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+|||++ .
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-E 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-C
Confidence 999999999999999987543 5789999999999999999999998 99999999999998 5
Q ss_pred CCcEEEeccchhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHc
Q 035992 168 QGEVKIGDLGLAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTS 242 (613)
Q Consensus 168 ~g~VKL~DFGla~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~ 242 (613)
++.+||+|||++...... .....+..|+|||.+.. .++.++|||||||++|||+| |..||.. .+....+..+..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~ 238 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQ 238 (303)
T ss_pred CCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc-CChHHHHHHHhc
Confidence 679999999998633211 11122457999998765 47899999999999999998 9999965 344555666655
Q ss_pred CCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 243 GIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 243 g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+..+ ..+...+..+.++|.+||+ +|.+||++.+++.+
T Consensus 239 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4322 2233467889999999999 99999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=302.45 Aligned_cols=243 Identities=23% Similarity=0.414 Sum_probs=200.2
Q ss_pred eeEeeeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+++.+.||+|+||+||+|.++.+ ...||+|.++.. ........+..|+.+++.++||||+++++++.. +..+
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK--SRPV 80 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEec--CCce
Confidence 47789999999999999988754 457898876532 234556778899999999999999999998743 5578
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++|||+.+++|.+++... +.+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.++|+|||++..+.
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhccc
Confidence 9999999999999998764 57999999999999999999999998 99999999999998 56799999999998774
Q ss_pred hhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 184 QAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 184 ~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
... ...++..|+|||.+.. .++.++||||||+++|+|++ |..||.... ...+...+..+..+ ..+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~ 235 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRL-PPPMDCPS 235 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCH
Confidence 211 1122357999998764 58999999999999999998 999997644 44555666655432 23445688
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+.+++.+||+ +|.+||++.+++++
T Consensus 236 ~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 236 ALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=302.06 Aligned_cols=242 Identities=26% Similarity=0.449 Sum_probs=197.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
...+++.++||+|+||+||+|.+. ++..||+|.++.. ....+.+..|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 76 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK--EEPI 76 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCCc
Confidence 345688899999999999999864 5677998876532 2345778999999999999999999998743 4568
Q ss_pred EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++|||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+||+++ ..+.++|+|||++...
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVI 153 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceec
Confidence 9999999999999998763 56899999999999999999999998 99999999999998 6789999999999765
Q ss_pred hhhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 183 AQAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 183 ~~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.... ...++..|+|||.+.. .++.++||||||+++|+|++ |..||... ....+...+..+...+ .....+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~ 231 (261)
T cd05072 154 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-SNSDVMSALQRGYRMP-RMENCPD 231 (261)
T ss_pred CCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCH
Confidence 4321 1223457999997754 58889999999999999998 99999664 4445555665554332 2345678
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+.++|.+||. +|.+||+++++++
T Consensus 232 ~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 232 ELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.39 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=201.1
Q ss_pred CCCcceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSW 96 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 96 (613)
|..|| ++.++||+|+||+||+|.+ ..+++.||+|+++.. ........+.+|+.++..+ +||||+++++++
T Consensus 5 ~~~~~-~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 5 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred chhHh-cccccccCCccceEEEEeeccCCccccceeEEEEEeccC---CChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 45565 8899999999999999984 356789999987632 2234567788999999999 689999999987
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKH----------------------------------------------------- 123 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~----------------------------------------------------- 123 (613)
... +..++++|||+.+|+|.+++...
T Consensus 81 ~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 81 TKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 543 45788999999999999998653
Q ss_pred --------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----
Q 035992 124 --------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---- 185 (613)
Q Consensus 124 --------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~---- 185 (613)
..++...+..|+.||+.||+|||+++ |+||||||+||+++ ..+.+||+|||++..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 236 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYV 236 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchh
Confidence 23678888999999999999999998 99999999999998 5689999999998765321
Q ss_pred --ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 --RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
....++..|+|||.+. ..++.++||||||+++|+|++ |..||........+...+..+..+ ..+...++.+.+++
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 315 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTM 315 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHH
Confidence 1122345799999765 458999999999999999997 999997655555555555555433 23445678899999
Q ss_pred HHHhh-cccCCCCHHHHhcC
Q 035992 262 EKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~H 280 (613)
.+||+ +|.+||++.+|++|
T Consensus 316 ~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 316 LDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=305.27 Aligned_cols=243 Identities=24% Similarity=0.405 Sum_probs=199.3
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCc----EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGI----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~----~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
..+++.++||+|+||+||+|.+..+|. .||+|+++.. ........+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--- 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--- 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---
Confidence 445778999999999999999887776 4787776532 234556778899999999999999999998753
Q ss_pred CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+++++|+++|+|.+++... +.+++..+..|+.||+.||.|||+++ |+||||||+|||++ +++.+||+|||++.
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~ 157 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLAR 157 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCcee
Confidence 3477899999999999998764 56999999999999999999999998 99999999999997 66799999999987
Q ss_pred HHhhhcc------CcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 181 ILAQARS------AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 181 ~l~~~~~------~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
.+..... ..++..|+|||.+. ..++.++|||||||++|||++ |..||.. .....+...+..+..+. .+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~ 235 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERLP-QPPI 235 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcCC-CCcc
Confidence 6643211 12245799999765 458999999999999999998 8999955 44555666666554332 3445
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+.++|.+||. +|.+||++.+++.
T Consensus 236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 236 CTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999 9999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.57 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=197.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC-------
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE------- 100 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~------- 100 (613)
|.+.+.||+|+||+||+|.++.+|+.||+|.++.... .......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 3667999999999999999999999999998875432 1223356778999999999999999999876533
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 101 -NEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 101 -~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++++||+.+ ++..++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccc
Confidence 3478999999986 676666654 57999999999999999999999998 99999999999998 678999999999
Q ss_pred hHHHhhhc-----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc---CCCCCc
Q 035992 179 AAILAQAR-----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---GIKPAS 248 (613)
Q Consensus 179 a~~l~~~~-----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---g~~p~~ 248 (613)
+..+.... ....+..|+|||.+.+ .++.++|||||||++|+|++|.+||........+ ..+.. +..+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL-ELISRLCGSPCPAV 241 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhh
Confidence 98664322 1123457999997753 3788999999999999999999999764433322 22221 111110
Q ss_pred -------------------------ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 249 -------------------------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 249 -------------------------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.....+..+.++|.+||+ +|.+||++.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 112357889999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=316.43 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=204.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC-
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN- 101 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~- 101 (613)
..+|| +..+.||+|+||+||+|.+..+|..||+|.++... ........+.+|+.+|+.++||||++++++|.....
T Consensus 13 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 13 VPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred cccce-EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34566 56799999999999999999999999999875321 233445678899999999999999999998764332
Q ss_pred ---CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 102 ---EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 102 ---~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
..+++||+|+ +++|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +.+.++|+|||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~ 164 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL 164 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeccc
Confidence 2468999998 7799888764 57999999999999999999999998 99999999999998 578999999999
Q ss_pred hHHHhhhc-cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC----------
Q 035992 179 AAILAQAR-SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK---------- 245 (613)
Q Consensus 179 a~~l~~~~-~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~---------- 245 (613)
+....... ...++..|+|||.+.+ .++.++|+||||+++|+|++|..||............+.....
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 87654322 2345678999998764 4889999999999999999999999765443332221111000
Q ss_pred ---------------C---CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 246 ---------------P---ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 246 ---------------p---~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+ ..+....+..+.++|.+||. +|.+|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 01123457789999999999 99999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=300.44 Aligned_cols=239 Identities=22% Similarity=0.400 Sum_probs=198.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-+++.+.||+|+||.||+|.. .|..||+|.++. ....+.+.+|+.+++.++|+|++++++++... +..+++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~l 77 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 77 (256)
T ss_pred hCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCC------CchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-CCceEE
Confidence 457789999999999999965 488899887652 23356788999999999999999999976543 456899
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+|||+.+++|.+++.+.+ .+++..+..++.||+.||+|||+++ ++||||||+||+++ +++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASS 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceeccc
Confidence 999999999999987654 4899999999999999999999998 99999999999998 678999999999875543
Q ss_pred hc-cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 AR-SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 ~~-~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.. ....+..|+|||++.. .++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.++++|
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li 232 (256)
T cd05082 155 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVM 232 (256)
T ss_pred cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHH
Confidence 22 2233457999998765 48899999999999999998 9999965 4566666667666443 34456788999999
Q ss_pred HHHhh-cccCCCCHHHHhc
Q 035992 262 EKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~ 279 (613)
.+||. +|.+|||+.++++
T Consensus 233 ~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 233 KQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 99999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=305.55 Aligned_cols=244 Identities=22% Similarity=0.382 Sum_probs=194.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEE-eeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk-~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
+++.+.||+|+||+||+|.+..+|..+++|+.. .............+..|+.+++.+.||||+++++++. ....++
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~---~~~~~~ 85 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP---GASLQL 85 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC---CCccEE
Confidence 367799999999999999998888754433322 1111222344567888999999999999999999763 235788
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
++||+.+|+|.+++... +.+++..+..|+.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+...
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceeccCC
Confidence 99999999999999764 57999999999999999999999998 99999999999998 5789999999999765322
Q ss_pred c------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 186 R------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 186 ~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
. ...++..|+|||.+. +.|+.++||||||+++|||++ |..||.+. ....+...+..+..+ ..+...+..+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQICTIDV 240 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCCCCCHHH
Confidence 1 223445899999875 459999999999999999998 99999664 444455555555433 3344567789
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..++.+||. +|.+||++.|+++
T Consensus 241 ~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 241 YMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 999999998 9999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=299.69 Aligned_cols=241 Identities=22% Similarity=0.396 Sum_probs=201.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
...+++.+.||.|+||.||+|.. .|+.||+|.++... ...+++.+|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 75 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPL 75 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCe
Confidence 44567889999999999999976 48899988876422 256789999999999999999999998754 5678
Q ss_pred EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++||||||+||+++ .++.++|+|||++...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEccccccccc
Confidence 99999999999999998765 7999999999999999999999998 99999999999998 6789999999999876
Q ss_pred hhhcc-CcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 183 AQARS-AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 183 ~~~~~-~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
..... ......|+|||.+. +.++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...++.+.+
T Consensus 153 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 230 (256)
T cd05039 153 SQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPHVEKGYRM-EAPEGCPPEVYK 230 (256)
T ss_pred ccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhcCCCC-CCccCCCHHHHH
Confidence 43222 22334799999765 458889999999999999997 9999965 4556666666655433 334556889999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+|.+||. +|.+||++.++++
T Consensus 231 li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHhccChhhCcCHHHHHH
Confidence 9999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.52 Aligned_cols=242 Identities=28% Similarity=0.410 Sum_probs=197.3
Q ss_pred eEeeeecccCceEEEEEEEcC-----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCC
Q 035992 29 RYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENE 102 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~-----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~ 102 (613)
++.++||+|+||+||+|.+.. ++..||+|+++.. ......+.+.+|+.+|+.+. ||||++++++|.. ..
T Consensus 40 ~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~--~~ 114 (400)
T cd05105 40 VLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK--SG 114 (400)
T ss_pred ehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CC
Confidence 566999999999999998643 3457998887532 23445678999999999996 9999999998854 56
Q ss_pred EEEEEEeccCCCCHHHHHHhC-----------------------------------------------------------
Q 035992 103 HINFITEIFTSGTLRQYRKKH----------------------------------------------------------- 123 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~----------------------------------------------------------- 123 (613)
.+++|||||.+|+|.+++.+.
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 799999999999999987642
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC
Q 035992 124 -------------------------------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 124 -------------------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~ 166 (613)
..+++..+..++.||+.||+|||+++ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~- 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA- 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-
Confidence 24778889999999999999999998 99999999999998
Q ss_pred CCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHH
Q 035992 167 NQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYK 238 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~ 238 (613)
..+.+||+|||++..+.... ...++..|||||.+.+ .++.++|||||||++|||++ |..||........++.
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 56789999999987653221 1234457999997754 58999999999999999997 9999977655566666
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+..+ ..+...+..+.++|.+||+ +|.+||++.+|.+
T Consensus 352 ~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 352 KIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 67666443 2345668899999999999 9999999888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=301.40 Aligned_cols=240 Identities=25% Similarity=0.435 Sum_probs=196.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||+||+|.+.. +..+|+|.++... ...+.+.+|+.++++++||||+++++++.. ...++++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK--QRPIYIV 77 (256)
T ss_pred eEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-----ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc--CCCcEEE
Confidence 4778999999999999997653 4569988766322 223568899999999999999999998743 4568999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.+||+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCc
Confidence 9999999999999774 46899999999999999999999998 99999999999998 56899999999987553321
Q ss_pred -----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 -----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
...++..|+|||.+.. .++.++|||||||++|+|++ |..||.... ...+...+..+..+ ..+...+..+++
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVEKVSQGLRL-YRPHLASEKVYA 232 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHhcCCCC-CCCCCCCHHHHH
Confidence 1123357999998764 58999999999999999998 999996544 45556666666443 234456889999
Q ss_pred HHHHHhh-cccCCCCHHHHhcC
Q 035992 260 FIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~H 280 (613)
++.+||. +|.+||++.+|+.+
T Consensus 233 li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 233 IMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHcCCCcccCCCHHHHHHh
Confidence 9999998 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.88 Aligned_cols=243 Identities=25% Similarity=0.432 Sum_probs=197.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCc--EEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGI--EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~--~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l 104 (613)
+++.++||+|+||.||+|.++.++. .+|+|.++. .......+.+.+|+.++.++ +||||+++++++.. ...+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~---~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 78 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE---FASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYL 78 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc---cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcc
Confidence 4778999999999999999887775 467766552 22345567789999999999 79999999998754 4578
Q ss_pred EEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 105 NFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
+++|||+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ ++||||||+|||++ .+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~ 155 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-EN 155 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CC
Confidence 99999999999999997643 4889999999999999999999998 99999999999998 56
Q ss_pred CcEEEeccchhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcC
Q 035992 169 GEVKIGDLGLAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g 243 (613)
+.+||+|||++...... .....+..|+|||.+.. .++.++|||||||++|||++ |..||.. .....++..+..+
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~ 234 (297)
T cd05089 156 LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQG 234 (297)
T ss_pred CeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcC
Confidence 79999999998643221 11112346999997754 58999999999999999997 9999966 4455566666665
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+ ..+..++..+++||.+||. +|.+||++.++++.
T Consensus 235 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433 2345678899999999999 99999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=306.80 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=197.1
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCC----------------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEG----------------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg----------------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN 88 (613)
++| ++.+.||+|+||.||+|.+...+ ..||+|.+... ......+.+.+|+.+++.++|||
T Consensus 5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 5 QPL-NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD---ASDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred hhC-cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhcCCCC
Confidence 445 78899999999999999876644 45787776532 23456778899999999999999
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-----------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL 157 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~-----------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDL 157 (613)
|++++++|.. +..++++||++.+++|.+++.+.. .+++..++.++.|++.||.|||+++ ++||||
T Consensus 81 i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dl 156 (296)
T cd05051 81 IARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDL 156 (296)
T ss_pred EeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--cccccc
Confidence 9999998854 457899999999999999998766 7999999999999999999999998 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh--cCCCCC
Q 035992 158 KCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT--FEYPYV 228 (613)
Q Consensus 158 Kp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt--G~~Pf~ 228 (613)
||+||+++ +.+.++|+|||++..+.... ...++..|||||.+.. .++.++|||||||++|||++ +..||.
T Consensus 157 kp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 157 ATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred chhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 99999998 56899999999987543221 2234458999997764 68999999999999999998 778886
Q ss_pred CCCcHHHHHHHHHcC------CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 229 ECTNAAQIYKKVTSG------IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 229 ~~~~~~~i~~~I~~g------~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.... .+++..+... ......+...+.++.++|.+||+ +|.+||++.+|++
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTD-QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcCh-HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 5443 3444444322 11112233456899999999999 9999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=303.41 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=196.1
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
|.++| ++.++||+|+||+||+|.+..++ .||+|.++.... ..+.+.+|+.+++.++||||+++++.+. ..
T Consensus 4 ~~~~~-~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~ 73 (262)
T cd05071 4 PRESL-RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS---EE 73 (262)
T ss_pred ChHHe-eEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC---CC
Confidence 45565 89999999999999999887654 599888764221 2356888999999999999999998753 23
Q ss_pred EEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 103 HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++|||+.+|+|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCcee
Confidence 578999999999999999764 45899999999999999999999998 99999999999998 67899999999987
Q ss_pred HHhhhc-----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 181 ILAQAR-----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 181 ~l~~~~-----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
.+.... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||... ....++..+..+... ......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 228 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPEC 228 (262)
T ss_pred eccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCcccc
Confidence 654322 122344799999765 458999999999999999999 88898654 344555666555332 234456
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+..+.++|.+||+ +|.+||++.+++.
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7889999999999 9999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.58 Aligned_cols=242 Identities=21% Similarity=0.378 Sum_probs=198.2
Q ss_pred eeEeeeecccCceEEEEEEEcCC-----CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELE-----GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~t-----g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+++.+.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.++||||+++++++.. ..
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 82 (277)
T cd05032 8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGVVST--GQ 82 (277)
T ss_pred eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC--CC
Confidence 36789999999999999988644 488998876532 233455678899999999999999999998754 46
Q ss_pred EEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 103 HINFITEIFTSGTLRQYRKKH----------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
..+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEE
Confidence 789999999999999998653 23678899999999999999999998 99999999999998 578999
Q ss_pred EeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCC
Q 035992 173 IGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 173 L~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
|+|||++..+.... ...++..|+|||.+. +.++.++||||||+++|||++ |..||.. .+...+.+.+..+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCC
Confidence 99999987654321 223456899999775 458999999999999999998 9999965 44555666666543
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+ .++...+..+.++|.+||+ +|.+|||+.+|+.
T Consensus 239 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 239 HL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 32 3445568899999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=351.67 Aligned_cols=245 Identities=31% Similarity=0.546 Sum_probs=204.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec-------------
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD------------- 98 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~------------- 98 (613)
++||+||||.||+++++-+|..||||.|.... +.....++.+|+.+|.+|+|||||+||.+|+.
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 78999999999999999999999988776432 45677889999999999999999999998860
Q ss_pred ---------------------------------------------------------------C----------------
Q 035992 99 ---------------------------------------------------------------T---------------- 99 (613)
Q Consensus 99 ---------------------------------------------------------------~---------------- 99 (613)
.
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred -------------------------CCCEEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHhhhhhcCCCCEE
Q 035992 100 -------------------------ENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEGLSYLHSHDPPVI 153 (613)
Q Consensus 100 -------------------------~~~~l~lV~E~~~gGsL~~~l~~~~~l-se~~i~~i~~QIl~gL~yLHs~~~~II 153 (613)
....+||-||||..-+|++++.++... ....++++++||+.||.|+|++| ||
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g--iI 719 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG--II 719 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc--ee
Confidence 004578899999998888888776654 57889999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEeccchhHHHh----------------------hhccCcccccccCcccccc----ccCcc
Q 035992 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAILA----------------------QARSAHSVIEFMAPELYEE----EYNEL 207 (613)
Q Consensus 154 HrDLKp~NILl~~~~g~VKL~DFGla~~l~----------------------~~~~~~gt~~YmAPEvl~~----~ys~k 207 (613)
||||||.|||++ ..+.|||+|||+|+... ......||.-|+|||++.. .|+.|
T Consensus 720 HRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 720 HRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999 66799999999998732 0113356778999998863 59999
Q ss_pred chhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 208 VDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 208 sDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+|+|||||+++||+. ||........+...+..+..|.. +....-+.-..+|++||+ ||++||||.|||++.||.
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 999999999999985 78766677778888888877655 222234556789999999 999999999999999998
Q ss_pred C
Q 035992 285 S 285 (613)
Q Consensus 285 ~ 285 (613)
.
T Consensus 876 p 876 (1351)
T KOG1035|consen 876 P 876 (1351)
T ss_pred c
Confidence 4
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.56 Aligned_cols=247 Identities=27% Similarity=0.467 Sum_probs=203.1
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.+.||+|+||+||+|.+..++..+++|+++...... .......+..|+.+++.++||||+++++++.. ....+++
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 80 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFCII 80 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceEEE
Confidence 67799999999999999998888888877776544321 23344567789999999999999999998754 4568999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+||+.+++|..++.+ ...+++..++.++.|++.||.|||+++ ++|+||||+||+++ .+.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceeecC
Confidence 999999999988753 357999999999999999999999998 99999999999997 3579999999987653
Q ss_pred hh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 184 QA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 184 ~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
.. ....++..|+|||.+.. .++.++|+||||+++|+|++|..||.. .........+..+..+ .++...+..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP-SLPETYSRQLN 234 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCCCC-CCcchhcHHHH
Confidence 32 12345668999997754 478899999999999999999999965 3444455555555433 34566788999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
++|.+||. +|.+||++.+++.||||
T Consensus 235 ~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 235 SIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 99999998 99999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.18 Aligned_cols=243 Identities=28% Similarity=0.417 Sum_probs=197.7
Q ss_pred cceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
+-+.+.+.||+|+||.||+|.+. .++..+++|.++.. .....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 78 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD-- 78 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc--
Confidence 44577899999999999999754 34566887766532 23445678899999999999999999998754
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEE
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV 164 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl 164 (613)
....++||||+.+++|.+++..++ .+++..++.++.||+.||.|||+++ ++||||||+|||+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~ 156 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV 156 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE
Confidence 557899999999999999997643 3899999999999999999999998 9999999999999
Q ss_pred eCCCCcEEEeccchhHHHhhh------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHH
Q 035992 165 NGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQI 236 (613)
Q Consensus 165 ~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i 236 (613)
+ .++.++|+|||++...... ....++..|+|||.+. ..++.++||||||+++|||+| |..||.... ....
T Consensus 157 ~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~ 234 (291)
T cd05094 157 G-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEV 234 (291)
T ss_pred c-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHH
Confidence 8 5689999999998754321 1223456899999775 458899999999999999999 999996644 4445
Q ss_pred HHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 237 YKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 237 ~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+.+..+..+ ..+...+..+.++|.+||+ +|.+||++.++++
T Consensus 235 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 5566665443 2345568889999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.49 Aligned_cols=243 Identities=27% Similarity=0.425 Sum_probs=199.8
Q ss_pred eeEeeeecccCceEEEEEEEcCC-----CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELE-----GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~t-----g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 101 (613)
+++.+.||+|+||.||+|.+... ...+|+|.++.. ........+.+|+.+++.+ +|+||+++++++.. +
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~ 88 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--E 88 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC---CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--C
Confidence 47789999999999999987644 378898876632 2345567789999999999 89999999998743 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 102 EHINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
..++++|||+.+|+|..++... +.+++..+..++.||+.||.|||+++ |+||||||+|||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~ 166 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT 166 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc
Confidence 5799999999999999998642 46899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~ 237 (613)
+++.+||+|||++..+.... ...++..|+|||.+.. .++.++|||||||++|||++ |..||.. ....+++
T Consensus 167 -~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~ 244 (293)
T cd05053 167 -EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELF 244 (293)
T ss_pred -CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHH
Confidence 67899999999998654321 1123457999997654 58999999999999999997 9999965 4555666
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+..+..+. .+...+..+.+|+.+||. +|.+|||+.+++++
T Consensus 245 ~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 245 KLLKEGYRME-KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHcCCcCC-CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6676665432 344567899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=300.41 Aligned_cols=233 Identities=21% Similarity=0.377 Sum_probs=187.5
Q ss_pred eeecccCceEEEEEEEcCCC----------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 32 EVLGRGAFKKVYRAFDELEG----------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg----------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
+.||+|+||.||+|.+..++ ..+++|.++... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR--- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec---
Confidence 47999999999999998777 346666544221 226788899999999999999999998765
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC-------cEEE
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG-------EVKI 173 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g-------~VKL 173 (613)
...++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+ .+||
T Consensus 73 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl 149 (259)
T cd05037 73 DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKL 149 (259)
T ss_pred CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEe
Confidence 35789999999999999998776 7999999999999999999999998 99999999999998 344 6999
Q ss_pred eccchhHHHhhhccCcccccccCcccccc---ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcc
Q 035992 174 GDLGLAAILAQARSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASL 249 (613)
Q Consensus 174 ~DFGla~~l~~~~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 249 (613)
+|||++..........+...|+|||++.. .++.++||||||+++|+|++ |..||...... .......... ..
T Consensus 150 ~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~~~~~~~---~~ 225 (259)
T cd05037 150 SDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKERFYQDQH---RL 225 (259)
T ss_pred CCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHHHHhcCC---CC
Confidence 99999987665444556678999998764 48899999999999999999 58888665432 2222222111 11
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+......+.++|.+||. +|.+||++.++++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22223789999999999 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=302.52 Aligned_cols=240 Identities=26% Similarity=0.436 Sum_probs=199.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||.|+||+||+|.+.. +..+|+|+++... ......+..|+.+++.++||||+++++++.. ...++++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD----LLKQQDFQKEVQALKRLRHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc----hhhHHHHHHHHHHHhcCCCcchhheeeeEec--CCCeEEE
Confidence 4677999999999999999887 8899998876432 2345678899999999999999999998754 4578999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++ +++.+||+|||++..+...
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCCc
Confidence 9999999999999863 46899999999999999999999998 99999999999998 6789999999999766432
Q ss_pred c----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 186 R----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
. ...++..|+|||.+.. .++.++||||||+++|+|++ |..||... +...++..+..+..+ ..+...+..+.+
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM-NNHEVYDQITAGYRM-PCPAKCPQEIYK 235 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC-CHHHHHHHHHhCCcC-CCCCCCCHHHHH
Confidence 1 1223457999997754 58899999999999999998 89999654 445555566655433 334567889999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+|.+||+ +|.+|||+.+|++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 236 IMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHHHcCCCchhCcCHHHHHH
Confidence 9999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=305.20 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=200.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.+.||+|++|.||+|.+..+|+.+|+|.++.... .......+..|+.+++.++|+||+++++++.. +..+++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCCEEEEE
Confidence 456889999999999999999999999998764332 23456778899999999999999999998754 46799999
Q ss_pred eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 109 EIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||.+.......
T Consensus 78 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 78 EFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred eccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcc
Confidence 99975 78777766 468999999999999999999999998 99999999999998 56899999999987664432
Q ss_pred ---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC---------------
Q 035992 187 ---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--------------- 246 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--------------- 246 (613)
...++..|+|||.+.. .++.++|+||||+++|+|++|+.||.......++.........+
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 2234557999997653 48899999999999999999999997655544443322211110
Q ss_pred ------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 ------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 ------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.......+..+++||.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 01122357789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=309.12 Aligned_cols=245 Identities=27% Similarity=0.483 Sum_probs=201.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
.+||+|+||.||+|.+..+|..||+|.+... .......+.+|+.+++.++|+||++++++|.. +...+++|||+
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 99 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFL 99 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecC
Confidence 6899999999999999999999999876532 23456678999999999999999999998864 56899999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----cc
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----RS 187 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~~ 187 (613)
.+++|.+++.. +.+++..++.++.|++.||+|||+++ ++||||+|+||+++ .++.++|+|||++...... ..
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~ 175 (292)
T cd06657 100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKS 175 (292)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccc
Confidence 99999998754 56899999999999999999999998 99999999999998 5689999999987654321 12
Q ss_pred CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC-cccccccHHHHHHHHHHh
Q 035992 188 AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA-SLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~l~~lI~~cL 265 (613)
..++..|+|||.+.. .++.++|+||||+++|+|++|..||.... .......+..+..+. ......+..+.++|.+||
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 254 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-PLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL 254 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence 345668999997754 58899999999999999999999996543 333334444332211 112346788999999999
Q ss_pred h-cccCCCCHHHHhcCCCCCCCC
Q 035992 266 A-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 266 ~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
. +|.+||++.+++.||||....
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 9 999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=306.44 Aligned_cols=243 Identities=27% Similarity=0.425 Sum_probs=197.9
Q ss_pred cceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
+-+++.++||+|+||+||+|.. ..++..+|+|.++. ......+.+.+|+.+++.++|+||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 78 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTVLQHQHIVRFYGVCTE-- 78 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc----CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--
Confidence 3457789999999999999964 33567888877653 234556789999999999999999999998754
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK---------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~---------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
....+++|||+.+|+|.+++.+.+ .+++..+..++.||+.||+|||+++ ++||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~ 156 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG 156 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc
Confidence 456899999999999999987753 4889999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhh------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~ 237 (613)
+++.+||+|||++...... ....+++.|+|||.+. ..++.++|||||||++|||++ |..||..... ....
T Consensus 157 -~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~ 234 (280)
T cd05092 157 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAI 234 (280)
T ss_pred -CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHH
Confidence 5789999999998654321 1122346799999765 458999999999999999998 8999966444 4445
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+..+ ..+...++.+.+||.+||+ +|.+||++.+|+.
T Consensus 235 ~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 555555433 3345678889999999998 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.83 Aligned_cols=255 Identities=28% Similarity=0.425 Sum_probs=203.8
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN-- 101 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~-- 101 (613)
..+| .+.+.||+|+||+||+|.+..++..||+|.+.... ........+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y-~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 14 PDRY-QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cCce-EEEEEeccCCceEEEEEEECCCCcEEEEEeccccc--chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 3455 67799999999999999999999999999775421 223455678889999999999999999987654322
Q ss_pred --CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 102 --EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 102 --~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
..+++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ +++.++|+|||++
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~ 165 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLA 165 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccc
Confidence 3589999998 6699998876 57999999999999999999999998 99999999999998 5789999999998
Q ss_pred HHHhhh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--C--------
Q 035992 180 AILAQA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--P-------- 246 (613)
Q Consensus 180 ~~l~~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p-------- 246 (613)
...... ....++..|+|||.+.+ .++.++|||||||++|+|++|..||....... .+..+..... +
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 166 RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHHHhhcc
Confidence 765432 23345668999998754 47899999999999999999999997644433 3333322110 0
Q ss_pred ----------------C---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 ----------------A---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 ----------------~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
. ......+..+.+||.+||+ +|.+|||+.+|+.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0 0112347889999999998 999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=320.36 Aligned_cols=268 Identities=22% Similarity=0.366 Sum_probs=227.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+..+||+|+||+|.+|..+.+.+.+|||++++.-..+ .++++--+.|.++|... +-|.+++++.+|.. -..+|||
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-dDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRLyFV 428 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRLYFV 428 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeee-cCcccceehhhhheecCCCCchHHHHHHHhhh--hhheeeE
Confidence 45689999999999999999999999999998655444 35566667788888777 46778888888754 4579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH----h
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL----A 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l----~ 183 (613)
|||+.||+|...++..+++.|..+..++.+|+-||-|||++| ||+||||.+|||++ ..|+|||+|||+++.- .
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCc
Confidence 999999999999999999999999999999999999999999 99999999999998 5689999999998743 2
Q ss_pred hhccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 184 QARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 184 ~~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
..++++||+.|+|||++. +.|+..+|+||+|++||||+.|++||.+ .+..++++.|+... ..+++..+.++..++.
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~ehn--vsyPKslSkEAv~ick 582 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEHN--VSYPKSLSKEAVAICK 582 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcc--CcCcccccHHHHHHHH
Confidence 345789999999999776 5699999999999999999999999955 77888888888653 4567888999999999
Q ss_pred HHhh-cccCCCC-----HHHHhcCCCCCCCCcccc-----cccccccccCCccc
Q 035992 263 KCIA-EVSERLP-----AKELLGDPFLQSEDDESV-----GRSLRVKTHYSAET 305 (613)
Q Consensus 263 ~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~-----~~~~~~~~~~~~~~ 305 (613)
..|. .|.+|+. -+++-.||||+.++|+.+ .++.+|+.+...+.
T Consensus 583 g~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~ 636 (683)
T KOG0696|consen 583 GLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDA 636 (683)
T ss_pred HHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCch
Confidence 9998 8999986 478999999999988654 44555555443333
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=303.65 Aligned_cols=245 Identities=28% Similarity=0.466 Sum_probs=195.1
Q ss_pred ceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
-+++.+.||+|+||+||+|. +..++..||+|.++.. .....+.+.+|+++++.++||||+++++++......
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 34778999999999999997 4567899999887632 345567889999999999999999999987666666
Q ss_pred EEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~ 157 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKV 157 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCccccc
Confidence 799999999999999999765 46899999999999999999999998 99999999999997 568999999999986
Q ss_pred Hhhhcc-------CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH---------------HHHHH
Q 035992 182 LAQARS-------AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA---------------AQIYK 238 (613)
Q Consensus 182 l~~~~~-------~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~---------------~~i~~ 238 (613)
+..... ..+...|+|||.+.+ .++.++||||||+++|||++|..|+...... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 543221 112235999998764 4899999999999999999988776432110 01111
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+..+ ..+...+..+.+||.+||. +|.+|||+.++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 238 LLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22222221 2234567889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.34 Aligned_cols=237 Identities=19% Similarity=0.321 Sum_probs=188.2
Q ss_pred eeecccCceEEEEEEEcCCCcE-------EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIE-------VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~-------VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+.||+|+||+||+|.+...+.. ||+|.+... .....+.+..|+.+++.++||||+++++++.. +...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC--GDES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--CCCc
Confidence 4799999999999988665543 776665421 23445678889999999999999999998865 3468
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC-------cEEEecc
Q 035992 105 NFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG-------EVKIGDL 176 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g-------~VKL~DF 176 (613)
++||||+.+|+|..++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+||+++.+.. .++++||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEeccc
Confidence 89999999999999997754 5899999999999999999999998 999999999999974322 3799999
Q ss_pred chhHHHhhhccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcC-CCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 177 GLAAILAQARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFE-YPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 177 Gla~~l~~~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~-~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
|++..........++..|+|||.+.. .++.++||||||+++|+|++|. .||.... ........... ..++...
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~~~~~~~~~~~---~~~~~~~ 228 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-SQKKLQFYEDR---HQLPAPK 228 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-HHHHHHHHHcc---ccCCCCC
Confidence 99876655545567778999998864 4789999999999999999984 6664433 33222222221 2233345
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+..+.++|.+||+ +|.+|||++++++.
T Consensus 229 ~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 229 WTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 6789999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=305.31 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=200.0
Q ss_pred CCcceeEeeeecccCceEEEEEEE----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFD----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
++|++++.+.||+|+||.||+|.. ..++..||+|.++.. ........+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (284)
T cd05079 2 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTED 78 (284)
T ss_pred chhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 467888899999999999999974 467889998887532 2345567899999999999999999999988765
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
....++++|||+.+++|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||+
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~ 155 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGL 155 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCcc
Confidence 556789999999999999998765 46899999999999999999999998 99999999999998 578999999999
Q ss_pred hHHHhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC--------------cHHHH
Q 035992 179 AAILAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT--------------NAAQI 236 (613)
Q Consensus 179 a~~l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~--------------~~~~i 236 (613)
+..+.... ...++..|+|||.+.+ .++.++||||||+++|||+++..|+.... .....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 87654321 2234457999997654 58899999999999999999877653211 11112
Q ss_pred HHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 237 YKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 237 ~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
...+..+... ..+..++..+.+||.+||+ +|.+||++.++++.
T Consensus 236 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 236 VRVLEEGKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHHcCccC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 2223333222 2234567899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.26 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=204.4
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcC----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDEL----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
+..+.-+++.++||+|+||+||+|.+.. ++..||+|.++. .......+.+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~---~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~ 78 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD---HASEIQVTLLLQESCLLYGLSHQNILPILHVCI 78 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC---CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3455556889999999999999999876 357888877652 234566788899999999999999999999865
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKH--------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~--------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
.. +...+++++|+.+|+|..++... ..+++..+..++.||+.||+|||+++ ++||||||+||+++ ..+
T Consensus 79 ~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~ 154 (280)
T cd05043 79 ED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EEL 154 (280)
T ss_pred cC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCC
Confidence 43 45688999999999999998764 45899999999999999999999998 99999999999998 568
Q ss_pred cEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHH
Q 035992 170 EVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~ 241 (613)
.+||+|||++..+.... ...++..|+|||.+.. .++.++||||||+++|||++ |..||... +...+...+.
T Consensus 155 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~ 233 (280)
T cd05043 155 QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLK 233 (280)
T ss_pred cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHH
Confidence 99999999997653221 1233457999997754 48999999999999999999 99999664 5666777776
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+. .....+..+.+++.+||. +|++|||+.+++.
T Consensus 234 ~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 DGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 664432 234567889999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=308.08 Aligned_cols=243 Identities=27% Similarity=0.422 Sum_probs=200.0
Q ss_pred eeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 101 (613)
+.+.+.||+|+||.||+|.+ ..++..||+|.++... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 111 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNLLGACTI--G 111 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence 46789999999999999975 3456689988765322 245567889999999999 79999999998754 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
..++++|||+.+|+|..++.+.. .+++.++..++.||+.||.|||+++ ++|+||||+|||++ ..+.++|+|||++
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCccc
Confidence 57899999999999999987643 3899999999999999999999998 99999999999997 6679999999998
Q ss_pred HHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 180 AILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 180 ~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
..+.... ...++..|+|||.+. ..++.++||||||+++|+|++ |..||........+.+.+..+..+ ..+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCC
Confidence 7653321 122345799999765 458999999999999999998 999997766666666666655433 3344
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+.+||.+||. +|.+||++.+++.
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 568899999999998 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.22 Aligned_cols=250 Identities=24% Similarity=0.459 Sum_probs=201.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
+++.+.||+|+||+||+|.+..+|..||+|.++... .......+..|+.++..+ .||||+++++++.. ...+++
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~ 91 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFI 91 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEE
Confidence 477899999999999999999999999999887432 234455667788777666 49999999998865 457999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+|||+. ++|..++.. .+.+++..+..++.||+.||.|||+ ++ |+||||+|+||+++ +++.+||+|||++..+..
T Consensus 92 v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 92 CMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccC
Confidence 999985 477777665 4679999999999999999999997 46 99999999999998 678999999999876543
Q ss_pred hc---cCcccccccCcccccc-----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc-ccccccH
Q 035992 185 AR---SAHSVIEFMAPELYEE-----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-LAKVADN 255 (613)
Q Consensus 185 ~~---~~~gt~~YmAPEvl~~-----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~-l~~~~s~ 255 (613)
.. ...++..|+|||.+.. .++.++||||||+++|+|++|..||.......+.+..+.....+.. ....++.
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 22 2235568999998753 3788999999999999999999999765444455555554432221 1224678
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+.+||.+||. +|.+||++.+++.||||+..
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 89999999999 99999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.96 Aligned_cols=242 Identities=24% Similarity=0.401 Sum_probs=201.2
Q ss_pred eeeecccCceEEEEEEEcCCCc---E-EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGI---E-VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~---~-VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.++||+|+||.||+|..+..+. . ||+|..+.. .......+..+++|+++|++++|||||++||+.+. ...+++
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~--~~Pl~i 238 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL--EEPLML 238 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC--CCccEE
Confidence 4899999999999998876533 3 898887742 22356888999999999999999999999997655 557999
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+|.||+|.+|+++.+ .++..+...++.+.+.||+|||+++ +|||||-..|+|+. ..+.+||+|||++......
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcce
Confidence 999999999999999987 4999999999999999999999999 99999999999997 5567899999998765421
Q ss_pred cc---Cc-ccccccCccccccc-cCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 186 RS---AH-SVIEFMAPELYEEE-YNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 186 ~~---~~-gt~~YmAPEvl~~~-ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.. .. -.+.|+|||.+... |+.++|||||||++||+.+ |..||.+.. ..++..+|.....+..++...+..+..
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~-~~~v~~kI~~~~~r~~~~~~~p~~~~~ 394 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK-NYEVKAKIVKNGYRMPIPSKTPKELAK 394 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC-HHHHHHHHHhcCccCCCCCCCHHHHHH
Confidence 11 11 22489999988765 9999999999999999998 888997754 456667774433444556677889999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++.+|+. +|.+||++.++.+
T Consensus 395 ~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 395 VMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHhccCChhhccCHHHHHH
Confidence 9999999 9999999888764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=300.90 Aligned_cols=240 Identities=23% Similarity=0.413 Sum_probs=196.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+|+.+++.++||||+++++++. ....+++|
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 77 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-----MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIV 77 (256)
T ss_pred cchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEE
Confidence 577899999999999999876 46689988765322 12345778999999999999999999874 34578999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+++|.+++.+. +.+++..+..++.||+.||.|||+++ ++||||||+||+++ +++.+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceeccccc
Confidence 9999999999998764 56899999999999999999999998 99999999999998 67899999999987553321
Q ss_pred c-----CcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 S-----AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 ~-----~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
. ..++..|+|||.+. ..++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+...+..+.+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYT 232 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHH
Confidence 1 11224799999776 458999999999999999999 89999654 445566666665433 334567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcC
Q 035992 260 FIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~H 280 (613)
++.+||. +|.+|||+.++++.
T Consensus 233 li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 233 IMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHhcCChhhCcCHHHHHHH
Confidence 9999998 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=346.72 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=197.1
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+|| ++.++||+|+||+||+|.+..+|+.||+|+++.. ........+++.+|+.+++.++||||+++++++.+ +...
T Consensus 2 grY-eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~-l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~~~l 77 (932)
T PRK13184 2 QRY-DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIRED-LSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD--GDPV 77 (932)
T ss_pred CCe-EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcc-cccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--CCEE
Confidence 455 7789999999999999999999999999988642 23344556789999999999999999999998754 5689
Q ss_pred EEEEeccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 105 NFITEIFTSGTLRQYRKKH-----------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
+++|||+.||+|.+++.+. ..++...+..++.||+.||+|||+++ |+||||||+|||++ ..|.++|
T Consensus 78 yLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKL 154 (932)
T PRK13184 78 YYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVI 154 (932)
T ss_pred EEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEE
Confidence 9999999999999988642 23566788899999999999999998 99999999999998 6789999
Q ss_pred eccchhHHHhh----------------------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC
Q 035992 174 GDLGLAAILAQ----------------------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC 230 (613)
Q Consensus 174 ~DFGla~~l~~----------------------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~ 230 (613)
+|||++..... .....|++.|||||++.+ .++.++|||||||++|||+||..||...
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999976511 012357889999998764 5899999999999999999999999764
Q ss_pred CcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 231 TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 231 ~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
......+................++.+.+++.+||. +|.+|++..+.+.
T Consensus 235 ~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 235 KGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred chhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 433333222221111111123467889999999999 9999988655543
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=297.91 Aligned_cols=240 Identities=22% Similarity=0.383 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEEcC---CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~---tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+.||+|+||+||+|.+.. .+..||+|.+.. .......+.+.+|+.+++.++||||+++++++... +...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~---~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR---ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc---cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEE
Confidence 468999999999998654 345788776542 22345677889999999999999999999976543 34578999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 109 EIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+|||++ ..+.+||+|||++..+...
T Consensus 77 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 77 PYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcc
Confidence 999999999998764 45788888999999999999999998 99999999999998 5789999999998754321
Q ss_pred ------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhc-CCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 186 ------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 186 ------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG-~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
....++..|+|||.+. ..++.++||||||+++|||++| .+||.. .+...+...+..+..+ ..+...+..+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL-LQPEYCPDPL 231 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHH
Confidence 1122345799999775 4589999999999999999995 555643 4555666666665433 2344567889
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+++.+||. +|.+||++.+++..
T Consensus 232 ~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 232 YEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.15 Aligned_cols=240 Identities=21% Similarity=0.323 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+.||+|+||.||+|... .++..+|+|.++... .......+.+|+.+++.++||||+++++++.. ...+++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEEEEE
Confidence 36899999999999754 355678887665322 23445578889999999999999999998754 456899999
Q ss_pred ccCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 110 IFTSGTLRQYRKKHK-----HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~-----~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+.+|+|.+++.... ..++..+..++.|++.||+|||+++ ++||||||+||+++ ..+.+||+|||++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~ 152 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYK 152 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccC
Confidence 999999999987532 4577788899999999999999998 99999999999998 568999999999865332
Q ss_pred h------ccCcccccccCcccccc--------ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCC---C
Q 035992 185 A------RSAHSVIEFMAPELYEE--------EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIK---P 246 (613)
Q Consensus 185 ~------~~~~gt~~YmAPEvl~~--------~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~---p 246 (613)
. ....++..|+|||++.. .++.++||||||+++|||++ |..||....+.......+..... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T cd05087 153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK 232 (269)
T ss_pred cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC
Confidence 1 12234567999998753 25789999999999999996 99999765554444333333221 1
Q ss_pred CcccccccHHHHHHHHHHhhcccCCCCHHHHhc
Q 035992 247 ASLAKVADNGVRAFIEKCIAEVSERLPAKELLG 279 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~dP~~Rpta~eLL~ 279 (613)
+.+....+..+.+++++|+.+|.+|||+.+|+.
T Consensus 233 ~~~~~~~~~~~~~l~~~c~~~P~~Rpt~~~l~~ 265 (269)
T cd05087 233 PRLKLPLSDRWYEVMQFCWLQPEQRPSAEEVHL 265 (269)
T ss_pred CccCCCCChHHHHHHHHHhcCcccCCCHHHHHH
Confidence 222334678899999999989999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.16 Aligned_cols=242 Identities=21% Similarity=0.328 Sum_probs=185.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
+.||+|+||+||+|..... ..++.++++...........+.+.+|+.+++.++||||+++++.|.. ...++++|||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTD-TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcC-CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecC
Confidence 3699999999999975433 23333334433333334566789999999999999999999998864 45789999999
Q ss_pred CCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh----
Q 035992 112 TSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA---- 183 (613)
Q Consensus 112 ~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~---- 183 (613)
.+|+|.+++.+. ..+++..++.++.||+.||+|||+++ ++||||||+|||++ ..+.++|+|||++....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcchh
Confidence 999999998764 34677888999999999999999998 99999999999998 56899999999875321
Q ss_pred --hhccCcccccccCcccccc--------ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCC---CCCcc
Q 035992 184 --QARSAHSVIEFMAPELYEE--------EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGI---KPASL 249 (613)
Q Consensus 184 --~~~~~~gt~~YmAPEvl~~--------~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~---~p~~l 249 (613)
......++..|+|||++.. .++.++||||||+++|||++ |..||........+...+..+. ..+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 1123345678999998642 35778999999999999997 5678866554443333333221 11233
Q ss_pred cccccHHHHHHHHHHhhcccCCCCHHHHhc
Q 035992 250 AKVADNGVRAFIEKCIAEVSERLPAKELLG 279 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~dP~~Rpta~eLL~ 279 (613)
...++..+.+++..||.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~l~~~c~~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCWLSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHhhCcccCCCHHHHHH
Confidence 445788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=339.76 Aligned_cols=150 Identities=27% Similarity=0.390 Sum_probs=133.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
-.-|++.+.||+|+||+||+|.+..+++.||+|+++.... ........+..|+.+++.++||||++++.++.. ...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--CCEE
Confidence 3345788999999999999999999999999999875443 334556788999999999999999999987754 4589
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
|+||||+.+++|.+++...+.+++..++.|+.||+.||+|||.++ ||||||||+|||++ ..+.+||+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~-~~g~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEc-CCCCEEEEeCCCCc
Confidence 999999999999999998889999999999999999999999998 99999999999998 57899999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=300.42 Aligned_cols=249 Identities=29% Similarity=0.409 Sum_probs=195.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCCcceeeeeeecCCC---
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVDTEN--- 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~~~~--- 101 (613)
|++.+.||+|+||.||+|.++.++..||+|.++.... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 78 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE 78 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence 3677999999999999999999999999998875332 222334566788777666 59999999999865432
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
..++++|||+.+ +|.+++.+.. .+++..++.++.||+.||.|||+++ ++|+||+|+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~ 154 (287)
T cd07838 79 LKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLA 154 (287)
T ss_pred ceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcc
Confidence 248999999975 8988887643 5999999999999999999999998 99999999999998 4589999999998
Q ss_pred HHHhhhc---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-C---------
Q 035992 180 AILAQAR---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-K--------- 245 (613)
Q Consensus 180 ~~l~~~~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-~--------- 245 (613)
..+.... ...++..|+|||.+.+ .++.++||||||+++|+|++|.+||......+. +.++.... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCCC
Confidence 7654322 2235568999997754 588999999999999999999999976544333 33332210 0
Q ss_pred ------------C---CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 246 ------------P---ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 246 ------------p---~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
+ .......+..+.++|.+||+ +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00011235678899999998 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.51 Aligned_cols=241 Identities=24% Similarity=0.410 Sum_probs=196.9
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..+++.+.||+|+||.||+|.+. ++..||+|.++... ...+.+.+|+.++++++||||+++++++.. ...++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL--EEPIY 77 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-----ccHHHHHHHHHHHHHCCCCCccceeEEEec--CCCee
Confidence 33588899999999999999875 45789988876422 224568889999999999999999998754 45689
Q ss_pred EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++|||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ ..+.++|+|||++....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIK 154 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEcc
Confidence 9999999999999997654 7999999999999999999999998 99999999999998 56899999999987654
Q ss_pred hhc--cCcc---cccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 QAR--SAHS---VIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~~~--~~~g---t~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
... ...+ ...|+|||.+.. .++.++||||||+++|||++ |+.||... +...++..+...... ..+...+..
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (261)
T cd05068 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGCPKE 232 (261)
T ss_pred CCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHH
Confidence 321 1112 237999997764 58999999999999999999 99999664 445555566554332 234456789
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhc
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+.+++.+||+ +|.+||++.+|++
T Consensus 233 ~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 233 LYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=300.90 Aligned_cols=242 Identities=26% Similarity=0.444 Sum_probs=200.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCc----EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGI----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~----~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
.+++.+.||+|+||+||+|.++.+|. .+|+|.++.. ........+.+|+.+++.++||||+++++++.. .
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDEAYVMASVDHPHVVRLLGICLS---S 81 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---C
Confidence 34788999999999999999877765 5787765432 234566788999999999999999999998764 5
Q ss_pred EEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++|||+.+|+|.+++.+. ..+++..+..|+.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++..
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~ 158 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKL 158 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCccccc
Confidence 789999999999999998875 56999999999999999999999988 99999999999997 567999999999986
Q ss_pred Hhhhcc------CcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 182 LAQARS------AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 182 l~~~~~------~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
+..... ..++..|+|||.+. ..++.++|+||||+++|||++ |..||... ....+...+..+... ..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 236 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERL-PQPPIC 236 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCCCC
Confidence 643221 11234799999775 458999999999999999998 99999664 556677777765432 334457
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+..+.+++.+||. +|.+||++.++++
T Consensus 237 ~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 237 TIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 7889999999998 9999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=297.89 Aligned_cols=242 Identities=24% Similarity=0.430 Sum_probs=197.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCc---EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGI---EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~---~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+...+.||+|+||.||+|.++.++. .+|+|.++.. ......+.+..|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 81 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG---YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK--FKPA 81 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc--CCCc
Confidence 4678999999999999999887665 6787766532 234556778999999999999999999998754 4578
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++|||+.+++|.+++.+. +.+++..+..++.|++.||+|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceecc
Confidence 9999999999999998764 67899999999999999999999998 99999999999998 57799999999987654
Q ss_pred hhcc-------CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 184 QARS-------AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 184 ~~~~-------~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.... ......|+|||++.. .++.++||||||+++|||++ |..||.... ...+...+..+... ......+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~~~~ 236 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-NHEVMKAINDGFRL-PAPMDCP 236 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-HHHHHHHHhcCCCC-CCCCCCC
Confidence 3211 111236999997764 58999999999999999998 999996644 44566666554322 2233467
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+.+++.+||+ +|.+||++.++++
T Consensus 237 ~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 237 SAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 889999999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=301.76 Aligned_cols=247 Identities=30% Similarity=0.404 Sum_probs=198.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|....+++.||+|.+..... ........+|+..+++++ ||||+++++++.. +...++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY---SWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc---chhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEE
Confidence 3677999999999999999999999999988764221 123334567999999999 9999999998765 568999
Q ss_pred EEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||||+ +|+|.+++.... .+++..+..++.||+.+|.|||+++ ++|+||+|+||+++ ..+.++|+|||++.....
T Consensus 76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRS 151 (283)
T ss_pred EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccC
Confidence 99999 789998887764 7899999999999999999999998 99999999999998 578999999999876543
Q ss_pred hc---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-------------
Q 035992 185 AR---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP------------- 246 (613)
Q Consensus 185 ~~---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p------------- 246 (613)
.. ...++..|+|||++.. .++.++|+||||+++++|++|.+||.........++.......+
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 21 2345668999997743 47899999999999999999999997655544443322111000
Q ss_pred -----------C---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 247 -----------A---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 247 -----------~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
. .+....+..+.+||.+||+ +|.+||+++|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0011225789999999999 99999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.56 Aligned_cols=253 Identities=28% Similarity=0.408 Sum_probs=198.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
.|| .+.+.||+|+||.||+|.+..+|+.||+|.++... ......+.+.+|+.++++++||||+++++++....
T Consensus 17 ~~y-~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 17 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred Cce-EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc--hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 455 67799999999999999999999999998876422 22334567889999999999999999999875322
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...++++++++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEecccccc
Confidence 23467788776 7899887765 46999999999999999999999998 99999999999998 67899999999987
Q ss_pred HHhhhc-cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-------------
Q 035992 181 ILAQAR-SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI------------- 244 (613)
Q Consensus 181 ~l~~~~-~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~------------- 244 (613)
...... ...++..|+|||.+.+ .++.++||||||+++|+|++|..||........+ ..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHhhccc
Confidence 654322 2345678999997754 4788999999999999999999999654333222 2221100
Q ss_pred -------------CCCc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 245 -------------KPAS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 245 -------------~p~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.... .....++.+.+||.+||+ +|.+||++.+++.||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 0000 011246789999999999 99999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=298.28 Aligned_cols=238 Identities=27% Similarity=0.424 Sum_probs=193.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||+||+|.+..++ .+|+|.+.... ...+.+.+|+.+++.++||||+++++++. ....+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v 78 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS---EEPIYIV 78 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc---CCCcEEE
Confidence 478899999999999999876554 58888765322 22356788999999999999999998763 2457899
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ +++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEccCC
Confidence 9999999999999764 34899999999999999999999998 99999999999998 6789999999999765332
Q ss_pred c-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 R-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
. ...++..|+|||.... .++.++||||||+++|+|++ |..||.+... ......+..+..+ ..+...+..++
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-REVLEQVERGYRM-PCPQGCPESLH 233 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC-CCCcccCHHHH
Confidence 1 1223457999997754 58899999999999999999 8999976444 4455556555333 23445678999
Q ss_pred HHHHHHhh-cccCCCCHHHHhc
Q 035992 259 AFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++|.+||. +|.+||+++++++
T Consensus 234 ~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 234 ELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHHHccCCcccCcCHHHHHH
Confidence 99999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=311.26 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=199.0
Q ss_pred eeEeeeecccCceEEEEEEEcCC--CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecC--CCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELE--GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT--ENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~t--g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~--~~~ 102 (613)
|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+.+|+.+++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 47789999999999999999888 9999999876321 2233456788899999999 599999999875432 234
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.++++++|+. ++|..++.....+++..++.++.||+.||+|||+++ ++||||||+|||++ .++.+||+|||++..+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGF 155 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceec
Confidence 5788888885 689999988889999999999999999999999998 99999999999998 5689999999998755
Q ss_pred hhh--------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc----------
Q 035992 183 AQA--------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---------- 242 (613)
Q Consensus 183 ~~~--------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---------- 242 (613)
... ....++..|+|||.+.+ .++.++||||||+++|+|++|..||....... ....+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEETL 234 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 321 12246678999997643 48999999999999999999999996543222 1111110
Q ss_pred ----------------CCCCCc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 243 ----------------GIKPAS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 243 ----------------g~~p~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...... .....+..+++||.+||+ +|.+|||+.+++.||||+.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 000111 112347789999999999 99999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=297.94 Aligned_cols=243 Identities=23% Similarity=0.392 Sum_probs=198.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCc---EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGI---EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~---~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+++.+.||+|+||.||+|.++.++. .||+|.++.. ........+..|+.+++.++||||+++++++.. +..
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC--CCc
Confidence 45889999999999999999887765 5998876532 245567789999999999999999999998743 557
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
++++|||+.+|+|.+++... +.+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFL 156 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCcccccc
Confidence 89999999999999998764 56899999999999999999999998 99999999999998 5679999999998765
Q ss_pred hhhcc-------Ccc--cccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 183 AQARS-------AHS--VIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 183 ~~~~~-------~~g--t~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
..... ..+ +..|+|||.+.. .++.++||||||+++|||++ |..||.... ...+...+...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~ 234 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-NQDVINAIEQDYRL-PPPM 234 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC-HHHHHHHHHcCCcC-CCcc
Confidence 43211 111 236999998764 58999999999999999886 999997643 44555566544322 2234
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+.+++.+||. +|.+||++.+++.
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 235 DCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 567889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.29 Aligned_cols=237 Identities=24% Similarity=0.420 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
++||+|+||.||+|.+.. ++.||+|.++... .......+..|+.++++++|+||+++++++.. ....+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTL---PPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcC
Confidence 479999999999999887 9999988776433 22456788999999999999999999998754 45789999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc----
Q 035992 112 TSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---- 186 (613)
Q Consensus 112 ~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 186 (613)
.+++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||||+|||++ ..+.++|+|||++.......
T Consensus 75 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 75 PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceec
Confidence 999999998664 56899999999999999999999998 99999999999998 56799999999987654211
Q ss_pred --cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 187 --SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 187 --~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....+..|+|||.+.+ .++.++||||||+++|+|+| |..||.... .......+..+. ....+...+..+.++|.
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 229 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS-NQQTRERIESGY-RMPAPQLCPEEIYRLML 229 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC-HHHHHHHHhcCC-CCCCCccCCHHHHHHHH
Confidence 1112346999997754 58999999999999999999 888986543 444555555443 22334566789999999
Q ss_pred HHhh-cccCCCCHHHHhc
Q 035992 263 KCIA-EVSERLPAKELLG 279 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~ 279 (613)
+||. +|.+||++.|+++
T Consensus 230 ~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 230 QCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHhccChhhCcCHHHHHH
Confidence 9998 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.59 Aligned_cols=245 Identities=28% Similarity=0.452 Sum_probs=199.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSW 96 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 96 (613)
.+| .+.+.||+|+||+||+|.+.. ++..+|+|.++.. ........+..|+.+++.+ +||||+++++++
T Consensus 18 ~~~-~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 18 DRL-VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred HHe-EEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC---CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 344 788999999999999998643 3356888876632 2345567788999999999 799999999987
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCC
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~ 160 (613)
.. ...+++||||+.+|+|.+++.+.+ .++...+..++.||+.||+|||+++ ++||||||+
T Consensus 94 ~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~ 169 (307)
T cd05098 94 TQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 169 (307)
T ss_pred ec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHH
Confidence 54 457899999999999999997642 4888999999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHHhhhc----c--CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCc
Q 035992 161 NIFVNGNQGEVKIGDLGLAAILAQAR----S--AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTN 232 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l~~~~----~--~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~ 232 (613)
|||++ .++.+||+|||++....... . ...+..|||||.+.+ .++.++|||||||++|||++ |..||.. .+
T Consensus 170 Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~ 247 (307)
T cd05098 170 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP 247 (307)
T ss_pred heEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CC
Confidence 99998 56899999999987553211 1 122357999997754 58999999999999999998 8888854 56
Q ss_pred HHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 233 ~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
...+...+..+..+ ..+...+..+.+||.+||. +|.+||++.+++.+
T Consensus 248 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 248 VEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 67777777666433 3455678899999999998 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.40 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=196.6
Q ss_pred eeEeeeecccCceEEEEEEEcC-----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~-----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+++.+.||+|+||+||+|.+.. ....+|+|.++.. ........+.+|+.+++.++||||+++++.+.. ..
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 76 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ--DG 76 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC---CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec--CC
Confidence 3677999999999999998753 2356887766532 234556789999999999999999999998754 45
Q ss_pred EEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCC
Q 035992 103 HINFITEIFTSGTLRQYRKKH------------------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLK 158 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLK 158 (613)
..++++||+.+|+|.+++.+. ..+++..+..++.|++.||+|||+++ ++|||||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dik 154 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLA 154 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhh
Confidence 688999999999999998653 24788999999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCC
Q 035992 159 CDNIFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVEC 230 (613)
Q Consensus 159 p~NILl~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~ 230 (613)
|+|||++ +++.+||+|||++...... ....++..|+|||.+.. .++.++||||||+++|||++ |..||..
T Consensus 155 p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~- 232 (290)
T cd05045 155 ARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG- 232 (290)
T ss_pred hheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC-
Confidence 9999998 5789999999998754321 12233458999997654 58999999999999999999 9999955
Q ss_pred CcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 231 TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 231 ~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+.+.+..+..+. .+...+..+.+||.+||+ +|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTGYRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCCCCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 45666776666654332 345677899999999998 9999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.90 Aligned_cols=238 Identities=26% Similarity=0.431 Sum_probs=195.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.++||+|+||+||+|... ++..||+|.+.... .....+.+|+.+++.++|+||+++++++. ...++++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v 78 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-----MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYII 78 (260)
T ss_pred ceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEE
Confidence 478899999999999999854 67889998876322 23457889999999999999999999753 3458999
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++.+. ..+++..+..++.|++.||+|||+++ ++||||||+||+++ +++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecCCC
Confidence 9999999999998753 46899999999999999999999998 99999999999998 6789999999998765421
Q ss_pred c-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 R-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
. ...++..|+|||.+.. .++.++||||||+++|||++ |+.||.... ...+...+..+..+ ..+...+..+.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-NPEVIQNLERGYRM-PRPDNCPEELY 233 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-hHHHHHHHHcCCCC-CCCCCCCHHHH
Confidence 1 1223457999998764 48899999999999999999 999997644 44555556555433 23445678999
Q ss_pred HHHHHHhh-cccCCCCHHHHhc
Q 035992 259 AFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++|.+||. +|.+||++.+++.
T Consensus 234 ~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 234 ELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 99999999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=302.80 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=198.5
Q ss_pred eeEeeeecccCceEEEEEEEcC-----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~-----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+++.+.||+|+||+||+|.+.. .+..||+|.++.. ......+.+..|+.+++.++||||+++++++.. ..
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~ 81 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK---AEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK--EQ 81 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CC
Confidence 4677999999999999998754 3578998887632 233455778899999999999999999998754 45
Q ss_pred EEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC
Q 035992 103 HINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~ 166 (613)
.+++++||+.+++|.+++... ..+++..+..++.|++.||.|||+++ |+||||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~- 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF- 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-
Confidence 689999999999999998532 34888999999999999999999998 99999999999998
Q ss_pred CCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHH
Q 035992 167 NQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYK 238 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~ 238 (613)
+++.+||+|||++..+.... ...+++.|+|||.+. +.++.++|||||||++|||++ |..||.+ .....++.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05091 159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIE 237 (283)
T ss_pred CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 56789999999987553221 223345899999765 458999999999999999998 8888865 44556777
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+..+..+ ..+..++..+.+++.+||+ +|.+||++++++..
T Consensus 238 ~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 77766533 2345678889999999998 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.30 Aligned_cols=238 Identities=25% Similarity=0.422 Sum_probs=191.7
Q ss_pred eeecccCceEEEEEEEcCCCcE--EEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIE--VAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~--VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++||+|+||.||+|.+..++.. +|+|.++. .......+.+..|+.+++++ +||||+++++++.. ...++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc---cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEE
Confidence 4699999999999999888764 57666542 22345567888999999999 89999999998754 45689999
Q ss_pred eccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 109 EIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
||+.+|+|.+++.+.+ .+++..+..++.|++.||+|||+++ ++||||||+||+++ .++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEE
Confidence 9999999999987643 4789999999999999999999988 99999999999998 568999
Q ss_pred EeccchhHHHhh---hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 173 IGDLGLAAILAQ---ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 173 L~DFGla~~l~~---~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
|+|||++..... ......+..|+|||++.. .++.++||||||+++|||++ |..||.. .+....+..+..+...
T Consensus 153 l~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~- 230 (270)
T cd05047 153 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL- 230 (270)
T ss_pred ECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-
Confidence 999999853221 111222347999998754 58899999999999999997 9999965 3445556666555333
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+...+..+.+++.+||. +|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 2334567889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=297.29 Aligned_cols=236 Identities=19% Similarity=0.364 Sum_probs=193.4
Q ss_pred eecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 33 VLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 33 ~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
.||+|+||.||+|.+. .++..||+|+++.. ......+.+.+|+.++++++||||+++++++. ....++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEe
Confidence 3899999999999765 45567998876532 23455677999999999999999999999763 3468999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc--
Q 035992 111 FTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-- 187 (613)
Q Consensus 111 ~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-- 187 (613)
+.+|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++..+.....
T Consensus 76 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 76 ASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccce
Confidence 999999999875 457999999999999999999999998 99999999999998 567999999999875533211
Q ss_pred -----CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 188 -----AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 188 -----~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
..++..|+|||.+.. .++.++||||||+++|+|++ |..||.... ...+...+..+..+ ..+...+.++.++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~l 230 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK-GPEVMSFIEQGKRL-DCPAECPPEMYAL 230 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHHCCCCC-CCCCCCCHHHHHH
Confidence 112357999997764 58999999999999999996 999997654 44556666666543 4555678999999
Q ss_pred HHHHhh-cccCCCCHHHHhc
Q 035992 261 IEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~ 279 (613)
|.+||. +|.+||++.++++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 999999 9999999988864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=301.55 Aligned_cols=247 Identities=28% Similarity=0.430 Sum_probs=198.8
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+..|+.+++.++|+||+++++++.. ...++++|
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEe
Confidence 56789999999999999999999999999887543 223345677889999999999999999998754 46799999
Q ss_pred eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 109 EIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
||+. ++|.+++.+. ..+++..+..++.|++.||.|||+++ ++||||+|+||+++ +.+.++|+|||++.......
T Consensus 78 e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 78 EYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCcc
Confidence 9998 5899999887 68999999999999999999999998 99999999999998 57899999999987654322
Q ss_pred ---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC------------------
Q 035992 187 ---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG------------------ 243 (613)
Q Consensus 187 ---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g------------------ 243 (613)
....+..|+|||.+.. .++.++|||||||++|||++|..||........+.+.....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 1223457999997643 58889999999999999999999996644433322211100
Q ss_pred -CCCC-------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 244 -IKPA-------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 244 -~~p~-------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
..+. ......+..+.+||.+||. +|.+||++.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0011236789999999999 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.94 Aligned_cols=247 Identities=27% Similarity=0.445 Sum_probs=199.6
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEc-------CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDE-------LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFY 93 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~-------~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~ 93 (613)
.|..|| .+.+.||+|+||.||+|.+. ..+..+|+|.++.. ........+..|+.+++.+ +||||++++
T Consensus 9 ~~~~~~-~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 9 FPRDRL-VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred ccHHHe-eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 344566 67899999999999999763 23457888876532 2345567889999999999 699999999
Q ss_pred eeeecCCCCEEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCC
Q 035992 94 NSWVDTENEHINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL 157 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDL 157 (613)
+++.. ...++++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ ++||||
T Consensus 85 ~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dl 160 (314)
T cd05099 85 GVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDL 160 (314)
T ss_pred EEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence 98754 45789999999999999999764 34889999999999999999999998 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCC
Q 035992 158 KCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVE 229 (613)
Q Consensus 158 Kp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~ 229 (613)
||+|||++ .++.+||+|||++....... ...++..|||||.+.+ .++.++||||||+++|+|++ |..||..
T Consensus 161 kp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 161 AARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred cceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 99999998 57899999999997653211 1122347999997654 58999999999999999999 8899955
Q ss_pred CCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 230 CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 230 ~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+...++..+..+..+ ..+...+..++++|.+||. +|.+||++.++++
T Consensus 240 -~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 -IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred -CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4556677777665433 2344567789999999998 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.58 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=214.5
Q ss_pred CCCCcceeE-eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 22 DPSARYGRY-KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 22 dp~gRy~r~-~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
|...-|.-| +++||+|-||+||-|+++.+|+.||+|+|.+..+..+.+ ..+++|+.||+.+.||.||.+-..|..
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe--sqlR~EVaILq~l~HPGiV~le~M~ET-- 634 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE--SQLRNEVAILQNLHHPGIVNLECMFET-- 634 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchH--HHHHHHHHHHHhcCCCCeeEEEEeecC--
Confidence 344455444 499999999999999999999999999998877654433 778999999999999999999887743
Q ss_pred CCEEEEEEeccCCCCHHHHH-H-hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEecc
Q 035992 101 NEHINFITEIFTSGTLRQYR-K-KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDL 176 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l-~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DF 176 (613)
...+++|||-+.| ++..+| . ..+++++...+.++.||+.||.|||-++ |+|+||||+|||+... .-+||||||
T Consensus 635 ~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 635 PERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred CceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccc
Confidence 5679999999976 555544 3 3578999999999999999999999999 9999999999999743 347999999
Q ss_pred chhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 177 GLAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 177 Gla~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
|+|+++... +...||+.|+|||++.. +|+..-|+||.|+|+|--+.|..||.+..+.....+... ...|+..++.
T Consensus 712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa-FMyPp~PW~e 790 (888)
T KOG4236|consen 712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA-FMYPPNPWSE 790 (888)
T ss_pred cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc-cccCCCchhh
Confidence 999988653 35678999999998865 699999999999999999999999976554433332222 2346666778
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++++.+||..+|+ ...+|.++...|.|||++..
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 89999999999999 99999999999999999986
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.17 Aligned_cols=260 Identities=27% Similarity=0.465 Sum_probs=214.2
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc---ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR---NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~---~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
.|| -+..+||+|||+.||+|++...+++||+|+-.+.+..+ .........+|..|-+.|+||-||++|++|.. +.
T Consensus 463 ~RY-LlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl-Dt 540 (775)
T KOG1151|consen 463 DRY-LLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL-DT 540 (775)
T ss_pred HHH-HHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee-cc
Confidence 455 45699999999999999999999999999876654332 23345677899999999999999999999854 45
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe-C-CCCcEEEeccchh
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN-G-NQGEVKIGDLGLA 179 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~-~-~~g~VKL~DFGla 179 (613)
..+|-|+|||+|.+|.-|++.++.+++..++.|+.||+.||.||....+||||-||||.|||+- + .-|.+||.|||++
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 6788999999999999999999999999999999999999999999999999999999999984 1 3468999999999
Q ss_pred HHHhhhc-----------cCcccccccCccccc-c----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHH--HH
Q 035992 180 AILAQAR-----------SAHSVIEFMAPELYE-E----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK--VT 241 (613)
Q Consensus 180 ~~l~~~~-----------~~~gt~~YmAPEvl~-~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~--I~ 241 (613)
+++.... ...||.+|++||.+- + +.+.++||||+|||+|.++.|+.||........+++. |.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl 700 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL 700 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence 9986422 345778999999552 2 3788999999999999999999999665544444332 22
Q ss_pred cCCC-CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 SGIK-PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 ~g~~-p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.... ......+.+.++++||++||+ ...+|..+.+|.+||+|...
T Consensus 701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 2211 111234678999999999999 88999999999999999863
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.01 Aligned_cols=253 Identities=27% Similarity=0.391 Sum_probs=198.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--- 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 101 (613)
.+| ...+.||+|+||+||+|.+..+|+.||+|.++... ........+.+|+.+++.++||||++++++|.....
T Consensus 15 ~~y-~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 15 ERY-TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred cce-EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc--ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 455 56799999999999999999999999999876432 122334567899999999999999999998754322
Q ss_pred -CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 -EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 -~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..++++++|+.. +|..++ ...+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.+||+|||++.
T Consensus 92 ~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCc
Confidence 357899999864 777665 346899999999999999999999998 99999999999998 57899999999987
Q ss_pred HHhhhc-cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-------------
Q 035992 181 ILAQAR-SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI------------- 244 (613)
Q Consensus 181 ~l~~~~-~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~------------- 244 (613)
...... ...++..|+|||.+.+ .++.++|||||||++|||++|+.||........+ ..+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 166 HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHHHHhcc
Confidence 543221 2345668999998754 4889999999999999999999999764433322 2222110
Q ss_pred ---------CC----Ccc---cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ---------KP----ASL---AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ---------~p----~~l---~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+ ..+ ....+..+.+||.+||+ +|.+||++.+++.||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 000 12356778999999999 999999999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.86 Aligned_cols=242 Identities=24% Similarity=0.415 Sum_probs=198.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCc---EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGI---EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~---~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+++.+.||+|+||.||+|.+..++. .+|+|.++.. ........+..|+.+++.++||||+++++++.. +..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 80 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK--SKPV 80 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CCcc
Confidence 4788999999999999998875553 6887776532 234456788999999999999999999998753 4578
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++|||+.+++|.+++.+. +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccccc
Confidence 9999999999999999775 56899999999999999999999998 99999999999998 56799999999987654
Q ss_pred hhcc-----C--cccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 184 QARS-----A--HSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 184 ~~~~-----~--~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.... . ..+..|+|||.+.. .++.++|+||||+++|+|++ |..||.... ...+...+..+..++ .+...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~ 235 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEGYRLP-APMDCP 235 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCCCcCC-CCCCCC
Confidence 3211 1 11347999998764 58999999999999999886 999997644 445566666654332 334567
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+.+++.+||+ +|.+||++.+++.
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 236 AALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHHHHcccCchhCCCHHHHHH
Confidence 889999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=298.46 Aligned_cols=243 Identities=22% Similarity=0.374 Sum_probs=197.7
Q ss_pred eEeeeecccCceEEEEEEEcCC-----CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELE-----GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~t-----g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
+..+.||+|+||+||+|+.+.+ .+.||+|.+.. .......+.+.+|+.++++++|+||+++++++.. ...
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 82 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK---TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE--AEP 82 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC---ccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC--CCc
Confidence 6779999999999999997643 46677765542 2233356789999999999999999999997743 457
Q ss_pred EEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 104 INFITEIFTSGTLRQYRKKHK---------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~---------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
.+++|||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+||+++ ..+.++|+
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEEc
Confidence 899999999999999998766 7999999999999999999999998 99999999999998 57899999
Q ss_pred ccchhHHHhhh-----ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 175 DLGLAAILAQA-----RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 175 DFGla~~l~~~-----~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
|||++...... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.... ...++..+..+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-~~~~~~~~~~~~~~~ 238 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-DEEVLNRLQAGKLEL 238 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-hHHHHHHHHcCCcCC
Confidence 99998644221 1223445799999765 458889999999999999999 888996544 345555665554444
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+...+..+.++|.+||+ +|.+||++.+++..
T Consensus 239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 4455678899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.95 Aligned_cols=248 Identities=28% Similarity=0.475 Sum_probs=199.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcC----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDEL----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
.+++++.+.||+|+||+||+|.... ++..||+|+++.... ....+.+.+|+.+++.+.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence 4667888999999999999998643 488999988764322 245678999999999999999999999886655
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
....+++|||+.+++|.+++.+.. .+++..+..++.||+.||+|||+++ ++||||||+||+++ .++.++|+|||++
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~ 156 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLA 156 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccc
Confidence 678999999999999999998765 6999999999999999999999998 99999999999998 5689999999999
Q ss_pred HHHhhhcc-------CcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcH--------------HHHH
Q 035992 180 AILAQARS-------AHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNA--------------AQIY 237 (613)
Q Consensus 180 ~~l~~~~~-------~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~--------------~~i~ 237 (613)
........ ......|+|||.+. ..++.++||||||+++|||++|..||...... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 87653211 12234699999765 45889999999999999999999998553221 1122
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+.. ...+...+..+.+++.+||+ +|.+||++.+++.
T Consensus 237 ~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22333222 22234556889999999999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=291.99 Aligned_cols=241 Identities=27% Similarity=0.470 Sum_probs=202.3
Q ss_pred eEeeeecccCceEEEEEEEcCCC----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
.+.+.||.|+||.||+|.+...+ ..||+|.++.. ........+..|+.+++.++|+||+++++++.. ....
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED---ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC---CChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCee
Confidence 35689999999999999998876 89998887532 223367789999999999999999999998755 3679
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++|||+.+++|.+++..... +++..+..++.||+.||.|||+++ ++||||||+||+++ +++.++|+|||++...
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDL 153 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceec
Confidence 999999999999999977554 999999999999999999999998 99999999999998 6679999999998765
Q ss_pred hhhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 183 AQAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 183 ~~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.... ...++..|+|||.+.. .++.++||||||+++|+|++ |..||.. .+...+++.+..+..+. .+...+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRLP-KPENCPP 231 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCCC-CCCcCCH
Confidence 4321 1224568999997754 48999999999999999998 7888855 55666677777665443 3445788
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+.+++.+||. +|.+|||+.++++
T Consensus 232 ~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 232 EIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHHHHHCcCChhhCcCHHHHHh
Confidence 99999999999 9999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=333.14 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=185.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCC-cEEEEEEEE-------------eeccccChHHHHHHHHHHHHHHhCCCCCcceee
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIK-------------VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg-~~VAiK~vk-------------~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~ 93 (613)
|++.+.||+|+||+||+|..+... ..++.|.+. .............+.+|+.+|++++||||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 478899999999999998765432 222222110 001112233456788999999999999999999
Q ss_pred eeeecCCCCEEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 94 NSWVDTENEHINFITEIFTSGTLRQYRKKH-----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
+++.. ....|++++++. ++|..++... .......++.++.||+.||+|||+++ ||||||||+|||++ .+
T Consensus 230 ~~~~~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~-~~ 303 (501)
T PHA03210 230 EILRS--EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN-CD 303 (501)
T ss_pred EEEEE--CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CC
Confidence 98754 456889999985 4677666432 23456778899999999999999998 99999999999998 57
Q ss_pred CcEEEeccchhHHHhhhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCC-CCCC-c-HHHHHHH
Q 035992 169 GEVKIGDLGLAAILAQAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPY-VECT-N-AAQIYKK 239 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf-~~~~-~-~~~i~~~ 239 (613)
+.+||+|||++..+.... ...++..|+|||++.+ .|+.++|||||||++|||++|..++ .... . ..++.+.
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 899999999997654321 2457889999998765 5999999999999999999988654 3221 2 2333322
Q ss_pred HHcCC-----CC-------------------Ccc-----cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 240 VTSGI-----KP-------------------ASL-----AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 240 I~~g~-----~p-------------------~~l-----~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+.... .| ..+ ....+..+.++|.+||+ ||.+|||+.|+|.||||....
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 22100 00 000 01234567888999999 999999999999999998754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.92 Aligned_cols=248 Identities=28% Similarity=0.435 Sum_probs=200.8
Q ss_pred CCCcceeEeeeecccCceEEEEEEEc-------CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDE-------LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYN 94 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~-------~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~ 94 (613)
....-+.+.+.||+|+||.||+|.+. .++..||+|.++.. ........+.+|+.+++.+ +||||+++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 33444578899999999999999753 24457898876532 2345567899999999999 8999999999
Q ss_pred eeecCCCCEEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCC
Q 035992 95 SWVDTENEHINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLK 158 (613)
Q Consensus 95 ~fv~~~~~~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLK 158 (613)
++.. ...++++|||+.+|+|.+++.+. ..++...+..++.||+.||.|||+++ ++|||||
T Consensus 89 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlk 164 (304)
T cd05101 89 ACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLA 164 (304)
T ss_pred EEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccc
Confidence 8754 45789999999999999999764 24778889999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCC
Q 035992 159 CDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVEC 230 (613)
Q Consensus 159 p~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~ 230 (613)
|+||+++ .++.+||+|||++..+.... ...++..|+|||++.+ .|+.++||||||+++|+|++ |..||..
T Consensus 165 p~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~- 242 (304)
T cd05101 165 ARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG- 242 (304)
T ss_pred cceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-
Confidence 9999998 56899999999987654311 1223457999997754 58999999999999999998 7888865
Q ss_pred CcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 231 TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 231 ~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+...+.+.+..+..+ ..+...+..+++||.+||. +|.+||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 243 IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 4566777777666433 2345578899999999998 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=296.45 Aligned_cols=238 Identities=26% Similarity=0.426 Sum_probs=193.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||+||+|.+. .+..+|+|.++.... ..+.+.+|+.++++++|+||+++++++. ....+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~---~~~~~lv 78 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS---EEPIYIV 78 (260)
T ss_pred hhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC---CCCcEEE
Confidence 377899999999999999765 566799888764321 2356889999999999999999999763 2357899
Q ss_pred EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ +++.++|+|||++..+...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeeccCc
Confidence 9999999999998764 45899999999999999999999998 99999999999998 5789999999999765432
Q ss_pred c-----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 186 R-----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 186 ~-----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
. ...++..|+|||.+. ..++.++||||||+++|+|++ |..||.... ...+...+..+..+ ..+...+..++
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~ 233 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERGYRM-PCPQDCPISLH 233 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHH
Confidence 1 112334799999765 458899999999999999999 899996644 44455556554333 33456788999
Q ss_pred HHHHHHhh-cccCCCCHHHHhc
Q 035992 259 AFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+||.+||. +|.+|||+.+++.
T Consensus 234 ~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 234 ELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHHHcccCcccCcCHHHHHH
Confidence 99999998 9999999998873
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=302.34 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=192.3
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCC--------------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcc
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEG--------------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg--------------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 90 (613)
.|| ++.+.||+|+||.||+|.+..++ ..||+|.++.. ......+.+.+|++++++++||||+
T Consensus 5 ~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 5 QQL-RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred HhC-eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 344 88899999999999999875432 35888776532 2345567799999999999999999
Q ss_pred eeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCC
Q 035992 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLK 158 (613)
Q Consensus 91 kl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLK 158 (613)
++++++.. ...+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ ++|||||
T Consensus 81 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk 156 (295)
T cd05097 81 RLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA 156 (295)
T ss_pred eEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence 99998754 457899999999999999986542 3688899999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh--cCCCCCC
Q 035992 159 CDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT--FEYPYVE 229 (613)
Q Consensus 159 p~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt--G~~Pf~~ 229 (613)
|+||+++ +++.+||+|||++..+.... ...++..|+|||.+. +.++.++||||||+++|+|++ +..||..
T Consensus 157 p~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 157 TRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999998 56799999999987653221 122345799999765 458999999999999999988 6788865
Q ss_pred CCcHHHHHHHHHc------CCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 230 CTNAAQIYKKVTS------GIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 230 ~~~~~~i~~~I~~------g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
... .++...+.. .......+...+..+.+||.+||. +|.+||++.++++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSD-EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cCh-HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 443 333322211 111122234567899999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=307.47 Aligned_cols=252 Identities=31% Similarity=0.433 Sum_probs=199.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|.+.+.||.|+||.||+|.+..+|..||+|.+.+.. ......+.+..|+.+++.++||||++++++|... ....+++
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~lv 88 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF--STPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYFV 88 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc--cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEEE
Confidence 477899999999999999999999999999876432 2234456788999999999999999999988643 3468899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-c
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-R 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~ 186 (613)
+||+ +++|..++.. ..+++..+..++.||+.||.|||+++ ++||||+|+||+++ ..+.++|+|||++...... .
T Consensus 89 ~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 89 TELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred eehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCCCcC
Confidence 9998 5688887764 46889999999999999999999998 99999999999998 6789999999998755332 1
Q ss_pred cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH--------------HHHHHcC-------
Q 035992 187 SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI--------------YKKVTSG------- 243 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i--------------~~~I~~g------- 243 (613)
...++..|+|||.+.+ .++.++||||||+++|+|++|..||......... ...+...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQ 243 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHh
Confidence 2345668999997754 5899999999999999999999999653321111 1000000
Q ss_pred --C--CCC---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 244 --I--KPA---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 244 --~--~p~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
. .+. ......+..++++|.+||+ +|.+||++.+++.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 244 SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 0 000 1112356889999999998 999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=293.34 Aligned_cols=241 Identities=27% Similarity=0.431 Sum_probs=196.5
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..+++.++||+|+||+||+|.+. .+..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 77 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE--EEPIY 77 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeec--CCceE
Confidence 34588899999999999999875 55789988776322 234568899999999999999999998743 45789
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ .++.++|+|||++..+.
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIE 154 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceecc
Confidence 999999999999999765 36899999999999999999999998 99999999999998 56899999999987653
Q ss_pred hh-----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 QA-----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~~-----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.. .....+..|+|||.+.+ .++.++||||||+++|+|++ |..||.... .......+..+... ..+...+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 232 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-NREVLEQVERGYRM-PRPPNCPEE 232 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHH
Confidence 21 11223357999997764 58899999999999999999 999996644 44555566555332 223345788
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhc
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+.+++.+||. +|.+||++++++.
T Consensus 233 ~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 233 LYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHHHHHcccCcccCCCHHHHHH
Confidence 9999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.94 Aligned_cols=236 Identities=20% Similarity=0.303 Sum_probs=184.2
Q ss_pred eecccCceEEEEEEEcCCC------------------------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC
Q 035992 33 VLGRGAFKKVYRAFDELEG------------------------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88 (613)
Q Consensus 33 ~LG~GafGtVYka~~~~tg------------------------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN 88 (613)
.||+|+||.||+|....++ ..||+|++... .......+.+|+.+++.++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence 5899999999999754322 34676655421 2234567888999999999999
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
|+++++++.. ....++||||+.+|+|..++.+ .+.+++..+..++.||+.||+|||+++ |+||||||+|||++..
T Consensus 78 iv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~ 153 (274)
T cd05076 78 LAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARL 153 (274)
T ss_pred eeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEecc
Confidence 9999998764 4578899999999999999876 467899999999999999999999998 9999999999999732
Q ss_pred ------CCcEEEeccchhHHHhhhccCcccccccCcccccc--ccCccchhhhhhHHHHHHH-hcCCCCCCCCcHHHHHH
Q 035992 168 ------QGEVKIGDLGLAAILAQARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELV-TFEYPYVECTNAAQIYK 238 (613)
Q Consensus 168 ------~g~VKL~DFGla~~l~~~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~Eml-tG~~Pf~~~~~~~~i~~ 238 (613)
...+|++|||++..........++..|+|||.+.+ .++.++||||||+++|||+ +|..||..... .....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~ 232 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEKER 232 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHHHH
Confidence 22489999999865444334456678999997754 4899999999999999995 69999966443 22222
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+.... .++....+.+.++|.+||+ +|.+||++.++|++
T Consensus 233 ~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 222211 1223345789999999999 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=293.74 Aligned_cols=236 Identities=23% Similarity=0.433 Sum_probs=194.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||.||++. .+++.||+|.++.. ...+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~~~~v 76 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILH---NGLYIV 76 (254)
T ss_pred ceeeeeeccCCCCceEecc--cCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CCcEEE
Confidence 4778999999999999985 57889998877532 234578899999999999999999998753 247899
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+++|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecccc
Confidence 99999999999997653 5899999999999999999999988 99999999999998 5689999999998754332
Q ss_pred c-cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 R-SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 ~-~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
. .......|+|||.+. ..++.++|+||||+++|+|++ |..||... ........+..+..+. .+...+..+.++|.
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~ 231 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYVLMT 231 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHH
Confidence 1 122334799999775 458899999999999999998 99999664 4455666666664433 34556789999999
Q ss_pred HHhh-cccCCCCHHHHhc
Q 035992 263 KCIA-EVSERLPAKELLG 279 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~ 279 (613)
+||+ +|.+||++++|+.
T Consensus 232 ~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 232 SCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 9999 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=336.15 Aligned_cols=241 Identities=26% Similarity=0.406 Sum_probs=203.6
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
.++.+.||+|+||+||+|... .....||+|.+|... +....+.|++|+.+|..|+|||||++++.+ ..++
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC--~~~~ 562 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVC--REGD 562 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEE--ccCC
Confidence 466799999999999999653 344689988877432 455788999999999999999999999976 5567
Q ss_pred EEEEEEeccCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 103 HINFITEIFTSGTLRQYRKKHK--------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~--------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
.+++|+|||..|+|.+++..+. .++..+...++.||+.|++||-++. ++||||-..|+||. +.
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-EN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cc
Confidence 8999999999999999987532 2788999999999999999999999 99999999999997 66
Q ss_pred CcEEEeccchhHHHhhhc------cCcccccccCcc-ccccccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHH
Q 035992 169 GEVKIGDLGLAAILAQAR------SAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKV 240 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~~------~~~gt~~YmAPE-vl~~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I 240 (613)
-.|||+|||+++..-... ...-.++||||| ++.++|+.++|||||||+|||+++ |..||.+..+.+ ..+.|
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-VIe~i 718 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-VIECI 718 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-HHHHH
Confidence 799999999998643321 122234999999 566789999999999999999998 899998877654 45678
Q ss_pred HcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 241 TSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 241 ~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
.+|.. ..-+..++.++..++..||+ .|.+||+++||=
T Consensus 719 ~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 719 RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 88876 56678899999999999999 999999999873
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=295.92 Aligned_cols=226 Identities=18% Similarity=0.279 Sum_probs=185.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCH
Q 035992 37 GAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL 116 (613)
Q Consensus 37 GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL 116 (613)
|.||+||+|.++.+|+.||+|.++... ....|...+....||||+++++++.. ....+++|||+.+|+|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCH
Confidence 899999999999999999999886432 12334555566679999999998754 4679999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-cCccccccc
Q 035992 117 RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-SAHSVIEFM 195 (613)
Q Consensus 117 ~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~gt~~Ym 195 (613)
.+++.+...+++..+..|+.|++.||+|||+++ ++||||||+||+++ ..+.++++|||.+..+.... ...++..|+
T Consensus 73 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~y~ 149 (237)
T cd05576 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSCDGEAVENMYC 149 (237)
T ss_pred HHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhccccccccCCcCcccc
Confidence 999988888999999999999999999999998 99999999999998 56799999999876554321 233445799
Q ss_pred Ccccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCC
Q 035992 196 APELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLP 273 (613)
Q Consensus 196 APEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpt 273 (613)
|||.+.. .++.++|+||||+++|||++|..||...... + .......++...+..++++|.+||+ +|.+|++
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 222 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--I-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG 222 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--c-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence 9998764 5889999999999999999999988542211 1 1111123445678899999999998 9999998
Q ss_pred H-----HHHhcCCCC
Q 035992 274 A-----KELLGDPFL 283 (613)
Q Consensus 274 a-----~eLL~HPff 283 (613)
+ +++++||||
T Consensus 223 ~~~~~~~~~~~h~~~ 237 (237)
T cd05576 223 AGVAGVEDIKSHPFF 237 (237)
T ss_pred CCccchHHHHcCCCC
Confidence 5 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=301.26 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=192.4
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcC----------------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDEL----------------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~----------------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H 86 (613)
|.++| ++.+.||+|+||+||+|.+.. ++..||+|+++.. ........+.+|+.+++.++|
T Consensus 3 ~~~~~-~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~E~~~l~~l~~ 78 (296)
T cd05095 3 PRKRL-TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDFLKEIKIMSRLKD 78 (296)
T ss_pred Chhhc-eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCC
Confidence 45565 888999999999999986542 3456887776532 234556788999999999999
Q ss_pred CCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEec
Q 035992 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-----------HVDLRALKKWSRQILEGLSYLHSHDPPVIHR 155 (613)
Q Consensus 87 pNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~-----------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHr 155 (613)
+||+++++++.. ....+++|||+.+|+|.+++.+.. .+++..+..++.||+.||+|||+++ ++||
T Consensus 79 ~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~ 154 (296)
T cd05095 79 PNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHR 154 (296)
T ss_pred CCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence 999999998855 456899999999999999987643 3677899999999999999999998 9999
Q ss_pred CCCCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh--cCCC
Q 035992 156 DLKCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT--FEYP 226 (613)
Q Consensus 156 DLKp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt--G~~P 226 (613)
||||+|||++ .++.++|+|||++..+.... ....+..|+|||... +.++.++|||||||++|||++ |..|
T Consensus 155 dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p 233 (296)
T cd05095 155 DLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233 (296)
T ss_pred cCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCC
Confidence 9999999998 57899999999987653321 122245799999654 568999999999999999998 7889
Q ss_pred CCCCCcHHHHHHHHHc----C--CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 227 YVECTNAAQIYKKVTS----G--IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 227 f~~~~~~~~i~~~I~~----g--~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
|..... .++...... . ......+..++..+.+||.+||+ +|.+||++.++++
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 234 YSQLSD-EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccccCh-HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 965443 333222211 0 01111233456889999999999 9999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.11 Aligned_cols=237 Identities=25% Similarity=0.407 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
++||+|+||.||+|... ++..+|+|.++.. ........+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKED---LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECC
Confidence 47999999999999854 6889998876532 223445578899999999999999999998754 45789999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc----
Q 035992 112 TSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---- 186 (613)
Q Consensus 112 ~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~---- 186 (613)
.+++|.+++... ..+++..+..++.|++.||.|||+++ ++||||||+||+++ .++.+||+|||++.......
T Consensus 75 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 75 PGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccC
Confidence 999999998754 46899999999999999999999998 99999999999997 67899999999986543221
Q ss_pred -cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 187 -SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 187 -~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
...+...|+|||++.. .++.++||||||+++|+|++ |..||... ........+..+... ..+...+..+.+++.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHH
Confidence 1122347999998764 48899999999999999998 99999765 344455555555433 3344567899999999
Q ss_pred Hhh-cccCCCCHHHHhc
Q 035992 264 CIA-EVSERLPAKELLG 279 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~ 279 (613)
||. +|.+||++.++++
T Consensus 230 ~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 230 CWDYKPENRPKFSELQK 246 (250)
T ss_pred HcccCcccCCCHHHHHH
Confidence 999 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.73 Aligned_cols=242 Identities=25% Similarity=0.443 Sum_probs=196.4
Q ss_pred eeEeeeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+.+.++||+|+||.||+|.+... ...||+|..... ......+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~ 81 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPV 81 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCc
Confidence 46789999999999999987654 346887765432 224566789999999999999999999998753 357
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++|||+.+|+|.+++.+.+ .+++..+..++.||+.||+|||+++ ++||||||+||+++ ..+.++|+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeecc
Confidence 89999999999999998754 5899999999999999999999998 99999999999998 56799999999987654
Q ss_pred hhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 QAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
... ...+...|+|||.+.. .++.++||||||+++|||++ |..||...... .....+..+..+ ..+...+..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~ 236 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIENGERL-PMPPNCPPT 236 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCcC-CCCCCCCHH
Confidence 321 1122347999997754 58899999999999999986 99999765544 444555555433 334567889
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.++|.+||. +|.+|||+.+++..
T Consensus 237 ~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 237 LYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999998 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.50 Aligned_cols=240 Identities=22% Similarity=0.427 Sum_probs=196.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||.||+|.+. .+..+|+|.++... .....+..|+.+++.++||||+++++++.. ....+++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-----MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE--RSPICLV 77 (256)
T ss_pred eEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-----CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc--CCceEEE
Confidence 477899999999999999875 46789988765322 123467889999999999999999998744 4578999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+++|.+++... +.+++..++.++.|++.||+|||+++ ++||||||+||+++ .++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCc
Confidence 9999999999998764 56899999999999999999999998 99999999999997 66799999999986543211
Q ss_pred -----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 -----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
....+..|+|||.+. +.++.++||||||+++|||++ |..||.. .....+.+.+..+..+ ..+...+..+.+
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 232 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYE 232 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHH
Confidence 112335799999776 458899999999999999998 9999965 4445566666655433 234456889999
Q ss_pred HHHHHhh-cccCCCCHHHHhcC
Q 035992 260 FIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~H 280 (613)
|+.+||+ +|.+||++.++++.
T Consensus 233 l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 233 LMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHcccChhhCCCHHHHHHh
Confidence 9999999 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=297.79 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=196.3
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+++.+.||+|+||.||+|.+. .++..||+|+++.. ........+.+|+.+++.++||||+++++++.. +.
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~--~~ 81 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPNIVKLLGVCAV--GK 81 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CC
Confidence 477899999999999999874 36788998876532 234456778899999999999999999998754 45
Q ss_pred EEEEEEeccCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCC
Q 035992 103 HINFITEIFTSGTLRQYRKKHK----------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~----------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~ 160 (613)
.++++|||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ ++||||||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ 159 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATR 159 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHh
Confidence 7899999999999999987532 3788889999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCc
Q 035992 161 NIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTN 232 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~ 232 (613)
|||++ .++.++|+|||++..+.... ....+..|+|||.+. ..++.++|||||||++|||++ |..||.+. +
T Consensus 160 nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~ 237 (288)
T cd05050 160 NCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-A 237 (288)
T ss_pred heEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-C
Confidence 99997 67899999999987543221 112234799999765 458999999999999999998 88899653 4
Q ss_pred HHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 233 ~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
...+...+..+..+ ..+...+..+.+||.+||+ +|.+||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 238 HEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 45566666655433 2334567899999999999 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=316.91 Aligned_cols=243 Identities=28% Similarity=0.431 Sum_probs=198.6
Q ss_pred eEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCC
Q 035992 29 RYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENE 102 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~ 102 (613)
.+.++||+|+||.||+|.+. .++..||+|+++.. ......+.+.+|+.+|.++. ||||++++++|.. ..
T Consensus 40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--~~ 114 (401)
T cd05107 40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST---ARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--GG 114 (401)
T ss_pred ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC---CChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--CC
Confidence 45689999999999999853 45678999887642 23344567889999999997 9999999998854 45
Q ss_pred EEEEEEeccCCCCHHHHHHhCC----------------------------------------------------------
Q 035992 103 HINFITEIFTSGTLRQYRKKHK---------------------------------------------------------- 124 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~---------------------------------------------------------- 124 (613)
.+++||||+.+|+|.+++.+.+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 7999999999999999986532
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEE
Q 035992 125 ----------------------------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV 164 (613)
Q Consensus 125 ----------------------------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl 164 (613)
.+++..+..++.||+.||+|||+++ ++||||||+|||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl 272 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLI 272 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEE
Confidence 3567788899999999999999988 9999999999999
Q ss_pred eCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHH
Q 035992 165 NGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQI 236 (613)
Q Consensus 165 ~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i 236 (613)
+ ..+.+||+|||++...... ....++..|||||.+.. .++.++||||||+++|||++ |..||......+.+
T Consensus 273 ~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 273 C-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred e-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 8 5679999999998754321 12234567999997764 48899999999999999998 89999776666666
Q ss_pred HHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 237 YKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 237 ~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
...+..+..+ ..+...+..+.++|.+||. +|.+||++++|+..
T Consensus 352 ~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 352 YNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6666666433 2345578899999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.40 Aligned_cols=239 Identities=27% Similarity=0.441 Sum_probs=194.6
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.+++.+.||+|+||.||+|.+. .+..+|+|.++. .....+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~ 77 (260)
T cd05073 7 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKP-----GSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYI 77 (260)
T ss_pred ceeEEeEecCccceEEEEEEec-CCccEEEEecCC-----ChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEE
Confidence 3488999999999999999754 556788887653 22345678899999999999999999998754 46889
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++||||||+||+++ ..+.+||+|||++..+..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeeccC
Confidence 99999999999999764 45788999999999999999999988 99999999999998 578999999999876543
Q ss_pred hc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 185 AR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 185 ~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.. ...++..|+|||++.. .++.++|+||||+++|+|++ |..||... +...+...+..+.... .....+.++
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEEL 232 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhCCCCCC-CcccCCHHH
Confidence 21 1123356999998764 48889999999999999999 89999664 4445555666554332 334567889
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+++.+||+ +|.+||++.+++.
T Consensus 233 ~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 233 YNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHHHcccCcccCcCHHHHHH
Confidence 999999999 9999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.46 Aligned_cols=245 Identities=27% Similarity=0.435 Sum_probs=198.7
Q ss_pred cceeEeeeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeee
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWV 97 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv 97 (613)
..+++.+.||+|+||.||+|.+.. .+..||+|.++.. ......+.+.+|+.+++++ +||||++++++|.
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 445889999999999999998643 2346888866532 2345567899999999999 7999999999875
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDN 161 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~N 161 (613)
. ...++++|||+.+|+|.+++.+.+ .++...+..++.||+.||.|||+++ ++||||||+|
T Consensus 89 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~N 164 (334)
T cd05100 89 Q--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARN 164 (334)
T ss_pred c--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccce
Confidence 4 457899999999999999987642 3778889999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcH
Q 035992 162 IFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNA 233 (613)
Q Consensus 162 ILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~ 233 (613)
||++ .++.+||+|||++....... ...++..|||||++.. .++.++||||||+++|||++ |..||.. .+.
T Consensus 165 ill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~ 242 (334)
T cd05100 165 VLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPV 242 (334)
T ss_pred EEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCH
Confidence 9998 56899999999987553321 1122347999997754 58999999999999999998 8899965 455
Q ss_pred HHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 234 AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 234 ~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..++..+..+..+. .+...+..+.++|.+||+ +|.+||++.+++.+
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGHRMD-KPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66666776654432 344567889999999999 99999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=296.11 Aligned_cols=236 Identities=21% Similarity=0.360 Sum_probs=184.6
Q ss_pred eeecccCceEEEEEEEcCC------------CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 32 EVLGRGAFKKVYRAFDELE------------GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~t------------g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
+.||+|+||.||+|..... ...||+|++.. ........+..|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~----~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~- 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVR- 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh----hhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 4689999999999975322 23567665432 123445678889999999999999999998764
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC-------cE
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG-------EV 171 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g-------~V 171 (613)
+...+++|||+.+|+|..++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+ .+
T Consensus 76 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~ 151 (262)
T cd05077 76 -DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFI 151 (262)
T ss_pred -CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCcee
Confidence 34678999999999999988764 56999999999999999999999998 99999999999997 333 38
Q ss_pred EEeccchhHHHhhhccCcccccccCccccc--cccCccchhhhhhHHHHHHH-hcCCCCCCCCcHHHHHHHHHcCCCCCc
Q 035992 172 KIGDLGLAAILAQARSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELV-TFEYPYVECTNAAQIYKKVTSGIKPAS 248 (613)
Q Consensus 172 KL~DFGla~~l~~~~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~Eml-tG~~Pf~~~~~~~~i~~~I~~g~~p~~ 248 (613)
+++|||++..........++..|||||.+. ..++.++|||||||++|||+ +|..||.... ..... .+..+...
T Consensus 152 ~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~-~~~~~~~~-- 227 (262)
T cd05077 152 KLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEKE-RFYEGQCM-- 227 (262)
T ss_pred EeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHHH-HHHhcCcc--
Confidence 999999987665544556677899999875 35899999999999999998 5888886533 22222 22222211
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.......+++++|.+||+ +|.+||++.+|+.+
T Consensus 228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 122235789999999999 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=300.37 Aligned_cols=242 Identities=26% Similarity=0.448 Sum_probs=194.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcE----EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIE----VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~----VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
++..+.||+|+||.||+|.+..+|.. ||+|.+.. .........+.+|+.+++.++||||+++++++.. ..
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~---~~ 82 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE---TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS---PT 82 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccc---cCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC---CC
Confidence 46678999999999999999888864 56665442 2233445578899999999999999999998753 24
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++++|+++|+|.+++..+. .+++..+..|+.||+.||.|||+++ |+||||||+||+++ +++.+||+|||++..+
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccc
Confidence 678999999999999987754 6899999999999999999999998 99999999999997 5678999999999865
Q ss_pred hhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 183 AQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 183 ~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.... ...++..|+|||.+.+ .++.++||||||+++|||++ |..||.+. ....+...+..+..+ ..+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~ 237 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPICT 237 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCC
Confidence 4321 1223457999997764 58999999999999999997 89999653 344444445444333 2344567
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+.+++.+||. +|.+||++.+++..
T Consensus 238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 238 IDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999998 99999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.60 Aligned_cols=247 Identities=24% Similarity=0.424 Sum_probs=200.5
Q ss_pred eeEeeeecccCceEEEEEEEcC-CCcEEEEEEEEeeccc------cChHHHHHHHHHHHHHHh-CCCCCcceeeeeeecC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL-EGIEVAWNQIKVIDLL------RNSEDLERLYSEVHLLKT-LKHKNIIKFYNSWVDT 99 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~-tg~~VAiK~vk~~~~~------~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fv~~ 99 (613)
|.+.+.||+|+||.||+|.+.. +++.+|+|.++..... ........+..|+.++.+ ++||||+++++++..
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~- 80 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE- 80 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc-
Confidence 4567899999999999999988 7889999988754321 233456678889998875 799999999998754
Q ss_pred CCCEEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 100 ENEHINFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
+...+++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++ ..+.++|+
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~ 156 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTIT 156 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEe
Confidence 5689999999999999988743 3569999999999999999999996 55 99999999999997 67899999
Q ss_pred ccchhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 175 DLGLAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 175 DFGla~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
|||++...... ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.. .+.......+..+...+...
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc-cCHHHHHHHHhhccCCcCCc
Confidence 99998765433 23345668999997764 488999999999999999999999965 44444555555554433334
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
...+..+.++|.+||+ +|.+||++.|+..+
T Consensus 236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 4678899999999998 99999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.75 Aligned_cols=239 Identities=21% Similarity=0.415 Sum_probs=204.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|.+...+|.|+|+.|-.+.+..+++..++|++.... .....|+.++... +||||+++++.+ .++..+|+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~--------~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~ 393 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA--------DDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYL 393 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc--------cccccccchhhhhcCCCcceeeccee--cCCceeee
Confidence 356678999999999999999999999988877541 1223467555555 799999999976 45778999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||++.|+-|.+.+...+.+. ..+..|+.||+.|+.|||++| ||||||||+|||+.++.|+++|+|||.++.+....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 999999999998888877666 788889999999999999998 99999999999996578899999999999876652
Q ss_pred -cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 187 -SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 187 -~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
+.+.|..|.|||++.. +|++++||||||++||+|++|..||...++..+++..+..+ .+....+..+++||++|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~~s~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----KFSECVSDEAKDLLQQL 546 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC----ccccccCHHHHHHHHHh
Confidence 3355668999998875 59999999999999999999999998777776777777655 34478899999999999
Q ss_pred hh-cccCCCCHHHHhcCCCC
Q 035992 265 IA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~HPff 283 (613)
|+ +|.+|+++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99 99999999999999999
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=328.91 Aligned_cols=255 Identities=25% Similarity=0.453 Sum_probs=215.8
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecC-
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT- 99 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~- 99 (613)
||+..+ .+.++||.|.+|.||++.++.+|+.+|+|+.... .+.-+.+..|..+|+.+ +|||++.+|++|.-.
T Consensus 16 dp~d~~-ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 16 DPADIF-EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCcc-EEEEEEeeccceeEEEEeeeecCceeeeEeecCC-----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 566666 6779999999999999999999999998764422 23445677788899887 699999999988643
Q ss_pred --CCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 100 --ENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 100 --~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
.++.+|||||||.||+..+++++. ..+.|..+..|++.++.||.+||.+. +||||||-.|||++ ..|.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEee
Confidence 356899999999999999998764 57999999999999999999999998 99999999999999 678999999
Q ss_pred cchhHHHhh----hccCcccccccCcccccc------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC
Q 035992 176 LGLAAILAQ----ARSAHSVIEFMAPELYEE------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245 (613)
Q Consensus 176 FGla~~l~~----~~~~~gt~~YmAPEvl~~------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~ 245 (613)
||++..+.. ..+..||+.|||||++.. .|+..+|+||||++.+||.-|.+|+.+......++....+. .
T Consensus 167 FGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNP-P 245 (953)
T KOG0587|consen 167 FGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-P 245 (953)
T ss_pred eeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCC-C
Confidence 999987654 346678899999998752 37789999999999999999999998877776666444433 3
Q ss_pred CCcc-cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 246 PASL-AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 246 p~~l-~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|... ++.++.++.+||..||. +-.+||+..+||+|||+...
T Consensus 246 PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 246 PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 3333 67889999999999998 99999999999999999854
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.56 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=196.3
Q ss_pred eeEeeeecccCceEEEEEEEcC---CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--- 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~---tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 101 (613)
|++.++||+|+||+||+|.... +++.||+|+++... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI--FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc--CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 3667899999999999998653 57899999876322 234567788999999999999999999998765432
Q ss_pred -CEEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 102 -EHINFITEIFTSGTLRQYRKKH------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 102 -~~l~lV~E~~~gGsL~~~l~~~------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
...+++++|+.+|+|..++... ..++...+..++.||+.||+|||+++ |+||||||+||+++ .++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEEC
Confidence 2346789999999999886432 24789999999999999999999998 99999999999998 57799999
Q ss_pred ccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCC
Q 035992 175 DLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKP 246 (613)
Q Consensus 175 DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p 246 (613)
|||++..+.... ...+...|++||.+.. .++.++||||||+++|+|++ |..||.. .+...++..+..+...
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~ 234 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL 234 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC
Confidence 999988654321 1223357999997764 48889999999999999999 8899865 4455666666555332
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+...+..+.+++.+||+ +|.+||++.+++..
T Consensus 235 -~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 235 -KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2334567899999999998 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=338.17 Aligned_cols=241 Identities=23% Similarity=0.416 Sum_probs=202.0
Q ss_pred eEeeeecccCceEEEEEEEcCCC-----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEG-----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg-----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+.+.||+|+||.||.|.-..-. ..||+|.++. ..+......|++|..+|+.++|||||++++.+++ ...
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~---~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~~~ 769 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR---LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--SGP 769 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccc---cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--CCC
Confidence 56799999999999999765433 2478766653 3467888999999999999999999999998876 556
Q ss_pred EEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 104 INFITEIFTSGTLRQYRKKH-------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
.++++|||.||+|+.|+++. ..++...+..++.||++|+.||++++ +|||||.+.|+||+ ....|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEccc
Confidence 88999999999999999876 34899999999999999999999998 99999999999998 4579999999
Q ss_pred chhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCc
Q 035992 177 GLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPAS 248 (613)
Q Consensus 177 Gla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~ 248 (613)
|+|+.+.... ...-.+.|||||.+. +.|+.|+|||||||++||++| |..||.+..+.+.+......|. ..
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggR--L~ 924 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGR--LD 924 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCc--cC
Confidence 9999543221 112234899999776 569999999999999999999 8899988666655554566663 34
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..++..+.+++.+||+ +|.+||++..|++
T Consensus 925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 567788889999999999 9999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=300.17 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=205.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh-CCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT-LKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
..||.|+||+|++..++..|+..|+|.|.... ...++.+++.|.....+ -+.||||+||+..+.+ +-.|+.||+
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n---~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E--GdcWiCMEL 144 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN---IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE--GDCWICMEL 144 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeecc---chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--CceeeeHHH
Confidence 57999999999999999999999988887544 35677888888886554 5799999999987653 458999999
Q ss_pred cCCCCHHHHH-----HhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 111 FTSGTLRQYR-----KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 111 ~~gGsL~~~l-----~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|.- +|..+- .+...++|..+..+....+.||+||-..- .|||||+||+|||++ ..|.|||||||++..+..+
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHH
Confidence 965 655432 34567999999999999999999997652 499999999999999 6789999999999877653
Q ss_pred ---ccCcccccccCccccc---cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc-c---cccH
Q 035992 186 ---RSAHSVIEFMAPELYE---EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA-K---VADN 255 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~---~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~-~---~~s~ 255 (613)
....|...|||||.+. .+|+.++|+||||++|||++||.+||.+..+..+....+..|-.|.... . .++.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 2335666899999875 3599999999999999999999999988887777777777776554332 2 2678
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+..||..||. +.+.||...+|+++||++..
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 89999999998 99999999999999999864
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=298.06 Aligned_cols=252 Identities=18% Similarity=0.224 Sum_probs=185.8
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHH-------HHHHHHHHHHHHhCCCCCcc
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSED-------LERLYSEVHLLKTLKHKNII 90 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~-------~~~l~~Ei~iLk~L~HpNIV 90 (613)
.+..+..|++.++||+|+||+||+|.+..+ +..+|+|+..........+. ......+...+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 445555669999999999999999998877 66777665432221100000 01122334455677899999
Q ss_pred eeeeeeecCCC--CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 91 KFYNSWVDTEN--EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 91 kl~~~fv~~~~--~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
++++++..... ...+++++++.. ++.+.+......++..++.++.||+.||+|||+++ |+||||||+|||++ ..
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~ 162 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GN 162 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CC
Confidence 99987544322 244677887644 67777777666889999999999999999999998 99999999999998 56
Q ss_pred CcEEEeccchhHHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH-
Q 035992 169 GEVKIGDLGLAAILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ- 235 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~- 235 (613)
+.++|+|||++..+... ....+++.|+|||++.+ .|+.++|||||||++|||++|..||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 79999999998765211 12357889999998765 489999999999999999999999976533222
Q ss_pred -------HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 236 -------IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 236 -------i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
....+..+.. .....++.+.+++..|+. +|.+||+..+|++
T Consensus 243 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 243 IHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2233333321 123346889999999999 9999999999874
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.81 Aligned_cols=238 Identities=27% Similarity=0.447 Sum_probs=191.3
Q ss_pred eeecccCceEEEEEEEcCCC------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEG------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
+.||+|+||.||+|.+.... ..+|+|.+... ........+.+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG---ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc---cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeE
Confidence 36999999999999876544 78998876532 123456678899999999999999999998754 45689
Q ss_pred EEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC-----cEEE
Q 035992 106 FITEIFTSGTLRQYRKKH-------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG-----EVKI 173 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~-------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g-----~VKL 173 (613)
++|||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||+||+++ ..+ .++|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEE
Confidence 999999999999998643 34788999999999999999999988 99999999999998 344 7999
Q ss_pred eccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCC
Q 035992 174 GDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIK 245 (613)
Q Consensus 174 ~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~ 245 (613)
+|||++..+.... ....+..|+|||.+.+ .++.++||||||+++|+|++ |..||.... .......+..+..
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~-~~~~~~~~~~~~~ 231 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-NQEVLQHVTAGGR 231 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC-HHHHHHHHhcCCc
Confidence 9999987553221 2233468999997764 58999999999999999998 999996644 3445555554432
Q ss_pred CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 246 PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 246 p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+ ..+...+..+.++|.+||. +|.+||++.++++
T Consensus 232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 232 L-QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred c-CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 3344567889999999998 9999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.37 Aligned_cols=241 Identities=25% Similarity=0.434 Sum_probs=185.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
.+||+|+||+||+|... +|..||+|.+.... ... ..+|.+|+.++.+++|||+|++++||.+... ..++|+||+
T Consensus 81 ~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~---~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LVYEym 154 (361)
T KOG1187|consen 81 NLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNS---GQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLVYEYM 154 (361)
T ss_pred cceecCCCeEEEEEEEC-CCCEEEEEEecCCC---Ccc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEEEEcc
Confidence 69999999999999754 44899988554322 111 4459999999999999999999999876443 689999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCC-CCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-hcc
Q 035992 112 TSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-ARS 187 (613)
Q Consensus 112 ~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~-~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-~~~ 187 (613)
..|+|.+++.... .+++....+|+.++++||+|||... ++|||||||++|||+| .+.+.||+|||+|..... ...
T Consensus 155 ~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 155 PNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred CCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccc
Confidence 9999999998765 8999999999999999999999954 4799999999999999 667999999999965543 221
Q ss_pred ---C-cccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHH----HHHHHcCC-----CCCcccc
Q 035992 188 ---A-HSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQI----YKKVTSGI-----KPASLAK 251 (613)
Q Consensus 188 ---~-~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i----~~~I~~g~-----~p~~l~~ 251 (613)
. .||..|+|||.+. +..+.++|||||||+++||+||+.|..... ....+ ...+..+. .|.....
T Consensus 234 ~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~ 313 (361)
T KOG1187|consen 234 VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEG 313 (361)
T ss_pred eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCC
Confidence 1 6888999999876 569999999999999999999998885432 11111 12222221 1211101
Q ss_pred ccc-----HHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 252 VAD-----NGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 252 ~~s-----~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
... ..+..+..+|++ +|.+||++.|++.
T Consensus 314 ~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 314 EYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 112 224567778998 8999999998754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=298.45 Aligned_cols=259 Identities=19% Similarity=0.344 Sum_probs=220.4
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l 104 (613)
.-+++.++||+|+|++|.+++++.|.+.+|+|++|+. +....++++....|.++..+. +||.+|-++.+|.. ...+
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkke-l~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKE-LVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHH-hcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 3467889999999999999999999999999998854 455678889999999999877 79999999998854 4579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh-
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA- 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~- 183 (613)
+||.||++||+|.-+.++.++++++.++.+...|+.||.|||++| ||+||||.+|+|++ ..|++||.|+|+++.--
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCC
Confidence 999999999999999999999999999999999999999999999 99999999999999 56899999999987532
Q ss_pred ---hhccCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCC-------CCCcHHHHHHHHHcCCCCCccccc
Q 035992 184 ---QARSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYV-------ECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 184 ---~~~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~-------~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
...+++||+.|+|||++.+. |+..+|+|+||++|+||+.|+.||. +......+++.|.... ..++..
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq--iriprs 481 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ--IRIPRS 481 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc--ccccce
Confidence 24578899999999998864 9999999999999999999999993 2233455677666543 234445
Q ss_pred ccHHHHHHHHHHhh-cccCCCC------HHHHhcCCCCCCCCccccc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLP------AKELLGDPFLQSEDDESVG 292 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpt------a~eLL~HPff~~~~~~~~~ 292 (613)
.+-.+..+++..|+ ||.+|+. ..++..|+||+..+|..+.
T Consensus 482 lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 482 LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 55666677777787 9999985 7899999999999886653
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.19 Aligned_cols=199 Identities=30% Similarity=0.471 Sum_probs=170.4
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----CCEEE
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE----NEHIN 105 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~~~l~ 105 (613)
..+.||+||||.||+|+++.+|+.||+|.++... .....++..+|+++|++|+|+|||+++++=.... ...-.
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3589999999999999999999999988877544 4566788899999999999999999999632222 34567
Q ss_pred EEEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe-CCCCc--EEEeccchh
Q 035992 106 FITEIFTSGTLRQYRKKH---KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN-GNQGE--VKIGDLGLA 179 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~---~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~-~~~g~--VKL~DFGla 179 (613)
++||||.||+|+.++.+. ..+++.++..++..+..||.|||.+| |+||||||.||++- +.+|+ -||+|||.|
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 899999999999999754 57999999999999999999999999 99999999999985 34343 499999999
Q ss_pred HHHhhhc---cCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcH
Q 035992 180 AILAQAR---SAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNA 233 (613)
Q Consensus 180 ~~l~~~~---~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~ 233 (613)
+-+.... ...||..|++||+++ +.|+..+|.|||||++|+++||..||.....+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9887643 567889999999998 45899999999999999999999999554433
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.78 Aligned_cols=255 Identities=30% Similarity=0.433 Sum_probs=195.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCC----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
|.....||+|.||.||+|..+.++ +.+|+|.++-.+. .........+|+.+++.++|||++.+..+|... +..
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd--~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~~ 102 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD--GTGISMSACREIALLRELKHPNVISLVKVFLSH-DKK 102 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC--CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cce
Confidence 455578999999999999766554 3789888774321 112234567899999999999999999988754 678
Q ss_pred EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC---CCcEEEec
Q 035992 104 INFITEIFTSGTLRQYRKKH-----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN---QGEVKIGD 175 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~---~g~VKL~D 175 (613)
+|++++|... +|.+.|+-+ +.++...++.++.||+.|+.|||++- |+||||||.||||.++ .|.|||+|
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeec
Confidence 9999999977 888887643 45999999999999999999999999 9999999999999843 48999999
Q ss_pred cchhHHHhhhc-------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCC------cHHH--HHH
Q 035992 176 LGLAAILAQAR-------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECT------NAAQ--IYK 238 (613)
Q Consensus 176 FGla~~l~~~~-------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~------~~~~--i~~ 238 (613)
||+++.+...- ...-|++|.|||++-+ .|+.++|||++|||+.||+|.++-|.... ++.+ ...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999886532 2234569999997643 59999999999999999999888774311 1111 111
Q ss_pred HHHc--C-C--------------------------CCCcc------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 239 KVTS--G-I--------------------------KPASL------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 239 ~I~~--g-~--------------------------~p~~l------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
+|.. | . .+..+ .++.++...+++.++|+ ||.+|.|+++.|+|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 1110 0 0 00001 12235568899999999 9999999999999999
Q ss_pred CCCCCc
Q 035992 283 LQSEDD 288 (613)
Q Consensus 283 f~~~~~ 288 (613)
|.....
T Consensus 340 F~~d~l 345 (438)
T KOG0666|consen 340 FTEDPL 345 (438)
T ss_pred cccCCC
Confidence 998643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=274.89 Aligned_cols=238 Identities=33% Similarity=0.546 Sum_probs=202.5
Q ss_pred CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHH
Q 035992 38 AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLR 117 (613)
Q Consensus 38 afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~ 117 (613)
+||.||+|.+..+|+.+|+|++..... ....+.+.+|+..++.++|+||+++++++.. ....++++|++.+++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKI---KKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccc---ccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHH
Confidence 589999999999999999998764332 1116788999999999999999999998754 46789999999999999
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---ccCcccccc
Q 035992 118 QYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHSVIEF 194 (613)
Q Consensus 118 ~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~---~~~~gt~~Y 194 (613)
.++.....++...+..++.+++.+|.|||+.+ ++|+||+|+||+++ +.+.++|+|||.+...... ....++..|
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 152 (244)
T smart00220 76 DLLKKRGRLSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEY 152 (244)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCC
Confidence 99988777999999999999999999999998 99999999999998 5589999999999876543 334456689
Q ss_pred cCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc-ccHHHHHHHHHHhh-cccCC
Q 035992 195 MAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV-ADNGVRAFIEKCIA-EVSER 271 (613)
Q Consensus 195 mAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~-~s~~l~~lI~~cL~-dP~~R 271 (613)
+|||.+. ..++.++||||||+++|+|++|..||....+...+.+.+..+......... .+..+.+++.+||. +|.+|
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 232 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR 232 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence 9999775 458889999999999999999999997756777777777665544332222 67889999999998 99999
Q ss_pred CCHHHHhcCCCC
Q 035992 272 LPAKELLGDPFL 283 (613)
Q Consensus 272 pta~eLL~HPff 283 (613)
|++.++++||||
T Consensus 233 p~~~~~~~~~~~ 244 (244)
T smart00220 233 LTAEEALQHPFF 244 (244)
T ss_pred cCHHHHhhCCCC
Confidence 999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=308.04 Aligned_cols=247 Identities=28% Similarity=0.483 Sum_probs=205.5
Q ss_pred cCCCCcceeEe-------eeecccCceEEEEEEEcC--CC--cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc
Q 035992 21 IDPSARYGRYK-------EVLGRGAFKKVYRAFDEL--EG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89 (613)
Q Consensus 21 ~dp~gRy~r~~-------e~LG~GafGtVYka~~~~--tg--~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI 89 (613)
.-|++|.|++. ++||.|-||.||+|.... .| ..||+|.-| ....++..+.|+.|..+|+.++||||
T Consensus 377 ~~P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK---~d~t~d~tekflqEa~iMrnfdHphI 453 (974)
T KOG4257|consen 377 STPTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCK---TDCTPDDTEKFLQEASIMRNFDHPHI 453 (974)
T ss_pred cCCCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhc---cCCChhhHHHHHHHHHHHHhCCCcch
Confidence 45889988885 689999999999997533 33 457766554 33456778999999999999999999
Q ss_pred ceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 90 Vkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
|++++.+.+ ..+|+|||+++-|.|+.|++.++ .++...+..++.||+.||.|||+.. ++||||-..||||.+ .
T Consensus 454 ikLIGv~~e---~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsS-p 527 (974)
T KOG4257|consen 454 IKLIGVCVE---QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSS-P 527 (974)
T ss_pred hheeeeeec---cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecC-c
Confidence 999998754 46999999999999999998764 6999999999999999999999998 999999999999984 4
Q ss_pred CcEEEeccchhHHHhhhccCc-----ccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHH
Q 035992 169 GEVKIGDLGLAAILAQARSAH-----SVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~~~~~-----gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~ 241 (613)
..|||+|||+++.+....... -.+.|||||.++ ..++.++|||.||+||||++. |..||.+-.|.+.+ -.+.
T Consensus 528 ~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-~~iE 606 (974)
T KOG4257|consen 528 QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-GHIE 606 (974)
T ss_pred ceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-EEec
Confidence 599999999999886543222 223799999776 569999999999999999876 88999887765544 3566
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
+|..+ ..+..+++.+..++.+||. +|.+||.+.+|.
T Consensus 607 nGeRl-P~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 607 NGERL-PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred CCCCC-CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 66554 3566788999999999999 999999987764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=268.37 Aligned_cols=247 Identities=25% Similarity=0.457 Sum_probs=196.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
.++||+|.||+||+|++..+++.||+|.++..+- +........+||.+|+.++|.|||++++.. ..++.+-+|+||
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddd--degvpssalreicllkelkhknivrl~dvl--hsdkkltlvfe~ 82 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVL--HSDKKLTLVFEF 82 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCC--CCCCcHHHHHHHHHHHHhhhcceeehhhhh--ccCceeEEeHHH
Confidence 3899999999999999999999999998876442 223345678999999999999999999954 456678999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---
Q 035992 111 FTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR--- 186 (613)
Q Consensus 111 ~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 186 (613)
|.. +|..|... ++.++.+.++.++.|+++||.|+|+++ +.||||||.|+|++ .+|.+||+|||+++.+.-.-
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEee
Confidence 965 88888765 478999999999999999999999999 99999999999999 67999999999998765432
Q ss_pred -cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--CC---------------CC
Q 035992 187 -SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS--GI---------------KP 246 (613)
Q Consensus 187 -~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~--g~---------------~p 246 (613)
...-|..|.+|.++-+ -|+...|+||-||++.|+.....|.....+.....++|.. |. ++
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 1233568999997643 3999999999999999999855554444555544444431 10 00
Q ss_pred -Cccc---------ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 247 -ASLA---------KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 247 -~~l~---------~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+.++ ...+..-+++++++|. +|.+|+++++.++||||..
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 0011 1123456899999998 9999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=317.72 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=173.9
Q ss_pred ceeEeeeecccCceEEEEEEEcCC----CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee----c
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELE----GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV----D 98 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~t----g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv----~ 98 (613)
.|.+.++||+|+||+||+|.+..+ +..||+|.++... ..+....+ .++...+.++..++..|. .
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 357789999999999999999998 9999988765321 11111111 122223333333333221 1
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCC
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKH--------------------VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLK 158 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~--------------------lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLK 158 (613)
.....+++|+||+.+++|.+++..... .....++.++.||+.||+|||+++ |+|||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLK 282 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVK 282 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCC
Confidence 345679999999999999998875421 123457789999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhHHHhhh-----ccCcccccccCcccccc-----------------------ccCccchh
Q 035992 159 CDNIFVNGNQGEVKIGDLGLAAILAQA-----RSAHSVIEFMAPELYEE-----------------------EYNELVDI 210 (613)
Q Consensus 159 p~NILl~~~~g~VKL~DFGla~~l~~~-----~~~~gt~~YmAPEvl~~-----------------------~ys~ksDI 210 (613)
|+|||++.+.+.+||+|||+|..+... ....+++.|||||.+.. .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 999999865689999999999765322 23456779999995521 23456799
Q ss_pred hhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-------------CCcc------cccccHHHHHHHHHHhh-cccC
Q 035992 211 YAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-------------PASL------AKVADNGVRAFIEKCIA-EVSE 270 (613)
Q Consensus 211 WSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-------------p~~l------~~~~s~~l~~lI~~cL~-dP~~ 270 (613)
|||||++|||+++..|+.. ...++...+..... ...+ .........+||.+||+ ||.+
T Consensus 363 wSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 9999999999997766532 22222222221110 0000 00112335589999999 9999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 035992 271 RLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 271 Rpta~eLL~HPff~~~~~ 288 (613)
|||+.++|+||||+....
T Consensus 441 R~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 441 RISAKAALAHPYFDREGL 458 (566)
T ss_pred CCCHHHHhCCcCcCCCCc
Confidence 999999999999987643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=312.74 Aligned_cols=263 Identities=25% Similarity=0.446 Sum_probs=218.0
Q ss_pred CCCCCCCCCCCcc-cccCCCCcceeEeeeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHH
Q 035992 6 TSEQDPDDSDAEF-VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81 (613)
Q Consensus 6 ~~~~~~~~~~~~~-v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iL 81 (613)
-..+||.+..-+| .||||+ |.+++++||.|.||.||+|+.+..| ..||||.+|. .....+...|+.|+.||
T Consensus 610 ~TYEDPnqAvreFakEId~s--~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~---GytekqrrdFL~EAsIM 684 (996)
T KOG0196|consen 610 HTYEDPNQAVREFAKEIDPS--CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA---GYTEKQRRDFLSEASIM 684 (996)
T ss_pred ccccCccHHHHHhhhhcChh--heEEEEEEecccccceecccccCCCCcceeEEEeeecc---CccHHHHhhhhhhhhhc
Confidence 3445555555554 356654 5578999999999999999998877 5799888874 34567788899999999
Q ss_pred HhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCC
Q 035992 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160 (613)
Q Consensus 82 k~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~ 160 (613)
-+++||||+++-+. .+..+.+.||+|||..|+|..+++++ +.|+.-++..+++.|+.|++||-+++ +|||||-+.
T Consensus 685 GQFdHPNIIrLEGV--VTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAAR 760 (996)
T KOG0196|consen 685 GQFDHPNIIRLEGV--VTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAAR 760 (996)
T ss_pred ccCCCCcEEEEEEE--EecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhh
Confidence 99999999999994 46678899999999999999998766 67999999999999999999999999 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHHhhhccC-ccc------ccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCC
Q 035992 161 NIFVNGNQGEVKIGDLGLAAILAQARSA-HSV------IEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECT 231 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l~~~~~~-~gt------~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~ 231 (613)
|||||. +-..|++|||+++.+...... .+| ++|.|||.+. .+++.++||||||++|||.++ |+.||.+..
T Consensus 761 NILVNs-nLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 761 NILVNS-NLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred heeecc-ceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 999994 457899999999988654322 111 3899999775 579999999999999999765 999999988
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
|.+. .+.|..|...+ .+-.++..+.+|+..||+ +-.+||.+.||+.+
T Consensus 840 NQdV-IkaIe~gyRLP-pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 840 NQDV-IKAIEQGYRLP-PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred hHHH-HHHHHhccCCC-CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 7655 46777776432 233578899999999999 99999999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-34 Score=283.21 Aligned_cols=265 Identities=22% Similarity=0.382 Sum_probs=207.3
Q ss_pred CCcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeee
Q 035992 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYN 94 (613)
Q Consensus 15 ~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~ 94 (613)
+..+-.++..+.|.|+ .+||+|.||.||+|+++.+|+.||+|.+-..+ .....-....+|+.+|..|+|+|++.+++
T Consensus 7 s~~~P~~~~~~~yek~-~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nliE 83 (376)
T KOG0669|consen 7 SMYEPFCDEVSKYEKL-AKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIE 83 (376)
T ss_pred cccCCceecchHHHHH-HhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHH
Confidence 4556677888888776 88999999999999999999999966543211 11223345678999999999999998887
Q ss_pred eeec------CCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 95 SWVD------TENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 95 ~fv~------~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
.+-. .....+|+|+.+|.. +|.-++... -+++...|+.++.+++.||.|+|.+. |+|||+||.|+||+ .
T Consensus 84 ic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~ 159 (376)
T KOG0669|consen 84 ICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-K 159 (376)
T ss_pred HHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-C
Confidence 5421 234569999999977 788887765 67999999999999999999999998 99999999999998 5
Q ss_pred CCcEEEeccchhHHHhhhc--------cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHH
Q 035992 168 QGEVKIGDLGLAAILAQAR--------SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237 (613)
Q Consensus 168 ~g~VKL~DFGla~~l~~~~--------~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~ 237 (613)
+|.+||+|||+++.+.... ...-|..|.+||.+-+ .|+++.|||.-||++.||.|+.+-+.+.++..++.
T Consensus 160 dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~ 239 (376)
T KOG0669|consen 160 DGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH 239 (376)
T ss_pred CceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH
Confidence 6899999999997665432 1223669999997643 59999999999999999999999997766554442
Q ss_pred HHHH---cCCCCCc-----------------c-------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 238 KKVT---SGIKPAS-----------------L-------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 238 ~~I~---~g~~p~~-----------------l-------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
.|. ....+.. + +-+.+++..++++++|. ||.+|+.+.++|+|.||
T Consensus 240 -~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F 318 (376)
T KOG0669|consen 240 -LISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFF 318 (376)
T ss_pred -HHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhh
Confidence 221 1110100 0 11235678899999999 99999999999999999
Q ss_pred CCCC
Q 035992 284 QSED 287 (613)
Q Consensus 284 ~~~~ 287 (613)
..+.
T Consensus 319 ~kdp 322 (376)
T KOG0669|consen 319 WKDP 322 (376)
T ss_pred hcCC
Confidence 8763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=300.47 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=209.7
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
-|++.. ++.|+||+|.||+|++|.++..+ ..||+|+++..... ..+..|++|+.+|.+|+|+|++++|+...+
T Consensus 107 Ipee~i-~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 107 IPEEQI-KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred ccHHHH-HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 344444 45599999999999999887643 57899988765442 378899999999999999999999997543
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 99 TENEHINFITEIFTSGTLRQYRKK--HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
..+.+|||+++.|+|.+.+.+ ...|-...+-.|+.||+.|+.||.+++ +|||||-..|+|+.. ...|||+||
T Consensus 183 ---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllas-prtVKI~DF 256 (1039)
T KOG0199|consen 183 ---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLAS-PRTVKICDF 256 (1039)
T ss_pred ---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecc-cceeeeecc
Confidence 468899999999999998877 356889999999999999999999998 999999999999974 569999999
Q ss_pred chhHHHhhhccCc-------ccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 177 GLAAILAQARSAH-------SVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 177 Gla~~l~~~~~~~-------gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
|+.+-+......+ --..|+|||.+. ..++.++|||+|||+||||+| |+.||.++ ...+|+++|..+...
T Consensus 257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~erL- 334 (1039)
T KOG0199|consen 257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGERL- 334 (1039)
T ss_pred cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhccccccC-
Confidence 9998876543222 123799999876 469999999999999999998 78999775 567788888865432
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.-++.++..+.+++..||. +|.+|||+..|...-+++..
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 3456789999999999999 99999999999776666543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=306.02 Aligned_cols=258 Identities=26% Similarity=0.492 Sum_probs=226.4
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
.-.+|.-.|+ +..++|.|+||.||+|+++.+++..|+|+||... ..+..-+.+||-+++.++|||||.|++.+..
T Consensus 9 srrnP~ddye-llqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 9 SRRNPQDDYE-LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred hhcCCccchh-heeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhh
Confidence 3447777884 4589999999999999999999999999988543 4566778899999999999999999998864
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+|+.||||.||+|.+.-.-.+.+++.++...++..++||+|||+.+ -+|||||-.||+++ +.|.||++|||.
T Consensus 84 --~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgv 158 (829)
T KOG0576|consen 84 --RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGV 158 (829)
T ss_pred --hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCc
Confidence 4569999999999999998777889999999999999999999999998 89999999999998 789999999999
Q ss_pred hHHHh----hhccCcccccccCcccc----ccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 179 AAILA----QARSAHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 179 a~~l~----~~~~~~gt~~YmAPEvl----~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
+..+. ..+.+.||+.|||||+. .++|++++|||++|++..|+.--++|..+......++-.-.++..|+.+.
T Consensus 159 saqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 159 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK 238 (829)
T ss_pred hhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCccc
Confidence 87654 35678899999999964 25699999999999999999999999878777777776777787776654
Q ss_pred c--cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 251 K--VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 251 ~--~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
. .+++.+.+|++.||. +|.+||+++.+|.|||....
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3 478899999999998 99999999999999999875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=290.08 Aligned_cols=236 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
..++||-|-||.||.|.++...-.||+|.+|- +.-.+++|+.|..+|+.++|||+|+++++| .....+|||+|
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-----DtMeveEFLkEAAvMKeikHpNLVqLLGVC--T~EpPFYIiTE 343 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC--THEPPFYIITE 343 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhh-----cchhHHHHHHHHHHHHhhcCccHHHHhhhh--ccCCCeEEEEe
Confidence 45899999999999999999999999888763 446789999999999999999999999976 44567999999
Q ss_pred ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc
Q 035992 110 IFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 187 (613)
||+.|+|.+|+++.. .++.-.+..++.||..|++||..++ +|||||-..|+||. ++..||++|||+++++.....
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCce
Confidence 999999999998764 4777778899999999999999999 99999999999996 667899999999999865432
Q ss_pred C-----cccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 188 A-----HSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 188 ~-----~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
. .-.+.|.|||-+. +.++.|+|||+||++|||+.| |-.||.+ .+..+.|..+..|.... -+..+++.+..|
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM~-~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRMD-GPEGCPPKVYEL 498 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhcccccc-CCCCCCHHHHHH
Confidence 1 1124799999765 569999999999999999998 6778855 77889999998887543 355678899999
Q ss_pred HHHHhh-cccCCCCHHHH
Q 035992 261 IEKCIA-EVSERLPAKEL 277 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eL 277 (613)
++.||+ .|++||+++|+
T Consensus 499 MraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHhcCCcccCccHHHH
Confidence 999999 99999998776
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=263.59 Aligned_cols=208 Identities=27% Similarity=0.464 Sum_probs=176.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
+.||+|++|.|-+.++..+|...|+|.++.. -+...+.+++.|+.+..+. ..|.+|.||+.++.. ..+|+.||.
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~t---vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re--gdvwIcME~ 126 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRAT---VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE--GDVWICMEL 126 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhh---cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc--ccEEEeHHH
Confidence 6799999999999999999999998876642 3467788899999876665 799999999987653 469999999
Q ss_pred cCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 111 FTSGTLRQY----RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 111 ~~gGsL~~~----l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|.. +|..+ +++.+.++|..+-+++..++.||.|||++- .+||||+||+|||+| ..|+||+||||++..+..+-
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEc-cCCcEEEcccccceeehhhh
Confidence 975 66543 567789999999999999999999999973 599999999999999 67999999999998776532
Q ss_pred --c-CcccccccCcccccc-----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 187 --S-AHSVIEFMAPELYEE-----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 187 --~-~~gt~~YmAPEvl~~-----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
+ ..|.-.|||||.+.. +|+.++||||||++++||+++++||.....+.++++.+.....|.
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~ 272 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ 272 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence 2 346668999997752 599999999999999999999999998888888888888776553
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=285.80 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=199.8
Q ss_pred ccccCC-CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC--CCC----cc
Q 035992 18 FVEIDP-SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK--HKN----II 90 (613)
Q Consensus 18 ~v~~dp-~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~--HpN----IV 90 (613)
|..-|- ..|| .+...+|+|.||.|-.+.+..++..||+|+++-.. ...+..+-|+.+|.++. .|+ +|
T Consensus 81 ~~~gD~l~~Ry-~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-----kYreAa~iEi~vLqki~~~DP~g~~rcv 154 (415)
T KOG0671|consen 81 YQVGDILTNRY-EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-----KYREAALIEIEVLQKINESDPNGKFRCV 154 (415)
T ss_pred EEeccccccce-ehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-----HHhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence 444444 5666 45599999999999999999999999988877432 44566778999999993 232 66
Q ss_pred eeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC-
Q 035992 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN- 167 (613)
Q Consensus 91 kl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~- 167 (613)
.+.++| +-.+++++|+|.+ |-+++++++.++ +++...++.+++|++++++|||+++ ++|.||||+|||+-..
T Consensus 155 ~m~~wF--dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 155 QMRDWF--DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSE 229 (415)
T ss_pred eeehhh--hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccc
Confidence 676665 3356899999988 569999998864 6899999999999999999999998 9999999999998311
Q ss_pred ------------------CCcEEEeccchhHHHhhhc-cCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCC
Q 035992 168 ------------------QGEVKIGDLGLAAILAQAR-SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPY 227 (613)
Q Consensus 168 ------------------~g~VKL~DFGla~~l~~~~-~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf 227 (613)
.-.|+|+|||.|+.-.... ....|-.|.|||++- -+++..+||||+||||+|+.||..-|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 1258999999998765543 345566999999765 57999999999999999999999999
Q ss_pred CCCCcHHHH--HHHHHcCCCCCcc------------------------------------cc------cccHHHHHHHHH
Q 035992 228 VECTNAAQI--YKKVTSGIKPASL------------------------------------AK------VADNGVRAFIEK 263 (613)
Q Consensus 228 ~~~~~~~~i--~~~I~~g~~p~~l------------------------------------~~------~~s~~l~~lI~~ 263 (613)
....+.+.+ .+.|.. ..|..+ .. .....+.+||++
T Consensus 310 qtHen~EHLaMMerIlG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred ccCCcHHHHHHHHHhhC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 876665543 333332 111110 00 012357799999
Q ss_pred Hhh-cccCCCCHHHHhcCCCCCCC
Q 035992 264 CIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||. ||.+|+|+.|+|.||||...
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcC
Confidence 999 99999999999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=292.79 Aligned_cols=255 Identities=20% Similarity=0.259 Sum_probs=180.1
Q ss_pred eeEeeeecccCceEEEEEEEc----------------CCCcEEEEEEEEeeccccCh----------HHHHHHHHHHHHH
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE----------------LEGIEVAWNQIKVIDLLRNS----------EDLERLYSEVHLL 81 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~----------------~tg~~VAiK~vk~~~~~~~~----------~~~~~l~~Ei~iL 81 (613)
|++.++||+|+||+||+|... ..++.||+|.++........ ...+....|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 477899999999999999752 34567999887643211000 0112234477777
Q ss_pred HhCCCCCc-----ceeeeeeecC------CCCEEEEEEeccCCCCHHHHHHhC------------------------CCC
Q 035992 82 KTLKHKNI-----IKFYNSWVDT------ENEHINFITEIFTSGTLRQYRKKH------------------------KHV 126 (613)
Q Consensus 82 k~L~HpNI-----Vkl~~~fv~~------~~~~l~lV~E~~~gGsL~~~l~~~------------------------~~l 126 (613)
.+++|.++ ++++++|... .....|+||||+.+++|.+++... ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77776654 6677766432 234689999999999999987642 124
Q ss_pred CHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-----cCcccccccCccccc
Q 035992 127 DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-----SAHSVIEFMAPELYE 201 (613)
Q Consensus 127 se~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-----~~~gt~~YmAPEvl~ 201 (613)
++..++.++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||++..+.... ....++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 56788999999999999999998 99999999999998 56799999999987553321 112356899999763
Q ss_pred cc---------------------cC--ccchhhhhhHHHHHHHhcCC-CCCCCCcHH----------HHHHHHHcCCCCC
Q 035992 202 EE---------------------YN--ELVDIYAFGMCLLELVTFEY-PYVECTNAA----------QIYKKVTSGIKPA 247 (613)
Q Consensus 202 ~~---------------------ys--~ksDIWSLGviL~EmltG~~-Pf~~~~~~~----------~i~~~I~~g~~p~ 247 (613)
.. |+ .+.||||+||++|+|++|.. ||....... ..+..+.......
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~ 463 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDF 463 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCc
Confidence 21 22 34799999999999999885 775322111 1111122222222
Q ss_pred cccccccHHHHHHHHHHhh-cc---cCCCCHHHHhcCCCCCC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EV---SERLPAKELLGDPFLQS 285 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP---~~Rpta~eLL~HPff~~ 285 (613)
......+...++||.+||. +| .+|+|++|+|.||||..
T Consensus 464 ~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 464 SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 2334467889999999998 44 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=288.61 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=197.3
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC------CCCcceeeeeeecCCCC
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK------HKNIIKFYNSWVDTENE 102 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~------HpNIVkl~~~fv~~~~~ 102 (613)
.+.-..|+|-|++|..|.+...|..||||+|... ......=+.|+++|++|+ -.++++++..|.. ..
T Consensus 435 ~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-----E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h--kn 507 (752)
T KOG0670|consen 435 EVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-----EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH--KN 507 (752)
T ss_pred EEEeccccceeeeeeeccccCCCCeeEEEEeecc-----hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh--cc
Confidence 3345678999999999999999999999988743 333345578999999995 3489999998855 56
Q ss_pred EEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 103 HINFITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
++|+|+|.+ ..+|+..+++.| .|...+++.|++|+..||..|-..| |+|.||||+||||+.....+||||||.|
T Consensus 508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccc
Confidence 899999988 458999999876 4899999999999999999999988 9999999999999977778899999999
Q ss_pred HHHhhhccCcccc--cccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHH-HcCC-----------
Q 035992 180 AILAQARSAHSVI--EFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV-TSGI----------- 244 (613)
Q Consensus 180 ~~l~~~~~~~gt~--~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I-~~g~----------- 244 (613)
........+.... .|.|||++-+ .|+...|+||.||+||||.||+.-|.+.++...+.-.. ..|.
T Consensus 585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred cccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 8876554333322 6999997655 69999999999999999999999998877765542111 0111
Q ss_pred -------------------------------CC-Ccc----------c---ccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 245 -------------------------------KP-ASL----------A---KVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 245 -------------------------------~p-~~l----------~---~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
+| ..+ + ...-..+++|+.+||. ||.+|.|..+.|
T Consensus 665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL 744 (752)
T KOG0670|consen 665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL 744 (752)
T ss_pred hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence 11 000 0 0112468899999999 999999999999
Q ss_pred cCCCCCC
Q 035992 279 GDPFLQS 285 (613)
Q Consensus 279 ~HPff~~ 285 (613)
+||||+.
T Consensus 745 ~HpFi~~ 751 (752)
T KOG0670|consen 745 KHPFITE 751 (752)
T ss_pred cCCcccC
Confidence 9999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=277.52 Aligned_cols=132 Identities=28% Similarity=0.506 Sum_probs=113.2
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----C---CCcceeeeee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-----H---KNIIKFYNSW 96 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-----H---pNIVkl~~~f 96 (613)
||| -+.++||-|-|+|||+|.|..+.+.||+|++|- .....+....||.+|+++. | ..||++++.|
T Consensus 78 gRY-~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRY-HVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceE-EEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 666 567999999999999999999999999998873 3455677889999999983 3 3699999999
Q ss_pred ecC--CCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEE
Q 035992 97 VDT--ENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV 164 (613)
Q Consensus 97 v~~--~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl 164 (613)
... ++.+++||+|++ |-+|..+|++. +.++...++.|++||+.||.|||.. ++|||.||||+|||+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e-cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE-CGIIHTDLKPENVLL 221 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh-cCccccCCCcceeee
Confidence 654 467899999998 55777777654 6799999999999999999999987 479999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=263.73 Aligned_cols=246 Identities=21% Similarity=0.365 Sum_probs=202.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.+++|+|.++.||.|++..+++.+.+|++| +...+.+.+|+.+|..|. ||||+++++...+.......+|
T Consensus 41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-------PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILK-------PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred HHHHHHcCccHhhHhcccccCCCceEEEeeec-------hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 45588999999999999999999999999887 445578999999999997 9999999998888888889999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 187 (613)
+||+...+..++ ...++...++.++.|+++||.|||++| |+|||+||.|++++.....++|+|+|+|.+......
T Consensus 114 FE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 114 FEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 999988766554 455888999999999999999999999 999999999999997778899999999999876532
Q ss_pred ---CcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCC-CCCcHHHHHHHHH--c------------CCCCC
Q 035992 188 ---AHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYV-ECTNAAQIYKKVT--S------------GIKPA 247 (613)
Q Consensus 188 ---~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~-~~~~~~~i~~~I~--~------------g~~p~ 247 (613)
...+-.|--||++-. .|+..-|+|||||++..|+..+-||. +..+..|+.+... . -..++
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 223336789997753 59999999999999999999998884 4456666643221 0 00000
Q ss_pred --------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 248 --------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 248 --------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.-....++++.+|+.++|. |-.+|+||+|.+.||||...
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~ 328 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV 328 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence 0112346899999999999 99999999999999999865
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=288.01 Aligned_cols=247 Identities=27% Similarity=0.415 Sum_probs=197.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
|..+. ++.++||+|-||.|.++.-. .+..||+|.++-. .+......|.+||++|.+|+||||+.+++.|+. ++
T Consensus 536 PRs~L-~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~---a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~--De 608 (807)
T KOG1094|consen 536 PRSRL-RFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPD---ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ--DD 608 (807)
T ss_pred chhhe-ehhhhhcCcccceeEEEEec-CceEEEEeecCcc---cchhHHHHHHHHHHHHhccCCCCeeEEEeeeec--CC
Confidence 33443 67899999999999999533 3589998876633 345567889999999999999999999998865 45
Q ss_pred EEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 103 HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
.+++|+||+..|+|.+|+.++ ..+.-....+++.||+.|++||.+.+ ++||||.+.|+|+++ .+++||+|||+++
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~-e~~iKiadfgmsR 685 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDG-EFTIKIADFGMSR 685 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecC-cccEEecCccccc
Confidence 799999999999999999998 34455666779999999999999999 999999999999985 5799999999998
Q ss_pred HHhhhc------cCcccccccCcc-ccccccCccchhhhhhHHHHHHHh--cCCCCCCCCcHHHHHHH--HHcCCC---C
Q 035992 181 ILAQAR------SAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVT--FEYPYVECTNAAQIYKK--VTSGIK---P 246 (613)
Q Consensus 181 ~l~~~~------~~~gt~~YmAPE-vl~~~ys~ksDIWSLGviL~Emlt--G~~Pf~~~~~~~~i~~~--I~~g~~---p 246 (613)
.+-... ...-.++||||| ++.++++.++|+|+||+++|||++ .+.||...++.+.+-+. +..... -
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence 654322 122235899999 567889999999999999999765 68999876654433221 111111 1
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
...+..++..+.++|.+||. +-.+||++++|-.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 23466788899999999999 9999999999854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=301.01 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=188.4
Q ss_pred EeeeecccCceE-EEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEE
Q 035992 30 YKEVLGRGAFKK-VYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 30 ~~e~LG~GafGt-VYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
..+++|.|+-|+ ||+|. -.|+.||+|.+- .+..+...+||..|+.. +|||||++|+ .+.+...+|+.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll-------~e~~~~A~rEi~lL~eSD~H~NviRyyc--~E~d~qF~YIa 581 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLL-------EEFFDFAQREIQLLQESDEHPNVIRYYC--SEQDRQFLYIA 581 (903)
T ss_pred cHHHcccCCCCcEEEEEe--eCCceehHHHHh-------hHhHHHHHHHHHHHHhccCCCceEEEEe--eccCCceEEEE
Confidence 358999999986 79995 468899966543 34556778999999998 5999999999 55667899999
Q ss_pred EeccCCCCHHHHHHhCCC-C---CHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC----CCcEEEeccchh
Q 035992 108 TEIFTSGTLRQYRKKHKH-V---DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN----QGEVKIGDLGLA 179 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~-l---se~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~----~g~VKL~DFGla 179 (613)
.|+|.. +|.+++...+. + ..-..+..+.|+++||++||+.+ ||||||||.||||... ...++|+|||++
T Consensus 582 lELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 582 LELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred ehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccc
Confidence 999977 99999988521 1 11334778999999999999988 9999999999999852 246899999999
Q ss_pred HHHhhh-------ccCcccccccCccccccc-cCccchhhhhhHHHHHHHhc-CCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 180 AILAQA-------RSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 180 ~~l~~~-------~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG-~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
+.+... ....||.+|+|||++.+. -..++|||||||++|+.++| ..||.+ ..++..+.+........+.
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANILTGNYTLVHLE 736 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhhhcCccceeeec
Confidence 987543 234577799999988764 56689999999999999996 899954 2333333333333222333
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...+.++++||.+||. +|..||+|.++|.||||-.-
T Consensus 737 ~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 737 PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 3333389999999999 99999999999999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=314.34 Aligned_cols=237 Identities=23% Similarity=0.340 Sum_probs=178.6
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+..++||+|+||.||+|.+..+|..||+|.++.... ....|++++++++|||||++++++.. ....++||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~~~lv~ 762 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--------IPSSEIADMGKLQHPNIVKLIGLCRS--EKGAYLIH 762 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--------ccHHHHHHHhhCCCCCcceEEEEEEc--CCCCEEEE
Confidence 345789999999999999999999999987753221 11246889999999999999999865 34688999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 187 (613)
||+.+|+|.++++. +++..+..++.||+.||+|||.+ .++|+||||||+||+++ ..+..++. ||.+........
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~~~~ 837 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCTDTK 837 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-eccccccccCCC
Confidence 99999999999964 88999999999999999999954 34499999999999998 44566664 665544333334
Q ss_pred CcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc----HHHHHHHHHcC------CCCC-----cccc
Q 035992 188 AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN----AAQIYKKVTSG------IKPA-----SLAK 251 (613)
Q Consensus 188 ~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~----~~~i~~~I~~g------~~p~-----~l~~ 251 (613)
..++..|||||++.. .|+.++|||||||++|||+||+.||..... .....+..... ..|. ....
T Consensus 838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 456789999998765 599999999999999999999999843211 11111111100 0010 0111
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
....++.+++.+||+ +|.+||++.|+++.
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 122356789999999 99999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=291.85 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=206.5
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCc
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNI 89 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNI 89 (613)
..+++.+.+ .+.+.||+|+||.|++|.-.. ....||+|..+.. ....+.+.+..|+.+|+.+ +|+||
T Consensus 290 ~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~---~~~~~~~~~~~El~~m~~~g~H~ni 364 (609)
T KOG0200|consen 290 KWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN---ASSSEKKDLMSELNVLKELGKHPNI 364 (609)
T ss_pred ceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccc---cCcHHHHHHHHHHHHHHHhcCCcch
Confidence 455555555 455799999999999996431 1457887776643 2347788999999999999 69999
Q ss_pred ceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEE
Q 035992 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVI 153 (613)
Q Consensus 90 Vkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~II 153 (613)
+.+++++.. ...+++|+||+..|+|..|++..+ .++...+..++.||+.|++||++.. +|
T Consensus 365 v~llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~v 440 (609)
T KOG0200|consen 365 VNLLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CV 440 (609)
T ss_pred hhheeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--cc
Confidence 999998754 678999999999999999998766 4889999999999999999999988 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-----cCcc--cccccCcccccc-ccCccchhhhhhHHHHHHHh-cC
Q 035992 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-----SAHS--VIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FE 224 (613)
Q Consensus 154 HrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-----~~~g--t~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~ 224 (613)
||||-+.|||+. .+..+||+|||+|+...... ...+ ...|||||.+.. .|+.++||||||++||||+| |.
T Consensus 441 HRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCC
Confidence 999999999998 45689999999998543321 1111 236999997765 59999999999999999998 88
Q ss_pred CCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 225 YPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 225 ~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.||.+......+++.+..|.... .|..++.++.++++.||+ +|.+||++.++..
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 99988665777788899987654 455669999999999999 9999999988864
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=290.45 Aligned_cols=240 Identities=29% Similarity=0.472 Sum_probs=200.5
Q ss_pred eEeeeecccCceEEEEEEEcCCCc----EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGI----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~----~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
|..++||+|+||+||+|.+...|+ +||+|++.. .........++.|+-+|.+++|||++++++++... .+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~---~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~ 772 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE---FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TL 772 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeec---cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hH
Confidence 345899999999999999988875 456555432 23455678899999999999999999999987543 48
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
.+|++|++.|.|.+|++.+ ..+-......|+.||++||.|||.+. ++||||-..||||. ....|||.|||++..+.
T Consensus 773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccC
Confidence 8899999999999999876 57899999999999999999999998 99999999999998 55699999999999886
Q ss_pred hhccCcc------cccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 184 QARSAHS------VIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 184 ~~~~~~g------t~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
....... .+.|||-|.+.. .|+.++|||||||++||++| |..||.+ ...++|...+..|.+ ..-+...+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCti 927 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTI 927 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccH
Confidence 5432222 236888886654 59999999999999999999 7889965 566778777777765 455678899
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++..++.+||. |+..||++++|..
T Consensus 928 DVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 928 DVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999998 9999999988854
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=274.20 Aligned_cols=237 Identities=27% Similarity=0.441 Sum_probs=186.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC--CCCCcceeeeeeecCC--CCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL--KHKNIIKFYNSWVDTE--NEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~fv~~~--~~~ 103 (613)
..+.++||+|.||.||+|. .+++.||+|++. ..+.+.+..|..|.+.. +|+||++|+++=.... ...
T Consensus 212 l~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp-------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e 282 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFP-------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME 282 (534)
T ss_pred hhhHHHhhcCccceeehhh--ccCceeEEEecC-------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence 3456999999999999994 567999988865 46667788888888764 8999999998532111 347
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-------CCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-------HDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-------~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
+|+|++|.+.|+|.+|++.+ .+++....+++..+++||+|||+ +.|+|+|||||..||||. ++++.-|+||
T Consensus 283 ywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDF 360 (534)
T KOG3653|consen 283 YWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADF 360 (534)
T ss_pred eeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeecc
Confidence 99999999999999999985 58999999999999999999996 446799999999999997 7899999999
Q ss_pred chhHHHhhhc------cCcccccccCccccccccC-------ccchhhhhhHHHHHHHhc------------CCCCC---
Q 035992 177 GLAAILAQAR------SAHSVIEFMAPELYEEEYN-------ELVDIYAFGMCLLELVTF------------EYPYV--- 228 (613)
Q Consensus 177 Gla~~l~~~~------~~~gt~~YmAPEvl~~~ys-------~ksDIWSLGviL~EmltG------------~~Pf~--- 228 (613)
|+|.++.... ...||.+|||||++++-.+ .+.||||+|.++|||++. +.||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998875432 3467889999999987433 358999999999999984 23342
Q ss_pred -CCCcHHHHHHHHHcCCCCCcccccc-----cHHHHHHHHHHhh-cccCCCCHH
Q 035992 229 -ECTNAAQIYKKVTSGIKPASLAKVA-----DNGVRAFIEKCIA-EVSERLPAK 275 (613)
Q Consensus 229 -~~~~~~~i~~~I~~g~~p~~l~~~~-----s~~l~~lI~~cL~-dP~~Rpta~ 275 (613)
..+..+++...+......+.++..+ -..+++.++.||. |+..|+||.
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 1233445555555544433443322 3568899999998 999999963
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=264.57 Aligned_cols=249 Identities=24% Similarity=0.452 Sum_probs=197.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---CEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN---EHINFI 107 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~---~~l~lV 107 (613)
++-||.|+||+||.+.+..+|+.||+|.+. +...+-...+++.+|+.+|..++|.|++..++......- ..+|++
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~p--nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMP--NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcc--hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 378999999999999999999999987654 344555677899999999999999999998875432211 247789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~ 187 (613)
+|+|.+ +|..++-....++...++-+++||++||+|||+.+ |.||||||.|+|+| .+..+||||||+++.......
T Consensus 136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhh
Confidence 999866 89999999999999999999999999999999998 99999999999999 456889999999987655433
Q ss_pred Ccc-----cccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH-------------------
Q 035992 188 AHS-----VIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT------------------- 241 (613)
Q Consensus 188 ~~g-----t~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~------------------- 241 (613)
.+- |-.|.|||++.+ .|+.++||||.|||+.|++..+.-|......+++ +.|+
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhhhhH
Confidence 332 337999997764 5999999999999999999888888664444333 3332
Q ss_pred -----cCCCCCccccc--------ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 -----SGIKPASLAKV--------ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 -----~g~~p~~l~~~--------~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+.+++.++.. ...+...++.++|. +|.+|.+.++.+.|+++...
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 23334443322 22455667777777 99999999999999998764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=264.95 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=196.4
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC---
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE--- 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~--- 100 (613)
..||-.+ ..+|.|+- .|..|.|..+++.||+|.+... ..+.....+.++|..++..++|+||++++.+|....
T Consensus 16 ~~Ry~nL-~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p--f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 16 PKRYVNL-KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP--FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeee-cccCCCCc-eEEecchhhccCceehhhhcCc--cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 3466444 78899998 8899999999999998877654 334455678899999999999999999999885332
Q ss_pred -CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 -NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 -~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
-..+|+|||+|.. +|.+.+. -.++.+.++.++.|++.|++|||+.+ |+||||||+||+++ .++.+||.|||+|
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLA 165 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhh
Confidence 1357899999965 8888776 45788999999999999999999999 99999999999998 6789999999999
Q ss_pred HHHhhh-cc--CcccccccCcccc-ccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-------------
Q 035992 180 AILAQA-RS--AHSVIEFMAPELY-EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS------------- 242 (613)
Q Consensus 180 ~~l~~~-~~--~~gt~~YmAPEvl-~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~------------- 242 (613)
..-... .. ...+-.|.|||++ +-+|.+.+||||+||++.||++|+.-|.+.....+..+.+..
T Consensus 166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 765443 11 1122269999965 446999999999999999999999999764444443322210
Q ss_pred --------------C-----CCCCc-------ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 243 --------------G-----IKPAS-------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 243 --------------g-----~~p~~-------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+ ..|.. .++.....+++++.+||. +|++|.+++++|.||||+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 0 00100 012234578999999998 999999999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=266.18 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=186.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh--CCCCCcceeeeeeecCC--
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT--LKHKNIIKFYNSWVDTE-- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~--L~HpNIVkl~~~fv~~~-- 100 (613)
+|..++.+.||+|.||.||+|.+ .|+.||+|++.-. +-....+|.++.+. |+|+||+.|+++=....
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~sr-------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSR-------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEeccc-------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 46678899999999999999955 6999999987632 23446677777776 59999999998522111
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc------CCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS------HDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs------~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
-..+|+|++|.+.|+|.+|+.+ ..++.+...+++..++.||++||. ..|.|.|||||..||||. .+|..-|+
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IA 358 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIA 358 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEe
Confidence 1369999999999999999999 679999999999999999999994 346699999999999997 67899999
Q ss_pred ccchhHHHhh--------hccCcccccccCccccccccC-------ccchhhhhhHHHHHHHhc----------CCCCCC
Q 035992 175 DLGLAAILAQ--------ARSAHSVIEFMAPELYEEEYN-------ELVDIYAFGMCLLELVTF----------EYPYVE 229 (613)
Q Consensus 175 DFGla~~l~~--------~~~~~gt~~YmAPEvl~~~ys-------~ksDIWSLGviL~EmltG----------~~Pf~~ 229 (613)
|||||..... .....||.+|||||++.+..+ ..+||||||.++||++.. .+||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999975543 245678899999999976432 359999999999999862 788865
Q ss_pred CC----cHHHHHHHHHcCCCCCcccccc--c---HHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 230 CT----NAAQIYKKVTSGIKPASLAKVA--D---NGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 230 ~~----~~~~i~~~I~~g~~p~~l~~~~--s---~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
.. ..+++.+.+--....+.++..+ . ..+..+++.||. +|.-|.||-.+.
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 43 3444544443333222333322 1 245578999998 999999976554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=276.00 Aligned_cols=218 Identities=28% Similarity=0.419 Sum_probs=180.3
Q ss_pred CCCCCCCCCCcccccCCCCcceeE-----eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChH----HHHHHHHH
Q 035992 7 SEQDPDDSDAEFVEIDPSARYGRY-----KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE----DLERLYSE 77 (613)
Q Consensus 7 ~~~~~~~~~~~~v~~dp~gRy~r~-----~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~----~~~~l~~E 77 (613)
..+++-..+..++-+--+++|-++ .+.||.|+||.|++|.++.+...|.+|.|.+.+...+.- .+-.+-.|
T Consensus 537 ~~ee~~~a~e~e~~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~E 616 (772)
T KOG1152|consen 537 WFEEPTKAVEPEGNIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSE 616 (772)
T ss_pred CCcCCccccCccccccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchh
Confidence 333333333444444444555443 489999999999999999999999999998766544322 22345679
Q ss_pred HHHHHhCC---CCCcceeeeeeecCCCCEEEEEEeccC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEE
Q 035992 78 VHLLKTLK---HKNIIKFYNSWVDTENEHINFITEIFT-SGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVI 153 (613)
Q Consensus 78 i~iLk~L~---HpNIVkl~~~fv~~~~~~l~lV~E~~~-gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~II 153 (613)
|+||..|+ |+||+|++++|.+ ++++|++||-.. |-+|+++|..++.++|..++.+++||+.|+++||++| ||
T Consensus 617 IqIla~l~~~sH~NIlKlLdfFEd--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~--iv 692 (772)
T KOG1152|consen 617 IQILATLNKHSHENILKLLDFFED--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG--IV 692 (772)
T ss_pred HHHHHHhhhcCccchhhhhheeec--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC--ce
Confidence 99999997 9999999999854 678999999865 4589999999999999999999999999999999999 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCC
Q 035992 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA--RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVE 229 (613)
Q Consensus 154 HrDLKp~NILl~~~~g~VKL~DFGla~~l~~~--~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~ 229 (613)
|||||-+|+.++ ..|.+||+|||.|...... ..+.||..|.|||++.+. | +..-|||+||+++|.++..+.||++
T Consensus 693 hrdikdenvivd-~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 693 HRDIKDENVIVD-SNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ecccccccEEEe-cCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999998 5689999999999887654 467899999999999865 4 6779999999999999999999965
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=231.96 Aligned_cols=207 Identities=37% Similarity=0.609 Sum_probs=179.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCC
Q 035992 34 LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113 (613)
Q Consensus 34 LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~g 113 (613)
||+|++|.||++.+..+|+.+++|.+..... ....+.+.+|+.+++.+.|++|+++++++.. ....++++|++.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS---SSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccc---hhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCC
Confidence 6899999999999988899999888774332 1145789999999999999999999998754 3678999999999
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----ccC
Q 035992 114 GTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----RSA 188 (613)
Q Consensus 114 GsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~~~ 188 (613)
++|..++... ..++...+..++.+++.+|.|||+++ ++|+||+|.||+++...+.++|+|||.+...... ...
T Consensus 76 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 76 GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 9999999876 57999999999999999999999998 9999999999999842679999999998765443 223
Q ss_pred cccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh
Q 035992 189 HSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266 (613)
Q Consensus 189 ~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~ 266 (613)
.+...|++||.+.. .++.+.|+|+||+++++| ..+.+++.+|+.
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~ 199 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQ 199 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhh
Confidence 45568999998765 678899999999999999 568899999998
Q ss_pred -cccCCCCHHHHhcCC
Q 035992 267 -EVSERLPAKELLGDP 281 (613)
Q Consensus 267 -dP~~Rpta~eLL~HP 281 (613)
+|.+||++.++++|+
T Consensus 200 ~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 200 KDPEKRPSAKEILEHL 215 (215)
T ss_pred CCcccCcCHHHHhhCC
Confidence 999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-28 Score=235.42 Aligned_cols=209 Identities=33% Similarity=0.508 Sum_probs=179.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||.|++|+||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++++.. ....+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEE
Confidence 36779999999999999999998999999887743321 356788999999999999999999998754 4578899
Q ss_pred EeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKHKH-VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
+|++.+++|.+++..... +++..+..++.+++.+|.|||+++ ++|+||+|.||+++ ..+.++|+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcc
Confidence 999999999999988777 899999999999999999999998 99999999999998 4589999999998876543
Q ss_pred ----ccCcccccccCcccc-c-cccCccchhhhhhHHHHHHHhcCCCCCC-CCcHHHHHHHHHcCC
Q 035992 186 ----RSAHSVIEFMAPELY-E-EEYNELVDIYAFGMCLLELVTFEYPYVE-CTNAAQIYKKVTSGI 244 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl-~-~~ys~ksDIWSLGviL~EmltG~~Pf~~-~~~~~~i~~~I~~g~ 244 (613)
....+...|++||.+ . ..++.++|+|+||+++++|++|+.||.. ..+...+++.+..+.
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 218 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV 218 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence 233455689999987 3 3477799999999999999999999966 566668888888775
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-29 Score=259.72 Aligned_cols=249 Identities=24% Similarity=0.422 Sum_probs=198.8
Q ss_pred CcceeEeeeecccCceEEEEEEEcC---CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTE 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~---tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 100 (613)
..+++..++||.|.|++||+|.+.. .++.||+|.+.... ...++..|+++|..+ -+.||+++.+++ ..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts------~p~ri~~El~~L~~~gG~~ni~~~~~~~--rn 106 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS------SPSRILNELEMLYRLGGSDNIIKLNGCF--RN 106 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc------CchHHHHHHHHHHHhccchhhhcchhhh--cc
Confidence 4567888999999999999999888 88999988877543 235689999999999 599999999987 45
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
++...+|+||++.-...++... ++...++.+++.++.||.++|++| ||||||||.|+|.+...+.-.|+|||+|.
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred CCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHH
Confidence 6789999999999888887765 678999999999999999999999 99999999999999878889999999997
Q ss_pred HHhh--------h----------------------------------------ccCcccccccCcccccc--ccCccchh
Q 035992 181 ILAQ--------A----------------------------------------RSAHSVIEFMAPELYEE--EYNELVDI 210 (613)
Q Consensus 181 ~l~~--------~----------------------------------------~~~~gt~~YmAPEvl~~--~ys~ksDI 210 (613)
.... . -...||++|.|||++.. .-+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 3210 0 01135668999998754 36789999
Q ss_pred hhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH--------------cCC--------------------------------
Q 035992 211 YAFGMCLLELVTFEYPYVECTNAAQIYKKVT--------------SGI-------------------------------- 244 (613)
Q Consensus 211 WSLGviL~EmltG~~Pf~~~~~~~~i~~~I~--------------~g~-------------------------------- 244 (613)
||.|+|++-++++.+||....+.......+. -|.
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 9999999999999999966443221111110 000
Q ss_pred ---CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 245 ---KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 245 ---~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+.......+..+.+|+.+||. +|.+|.||++.|+||||...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 0011122345578899999999 99999999999999999854
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=275.97 Aligned_cols=197 Identities=19% Similarity=0.202 Sum_probs=145.1
Q ss_pred hCCC-CCcceeeeeeecC-----CCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEec
Q 035992 83 TLKH-KNIIKFYNSWVDT-----ENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHR 155 (613)
Q Consensus 83 ~L~H-pNIVkl~~~fv~~-----~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHr 155 (613)
.++| .||++++++|... ....+++++|++ +++|.+++... ..+++..++.+++||+.||.|||+++ |+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--IvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG--IVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence 4455 5788888876211 124577788876 66999999764 56999999999999999999999998 9999
Q ss_pred CCCCCcEEEeC------------------CCCcEEEeccchhHHHhhh--------------------ccCcccccccCc
Q 035992 156 DLKCDNIFVNG------------------NQGEVKIGDLGLAAILAQA--------------------RSAHSVIEFMAP 197 (613)
Q Consensus 156 DLKp~NILl~~------------------~~g~VKL~DFGla~~l~~~--------------------~~~~gt~~YmAP 197 (613)
||||+||||+. ..+.+||+|||++...... ....+|+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999952 2346777788877532110 012356679999
Q ss_pred cccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHH
Q 035992 198 ELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAK 275 (613)
Q Consensus 198 Evl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~ 275 (613)
|++. ..|+.++|||||||+||||++|..|+... ......+.....+..... ..+....++.+||. +|.+||++.
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~L~~~P~~Rps~~ 260 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQILL-NWPKEASFCLWLLHPEPSCRPSMS 260 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhhh-cCHHHHHHHHHhCCCChhhCcChH
Confidence 9765 45999999999999999999998887432 222223332222322211 24556789999999 999999999
Q ss_pred HHhcCCCCCCC
Q 035992 276 ELLGDPFLQSE 286 (613)
Q Consensus 276 eLL~HPff~~~ 286 (613)
|+|+||||...
T Consensus 261 eil~h~~~~~~ 271 (793)
T PLN00181 261 ELLQSEFINEP 271 (793)
T ss_pred HHhhchhhhhh
Confidence 99999999763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=221.14 Aligned_cols=159 Identities=23% Similarity=0.336 Sum_probs=128.5
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccCcccc
Q 035992 114 GTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI 192 (613)
Q Consensus 114 GsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~gt~ 192 (613)
|+|.+++.++ +.+++..++.|+.||+.||.|||+++ ||+|||++ .++.+|+ ||++....... ..+++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~~-~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPEQ-SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeecccc-CCCcc
Confidence 6899999874 56999999999999999999999986 99999998 6678999 99987654433 36778
Q ss_pred cccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc-----ccccccH--HHHHHHHHH
Q 035992 193 EFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-----LAKVADN--GVRAFIEKC 264 (613)
Q Consensus 193 ~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~-----l~~~~s~--~l~~lI~~c 264 (613)
.|||||++.+ .|+.++|||||||++|||+||..||.........+..+..+..+.. .....+. .+++||.+|
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c 148 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC 148 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence 9999998765 5899999999999999999999999765554555555544332221 1122233 699999999
Q ss_pred hh-cccCCCCHHHHhcCCCCC
Q 035992 265 IA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~HPff~ 284 (613)
|. +|.+||++.+++.|+|+.
T Consensus 149 l~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 149 ASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhcccccccCHHHHHHHHHHH
Confidence 99 999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-27 Score=235.25 Aligned_cols=248 Identities=22% Similarity=0.342 Sum_probs=192.0
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.+.||+|.||.+-+|.|+.++..+++|.+.. ....+..|.+|.+.--.| .|.||+.-|+.-+... +.++|+
T Consensus 27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-----p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~-d~YvF~ 100 (378)
T KOG1345|consen 27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-----PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS-DAYVFV 100 (378)
T ss_pred hHHHHhcccceeeEEeeeccCCceEEEeeccCc-----chhhHHHHHHHhccceeeccchhhhHHHHHHhhcC-ceEEEe
Confidence 567999999999999999999999999888764 346678899999887777 5999999998655443 478899
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe-CCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~-~~~g~VKL~DFGla~~l~~~- 185 (613)
+||++-|+|..-+... .+-|...+.++.|++.||.|+|+.+ +||||||.+||||- .+.-.|||||||+.......
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999999888764 4889999999999999999999999 99999999999985 45568999999998754432
Q ss_pred ccCcccccccCcccccc----c--cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHH---HcCCCC--Cccccccc
Q 035992 186 RSAHSVIEFMAPELYEE----E--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV---TSGIKP--ASLAKVAD 254 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~----~--ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I---~~g~~p--~~l~~~~s 254 (613)
.....+..|.+||+... . .++.+|||.||+++|.++||.+||....-...-|... ..+..+ +...+.++
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 12223447999996642 2 4778999999999999999999997544333333322 233222 22234467
Q ss_pred HHHHHHHHHHhh-cccCC---CCHHHHhcCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSER---LPAKELLGDPFLQS 285 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~R---pta~eLL~HPff~~ 285 (613)
+.+..+.++-|. ++.+| .+++...+.-|...
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred HHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 778888888888 78877 56666666767653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=231.96 Aligned_cols=243 Identities=23% Similarity=0.322 Sum_probs=198.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCc-----EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGI-----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~-----~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
.|+..++-+|.||.||.|.+.++.. .|-+|.++ ...++-++..++.|--++..+.|||+..+.+..+. +..
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk---~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-~~~ 361 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK---QHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-DYA 361 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH---hcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-ccC
Confidence 5677889999999999997765442 33333222 22355667889999999999999999999998764 345
Q ss_pred EEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 103 HINFITEIFTSGTLRQYRKKH--------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
..+.++.++.-|+|..++... +.++..++..++.|++.|++|||+++ |||.||-..|.+|+ +.-+|||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEec
Confidence 677889999999999999832 34778888999999999999999999 99999999999998 66799999
Q ss_pred ccchhHHHhhhccC------cccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCC
Q 035992 175 DLGLAAILAQARSA------HSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKP 246 (613)
Q Consensus 175 DFGla~~l~~~~~~------~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p 246 (613)
|=.+++.+-..... .....||+||.+. ..|+.++|+||||++||||+| |+.||.+ -++.+++..+..|..-
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRL 517 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcccee
Confidence 99999876553322 1234799999775 469999999999999999998 8999966 6788888888888754
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
. .|..++.++..++-.||. .|.+||+.+||..
T Consensus 518 a-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 518 A-QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred c-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 3 345678899999999999 9999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-23 Score=208.98 Aligned_cols=251 Identities=28% Similarity=0.401 Sum_probs=201.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC-CcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK-NIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp-NIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||.|+||.||++.+. ..+++|.+...... .......+.+|+.++..+.|+ +|+++++.+. .....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~-~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLES-KSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhcc-chhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEE
Confidence 477899999999999999887 78888877654322 223577899999999999988 7999999883 3445899
Q ss_pred EEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 107 ITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++++.++++.+++.... .+++..+..++.|++.++.|+|+.+ ++|||+||+||+++.....++++|||++..+.
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 999999999998887775 7999999999999999999999998 99999999999998443379999999987554
Q ss_pred hh----------ccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHcCCCC
Q 035992 184 QA----------RSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTSGIKP 246 (613)
Q Consensus 184 ~~----------~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~g~~p 246 (613)
.. ....++..|+|||.+.. .+....|+|++|++++++++|..||..... .......+.....+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 32 34456779999998764 588899999999999999999999866553 45566555554433
Q ss_pred -Ccccccc------cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 -ASLAKVA------DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 -~~l~~~~------s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
....... ...+.+++..|+. +|..|.+..+...++|....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 1111111 2578899999998 89999999999988766554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-26 Score=255.89 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=201.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEee--ccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~--~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
..|++...++|.|++|.|+.+........+++|.+.+. ...........+..|+.+-..++|||++.....+.. ..
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~ 394 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--ID 394 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cc
Confidence 46888889999999999999988888888887766532 111111222237778888899999999887765433 22
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
...-.||||++ +|+.++.+.+.+....+-.+++|++.|++|+|++| |.|||||++|+++. ..|.+||+|||.+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVF 470 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceee
Confidence 33344999999 99999999889999999999999999999999999 99999999999998 6789999999999876
Q ss_pred hhhc--------cCcccccccCcccccc-ccCc-cchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH-cC-----CCC
Q 035992 183 AQAR--------SAHSVIEFMAPELYEE-EYNE-LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT-SG-----IKP 246 (613)
Q Consensus 183 ~~~~--------~~~gt~~YmAPEvl~~-~ys~-ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~-~g-----~~p 246 (613)
.... ...|.-.|+|||++.+ .|++ .+||||.|++++.|++|+.||......++.+.... .. ..+
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP 550 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh
Confidence 5432 3345568999998865 4765 69999999999999999999965444433321111 11 112
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
..+....+...+.+|.+||+ +|.+|.|+++|++++||+....
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 33445567788999999999 9999999999999999998754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=238.98 Aligned_cols=243 Identities=21% Similarity=0.305 Sum_probs=206.0
Q ss_pred eecccCceEEEEEE---EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEEE
Q 035992 33 VLGRGAFKKVYRAF---DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 33 ~LG~GafGtVYka~---~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
++|.|+||.|+++. -...|..+|+|+.++......... +...|..++..++ ||.++++...|.. ...+++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~l 76 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLIL 76 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeecc--ccchhHhh
Confidence 47999999999763 345678899998876654433222 6677889999987 9999999998854 45688999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccC
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA 188 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~ 188 (613)
++..||.|...+.+...+.+...+.+...++-+++++|+.+ ++|||+|++||+++ ..|++++.|||+++..-.....
T Consensus 77 d~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred hhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc
Confidence 99999999999999999999999999999999999999999 99999999999998 6799999999999988777667
Q ss_pred cccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-c
Q 035992 189 HSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-E 267 (613)
Q Consensus 189 ~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-d 267 (613)
+|+..|||||++. ++...+|+||||++++||+||..||.. .+...|.... ..++...+..+++++..++. +
T Consensus 154 cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~ 225 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRN 225 (612)
T ss_pred ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhC
Confidence 9999999999988 778899999999999999999999966 4444444432 23466678889999999998 8
Q ss_pred ccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 268 VSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 268 P~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
|..|.. +.|+++|+||+..+|..
T Consensus 226 p~nrLg~~~~~~~eik~h~f~~~i~~~~ 253 (612)
T KOG0603|consen 226 PENRLGAGPDGVDEIKQHEFFQSIDWNE 253 (612)
T ss_pred HHHHhccCcchhHHHhccchheeeeHhh
Confidence 998875 58999999999997753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=215.17 Aligned_cols=170 Identities=19% Similarity=0.167 Sum_probs=127.9
Q ss_pred cceeEeeeecccCceEEEEEEEcC-CCcEEEEEEEEeecc-ccChHHHHHHHHHHHHHHhCCCCCcce-eeeeeecCCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDEL-EGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKNIIK-FYNSWVDTENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~-tg~~VAiK~vk~~~~-~~~~~~~~~l~~Ei~iLk~L~HpNIVk-l~~~fv~~~~~ 102 (613)
..|++.++||+|+||+||+|.+.. +++.||+|.+..... .......+.+.+|+.+|+.++|+||+. ++. + .
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~-----~ 91 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T-----G 91 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c-----C
Confidence 345889999999999999999876 677789886542110 013345677999999999999999985 443 1 2
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCC-CCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDL-Kp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..|+||||+.|++|... .. .. ...|+.|++.+|.|||+++ |+|||| ||+|||++ .++.+||+|||+|..
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASV 161 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECcccee
Confidence 47899999999999732 11 11 1578899999999999998 999999 99999997 567999999999985
Q ss_pred Hhhh------------ccCcccccccCccccccc-------cCccchhh
Q 035992 182 LAQA------------RSAHSVIEFMAPELYEEE-------YNELVDIY 211 (613)
Q Consensus 182 l~~~------------~~~~gt~~YmAPEvl~~~-------ys~ksDIW 211 (613)
+... ....++..|+|||.+... .+...|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 4321 123455679999988532 33456766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-21 Score=200.41 Aligned_cols=244 Identities=19% Similarity=0.226 Sum_probs=179.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCC-cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC----CCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH----KNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg-~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H----pNIVkl~~~fv~~~~~ 102 (613)
|++.+.||+|+||.||+|.+..++ ..+|+|+........ . ..+..|+.++..+.. +++..+++... ....
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~-~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~ 94 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---P-SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STED 94 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---C-ccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCc
Confidence 488899999999999999988775 678877766432211 1 157788999988863 58888888653 3456
Q ss_pred EEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC----CcEEEecc
Q 035992 103 HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ----GEVKIGDL 176 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~----g~VKL~DF 176 (613)
+-|+||+++ |.+|.+++... +.++..++..++.|++.+|++||+.| ++||||||+|+++.... ..+.|.||
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEec
Confidence 788899987 77999988655 58999999999999999999999999 99999999999997332 46999999
Q ss_pred chhHHHh---h-----------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH--HHH
Q 035992 177 GLAAILA---Q-----------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI--YKK 239 (613)
Q Consensus 177 Gla~~l~---~-----------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i--~~~ 239 (613)
|+++... . .....||..|+++....+ ..+.+.|+||++.++.+|+.|..||......... +..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~ 251 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK 251 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence 9998221 1 112348889999996654 5899999999999999999999999665543222 222
Q ss_pred HHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 240 VTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 240 I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.........+......++..+...+-. +...+|....+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 221111111223334566666665555 7778888665544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=220.15 Aligned_cols=215 Identities=25% Similarity=0.383 Sum_probs=165.0
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
...++|..|+||.||..+|+.+.+.+|+|+ .+.++ +++ ||..+-+ ..+.|
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l---------------ilR-----nilt~a~--------npfvv- 135 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL---------------ILR-----NILTFAG--------NPFVV- 135 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhhcc-cccch---------------hhh-----ccccccC--------Cccee-
Confidence 344899999999999999999999999732 22111 111 1222222 11112
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ---- 184 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~---- 184 (613)
|+-...++.-++++... +.+++|||+-+ |+|||+||+|.+|+ ..|++|++|||+++....
T Consensus 136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -----chhhhhcccCCCCcchh--------hHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccc
Confidence 67777777777766544 78899999988 99999999999998 689999999999875421
Q ss_pred ---------------hccCcccccccCcccc-ccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC--CC
Q 035992 185 ---------------ARSAHSVIEFMAPELY-EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KP 246 (613)
Q Consensus 185 ---------------~~~~~gt~~YmAPEvl-~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~--~p 246 (613)
.+..++|+.|+|||++ .++|+..+|||++|+|+||.+.|..||.+ ..+++++..+.... .|
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wp 278 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWP 278 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccc
Confidence 2345789999999965 57799999999999999999999999976 55666666665432 33
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCC---HHHHhcCCCCCCCCcccc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLP---AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpt---a~eLL~HPff~~~~~~~~ 291 (613)
+. .....++++++|.++|+ +|..|.. +-++.+|+||+..+|..+
T Consensus 279 E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~l 326 (1205)
T KOG0606|consen 279 EE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSL 326 (1205)
T ss_pred cc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchh
Confidence 33 44567899999999998 9998864 789999999999988754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=184.58 Aligned_cols=144 Identities=18% Similarity=0.148 Sum_probs=112.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChH----------------------HHHHHHHHHHHHHhCCCCC
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE----------------------DLERLYSEVHLLKTLKHKN 88 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~----------------------~~~~l~~Ei~iLk~L~HpN 88 (613)
...||+|+||+||+|.+. +|+.||+|+++......... .......|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 89999999987643211110 0123345999999998887
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhh-hcCCCCEEecCCCCCcEEEeCC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL-HSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IIHrDLKp~NILl~~~ 167 (613)
+...+.... .. .++||||+.|+++...+.+.+.+++..+..++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 81 v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~-- 152 (190)
T cd05147 81 IPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH-- 152 (190)
T ss_pred CCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--
Confidence 754333221 11 379999999988876655567899999999999999999999 6888 99999999999997
Q ss_pred CCcEEEeccchhHHHh
Q 035992 168 QGEVKIGDLGLAAILA 183 (613)
Q Consensus 168 ~g~VKL~DFGla~~l~ 183 (613)
.+.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 3689999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=188.32 Aligned_cols=176 Identities=16% Similarity=0.137 Sum_probs=133.5
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHH------HHHHHHHHHhCCCCCcceeeeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER------LYSEVHLLKTLKHKNIIKFYNSW 96 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~------l~~Ei~iLk~L~HpNIVkl~~~f 96 (613)
..+|| |..++||.|+||.||++.. ++..+|+|++... ....+...+. +.+|++.+.++.|++|..+..++
T Consensus 29 l~~~y-~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~-~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 29 LSYNI-KTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPK-VKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred hhCce-EEEEEecCCCceEEEEEec--CCCcEEEEEechh-cCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 46677 8899999999999999744 5778999987632 2233344344 57899999999999999999987
Q ss_pred ecCC------CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc
Q 035992 97 VDTE------NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE 170 (613)
Q Consensus 97 v~~~------~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~ 170 (613)
.+.. ....+++|||++|.+|.++. .+++. ...+|+.+|..||.+| ++|||+||+||+++ .+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-
Confidence 6543 23578999999999998873 23332 4569999999999998 99999999999998 566
Q ss_pred EEEeccchhHHHhhhccCcccccccCccccccccCccchhhhhhHHHHHHH
Q 035992 171 VKIGDLGLAAILAQARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELV 221 (613)
Q Consensus 171 VKL~DFGla~~l~~~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~Eml 221 (613)
++|+|||........... . .| +++..|+.++|+|+||+++....
T Consensus 173 i~liDfg~~~~~~e~~a~-d--~~----vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-D--RI----DLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-H--HH----HHHhHhcccccccceeEeehHHH
Confidence 999999987654221110 0 00 23445888999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=181.95 Aligned_cols=238 Identities=18% Similarity=0.282 Sum_probs=182.0
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CCcceeeeeeecCCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNIIKFYNSWVDTENE 102 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~fv~~~~~ 102 (613)
.|.| |+.+.||+|+||.+|.|.....|+.||||+-... ...-.+..|..+.+.|++ ..|..++.++ .+..
T Consensus 14 ~gky-~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~------a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ 84 (341)
T KOG1163|consen 14 GGKY-KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK------AKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKD 84 (341)
T ss_pred ccce-EEEEeecCCchhheeeeeeccCCceEEEEeeccc------CCCcchhHHHHHHHHhccCCCCchhhhhc--cccc
Confidence 3455 8899999999999999999999999998864321 112346778899999864 5666666654 4466
Q ss_pred EEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccchh
Q 035992 103 HINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLA 179 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFGla 179 (613)
+-.+||+++ |.+|.+++.-. +.|+..++.-++-|++.-++|+|.++ +|||||||+|+|.. .....+.|+|||+|
T Consensus 85 ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 85 YNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccch
Confidence 778899988 66998877643 67999999999999999999999999 99999999999984 23346899999999
Q ss_pred HHHhhh-----------ccCcccccccCccc-cccccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcCCC
Q 035992 180 AILAQA-----------RSAHSVIEFMAPEL-YEEEYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSGIK 245 (613)
Q Consensus 180 ~~l~~~-----------~~~~gt~~YmAPEv-l~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g~~ 245 (613)
+.+... ....||..|.+-.. +.-.-+...|+-|+|.++.+..-|..||.+.. +..|-|++|.....
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~ 241 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM 241 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence 876432 23346667777552 22345778999999999999999999998754 35566777775542
Q ss_pred ---CCcccccccHHHHHHHHHHhh-cccCCCC
Q 035992 246 ---PASLAKVADNGVRAFIEKCIA-EVSERLP 273 (613)
Q Consensus 246 ---p~~l~~~~s~~l~~lI~~cL~-dP~~Rpt 273 (613)
+..+.+.++.++.-.+.-|-. --.+-|.
T Consensus 242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 334556678888888888876 5555555
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-20 Score=187.30 Aligned_cols=210 Identities=18% Similarity=0.286 Sum_probs=170.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~ 103 (613)
|--||+.++||.|+||..+.|.+..++++||||.-... ...-.+..|....+.|. .++|...|- +..++.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk------S~APQLrdEYr~YKlL~g~~GIP~vYY--FGqeG~~ 98 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK------SEAPQLRDEYRTYKLLGGTEGIPQVYY--FGQEGKY 98 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc------CCcchHHHHHHHHHHHcCCCCCCceee--eccccch
Confidence 45579999999999999999999999999998754321 22235677888888884 788888776 4456667
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe----CCCCcEEEeccch
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGL 178 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~----~~~g~VKL~DFGl 178 (613)
-.+|++++ |.+|.+++.=. ++|+.+++.-++.|++.-++|+|+++ +|+|||||+|+||. .+...|.|+|||+
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 77899987 66998887754 57999999999999999999999999 99999999999995 2233589999999
Q ss_pred hHHHhhh-----------ccCcccccccCcc-ccccccCccchhhhhhHHHHHHHhcCCCCCCC--CcHHHHHHHHHcCC
Q 035992 179 AAILAQA-----------RSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVEC--TNAAQIYKKVTSGI 244 (613)
Q Consensus 179 a~~l~~~-----------~~~~gt~~YmAPE-vl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~--~~~~~i~~~I~~g~ 244 (613)
|+..... +...||.+||+-. .+..+-+..-|+-|||-++++.+-|..||.+. .+..+-|++|-...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 9987542 3456788999977 34556788999999999999999999999664 45677788887654
Q ss_pred C
Q 035992 245 K 245 (613)
Q Consensus 245 ~ 245 (613)
.
T Consensus 256 r 256 (449)
T KOG1165|consen 256 R 256 (449)
T ss_pred c
Confidence 3
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-20 Score=178.36 Aligned_cols=144 Identities=21% Similarity=0.172 Sum_probs=113.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc--------------------Ch--HHHHHHHHHHHHHHhCCCCC
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR--------------------NS--EDLERLYSEVHLLKTLKHKN 88 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~--------------------~~--~~~~~l~~Ei~iLk~L~HpN 88 (613)
...||+|+||+||+|.+. +|+.||+|+++...... +. .....+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 99999999987542110 00 01233568999999999998
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~ 167 (613)
|.....++.. ..++||||+.|+++.........++...+..++.|++.+|.++|+ +| |+||||||+|||++
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~-- 152 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH-- 152 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--
Confidence 8554443322 237999999998665443344678899999999999999999999 88 99999999999997
Q ss_pred CCcEEEeccchhHHHh
Q 035992 168 QGEVKIGDLGLAAILA 183 (613)
Q Consensus 168 ~g~VKL~DFGla~~l~ 183 (613)
.+.++|+|||++..+.
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 5799999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.2e-20 Score=189.17 Aligned_cols=232 Identities=17% Similarity=0.237 Sum_probs=146.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC---C-------Ccceeeee--
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH---K-------NIIKFYNS-- 95 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H---p-------NIVkl~~~-- 95 (613)
.+..+.||.|+++.||.+.+..||+.+|+|++.... .......+.+.+|......+.+ | .++..++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 344689999999999999999999999999988766 3344567778777766655432 1 11111111
Q ss_pred -------eecCCCC------EEEEEEeccCCCCHHHHHH---hCCC----CCHHHHHHHHHHHHHHhhhhhcCCCCEEec
Q 035992 96 -------WVDTENE------HINFITEIFTSGTLRQYRK---KHKH----VDLRALKKWSRQILEGLSYLHSHDPPVIHR 155 (613)
Q Consensus 96 -------fv~~~~~------~l~lV~E~~~gGsL~~~l~---~~~~----lse~~i~~i~~QIl~gL~yLHs~~~~IIHr 155 (613)
+....+. ..+++|+-+ .++|.+++. .... +....-..+..|+++.+++||++| ++|+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--lVHg 169 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--LVHG 169 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--EEES
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--eEec
Confidence 1111111 235677776 458877643 2222 223333455689999999999999 9999
Q ss_pred CCCCCcEEEeCCCCcEEEeccchhHHHhhhcc-CcccccccCcccccc---------ccCccchhhhhhHHHHHHHhcCC
Q 035992 156 DLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVIEFMAPELYEE---------EYNELVDIYAFGMCLLELVTFEY 225 (613)
Q Consensus 156 DLKp~NILl~~~~g~VKL~DFGla~~l~~~~~-~~gt~~YmAPEvl~~---------~ys~ksDIWSLGviL~EmltG~~ 225 (613)
||+|+|+|++ .+|.++|+||+.....+.... ...+..|.+||+... .++.+.|.|+||+++|.|.|+..
T Consensus 170 di~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 170 DIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp T-SGGGEEE--TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ccceeeEEEc-CCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999998 679999999987765544332 223347999996532 37889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCC
Q 035992 226 PYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSER 271 (613)
Q Consensus 226 Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~R 271 (613)
||............+. . ....+..++.+|..+|+ +|.+|
T Consensus 249 Pf~~~~~~~~~~~~f~------~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEWDFS------R-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGGGGT------T-SS---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccccch------h-cCCcCHHHHHHHHHHccCCcccC
Confidence 9954322111000111 1 12457889999999999 89887
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-20 Score=211.84 Aligned_cols=240 Identities=23% Similarity=0.293 Sum_probs=176.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+-+.+.||++.|=+|.+|++. +|. |.+|++-+.+..-.-....+...|++ ....+|||.+.|--.- ..++..|+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAylv 99 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYLV 99 (1431)
T ss_pred eeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHHH
Confidence 456799999999999999764 444 88898876553334445555556666 6677999999987642 334566777
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH--hhh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL--AQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l--~~~ 185 (613)
-+|+.. +|.+.+..++-+..-+.+.|+.||+.||.-+|..| |+|||||++||||+ .-.-+.|+||..-+.. ...
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiT-SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILIT-SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEe-eechhhhhcccccCCccCCCC
Confidence 788765 88888888888899999999999999999999999 99999999999998 4568899999865322 111
Q ss_pred c---------cCcccccccCcccccc-----------c-cCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcC
Q 035992 186 R---------SAHSVIEFMAPELYEE-----------E-YNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 186 ~---------~~~gt~~YmAPEvl~~-----------~-ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g 243 (613)
. +...-.+|+|||.+-. . ..++.||||+||++.||++ |++||. ..|++.--..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC
Confidence 1 0111137999996632 1 3568999999999999988 677772 23333221111
Q ss_pred C-CC-CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 244 I-KP-ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 244 ~-~p-~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
. .+ ..+.+..+..++.+|..|++ +|++|.+|++.|+-
T Consensus 252 ~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1 11 12344556789999999999 99999999999875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=174.64 Aligned_cols=136 Identities=18% Similarity=0.260 Sum_probs=106.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-----CCCCcceeeeeeecCCC-CE-E
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-----KHKNIIKFYNSWVDTEN-EH-I 104 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-----~HpNIVkl~~~fv~~~~-~~-l 104 (613)
++||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++|+++....+ .. +
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~----~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG----DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccc----cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 7899999999995 7777666 577765422 23456789999999999 67999999998866432 34 3
Q ss_pred EEEEec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHh-hhhhcCCCCEEecCCCCCcEEEeC---CCCcEEEec-cc
Q 035992 105 NFITEI--FTSGTLRQYRKKHKHVDLRALKKWSRQILEGL-SYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGD-LG 177 (613)
Q Consensus 105 ~lV~E~--~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL-~yLHs~~~~IIHrDLKp~NILl~~---~~g~VKL~D-FG 177 (613)
.+|+|| +.+|+|.+++++. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. ..+.++|+| ||
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 478999 5589999999774 57666 46788888888 9999999 999999999999973 234799999 55
Q ss_pred hh
Q 035992 178 LA 179 (613)
Q Consensus 178 la 179 (613)
..
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-20 Score=192.50 Aligned_cols=267 Identities=34% Similarity=0.593 Sum_probs=192.9
Q ss_pred CCCcccccCCCCcceeEeeeeccc---CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcc
Q 035992 14 SDAEFVEIDPSARYGRYKEVLGRG---AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90 (613)
Q Consensus 14 ~~~~~v~~dp~gRy~r~~e~LG~G---afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 90 (613)
...++.+-.|-+|+++-.+..|+. +.-.||++.+...|.+|.|..|+......-...-+....-++-|-.+.|.|||
T Consensus 51 ~~~eIleesp~~rw~krreqv~qrdvPgid~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlv 130 (458)
T KOG1266|consen 51 DESEILEESPCGRWGKRREQVGQRDVPGIDDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLV 130 (458)
T ss_pred chhhhhccCchhhhhhhhhhccCCCCCchHHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHH
Confidence 346688899999999988888864 34569999999999999998776433221112222233345556677899999
Q ss_pred eeeeeeecCC---CCEEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEE
Q 035992 91 KFYNSWVDTE---NEHINFITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIF 163 (613)
Q Consensus 91 kl~~~fv~~~---~~~l~lV~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NIL 163 (613)
+++.||-+.. ...+.|++||+..|+|.+++++- ..+.....++|+-||+.||.|||+..|||+|+++.++.|+
T Consensus 131 kfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tif 210 (458)
T KOG1266|consen 131 KFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIF 210 (458)
T ss_pred HHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhhee
Confidence 9999986543 34688999999999999998753 4589999999999999999999999999999999999999
Q ss_pred EeCCCCcEEEeccchhHHH--------hhhccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHH
Q 035992 164 VNGNQGEVKIGDLGLAAIL--------AQARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAA 234 (613)
Q Consensus 164 l~~~~g~VKL~DFGla~~l--------~~~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~ 234 (613)
+. .+|-|||+--...... .......+.++|.|||.-. .+.+.++|||+||+|.++|..++.--.+.....
T Consensus 211 iq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~ 289 (458)
T KOG1266|consen 211 IQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKV 289 (458)
T ss_pred ec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCccee
Confidence 98 6788887542221111 0111223456899998543 346778999999999999999876543322211
Q ss_pred HHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 235 ~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..-..+.+.. .......-+.+|.+||+ .|..||+++++|.||.+-..
T Consensus 290 ~~ee~ia~~i-----~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 290 EVEENIANVI-----IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred ehhhhhhhhe-----eeccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 1111111110 11122345678999999 99999999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=173.06 Aligned_cols=182 Identities=15% Similarity=0.068 Sum_probs=133.5
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEEE
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
...+|++|+||+||.+.. .+..++.+.+..............+.+|+++|++|. |++|++++++ ...+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEEEE
Confidence 358899999999998744 677777554443222111222336789999999995 5889999884 2368999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCC-CCCcEEEeCCCCcEEEeccchhHHHhhhc-
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL-KCDNIFVNGNQGEVKIGDLGLAAILAQAR- 186 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDL-Kp~NILl~~~~g~VKL~DFGla~~l~~~~- 186 (613)
+|+.|.+|.+.+.. . ...++.|++.+|.++|.+| |+|||| ||+|||++ .+|.++|+|||++.......
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcch
Confidence 99999998754322 1 1357889999999999999 999999 79999997 56899999999997432111
Q ss_pred ----------------cCcccccccCcccc--ccccC-ccchhhhhhHHHHHHHhcCCCCCC
Q 035992 187 ----------------SAHSVIEFMAPELY--EEEYN-ELVDIYAFGMCLLELVTFEYPYVE 229 (613)
Q Consensus 187 ----------------~~~gt~~YmAPEvl--~~~ys-~ksDIWSLGviL~EmltG~~Pf~~ 229 (613)
....++.|++|+.. -...+ ...++++.|.-+|.++|+..|+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 11234567777632 22333 567899999999999999998854
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=172.39 Aligned_cols=152 Identities=21% Similarity=0.145 Sum_probs=118.6
Q ss_pred CCcceeEeeeecccCceEEEEEE-EcCCCcEEEEEEEEeecccc------------------ChH--HHHHHHHHHHHHH
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAF-DELEGIEVAWNQIKVIDLLR------------------NSE--DLERLYSEVHLLK 82 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~-~~~tg~~VAiK~vk~~~~~~------------------~~~--~~~~l~~Ei~iLk 82 (613)
.|+.|++.+.||+|+||.||+|. +..+|+.||+|+++...... ... ....+..|+++++
T Consensus 26 ~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 26 RGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred cCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 46677889999999999999998 77899999999987543110 000 1234678999999
Q ss_pred hCCCC--CcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCC
Q 035992 83 TLKHK--NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160 (613)
Q Consensus 83 ~L~Hp--NIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~ 160 (613)
.+.+. .+.+++.. . ..++||||+.|++|..+......+....+..++.||+.+|.+||+++ .++||||||+
T Consensus 106 ~L~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~ 178 (237)
T smart00090 106 RLYEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEG-ELVHGDLSEY 178 (237)
T ss_pred HHHhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcC-CEEeCCCChh
Confidence 99753 34445542 1 24799999999988776645556777788899999999999999986 4999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHHhh
Q 035992 161 NIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||+++ .+.++|+|||.+.....
T Consensus 179 NIli~--~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH--DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE--CCCEEEEEChhhhccCC
Confidence 99998 57899999999875443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=174.98 Aligned_cols=237 Identities=16% Similarity=0.285 Sum_probs=181.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
..+|...-.|..|+|++. |..++.|++++... .......|..|.-.|+-+.||||..+++.+.. ...+.+|..|
T Consensus 195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacns--ppnlv~isq~ 268 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNS--PPNLVIISQY 268 (448)
T ss_pred hhhhccCCCccccccccc--Ccchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccC--CCCceEeeee
Confidence 356778888999999775 44455566665442 22334567889999999999999999998754 4568899999
Q ss_pred cCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEE--eccchhHHHhhhc
Q 035992 111 FTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI--GDLGLAAILAQAR 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL--~DFGla~~l~~~~ 186 (613)
|+.|+|...+..... ++..++.+++.+|++|+.|||+..|-|.---|....++++ ++-+.+| +|--++ -+..
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfs---fqe~ 344 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFS---FQEV 344 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceee---eecc
Confidence 999999999987643 6888999999999999999999985455557888899998 3434443 332222 2222
Q ss_pred cCcccccccCccccccc----cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 187 SAHSVIEFMAPELYEEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~~----ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
.....+.||+||.+... .-.++|+|||++++||+.|.+.||.+..+++--.+....|..+ .++...+..+..++.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm~ 423 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLMN 423 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHHH
Confidence 34556799999987643 2357999999999999999999999988877766666777654 455567888999999
Q ss_pred HHhh-cccCCCCHHHHh
Q 035992 263 KCIA-EVSERLPAKELL 278 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL 278 (613)
-|+. ||.+||.+..++
T Consensus 424 icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 424 ICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHhcCCCCcCCCcceeh
Confidence 9998 999999876553
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=174.62 Aligned_cols=195 Identities=23% Similarity=0.355 Sum_probs=144.4
Q ss_pred CCCCcceeeeeeec-------------------------CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 035992 85 KHKNIIKFYNSWVD-------------------------TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQIL 139 (613)
Q Consensus 85 ~HpNIVkl~~~fv~-------------------------~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl 139 (613)
+|||||+++++|.+ ..+.++|+||..... +|+.|+-.+ +.+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999998863 245679999998866 899998764 467778888999999
Q ss_pred HHhhhhhcCCCCEEecCCCCCcEEEeC-CCC--cEEEeccchhHHHhhhc----------cCcccccccCccccccc---
Q 035992 140 EGLSYLHSHDPPVIHRDLKCDNIFVNG-NQG--EVKIGDLGLAAILAQAR----------SAHSVIEFMAPELYEEE--- 203 (613)
Q Consensus 140 ~gL~yLHs~~~~IIHrDLKp~NILl~~-~~g--~VKL~DFGla~~l~~~~----------~~~gt~~YmAPEvl~~~--- 203 (613)
+|+.|||.+| |.|||+|.+|||+.- +++ .+.|+|||++---.... ...|.-..||||+...-
T Consensus 352 Eav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp 429 (598)
T KOG4158|consen 352 EAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP 429 (598)
T ss_pred HHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence 9999999999 999999999999952 222 46899999874322110 12233468999987532
Q ss_pred ----cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH-HHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCC---H
Q 035992 204 ----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQI-YKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLP---A 274 (613)
Q Consensus 204 ----ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i-~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpt---a 274 (613)
-..++|.|+.|.+.||+++...||+.... ..+ ....... ..+.++..+++.+++++..+|+ +|++|++ |
T Consensus 430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yqe~-qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQES-QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred ceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhhhh-hCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 23589999999999999999999976221 111 1111222 2345677789999999999999 9999998 4
Q ss_pred HHHhcCCCCCC
Q 035992 275 KELLGDPFLQS 285 (613)
Q Consensus 275 ~eLL~HPff~~ 285 (613)
+.+|+--.+..
T Consensus 508 ANvl~LsLw~~ 518 (598)
T KOG4158|consen 508 ANVLNLSLWRM 518 (598)
T ss_pred HhHHHHHHhcC
Confidence 56665444433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-17 Score=181.52 Aligned_cols=172 Identities=27% Similarity=0.465 Sum_probs=136.4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
.++||.|++|...+|.+++.+.. .-+....+.|+.|++.|++| ++ .+|||+||.||+.. .+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhh
Confidence 36899999999999999997654 36777889999999999999 56 99999999999997 566899999999
Q ss_pred hHHHhhh----------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCC
Q 035992 179 AAILAQA----------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKP 246 (613)
Q Consensus 179 a~~l~~~----------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p 246 (613)
....... ....+|..||+||.+. +.|+.++||||||++|+|+++ ...+| ........+..+..|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGIIP 478 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCCC
Confidence 8755332 2345677999999877 569999999999999999998 34444 233345566777766
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+.+.. -.+.-..|+.++|. .|.+||++.+.-.|+|.+
T Consensus 479 ~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 44332 24556789999998 999999888888887763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.9e-17 Score=190.43 Aligned_cols=191 Identities=20% Similarity=0.239 Sum_probs=148.0
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCCcceeeeeeecCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK---HKNIIKFYNSWVDTE 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~ 100 (613)
.|.-+-+.+.||+|+||+||.|.+.. |+.||+|+=+-... -.|+--.+++.+|+ -+.|+.++.+++-.+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~-------WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP-------WEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc-------eeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 44455678999999999999999877 99999886543221 12333334555555 345555555544433
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe------CCCCcEEEe
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN------GNQGEVKIG 174 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~------~~~g~VKL~ 174 (613)
.-++|++|.+.|+|.+++...+.+++..+..++.|++..++.||.++ |||+||||+|.||. .+..-++|+
T Consensus 768 --~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 768 --ASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred --cceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEE
Confidence 45689999999999999999999999999999999999999999999 99999999999994 122358999
Q ss_pred ccchhHHHhh---h---ccCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCC
Q 035992 175 DLGLAAILAQ---A---RSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYP 226 (613)
Q Consensus 175 DFGla~~l~~---~---~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~P 226 (613)
|||.+..+.. . ...++|-.|-.+|+..+. ++..+|.|.|+.+++-||.|++-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999976542 1 123445578889988775 88999999999999999998753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=154.65 Aligned_cols=137 Identities=23% Similarity=0.280 Sum_probs=110.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh-----HHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-----EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~-----~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
+.||+|++|.||+|.+ .|..|++|+..... .... ....++.+|+.++..+.|++|+....++.+. ...++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~-~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKR-YRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcC-CcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEE
Confidence 5799999999999976 77889988654221 1111 1235678899999999999987766665543 35778
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+|||+.|++|.+++..... ....++.+++.+|.+||+.+ ++|||++|.|||++ .+.++|+|||++..
T Consensus 77 v~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 9999999999999876432 78899999999999999998 99999999999998 57899999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.8e-16 Score=173.99 Aligned_cols=194 Identities=24% Similarity=0.367 Sum_probs=151.0
Q ss_pred HHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCC
Q 035992 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKC 159 (613)
Q Consensus 81 Lk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp 159 (613)
|+.+.|.|+.+|++..++. ..++.|.+||..|+|.+.+.. .-.++......++++|+.||+|||.-- ...|+.++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeecc
Confidence 4678999999999988765 678899999999999999987 457888899999999999999999864 239999999
Q ss_pred CcEEEeCCCCcEEEeccchhHHHhh------hccCcccccccCccccccc--------cCccchhhhhhHHHHHHHhcCC
Q 035992 160 DNIFVNGNQGEVKIGDLGLAAILAQ------ARSAHSVIEFMAPELYEEE--------YNELVDIYAFGMCLLELVTFEY 225 (613)
Q Consensus 160 ~NILl~~~~g~VKL~DFGla~~l~~------~~~~~gt~~YmAPEvl~~~--------ys~ksDIWSLGviL~EmltG~~ 225 (613)
.|.+++. .-.+||+|||+...... ........-|.|||++... .+.+.|||||||+++|+++..-
T Consensus 78 ~nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 78 SNCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred ccceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 9999984 45899999999887642 1111122369999988652 4667999999999999999999
Q ss_pred CCCCCC---cHHHHHHHHHcCCCCCcccc-----cccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 226 PYVECT---NAAQIYKKVTSGIKPASLAK-----VADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 226 Pf~~~~---~~~~i~~~I~~g~~p~~l~~-----~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
||.... .+.++...+..+..+...+. ...+.+..++.+||. +|.+||+++++-
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 996532 23456556665222211111 234578899999998 999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-18 Score=194.00 Aligned_cols=251 Identities=22% Similarity=0.299 Sum_probs=197.7
Q ss_pred eeEeeeecccCceEEEEEEEcC-CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL-EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~-tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~ 105 (613)
+++.+.||+|+|+.|-.+.... ....+|.|.+.... .......+...|..+-+.+. |.|++.+++.. ......+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~ 97 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYL 97 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCcc--CCCcccc
Confidence 3667889999999999887643 33455544443322 34556677778888888887 99999999976 4456788
Q ss_pred EEEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHhhhhh-cCCCCEEecCCCCCcEEEeCCCC-cEEEeccchhHH
Q 035992 106 FITEIFTSGTLRQYR-KKHK-HVDLRALKKWSRQILEGLSYLH-SHDPPVIHRDLKCDNIFVNGNQG-EVKIGDLGLAAI 181 (613)
Q Consensus 106 lV~E~~~gGsL~~~l-~~~~-~lse~~i~~i~~QIl~gL~yLH-s~~~~IIHrDLKp~NILl~~~~g-~VKL~DFGla~~ 181 (613)
++++|..|++++..+ .... ..+......++.|+..++.|+| ..+ +.||||||+|.+++ ..+ .++++|||+|..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGLATA 174 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchhhcc
Confidence 899999999999988 5554 6888889999999999999999 777 99999999999998 456 899999999987
Q ss_pred Hhh-h------ccCcc-cccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC--CCCcc
Q 035992 182 LAQ-A------RSAHS-VIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASL 249 (613)
Q Consensus 182 l~~-~------~~~~g-t~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~--~p~~l 249 (613)
+.. . ....| ++.|+|||.+.+ ...+..|+||.|+++.-|++|..||.........+....... .-..+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP 254 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence 655 2 13456 889999998766 467889999999999999999999965444333322222221 12344
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
....+....+++.++|. +|..|.+.+++..+||+..
T Consensus 255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 255 WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 56678889999999997 9999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.7e-16 Score=151.27 Aligned_cols=134 Identities=19% Similarity=0.247 Sum_probs=104.7
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEEEeeccccC----hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN----SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 33 ~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.||+|+||+||+|. .+|..|++|+......... .....++.+|+.+++.+.|+++....-++.. ....+++|
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVM 76 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEE
Confidence 48999999999997 4678899887543221111 1224677899999999998876544444343 23467899
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
||+.|++|.+++..... .++.|++.+|.+||+.+ ++|||++|.||+++ .+.++++|||++..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~ 138 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY 138 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence 99999999988765432 78999999999999998 99999999999998 57999999999765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.3e-16 Score=174.44 Aligned_cols=142 Identities=18% Similarity=0.186 Sum_probs=109.3
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc----cChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL----RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~----~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
..++...+.||+|+||+||+|..... .+++|+....... ......+++.+|+.+++.++|++|+..+.++...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 34445679999999999999976433 3444432211111 1112346788999999999999998877665543
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...++||||+.|++|.+++. ....++.|++.+|.|||+++ ++||||||+|||++ .+.++|+|||++.
T Consensus 409 -~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~ 475 (535)
T PRK09605 409 -EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGK 475 (535)
T ss_pred -CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccc
Confidence 34679999999999999886 34678999999999999998 99999999999994 5689999999986
Q ss_pred HH
Q 035992 181 IL 182 (613)
Q Consensus 181 ~l 182 (613)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.5e-16 Score=153.54 Aligned_cols=144 Identities=22% Similarity=0.182 Sum_probs=109.7
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc-----cCh-------------HHHHHHHHHHHHHHhCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL-----RNS-------------EDLERLYSEVHLLKTLK 85 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~-----~~~-------------~~~~~l~~Ei~iLk~L~ 85 (613)
.++.+++.+.||+|+||.||+|.+. +|+.||+|++...... ... ........|+.++..+.
T Consensus 13 ~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 91 (198)
T cd05144 13 RGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY 91 (198)
T ss_pred cCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence 3455678899999999999999875 8999999987643200 000 01123577899999998
Q ss_pred CCC--cceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEE
Q 035992 86 HKN--IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIF 163 (613)
Q Consensus 86 HpN--IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NIL 163 (613)
|++ ++..++. ...+++|||+.|++|..+... .....++.+|+.++.++|.++ ++||||||+||+
T Consensus 92 ~~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nil 157 (198)
T cd05144 92 EEGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEFNIL 157 (198)
T ss_pred HcCCCCCceeec------CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEE
Confidence 874 4444431 245899999999999765431 345788999999999999988 999999999999
Q ss_pred EeCCCCcEEEeccchhHHHh
Q 035992 164 VNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 164 l~~~~g~VKL~DFGla~~l~ 183 (613)
++ .++.++|+|||++..+.
T Consensus 158 l~-~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 158 VD-DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred Ec-CCCcEEEEECCccccCC
Confidence 98 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.5e-15 Score=143.32 Aligned_cols=140 Identities=23% Similarity=0.182 Sum_probs=98.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHH--------------------HHHHHHHHHHHhCCCC--C
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL--------------------ERLYSEVHLLKTLKHK--N 88 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~--------------------~~l~~Ei~iLk~L~Hp--N 88 (613)
.+.||+|+||+||+|.+. +|+.||+|+++........... .....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999876 8999999987643211100000 0113566667666543 3
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~-l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~ 166 (613)
+.+.+.+. ..+++|||+.++.+... +.... .. ..++.++.+++.++.++|. ++ |+||||||+||+++
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~- 149 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD- 149 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE-
Confidence 45555421 35899999999543211 11111 11 6678999999999999999 87 99999999999998
Q ss_pred CCCcEEEeccchhHHHh
Q 035992 167 NQGEVKIGDLGLAAILA 183 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~ 183 (613)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 6799999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=131.92 Aligned_cols=134 Identities=20% Similarity=0.125 Sum_probs=107.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CCcceeeeeeecCCCCEEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH--KNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.+.||+|.++.||++.... ..+++|.+..... ...+..|+.+++.+.| .++++++.++.. ....+++|
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~ 72 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLM 72 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEE
Confidence 3679999999999998743 6788777643211 4578899999999976 588888886533 35789999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCC-CCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD-PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~-~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
||+.++.+..+ +......++.+++.+|.+||... .+++|+|++|.||+++ ..+.++++|||.+...
T Consensus 73 e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 73 EWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGYG 139 (155)
T ss_pred EecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccCC
Confidence 99999887654 55667788999999999999852 2499999999999998 4679999999988653
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.6e-14 Score=143.55 Aligned_cols=141 Identities=16% Similarity=0.207 Sum_probs=107.2
Q ss_pred eeeec-ccCceEEEEEEEcCCCcEEEEEEEEeecc----cc-----ChHHHHHHHHHHHHHHhCCCCCc--ceeeeeeec
Q 035992 31 KEVLG-RGAFKKVYRAFDELEGIEVAWNQIKVIDL----LR-----NSEDLERLYSEVHLLKTLKHKNI--IKFYNSWVD 98 (613)
Q Consensus 31 ~e~LG-~GafGtVYka~~~~tg~~VAiK~vk~~~~----~~-----~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~~fv~ 98 (613)
..+|| .|+.|+||.+.. .+..+++|.+....+ .. ......++.+|+.++..|.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 46788 899999999965 378899888864321 11 12344678899999999998875 666665433
Q ss_pred CCCC--EEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 99 TENE--HINFITEIFTS-GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 99 ~~~~--~l~lV~E~~~g-GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
.... ..++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||.+| |+||||||.|||++ .++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEE
Confidence 2221 23599999997 689988865 4566543 578999999999998 99999999999998 456899999
Q ss_pred cchhHH
Q 035992 176 LGLAAI 181 (613)
Q Consensus 176 FGla~~ 181 (613)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.5e-14 Score=166.54 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=205.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
+-+-+|+++.++.+.-..+|...++|+.++...... ...+.+..+-.++-...+|-++.....|. .....+++++|.
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~-~~~~s~r~~s~~~i~p~~P~v~~~~~s~~--~rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRT-NDYESIRSKSNILITPRSPAVVRSFPSFP--CRSPLPLVGHYL 886 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhcc-ccccccCCccCccccCCCCceecccCCCC--CCCCcchhhHHh
Confidence 567789999999998888888888877766554432 23344555555665667788887776653 355689999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-------
Q 035992 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ------- 184 (613)
Q Consensus 112 ~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~------- 184 (613)
.+++|...+.+.+..+.+..+.++..+..+++|||+.. +.|||++|.|++.. ..|..++.|||.......
T Consensus 887 ~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred ccCCchhhhhcCCCcccccccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCCc
Confidence 99999999999999999999999999999999999987 89999999999997 678999999984332100
Q ss_pred ----------------------------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH
Q 035992 185 ----------------------------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235 (613)
Q Consensus 185 ----------------------------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~ 235 (613)
.....+++.|.+||...+ .....+|+|++|++++|.++|.+||.. ..+.+
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhh
Confidence 012235668999996654 578899999999999999999999955 66778
Q ss_pred HHHHHHcCCCCCc-ccccccHHHHHHHHHHhh-cccCCCCHH---HHhcCCCCCCCCccccccccccc
Q 035992 236 IYKKVTSGIKPAS-LAKVADNGVRAFIEKCIA-EVSERLPAK---ELLGDPFLQSEDDESVGRSLRVK 298 (613)
Q Consensus 236 i~~~I~~g~~p~~-l~~~~s~~l~~lI~~cL~-dP~~Rpta~---eLL~HPff~~~~~~~~~~~~~~~ 298 (613)
+++.+..+..+.. -+...+..+++++...|. ++.+|.++. ++-.||||+..+|..+.......
T Consensus 1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~ 1110 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEF 1110 (1205)
T ss_pred hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCcc
Confidence 8888777755433 344568899999999998 999999977 99999999999988775544333
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.9e-14 Score=153.68 Aligned_cols=246 Identities=21% Similarity=0.261 Sum_probs=191.5
Q ss_pred eeeecc--cCceEEEEEEE--cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEE
Q 035992 31 KEVLGR--GAFKKVYRAFD--ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 31 ~e~LG~--GafGtVYka~~--~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.+.+|. |.+|.||.+.+ ..++..+|+|.-++. ...+....+-++|+...+.+ .|+|.++.+..|.. .+.++
T Consensus 119 ~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p--~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~~lf 194 (524)
T KOG0601|consen 119 SSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIP--FSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SGILF 194 (524)
T ss_pred ccccccCCCCCceeecccCCcccCCcccccccccCC--CCCccccccccchhhcccccCccccccccCccccc--CCcce
Confidence 377899 99999999998 889999997653321 22233344456677777777 49999998888844 56788
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHH----HhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 106 FITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILE----GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~----gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+-+|+|. .+|..+..... .++...++..+.+... ||.++|+.+ ++|-|+||+||+...+....+++|||+..
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeE
Confidence 8888875 78888887654 4899999999999999 999999998 99999999999998554788999999987
Q ss_pred HHhhhc---------cCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 181 ILAQAR---------SAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 181 ~l~~~~---------~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
.+.... ...+...|++||+.++-++...|||+||.++.+-.++..++....+. -+..+..+..|..+..
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS--SWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC--CccccccccCchhhhc
Confidence 665432 12445579999999999999999999999999999987766443111 1223344445555555
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..+..++..+..++. ++..|++++.+++|+++..
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 566777778888888 8999999999999999984
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=6e-11 Score=132.51 Aligned_cols=166 Identities=25% Similarity=0.285 Sum_probs=126.6
Q ss_pred EEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhC
Q 035992 44 RAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123 (613)
Q Consensus 44 ka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~ 123 (613)
.|..+.++.+|.+.+.+... ....+...+-++.|+.++||||++|++.+.. ..++|+|+|.+. .|..++++-
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~----~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV~--Pl~~~lk~l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSN----GEVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERVR--PLETVLKEL 101 (690)
T ss_pred ccceeccCCceEEEEEeCCC----chhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeeccc--cHHHHHHHh
Confidence 46778899999987766432 2445667778899999999999999998854 458999999986 467777764
Q ss_pred CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhcc----CcccccccCccc
Q 035992 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS----AHSVIEFMAPEL 199 (613)
Q Consensus 124 ~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~----~~gt~~YmAPEv 199 (613)
+ ...+..-++||+.||-|||..+ .++|++|.-+.|||+ ..|..||++|.++........ ......|..|+.
T Consensus 102 ~---~~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 102 G---KEEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE 176 (690)
T ss_pred H---HHHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence 4 6777788999999999998543 499999999999999 679999999998765433221 111114666664
Q ss_pred cccccCccchhhhhhHHHHHHHhc
Q 035992 200 YEEEYNELVDIYAFGMCLLELVTF 223 (613)
Q Consensus 200 l~~~ys~ksDIWSLGviL~EmltG 223 (613)
+... .-..|.|.||++++|++.|
T Consensus 177 ~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc-ccchhhhhHHHHHHHHhCc
Confidence 3221 1347999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.8e-11 Score=137.60 Aligned_cols=141 Identities=18% Similarity=0.174 Sum_probs=92.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-------------------------Ch-----HHHHHHHHHHHH-
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-------------------------NS-----EDLERLYSEVHL- 80 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-------------------------~~-----~~~~~l~~Ei~i- 80 (613)
+.||+|++|.||+|..+.+|+.||+|+++...... +. +..+.+.+|+.+
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 68999999999999998889999999886321000 00 112223334433
Q ss_pred -----HHhC----CCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHhhhh
Q 035992 81 -----LKTL----KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHK----HVDLRALKKWSRQILEGLSYL 145 (613)
Q Consensus 81 -----Lk~L----~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~--l~~~~----~lse~~i~~i~~QIl~gL~yL 145 (613)
+.++ .+.+.+.+-..+.+- ....+++|||+.|+.+.++ +...+ .+.+..+..++.||+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~----- 278 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR----- 278 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-----
Confidence 3333 233333333322211 2346799999999999874 33433 3566667777777764
Q ss_pred hcCCCCEEecCCCCCcEEEeCCCC----cEEEeccchhHHHh
Q 035992 146 HSHDPPVIHRDLKCDNIFVNGNQG----EVKIGDLGLAAILA 183 (613)
Q Consensus 146 Hs~~~~IIHrDLKp~NILl~~~~g----~VKL~DFGla~~l~ 183 (613)
.| ++|+|+||.||+++ .+| .++++|||+...+.
T Consensus 279 --~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 279 --DG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --CC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECC
Confidence 56 99999999999998 445 89999999986553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.19 E-value=6e-11 Score=130.96 Aligned_cols=144 Identities=21% Similarity=0.179 Sum_probs=93.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh--------------------------HHH----H------HHH
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS--------------------------EDL----E------RLY 75 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~--------------------------~~~----~------~l~ 75 (613)
+.||.|++|.||+|..+ +|+.||+|+.+......-. ... . .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999864 7999999987532100000 000 0 134
Q ss_pred HHHHHHHhC----CCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HhhhhhcCC
Q 035992 76 SEVHLLKTL----KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILE-GLSYLHSHD 149 (613)
Q Consensus 76 ~Ei~iLk~L----~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~-gL~yLHs~~ 149 (613)
+|...+.++ .|.+-+.+-..+... ....+++|||+.|++|.++.... ..++ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 455555554 233323322222111 22468999999999998876532 1222 2345555555 467789888
Q ss_pred CCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 150 ~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++|+|+||.||+++ .+|.++|+|||++..+.
T Consensus 278 --~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 --FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS 308 (437)
T ss_pred --ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence 99999999999997 66899999999986554
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.9e-11 Score=111.12 Aligned_cols=129 Identities=22% Similarity=0.086 Sum_probs=93.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcc-eeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII-KFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV-kl~~~fv~~~~~~l~lV~E~ 110 (613)
+.|+.|.++.||++... |..|++|+..... .....+..|+.+++.+.+.+++ +++.+. .. .-++|||+
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~--~~~lv~e~ 72 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT-----ELLINRENEAENSKLAAEAGIGPKLYYFD--PE--TGVLITEF 72 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCc-----ccccCHHHHHHHHHHHHHhCCCCceEEEe--CC--CCeEEEEe
Confidence 67899999999999754 7789977654211 1123457899999988655544 454432 22 24689999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCC---CEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP---PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~---~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+.|.++... ......++.+++.+|..||..+. .++|+|++|.||+++ .+.++++|||.+..
T Consensus 73 i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 999887643 11123567899999999999862 259999999999998 45899999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.8e-10 Score=111.57 Aligned_cols=141 Identities=16% Similarity=0.110 Sum_probs=102.1
Q ss_pred eeecccCceEEEEEEEcC------CCcEEEEEEEEeecc--cc----------------ChHHHHHH----HHHHHHHHh
Q 035992 32 EVLGRGAFKKVYRAFDEL------EGIEVAWNQIKVIDL--LR----------------NSEDLERL----YSEVHLLKT 83 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~------tg~~VAiK~vk~~~~--~~----------------~~~~~~~l----~~Ei~iLk~ 83 (613)
-.||.|-=+.||.|.... .+..+|+|+.+.... .. .......+ .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997653 358999998875321 00 01112233 379999999
Q ss_pred CC--CCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhh-hcCCCCEEecCCCCC
Q 035992 84 LK--HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL-HSHDPPVIHRDLKCD 160 (613)
Q Consensus 84 L~--HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IIHrDLKp~ 160 (613)
+. .-++.+.+.+ ..-++||||+.++.+....-+...+++..+..++.+++.+|.+| |..+ +||+||++.
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence 85 3566777763 13467999998754432222333566677788899999999999 8888 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHH
Q 035992 161 NIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l 182 (613)
||++. ++.++|+|||.+...
T Consensus 155 NIL~~--~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH--DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE--CCcEEEEECCCceeC
Confidence 99997 468999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=129.13 Aligned_cols=249 Identities=20% Similarity=0.206 Sum_probs=175.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEc-CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDE-LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTE 100 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~-~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 100 (613)
+.+.+. +...||.|.|+.||..... .++..+++|.++..- ........-..|+.+...+ .|.+++.++..|..
T Consensus 263 ~~~df~-~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-- 337 (524)
T KOG0601|consen 263 KLTDFG-LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-- 337 (524)
T ss_pred ecCCcc-eeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccc--
Confidence 344443 3488999999999987644 677788877655322 1122222334566666666 59999999998865
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
....|+=.|||.++++...+.-...+++...++...|++.++.++|+.. ++|+|+||+||++..+++.-+++|||+.+
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccccc
Confidence 4456678899999998887766667899999999999999999999988 99999999999997434778999999987
Q ss_pred HHhhhc-cCcccccccC-cccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 181 ILAQAR-SAHSVIEFMA-PELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 181 ~l~~~~-~~~gt~~YmA-PEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.+.-.. .......++| +|++.+ .+..++|++|||..+.+.+++. |+... ......+.++..|. .+... .+
T Consensus 416 ~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~-~ls~~---~~~~~~i~~~~~p~-~~~~~-~~ 489 (524)
T KOG0601|consen 416 RLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGS-PLSES---GVQSLTIRSGDTPN-LPGLK-LQ 489 (524)
T ss_pred ccceecccccccccccccchhhccccccccccccccccccccccccCc-ccCcc---cccceeeecccccC-CCchH-Hh
Confidence 543222 2233345663 555443 3788999999999999999865 33221 11223344443332 22222 66
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+..+.+.++. ++..|+.+.++..|+=|.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhh
Confidence 6777777777 788899999998887554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=5.5e-09 Score=102.62 Aligned_cols=145 Identities=18% Similarity=0.205 Sum_probs=103.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CCcceeeeeeecCC-CCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH--KNIIKFYNSWVDTE-NEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fv~~~-~~~l~lV~ 108 (613)
+.||.|.++.||++... +|..+++|....... ......+..|+.+++.+.+ .++.+++.+..... ....++||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~---~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGAL---LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCccc---CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 67899999999999764 367888776543211 1134567899999999975 34566666532211 12568999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC----------------------------------------
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH---------------------------------------- 148 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~---------------------------------------- 148 (613)
||+.|.++...+.. ..+++.....++.+++++|.+||+.
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888765432 4567777777777888887777742
Q ss_pred --------------CCCEEecCCCCCcEEEeCC-CCcEEEeccchhHH
Q 035992 149 --------------DPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAI 181 (613)
Q Consensus 149 --------------~~~IIHrDLKp~NILl~~~-~g~VKL~DFGla~~ 181 (613)
...++|+|+++.||+++.+ .+.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1248999999999999843 45689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-08 Score=98.34 Aligned_cols=145 Identities=22% Similarity=0.278 Sum_probs=105.2
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh-----HHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-----EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~-----~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..+|-+|+-+.|+++.. .|+.+.||.=- .+.-+.+ -...+..+|+.+|.++.--.|.-..-+|++..++.
T Consensus 12 l~likQGAEArv~~~~~--~Ge~~iIK~Rf-~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~-- 86 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF--SGEAAIIKERF-SKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQ-- 86 (229)
T ss_pred ceeeeccceeeEeeecc--CCceeEEeecc-cccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCe--
Confidence 47888999999999954 57777665321 1211222 23467788999999987555554444556655554
Q ss_pred EEEeccCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcE--EEeccchhH
Q 035992 106 FITEIFTS-GTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV--KIGDLGLAA 180 (613)
Q Consensus 106 lV~E~~~g-GsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~V--KL~DFGla~ 180 (613)
++|||+.| .++.+++.... .........++++|-+.+.-||.++ |||+||..+||++..+.+.+ .++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchh
Confidence 57899987 47888887652 2333444789999999999999999 99999999999998555554 899999987
Q ss_pred HH
Q 035992 181 IL 182 (613)
Q Consensus 181 ~l 182 (613)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 54
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.2e-08 Score=97.32 Aligned_cols=134 Identities=21% Similarity=0.267 Sum_probs=95.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHH-----HHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-----LERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~-----~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
..+++|+=+.+|.+.. -|..+.+| ..+.+.-+.+.- ..+-.+|+.++.++.--.|...+=++++..+ -.+
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K-~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~--~~I 76 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVK-ERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN--GLI 76 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEE-eecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CEE
Confidence 4678999999999844 34455444 333333333332 3455779999998865444433333355544 456
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+|||+.|-.|++++... . ..+++.+-.-+.-||..| |+|+||.++||++.+ +.+.++|||++.+
T Consensus 77 ~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~--~~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSG--GRIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcC--eecCCCccceEEEeC--CcEEEEECCcccc
Confidence 99999999999998876 2 455666666677799999 999999999999973 4699999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=7e-08 Score=105.59 Aligned_cols=214 Identities=18% Similarity=0.252 Sum_probs=149.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC--CCCEEEEEEeccCC-C
Q 035992 38 AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT--ENEHINFITEIFTS-G 114 (613)
Q Consensus 38 afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~--~~~~l~lV~E~~~g-G 114 (613)
--.+.|+|+...+|..|.+|.+..... ... .....-+++++++.|+|+|+|.+.|... .+..++||++|.++ +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD-QST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc-cCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 446899999999999999877732111 111 1223457899999999999999988632 34578999999876 4
Q ss_pred CHHHHH---------------HhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 115 TLRQYR---------------KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 115 sL~~~l---------------~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+|.++- ..+.+.+|+.+|.++.|+..||.++|+.| +..+-|.|.+|+++++. +++|...|+.
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~-RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKM-RIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcc-eEEEecccce
Confidence 565432 12345889999999999999999999999 88899999999999654 8888877776
Q ss_pred HHHhhhccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH-HHHHHcCCCCCcccccccHHHH
Q 035992 180 AILAQARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI-YKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 180 ~~l~~~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i-~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
.++.... . +.+++ -++-|.=.||.+++.|.||..--......... ...|. ..++.+++
T Consensus 441 Dvl~~d~--------~--~~le~--~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~---------~~yS~D~r 499 (655)
T KOG3741|consen 441 DVLQEDP--------T--EPLES--QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT---------TTYSTDLR 499 (655)
T ss_pred eeecCCC--------C--cchhH--HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh---------hhhhHHHH
Confidence 5554432 0 11111 23567888999999999985432121222222 22222 34577888
Q ss_pred HHHHHHhh-cccCCCCHHHHhcC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
++|.-+.. .+.+ .++.+|+.+
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHHH
Confidence 88887776 5554 677777654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=4e-07 Score=97.62 Aligned_cols=231 Identities=19% Similarity=0.259 Sum_probs=146.7
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh-CCCCCcceeeeee-----ec-CCC
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT-LKHKNIIKFYNSW-----VD-TEN 101 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~f-----v~-~~~ 101 (613)
-...-||+|+-+.+|..- +-+-.|| |+..... +..... -+..|.. -.||-+-.-+ .| .. ...
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VA-KIYh~Pp----pa~~aq---k~a~la~~p~~p~~~~rv-aWPqa~L~G~~~~ 82 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVA-KIYHAPP----PAAQAQ---KVAELAATPDAPLLNYRV-AWPQATLHGGRRG 82 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhh-eeecCCC----chHHHH---HHHHhccCCCCcchhhhh-cccHHHhhCCCcc
Confidence 344679999999999762 2333454 4333221 111111 1222333 3566433211 11 11 223
Q ss_pred CEEEEEEeccCCCC-H------HHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 102 EHINFITEIFTSGT-L------RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 102 ~~l~lV~E~~~gGs-L------~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
..+.|+|..+.|.. . ...++......+..+.+.++.|+.+...||.+| .+-+|+.++|+|+. +.+.|.|.
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LV 159 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLV 159 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEE
Confidence 34889999988763 1 122344567889999999999999999999999 99999999999997 77899999
Q ss_pred ccchhHHHhhhc---cCcccccccCccccc-c-----ccCccchhhhhhHHHHHHHhc-CCCCCCCC------cHHHHHH
Q 035992 175 DLGLAAILAQAR---SAHSVIEFMAPELYE-E-----EYNELVDIYAFGMCLLELVTF-EYPYVECT------NAAQIYK 238 (613)
Q Consensus 175 DFGla~~l~~~~---~~~gt~~YmAPEvl~-~-----~ys~ksDIWSLGviL~EmltG-~~Pf~~~~------~~~~i~~ 238 (613)
|-..-.+..... ...+..+|.+||.-. . ..+...|-|.||+++++++.| +.||.+.. ++-+ .
T Consensus 160 dsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~ 237 (637)
T COG4248 160 DSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--T 237 (637)
T ss_pred cccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--h
Confidence 854332222221 234566899999644 1 246679999999999999887 99997632 1111 1
Q ss_pred HHHc-----------CCCCCc---ccccccHHHHHHHHHHhhc---ccCCCCHH
Q 035992 239 KVTS-----------GIKPAS---LAKVADNGVRAFIEKCIAE---VSERLPAK 275 (613)
Q Consensus 239 ~I~~-----------g~~p~~---l~~~~s~~l~~lI~~cL~d---P~~Rpta~ 275 (613)
.|.. |.+|.. ......+.+..+..+|+.+ +.-|||++
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 2222 222211 1245678899999999973 55899954
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=3.1e-07 Score=90.37 Aligned_cols=129 Identities=27% Similarity=0.250 Sum_probs=81.0
Q ss_pred EEEEEEEcCCCcEEEEEEEEeecccc----------------------ChHHHHHHHHHHHHHHhCCCC--Ccceeeeee
Q 035992 41 KVYRAFDELEGIEVAWNQIKVIDLLR----------------------NSEDLERLYSEVHLLKTLKHK--NIIKFYNSW 96 (613)
Q Consensus 41 tVYka~~~~tg~~VAiK~vk~~~~~~----------------------~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~f 96 (613)
.||.|.. .+|..+|+|+.+.....- .........+|...|.++..- ++.+.+.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888865 577899999887531100 011234567899999999765 567777632
Q ss_pred ecCCCCEEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhh-hhcCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 97 VDTENEHINFITEIFT--SGTLRQYRKKHKHVDLRALKKWSRQILEGLSY-LHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~--gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~y-LHs~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
. -.+||||+. |..+..+.... ++......++.+++..+.. +|..| ++|+||.+.||+++. +.+.|
T Consensus 80 ----~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~--~~~~i 147 (188)
T PF01163_consen 80 ----R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD--GKVYI 147 (188)
T ss_dssp ----T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET--TCEEE
T ss_pred ----C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec--ceEEE
Confidence 2 258999999 65554433321 1134556777788885555 57887 999999999999983 48999
Q ss_pred eccchhHHH
Q 035992 174 GDLGLAAIL 182 (613)
Q Consensus 174 ~DFGla~~l 182 (613)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.52 E-value=5.1e-08 Score=109.79 Aligned_cols=149 Identities=17% Similarity=0.314 Sum_probs=106.3
Q ss_pred HHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccC-------------cccccccCccccccc
Q 035992 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA-------------HSVIEFMAPELYEEE 203 (613)
Q Consensus 137 QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~-------------~gt~~YmAPEvl~~~ 203 (613)
+++.||.|+|.. +++||+.|.|++|+++ ..|.+||+.|+++......... .-...|.|||++...
T Consensus 107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 344999999987 5799999999999999 5689999999988654431110 011269999977654
Q ss_pred -cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH--cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 204 -YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT--SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 204 -ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~--~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+.++|+||||+++|.+..|..+-....+....+.... .+..........+.++++=+.++|. ++..||++.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 67899999999999999855444323222111221111 1111222345677889999999998 9999999999999
Q ss_pred CCCCCCCC
Q 035992 280 DPFLQSED 287 (613)
Q Consensus 280 HPff~~~~ 287 (613)
-|||+...
T Consensus 265 ~~ff~D~~ 272 (700)
T KOG2137|consen 265 IPFFSDPG 272 (700)
T ss_pred ccccCCch
Confidence 99998753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.5e-06 Score=88.48 Aligned_cols=107 Identities=16% Similarity=0.128 Sum_probs=80.3
Q ss_pred HHHHHHHHHHhCCCCCc--ceeeeeeecCC---CCEEEEEEeccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHhhh
Q 035992 73 RLYSEVHLLKTLKHKNI--IKFYNSWVDTE---NEHINFITEIFTSG-TLRQYRKK--HKHVDLRALKKWSRQILEGLSY 144 (613)
Q Consensus 73 ~l~~Ei~iLk~L~HpNI--Vkl~~~fv~~~---~~~l~lV~E~~~gG-sL~~~l~~--~~~lse~~i~~i~~QIl~gL~y 144 (613)
.+.+|...+..|..-+| +....++.... ...-++|||++.+- +|.+++.. ....+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 46788888888743333 23333332221 23567999999886 89998864 3456677888999999999999
Q ss_pred hhcCCCCEEecCCCCCcEEEeC------CCCcEEEeccchhHH
Q 035992 145 LHSHDPPVIHRDLKCDNIFVNG------NQGEVKIGDLGLAAI 181 (613)
Q Consensus 145 LHs~~~~IIHrDLKp~NILl~~------~~g~VKL~DFGla~~ 181 (613)
||.+| |+|+|+++.|||++. +.+.+.|+||+.+..
T Consensus 154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999 999999999999973 246899999998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.2e-08 Score=113.74 Aligned_cols=237 Identities=16% Similarity=0.184 Sum_probs=162.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC-cceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN-IIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~~~~l~ 105 (613)
++.+-+-+++|+++++||.+...+...+ .+.+.. . ....-++++|.+++||| .+.+++.+ +...+.+
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~-------~--l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~ 310 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQ-------T--LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLW 310 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeecc-------c--hhhHHHHHHHHHccCCCCcccccccC--Ccccccc
Confidence 3355578899999999999877666544 333321 1 34556899999999999 55555543 3456889
Q ss_pred EEEeccCCC-CHH-HHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSG-TLR-QYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gG-sL~-~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+.++++.++ +-. ..-...-.+.+-+....++.-+++|+|||+-. -+||| ||+.. .+.++..||+....+.
T Consensus 311 i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccC
Confidence 999999988 211 11111122445566677888889999999874 58898 88775 4689999999987765
Q ss_pred hh---ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-CCCccc-ccccHHH
Q 035992 184 QA---RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-KPASLA-KVADNGV 257 (613)
Q Consensus 184 ~~---~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-~p~~l~-~~~s~~l 257 (613)
.. +...+++.|+|||+.. +.+....|.|++|.-..+|.-|.+|-.. .+... ..+-.+. .+.... ..+++..
T Consensus 383 ~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~-~~~g~~p~s~~L~~~~aw~~~~ 459 (829)
T KOG0576|consen 383 RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVL-PMIGNGPNSPMLTDKSAWSPVF 459 (829)
T ss_pred cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Ccccc-CCCCCCCCccccchhhhcCccc
Confidence 43 4556778999999665 4599999999999999999988888643 11111 1111111 111111 1222223
Q ss_pred H-HHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 258 R-AFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 258 ~-~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
. ++...|+. .|..|+.....+.|.||..-
T Consensus 460 ~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 3 47788988 89999999999999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=4.5e-06 Score=83.03 Aligned_cols=109 Identities=19% Similarity=0.193 Sum_probs=82.9
Q ss_pred HHHHHHHHHHHHhCCCC--CcceeeeeeecCC--CCEEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHhhhh
Q 035992 71 LERLYSEVHLLKTLKHK--NIIKFYNSWVDTE--NEHINFITEIFTSG-TLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145 (613)
Q Consensus 71 ~~~l~~Ei~iLk~L~Hp--NIVkl~~~fv~~~--~~~l~lV~E~~~gG-sL~~~l~~~~~lse~~i~~i~~QIl~gL~yL 145 (613)
..+..+|...+..|..- .+.+.+.+..... ...-++|||++++. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 34677888888777433 2334444333222 23458899999884 7999998866678888899999999999999
Q ss_pred hcCCCCEEecCCCCCcEEEeCCC--CcEEEeccchhHH
Q 035992 146 HSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAI 181 (613)
Q Consensus 146 Hs~~~~IIHrDLKp~NILl~~~~--g~VKL~DFGla~~ 181 (613)
|.+| |+|+|+++.|||++.+. ..+.++||+-+..
T Consensus 135 H~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 99999999999998432 2689999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.9e-06 Score=87.20 Aligned_cols=142 Identities=22% Similarity=0.191 Sum_probs=99.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecc-----ccC-------------hHHHHHHHHHHHHHHhCCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-----LRN-------------SEDLERLYSEVHLLKTLKH 86 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~-----~~~-------------~~~~~~l~~Ei~iLk~L~H 86 (613)
+.+.++...||-|-=+.||.|.+. .|.++|+|.-+.-.. ... ........+|..+|..|.-
T Consensus 90 ~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~ 168 (304)
T COG0478 90 GIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP 168 (304)
T ss_pred ChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence 345567899999999999999865 789999886653210 000 0123345789999999975
Q ss_pred C--CcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEE
Q 035992 87 K--NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV 164 (613)
Q Consensus 87 p--NIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl 164 (613)
. .+.+.+++ ..-.+|||++.|-.|....- +.+....++..|+.-+.-+-..| |||+|+.+=||++
T Consensus 169 ~G~~VP~P~~~------nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV 235 (304)
T COG0478 169 EGVKVPKPIAW------NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFNILV 235 (304)
T ss_pred cCCCCCCcccc------ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHcC--ccccCCchheEEE
Confidence 5 77777772 23567999999977754331 23344445555555554444556 9999999999999
Q ss_pred eCCCCcEEEeccchhHH
Q 035992 165 NGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 165 ~~~~g~VKL~DFGla~~ 181 (613)
+ ++|.+.++||--+..
T Consensus 236 ~-~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 T-EDGDIVVIDWPQAVP 251 (304)
T ss_pred e-cCCCEEEEeCccccc
Confidence 8 678999999986643
|
|
| >PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress | Back alignment and domain information |
|---|
Probab=98.27 E-value=1e-06 Score=63.15 Aligned_cols=32 Identities=44% Similarity=0.545 Sum_probs=27.6
Q ss_pred eEEEEEEecCCC------CeeeeEecccCCCCCHHHHH
Q 035992 338 IFLKLRISDSTG------HFRNIHFPFDTEADTAFAVA 369 (613)
Q Consensus 338 i~L~lri~~~~~------~~~~i~F~F~~~~Dta~~Va 369 (613)
|.|+||+.|+++ +.++|+|+|++++|+|++||
T Consensus 1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA 38 (38)
T PF12202_consen 1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA 38 (38)
T ss_dssp EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence 679999999998 89999999999999999998
|
This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.21 E-value=2.5e-06 Score=100.95 Aligned_cols=204 Identities=24% Similarity=0.335 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE--EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhh
Q 035992 69 EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH--INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146 (613)
Q Consensus 69 ~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~--l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLH 146 (613)
..+.....|+..+.++.|+|++.++.+-+...... +.+..++|..-++...+..-+.++.+.++.|..++++||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 34555566778888899999999999765443222 3345688999999999999999999999999999999999999
Q ss_pred cCCCCEEecCCCCC---cEEEeCCCCcEEEe--ccchhHHHhhhcc---CcccccccCccccccc-c--CccchhhhhhH
Q 035992 147 SHDPPVIHRDLKCD---NIFVNGNQGEVKIG--DLGLAAILAQARS---AHSVIEFMAPELYEEE-Y--NELVDIYAFGM 215 (613)
Q Consensus 147 s~~~~IIHrDLKp~---NILl~~~~g~VKL~--DFGla~~l~~~~~---~~gt~~YmAPEvl~~~-y--s~ksDIWSLGv 215 (613)
+.. ..|.-|..+ +--++ ..+.+.++ ||+.+..+..... ......|.+||..... + ....|+|.+|.
T Consensus 304 ~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred Hhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 985 444444433 22222 12355555 7877765543221 1122357778866544 3 34479999999
Q ss_pred HHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 216 CLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 216 iL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
....+..|..+-.....+.. .++........+++.+|+. ++.+|+++.+++.|||.+...
T Consensus 381 l~~~~~~~~~i~~~~~~~~~------------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVPVS------------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccccchhh------------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99999987765422111111 1111222267788999997 899999999999999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.1e-05 Score=75.40 Aligned_cols=142 Identities=14% Similarity=0.134 Sum_probs=96.7
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEEE-e-eccccChHHHHHHHHHHHHHHhCCCCC--cceee--eeeecCCCCEEEEEE
Q 035992 35 GRGAFKKVYRAFDELEGIEVAWNQIK-V-IDLLRNSEDLERLYSEVHLLKTLKHKN--IIKFY--NSWVDTENEHINFIT 108 (613)
Q Consensus 35 G~GafGtVYka~~~~tg~~VAiK~vk-~-~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~--~~fv~~~~~~l~lV~ 108 (613)
|+||-+.|+.... .|..+=+|.-. . .....-+-....+.+|+..+..|..-+ +.+.. +.-.......-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 3478888888643 33345555432 1 111111445677899999999985332 33333 211112233467899
Q ss_pred eccCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc--EEEeccchhHH
Q 035992 109 EIFTS-GTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAI 181 (613)
Q Consensus 109 E~~~g-GsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~--VKL~DFGla~~ 181 (613)
|-+.+ -+|.+++... ...++.....++.+|+..|.-||..| +.|+|+-+.|||++. .|. |+++||.-+..
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 96654 5888888664 34677888899999999999999999 999999999999973 345 99999987654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00021 Score=70.22 Aligned_cols=141 Identities=23% Similarity=0.282 Sum_probs=79.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--Ccceeeeeeec-CCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK--NIIKFYNSWVD-TENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~fv~-~~~~~l~lV~ 108 (613)
+.|+.|..+.||++.... + .+++|... .......+..|..+++.+... .+.+++.+... ......+++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~-~~vlK~~~------~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-G-RYVLKFYR------PPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEESSSSEEEEEEETT-S-EEEEEEES------SHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-c-EEEEEEeC------CCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 678999999999997654 4 67766532 124567788899998888533 34566653322 2234578999
Q ss_pred eccCCCCHHH----------------HHH---hC----CCCCHHH------HH---HH------------HHHHHH-Hhh
Q 035992 109 EIFTSGTLRQ----------------YRK---KH----KHVDLRA------LK---KW------------SRQILE-GLS 143 (613)
Q Consensus 109 E~~~gGsL~~----------------~l~---~~----~~lse~~------i~---~i------------~~QIl~-gL~ 143 (613)
+++.|..+.. .+. .. ..+.... .. .+ ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988777 111 11 0000000 00 00 011111 222
Q ss_pred hhhc-----CCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 144 YLHS-----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 144 yLHs-----~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
.++. ....++|+|+.|.|||++..++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 3321 223499999999999998455677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0001 Score=74.59 Aligned_cols=132 Identities=14% Similarity=0.197 Sum_probs=78.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc--ceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI--IKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~~fv~~~~~~l~lV~E 109 (613)
+.||+|..+.||+. .|..+++|.... ......+.+|.++++.+..-.+ .+.+.+. .......++|+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~------~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNP------GFDKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCC------CCCHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeee
Confidence 67899999999984 244566565431 1123456889999998864433 5555543 33456788999
Q ss_pred ccCCCC-HH--------------HHHHh-----C----CCCCHHH------------------HHHHHHHHHHHhhhhhc
Q 035992 110 IFTSGT-LR--------------QYRKK-----H----KHVDLRA------------------LKKWSRQILEGLSYLHS 147 (613)
Q Consensus 110 ~~~gGs-L~--------------~~l~~-----~----~~lse~~------------------i~~i~~QIl~gL~yLHs 147 (613)
++.|.+ +. ..+.+ + ....... ++..+...+.. +.
T Consensus 75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~----~~ 150 (226)
T TIGR02172 75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE----VP 150 (226)
T ss_pred ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh----CC
Confidence 999963 11 11100 1 0111111 11111111111 22
Q ss_pred CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 148 ~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+.++|+|+.|.||+++ +.+ +.|+||+.+..
T Consensus 151 ~~~~~~HgD~~~~Nii~~-~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 151 DTSTCLHGDFQIGNLITS-GKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCceEecCCCCCcEEEc-CCC-cEEEechhcCc
Confidence 233589999999999998 455 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.82 E-value=4.9e-05 Score=85.55 Aligned_cols=152 Identities=17% Similarity=0.173 Sum_probs=90.7
Q ss_pred CCCcceeEe-eeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-------------------------C-hHH----H
Q 035992 23 PSARYGRYK-EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-------------------------N-SED----L 71 (613)
Q Consensus 23 p~gRy~r~~-e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-------------------------~-~~~----~ 71 (613)
....|..+. +-|+.++-|.||+|..+. |+.||+|+.+-.-... . ... .
T Consensus 121 iee~F~eF~~~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 121 IEELFSEFEPEPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred HHHHHHHcCCCchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 334555565 789999999999998764 9999999765210000 0 001 1
Q ss_pred HH------HHHHHHHHHhC----C-CCCcceeeeeeecCCCCEEEEEEeccCCCCHHHH--HHhCCCCCHHHHHHHHHHH
Q 035992 72 ER------LYSEVHLLKTL----K-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWSRQI 138 (613)
Q Consensus 72 ~~------l~~Ei~iLk~L----~-HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~--l~~~~~lse~~i~~i~~QI 138 (613)
+. +.+|...+.++ + .+++. +-..+.+- ...-.++|||+.|-.+.+. ++. ..++...+...+.++
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~ 276 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVY-VPKVYWEY-TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA 276 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhc-cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH
Confidence 11 23344444443 2 33322 22222111 2345689999999988877 444 445544433332222
Q ss_pred HHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 139 l~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
.--.-+- .| ++|.|..|.||+++ .+|.+.+.|||+...+.
T Consensus 277 f~~q~~~--dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 277 FLRQLLR--DG--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHHh--cC--ccccCCCccceEEe-cCCcEEEEcCcceecCC
Confidence 2211111 35 99999999999998 56899999999976553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00031 Score=71.03 Aligned_cols=78 Identities=15% Similarity=0.081 Sum_probs=48.3
Q ss_pred eEeeeecccCc-eEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 29 RYKEVLGRGAF-KKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 29 r~~e~LG~Gaf-GtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
|+ +.|-.|.+ ..||+.... +..+.+|..... . ...+.+|+++++.+. +--+.+++.+... ...-++
T Consensus 2 ~~-~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~------~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 69 (244)
T cd05150 2 RW-ERVTEGQSGATVYRLDGK--NPGLYLKIAPSG------P-TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWL 69 (244)
T ss_pred cc-eecCCCCCcCeEEEEcCC--CCcEEEEecCCC------c-ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEE
Confidence 44 33444544 889999543 355655543211 1 335677999988884 4445667775432 345788
Q ss_pred EEeccCCCCHHH
Q 035992 107 ITEIFTSGTLRQ 118 (613)
Q Consensus 107 V~E~~~gGsL~~ 118 (613)
||++++|.+|..
T Consensus 70 v~e~i~G~~l~~ 81 (244)
T cd05150 70 LTSAVPGVPAAA 81 (244)
T ss_pred EEEeeCCccHhH
Confidence 999999987653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00041 Score=70.89 Aligned_cols=141 Identities=19% Similarity=0.135 Sum_probs=94.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC------------------hH--HHHHHHHHHHHHHhCC--CCC
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN------------------SE--DLERLYSEVHLLKTLK--HKN 88 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~------------------~~--~~~~l~~Ei~iLk~L~--HpN 88 (613)
.-.|..|--+.||+|.. .++..+|+|+++....... .. .......|+.-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34666777788999964 5688999998875321110 01 1123456888888874 555
Q ss_pred cceeeeeeecCCCCEEEEEEeccCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeC
Q 035992 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQ-YRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 89 IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~-~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~ 166 (613)
+.+.+.++ .-.+||||+....+-. .++. -.+.......+..++++.+.-|-. .+ +||+||..=|||+.
T Consensus 132 vP~Pi~~~------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~- 201 (268)
T COG1718 132 VPEPIAFR------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH- 201 (268)
T ss_pred CCCceeec------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE-
Confidence 66666643 2457999987642111 1111 123333677788888888887766 55 99999999999997
Q ss_pred CCCcEEEeccchhHHHh
Q 035992 167 NQGEVKIGDLGLAAILA 183 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~ 183 (613)
.+.+.|+|||-|....
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 5789999999887654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00066 Score=68.46 Aligned_cols=66 Identities=23% Similarity=0.323 Sum_probs=51.7
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++|||+.|..|.++.. +++ .+...|.+++.-||..| ++|+|..|.|+++. + +.++++||+...
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~-~-~~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS-N-NGIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEEE-C-CcEEEEECcccc
Confidence 4568999999988876532 232 24456777889999999 99999999999997 3 469999998754
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00045 Score=77.90 Aligned_cols=151 Identities=17% Similarity=0.177 Sum_probs=92.7
Q ss_pred CCCcceeEe-eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC----------------------------hHHHHH
Q 035992 23 PSARYGRYK-EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN----------------------------SEDLER 73 (613)
Q Consensus 23 p~gRy~r~~-e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~----------------------------~~~~~~ 73 (613)
++.-|..+. +.||.-+.|.||+|+.+. |+.||+|+-+ ..+... .+-.+.
T Consensus 157 ie~if~~f~~~piaaASlaQVhrA~L~~-G~~VaVKVQ~-P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~ 234 (538)
T KOG1235|consen 157 IEDIFSEFDEEPIAAASLAQVHRARLKN-GEDVAVKVQH-PGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKS 234 (538)
T ss_pred HHHHHHhcCcchhhhcchhheEEEEecC-CCEEEEEecC-cChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhh
Confidence 344455555 789999999999998765 9999988654 211110 011122
Q ss_pred HHHHHHHH----------HhCCCCC------cceeeeeeecCCCCEEEEEEeccCCCCHHH--HHHhCCCCCHHHHHHHH
Q 035992 74 LYSEVHLL----------KTLKHKN------IIKFYNSWVDTENEHINFITEIFTSGTLRQ--YRKKHKHVDLRALKKWS 135 (613)
Q Consensus 74 l~~Ei~iL----------k~L~HpN------IVkl~~~fv~~~~~~l~lV~E~~~gGsL~~--~l~~~~~lse~~i~~i~ 135 (613)
+..|+..+ +.+.|-+ |.++|-.+ ...-.++||||.|..+.+ ++.+.+ ++...+..-+
T Consensus 235 L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l 309 (538)
T KOG1235|consen 235 LPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKL 309 (538)
T ss_pred hHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHH
Confidence 33333322 2234555 55555433 235779999999987654 456654 4444443333
Q ss_pred HHHHHHhhhhhcCCCCEEecCCCCCcEEEeC---CCCcEEEeccchhHHHhh
Q 035992 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 136 ~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~---~~g~VKL~DFGla~~l~~ 184 (613)
.+...-+=+ ..| ++|+|-.|.||++.. .++.+.+.|||+...+..
T Consensus 310 ~~~~~~qIf--~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 310 VEAYLEQIF--KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHH--hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 333222222 235 999999999999983 367899999999876543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0025 Score=63.55 Aligned_cols=133 Identities=20% Similarity=0.256 Sum_probs=90.5
Q ss_pred CCcceeEeeeecccCc-eEEEEEEEcCCCcEEEEEEEEeecccc----------Ch-------HHHHHHHHHHHHHHhCC
Q 035992 24 SARYGRYKEVLGRGAF-KKVYRAFDELEGIEVAWNQIKVIDLLR----------NS-------EDLERLYSEVHLLKTLK 85 (613)
Q Consensus 24 ~gRy~r~~e~LG~Gaf-GtVYka~~~~tg~~VAiK~vk~~~~~~----------~~-------~~~~~l~~Ei~iLk~L~ 85 (613)
-+.-..+.+.||.|.- |.||++. ..|+.+|+|+++.-.... .. ...+-|..|.++..+|+
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3355677899999999 9999994 578899999844311111 11 22345778888877774
Q ss_pred ---CCCc--ceeeeeeecCC----------------CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhh
Q 035992 86 ---HKNI--IKFYNSWVDTE----------------NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144 (613)
Q Consensus 86 ---HpNI--Vkl~~~fv~~~----------------~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~y 144 (613)
+.++ |+.|+++.-.. .....||.||..... .+... -+.+|++-|..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHH
Confidence 4455 89999864321 112456777766543 22333 35677777888
Q ss_pred hhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 145 LHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+|..| |+-+|+++.|.. + -||+|||.+
T Consensus 180 ~~k~g--I~~~Dv~~~ny~-~-----G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG--IVPRDVKPRNYR-G-----GKLVDFSSS 206 (207)
T ss_pred HHHCC--eeeccCcccccc-C-----CEEEecccC
Confidence 99998 999999999976 2 378999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00031 Score=68.43 Aligned_cols=131 Identities=22% Similarity=0.225 Sum_probs=89.7
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcce-eeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK-FYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVk-l~~~fv~~~~~~l~lV 107 (613)
+..+.||+|.+|.||++.. .|..+|+|+-+ .+.....+..|+++|..+.--++.. +|.+ + ..++.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr------~ds~r~~l~kEakiLeil~g~~~~p~vy~y--g----~~~i~ 90 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRR------RDSPRRNLEKEAKILEILAGEGVTPEVYFY--G----EDFIR 90 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEec------CCcchhhHHHHHHHHHHhhhcCCCceEEEe--c----hhhhh
Confidence 4558999999999999954 57789877533 3455667899999999998776644 4443 1 34556
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCC--CcEEEeCCCCcEEEeccchhHHHhh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKC--DNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp--~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|||+.|-.|...-... +... +..+++.-.-|-..| |-|..|.- .||+++ ++.+.|+||.-|++...
T Consensus 91 me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~--~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 91 MEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVN--DRDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEec--CCcEEEEEccchhhccC
Confidence 9999998887654431 2222 334444433445555 88888864 466664 45899999999986543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.41 E-value=5.6e-05 Score=91.59 Aligned_cols=213 Identities=15% Similarity=0.040 Sum_probs=145.7
Q ss_pred HHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhh
Q 035992 71 LERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLH 146 (613)
Q Consensus 71 ~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLH 146 (613)
.+.+..|...++...|+++...+.-.....+...|..++|+.+|.++..+.++ ..+++.-+.....+.+.+..-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 34456677777778999999888866556677789999999999999988664 34555555555555566666655
Q ss_pred cCC---CCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc----cCcccccccCcccccc-ccCccchhhhhhHHHH
Q 035992 147 SHD---PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLL 218 (613)
Q Consensus 147 s~~---~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~ 218 (613)
+.. --.+|++||+-|.+|..+. .||++++|+.++..... ...+++.|++|++.+. .++.+.|+|..|+.+|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 432 2279999999999998554 89999999998544322 3344557899988776 5888899999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 219 ELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 219 EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..-|..+|-.. ..-..+.+........++...+.+.......+|- .-..||.-...+.-+.|...
T Consensus 1432 ~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred HHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence 999888887321 1111222222223334444444444444444444 66778888888877776543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0028 Score=75.81 Aligned_cols=148 Identities=18% Similarity=0.261 Sum_probs=88.0
Q ss_pred eeecccCceEEEEEEEcCCC--cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCc--ceeeeeeecCC-CCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNI--IKFYNSWVDTE-NEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg--~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNI--Vkl~~~fv~~~-~~~l~ 105 (613)
+.|+.|.+..+|+......+ ..+++|...... .......+.+|+.+|+.+. |+++ .+++.++.+.. ....|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~---~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK---LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc---cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 77899999999998654332 345544322111 1122346779999999995 6665 66666543321 23578
Q ss_pred EEEeccCCCCHHH--------------------HHH---hC----------C---CCCHHHHHHHHHHH-----------
Q 035992 106 FITEIFTSGTLRQ--------------------YRK---KH----------K---HVDLRALKKWSRQI----------- 138 (613)
Q Consensus 106 lV~E~~~gGsL~~--------------------~l~---~~----------~---~lse~~i~~i~~QI----------- 138 (613)
+||||+.|..+.+ .+. .- + ..-...+..|..+.
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999999864311 111 10 0 01123454444332
Q ss_pred ----HHHhhhhhcCCC---------CEEecCCCCCcEEEeCCCCc-EEEeccchhHHH
Q 035992 139 ----LEGLSYLHSHDP---------PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAIL 182 (613)
Q Consensus 139 ----l~gL~yLHs~~~---------~IIHrDLKp~NILl~~~~g~-VKL~DFGla~~l 182 (613)
...+.+|..+-| .+||+|+++.||+++.+.+. +-|.||+++..-
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 223456644322 39999999999999743344 479999988653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.001 Score=67.10 Aligned_cols=74 Identities=12% Similarity=0.048 Sum_probs=42.4
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC---CcceeeeeeecCCC-CEEEE
Q 035992 32 EVLGRGAFK-KVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK---NIIKFYNSWVDTEN-EHINF 106 (613)
Q Consensus 32 e~LG~GafG-tVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVkl~~~fv~~~~-~~l~l 106 (613)
+.|+.|+.. .||+. +..+.+|..+ .......+..|..+|..+... .+.+++......+. ...++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~------~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPS------AAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCC------ccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 457767666 59976 1234444322 112345788899999888532 34444442211111 23578
Q ss_pred EEeccCCCCH
Q 035992 107 ITEIFTSGTL 116 (613)
Q Consensus 107 V~E~~~gGsL 116 (613)
+|+++.|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999998765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0037 Score=62.24 Aligned_cols=137 Identities=21% Similarity=0.331 Sum_probs=87.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccc------------cChHHHHHHHHHHHHHHhCC------CCCcceee
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL------------RNSEDLERLYSEVHLLKTLK------HKNIIKFY 93 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~------------~~~~~~~~l~~Ei~iLk~L~------HpNIVkl~ 93 (613)
..||+|+.-.||.- .......||+++..... ..........+|+.....+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 67999999999964 34444557776644300 00112344555666555554 88999999
Q ss_pred eeeecCCCCEEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 94 NSWVDTENEHINFITEIFTS------GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~g------GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
+.. +.+..+.+|+|.+.. -+|.+++++ +.+++ .++..+.++. +||-.++ |+.+||+|.||++...
T Consensus 84 G~v--eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~~f~---~~l~~~~--Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFV--ETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALDEFK---RYLLDHH--IVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEE--ecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHHHHH---HHHHHcC--CeecCCCcccEEEEec
Confidence 964 334557888887654 268888855 44666 4444444444 4566666 9999999999999622
Q ss_pred -CC--cEEEec-cchhH
Q 035992 168 -QG--EVKIGD-LGLAA 180 (613)
Q Consensus 168 -~g--~VKL~D-FGla~ 180 (613)
.+ .+.|+| ||...
T Consensus 155 ~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGEKE 171 (199)
T ss_pred CCCceEEEEEeCCCCcc
Confidence 22 477777 56543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.001 Score=65.59 Aligned_cols=102 Identities=24% Similarity=0.194 Sum_probs=79.3
Q ss_pred HHHHHHHhCCC-CCcceeeeeeecCCCCEEEEEEeccCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCC-
Q 035992 76 SEVHLLKTLKH-KNIIKFYNSWVDTENEHINFITEIFTSGTLRQ---YRKKHKHVDLRALKKWSRQILEGLSYLHSHDP- 150 (613)
Q Consensus 76 ~Ei~iLk~L~H-pNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~---~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~- 150 (613)
.|.-+|+.+.+ +++++++|++ + -++++||...+++.. .+...-..++.....++.++++.+++|+....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----G--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----C--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 48888999976 6999999987 2 356899998776542 12222345889999999999999999987321
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
.+.-.|++++|+-++ ++|.+|++|+..+.....
T Consensus 82 ~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~~~~ 114 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN-DDGRLKLIDLDDVFVEDK 114 (188)
T ss_pred cEEEeecchHHeEEe-CCCcEEEEechhcchhHH
Confidence 288899999999998 678999999998766543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0038 Score=62.54 Aligned_cols=74 Identities=19% Similarity=0.182 Sum_probs=44.9
Q ss_pred eeecccCceEEEEEEEcC-CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC-cceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFDEL-EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN-IIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~-tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~~~~l~lV~E 109 (613)
+.|..|-...+|++.... .+..|.+|+.... . ...-...+|+.+++.+...+ .++++..+ . + .++||
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~----~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~-~---~~l~e 72 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK----T-ELIIDRERELRIHKLLSKHGLAPKLYATF--Q-N---GLIYE 72 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCC----c-cceecHHHHHHHHHHHHhCCCCCeEEEEe--C-C---cEEEE
Confidence 567788889999985433 3567777754321 1 11112346888888885433 34455432 1 1 37999
Q ss_pred ccCCCCH
Q 035992 110 IFTSGTL 116 (613)
Q Consensus 110 ~~~gGsL 116 (613)
|+.|.++
T Consensus 73 ~i~G~~l 79 (235)
T cd05157 73 FIPGRTL 79 (235)
T ss_pred eeCCCcC
Confidence 9998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0078 Score=63.39 Aligned_cols=77 Identities=10% Similarity=0.101 Sum_probs=51.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC---CCcceeeeeeecC-CCCEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH---KNIIKFYNSWVDT-ENEHINFI 107 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H---pNIVkl~~~fv~~-~~~~l~lV 107 (613)
+.||.|..+.||.... .++ .+.+|..+. ......+..|...|+.|.- ..+.++++++.+. ..+.-++|
T Consensus 20 ~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~------~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 20 ECISEQPYAALWALYD-SQG-NPMPLMARS------FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eecCCccceeEEEEEc-CCC-CEEEEEecc------cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 6899999999999843 233 454455321 1122467889999988853 4677888754332 23457899
Q ss_pred EeccCCCCH
Q 035992 108 TEIFTSGTL 116 (613)
Q Consensus 108 ~E~~~gGsL 116 (613)
||++.|+++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.027 Score=61.88 Aligned_cols=80 Identities=23% Similarity=0.178 Sum_probs=54.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeecc---ccChHHHHHHHHHHHHHHhCC---CCCcceeeeeeecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL---LRNSEDLERLYSEVHLLKTLK---HKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~---~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~l~ 105 (613)
+.||.|.+..||++.....++.|.+|+-.-... ...+-..++...|...|+.+. -.+++++|.+ +. ..-+
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~--~~~~ 107 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE--ELAV 107 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC--CCCE
Confidence 689999999999998864446888887431110 011345677888888888863 3467778874 33 3467
Q ss_pred EEEeccCCCC
Q 035992 106 FITEIFTSGT 115 (613)
Q Consensus 106 lV~E~~~gGs 115 (613)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 8999998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.022 Score=59.46 Aligned_cols=74 Identities=23% Similarity=0.209 Sum_probs=44.6
Q ss_pred eeecccCceEEEEEEEcC------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCEE
Q 035992 32 EVLGRGAFKKVYRAFDEL------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEHI 104 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l 104 (613)
+.|..|-...||+..... .++.+.+|+.... ........+|+.+++.+....+ .+++.++ .+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---- 72 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQS-----VELLIDRERELVVFARLSERNLGPKLYGIF--PN---- 72 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCC-----CcceechHHHHHHHHHHHhCCCCCceEEEe--CC----
Confidence 456667778999886433 2577876764321 1222345678888888853333 3455543 21
Q ss_pred EEEEeccCCCCH
Q 035992 105 NFITEIFTSGTL 116 (613)
Q Consensus 105 ~lV~E~~~gGsL 116 (613)
.+|++|+.|..+
T Consensus 73 ~~v~e~i~G~~l 84 (302)
T cd05156 73 GRIEEFIPSRTL 84 (302)
T ss_pred CchhheeCCCcC
Confidence 247899888655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.031 Score=60.31 Aligned_cols=143 Identities=19% Similarity=0.184 Sum_probs=94.0
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc--------------------ChHHH--HHHHHHHHHHHhCCCC
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR--------------------NSEDL--ERLYSEVHLLKTLKHK 87 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~--------------------~~~~~--~~l~~Ei~iLk~L~Hp 87 (613)
+.-.|..|--+.||.|. ..+|..+|||++|-..+.. ++..+ -....|+.-|++++..
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 34567777888899986 5578889999887533211 11112 1234577888888765
Q ss_pred CcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 88 NIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
.|.-.--..+ ..-.+||+|+.....-.-+-+.-.++...+..+-.|++.-+.-|-.. +.+||.||.-=|+|+.
T Consensus 227 GIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN~Lyh-- 299 (520)
T KOG2270|consen 227 GIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFNLLYH-- 299 (520)
T ss_pred CCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhhheEE--
Confidence 5432211111 12457999986433222222334577777888888888887766443 2499999999999996
Q ss_pred CCcEEEeccchhH
Q 035992 168 QGEVKIGDLGLAA 180 (613)
Q Consensus 168 ~g~VKL~DFGla~ 180 (613)
.|.+.|+|.+-+.
T Consensus 300 dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 DGKLYIIDVSQSV 312 (520)
T ss_pred CCEEEEEEccccc
Confidence 6899999988764
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.017 Score=58.89 Aligned_cols=134 Identities=20% Similarity=0.248 Sum_probs=73.4
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHH-HHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCEEEEEEec
Q 035992 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 33 ~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~-~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l~lV~E~ 110 (613)
.+..|-...+|+.. .+|..+.+|..... .... -...+|..+++.+....+ .+++.. .. -++||+|
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~-----~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPV-----CKALGVDRQREYQILQALSALGLAPKPILV--NE----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcc-----cccccCcHHHHHHHHHHHHhcCCCCceEEE--eC----CEEEEEe
Confidence 35568888999885 45667776543211 1111 124678899988864433 334432 22 2579999
Q ss_pred cCCCCHHH--------------HHHh-C------CCCCH-HHHHHHHHHH---------HHHhhhhhcC------CCCEE
Q 035992 111 FTSGTLRQ--------------YRKK-H------KHVDL-RALKKWSRQI---------LEGLSYLHSH------DPPVI 153 (613)
Q Consensus 111 ~~gGsL~~--------------~l~~-~------~~lse-~~i~~i~~QI---------l~gL~yLHs~------~~~II 153 (613)
+.|..+.. .+.+ | ..++. ..+..+..++ ...+..+-.. .+.++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 99866431 1111 1 11121 1222222222 1111112111 12389
Q ss_pred ecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 154 HrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
|+|+.|.||++++ ++ +.|+||+.+..
T Consensus 150 H~Dl~~~Nil~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeC-CC-CEEEeccccCc
Confidence 9999999999984 44 88999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.021 Score=59.27 Aligned_cols=140 Identities=14% Similarity=0.110 Sum_probs=76.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--Ccceeeee----eecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK--NIIKFYNS----WVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~----fv~~~~~~l~ 105 (613)
+.|..|....+|+... ++..+++|+... .....+..|+.++..+.+. .+.+++.. ++...++..+
T Consensus 20 ~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 20 EGISAGIENTNYFVTT--DSGRYVLTLFEK-------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred ecccCccccceEEEEe--CCCcEEEEEcCC-------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 5677788889998843 344677665432 1234566788888877433 24444432 1111234568
Q ss_pred EEEeccCCCCHHH--------H---H---HhC-CCCCH--------HHHH------------HHHHHHHHHhhhhhc---
Q 035992 106 FITEIFTSGTLRQ--------Y---R---KKH-KHVDL--------RALK------------KWSRQILEGLSYLHS--- 147 (613)
Q Consensus 106 lV~E~~~gGsL~~--------~---l---~~~-~~lse--------~~i~------------~i~~QIl~gL~yLHs--- 147 (613)
+++++++|..+.. . + ... ..+.. .-.. .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 8999999866421 0 1 000 00000 0000 011112223333332
Q ss_pred --CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 148 --HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 148 --~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~-~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFD-GDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEe-CCceEEEeehhhhcC
Confidence 112499999999999998 444568999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.057 Score=58.55 Aligned_cols=84 Identities=15% Similarity=0.093 Sum_probs=55.0
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEEEeecc---ccChHHHHHHHHHHHHHHhCC--CC-CcceeeeeeecCCCCEEEE
Q 035992 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL---LRNSEDLERLYSEVHLLKTLK--HK-NIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 33 ~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~---~~~~~~~~~l~~Ei~iLk~L~--Hp-NIVkl~~~fv~~~~~~l~l 106 (613)
.||-|....||++.+...++.|.+|+-.-.-. ...+-..++..-|...|+... -| .++++|.+ + .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D--~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D--TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c--ccccee
Confidence 57999999999999754446898887542211 123556677788888888763 23 46667663 3 334568
Q ss_pred EEeccCCCC-HHHHH
Q 035992 107 ITEIFTSGT-LRQYR 120 (613)
Q Consensus 107 V~E~~~gGs-L~~~l 120 (613)
+||+++... |+..+
T Consensus 78 vMEdL~~~~ilR~~L 92 (370)
T TIGR01767 78 VMEDLSHHKIARKGL 92 (370)
T ss_pred hHhhCccchHHHHHH
Confidence 999996543 44444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.19 Score=52.87 Aligned_cols=30 Identities=30% Similarity=0.287 Sum_probs=24.3
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
++||+|+.|.||+++ .+..+-|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~-~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 188 GVIHADLFRDNVLFE-GDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCCCCCCCcEEEE-CCceEEEEecccccC
Confidence 499999999999998 333447999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.23 Score=53.14 Aligned_cols=30 Identities=23% Similarity=0.447 Sum_probs=26.3
Q ss_pred EEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 152 IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+|.|+.+.|||++.+.+.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 899999999999975557899999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.03 Score=62.66 Aligned_cols=164 Identities=21% Similarity=0.261 Sum_probs=101.9
Q ss_pred HHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCC
Q 035992 72 ERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151 (613)
Q Consensus 72 ~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~ 151 (613)
..+...+++++.+.|+|...++++- ........+|+|++. .+|.+++..+. +-..... .++
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~-r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~-- 87 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFS-RGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHG-- 87 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeee-cCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccc--
Confidence 3456778999999999999998853 334455778899884 58888877654 2211111 122
Q ss_pred EEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCC
Q 035992 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECT 231 (613)
Q Consensus 152 IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~ 231 (613)
+.|- | .++++| ..+.. | |=. ..+|+|||++|.++.++.-|..-|....
T Consensus 88 ~~~~-----~--------~~~~td----~~~t~---------~--~~~----~~pKsdVwsl~~i~~el~L~~~l~~~~~ 135 (725)
T KOG1093|consen 88 VLHL-----N--------IIYITD----HFLTK---------Y--PSP----IGPKSDVWSLGFIILELYLGISLEAELT 135 (725)
T ss_pred ccee-----h--------hhhccc----ccccc---------C--CCC----CCcchhhhhHHHHHHHHHHhhHHHHHHH
Confidence 2221 1 233333 00000 0 111 1249999999999999999987776555
Q ss_pred cHHHHHHHHHcCCCCC---------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 232 NAAQIYKKVTSGIKPA---------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~---------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+.+++.....-+..+. .+...++..+.++..+|+- .|..||...++.+++-|...
T Consensus 136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 4444322222111111 1222346677888899988 89999999999999988764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.011 Score=62.79 Aligned_cols=137 Identities=20% Similarity=0.223 Sum_probs=89.9
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeec-----cccCh---------H--HHH--HHHHHHHHHHhCCC--
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-----LLRNS---------E--DLE--RLYSEVHLLKTLKH-- 86 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~-----~~~~~---------~--~~~--~l~~Ei~iLk~L~H-- 86 (613)
.+-++..||-|--+-||.+-+. .|.+.++|.-+.-. +..+. . .+. ...+|+..|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3456788999999999999654 67788877543211 00000 0 011 23569999999853
Q ss_pred CCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC
Q 035992 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 87 pNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~ 166 (613)
--+.+.+++ ..-++|||++.|-.|.+... ..+..+ +...++.-+.-|-.+| +||+|..-=||++.
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~---v~d~~~---ly~~lm~~Iv~la~~G--lIHgDFNEFNimv~- 236 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRH---VEDPPT---LYDDLMGLIVRLANHG--LIHGDFNEFNIMVK- 236 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeee---cCChHH---HHHHHHHHHHHHHHcC--ceecccchheeEEe-
Confidence 345555552 24567999999988865432 223333 3444444455566777 99999999999998
Q ss_pred CCCcEEEeccchh
Q 035992 167 NQGEVKIGDLGLA 179 (613)
Q Consensus 167 ~~g~VKL~DFGla 179 (613)
+++.++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 6778999999754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.1 Score=54.41 Aligned_cols=31 Identities=19% Similarity=0.294 Sum_probs=25.3
Q ss_pred CEEecCCCCCcEEEeCCCCc-EEEeccchhHHH
Q 035992 151 PVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAIL 182 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~-VKL~DFGla~~l 182 (613)
.++|+|++|.|||++.+ +. .-|+||+.+.+-
T Consensus 186 ~lvHGD~~~~Nilv~~~-~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDED-ARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCC-CCEEEEECcHhcccC
Confidence 39999999999999843 45 469999998654
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.22 Score=54.96 Aligned_cols=76 Identities=14% Similarity=0.055 Sum_probs=50.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeecccc---ChHHHHHHHHHHHHHHhCC---CCCcceeeeeeecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR---NSEDLERLYSEVHLLKTLK---HKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~---~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~l~ 105 (613)
+.||.|....||+..+ .+..+.+|+-....... .+....+...|...|+.+. ..++.++|.+. . ..-+
T Consensus 38 ~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--e--d~~v 111 (418)
T PLN02756 38 KEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--R--TMAL 111 (418)
T ss_pred EEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--C--CCCE
Confidence 7889999999999876 34567777644211111 1235666677788887764 24788888854 3 3456
Q ss_pred EEEeccCC
Q 035992 106 FITEIFTS 113 (613)
Q Consensus 106 lV~E~~~g 113 (613)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999977
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.011 Score=66.71 Aligned_cols=64 Identities=25% Similarity=0.353 Sum_probs=53.0
Q ss_pred eEEEEEEecCCC----CeeeeEecccCCCCCHHHHHHHHHHhhCCCCccHHHHHHHHHHHHHhhCCCC
Q 035992 338 IFLKLRISDSTG----HFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDW 401 (613)
Q Consensus 338 i~L~lri~~~~~----~~~~i~F~F~~~~Dta~~Va~Emv~~~~l~~~d~~~ia~~i~~~i~~~~~~~ 401 (613)
+.|++|..+..+ ..+.|.|.|+++.|+++.||+|||+++.+++.|-..+|++|...+.++.-.-
T Consensus 319 ~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr 386 (632)
T KOG0584|consen 319 LSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKR 386 (632)
T ss_pred ccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhh
Confidence 345566666542 2357999999999999999999999999999999999999999888876444
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.15 Score=54.90 Aligned_cols=139 Identities=15% Similarity=0.170 Sum_probs=78.2
Q ss_pred eeecccCceEEEEEEEcC----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCEEEE
Q 035992 32 EVLGRGAFKKVYRAFDEL----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEHINF 106 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l~l 106 (613)
+.|-.|-.-.+|++.... .++.|.+|+.... ....+++ .+|+.+++.+..-++ .++++.| .. . .
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~----t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~--~~-g---~ 110 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG----VELFFDR-DDEIRTFECMSRHGQGPRLLGRF--PN-G---R 110 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC----CCeeech-HHHHHHHHHHHHcCCCCceEEEE--CC-c---e
Confidence 455558888999986432 2467776654321 1122222 678999988865444 3455654 22 2 4
Q ss_pred EEeccCCCCHHHH--------------HHhC---C------CCCHHHHHHHHHHHHH--------------------Hhh
Q 035992 107 ITEIFTSGTLRQY--------------RKKH---K------HVDLRALKKWSRQILE--------------------GLS 143 (613)
Q Consensus 107 V~E~~~gGsL~~~--------------l~~~---~------~lse~~i~~i~~QIl~--------------------gL~ 143 (613)
|++|+.+.+|... +.+- . ....+.+..|+.++.. .|+
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7888877664311 1110 0 1112344455433211 111
Q ss_pred -hhhc--CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 144 -YLHS--HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 144 -yLHs--~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+.. ....++|+|+++.|||++...+.+.|+||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1111 1123899999999999985457899999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.36 Score=51.59 Aligned_cols=141 Identities=15% Similarity=0.174 Sum_probs=78.4
Q ss_pred cCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--CcceeeeeeecCCCCEEEEEEeccCCC
Q 035992 37 GAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK--NIIKFYNSWVDTENEHINFITEIFTSG 114 (613)
Q Consensus 37 GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~fv~~~~~~l~lV~E~~~gG 114 (613)
|..-.+|..... ++.+.+. ...............+|+.+|+.+.-- -+...++.+.+..-...|+||+++.|.
T Consensus 36 G~sn~t~~~~~~--~~~~vlR---~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe 110 (321)
T COG3173 36 GWSNDTFRLGDT--GQKYVLR---KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE 110 (321)
T ss_pred CcccceEEEecC--CceEEEe---cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence 333344544333 6666643 221223334556677888888887532 333444444332224678999999883
Q ss_pred C---------HH-HHHH--------h--------------CCCCCHHHHHHHHHHH--------------HHHhhhhhcC
Q 035992 115 T---------LR-QYRK--------K--------------HKHVDLRALKKWSRQI--------------LEGLSYLHSH 148 (613)
Q Consensus 115 s---------L~-~~l~--------~--------------~~~lse~~i~~i~~QI--------------l~gL~yLHs~ 148 (613)
. .. ++.. . .......++..|..+. ..-..||+.+
T Consensus 111 ~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~ 190 (321)
T COG3173 111 VVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEAN 190 (321)
T ss_pred eccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhc
Confidence 2 11 2211 0 0112333444444444 2223455544
Q ss_pred CC------CEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 149 DP------PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 149 ~~------~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
-+ .++|+|+.+.||+++. .+-+-+.||+++..-.
T Consensus 191 ~p~~~~~~~lvHGD~~~gNlii~~-~~~~gVlDwe~~~lGD 230 (321)
T COG3173 191 RPPWAGPPVLVHGDYRPGNLIIDP-GRPTGVLDWELATLGD 230 (321)
T ss_pred CCCcCCCceeeeCCcccCCEEEeC-CCeeEEEeccccccCC
Confidence 33 4999999999999984 4558999999987543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.31 E-value=0.5 Score=49.61 Aligned_cols=140 Identities=20% Similarity=0.165 Sum_probs=74.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--Ccceeeee----eecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK--NIIKFYNS----WVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~----fv~~~~~~l~ 105 (613)
+.++.|....||++.. .+| .+.+|+... ... .+.+..|+.++..|... .+.+++.. ++...++..+
T Consensus 28 ~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~---~~~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 28 KGIAEGVENSNYLLTT-DVG-RYILTLYEK---RVK---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred cccCCccccceEEEEe-CCC-cEEEEEecC---CCC---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 5677787789998853 344 455665432 111 23345566777766322 23444332 1112235678
Q ss_pred EEEeccCCCCHH-----HH------H---Hh-CCCC--------CHHH-----HH----------HHHHHHHHHhhhhhc
Q 035992 106 FITEIFTSGTLR-----QY------R---KK-HKHV--------DLRA-----LK----------KWSRQILEGLSYLHS 147 (613)
Q Consensus 106 lV~E~~~gGsL~-----~~------l---~~-~~~l--------se~~-----i~----------~i~~QIl~gL~yLHs 147 (613)
++++|++|..+. ++ + .+ ...+ .... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999885421 11 1 10 0001 0000 00 001112234444432
Q ss_pred -----CCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 148 -----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 148 -----~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...++||+|+.+.||+++. ++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~-~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDG-DSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEEC-CceEEEeeccccc
Confidence 2245999999999999984 4556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.16 E-value=0.22 Score=52.47 Aligned_cols=30 Identities=10% Similarity=0.146 Sum_probs=25.8
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
++||+|+.++||+++ .++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~-~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD-ETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEc-CCCCEEEEEhhhccc
Confidence 499999999999997 456899999998754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.33 Score=53.34 Aligned_cols=87 Identities=22% Similarity=0.217 Sum_probs=58.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeec-c-ccChHHHHHHHHHHHHHHhCC--CC-CcceeeeeeecCCCCEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-L-LRNSEDLERLYSEVHLLKTLK--HK-NIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~-~-~~~~~~~~~l~~Ei~iLk~L~--Hp-NIVkl~~~fv~~~~~~l~l 106 (613)
+.||-|...-||++.+...+..|.+|+-.-.- . ...+-..++..-|..+|+... -| .++++|.+ + .....+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D--~e~~~~ 110 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D--SVMNCC 110 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C--cHHhhH
Confidence 78899999999999885445678888754211 1 234566788888999998773 34 46667763 3 334567
Q ss_pred EEeccCCCC-HHHHHHh
Q 035992 107 ITEIFTSGT-LRQYRKK 122 (613)
Q Consensus 107 V~E~~~gGs-L~~~l~~ 122 (613)
|||+++... |++.+.+
T Consensus 111 vMEdL~~~~ilR~~Li~ 127 (409)
T PRK12396 111 VMEDLSDHTILRTALIN 127 (409)
T ss_pred HHHhCcccHHHHHHHHc
Confidence 999996533 4444433
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.36 E-value=0.14 Score=55.33 Aligned_cols=105 Identities=20% Similarity=0.250 Sum_probs=68.6
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+..+.|++|++. |+.+.- + +....+++..++++.+..++-+... .+.-||++..+||||+ .|+|.|+||-++
T Consensus 297 e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfkls 368 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLS 368 (488)
T ss_pred CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeee
Confidence 345667777775 334331 1 2235677888899888877777665 4799999999999997 689999999999
Q ss_pred HHHhhhccCcccccccCccccccccCccchhhhh
Q 035992 180 AILAQARSAHSVIEFMAPELYEEEYNELVDIYAF 213 (613)
Q Consensus 180 ~~l~~~~~~~gt~~YmAPEvl~~~ys~ksDIWSL 213 (613)
+ +...........+--|-.+.+.-+..-+||-+
T Consensus 369 R-l~~~q~~isy~rldhp~lF~G~dd~QFeIYrl 401 (488)
T COG5072 369 R-LSYSQGIISYNRLDHPDLFNGVDDYQFEIYRL 401 (488)
T ss_pred e-cccCCceeeccccCchhhhcCccceeeeHHHH
Confidence 8 33322222222333455555444555666643
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.42 Score=48.70 Aligned_cols=87 Identities=18% Similarity=0.251 Sum_probs=60.2
Q ss_pred HHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCC
Q 035992 72 ERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151 (613)
Q Consensus 72 ~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~ 151 (613)
..++.+..++.+++ .|+++.. .++..+.+|.|.|...... .. .++..=+.+|.-+|+.+..
T Consensus 103 ~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i~------------~~-N~i~agi~~L~~fH~~~~~ 163 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKIN------------FS-NFITAGIKDLMDFHSENQH 163 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCcccc------------hh-HHHHHhHHHHHHhhccCCC
Confidence 44577788887764 5677664 3556688899998642211 11 1222224667778977678
Q ss_pred EEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 152 VIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 152 IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
.+|+|-.|+||+.+ ..|.+||.|=+.
T Consensus 164 ~lHGD~np~NiM~D-~~G~lKlVDP~~ 189 (308)
T PF07387_consen 164 CLHGDCNPDNIMCD-KFGYLKLVDPVC 189 (308)
T ss_pred eecCCCChhheeec-CCCCEEecChhh
Confidence 99999999999998 678999998554
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.62 Score=51.03 Aligned_cols=79 Identities=14% Similarity=0.034 Sum_probs=43.4
Q ss_pred eeecccCceEEEEEEEcCC-CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFDELE-GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~t-g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l~lV~E 109 (613)
+.|..|-...+|++..... +..+.+|.|-+..........-.-.+|+.+++.+...++ .++++.|. -+++.|
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~------~g~l~e 129 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG------DFTIQE 129 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC------CEEEEE
Confidence 4555588899999864332 122222222111111111111123568999999975555 55666551 257899
Q ss_pred ccCCCCH
Q 035992 110 IFTSGTL 116 (613)
Q Consensus 110 ~~~gGsL 116 (613)
|+.|..|
T Consensus 130 fIeGr~l 136 (383)
T PTZ00384 130 WVEGNTM 136 (383)
T ss_pred EeccccC
Confidence 9988765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.34 E-value=1.9 Score=45.45 Aligned_cols=73 Identities=16% Similarity=0.111 Sum_probs=41.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCCcceeeeeeecCCCCEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK---HKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.|+.|....+|+.. .+++.+.+|+-. ......+..|..-|+.|. --.+.+.+.+....+ .-++|
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-------~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNS-------ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEE-------GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEEE
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecC-------hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceEE
Confidence 3778889999999985 667777766543 223346777888888873 334667777543332 34899
Q ss_pred EeccCCC
Q 035992 108 TEIFTSG 114 (613)
Q Consensus 108 ~E~~~gG 114 (613)
|||+..+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=88.99 E-value=2.2 Score=47.15 Aligned_cols=62 Identities=15% Similarity=0.173 Sum_probs=41.3
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhh-hcCCCCEEecCCCCCcEEEeCCC
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL-HSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yL-Hs~~~~IIHrDLKp~NILl~~~~ 168 (613)
..++-+|..|-++..+++..+ .+++..+.++.-.+.||--+ --.+ ++|.|+.|.||++.-+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEecC
Confidence 456777888888888876543 45556666655555554322 2234 99999999999996433
|
|
| >PF06631 DUF1154: Protein of unknown function (DUF1154); InterPro: IPR009535 This entry represents group a 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta conserved site | Back alignment and domain information |
|---|
Probab=87.34 E-value=0.95 Score=34.53 Aligned_cols=26 Identities=46% Similarity=0.630 Sum_probs=21.5
Q ss_pred HHHHHHHhHHHHHHHHHHHHHHHHHH
Q 035992 561 FEYLLVKQQNEVDELKRKHELAISDF 586 (613)
Q Consensus 561 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (613)
+.-|+-+||+||++|++||.-+.+.+
T Consensus 20 y~Kl~KKq~KEl~~lkKKh~Ke~~~m 45 (47)
T PF06631_consen 20 YVKLLKKQQKELEELKKKHQKERSSM 45 (47)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 45678999999999999998776543
|
; GO: 0004435 phosphatidylinositol phospholipase C activity, 0005509 calcium ion binding, 0006629 lipid metabolic process |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=87.19 E-value=0.16 Score=56.71 Aligned_cols=67 Identities=25% Similarity=0.491 Sum_probs=55.9
Q ss_pred EeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 30 ~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
....+|.|+||+|+.+..+.++..+|||.|... .......+..+|..-+..+.|++|++++..|...
T Consensus 53 ~~~~~~~~g~~~~~~~~n~~d~~~~avkritlk---n~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~ 119 (516)
T KOG1033|consen 53 PGQCLGRGGFGVVFSAQNKADENKYAVKRITLK---NREESRSRVLREVSSLAEFEHPGIKRYFHAWYER 119 (516)
T ss_pred ccccccccCccccCCccccccchhhHHHHhccc---chhhhhhhhhccccchhhhcccchhhheeceecC
Confidence 358899999999999999989889997766543 3456677888999999999999999999988543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=86.73 E-value=1.1 Score=46.54 Aligned_cols=29 Identities=24% Similarity=0.375 Sum_probs=24.6
Q ss_pred CCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 150 ~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
.++||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~--~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD--NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC--CcEEEEECcccc
Confidence 35999999999999984 578999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.63 E-value=0.5 Score=46.70 Aligned_cols=30 Identities=40% Similarity=0.598 Sum_probs=20.5
Q ss_pred EEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 152 IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
++|.|+.|.|||++..++.++|+||..|..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 999999999999944678999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 613 | ||||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-68 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-26 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-23 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-19 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-18 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-18 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-18 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-18 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-17 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-17 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-16 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-16 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-13 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-11 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-11 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-08 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-07 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 9e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-04 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 6e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-04 |
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 411 bits (1059), Expect = e-141
Identities = 136/286 (47%), Positives = 187/286 (65%), Gaps = 9/286 (3%)
Query: 7 SEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR 66
+ D ++ + + V + R+ ++ +GRG+FK VY+ D +EVAW +++ L
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-- 64
Query: 67 NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT--ENEHINFITEIFTSGTLRQYRKKHK 124
+ +R E +LK L+H NI++FY+SW T + I +TE+ TSGTL+ Y K+ K
Sbjct: 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK 124
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+ ++ L+ W RQIL+GL +LH+ PP+IHRDLKCDNIF+ G G VKIGDLGLA + +
Sbjct: 125 VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-R 183
Query: 185 ARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241
A A +VI EFMAPE+YEE+Y+E VD+YAFGMC+LE+ T EYPY EC NAAQIY++VT
Sbjct: 184 ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVT 243
Query: 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286
SG+KPAS KVA V+ IE CI ER K+LL F Q E
Sbjct: 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 71/277 (25%), Positives = 127/277 (45%), Gaps = 22/277 (7%)
Query: 24 SARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHL 80
+R Y+ +G G++ + + + +G + W K +D + + L SEV+L
Sbjct: 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVW---KELDYGSMTEAEKQMLVSEVNL 58
Query: 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSR 136
L+ LKH NI+++Y+ +D N + + E G L + K+ +++D + +
Sbjct: 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 137 QILEGLSYLHSHDPP---VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVI 192
Q+ L H V+HRDLK N+F++G VK+GD GLA IL S A + +
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 193 E---FMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
+M+PE YNE DI++ G L EL P+ + ++ K+ G K
Sbjct: 178 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRR 235
Query: 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
+ + + I + + + R +E+L +P +
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-54
Identities = 63/291 (21%), Positives = 116/291 (39%), Gaps = 26/291 (8%)
Query: 7 SEQDPDDSDAEFVEIDPSARYGRYK------EVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
S + + DPS ++ LG G++ +V++ + +G A +K
Sbjct: 32 SFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA---VK 88
Query: 61 VIDL-LRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ 118
R +D R +EV + + +H ++ +W E + TE +L+Q
Sbjct: 89 RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE--EGGILYLQTE-LCGPSLQQ 145
Query: 119 YRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177
+ + + + + R L L++LHS ++H D+K NIF+ G K+GD G
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPR-GRCKLGDFG 202
Query: 178 LAAILAQARSAHSVI---EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAA 234
L L A + +MAPEL + Y D+++ G+ +LE+
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ 262
Query: 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
Q+ + A L+ R+ + + + R A+ LL P L+
Sbjct: 263 QLRQGYLPPEFTAGLSSEL----RSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-54
Identities = 85/292 (29%), Positives = 134/292 (45%), Gaps = 21/292 (7%)
Query: 7 SEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL 64
S + ++ D E ++ Y VLG+G + VY D + +A IK I
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIA---IKEIPE 57
Query: 65 LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ-YRKKH 123
R+S + L+ E+ L K LKHKNI+++ S +EN I E G+L R K
Sbjct: 58 -RDSRYSQPLHEEIALHKHLKHKNIVQYLGS--FSENGFIKIFMEQVPGGSLSALLRSKW 114
Query: 124 KHVDLR--ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
+ + +++QILEGL YLH + ++HRD+K DN+ +N G +KI D G +
Sbjct: 115 GPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 182 LAQARS-AHSVI---EFMAPE---LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAA 234
LA + ++MAPE Y + DI++ G ++E+ T + P+ E
Sbjct: 173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ 232
Query: 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQS 285
KV + + +AFI KC + +R A +LL D FL+
Sbjct: 233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 9e-54
Identities = 70/291 (24%), Positives = 128/291 (43%), Gaps = 27/291 (9%)
Query: 6 TSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
+S D + F ++ +Y + +G G+F K +G + IK I+
Sbjct: 8 SSGVDLGTENLYFQSME------KYVRLQKIGEGSFGKAILVKSTEDGRQYV---IKEIN 58
Query: 64 LLRNSE-DLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK 122
+ R S + E EV +L +KH NI+++ S+ + N + + + G L +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINA 116
Query: 123 HKHVDL--RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
K V + W QI L ++H ++HRD+K NIF+ + G V++GD G+A
Sbjct: 117 QKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKD-GTVQLGDFGIAR 173
Query: 181 ILAQARS-AHSVI---EFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235
+L A + I +++PE+ E + YN DI+A G L EL T ++ + E +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKN 232
Query: 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
+ K+ SG ++ +R+ + + +R +L F+
Sbjct: 233 LVLKIISG-SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-52
Identities = 78/296 (26%), Positives = 141/296 (47%), Gaps = 25/296 (8%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI 59
P Q D + + ++ + +GRG F +VYRA L+G+ VA ++
Sbjct: 12 PVPQFQPQKALRPDMGYNTLA------NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL--- 116
++ DL+ +++ E+ LLK L H N+IK+Y S++ E+ +N + E+ +G L
Sbjct: 66 QIFDLM-DAKARADCIKEIDLLKQLNHPNVIKYYASFI--EDNELNIVLELADAGDLSRM 122
Query: 117 -RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175
+ ++K+ + + R + K+ Q+ L ++HS V+HRD+K N+F+ G VK+GD
Sbjct: 123 IKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITAT-GVVKLGD 179
Query: 176 LGLAAILAQARS-AHSVI---EFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPY-VE 229
LGL + + AHS++ +M+PE E YN DI++ G L E+ + P+ +
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 230 CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
N + KK+ P + +R + CI + +R +
Sbjct: 240 KMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 3e-52
Identities = 66/295 (22%), Positives = 115/295 (38%), Gaps = 47/295 (15%)
Query: 28 GRY------KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
GRY + LGRG F V+ A ++++ A IK I L E++ EV L
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYA---IKRIRLPNRELAREKVMREVKAL 57
Query: 82 KTLKHKNIIKFYNSWVDTENEHINF----------ITEIFTSGTLRQY---RKKHKHVDL 128
L+H I++++N+W++ ++ L+ + R + +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA 188
QI E + +LHS ++HRDLK NIF + VK+GD GL + Q
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEE 174
Query: 189 HSVIEF----------------MAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECT 231
+V+ M+PE Y+ VDI++ G+ L EL+ YP+
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQM 231
Query: 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIAEV-SERLPAKELLGDPFLQS 285
+ V + P + ++ ++ ER A ++ + +
Sbjct: 232 ERVRTLTDVRNLKFPPLFTQKYPC-EYVMVQDMLSPSPMERPEAINIIENAVFED 285
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-52
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
E++G G F +V++A ++G IK + E+ EV L L H NI+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYV---IKRVKYNN-----EKAEREVKALAKLDHVNIVH 68
Query: 92 FYNSWVD--------------TENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWS 135
+ W ++ + + E GTL Q+ +++ + +D +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI--- 192
QI +G+ Y+HS +I+RDLK NIF+ +VKIGD GL L
Sbjct: 129 EQITKGVDYIHSKK--LINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 193 EFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251
+M+PE + Y + VD+YA G+ L EL+ E ++ + + GI
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGIISDIF-- 240
Query: 252 VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGR 293
D + ++K ++ + +R E+L + + E R
Sbjct: 241 --DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 5e-52
Identities = 75/273 (27%), Positives = 127/273 (46%), Gaps = 20/273 (7%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
T + D + ++I KE +G G+F V+RA E G +VA +K++
Sbjct: 17 TTENLYFQGAMDGDDMDIPWCDL--NIKEKIGAGSFGTVHRA--EWHGSDVA---VKILM 69
Query: 64 LLRNSED-LERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--- 119
+ + EV ++K L+H NI+ F + N I +TE + G+L +
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI--VTEYLSRGSLYRLLHK 127
Query: 120 RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
+ +D R + + +G++YLH+ +PP++HR+LK N+ V+ VK+ D GL+
Sbjct: 128 SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLS 186
Query: 180 AILAQ-ARSAHSV---IEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAA 234
+ A S+ S E+MAPE+ E NE D+Y+FG+ L EL T + P+ A
Sbjct: 187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246
Query: 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKCIAE 267
+ + + + + V A IE C
Sbjct: 247 VVAAVGFKCKRL-EIPRNLNPQVAAIIEGCWTN 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 83/306 (27%), Positives = 134/306 (43%), Gaps = 49/306 (16%)
Query: 24 SARYG-RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
S RY ++ VLG+GAF +V +A + L+ A IK I E L + SEV L
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALDSRYYA---IKKIRH--TEEKLSTILSEVML 55
Query: 81 LKTLKHKNIIKFYNSWVDTENE-----------HINFITEIFTSGTLRQY-RKKHKHVDL 128
L +L H+ ++++Y +W++ N + E +GTL ++ +
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA 188
+ RQILE LSY+HS +IHRDLK NIF++ + VKIGD GLA + ++
Sbjct: 116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDI 172
Query: 189 HSVIEF------------------MAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYV 228
+ +A E+ + YNE +D+Y+ G+ E++ YP+
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFS 229
Query: 229 ECTNAAQIYKKVTSGIK--PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
I KK+ S P + I I + ++R A+ LL +L
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289
Query: 286 EDDESV 291
+ + V
Sbjct: 290 KHQDEV 295
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 4e-49
Identities = 62/252 (24%), Positives = 105/252 (41%), Gaps = 25/252 (9%)
Query: 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED------LERLYSEVHLLKT 83
Y++ +G+G F V++ + VA IK + L + + + EV ++
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVA---IKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGL 142
L H NI+K Y + + + E G L K + + I G+
Sbjct: 80 LNHPNIVKLYG--LMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLAAILAQARSAHS-VIEFMAP 197
Y+ + +PP++HRDL+ NIF+ K+ D GL+ + S ++MAP
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAP 195
Query: 198 ELYEEE---YNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGIKPASLAKV 252
E E Y E D Y+F M L ++T E P+ E + I G++P ++ +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP-TIPED 254
Query: 253 ADNGVRAFIEKC 264
+R IE C
Sbjct: 255 CPPRLRNVIELC 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 5e-49
Identities = 69/258 (26%), Positives = 109/258 (42%), Gaps = 19/258 (7%)
Query: 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE 77
+EID + +E++G G F KVYRA G EVA + S+ +E + E
Sbjct: 1 LLEIDFAEL--TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ 137
L LKH NII V + ++ + E G L + + + L W+ Q
Sbjct: 57 AKLFAMLKHPNIIALRG--VCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQ 113
Query: 138 ILEGLSYLHSHDP-PVIHRDLKCDNIFVNGNQGE-------VKIGDLGLAAILAQARSAH 189
I G++YLH P+IHRDLK NI + +KI D GLA +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 190 SV--IEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246
+ +MAPE+ +++ D++++G+ L EL+T E P+ A Y + +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233
Query: 247 ASLAKVADNGVRAFIEKC 264
+ +E C
Sbjct: 234 -PIPSTCPEPFAKLMEDC 250
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 9e-49
Identities = 67/254 (26%), Positives = 115/254 (45%), Gaps = 22/254 (8%)
Query: 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE 77
ID +EV+GRGAF V +A + +VA IK + + + + E
Sbjct: 2 LHMIDYKEI--EVEEVVGRGAFGVVCKA--KWRAKDVA---IKQ---IESESERKAFIVE 51
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY---RKKHKHVDLRALKKW 134
+ L + H NI+K Y + ++ + + E G+L + + W
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 135 SRQILEGLSYLHSHDP-PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS-VI 192
Q +G++YLHS P +IHRDLK N+ + +KI D G A + + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSA 167
Query: 193 EFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ-IYKKVTSGIKPASLA 250
+MAPE++E Y+E D++++G+ L E++T P+ E A I V +G +P L
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLI 226
Query: 251 KVADNGVRAFIEKC 264
K + + + +C
Sbjct: 227 KNLPKPIESLMTRC 240
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 1e-48
Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 35/272 (12%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQ---IKVIDLLRNSEDLERLY- 75
EI + +G G+F VY+ W+ +K++++ + + +
Sbjct: 20 EIPDGQI--TVGQRIGSGSFGTVYKGK---------WHGDVAVKMLNVTAPTPQQLQAFK 68
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKW 134
+EV +L+ +H NI+ F + + +T+ +L + +++ L
Sbjct: 69 NEVGVLRKTRHVNILLFMGY---STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDI 125
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--- 191
+RQ G+ YLH+ +IHRDLK +NIF++ + VKIGD GLA ++ +H
Sbjct: 126 ARQTARGMDYLHAK--SIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 192 ---IEFMAPELYEEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244
I +MAPE+ + Y+ D+YAFG+ L EL+T + PY N QI + V G
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS 242
Query: 245 KPASLAKVADN---GVRAFIEKCIAEVSERLP 273
L+KV N ++ + +C+ + + P
Sbjct: 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-47
Identities = 59/296 (19%), Positives = 108/296 (36%), Gaps = 26/296 (8%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI 59
P+ +E + V+ + +GRG+F +V+R D+ G + A +
Sbjct: 32 PETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA---V 88
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY 119
K + L + E+ L I+ Y + E +N E+ G+L Q
Sbjct: 89 KKVRLEVFRVE------ELVACAGLSSPRIVPLYGA--VREGPWVNIFMELLEGGSLGQL 140
Query: 120 RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
K+ + + Q LEGL YLH+ ++H D+K DN+ ++ + + D G A
Sbjct: 141 IKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 180 AILAQARSAHSVIE---------FMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVE 229
L S++ MAPE+ + + VDI++ +L ++ +P+ +
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 230 CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQ 284
K + + I++ E R A EL
Sbjct: 259 YFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-47
Identities = 65/269 (24%), Positives = 122/269 (45%), Gaps = 36/269 (13%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-LERLYSEV 78
+I E++G+G F +VY G EVA I++ID+ R++ED L+ EV
Sbjct: 29 DIPFEQL--EIGELIGKGRFGQVYHGR--WHG-EVA---IRLIDIERDNEDQLKAFKREV 80
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQ 137
+ +H+N++ F + H+ IT + TL R +D+ ++ +++
Sbjct: 81 MAYRQTRHENVVLFMGAC--MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------ 191
I++G+ YLH+ ++H+DLK N+F + G+V I D GL +I ++
Sbjct: 139 IVKGMGYLHAK--GILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 192 ---IEFMAPEL----------YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK 238
+ +APE+ + +++ D++A G EL E+P+ + A I
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEAIIW 253
Query: 239 KVTSGIKPASLAKVADNGVRAFIEKCIAE 267
++ +G+KP + + C A
Sbjct: 254 QMGTGMKPNLSQIGMGKEISDILLFCWAF 282
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 44/255 (17%), Positives = 99/255 (38%), Gaps = 17/255 (6%)
Query: 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLY- 75
+ ID + L ++++ +G ++ +KV+ + S R +
Sbjct: 3 KHSGIDFKQL--NFLTKLNENHSGELWKG--RWQGNDIV---VKVLKVRDWSTRKSRDFN 55
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKK 133
E L+ H N++ + H IT G+L + VD K
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE 193
++ + G+++LH+ +P + L ++ ++ + +I + ++
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSPGRMYA-PA 173
Query: 194 FMAPELYEEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL 249
++APE +++ D+++F + L ELVT E P+ + +N K G++P ++
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-TI 232
Query: 250 AKVADNGVRAFIEKC 264
V ++ C
Sbjct: 233 PPGISPHVSKLMKIC 247
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-46
Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 45/284 (15%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTL-KHKNI 89
E +G G F V++ L+G A IK L S D + EV+ L +H ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYA---IKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSYL 145
++++++W E++H+ E G+L + + + LK Q+ GL Y+
Sbjct: 74 VRYFSAWA--EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 146 HSHDPPVIHRDLKCDNIFVNGN------------------QGEVKIGDLGLAAILAQARS 187
HS ++H D+K NIF++ + KIGDLG + S
Sbjct: 132 HSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISS 186
Query: 188 AHSVI---EFMAPELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS 242
F+A E+ +E + DI+A + ++ E + ++
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP----RNGDQWHEIRQ 242
Query: 243 GIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
G P + +V ++ I + R A L+ L S
Sbjct: 243 GRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 6e-45
Identities = 56/283 (19%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKN-- 88
+ +G G KV++ +E + A IK ++L +++ L+ +E+ L L+ +
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
II+ Y+ + +++I + E + L + KK K +D K + + +LE + +H H
Sbjct: 71 IIRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 149 DPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILAQARSAHSVIE-------FMAPEL- 199
++H DLK N V+G +K+ D G+A + Q + V + +M PE
Sbjct: 128 G--IVHSDLKPANFLIVDGM---LKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 200 -----------YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
+ + + D+++ G L + + P+ + N +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241
Query: 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
+ + ++ ++ C+ + +R+ ELL P++Q +
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 8e-45
Identities = 56/283 (19%), Positives = 121/283 (42%), Gaps = 37/283 (13%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKN-- 88
+ +G G KV++ +E + A IK ++L +++ L+ +E+ L L+ +
Sbjct: 34 KQIGSGGSSKVFQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
II+ Y+ + +++I + E + L + KK K +D K + + +LE + +H H
Sbjct: 90 IIRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 149 DPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILAQARSAHSVIE-------FMAPELY 200
++H DLK N V+G +K+ D G+A + Q + V + +M PE
Sbjct: 147 G--IVHSDLKPANFLIVDGM---LKLIDFGIANQM-QPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 201 EEE------------YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
++ + D+++ G L + + P+ + N +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
+ + ++ ++ C+ + +R+ ELL P++Q +
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 59/322 (18%), Positives = 130/322 (40%), Gaps = 39/322 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKN-- 88
+ +G G KV++ +E + A IK ++L +++ L+ +E+ L L+ +
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYA---IKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
II+ Y+ + +++I + E + L + KK K +D K + + +LE + +H H
Sbjct: 118 IIRLYDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 149 DPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILAQARSAHSVIE-------FMAPELY 200
++H DLK N V+G +K+ D G+A + Q + V + +M PE
Sbjct: 175 G--IVHSDLKPANFLIVDGM---LKLIDFGIANQM-QPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 201 EEE------------YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
++ + D+++ G L + + P+ + N +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288
Query: 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSH 307
+ + ++ ++ C+ + +R+ ELL P++Q + + T +
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV--NQMAKGTTEEMKYVL 346
Query: 308 QANLDKNAYGSSAETGRDFTVQ 329
+ N+ S + +
Sbjct: 347 GQLVGLNSPNSILKAAKTLYEH 368
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 7e-42
Identities = 73/277 (26%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 21 IDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYS 76
+DP RY LG+G F K + D A K++ LL E++
Sbjct: 9 VDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQREKMSM 64
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR 136
E+ + ++L H++++ F+ + D N+ + + E+ +L + K+ K + + + R
Sbjct: 65 EISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR 122
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---- 192
QI+ G YLH + VIHRDLK N+F+N + EVKIGD GLA + V+
Sbjct: 123 QIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASL 249
++APE L ++ ++ VD+++ G + L+ P E + + Y ++ P +
Sbjct: 180 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSCLKETYLRIKKNEYSIPKHI 238
Query: 250 AKVADNGVRAFIEKCIAEV-SERLPAKELLGDPFLQS 285
+ I+K + + R ELL D F S
Sbjct: 239 NP----VAASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 78/320 (24%), Positives = 129/320 (40%), Gaps = 50/320 (15%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
M +D+++ + D Y EV+G GA V A+ + +VA IK
Sbjct: 1 MSEDSSALPWSINRD----------DYELQ-EVIGSGATAVVQAAYCAPKKEKVA---IK 46
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
I+L + ++ L E+ + H NI+ +Y S+V + + + ++ + G++
Sbjct: 47 RINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL--VMKLLSGGSVLDII 104
Query: 121 KKHKHVDLRALKKWS--------RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172
K R++LEGL YLH + IHRD+K NI + G V+
Sbjct: 105 KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQ 161
Query: 173 IGDLGLAAILAQARSAHSVIE---------FMAPELYEE--EYNELVDIYAFGMCLLELV 221
I D G++A LA +MAPE+ E+ Y+ DI++FG+ +EL
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 222 TFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV---------RAFIEKC-IAEVSER 271
T PY + + + + P SL + R I C + +R
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQND--PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 272 LPAKELLGDPFLQSEDDESV 291
A ELL F Q ++
Sbjct: 280 PTAAELLRHKFFQKAKNKEF 299
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 75/296 (25%), Positives = 131/296 (44%), Gaps = 27/296 (9%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI 59
+ P E + +DP RY LG+G F K + D A
Sbjct: 17 APGAPAAAPPAKEIPEVL-VDPR-SRRRYVRGRFLGKGGFAKCFEISDADTKEVFA---G 71
Query: 60 KVID--LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLR 117
K++ LL E++ E+ + ++L H++++ F+ + D N+ + + E+ +L
Sbjct: 72 KIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFVFVVLELCRRRSLL 129
Query: 118 QYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177
+ K+ K + + + RQI+ G YLH + VIHRDLK N+F+N + EVKIGD G
Sbjct: 130 ELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNED-LEVKIGDFG 186
Query: 178 LAAILAQARSAHSVI----EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTN 232
LA + V+ ++APE L ++ ++ VD+++ G + L+ P E +
Sbjct: 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV-GKPPFETSC 245
Query: 233 AAQIYKKVTSGI--KPASLAKVADNGVRAFIEKCIAEV-SERLPAKELLGDPFLQS 285
+ Y ++ P + + I+K + + R ELL D F S
Sbjct: 246 LKETYLRIKKNEYSIPKHINP----VAASLIQKMLQTDPTARPTINELLNDEFFTS 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 53/235 (22%), Positives = 98/235 (41%), Gaps = 28/235 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
++LG+GA V+R + G A IKV + + ++ E +LK L HKNI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL---RALKKWSRQILEGLSYLHS 147
K + +T H I E G+L ++ + R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 148 HDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILAQARSAHSVI---EFMAPELYE 201
+ ++HR++K NI + K+ D G A L S+ E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 202 ---------EEYNELVDIYAFGMCLLELVT----FEYPYVECTNAAQIYKKVTSG 243
++Y VD+++ G+ T F P+ ++ K+ +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITG 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 31/228 (13%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
PS + EVLG+G F + + G + +K + + E EV
Sbjct: 6 IFRPSDL--IHGEVLGKGCFGQAIKVTHRETGEVMV---MKELIRF-DEETQRTFLKEVK 59
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQI 138
+++ L+H N++KF V +++ +NFITE GTLR + +++ I
Sbjct: 60 VMRCLEHPNVLKFIG--VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF---- 194
G++YLHS + +IHRDL N V N V + D GLA ++ ++ +
Sbjct: 118 ASGMAYLHSMN--IIHRDLNSHNCLVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 195 --------------MAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
MAPE + Y+E VD+++FG+ L E++
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 76/287 (26%), Positives = 135/287 (47%), Gaps = 18/287 (6%)
Query: 5 TTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL 64
S + ++ DP + + E +G+G+F +V++ D VA IK+IDL
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKL-EKIGKGSFGEVFKGIDNRTQKVVA---IKIIDL 57
Query: 65 LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK 124
+++E + E+ +L + K+Y S++ ++ + I E G+ +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL--KDTKLWIIMEYLGGGSALDLLEPGP 115
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+D + R+IL+GL YLHS IHRD+K N+ ++ GEVK+ D G+A L
Sbjct: 116 -LDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTD 171
Query: 185 ARS-AHSVIE---FMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
+ ++ + +MAPE+ ++ Y+ DI++ G+ +EL E P+ E ++
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
Query: 240 VTSGIKPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQS 285
+ P +L ++ F+E C E S R AKELL F+
Sbjct: 232 PKN--NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 61/291 (20%), Positives = 113/291 (38%), Gaps = 54/291 (18%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKNII 90
+ +G+G + +V+ + G +VA +KV S E E++ ++H+NI+
Sbjct: 43 KQIGKGRYGEVWMG--KWRGEKVA---VKVFFTTEEASWFRET---EIYQTVLMRHENIL 94
Query: 91 KFYNSWVDTENEHINF--ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS- 147
F + + IT+ +G+L Y K +D +++ K + + GL +LH+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 148 -----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI--------EF 194
P + HRDLK NI V N G I DLGLA + + +
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 195 MAPELYEE-------EYNELVDIYAFGMCLLELVT----------FEYPYVECTNAAQIY 237
M PE+ +E + + D+Y+FG+ L E+ ++ PY + + Y
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272
Query: 238 KKVTSG---------IKPASLAKVADNGVRAFIEKCI-AEVSERLPAKELL 278
+ + + + + +C + RL A +
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 84/303 (27%), Positives = 143/303 (47%), Gaps = 39/303 (12%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
DP +Y R+ E +G+GA VY A D G EVA I+ ++L + E + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVA---IRQMNL-QQQPKKELIINEILVM 71
Query: 82 KTLKHKNIIKFYNS-------WVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKW 134
+ K+ NI+ + +S WV E +T++ T + + +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE----------GQIAAV 121
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS-AHSVIE 193
R+ L+ L +LHS+ VIHRD+K DNI + G VK+ D G A + +S +++
Sbjct: 122 CRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 194 ---FMAPEL-YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI----K 245
+MAPE+ + Y VDI++ G+ +E++ E PY+ +Y T+G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 246 PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAE 304
P L+ + R F+ +C+ +V +R AKELL FL+ S L + +
Sbjct: 239 PEKLSAI----FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294
Query: 305 TSH 307
+H
Sbjct: 295 NNH 297
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 54/293 (18%)
Query: 30 YKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKN 88
+E +G+G F +V+R + G EVA +K+ S E E++ L+H+N
Sbjct: 46 LQESIGKGRFGEVWRG--KWRGEEVA---VKIFSSREERSWFREA---EIYQTVMLRHEN 97
Query: 89 IIKFYNSWVDTENEHINF--ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
I+ F + +++ G+L Y ++ V + + K + GL++LH
Sbjct: 98 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLH 156
Query: 147 S------HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI-------- 192
P + HRDLK NI V N G I DLGLA A +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 193 EFMAPELYEE-------EYNELVDIYAFGMCLLELVT----------FEYPYVECT---- 231
+MAPE+ ++ E + DIYA G+ E+ ++ PY +
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 232 NAAQIYKKVTSG-----IKPASLAKVADNGVRAFIEKCI-AEVSERLPAKELL 278
+ ++ K V I + A + + +C A + RL A +
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 2e-39
Identities = 61/278 (21%), Positives = 111/278 (39%), Gaps = 31/278 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
++LG+GA V+R + G A IKV + + ++ E +LK L HKNI+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFA---IKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL---RALKKWSRQILEGLSYLHS 147
K + +T H I E G+L ++ + R ++ G+++L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 148 HDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILAQARSAHSVI---EFMAPELYE 201
+ ++HR++K NI + K+ D G A L S+ E++ P++YE
Sbjct: 131 NG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188
Query: 202 ---------EEYNELVDIYAFGMCLLELVT----FEYPYVECTNAAQIYKKVTSGIKPAS 248
++Y VD+++ G+ T F P+ ++ K+ +G +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITGKPSGA 247
Query: 249 LAKVAD--NGVRAFIEKCIAEVSERLPAKELLGDPFLQ 284
++ V NG + S + LL P L
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL-TPVLA 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 54/291 (18%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLKHKNII 90
E +G+G + +V+R +G VA +K+ S E E++ L+H+NI+
Sbjct: 14 ECVGKGRYGEVWRG--SWQGENVA---VKIFSSRDEKSWFRET---ELYNTVMLRHENIL 65
Query: 91 KFYNSWVDTENEHINF--ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS- 147
F S + + + IT G+L Y + +D + + I GL++LH
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIE 124
Query: 148 -----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI--------EF 194
P + HRDLK NI V N G+ I DLGLA + +Q+ + V +
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 195 MAPELYEE-------EYNELVDIYAFGMCLLELVT----------FEYPYVECTNAAQIY 237
MAPE+ +E + + VDI+AFG+ L E+ ++ P+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243
Query: 238 KKVTSG---------IKPASLAKVADNGVRAFIEKC-IAEVSERLPAKELL 278
+ + I + + +++C S RL A +
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 78/315 (24%), Positives = 137/315 (43%), Gaps = 47/315 (14%)
Query: 2 PQDTTSEQDPDDSDAEFVEI--------DPSARYGRYKEVLGRGAFKKVYRAFDELEGIE 53
+ Q + +F DP Y +G G+ V A ++ G +
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSY-VKIGEGSTGIVCLAREKHSGRQ 72
Query: 54 VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNS-------WVDTENEHINF 106
VA +K++DL R + E L++EV +++ +H N+++ Y S WV E
Sbjct: 73 VA---VKMMDL-RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166
+T+I + L + + + +L+ L+YLH+ VIHRD+K D+I +
Sbjct: 129 LTDIVSQVRLNEEQ----------IATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT- 175
Query: 167 NQGEVKIGDLGLAAILAQARS-AHSVIE---FMAPEL-YEEEYNELVDIYAFGMCLLELV 221
G VK+ D G A +++ S++ +MAPE+ Y VDI++ G+ ++E+V
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235
Query: 222 TFEYPYVECTNAAQIYKKVTSGI----KPASLAKVADNGVRAFIEKCIA-EVSERLPAKE 276
E PY + + + S ++ V +R F+E+ + + ER A+E
Sbjct: 236 DGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPV----LRDFLERMLVRDPQERATAQE 291
Query: 277 LLGDPFLQSEDDESV 291
LL PFL
Sbjct: 292 LLDHPFLLQTGLPEC 306
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-39
Identities = 75/299 (25%), Positives = 134/299 (44%), Gaps = 26/299 (8%)
Query: 7 SEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR 66
S + + + ++DP+ + LG GAF KVY+A ++ G A KVI+ +
Sbjct: 1 SMRKSREYEHVRRDLDPNEVWEIV-GELGDGAFGKVYKAKNKETGALAA---AKVIET-K 55
Query: 67 NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ-YRKKHKH 125
+ E+LE E+ +L T H I+K ++ + + + E G + + +
Sbjct: 56 SEEELEDYIVEIEILATCDHPYIVKLLGAYY--HDGKLWIMIEFCPGGAVDAIMLELDRG 113
Query: 126 VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185
+ ++ RQ+LE L++LHS +IHRDLK N+ + +G++++ D G++A +
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKT 170
Query: 186 RS-AHSVIE---FMAPE------LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235
S I +MAPE + + Y+ DI++ G+ L+E+ E P+ E
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
Query: 236 IYKKVTSGIKPASLAKVAD--NGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
+ K S P +L + R F++ R A +LL PF+ S
Sbjct: 231 LLKIAKSD--PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 51/274 (18%), Positives = 89/274 (32%), Gaps = 35/274 (12%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+ LG G F V +G A +K I +D E E + + H NI+
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYA---LKRILC-HEQQDREEAQREADMHRLFNHPNIL 89
Query: 91 KFYNSWVDTENE--HINFITEIFTSGTLRQY----RKKHKHVDLRALKKWSRQILEGLSY 144
+ + + F GTL + K + + I GL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----------- 193
+H+ HRDLK NI + G+ + DLG
Sbjct: 150 IHA--KGYAHRDLKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 194 --FMAPELYEEE----YNELVDIYAFGMCLL-ELVTFEYPY-VECTNAAQIYKKVTSGIK 245
+ APEL+ + +E D+++ G C+L ++ E PY + + V + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 246 PASLAKVADNGVRAFIEKCIAE-VSERLPAKELL 278
+ + + + + +R LL
Sbjct: 266 IPQSPRHSS-ALWQLLNSMMTVDPHQRPHIPLLL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 74/298 (24%), Positives = 138/298 (46%), Gaps = 23/298 (7%)
Query: 3 QDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
+ D + + P + E LG G++ VY+A + G VA IK +
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVL-EKLGEGSYGSVYKAIHKETGQIVA---IKQV 62
Query: 63 DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ-YRK 121
+ DL+ + E+ +++ +++K+Y S+ +N + + E +G++ R
Sbjct: 63 PV---ESDLQEIIKEISIMQQCDSPHVVKYYGSYF--KNTDLWIVMEYCGAGSVSDIIRL 117
Query: 122 KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
++K + + + L+GL YLH IHRD+K NI +N +G K+ D G+A
Sbjct: 118 RNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQ 174
Query: 182 LAQARS-AHSVIE---FMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI 236
L + ++VI +MAPE + E YN + DI++ G+ +E+ + PY + I
Sbjct: 175 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI 234
Query: 237 YKKVTSGIKPASLAKVAD--NGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
+ T+ P + K + F+++C + +R A +LL PF++S S+
Sbjct: 235 FMIPTNP--PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-38
Identities = 84/342 (24%), Positives = 156/342 (45%), Gaps = 41/342 (11%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
M D+ + + D+ D + DP+ + E++G G + +VY+ G A IK
Sbjct: 2 MASDSPA-RSLDEIDLSALR-DPAGIFEL-VELVGNGTYGQVYKGRHVKTGQLAA---IK 55
Query: 61 VIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHIN----FITEIFTSGT 115
V+D+ ++ E + E+++LK H+NI +Y +++ ++ + E +G+
Sbjct: 56 VMDV--TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS 113
Query: 116 LRQYRKKHKHVDLRALKKW----SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171
+ K K L+ ++W R+IL GLS+LH H VIHRD+K N+ + EV
Sbjct: 114 VTDLIKNTKGNTLK--EEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEV 168
Query: 172 KIGDLGLAAILAQARS-AHSVIE---FMAPE------LYEEEYNELVDIYAFGMCLLELV 221
K+ D G++A L + ++ I +MAPE + Y+ D+++ G+ +E+
Sbjct: 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228
Query: 222 TFEYPYVEC--TNA-AQIYKKVTSGIKPASLAKVADNGVRAFIEKC-IAEVSERLPAKEL 277
P + A I + +K +K ++FIE C + S+R ++L
Sbjct: 229 EGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF----QSFIESCLVKNHSQRPATEQL 284
Query: 278 LGDPFLQSEDDESVGRSLRVKTHYSAETSHQANLDKNAYGSS 319
+ PF++ + +E R +K H + D+ Y S
Sbjct: 285 MKHPFIRDQPNERQVRIQ-LKDHIDRTKKKRGEKDETEYEYS 325
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 76/303 (25%), Positives = 132/303 (43%), Gaps = 30/303 (9%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV 61
S +DPD ++ F + DP + +G G+F VY A D VA IK
Sbjct: 32 GGRAGSLKDPDVAELFFKD-DPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVA---IKK 86
Query: 62 IDLLRNS--EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY 119
+ E + + EV L+ L+H N I++ ++ + E
Sbjct: 87 MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL--REHTAWLVMEYCLGSASDLL 144
Query: 120 RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
K + + + L+GL+YLHSH+ +IHRD+K NI ++ G VK+GD G A
Sbjct: 145 EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSA 201
Query: 180 AILAQARSAHSVIE---FMAPE----LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTN 232
+I+A A+S + +MAPE + E +Y+ VD+++ G+ +EL + P
Sbjct: 202 SIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258
Query: 233 AAQIYKKVTSG---IKPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDD 288
+ +Y + ++ ++ R F++ C +R ++ LL F+ E
Sbjct: 259 MSALYHIAQNESPALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314
Query: 289 ESV 291
+V
Sbjct: 315 PTV 317
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 61/302 (20%), Positives = 128/302 (42%), Gaps = 31/302 (10%)
Query: 3 QDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
T Q + + +G G +V++ G +A +K +
Sbjct: 12 YLTIGGQRYQAEINDLENL----------GEMGSGTCGQVWKMRFRKTGHVIA---VKQM 58
Query: 63 DLLRNSEDLERLYSEVH-LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRK 121
N E+ +R+ ++ +LK+ I++ + +++ N + E+ + + ++
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELMGTCAEKLKKR 116
Query: 122 KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
+ R L K + I++ L YL VIHRD+K NI ++ +G++K+ D G++
Sbjct: 117 MQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLD-ERGQIKLCDFGISGR 174
Query: 182 LAQARSAHSVI---EFMAPE------LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTN 232
L ++ +MAPE + +Y+ D+++ G+ L+EL T ++PY C
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
Query: 233 AAQIYKKVTSGIKPASLAKVAD--NGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDE 289
++ KV +P L ++F++ C + +R +LL F++ +
Sbjct: 235 DFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293
Query: 290 SV 291
V
Sbjct: 294 EV 295
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 22/274 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNII 90
LGRGA+ V + G +A +K I NS++ +RL ++ ++T+ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMA---VKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 91 KFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
FY + + E +L +Q K + + L K + I++ L +LH
Sbjct: 70 TFYGALFR--EGDVWICME-LMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE----- 198
S VIHRD+K N+ +N G+VK+ D G++ L + +MAPE
Sbjct: 127 S-KLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258
L ++ Y+ DI++ G+ ++EL +PY Q K+V P A
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244
Query: 259 AFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
F +C ER EL+ PF + +
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFFTLHESKGT 278
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 147 bits (371), Expect = 2e-37
Identities = 71/283 (25%), Positives = 109/283 (38%), Gaps = 29/283 (10%)
Query: 23 PSARYGRY--KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
P+ G + KE LG G F V R + G +VA IK + ++ ER E+ +
Sbjct: 9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVA---IKQCRQELSPKNRERWCLEIQI 65
Query: 81 LKTLKHKNIIKFY----NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL---RALKK 133
+K L H N++ N+ E G LR+Y + ++ ++
Sbjct: 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNI--FVNGNQGEVKIGDLGLAAILAQARSAHSV 191
I L YLH + +IHRDLK +NI + KI DLG A L Q
Sbjct: 126 LLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 192 I---EFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247
+ +++APEL E ++Y VD ++FG E +T P++ Q + KV
Sbjct: 184 VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243
Query: 248 SLAKVADNGVRAFIE---------KCIAEVSERLPAKELLGDP 281
+ G F +A ER L+
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQ 286
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 70/276 (25%), Positives = 126/276 (45%), Gaps = 26/276 (9%)
Query: 22 DPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSE 77
+ +K +LG+G+F VYRA G+EVA IK+ID + + ++R+ +E
Sbjct: 5 CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNE 61
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSR 136
V + LKH +I++ YN + D+ + + E+ +G + +Y + + K + +
Sbjct: 62 VKIHCQLKHPSILELYNYFEDSNY--VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---- 192
QI+ G+ YLHSH ++HRDL N+ + N +KI D GLA L H +
Sbjct: 120 QIITGMLYLHSHG--ILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASL 249
+++PE + D+++ G L+ P+ + KV P+ L
Sbjct: 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPSFL 235
Query: 250 AKVADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQ 284
+ A + I + + ++RL +L PF+
Sbjct: 236 SIEA----KDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 72/334 (21%), Positives = 128/334 (38%), Gaps = 64/334 (19%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
T ++ + D +F +I LG G V++ + G+ +A K+I
Sbjct: 21 LTQKQKVGELKDDDFEKI----------SELGAGNGGVVFKVSHKPSGLVMA---RKLIH 67
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
L ++ E+ +L I+ FY ++ + I+ E G+L Q KK
Sbjct: 68 LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKA 125
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+ + L K S +++GL+YL ++HRD+K NI VN ++GE+K+ D G++ L
Sbjct: 126 GRIPEQILGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLI 183
Query: 184 QARSAHSVI---EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
+ A+S + +M+PE L Y+ DI++ G+ L+E+ YP
Sbjct: 184 DSM-ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 240 VTSGIKPASLAKVADNGV-----------------------------------------R 258
A+ +
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 259 AFIEKCI-AEVSERLPAKELLGDPFLQSEDDESV 291
F+ KC+ +ER K+L+ F++ D E V
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 57/242 (23%), Positives = 92/242 (38%), Gaps = 39/242 (16%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK- 85
R + VL G F VY A D G E A +K + E + EV +K L
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYA---LKRLLS-NEEEKNRAIIQEVCFMKKLSG 84
Query: 86 HKNIIKFYNSWVDTENEHIN-----FITEIFTSGTLRQYRKKHKHVDL----RALKKWSR 136
H NI++F ++ + E + G L ++ KK + LK
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK-IFY 143
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE--- 193
Q + ++H PP+IHRDLK +N+ ++ G +K+ D G A ++ +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 194 -------------FMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI 236
+ PE+ + E DI+A G L L ++P+ E +I
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-EDGAKLRI 261
Query: 237 YK 238
Sbjct: 262 VN 263
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 2e-35
Identities = 52/287 (18%), Positives = 103/287 (35%), Gaps = 30/287 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
E+ A+ V A+ + + E E+ L + ++ ++
Sbjct: 54 EVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR 113
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR---ALKKWSR 136
+ KN + +I ++ L+ + + ++ R
Sbjct: 114 RMDPFSTKNTVGQLQPSSPKVYLYI--QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFI 171
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF-- 194
QI E + +LHS ++HRDLK NIF + VK+GD GL + Q +V+
Sbjct: 172 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 195 --------------MAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
M+PE Y+ VDI++ G+ L EL+ Y + +I
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQMERVRIITD 285
Query: 240 VTSGIKPASLAKVADNGVRAFIEKCIAEV-SERLPAKELLGDPFLQS 285
V + P + ++ ++ +ER A +++ + ++
Sbjct: 286 VRNLKFPLLFTQKYPQ-EHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 60/278 (21%), Positives = 123/278 (44%), Gaps = 26/278 (9%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNII 90
+GRGA+ V + + G +A +K I + ++ ++L ++ ++++ I+
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMA---VKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLR----ALKKWSRQILEGLSYLH 146
+FY + E+ ++ + Y+ + +D L K + ++ L++L
Sbjct: 85 QFYGALFR--EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE----- 198
+ +IHRD+K NI ++ G +K+ D G++ L + + +MAPE
Sbjct: 143 E-NLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG-- 256
+ Y+ D+++ G+ L EL T +PY + + +V G P L+ +
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFS 259
Query: 257 --VRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
F+ C + S+R KELL PF+ ++ +V
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 77/301 (25%), Positives = 125/301 (41%), Gaps = 36/301 (11%)
Query: 6 TSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL 65
+ EQD D + V + + K+VLG GA + + +VA +K I
Sbjct: 6 SLEQDDGDEETSVVIVG-KISFCP-KDVLGHGAEGTIVYR-GMFDNRDVA---VKRILP- 58
Query: 66 RNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKK 122
E EV LL+ +H N+I+++ + D + ++I E + TL++Y +K
Sbjct: 59 ---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYI--AIE-LCAATLQEYVEQKD 112
Query: 123 HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGL 178
H+ L +Q GL++LHS + ++HRDLK NI ++ I D GL
Sbjct: 113 FAHLGLEP-ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL 169
Query: 179 AAILAQARSAHSVIE-------FMAPELYEEE----YNELVDIYAFGMCLLELVTFEY-P 226
LA R + S ++APE+ E+ VDI++ G +++ P
Sbjct: 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 227 YVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
+ + + K D R IEK IA + +R AK +L PF S
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289
Query: 286 E 286
Sbjct: 290 L 290
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 67/261 (25%), Positives = 121/261 (46%), Gaps = 23/261 (8%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLLKTLKHKNII 90
LG+G F VY A ++ +A +KV+ L + +L EV + L+H NI+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILA---LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 72
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
+ Y + D + I E GT+ + +K D + + ++ LSY HS
Sbjct: 73 RLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR- 129
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPELYEE-EYNE 206
VIHRD+K +N+ + G+ GE+KI D G + +R + ++++ PE+ E ++E
Sbjct: 130 -VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDE 186
Query: 207 LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IK-PASLAKVADNGVRAFIEKC 264
VD+++ G+ E + P E + YK+++ P + G R I +
Sbjct: 187 KVDLWSLGVLCYEFLV-GKPPFEANTYQETYKRISRVEFTFPDFV----TEGARDLISRL 241
Query: 265 I-AEVSERLPAKELLGDPFLQ 284
+ S+R +E+L P++
Sbjct: 242 LKHNPSQRPMLREVLEHPWIT 262
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 48/323 (14%), Positives = 99/323 (30%), Gaps = 50/323 (15%)
Query: 11 PDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL--LRN 67
P +++ + R + E L G V+ D + A +KV + +
Sbjct: 46 PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA---LKVFTMGAENS 102
Query: 68 SEDLERLYSEVHLLKTLKHKN------------------------IIKFYNSWVDTENEH 103
+LERL+ L ++ + D +
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162
Query: 104 INFITEIFTS------GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL 157
+ + TL + AL + Q++ + L S ++H
Sbjct: 163 YLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVHGHF 220
Query: 158 KCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELY----EEEYNELVDIYAF 213
DN+F+ + G + +GD+ + A SV AP + + ++ +
Sbjct: 221 TPDNLFIMPD-GRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQL 279
Query: 214 GMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN------GVRAFIEKCIA- 266
G+ + + P+ T + K S P + + + V+ I + +
Sbjct: 280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339
Query: 267 EVSERLPAKELLGDPFLQSEDDE 289
+ RL E + P +E
Sbjct: 340 DRRRRLLPLEAMETPEFLQLQNE 362
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 53/335 (15%), Positives = 99/335 (29%), Gaps = 62/335 (18%)
Query: 4 DTTSEQDPDDSDAEF-VEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
D+ ++ F VE + R VLG+ A D+ G +
Sbjct: 48 DSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VH 104
Query: 61 VIDL--LRNSEDLERLYSEVHLLKTLK-------------------------HKNIIKFY 93
V S ++++ EV L+ L+ K +I+
Sbjct: 105 VPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164
Query: 94 NSWVDTENEHINFITEIFTS------GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
D F+ S L + HK + A + + Q++ L+ LH
Sbjct: 165 LDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 224
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYEEE---- 203
+ ++H L+ +I ++ G V + + F PEL
Sbjct: 225 YG--LVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATIS 281
Query: 204 --------YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
D +A G+ + + + P + A + + K
Sbjct: 282 YHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWIFRSCKNIP------Q 334
Query: 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289
VRA +E + +RL + + P + E
Sbjct: 335 PVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 58/366 (15%), Positives = 116/366 (31%), Gaps = 72/366 (19%)
Query: 22 DPSARYGRYKEVLGRGA--FKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEV 78
Y V+G+G V A + G V ++ I+L S E + L E+
Sbjct: 22 PEGGCY-ELLTVIGKGFEDLMTVNLARYKPTGEYVT---VRRINLEACSNEMVTFLQGEL 77
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL--RALKKWSR 136
H+ K H NI+ + +++ + + +T G+ + H + A+ +
Sbjct: 78 HVSKLFNHPNIVPYRATFI--ADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF-- 194
+L+ L Y+H +HR +K +I ++ + G+V + L + V+
Sbjct: 136 GVLKALDYIHHMG--YVHRSVKASHILISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 195 ---------MAPELYEE---EYNELVDIYAFGMCLLELVTFEYPY--------------- 227
++PE+ ++ Y+ DIY+ G+ EL P+
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252
Query: 228 ------------VECTNAAQIYKKVTSGIKPASLAKVADNGV----------------RA 259
E + SG+ +
Sbjct: 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312
Query: 260 FIEKC-IAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSHQANLDKNAYGS 318
F+E+C R A LL F + + + + T+ + + ++ G
Sbjct: 313 FVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGI 372
Query: 319 SAETGR 324
Sbjct: 373 FGLVTN 378
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 75/272 (27%), Positives = 133/272 (48%), Gaps = 20/272 (7%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL--LRNSEDLERLYSEVHLLKTLKHKN 88
+ VLG+G+F +V D++ G E A +KVI ++ D E L EV LLK L H N
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECA---VKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
I+K Y + D ++ + E++T G L K + RQ+L G++Y+H +
Sbjct: 88 IMKLYEFFEDKGYFYL--VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 149 DPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMAPELYEEE 203
++HRDLK +N+ + ++ ++I D GL+ ++ I ++APE+
Sbjct: 146 K--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 203
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADNGVRAF 260
Y+E D+++ G+ L L++ P+ I KKV G + KV+++ +
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNGANE-YDILKKVEKGKYTFELPQWKKVSES-AKDL 261
Query: 261 IEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291
I K + S R+ A++ L ++Q+ E +
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQI 293
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 59/237 (24%), Positives = 97/237 (40%), Gaps = 33/237 (13%)
Query: 13 DSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE 72
D E + + EV RG F V++A +L VA +K+ +
Sbjct: 13 DLGTENLYFQSMPL--QLLEVKARGRFGCVWKA--QLLNEYVA---VKI--FPIQDKQSW 63
Query: 73 RLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF--ITEIFTSGTLRQYRKKHKHVDLRA 130
+ EV+ L +KH+NI++F + + ++ IT G+L + K + V
Sbjct: 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNE 122
Query: 131 LKKWSRQILEGLSYLHS--------HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182
L + + GL+YLH H P + HRD+K N+ + N I D GLA
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF 181
Query: 183 AQARSAHSVI------EFMAPEL------YEEEYNELVDIYAFGMCLLELVTFEYPY 227
+SA +MAPE+ ++ + +D+YA G+ L EL +
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 65/261 (24%), Positives = 127/261 (48%), Gaps = 23/261 (8%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLLKTLKHKNII 90
LG+G F VY A ++ +A +KV+ L +L E+ + L+H NI+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMA---LKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNIL 77
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
+ YN + D + I + E G L + +KH D + + ++ + L Y H
Sbjct: 78 RMYNYFHDRKR--IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK- 134
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPELYE-EEYNE 206
VIHRD+K +N+ + G +GE+KI D G + R ++ ++++ PE+ E + ++E
Sbjct: 135 -VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEGKTHDE 191
Query: 207 LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IK-PASLAKVADNGVRAFIEKC 264
VD++ G+ E + P+ + + + ++++ + +K P L +G + I K
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL----SDGSKDLISKL 246
Query: 265 I-AEVSERLPAKELLGDPFLQ 284
+ +RLP K ++ P+++
Sbjct: 247 LRYHPPQRLPLKGVMEHPWVK 267
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-33
Identities = 67/270 (24%), Positives = 131/270 (48%), Gaps = 19/270 (7%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNI 89
+ LG GA+ +V D++ +E A IK+I ++ +L EV +LK L H NI
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERA---IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+K Y+ + D N ++ + E + G L + +Q+L G++YLH H+
Sbjct: 99 MKLYDFFEDKRNYYL--VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 150 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMAPELYEEEY 204
++HRDLK +N+ + + +KI D GL+A+ + + ++APE+ ++Y
Sbjct: 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADNGVRAFI 261
+E D+++ G+ L L+ P+ T+ +I +KV G V++ + I
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFDSPEWKNVSEG-AKDLI 272
Query: 262 EKCIA-EVSERLPAKELLGDPFLQSEDDES 290
++ + + R+ A++ L P+++ +
Sbjct: 273 KQMLQFDSQRRISAQQALEHPWIKEMCSKK 302
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 73/270 (27%), Positives = 130/270 (48%), Gaps = 19/270 (7%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNI 89
+LG+G+F +V + D + E A +KVI+ ++D + EV LLK L H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+K + D+ + +I + E++T G L K K + +Q+ G++Y+H H+
Sbjct: 84 MKLFEILEDSSSFYI--VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 150 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMAPELYEEEY 204
++HRDLK +NI + + ++KI D GL+ Q I ++APE+ Y
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADNGVRAFI 261
+E D+++ G+ L L++ P+ I K+V +G ++D+ + I
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYAFDLPQWRTISDD-AKDLI 257
Query: 262 EKCIA-EVSERLPAKELLGDPFLQSEDDES 290
K + S R+ A + L P++Q E+
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKYSSET 287
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 29/249 (11%)
Query: 9 QDPDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVID 63
+ P+ + + E + + +VLG GAF VY+ E I VA IK +
Sbjct: 2 EAPNQALLRILKETEF-----KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELR 53
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
+ + + + E +++ ++ + ++ + + + IT++ G L Y ++H
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLG--ICLT-STVQLITQLMPFGCLLDYVREH 110
Query: 124 K-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182
K ++ + L W QI +G++YL ++HRDL N+ V Q VKI D GLA +L
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167
Query: 183 AQARSAHSV------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAA 234
+ I++MA E + Y D++++G+ + EL+TF PY +
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-S 226
Query: 235 QIYKKVTSG 243
+I + G
Sbjct: 227 EISSILEKG 235
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 31/290 (10%)
Query: 20 EIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-------LLRNSED 70
+ P A Y + LG GA +V AF+ +VA I++I R ++
Sbjct: 127 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA---IRIISKRKFAIGSAREADP 183
Query: 71 LERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA 130
+ +E+ +LK L H IIK N D E+ +I + E+ G L +K +
Sbjct: 184 ALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYI--VLELMEGGELFDKVVGNKRLKEAT 240
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILAQARSA 188
K + Q+L + YLH + +IHRDLK +N+ + +KI D G + IL +
Sbjct: 241 CKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 189 HSVI---EFMAPE----LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241
++ ++APE + YN VD ++ G+ L ++ P+ E + ++T
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
Query: 242 SGI---KPASLAKVADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQSED 287
SG P A+V++ ++K + + R +E L P+LQ ED
Sbjct: 359 SGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 65/271 (23%), Positives = 123/271 (45%), Gaps = 31/271 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
K LG GAF V+ + G+E IK I+ R+ +E++ +E+ +LK+L H NII
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 91 KFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
K + + D N +I + E G L + + K + + + +Q++ L+Y H
Sbjct: 84 KIFEVFEDYHNMYI--VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 147 SHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMAPELYE 201
S V+H+DLK +NI F + + +KI D GLA + + + +MAPE+++
Sbjct: 142 SQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK 199
Query: 202 EEYNELVDIYAFGMCLLELVTFEYP--YVECTNAAQIYKKVTSGI-----KPASLAKVAD 254
+ DI++ G+ + L+T + ++ +K T + L A
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLT-GCLPFTGT--SLEEVQQKATYKEPNYAVECRPLTPQA- 255
Query: 255 NGVRAFIEKCI-AEVSERLPAKELLGDPFLQ 284
+++ + + R A ++L + +
Sbjct: 256 ---VDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 44/326 (13%), Positives = 88/326 (26%), Gaps = 61/326 (18%)
Query: 11 PDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN- 67
R VLG+ A D+ G + V
Sbjct: 62 NTGQPFRVESEL-GERPRTLVRGTVLGQEDPYAYLEATDQETGESFE---VHVPYFTERP 117
Query: 68 -SEDLERLYSEVHLLKTL----------------------KHKNIIKFYNSWVDTENEHI 104
S ++++ EV L+ L K K +D + +
Sbjct: 118 PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWV 177
Query: 105 NFITEIFTS---------GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHR 155
++ L + HK + A + + Q++ L+ LH + ++H
Sbjct: 178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--LVHT 235
Query: 156 DLKCDNIFVNGNQGEVKIGDLGLAAILAQAR--SAHSVI---EFMAPELY------EEEY 204
L+ +I ++ G V + + E A +
Sbjct: 236 YLRPVDIVLDQR-GGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLM 294
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264
D + G+ + + + P + A + + K VRA +E
Sbjct: 295 TFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRSCKNIPQP------VRALLEGF 347
Query: 265 IA-EVSERLPAKELLGDPFLQSEDDE 289
+ +RL + + P + E
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTE 373
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 59/280 (21%), Positives = 121/280 (43%), Gaps = 24/280 (8%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
D + Y + +GRG++ +V A + I A K I ED++R E+ ++
Sbjct: 6 DINQYY-TLENTIGRGSWGEVKIAVQKGTRIRRA---AKKIPK-YFVEDVDRFKQEIEIM 60
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
K+L H NII+ Y ++ D + ++ + E+ T G L + + + + +L
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYL--VMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 142 LSYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMA 196
++Y H + V HRDLK +N F+ + +K+ D GLAA + + + +++
Sbjct: 119 VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 197 PELYEEEYNELVDIYAFGMCLLELVTFEYP--YVECTNAAQIYKKVTSGI---KPASLAK 251
P++ E Y D ++ G+ + L+ YP +++ K+ G
Sbjct: 177 PQVLEGLYGPECDEWSAGVMMYVLLC-GYPPFSAP--TDSEVMLKIREGTFTFPEKDWLN 233
Query: 252 VADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQSEDDES 290
V+ + I + + +R+ + + L + + + S
Sbjct: 234 VSPQ-AESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 56/222 (25%), Positives = 95/222 (42%), Gaps = 41/222 (18%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL-RNSEDLERLYSEVHLLKTLKHKNII 90
E++GRG + VY+ L+ VA +KV R + E+ ++ + ++H NI
Sbjct: 19 ELIGRGRYGAVYKG--SLDERPVA---VKVFSFANRQNFINEK---NIYRVPLMEHDNIA 70
Query: 91 KFYNSWV-DTENEHINF--ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
+F T + + + + E + +G+L +Y H D + + + + GL+YLH+
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHT 129
Query: 148 -------HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--------- 191
+ P + HRDL N+ V + G I D GL+ L R
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 192 ---IEFMAPELYE--------EEYNELVDIYAFGMCLLELVT 222
I +MAPE+ E E + VD+YA G+ E+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 22 DPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEV 78
D G Y+ + +G+G F KV A L G EVA IK+ID + N L++L+ EV
Sbjct: 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVA---IKIIDKTQLNPTSLQKLFREV 65
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQI 138
++K L H NI+K + +TE + I E + G + Y H + + + RQI
Sbjct: 66 RIMKILNHPNIVKLFEVI-ETEK-TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFM 195
+ + Y H ++HRDLK +N+ ++ + +KI D G + + +
Sbjct: 124 VSAVQYCHQKR--IVHRDLKAENLLLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180
Query: 196 APELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244
APEL++ ++Y+ VD+++ G+ L LV+ P+ N ++ ++V G
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ-NLKELRERVLRGK 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 66/254 (25%), Positives = 111/254 (43%), Gaps = 25/254 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRA----FDELEGIEVAWNQIKVIDLLRNSEDLER-L 74
+ R+ +Y LG+G F V + G VA +K L + D +R
Sbjct: 19 IFEE--RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVA---VKQ--LQHSGPDQQRDF 71
Query: 75 YSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKK 133
E+ +LK L I+K+ + + + E SG LR + ++H+ +D L
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-- 191
+S QI +G+ YL S +HRDL NI V ++ VKI D GLA +L + + V
Sbjct: 132 YSSQICKGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKDYYVVRE 188
Query: 192 -----IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGI 244
I + APE L + ++ D+++FG+ L EL T+ + ++
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248
Query: 245 KPASLAKVADNGVR 258
+ L ++ + G R
Sbjct: 249 ALSRLLELLEEGQR 262
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 57/241 (23%), Positives = 107/241 (44%), Gaps = 32/241 (13%)
Query: 24 SARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID---LLRNSEDLERLYSEV 78
+ G+Y ++LG G++ KV D A +K++ L R + E+
Sbjct: 1 AKLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRA---VKILKKKKLRRIPNGEANVKKEI 57
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT--LRQYRKKHKHVDLRALKKWSR 136
LL+ L+HKN+I+ + + E + + + E G + + + +A +
Sbjct: 58 QLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-C 116
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR---------- 186
Q+++GL YLHS ++H+D+K N+ + G +KI LG+A L
Sbjct: 117 QLIDGLEYLHSQG--IVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 187 SAHSVIEFMAPELY--EEEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
S F PE+ + ++ VDI++ G+ L + T YP+ E N ++++ + G
Sbjct: 174 SPA----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKG 228
Query: 244 I 244
Sbjct: 229 S 229
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 8e-31
Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 43/255 (16%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRA----FDELEGIEVAWNQIKVI--DLLRNSEDLER 73
+ + R+ ++ + LG+G F V + G VA +K + + D ER
Sbjct: 6 QFEE--RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA---VKKLQHSTEEHLRDFER 60
Query: 74 LYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALK 132
E+ +LK+L+H NI+K+ ++ I E G+LR Y +KHK +D L
Sbjct: 61 ---EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 133 KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV- 191
+++ QI +G+ YL + IHRDL NI V N+ VKIGD GL +L Q + V
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVK 174
Query: 192 ------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF----------------EYPYV 228
I + APE L E +++ D+++FG+ L EL T+
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 234
Query: 229 ECTNAAQIYKKVTSG 243
+ + + + +
Sbjct: 235 QMIV-FHLIELLKNN 248
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 65/233 (27%), Positives = 116/233 (49%), Gaps = 22/233 (9%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRA----FDELEGIEVAWNQI 59
D SE+ P ++ + + R+ + LG G F KV + G +VA +
Sbjct: 2 DIVSEKKPA-TEVDPTHFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVA---V 55
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY 119
K + + L E+ +L+ L H+NI+K+ + I I E SG+L++Y
Sbjct: 56 KSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY 115
Query: 120 RKKHKH-VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
K+K+ ++L+ K++ QI +G+ YL S +HRDL N+ V ++ +VKIGD GL
Sbjct: 116 LPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGL 172
Query: 179 AAILAQARSAHSV-------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF 223
+ + ++V + + APE L + ++ D+++FG+ L EL+T+
Sbjct: 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 80/289 (27%), Positives = 126/289 (43%), Gaps = 40/289 (13%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRA----FDELEGIEVAW 56
Q D +F R+ ++ + LG+G F V + G VA
Sbjct: 21 YFQGAMGSAFEDRDPTQF-----EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVA- 74
Query: 57 NQIKVIDLLRNS--EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSG 114
+K L++S E L E+ +LK+L+H NI+K+ ++ I E G
Sbjct: 75 --VKK---LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 115 TLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173
+LR Y +KHK +D L +++ QI +G+ YL + IHRDL NI V N+ VKI
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKI 186
Query: 174 GDLGLAAILAQARSAHSV-------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEY 225
GD GL +L Q + + V I + APE L E +++ D+++FG+ L EL T
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT--- 243
Query: 226 PYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPA 274
Y+E + + G V + ++ + RLP
Sbjct: 244 -YIEKSKSPPAEFMRMIGNDKQGQMIVFH--LIELLKN-----NGRLPR 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-30
Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 30/282 (10%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID------------LLRNSEDLERLYSEV 78
LG GA+ +V ++ E A IKVI + E +Y+E+
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKA---IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQI 138
LLK+L H NIIK ++ + D + ++ +TE + G L + D +QI
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYL--VTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---E 193
L G+ YLH H+ ++HRD+K +NI N N +KI D GL++ ++ +
Sbjct: 156 LSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213
Query: 194 FMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLA 250
++APE+ +++YNE D+++ G+ + L+ P+ + I KKV G
Sbjct: 214 YIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEKGKYYFDFNDWK 272
Query: 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291
++D + I+ + + ++R A+E L +++ +
Sbjct: 273 NISDE-AKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 65/320 (20%), Positives = 111/320 (34%), Gaps = 69/320 (21%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID----LLRNSEDLERLYSEVHLLKTLKH 86
K +G+G++ V A + A IK+++ N +D+ER+ +EV L+K L H
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRA---IKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS----------- 135
NI + Y + D + + + E+ G L
Sbjct: 88 PNIARLYEVYEDEQYICL--VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 136 -----------------------------RQILEGLSYLHSHDPPVIHRDLKCDNI-FVN 165
RQI L YLH+ + HRD+K +N F
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFST 203
Query: 166 GNQGEVKIGDLGLAAILAQARSAHSVI--------EFMAPEL---YEEEYNELVDIYAFG 214
E+K+ D GL+ + + F+APE+ E Y D ++ G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 215 MCLLELVTFEYPYVECTNAAQIYKKVTSG---IKPASLAKVADNGVRAFIEKCI-AEVSE 270
+ L L+ P+ N A +V + + + ++ R + + V E
Sbjct: 264 VLLHLLLMGAVPF-PGVNDADTISQVLNKKLCFENPNYNVLSPL-ARDLLSNLLNRNVDE 321
Query: 271 RLPAKELLGDPFLQSEDDES 290
R A L P++ D+
Sbjct: 322 RFDAMRALQHPWISQFSDKI 341
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 18/222 (8%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
E +GRG F +V+ + VA +K + + E +LK H NI+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVA---VKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ V T+ + I + E+ G + R + + ++ L + G+ YL S
Sbjct: 176 RLIG--VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK- 232
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-----QARSAHSV-IEFMAPE-LYEE 202
IHRDL N V +KI D G++ A + V +++ APE L
Sbjct: 233 -CCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 203 EYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
Y+ D+++FG+ L E + PY +N Q + V G
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 75/271 (27%), Positives = 131/271 (48%), Gaps = 23/271 (8%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNI 89
+LG+G+F +V + D + E A +KVI+ ++D + EV LLK L H NI
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYA---VKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+K + D+ + +I + E++T G L K K + +Q+ G++Y+H H+
Sbjct: 84 MKLFEILEDSSSFYI--VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 150 PPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILAQARSAHSVI---EFMAPELYEEEY 204
++HRDLK +NI + + + +KI D GL+ Q I ++APE+ Y
Sbjct: 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199
Query: 205 NELVDIYAFGMCLLELVTFEYP--YVECTNAAQIYKKVTSGI---KPASLAKVADNGVRA 259
+E D+++ G+ L L++ P Y + N I K+V +G ++D+ +
Sbjct: 200 DEKCDVWSAGVILYILLS-GTPPFYGK--NEYDILKRVETGKYAFDLPQWRTISDD-AKD 255
Query: 260 FIEKCI-AEVSERLPAKELLGDPFLQSEDDE 289
I K + S R+ A + L P++Q E
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 52/260 (20%), Positives = 115/260 (44%), Gaps = 49/260 (18%)
Query: 22 DPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID---------------- 63
+ +Y + +G+G++ V A++E + A +KV+
Sbjct: 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYA---MKVLSKKKLIRQAGFPRRPPP 63
Query: 64 ---------LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSG 114
++ +E++Y E+ +LK L H N++K D +H+ + E+ G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 115 TLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174
+ + + +A + + + +++G+ YLH +IHRD+K N+ V + G +KI
Sbjct: 124 PVMEVPTLKPLSEDQA-RFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGED-GHIKIA 179
Query: 175 DLGLAAILAQARSAHSVIE-------FMAPEL---YEEEYN-ELVDIYAFGMCLLELVTF 223
D G++ + + +++ FMAPE + ++ + +D++A G+ L V
Sbjct: 180 DFGVSNEF---KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 224 EYPYVECTNAAQIYKKVTSG 243
+ P+++ ++ K+ S
Sbjct: 237 QCPFMD-ERIMCLHSKIKSQ 255
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 45/297 (15%)
Query: 23 PSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-------LLRNSEDLER 73
P A Y + LG GA +V AF+ +VA IK+I R ++
Sbjct: 5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVA---IKIISKRKFAIGSAREADPALN 61
Query: 74 LYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKK 133
+ +E+ +LK L H IIK N + D E+ +I + E+ G L +K + K
Sbjct: 62 VETEIEILKKLNHPCIIKIKN-FFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE--VKIGDLGLAAILAQARSAHSV 191
+ Q+L + YLH + +IHRDLK +N+ ++ + + +KI D G + IL + ++
Sbjct: 119 YFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 192 I---EFMAPE----LYEEEYNELVDIYAFGMCLLELVTFEY-------PYVECTNAAQIY 237
++APE + YN VD ++ G+ L + P+ E +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL-------FICLSGYPPFSEHRTQVSLK 229
Query: 238 KKVTSGI---KPASLAKVADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQSEDDES 290
++TSG P A+V++ ++K + + R +E L P+LQ ED +
Sbjct: 230 DQITSGKYNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 44/238 (18%), Positives = 96/238 (40%), Gaps = 21/238 (8%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRN--SEDLERLYS 76
+I + E LG+G F K+++ G ++ +V + +L E +
Sbjct: 4 KIRNEDL--IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWS 135
++ L HK+++ Y V + + E G+L Y KK+K+ +++ + +
Sbjct: 62 AASMMSKLSHKHLVLNYG--VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVN-------GNQGEVKIGDLGLAAILAQARSA 188
+Q+ + +L + +IH ++ NI + GN +K+ D G++ +
Sbjct: 120 KQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 189 HSVIEFMAPE--LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
I ++ PE + N D ++FG L E+ + + P + + +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQFYEDR 234
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 61/268 (22%), Positives = 119/268 (44%), Gaps = 19/268 (7%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
+ + LG GA+ +V A + + VA +K++D+ R + E + E+ + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H+N++KFY N E + G L + + +++ Q++ G+ YL
Sbjct: 64 HENVVKFYGHR-REGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF------MAPE- 198
H + HRD+K +N+ ++ +KI D GLA + + + +APE
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 199 LYEEEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257
L E++ E VD+++ G+ L ++ E P+ + +++ Q Y + K D+
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 238
Query: 258 RAFIEKC-IAEVSERLPAKELLGDPFLQ 284
A + K + S R+ ++ D +
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 29 RYKEVLGRGAFKKVYRA----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
+ LG G F KV ++ G VA +K + + E+ +L+TL
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA---VKALKADAGPQHRSGWKQEIDILRTL 90
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
H++IIK+ D + + E G+LR Y +H + L L +++QI EG++Y
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAY 149
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMAP 197
LH+ IHRDL N+ + N VKIGD GLA + + + V + + AP
Sbjct: 150 LHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206
Query: 198 E-LYEEEYNELVDIYAFGMCLLELVTF 223
E L E ++ D+++FG+ L EL+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTH 233
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 58/298 (19%), Positives = 106/298 (35%), Gaps = 53/298 (17%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNI 89
+++LG G+ V +G VA +K + + + + E+ LL H N+
Sbjct: 20 EKILGYGSSGTVVFQ-GSFQGRPVA---VKRMLI----DFCDIALMEIKLLTESDDHPNV 71
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS-------RQILEGL 142
I++Y S +I E + L+ + D + RQI G+
Sbjct: 72 IRYYCSETTDRFLYI--ALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 143 SYLHSHDPPVIHRDLKCDNIFVN------------GNQGEVKIGDLGLAAILAQARSAHS 190
++LHS +IHRDLK NI V+ + I D GL L +S+
Sbjct: 129 AHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 191 VIE--------FMAPEL--------YEEEYNELVDIYAFGMCLLELVTFEYP--YVECTN 232
+ APEL + +DI++ G +++ + +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246
Query: 233 AAQIYKKVTSGIKPASLA-KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288
+ I + + S + L + I + I + +R A ++L P +
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 63/308 (20%), Positives = 119/308 (38%), Gaps = 37/308 (12%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQ 58
P D A Y+ +LG+G F V+ + ++VA
Sbjct: 4 TKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVA--- 60
Query: 59 IKVID-----LLRNSEDLERLYSEVHLLKTL----KHKNIIKFYNSWVDTENEHINFITE 109
IKVI D EV LL + H +I+ + W +T+ + E
Sbjct: 61 IKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD-WFETQE-GFMLVLE 118
Query: 110 IFTSGT-LRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168
L Y + + + + Q++ + + HS V+HRD+K +NI ++ +
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRR 176
Query: 169 GEVKIGDLGLAAILAQARSAHSV--IEFMAPELYE-EEYN-ELVDIYAFGMCLLELVTFE 224
G K+ D G A+L + PE +Y+ +++ G+ L ++V +
Sbjct: 177 GCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
Query: 225 YPYVECTNAAQIYKKVTSGI--KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDP 281
P+ +++ PA ++ A I +C+A + S R +E+L DP
Sbjct: 237 IPFER-------DQEILEAELHFPAHVSP----DCCALIRRCLAPKPSSRPSLEEILLDP 285
Query: 282 FLQSEDDE 289
++Q+ ++
Sbjct: 286 WMQTPAED 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 54/191 (28%), Positives = 102/191 (53%), Gaps = 14/191 (7%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNI 89
KE LG+GAF V R + G+E A K+I+ + ++ D ++L E + + L+H NI
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFA---AKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ ++S + ++ + ++ T G L + + +QILE ++Y HS+
Sbjct: 68 VRLHDSIQEESFHYL--VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 150 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMAPE-LYEEE 203
++HR+LK +N+ + +G VK+ D GLA + + + H +++PE L ++
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 204 YNELVDIYAFG 214
Y++ VDI+A G
Sbjct: 184 YSKPVDIWACG 194
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 69/250 (27%), Positives = 113/250 (45%), Gaps = 29/250 (11%)
Query: 6 TSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAF---DELEGIEVAWNQIKVI 62
++ + P S I R E LG G+F V R + + VA +K +
Sbjct: 2 SAGEGPLQSLTC--LIGEKDL--RLLEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCL 54
Query: 63 --DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYR 120
D+L E ++ EV+ + +L H+N+I+ Y V + +TE+ G+L
Sbjct: 55 KPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG--VVLT-PPMKMVTELAPLGSLLDRL 111
Query: 121 KKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
+KH+ H L L +++ Q+ EG+ YL S IHRDL N+ + VKIGD GL
Sbjct: 112 RKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLM 168
Query: 180 AILAQARSAHSV-------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVEC 230
L Q + + + APE L ++ D + FG+ L E+ T+ + P++
Sbjct: 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
Query: 231 TNAAQIYKKV 240
+QI K+
Sbjct: 229 NG-SQILHKI 237
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 68/302 (22%), Positives = 126/302 (41%), Gaps = 35/302 (11%)
Query: 6 TSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
E+ P + E + +Y LG GAF V+ A D+ + EV +K I
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVV---VKFIK 58
Query: 64 -------LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT- 115
L ++ E+ +L ++H NIIK + + + + E SG
Sbjct: 59 KEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLD-IFENQG-FFQLVMEKHGSGLD 116
Query: 116 LRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175
L + +H +D RQ++ + YL D +IHRD+K +NI + + +K+ D
Sbjct: 117 LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAED-FTIKLID 173
Query: 176 LGLAAILAQARSAHSV---IEFMAPELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVEC 230
G AA L + + ++ IE+ APE+ Y +++++ G+ L LV E P+ E
Sbjct: 174 FGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE- 232
Query: 231 TNAAQIYKKVTSGI--KPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDD 288
++ P ++K + V ++ R ++L+ DP++ +
Sbjct: 233 ------LEETVEAAIHPPYLVSKELMSLVSGLLQP---VPERRTTLEKLVTDPWVTQPVN 283
Query: 289 ES 290
+
Sbjct: 284 LA 285
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-29
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
LG G + +VY + + VA +K L ++ ++E E ++K +KH N+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVA---VKT--LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHD 149
V T ITE T G L Y ++ + V L + QI + YL +
Sbjct: 281 LLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA----QARSAHSV-IEFMAPE-LYEEE 203
IHR+L N V N VK+ D GL+ ++ A + I++ APE L +
Sbjct: 339 --FIHRNLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 204 YNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
++ D++AFG+ L E+ T+ PY +Q+Y+ +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 55/233 (23%), Positives = 99/233 (42%), Gaps = 24/233 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEV 78
IDPS + + +G G F V+ +VA IK + + E E
Sbjct: 4 VIDPSEL--TFVQEIGSGQFGLVHLG--YWLNKDKVA---IKT--IREGAMSEEDFIEEA 54
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQ 137
++ L H +++ Y V E I +TE G L Y + + L
Sbjct: 55 EVMMKLSHPKLVQLYG--VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF-- 194
+ EG++YL VIHRDL N V G +K+ D G+ +L ++ + +F
Sbjct: 113 VCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 195 --MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+PE Y+ D+++FG+ + E+ + + PY +N +++ + +++G
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 26/236 (11%)
Query: 22 DPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSE 77
D + G Y + LG G F KV +L G +VA +K+++ +R+ + + ++ E
Sbjct: 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVA---VKILNRQKIRSLDVVGKIKRE 61
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ 137
+ LK +H +IIK Y T + E + G L Y KH V+ ++ +Q
Sbjct: 62 IQNLKLFRHPHIIKLYQVI-STPT-DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQ 119
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-------SAHS 190
IL + Y H H V+HRDLK +N+ ++ + KI D GL+ +++ S +
Sbjct: 120 ILSAVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNY 176
Query: 191 VIEFMAPELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244
APE+ Y VDI++ G+ L L+ P+ + + ++KK+ G+
Sbjct: 177 A----APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF-DDEHVPTLFKKIRGGV 227
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-29
Identities = 51/342 (14%), Positives = 116/342 (33%), Gaps = 61/342 (17%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARY---GRYK--EVLGRGAFKKVYRAFDELEGIEVAW 56
P + + + S+ ++ + Y+ L +G F K+ E + A
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFYA- 58
Query: 57 NQIKVID----------------LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100
+K + + + +E+ ++ +K++ + +
Sbjct: 59 --LKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN-- 114
Query: 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS--------RQILEGLSYLHSHDPPV 152
+ + I E + ++ ++ + +D + +L SY+H+ +
Sbjct: 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NI 173
Query: 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFMAPELYEEE---YNEL 207
HRD+K NI ++ N G VK+ D G + + + S EFM PE + E
Sbjct: 174 CHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAK 232
Query: 208 VDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASLAKVADNGVRAFIEKCI 265
VDI++ G+CL + P+ + +++ + + P
Sbjct: 233 VDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 266 AEVSE----------------RLPAKELLGDPFLQSEDDESV 291
+S R+ +++ L +L + E +
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL 334
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 29/249 (11%)
Query: 9 QDPDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVID 63
+ P+ + + E + + +VLG GAF VY+ E I VA IK +
Sbjct: 2 EAPNQALLRILKETEF-----KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA---IKELR 53
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH 123
+ + + + E +++ ++ + ++ + + + IT++ G L Y ++H
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLG--ICLT-STVQLITQLMPFGCLLDYVREH 110
Query: 124 K-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182
K ++ + L W QI +G++YL ++HRDL N+ V Q VKI D GLA +L
Sbjct: 111 KDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167
Query: 183 AQARSAHSV------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAA 234
+ I++MA E + Y D++++G+ + EL+TF PY +
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-S 226
Query: 235 QIYKKVTSG 243
+I + G
Sbjct: 227 EISSILEKG 235
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
E++ + K LG G + +VY + + VA +K ++ ++E E
Sbjct: 9 EMERTDI--TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAA 61
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQ 137
++K +KH N+++ V T ITE T G L Y ++ + V L + Q
Sbjct: 62 VMKEIKHPNLVQLLG--VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF-- 194
I + YL + IHRDL N V N VK+ D GL+ + +AH+ +F
Sbjct: 120 ISSAMEYLEKKN--FIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 195 --MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
APE L +++ D++AFG+ L E+ T+ PY +Q+Y+ +
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 70/269 (26%), Positives = 119/269 (44%), Gaps = 26/269 (9%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKT 83
RYK + LG G VY A D + I+VA IK I E L+R EVH
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVA---IKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 84 LKHKNIIKFYNSWVDT-ENEHINFIT-EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
L H+NI+ D E + ++ E TL +Y + H + + ++ QIL+G
Sbjct: 68 LSHQNIVSMI----DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDG 123
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR--SAHSVI---EFMA 196
+ + H ++HRD+K NI + + +KI D G+A L++ + V+ ++ +
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180
Query: 197 PELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASLAKVA 253
PE + E +E DIY+ G+ L E++ E P+ T + K + + + K
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240
Query: 254 DNGVRAFIEKCIA-EVSERLP-AKELLGD 280
+ I + + + R +E+ D
Sbjct: 241 PQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 70/336 (20%), Positives = 127/336 (37%), Gaps = 29/336 (8%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK------EVLGRGAFKKVYRAFDELEGIEVA 55
P+ ++ +D ++V + G E LG GAF V+R ++ G
Sbjct: 21 PKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFV 80
Query: 56 WNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT 115
K I+ D + +E+ ++ L H +I ++++ D + I E + G
Sbjct: 81 ---AKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL--ILEFLSGGE 134
Query: 116 L--RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQGEVK 172
L R + +K + + RQ EGL ++H H ++H D+K +NI VK
Sbjct: 135 LFDRIAAEDYKMSEAEV-INYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVK 191
Query: 173 IGDLGLAAILAQARSAHSVI---EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYV 228
I D GLA L EF APE + E D++A G+ L++ P+
Sbjct: 192 IIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251
Query: 229 ECTNAAQIYKKVTSGI---KPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQ 284
+ + + V + + V+ + FI+ E +RL + L P+L+
Sbjct: 252 GEDD-LETLQNVKRCDWEFDEDAFSSVSPEA-KDFIKNLLQKEPRKRLTVHDALEHPWLK 309
Query: 285 SEDDESVGRSLRVKTHYSAETSHQANLDKNAYGSSA 320
D ++ + + + A
Sbjct: 310 -GDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPA 344
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 51/230 (22%), Positives = 104/230 (45%), Gaps = 22/230 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
++ + + +G+G F V + G +VA +K ++N + +E
Sbjct: 17 ALNMKEL--KLLQTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEAS 66
Query: 80 LLKTLKHKNIIKFYNSWVDTENE-HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSR 136
++ L+H N+++ V E + + +TE G+L Y + + L K+S
Sbjct: 67 VMTQLRHSNLVQLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 124
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-IEFM 195
+ E + YL ++ +HRDL N+ V+ + K+ D GL + + + +++
Sbjct: 125 DVCEAMEYLEGNN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKLPVKWT 181
Query: 196 APE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
APE L E++++ D+++FG+ L E+ +F PY + +V G
Sbjct: 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 24/233 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEV 78
EIDP + + LG G F V + G +VA IK S + E
Sbjct: 20 EIDPKDL--TFLKELGTGQFGVVKYG--KWRGQYDVAIKMIKE-----GSMSEDEFIEEA 70
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQ 137
++ L H+ +++ Y V T+ I ITE +G L Y R+ + L + +
Sbjct: 71 KVMMNLSHEKLVQLYG--VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF-- 194
+ E + YL S +HRDL N VN G VK+ D GL+ +L ++ +F
Sbjct: 129 VCEAMEYLESKQ--FLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 195 --MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
PE L +++ DI+AFG+ + E+ + + PY TN ++ + + G
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 54/237 (22%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLY 75
+ R +VLG G F V++ E I V IKVI+ + + +
Sbjct: 9 IFKETEL--RKLKVLGSGVFGTVHKGVWIPEGESIKIPVC---IKVIEDKSGRQSFQAVT 63
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKW 134
+ + +L H +I++ + + +T+ G+L + ++H+ + + L W
Sbjct: 64 DHMLAIGSLDHAHIVRLLG--LCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL------AQARSA 188
QI +G+ YL H ++HR+L N+ + +V++ D G+A +L A
Sbjct: 121 GVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEA 177
Query: 189 HSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+ I++MA E ++ +Y D++++G+ + EL+TF PY A++ + G
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDLLEKG 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEV 78
E+ + LG G F V + +G +VA IK S + + E
Sbjct: 4 ELKREEI--TLLKELGSGQFGVVKLG--KWKGQYDVAVKMIKE-----GSMSEDEFFQEA 54
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQ 137
+ L H ++KFY V ++ I +TE ++G L Y R K ++ L +
Sbjct: 55 QTMMKLSHPKLVKFYG--VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF-- 194
+ EG+++L SH IHRDL N V+ + VK+ D G+ +L + +F
Sbjct: 113 VCEGMAFLESHQ--FIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 195 --MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
APE + +Y+ D++AFG+ + E+ + + PY TN +++ KV+ G
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 22/199 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID----LLRNSEDLERLYSEVHLLKTLKH 86
EV+G+G F V R + G + A +K++D E L E + LKH
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFA---VKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTL--RQYRKKHKHVDL--RALKKWSRQILEGL 142
+I++ ++ ++ + E L ++ + RQILE L
Sbjct: 86 PHIVELLETYSSDGMLYM--VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 143 SYLHSHDPPVIHRDLKCDNI-FVN-GNQGEVKIGDLGLAAILAQARSAHSVI----EFMA 196
Y H ++ +IHRD+K + + N VK+G G+A L ++ FMA
Sbjct: 144 RYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMA 201
Query: 197 PE-LYEEEYNELVDIYAFG 214
PE + E Y + VD++ G
Sbjct: 202 PEVVKREPYGKPVDVWGCG 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 6e-28
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 21/209 (10%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDE-LEGIEVAWNQIKVIDLLRNSED---LERLYSEVHLL 81
G+Y+ + G +Y A D + G V +K L +S D +E L
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVV---LKG---LVHSGDAEAQAMAMAERQFL 133
Query: 82 KTLKHKNIIKFYN--SWVDTENEHINFIT-EIFTSGTLRQYRKKHKHVDLRALKKWSRQI 138
+ H +I++ +N D + + +I E +L++ + + V A+ + +I
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVA-EAIA-YLLEI 191
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPE 198
L LSYLHS +++ DLK +NI + Q +K+ DLG + + + F APE
Sbjct: 192 LPALSYLHSI--GLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYLYGTPGFQAPE 247
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+ DIY G L L
Sbjct: 248 IVRTGPTVATDIYTVGRTLAALTLDLPTR 276
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 58/257 (22%), Positives = 105/257 (40%), Gaps = 25/257 (9%)
Query: 1 MPQDTTSEQDPDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAW 56
+ + ++P + F EI+ S ++++G G +V + G + VA
Sbjct: 25 FYAEPHTYEEPGRAGRSFTREIEAS--RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA- 81
Query: 57 NQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL 116
IK + SE ++ H NII+ V T +TE +G+L
Sbjct: 82 --IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG--VVTRGRLAMIVTEYMENGSL 137
Query: 117 RQYRKKHKH-VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175
+ + H + L R + G+ YL +HRDL N+ V+ N K+ D
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSN-LVCKVSD 194
Query: 176 LGLA-AILAQARSAHSV------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYP 226
GL+ + +A++ I + APE + ++ D+++FG+ + E++ + E P
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
Query: 227 YVECTNAAQIYKKVTSG 243
Y TN + V G
Sbjct: 255 YWNMTN-RDVISSVEEG 270
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 54/226 (23%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
+ + LG GA+ +V A + + VA +K++D+ R + E + E+ + K L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H+N++KFY N E + G L + + +++ Q++ G+ YL
Sbjct: 64 HENVVKFYGHR-REGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF------MAPEL 199
H + HRD+K +N+ ++ +KI D GLA + + + +APEL
Sbjct: 122 HGIG--ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 200 YE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+ E++ E VD+++ G+ L ++ E P+ + +++ Q Y
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 57/282 (20%), Positives = 113/282 (40%), Gaps = 35/282 (12%)
Query: 22 DPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-----LLRNSEDLERL 74
+ +Y+ +LG G F VY + + VA IK ++ + R+
Sbjct: 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVA---IKHVEKDRISDWGELPNGTRV 93
Query: 75 YSEVHLLKTLKHK--NIIKFYNSWVDTENEHINFITEIFT-SGTLRQYRKKHKHVDLRAL 131
EV LLK + +I+ + W + + I E L + + +
Sbjct: 94 PMEVVLLKKVSSGFSGVIRLLD-WFERPD-SFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
+ + Q+LE + + H+ V+HRD+K +NI ++ N+GE+K+ D G A+L
Sbjct: 152 RSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 209
Query: 192 --IEFMAPELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--K 245
+ PE Y+ +++ G+ L ++V + P+ +++ G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFF 262
Query: 246 PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286
++ + I C+A S+R +E+ P++Q
Sbjct: 263 RQRVSS----ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 67/306 (21%), Positives = 127/306 (41%), Gaps = 22/306 (7%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRY--KEVLGRGAFKKVYRAFDELEGIEVAWNQI 59
D + VEI Y E LG GAF V+R + G A
Sbjct: 131 NYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFA---A 187
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL-RQ 118
K + + D E + E+ + L+H ++ ++++ D + I E + G L +
Sbjct: 188 KFVMT-PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM--IYEFMSGGELFEK 244
Query: 119 YRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQGEVKIGDLG 177
+H + ++ RQ+ +GL ++H ++ +H DLK +NI F E+K+ D G
Sbjct: 245 VADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFG 302
Query: 178 LAAILAQARSAHSVI---EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNA 233
L A L +S EF APE + D+++ G+ L++ P+ +
Sbjct: 303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND- 361
Query: 234 AQIYKKVTSGI---KPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDE 289
+ + V S ++ + ++++G + FI K +A+ + R+ + L P+L +
Sbjct: 362 DETLRNVKSCDWNMDDSAFSGISEDG-KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420
Query: 290 SVGRSL 295
+
Sbjct: 421 GRDSQI 426
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 57/219 (26%), Positives = 110/219 (50%), Gaps = 16/219 (7%)
Query: 5 TTSEQDPDDSDAEFVEIDPSARYGRY--KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
+ + +EF+ + Y KE LG+GAF V R + G+E A K+I
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA---AKII 62
Query: 63 DLLR-NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRK 121
+ + ++ D ++L E + + L+H NI++ ++S + ++ + ++ T G L +
Sbjct: 63 NTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL--VFDLVTGGELFEDIV 120
Query: 122 KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLA 179
+ +QILE ++Y HS+ ++HR+LK +N+ + +G VK+ D GLA
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 180 AILAQARSAHSVI---EFMAPE-LYEEEYNELVDIYAFG 214
+ + + H +++PE L ++ Y++ VDI+A G
Sbjct: 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 18/234 (7%)
Query: 20 EIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE 77
++ RY + +G G F D+L VA +K I+ R + E + E
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVA---VKYIE--RGAAIDENVQRE 66
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQ 137
+ ++L+H NI++F T H+ I E + G L + + + +Q
Sbjct: 67 IINHRSLRHPNIVRFKEVI-LTPT-HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILAQARSAHSVI---E 193
+L G+SY HS + HRDLK +N ++G+ +KI D G + S +
Sbjct: 125 LLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182
Query: 194 FMAPELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245
++APE+ +EY+ ++ D+++ G+ L ++ YP+ E + Y+K I
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRIL 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 66/254 (25%), Positives = 112/254 (44%), Gaps = 25/254 (9%)
Query: 4 DTTSEQDPDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQI 59
D + +DP + EF E+D + +V+G G F +V +L I VA I
Sbjct: 24 DPHTFEDPTQTVHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVA---I 78
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY 119
K + + + E ++ H NII+ V T+++ + +TE +G+L +
Sbjct: 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG--VVTKSKPVMIVTEYMENGSLDSF 136
Query: 120 RKKHKH-VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
+KH + L R I G+ YL +HRDL NI +N N K+ D GL
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSN-LVCKVSDFGL 193
Query: 179 AAILA-------QARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVE 229
+L R I + +PE + ++ D++++G+ L E++++ E PY E
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 230 CTNAAQIYKKVTSG 243
+N + K V G
Sbjct: 254 MSN-QDVIKAVDEG 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 45/280 (16%), Positives = 93/280 (33%), Gaps = 43/280 (15%)
Query: 31 KEVLGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
+LG GAF +VY A D + +KV N + + LK
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFV---LKVQKP-ANPWEFYIGTQLMERLKPSM 125
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRAL-----KKWSRQILE 140
+KFY++ + + E+++ GTL +K+ + + ++ ++L
Sbjct: 126 QHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNG----------NQGEVKIGDLGLAAIL------AQ 184
+ +H + +IH D+K DN + + + DLG + +
Sbjct: 184 MIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 185 ARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+ F E L + +N +D + + ++ Y V+ + +
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 244 IKPASLAKVADNGVRAFIEKCI-AEVSERLPAKELLGDPF 282
+ + F + LP+ +LL
Sbjct: 302 LPHLDMWN-------EFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 85/327 (25%), Positives = 140/327 (42%), Gaps = 53/327 (16%)
Query: 26 RYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLL 81
G Y E LG G+F KV A +VA +K I LL+ S+ R+ E+ L
Sbjct: 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVA---LKFISRQLLKKSDMHMRVEREISYL 63
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
K L+H +IIK Y+ T I + E + G L Y + K + +++ +QI+
Sbjct: 64 KLLRHPHIIKLYDVI-TTPT-DIVMVIE-YAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-------SAHSVIEF 194
+ Y H H ++HRDLK +N+ ++ N VKI D GL+ I+ S +
Sbjct: 121 IEYCHRHK--IVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYA--- 174
Query: 195 MAPELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASLA 250
APE+ + Y VD+++ G+ L ++ P+ + ++KKV S + P L+
Sbjct: 175 -APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF-DDEFIPNLFKKVNSCVYVMPDFLS 232
Query: 251 KVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQ---------------SEDDESVGRSL 295
A + +R I + +R+ +E+ DP+ S D + L
Sbjct: 233 PGAQSLIRRMIVA---DPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKL 289
Query: 296 RVKTHYSAET------SHQANLDKNAY 316
+S + S + N K AY
Sbjct: 290 GEAMGFSEDYIVEALRSDENNEVKEAY 316
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/255 (25%), Positives = 112/255 (43%), Gaps = 26/255 (10%)
Query: 4 DTTSEQDPDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQ 58
DP+ + +F EI PS ++V+G G F +VY+ + + VA
Sbjct: 23 QGAMGSDPNQAVLKFTTEIHPSCV--TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA--- 77
Query: 59 IKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ 118
IK + + E ++ H NII+ V ++ + + ITE +G L +
Sbjct: 78 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG--VISKYKPMMIITEYMENGALDK 135
Query: 119 YRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177
+ ++ + L R I G+ YL + + +HRDL NI VN N K+ D G
Sbjct: 136 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN-LVCKVSDFG 192
Query: 178 LAAILA-------QARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYV 228
L+ +L I + APE + ++ D+++FG+ + E++T+ E PY
Sbjct: 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 252
Query: 229 ECTNAAQIYKKVTSG 243
E +N ++ K + G
Sbjct: 253 ELSN-HEVMKAINDG 266
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 43/217 (19%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
Y +V+G G+F V++A EVA IK + D E+ +++ +KH
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVA---IKKVLQ-----DKRFKNRELQIMRIVKH 91
Query: 87 KNIIK----FYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQI 138
N++ FY++ + +N + E + T+ R Y K + + + +K + Q+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM--- 195
L L+Y+HS + HRD+K N+ ++ G +K+ D G A IL E
Sbjct: 151 LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-------EPNVSY 201
Query: 196 -------APELY--EEEYNELVDIYAFGMCLL-ELVT 222
APEL Y +DI++ G C++ EL+
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQ 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 42/217 (19%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
Y +V+G G+F VY+A G VA IK + D E+ +++ L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQ-----DKRFKNRELQIMRKLDH 106
Query: 87 KNIIK----FYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQI 138
NI++ FY+S + ++N + + + T+ R Y + + + + +K + Q+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM--- 195
L+Y+HS + HRD+K N+ ++ + +K+ D G A L + E
Sbjct: 166 FRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-------EPNVSY 216
Query: 196 -------APELY--EEEYNELVDIYAFGMCLL-ELVT 222
APEL +Y +D+++ G C+L EL+
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLL 252
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-27
Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
EI + R + LG+G F +V+ VA IK L + E E
Sbjct: 263 EIPRES--LRLEVKLGQGCFGEVWMGTWNGT-TRVA---IKT--LKPGTMSPEAFLQEAQ 314
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQ 137
++K L+H+ +++ Y V +E E I +TE + G+L + K K++ L L + Q
Sbjct: 315 VMKKLRHEKLVQLYA--VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF-- 194
I G++Y+ + +HRDL+ NI V N K+ D GLA I +A +F
Sbjct: 372 IASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPI 428
Query: 195 --MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
APE + D+++FG+ L EL T PY N ++ +V G
Sbjct: 429 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERG 480
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 64/292 (21%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+ LGRGA VYR + A +KV+ + D + + +E+ +L L H NII
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYA---LKVLK---KTVDKKIVRTEIGVLLRLSHPNII 111
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
K + + + E+ T G L + + R +QILE ++YLH +
Sbjct: 112 KLKEIFETPTEISL--VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG- 168
Query: 151 PVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---EFMAPE-LYEEEY 204
++HRDLK +N+ + +KI D GL+ I+ +V + APE L Y
Sbjct: 169 -IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY 227
Query: 205 NELVDIYAFGMCLLELVTFEY-------PYVECTNAAQIYKKVTSGI---KPASLAKVAD 254
VD+++ G+ Y P+ + +++++ + +V+
Sbjct: 228 GPEVDMWSVGIIT-------YILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280
Query: 255 NGVRAFIEKCI-AEVSERLPAKELLGDPFLQSE--DDESVGRSLRVKTHYSA 303
N + + K I + +RL + L P++ + + + + + ++A
Sbjct: 281 N-AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNA 331
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 3e-27
Identities = 66/233 (28%), Positives = 103/233 (44%), Gaps = 24/233 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
EI R + LG+G F +V+ VA IK L + E E
Sbjct: 180 EIPRE--SLRLEVKLGQGCFGEVWMGTWNGT-TRVA---IKT--LKPGTMSPEAFLQEAQ 231
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQ 137
++K L+H+ +++ Y V +E E I +TE + G+L + K K++ L L + Q
Sbjct: 232 VMKKLRHEKLVQLYA--VVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF-- 194
I G++Y+ + +HRDL+ NI V N K+ D GLA I +A +F
Sbjct: 289 IASGMAYVERMN--YVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPI 345
Query: 195 --MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
APE + D+++FG+ L EL T PY N ++ +V G
Sbjct: 346 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERG 397
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 57/250 (22%), Positives = 112/250 (44%), Gaps = 25/250 (10%)
Query: 10 DPD-DSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAF---DELEGIEVAWNQIKVIDLL 65
+P+ + V I PS+ + EV+GRG F VY ++ + I A +K ++ +
Sbjct: 8 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSLNRI 64
Query: 66 RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF-ITEIFTSGTLRQY-RKKH 123
+ ++ + +E ++K H N++ + +E + G LR + R +
Sbjct: 65 TDIGEVSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNFIRNET 122
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL- 182
+ ++ L + Q+ +G+ YL S +HRDL N ++ VK+ D GLA +
Sbjct: 123 HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEK-FTVKVADFGLARDMY 179
Query: 183 ------AQARSAHSV-IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNA 233
++ + +++MA E L +++ D+++FG+ L EL+T PY +
Sbjct: 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT- 238
Query: 234 AQIYKKVTSG 243
I + G
Sbjct: 239 FDITVYLLQG 248
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 23/235 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYS 76
EI +G G F V++ + VA IK + E+
Sbjct: 11 EIQRERI--ELGRCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQ 65
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWS 135
E ++ H +I+K V TE + I E+ T G LR + + K+ +DL +L ++
Sbjct: 66 EALTMRQFDHPHIVKLIG--VITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-----QARSAHS 190
Q+ L+YL S +HRD+ N+ V + VK+GD GL+ + +A
Sbjct: 123 YQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
I++MAPE + + D++ FG+C+ E++ P+ N + ++ +G
Sbjct: 180 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 233
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 25/276 (9%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-----LLRNSEDLERLYSEVHLLKTLK 85
E LG G F V + ++ G+E A K I R E + EV +L+ +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYA---AKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H N+I ++ + + + + I E+ + G L + + + + + +QIL+G++YL
Sbjct: 74 HHNVITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 146 HSHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE- 198
H+ + H DLK +NI + N +K+ D GLA + ++ EF+APE
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADN 255
+ E D+++ G+ L++ P++ T + +TS + ++
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVSYDFDEEFFSHTSEL 248
Query: 256 GVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDES 290
+ FI K + E +RL +E L P++ D++
Sbjct: 249 A-KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 45/217 (20%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-------RLYSEVH 79
+Y+ +G G++ V++ + G VA IK SED R E+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVA---IKKF---LESEDDPVIKKIALR---EIR 54
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQI 138
+LK LKH N++ V ++ + E + T+ + + V +K + Q
Sbjct: 55 MLKQLKHPNLVNLLE--VFRRKRRLHLVFE-YCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM--- 195
L+ +++ H H+ IHRD+K +NI + +K+ D G AR ++
Sbjct: 112 LQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGF------ARLLTGPSDYYDDE 162
Query: 196 -------APELY--EEEYNELVDIYAFGMCLL-ELVT 222
+PEL + +Y VD++A G C+ EL++
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLS 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 63/326 (19%), Positives = 126/326 (38%), Gaps = 27/326 (8%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
E LGRG F V+R + K + D + E+ +L +H+NI+
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYM---AKFVK--VKGTDQVLVKKEISILNIARHRNIL 64
Query: 91 KFYNSWVDTENEHINFITEIFTSGTL--RQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ S+ E + I E + + R + + + Q+ E L +LHSH
Sbjct: 65 HLHESFESMEELVM--IFEFISGLDIFERINTSAFELNEREI-VSYVHQVCEALQFLHSH 121
Query: 149 DPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE-LYEEE 203
+ + H D++ +NI + +KI + G A L + + E+ APE +
Sbjct: 122 N--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADNGVRAF 260
+ D+++ G + L++ P++ TN QI + + + + +++ F
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYTFDEEAFKEISIEA-MDF 237
Query: 261 IEKC-IAEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSHQANLDKNAYGSS 319
+++ + E R+ A E L P+L+ + + + +R H + L K
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT----LIKKDLNMV 293
Query: 320 AETGRDFTVQGQRRDINTIFLKLRIS 345
R R K++++
Sbjct: 294 VSAARISCGGAIRSQKGVSVAKVKVA 319
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 67/238 (28%), Positives = 116/238 (48%), Gaps = 26/238 (10%)
Query: 20 EIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLY 75
+ D + G Y + LG G F KV EL G +VA +K+++ +R+ + + ++
Sbjct: 8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVA---VKILNRQKIRSLDVVGKIR 64
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
E+ LK +H +IIK Y T + I + E + G L Y K+ +D + ++
Sbjct: 65 REIQNLKLFRHPHIIKLYQVI-STPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-------SA 188
+QIL G+ Y H H V+HRDLK +N+ ++ + KI D GL+ +++ S
Sbjct: 123 QQILSGVDYCHRHM--VVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSP 179
Query: 189 HSVIEFMAPELYE-EEYN-ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244
+ APE+ Y VDI++ G+ L L+ P+ + + ++KK+ GI
Sbjct: 180 NYA----APEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGI 232
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 73/316 (23%), Positives = 135/316 (42%), Gaps = 26/316 (8%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRY----KEVLGRGAFKKVYRAFDELEGIEVAWN 57
P D V A Y E+LG G F +V++ + G+++A
Sbjct: 61 ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLA-- 118
Query: 58 QIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL- 116
K+I R +D E + +E+ ++ L H N+I+ Y+++ + + + E G L
Sbjct: 119 -AKIIKT-RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL--VMEYVDGGELF 174
Query: 117 -RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQGEVKIG 174
R + + +L + +QI EG+ ++H ++H DLK +NI VN + ++KI
Sbjct: 175 DRIIDESYNLTELDT-ILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKII 231
Query: 175 DLGLAAILAQARSAHSVI---EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVEC 230
D GLA EF+APE + + + D+++ G+ L++ P++
Sbjct: 232 DFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291
Query: 231 TNAAQIYKKVTSGI---KPASLAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQSE 286
+ A+ + + + +++ + FI K I E S R+ A E L P+L
Sbjct: 292 ND-AETLNNILACRWDLEDEEFQDISEEA-KEFISKLLIKEKSWRISASEALKHPWLSDH 349
Query: 287 DDESVGRSLRVKTHYS 302
S + + K S
Sbjct: 350 KLHSRLSAQKKKNRGS 365
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 55/253 (21%), Positives = 97/253 (38%), Gaps = 27/253 (10%)
Query: 9 QDPDD---SDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVI 62
+D D ++ + V I V+G+G F VY + I+ A IK +
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCA---IKSL 57
Query: 63 DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF-ITEIFTSGTLRQY-R 120
+ + +E E L++ L H N++ + E + + G L Q+ R
Sbjct: 58 SRITEMQQVEAFLREGLLMRGLNHPNVLALIG--IMLPPEGLPHVLLPYMCHGDLLQFIR 115
Query: 121 KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
++ ++ L + Q+ G+ YL +HRDL N ++ + VK+ D GLA
Sbjct: 116 SPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDES-FTVKVADFGLAR 172
Query: 181 ILAQ----ARSAHSVIEF----MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVEC 230
+ + H A E L + D+++FG+ L EL+T PY
Sbjct: 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232
Query: 231 TNAAQIYKKVTSG 243
+ + G
Sbjct: 233 DP-FDLTHFLAQG 244
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-27
Identities = 52/219 (23%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+ +G+G F V + G +VA +K ++N + +E ++ L+H N++
Sbjct: 198 LQTIGKGEFGDVMLG--DYRGNKVA---VKC---IKNDATAQAFLAEASVMTQLRHSNLV 249
Query: 91 KFYNSWVDTENEHINFI-TEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHS 147
+ V E + +I TE G+L Y + + L K+S + E + YL
Sbjct: 250 QLLG--VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-IEFMAPE-LYEEEYN 205
++ +HRDL N+ V+ + K+ D GL + + + +++ APE L E++++
Sbjct: 308 NN--FVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 206 ELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
D+++FG+ L E+ +F PY + +V G
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 402
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 62/277 (22%), Positives = 123/277 (44%), Gaps = 25/277 (9%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-----LLRNSEDLERLYSEVHLLKTLK 85
E LG G F V + ++ G++ A K I R E + EV +LK ++
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYA---AKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H N+I + + + + + I E+ G L + + + + ++ +QIL G+ YL
Sbjct: 73 HPNVITLHEVYENKTDVIL--ILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 146 HSHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE- 198
HS + H DLK +NI + N + +KI D GLA + ++ EF+APE
Sbjct: 131 HSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADN 255
+ E D+++ G+ L++ P++ T + V++ + + +
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNYEFEDEYFSNTSAL 247
Query: 256 GVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
+ FI + + + +R+ ++ L P+++ +D +
Sbjct: 248 A-KDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 51/240 (21%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 19 VEIDPSARYGRYKEVLGRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRN----SEDLE 72
V +D KE LG G F V + + + VA +K+ L+N +
Sbjct: 11 VYLDRKLLTLEDKE-LGSGNFGTVKKGYYQMKKVVKTVA---VKI---LKNEANDPALKD 63
Query: 73 RLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALK 132
L +E ++++ L + I++ + E + E+ G L +Y ++++HV + +
Sbjct: 64 ELLAEANVMQQLDNPYIVRMIG--ICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII 120
Query: 133 KWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV- 191
+ Q+ G+ YL + +HRDL N+ + Q KI D GL+ L + +
Sbjct: 121 ELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 192 ------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+++ APE + +++ D+++FG+ + E ++ + PY +++ + G
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SEVTAMLEKG 236
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 26/234 (11%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEV 78
E+ + E LG G F +V+ G +VA +K L + S + +E
Sbjct: 9 EVPRETL--KLVERLGAGQFGEVWMG--YYNGHTKVA---VKS--LKQGSMSPDAFLAEA 59
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRA--LKKWSR 136
+L+K L+H+ +++ Y V T+ E I ITE +G+L + K + L L +
Sbjct: 60 NLMKQLQHQRLVRLYA--VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF- 194
QI EG++++ + IHRDL+ NI V+ KI D GLA I +A +F
Sbjct: 117 QIAEGMAFIEERN--YIHRDLRAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 195 ---MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
APE + + D+++FG+ L E+VT PY TN ++ + + G
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERG 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 27/237 (11%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI 59
T Q + RY+ LG G + +VY+A D + VA I
Sbjct: 8 HMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVA---I 64
Query: 60 KVIDLLRNSEDLE----RLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGT 115
K I L E + R EV LLK L+H+NII+ + V N ++ I E +
Sbjct: 65 KRIRLEHEEEGVPGTAIR---EVSLLKELQHRNIIELKS--VIHHNHRLHLIFE-YAEND 118
Query: 116 LRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN----GNQGEV 171
L++Y K+ V +R +K + Q++ G+++ HS +HRDLK N+ ++ +
Sbjct: 119 LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVL 176
Query: 172 KIGDLGLA-AILAQARS-AHSVIE--FMAPELY--EEEYNELVDIYAFGMCLLELVT 222
KIGD GLA A R H +I + PE+ Y+ VDI++ E++
Sbjct: 177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 48/225 (21%), Positives = 99/225 (44%), Gaps = 22/225 (9%)
Query: 31 KEVLGRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
LG G F V + + I+VA IKV+ D E + E ++ L +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPY 71
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHS 147
I++ V E + + E+ G L ++ K + + + + + Q+ G+ YL
Sbjct: 72 IVRLIG--VCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 128
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMAPE-L 199
+ +HRDL N+ + N+ KI D GL+ L S ++ +++ APE +
Sbjct: 129 KN--FVHRDLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 200 YEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+++ D++++G+ + E +++ + PY + ++ + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 53/192 (27%), Positives = 96/192 (50%), Gaps = 15/192 (7%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNI 89
E LG+GAF V R L G E A +I+ + ++ D ++L E + + LKH NI
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYA---AMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ ++S + + ++ I ++ T G L + ++ +QILE + + H
Sbjct: 73 VRLHDSISEEGHHYL--IFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 150 PPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYEE 202
V+HR+LK +N+ + +G VK+ D GLA + + A +++PE L ++
Sbjct: 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 203 EYNELVDIYAFG 214
Y + VD++A G
Sbjct: 189 PYGKPVDLWACG 200
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+ LG G F +V+ A +VA +K + S +E +E +++KTL+H ++K
Sbjct: 194 KKLGAGQFGEVWMATYNKH-TKVA---VKT--MKPGSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHD 149
+ V T+ E I ITE G+L + K + L L +S QI EG++++ +
Sbjct: 248 LHA--VVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEF----MAPE-LYEEE 203
IHRDL+ NI V+ + KI D GLA I +A +F APE +
Sbjct: 305 --YIHRDLRAANILVSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361
Query: 204 YNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
+ D+++FG+ L+E+VT+ PY +N ++ + + G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIRALERG 401
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 66/280 (23%), Positives = 125/280 (44%), Gaps = 47/280 (16%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLLKTLKHKN 88
EVLG GAF +V+ L G A +K I LE E+ +LK +KH+N
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFA---LKCIKKSPAFRDSSLEN---EIAVLKKIKHEN 67
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
I+ + + T + ++ + ++ + G L + + +Q+L + YLH +
Sbjct: 68 IVTLEDIYESTTHYYL--VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 149 DPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSV--IEFMAPE-LYEEE 203
++HRDLK +N+ ++ + ++ I D GL+ + + + ++APE L ++
Sbjct: 126 G--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 204 YNELVDIYAFG--MCLLELVTFEYP--YVECTNAAQIYKKVTSG-----------IKPAS 248
Y++ VD ++ G +L L YP Y E +++++K+ G I +
Sbjct: 184 YSKAVDCWSIGVITYIL-LCG--YPPFYEE--TESKLFEKIKEGYYEFESPFWDDISES- 237
Query: 249 LAKVADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQSED 287
AK D FI + + +ER ++ L P++
Sbjct: 238 -AK--D-----FICHLLEKDPNERYTCEKALSHPWIDGNT 269
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE----RLYSEVHLLK 82
+Y+ E +G G + V++A + VA +K + L + E + R E+ LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALR---EICLLK 56
Query: 83 TLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEG 141
LKHKNI++ ++ V ++ + + E F L++Y D +K + Q+L+G
Sbjct: 57 ELKHKNIVRLHD--VLHSDKKLTLVFE-FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAP 197
L + HS + V+HRDLK N+ +N GE+K+ + GLA A R + V+ + P
Sbjct: 114 LGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 198 ELY--EEEYNELVDIYAFGMCLLELVTFEYPY 227
++ + Y+ +D+++ G EL P
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 23/235 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAF---DELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
I +LG G F +VY + E I VA +K ++ E+ S
Sbjct: 8 GIAREDV--VLNRILGEGFFGEVYEGVYTNHKGEKINVA---VKTCKKDCTLDNKEKFMS 62
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWS 135
E ++K L H +I+K + E E I E++ G L Y +++K+ + + L +S
Sbjct: 63 EAVIMKNLDHPHIVKLIG--IIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV--- 191
QI + ++YL S + +HRD+ NI V + VK+GD GL+ I + SV
Sbjct: 120 LQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 192 -IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
I++M+PE + + D++ F +C+ E+++F + P+ N + + G
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKG 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/243 (21%), Positives = 103/243 (42%), Gaps = 42/243 (17%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLYSEVHLLKTL 84
LG+G+F VY +G+ + +V I + + + +E ++K
Sbjct: 28 TMSRELGQGSFGMVYEG--VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 85
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH----------VDLRALKKW 134
++++ V ++ + I E+ T G L+ Y + + L + +
Sbjct: 86 NCHHVVRLLG--VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--- 191
+ +I +G++YL+++ +HRDL N V + VKIGD G+ R +
Sbjct: 144 AGEIADGMAYLNAN--KFVHRDLAARNCMVAEDF-TVKIGDFGM------TRDIYETDYY 194
Query: 192 ---------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKV 240
+ +M+PE L + + D+++FG+ L E+ T E PY +N Q+ + V
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRFV 253
Query: 241 TSG 243
G
Sbjct: 254 MEG 256
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 67/306 (21%), Positives = 127/306 (41%), Gaps = 30/306 (9%)
Query: 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK- 85
+ LG G+F + + A +K+I R + ++ E+ LK +
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFA---VKIIS-KRMEANTQK---EITALKLCEG 64
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H NI+K + + D + + + E+ G L + KK KH R+++ +S++
Sbjct: 65 HPNIVKLHEVFHDQLHTFL--VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 146 HSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI----EFMAPE- 198
H V+HRDLK +N+ F + N E+KI D G A + + APE
Sbjct: 123 HDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 199 LYEEEYNELVDIYAFGMCLLELVT----F--EYPYVECTNAAQIYKKVTSG---IKPASL 249
L + Y+E D+++ G+ L +++ F + CT+A +I KK+ G + +
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAW 240
Query: 250 AKVADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSHQ 308
V+ + I+ + + ++RL L + +LQ S + S+ +
Sbjct: 241 KNVSQE-AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVH 299
Query: 309 ANLDKN 314
+
Sbjct: 300 TCVKAT 305
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 64/289 (22%), Positives = 120/289 (41%), Gaps = 23/289 (7%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHL 80
+ + Y + LGRG F V + + G E A K + R + + E+ +
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYA---AKFLKKRRRGQDCRAEILHEIAV 81
Query: 81 LKTLKH-KNIIKFYNSWVDTENEHINFITEIFTSGTL--RQYRKKHKHVDLRALKKWSRQ 137
L+ K +I + + +T + I E G + + + V + + +Q
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQ-GEVKIGDLGLAAILAQARSAHSVI--- 192
ILEG+ YLH ++ ++H DLK NI + G++KI D G++ + A ++
Sbjct: 140 ILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPAS 248
E++APE L + D++ G+ L+T P+V N + Y ++ +
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-QETYLNISQVNVDYSEET 256
Query: 249 LAKVADNGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESVGRSLR 296
+ V+ FI+ + +R A+ L +LQ D E++
Sbjct: 257 FSSVSQLA-TDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEE 304
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 63/278 (22%), Positives = 120/278 (43%), Gaps = 29/278 (10%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-----LLRNSEDLERLYSEVHLLKTLK 85
E LG G F V + ++ G+E A K I R E + EV +L+ +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYA---AKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H NII ++ + + + + I E+ + G L + + + + + +QIL+G++YL
Sbjct: 74 HPNIITLHDVYENRTDVVL--ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 146 HSHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE- 198
H+ + H DLK +NI + N +K+ D GLA + ++ EF+APE
Sbjct: 132 HTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYP--YVECTNAAQIYKKVTSGI---KPASLAKVA 253
+ E D+++ G+ L++ + + +T+ ++ +
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLS-GASPFLGD--TKQETLANITAVSYDFDEEFFSQTS 246
Query: 254 DNGVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDES 290
+ + FI K + E +RL +E L P++ D +
Sbjct: 247 ELA-KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQ 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 56/255 (21%), Positives = 110/255 (43%), Gaps = 24/255 (9%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAF---DELEGIEVAWNQIK 60
D ++ + V I PS+ + EV+GRG F VY ++ + I A +K
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VK 123
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF-ITEIFTSGTLRQY 119
++ + + ++ + +E ++K H N++ + +E + G LR +
Sbjct: 124 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLG--ICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 120 -RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
R + + ++ L + Q+ +G+ +L S +HRDL N ++ VK+ D GL
Sbjct: 182 IRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEK-FTVKVADFGL 238
Query: 179 AAIL-----AQARSAHSV---IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYV 228
A + + +++MA E L +++ D+++FG+ L EL+T PY
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298
Query: 229 ECTNAAQIYKKVTSG 243
+ I + G
Sbjct: 299 DVNT-FDITVYLLQG 312
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 23/235 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYS 76
EI +G G F V++ + VA IK + E+
Sbjct: 386 EIQRERI--ELGRCIGEGQFGDVHQGIYMSPENPAMAVA---IKTCKNCTSDSVREKFLQ 440
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWS 135
E ++ H +I+K V TE + I E+ T G LR + + K +DL +L ++
Sbjct: 441 EALTMRQFDHPHIVKLIG--VITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-----QARSAHS 190
Q+ L+YL S +HRD+ N+ V + VK+GD GL+ + +A
Sbjct: 498 YQLSTALAYLESKR--FVHRDIAARNVLV-SSNDCVKLGDFGLSRYMEDSTYYKASKGKL 554
Query: 191 VIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
I++MAPE + + D++ FG+C+ E++ P+ N + ++ +G
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENG 608
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE-------RLYSEVH 79
+Y+ ++G G++ V + ++ G VA IK S+D + R E+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVA---IKKF---LESDDDKMVKKIAMR---EIK 76
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQI 138
LLK L+H+N++ V + + + E F T+ +D + ++K+ QI
Sbjct: 77 LLKQLRHENLVNLLE--VCKKKKRWYLVFE-FVDHTILDDLELFPNGLDYQVVQKYLFQI 133
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--F 194
+ G+ + HSH+ +IHRD+K +NI V+ G VK+ D G A + A V +
Sbjct: 134 INGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWY 190
Query: 195 MAPELY--EEEYNELVDIYAFGMCLL-ELVT 222
APEL + +Y + VD++A G CL+ E+
Sbjct: 191 RAPELLVGDVKYGKAVDVWAIG-CLVTEMFM 220
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 66/270 (24%), Positives = 117/270 (43%), Gaps = 23/270 (8%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKT 83
RY+ E+LG G +V+ A D + +VA +KV+ DL R+ R E
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 68
Query: 84 LKHKNIIKFYNS-WVDTENEHINFIT-EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
L H I+ Y++ +T + +I E TLR + + + +
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 128
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSA----HSVI---EF 194
L++ H + +IHRD+K NI + VK+ D G+A +A + ++ +VI ++
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 195 MAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-LAKV 252
++PE + + D+Y+ G L E++T E P+ + + Y+ V P S +
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 253 ADNGVRAFIEKCIA-EVSERLP-AKELLGD 280
+ A + K +A R A E+ D
Sbjct: 246 LSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 59/277 (21%), Positives = 121/277 (43%), Gaps = 25/277 (9%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-----LLRNSEDLERLYSEVHLLKTLK 85
E LG G F V + + G E A K I R E + EV++L+ ++
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYA---AKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H NII ++ + + + + I E+ + G L + + + + ++ +QIL+G+ YL
Sbjct: 67 HPNIITLHDIFENKTDVVL--ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 146 HSHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE- 198
HS + H DLK +NI + N +K+ D G+A + ++ EF+APE
Sbjct: 125 HSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 199 LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLAKVADN 255
+ E D+++ G+ L++ P++ T + +++ + ++
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLSGASPFLGETK-QETLTNISAVNYDFDEEYFSNTSEL 241
Query: 256 GVRAFIEKC-IAEVSERLPAKELLGDPFLQSEDDESV 291
+ FI + + + R+ + L ++++ +V
Sbjct: 242 A-KDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 48/252 (19%), Positives = 106/252 (42%), Gaps = 23/252 (9%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAF--DELEGIEVAWNQIKV 61
+ DP++ + + + LG G F V + + I+VA IKV
Sbjct: 315 FESPFSDPEELKDKKLFLKRD-NLLIADIELGCGNFGSVRQGVYRMRKKQIDVA---IKV 370
Query: 62 IDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRK 121
+ D E + E ++ L + I++ V E + + E+ G L ++
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG--VCQA-EALMLVMEMAGGGPLHKFLV 427
Query: 122 KHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+ + + + + Q+ G+ YL + +HR+L N+ + N+ KI D GL+
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLL-VNRHYAKISDFGLSK 484
Query: 181 ILAQARSAHSV-------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECT 231
L S ++ +++ APE + +++ D++++G+ + E +++ + PY +
Sbjct: 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
Query: 232 NAAQIYKKVTSG 243
++ + G
Sbjct: 545 G-PEVMAFIEQG 555
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 49/276 (17%)
Query: 1 MPQDTTSEQDPDDSDAEFV-EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQI 59
++P V I K LG GAF KV+ A E + +++
Sbjct: 17 SGLQGHIIENPQYFSDACVHHIKRRDI--VLKWELGEGAFGKVFLA--ECHNLLPEQDKM 72
Query: 60 KV-IDLLRNSEDLER--LYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTL 116
V + L+ + + R E LL L+H++I++F+ V TE + + E G L
Sbjct: 73 LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFG--VCTEGRPLLMVFEYMRHGDL 130
Query: 117 RQYRKKH---------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDN 161
++ + H + L L + Q+ G+ YL +HRDL N
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRN 188
Query: 162 IFVNGNQGEVKIGDLGLAAILAQARSAHSV------------IEFMAPE-LYEEEYNELV 208
V VKIGD G+ +R +S I +M PE + ++
Sbjct: 189 CLVGQGL-VVKIGDFGM------SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTES 241
Query: 209 DIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
D+++FG+ L E+ T+ + P+ + +N + +T G
Sbjct: 242 DVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 50/227 (22%), Positives = 96/227 (42%), Gaps = 25/227 (11%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK---EVLGRGAFKKVYRAFDELEGIEVAWNQ 58
P +Q P ++I +A YK +VLG G KV + F++ + A
Sbjct: 35 PPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA--- 91
Query: 59 IKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT--ENEHINFITEIFTSGT 115
+K++ D + EV L + +I++ + + + + + + E G
Sbjct: 92 LKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE 145
Query: 116 L--RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQG-EV 171
L R + + R + + I E + YLHS + + HRD+K +N+ + + +
Sbjct: 146 LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAIL 203
Query: 172 KIGDLGLAAILAQARSAHSVI---EFMAPE-LYEEEYNELVDIYAFG 214
K+ D G A S + ++APE L E+Y++ D+++ G
Sbjct: 204 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 54/244 (22%), Positives = 98/244 (40%), Gaps = 44/244 (18%)
Query: 29 RYKEVLGRGAFKKVYRAF-----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT 83
LG GAF +VY ++ ++VA +K + + + +D E ++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIISK 89
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-------KHVDLRALKKWSR 136
H+NI++ V ++ + E+ G L+ + ++ + + L +R
Sbjct: 90 FNHQNIVRCIG--VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILAQARSAHSV-- 191
I G YL + IHRD+ N + G KIGD G+ AR +
Sbjct: 148 DIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDFGM------ARDIYRASY 198
Query: 192 ----------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKK 239
+++M PE E + D ++FG+ L E+ + PY +N ++ +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEF 257
Query: 240 VTSG 243
VTSG
Sbjct: 258 VTSG 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 46/209 (22%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
Y ++VLG GA +V + + E A +K+I+ + R++ EV +L +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYA---VKIIE-KQPGHIRSRVFREVEMLYQCQ 68
Query: 86 -HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
H+N+++ + + + ++ + E G++ + K +H + + + L +
Sbjct: 69 GHRNVLELIEFFEEEDRFYL--VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDF 126
Query: 145 LHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQARSAHSVI---------- 192
LH+ + HRDLK +NI + NQ VKI D L + + +
Sbjct: 127 LHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 193 -EFMAPE------LYEEEYNELVDIYAFG 214
E+MAPE Y++ D+++ G
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 55/295 (18%), Positives = 102/295 (34%), Gaps = 28/295 (9%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI 59
++ E ++G Y+ ++GRG VY A D + VA +
Sbjct: 8 HHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVA---L 64
Query: 60 KVI--DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT-ENEHINFIT-EIFTSGT 115
K++ L + R+ E L+ +++ + D E + ++ +
Sbjct: 65 KLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH----DFGEIDGQLYVDMRLINGVD 120
Query: 116 LRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175
L ++ + RQI L H+ HRD+K +NI V+ + + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSAD-DFAYLVD 177
Query: 176 LGLAAILAQAR--SAHSVI---EFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVE 229
G+A+ + + + +MAPE + DIYA L E +T PY +
Sbjct: 178 FGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY-Q 236
Query: 230 CTNAAQIYKKVTSGIKPASLAKVAD--NGVRAFIEKCIA-EVSERLP-AKELLGD 280
+ + + I S A I + +A +R +L
Sbjct: 237 GDQLSVMGAHINQAIPRPS-TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/252 (25%), Positives = 102/252 (40%), Gaps = 50/252 (19%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLYSEVHLLKTL 84
+ + LG GAF KV A G+ + + V + +L+ + + E L SE+ +L L
Sbjct: 26 SFGKTLGAGAFGKVVEA--TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 85 -KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH------------------KH 125
H NI+ T ITE G L + ++
Sbjct: 84 GNHMNIVNLLG--ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 126 VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185
+DL L +S Q+ +G+++L S + IHRDL NI + + KI D GL A
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGL------A 192
Query: 186 RSAHSVIEF------------MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECT 231
R + + MAPE ++ Y D++++G+ L EL + PY
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 232 NAAQIYKKVTSG 243
++ YK + G
Sbjct: 253 VDSKFYKMIKEG 264
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 47/248 (18%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLER--LYSEVHLLKTLK 85
K LG GAF KV+ A E + +++ V + L++ R E LL L+
Sbjct: 18 VLKRELGEGAFGKVFLA--ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----------------KHVDLR 129
H++I+KFY V + + + + E G L ++ + H + L
Sbjct: 76 HEHIVKFYG--VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH 189
+ + QI G+ YL S +HRDL N V N VKIGD G+ +R +
Sbjct: 134 QMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM------SRDVY 184
Query: 190 SV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQ 235
S I +M PE + ++ D+++FG+ L E+ T+ + P+ + +N +
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TE 243
Query: 236 IYKKVTSG 243
+ + +T G
Sbjct: 244 VIECITQG 251
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 65/286 (22%), Positives = 121/286 (42%), Gaps = 37/286 (12%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID----LLRNSEDL----ERLYSEVHLLK 82
KE+LGRG V R + E A +K+ID ++E++ E EV +L+
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEYA---VKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 83 TLK-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+ H NII+ +++ + + ++ G L Y + + + +K R +LE
Sbjct: 79 KVSGHPNIIQLKDTYETNTFFFL--VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE 198
+ LH + ++HRDLK +NI ++ + +K+ D G + L V ++APE
Sbjct: 137 ICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193
Query: 199 -------LYEEEYNELVDIYAFGMCLLELVTFEYP--YVECTNAAQIYKKVTSGI---KP 246
Y + VD+++ G+ + L+ P + + + + SG
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHR--KQMLMLRMIMSGNYQFGS 250
Query: 247 ASLAKVADNGVRAFIEKCI-AEVSERLPAKELLGDPFLQSEDDESV 291
+D V+ + + + + +R A+E L PF Q E V
Sbjct: 251 PEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 59/312 (18%), Positives = 121/312 (38%), Gaps = 39/312 (12%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
+S + E + + Y K+VLG G KV F G + A +K
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCA---LK 60
Query: 61 VIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF--ITEIFTSGTL- 116
++ +S + EV +I+ + + + + I E G L
Sbjct: 61 LLY---DSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114
Query: 117 -RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKI 173
R + + R + R I + +LHSH+ + HRD+K +N+ + + + +K+
Sbjct: 115 SRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKL 172
Query: 174 GDLGLAAILAQAR------SAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYP 226
D G A Q + ++APE L E+Y++ D+++ G+ + L+ +P
Sbjct: 173 TDFGFAKETTQNALQTPCYTP----YYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GFP 227
Query: 227 --YVECTNAAQ--IYKKVTSG---IKPASLAKVADNGVRAFIEKCI-AEVSERLPAKELL 278
Y A + +++ G ++V+++ + I + + +ERL + +
Sbjct: 228 PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSED-AKQLIRLLLKTDPTERLTITQFM 286
Query: 279 GDPFLQSEDDES 290
P++
Sbjct: 287 NHPWINQSMVVP 298
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 46/212 (21%), Positives = 91/212 (42%), Gaps = 32/212 (15%)
Query: 29 RYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK- 85
Y+ V LGRG + +V+ A + +V +K++ +++ E+ +L+ L+
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVV---VKIL----KPVKKKKIKREIKILENLRG 89
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
NII + D + + E + +Q + D+R +IL+ L Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY---MYEILKALDYC 146
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE---------FMA 196
HS ++HRD+K N+ ++ ++++ D GL A H E F
Sbjct: 147 HSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGL------AEFYHPGQEYNVRVASRYFKG 198
Query: 197 PE--LYEEEYNELVDIYAFGMCLLELVTFEYP 226
PE + + Y+ +D+++ G L ++ + P
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 59/225 (26%), Positives = 90/225 (40%), Gaps = 49/225 (21%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
++ +LG GA+ V A + G VA IK I+ R E+ +LK KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVA---IKKIEPFDKPLFALRTLREIKILKHFKH 68
Query: 87 KNIIKFYNSWVDTENEHINF-----ITE--------IFTSGTLRQYRKKHKHVDLRALKK 133
+NII +N + + NF I E + ++ L H+ +
Sbjct: 69 ENIITIFN--IQRPDSFENFNEVYIIQELMQTDLHRVISTQML-----SDDHI-----QY 116
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----AILAQARSAH 189
+ Q L + LH + VIHRDLK N+ +N N ++K+ D GLA A
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPT 173
Query: 190 SVIEFM----------APE--LYEEEYNELVDIYAFGMCLLELVT 222
M APE L +Y+ +D+++ G L EL
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 38/218 (17%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
R++ + G+G F V ++ G+ VA IK + +++ R + L L H
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVA---IKKV--IQDPRFRNRELQIMQDLAVLHH 78
Query: 87 KNIIK----FYNSWVDTENE-HINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQ 137
NI++ FY + ++N + E + TL R Y ++ +K + Q
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVME-YVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM-- 195
++ + LH V HRD+K N+ VN G +K+ D G A L+ + E
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-------EPNVA 190
Query: 196 --------APELY--EEEYNELVDIYAFGMCLL-ELVT 222
APEL + Y VDI++ G C+ E++
Sbjct: 191 YICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMML 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 55/243 (22%), Positives = 99/243 (40%), Gaps = 41/243 (16%)
Query: 29 RYKEVLGRGAFKKVYRAF---DELEGIEVAWNQIKVI-DLLRNSEDLERLYSEVHLLKTL 84
+LG+G F V A ++ ++VA +K++ + S D+E E +K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVA---VKMLKADIIASSDIEEFLREAACMKEF 82
Query: 85 KHKNIIKFYNSWVDTENEHINF----ITEIFTSGTLRQYRKKHKHVD------LRALKKW 134
H ++ K + + + I G L + + + L+ L ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--- 191
I G+ YL S + IHRDL N + + V + D GL +R +S
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAED-MTVCVADFGL------SRKIYSGDYY 193
Query: 192 ---------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKV 240
++++A E L + Y D++AFG+ + E++T + PY N A+IY +
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNYL 252
Query: 241 TSG 243
G
Sbjct: 253 IGG 255
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 21 IDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE------ 72
+D +R RY+ + LG G F VY+A D+ VA IK I L SE +
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVA---IKKIKLGHRSEAKDGINRTA 59
Query: 73 -RLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRA 130
R E+ LL+ L H NII + +I+ + + F L + +
Sbjct: 60 LR---EIKLLQELSHPNIIGLLD--AFGHKSNISLVFD-FMETDLEVIIKDNSLVLTPSH 113
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS 190
+K + L+GL YLH H ++HRDLK +N+ ++ G +K+ D GL A+S S
Sbjct: 114 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGL------AKSFGS 164
Query: 191 VIEFM----------APELY--EEEYNELVDIYAFGMCLLELVT 222
APEL Y VD++A G L EL+
Sbjct: 165 PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 51/278 (18%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
+P D E+ P D+ E + + LGRGAF +V A + GI+
Sbjct: 6 LPLDEHCERLPYDASK--WEFPRDRL--KLGKPLGRGAFGQVIEA--DAFGIDKTATCRT 59
Query: 61 V-IDLLR---NSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGT 115
V + +L+ + L SE+ +L + H N++ + + I E G
Sbjct: 60 VAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA-CTKPGGPLMVIVEFCKFGN 118
Query: 116 LRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKC 159
L Y + + L L +S Q+ +G+ +L S IHRDL
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176
Query: 160 DNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------------IEFMAPE-LYEEEYNE 206
NI ++ VKI D GL AR + +++MAPE +++ Y
Sbjct: 177 RNILLSEK-NVVKICDFGL------ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 207 LVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSG 243
D+++FG+ L E+ + PY + +++ G
Sbjct: 230 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS----EVHLLKTLK-- 85
+G GA+ VY+A D G VA +K + + L EV LL+ L+
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 86 -HKNIIKFYNSWVDTENEHINFITEIF--TSGTLRQYRKKHKHVDLRA--LKKWSRQILE 140
H N+++ + + + +T +F LR Y K L A +K RQ L
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIE--FMAP 197
GL +LH++ ++HRDLK +NI V + G VK+ D GLA Q V+ + AP
Sbjct: 132 GLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAP 188
Query: 198 E-LYEEEYNELVDIYAFGMCLLELVT 222
E L + Y VD+++ G E+
Sbjct: 189 EVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 54/244 (22%), Positives = 99/244 (40%), Gaps = 44/244 (18%)
Query: 29 RYKEVLGRGAFKKVYRAF-----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT 83
LG GAF +VY ++ ++VA +K + + + +D E ++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVA---VKTLPEVCSEQDELDFLMEALIISK 130
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH-------VDLRALKKWSR 136
H+NI++ V ++ + E+ G L+ + ++ + + + L +R
Sbjct: 131 FNHQNIVRCIG--VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE---VKIGDLGLAAILAQARSAHSV-- 191
I G YL + IHRD+ N + G KIGD G+ AR +
Sbjct: 189 DIACGCQYLEENH--FIHRDIAARNCLLT-CPGPGRVAKIGDFGM------ARDIYRAGY 239
Query: 192 ----------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKK 239
+++M PE E + D ++FG+ L E+ + PY +N ++ +
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEF 298
Query: 240 VTSG 243
VTSG
Sbjct: 299 VTSG 302
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 50/222 (22%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
RY +G GA+ V A+D L + VA IK I + +R E+ +L +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 87 KNIIKFYNSWVDTENEHIN---FITEIFTSGTLRQYRKKHKHVDLRALKKWSR------- 136
+NII + E + + ++ + DL L K
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-------------DLYKLLKTQHLSNDHIC 131
Query: 137 ----QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI 192
QIL GL Y+HS + V+HRDLK N+ +N ++KI D GLA + A H
Sbjct: 132 YFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTT-CDLKICDFGLARV---ADPDHDHT 185
Query: 193 EFM----------APE--LYEEEYNELVDIYAFGMCLLELVT 222
F+ APE L + Y + +DI++ G L E+++
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 52/233 (22%), Positives = 98/233 (42%), Gaps = 28/233 (12%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRY--KEVLGRGAFKKVYRAFDELEGIEVAWNQI 59
+ Q D Y +Y K+V+GRG V R G E A +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA---V 124
Query: 60 KVIDLLR-------NSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFITEIF 111
K++++ E E E H+L+ + H +II +S+ + + + ++
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFL--VFDLM 182
Query: 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171
G L Y + + + + R +LE +S+LH+++ ++HRDLK +NI ++ N ++
Sbjct: 183 RKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN-MQI 239
Query: 172 KIGDLGLAAILAQARSAHSVI---EFMAPE-------LYEEEYNELVDIYAFG 214
++ D G + L + ++APE Y + VD++A G
Sbjct: 240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE----RLYSEVHLLK 82
+Y E +G G + VY+A + A +K I L + E + R E+ +LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET-FA---LKKIRLEKEDEGIPSTTIR---EISILK 55
Query: 83 TLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEG 141
LKH NI+K Y+ V + + + E L++ + + K + Q+L G
Sbjct: 56 ELKHSNIVKLYD--VIHTKKRLVLVFE-HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAP 197
++Y H V+HRDLK N+ +N +GE+KI D GLA A R H ++ + AP
Sbjct: 113 IAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 198 ELY--EEEYNELVDIYAFGMCLLELVT 222
++ ++Y+ +DI++ G E+V
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/266 (22%), Positives = 103/266 (38%), Gaps = 37/266 (13%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAF--DELEGIEVAWNQI 59
+ +PD + +D + ++++V+G G F +V +A + ++ A I
Sbjct: 5 HHHHHGKNNPDPTIYP--VLDWNDI--KFQDVIGEGNFGQVLKARIKKDGLRMDAA---I 57
Query: 60 KVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ 118
K + + +D E+ +L L H NII ++ E G L
Sbjct: 58 KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG--ACEHRGYLYLAIEYAPHGNLLD 115
Query: 119 YRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI 162
+ +K + + L ++ + G+ YL IHRDL NI
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNI 173
Query: 163 FVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPE-LYEEEYNELVDIYAFGMCLL 218
V N KI D GL+ + +MA E L Y D++++G+ L
Sbjct: 174 LVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232
Query: 219 ELVTF-EYPYVECTNAAQIYKKVTSG 243
E+V+ PY T A++Y+K+ G
Sbjct: 233 EIVSLGGTPYCGMTC-AELYEKLPQG 257
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/258 (24%), Positives = 101/258 (39%), Gaps = 50/258 (19%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLY 75
EI SA R+ E LG F KVY+ L G V I L+ E
Sbjct: 5 EISLSAV--RFMEELGEDRFGKVYKG--HLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH------------ 123
E L L+H N++ V T+++ ++ I + G L ++
Sbjct: 61 HEAMLRARLQHPNVVCLLG--VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 124 ----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
++ QI G+ YL SH V+H+DL N+ V VKI DLGL
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDK-LNVKISDLGL- 174
Query: 180 AILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EY 225
R ++ I +MAPE + +++ DI+++G+ L E+ ++
Sbjct: 175 -----FREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 226 PYVECTNAAQIYKKVTSG 243
PY +N + + + +
Sbjct: 230 PYCGYSN-QDVVEMIRNR 246
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 36/208 (17%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL----------LRNSEDLERLYSEVHLL 81
+ LG G + VY+ +L VA +K I L +R EV LL
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVA---LKEIRLEHEEGAPCTAIR----------EVSLL 54
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILE 140
K LKH NI+ ++ + + + + E + L+QY +++ +K + Q+L
Sbjct: 55 KDLKHANIVTLHD--IIHTEKSLTLVFE-YLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMA 196
GL+Y H V+HRDLK N+ +N +GE+K+ D GLA A ++ + V+ +
Sbjct: 112 GLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 197 PELY--EEEYNELVDIYAFGMCLLELVT 222
P++ +Y+ +D++ G E+ T
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMAT 196
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/257 (22%), Positives = 108/257 (42%), Gaps = 56/257 (21%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLYSEVHLLKTL 84
+ LG G F KV +A ++ V + +L+ + +L L SE ++LK +
Sbjct: 26 VLGKTLGEGEFGKVVKA--TAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--------------------- 123
H ++IK Y +++ + I E G+LR + ++
Sbjct: 84 NHPHVIKLYG--ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 124 ---KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+ + + L ++ QI +G+ YL ++HRDL NI V ++KI D GL
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEG-RKMKISDFGL-- 196
Query: 181 ILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYP 226
+R + +++MA E L++ Y D+++FG+ L E+VT P
Sbjct: 197 ----SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 227 YVECTNAAQIYKKVTSG 243
Y +++ + +G
Sbjct: 253 YPGIPP-ERLFNLLKTG 268
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 24/202 (11%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE----RLYSEVHLLKTLKHK 87
E +G G + VY+A D +G VA +K I L E + R E+ LLK L H
Sbjct: 27 EKVGEGTYGVVYKAKDS-QGRIVA---LKRIRLDAEDEGIPSTAIR---EISLLKELHHP 79
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-DLRALKKWSRQILEGLSYLH 146
NI+ + V + + E F L++ ++K +K + Q+L G+++ H
Sbjct: 80 NIVSLID--VIHSERCLTLVFE-FMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE--FMAPELY-- 200
H ++HRDLK N+ +N + G +K+ D GLA A RS H V+ + AP++
Sbjct: 137 QHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 201 EEEYNELVDIYAFGMCLLELVT 222
++Y+ VDI++ G E++T
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMIT 215
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 32/277 (11%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNI 89
KE +G G++ R + +E A +K+ID ++ D E+ LL+ +H NI
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFA---VKIID--KSKRDPTE---EIEILLRYGQHPNI 78
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
I + + D + ++ +TE+ G L + K R I + + YLH+
Sbjct: 79 ITLKDVYDDGKYVYV--VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 150 PPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYE 201
V+HRDLK NI +GN ++I D G A L F+APE L
Sbjct: 137 --VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 202 EEYNELVDIYAFGMCLLELVT----FEYPYVECTNAAQIYKKVTSG---IKPASLAKVAD 254
+ Y+ DI++ G+ L ++T F + +I ++ SG + V+D
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 255 NGVRAFIEKCI-AEVSERLPAKELLGDPFLQSEDDES 290
+ + K + + +RL A +L P++ D
Sbjct: 253 T-AKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLP 288
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 53/253 (20%)
Query: 29 RYKEVLGRGAFKKVYRA-------FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
+ LG GAF +V A E + VA +K++ +DL L SE+ ++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDATEKDLSDLVSEMEMM 94
Query: 82 KTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----------------K 124
K + KHKNII T++ + I E + G LR+Y + +
Sbjct: 95 KMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+ + L + Q+ G+ YL S IHRDL N+ V +KI D GL
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENNVMKIADFGL------ 203
Query: 185 ARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVEC 230
AR +++ +++MAPE L++ Y D+++FG+ + E+ T PY
Sbjct: 204 ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263
Query: 231 TNAAQIYKKVTSG 243
+++K + G
Sbjct: 264 PV-EELFKLLKEG 275
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 41/213 (19%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL----------LRNSEDLERLYSEVHLL 81
E LG G + VY+ ++ G+ VA +K + L +R E+ L+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVA---LKEVKLDSEEGTPSTAIR----------EISLM 57
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY------RKKHKHVDLRALKKWS 135
K LKH+NI++ Y+ V + + E F L++Y + ++L +K +
Sbjct: 58 KELKHENIVRLYD--VIHTENKLTLVFE-FMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARS-AHSVIE 193
Q+L+GL++ H + ++HRDLK N+ +N +G++K+GD GLA A + + V+
Sbjct: 115 WQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 194 --FMAPELY--EEEYNELVDIYAFGMCLLELVT 222
+ AP++ Y+ +DI++ G L E++T
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 53/228 (23%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
RY + LG G V+ A D VA IK I +L + + ++ E+ +++ L H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVA---IKKI-VLTDPQSVKHALREIKIIRRLDH 67
Query: 87 KNIIKFYN------------SWVDTENEHINFITE--------IFTSGTLRQYRKKHKHV 126
NI+K + TE + + E + G L +H
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPL-----LEEHA 122
Query: 127 DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186
+ + Q+L GL Y+HS + V+HRDLK N+F+N +KIGD GLA I+
Sbjct: 123 -----RLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD--- 172
Query: 187 SAHSVIEFM----------APE--LYEEEYNELVDIYAFGMCLLELVT 222
+S + +P L Y + +D++A G E++T
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 64/253 (25%), Positives = 107/253 (42%), Gaps = 53/253 (20%)
Query: 29 RYKEVLGRGAFKKVYRA-------FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
+ LG G F +V A E + VA +K++ +DL L SE+ ++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVA---VKMLKDDATEKDLSDLVSEMEMM 140
Query: 82 KTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----------------K 124
K + KHKNII T++ + I E + G LR+Y + +
Sbjct: 141 KMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+ + L + Q+ G+ YL S IHRDL N+ V +KI D GL
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLV-TENNVMKIADFGL------ 249
Query: 185 ARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVEC 230
AR +++ +++MAPE L++ Y D+++FG+ + E+ T PY
Sbjct: 250 ARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309
Query: 231 TNAAQIYKKVTSG 243
+++K + G
Sbjct: 310 PV-EELFKLLKEG 321
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 44/244 (18%)
Query: 29 RYKEVLGRGAFKKVYRAF---DELEGIEVAWNQIKVIDLLRNSE-DLERLYSEVHLLKTL 84
++LG G F V ++ ++VA +K + L +S+ ++E SE +K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVA---VKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 85 KHKNIIKFYNSWVDTENEHINF-----ITEIFTSGTLRQYRKKHK------HVDLRALKK 133
H N+I+ V E I G L Y + H+ L+ L K
Sbjct: 94 SHPNVIRLLG--VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-- 191
+ I G+ YL + + +HRDL N + + V + D GL ++ +S
Sbjct: 152 FMVDIALGMEYLSNRN--FLHRDLAARNCMLRDD-MTVCVADFGL------SKKIYSGDY 202
Query: 192 ----------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKK 239
++++A E L + Y D++AFG+ + E+ T PY N ++Y
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDY 261
Query: 240 VTSG 243
+ G
Sbjct: 262 LLHG 265
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 30/219 (13%)
Query: 26 RYGRYKEVLGRGAFKKVYRA--FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT 83
+ +GRG + VY+A D + + A QI+ + ++ E+ LL+
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CREIALLRE 74
Query: 84 LKHKNIIKFYNSWVDTENEHINFITE--------IFTSGTLRQYRKKHKHVDLRALKKWS 135
LKH N+I ++ + + + + I + KK + +K
Sbjct: 75 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNG---NQGEVKIGDLGLA-AILAQARS-AHS 190
QIL+G+ YLH++ V+HRDLK NI V G +G VKI D+G A + + A
Sbjct: 135 YQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 191 VIEFM-----APELY--EEEYNELVDIYAFGMCLLELVT 222
+ APEL Y + +DI+A G EL+T
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 46/248 (18%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLYSEVHLLKTL 84
++ + LG GAF KV A G+ +KV + +L+ ++++ E L SE+ ++ L
Sbjct: 49 QFGKTLGAGAFGKVVEA--TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 85 -KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--------------KHVDLR 129
+H+NI+ T + ITE G L + ++ R
Sbjct: 107 GQHENIVNLLG--ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH 189
L +S Q+ +G+++L S + IHRD+ N+ + N KIGD GLA R
Sbjct: 165 DLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGLA------RDIM 215
Query: 190 SV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQ 235
+ +++MAPE +++ Y D++++G+ L E+ + PY ++
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 236 IYKKVTSG 243
YK V G
Sbjct: 276 FYKLVKDG 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 66/257 (25%), Positives = 102/257 (39%), Gaps = 55/257 (21%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLYSEVHLLKTL 84
+ +VLG GAF KV A GI I+V + +L+ +S + E L SE+ ++ L
Sbjct: 48 EFGKVLGSGAFGKVMNA--TAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 85 -KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH------------------ 125
H+NI+ T + I I E G L Y + +
Sbjct: 106 GSHENIVNLLG--ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 126 -----VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+ L ++ Q+ +G+ +L +HRDL N+ V VKI D GL
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHG-KVVKICDFGL-- 218
Query: 181 ILAQARSAHSVIEF------------MAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYP 226
AR S + MAPE L+E Y D++++G+ L E+ + P
Sbjct: 219 ----ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 227 YVECTNAAQIYKKVTSG 243
Y A YK + +G
Sbjct: 275 YPGIPVDANFYKLIQNG 291
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 66/253 (26%), Positives = 107/253 (42%), Gaps = 53/253 (20%)
Query: 29 RYKEVLGRGAFKKVYRA-------FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
+ LG GAF +V A +VA +K++ +DL L SE+ ++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVA---VKMLKSDATEKDLSDLISEMEMM 128
Query: 82 KTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH----------------K 124
K + KHKNII T++ + I E + G LR+Y + +
Sbjct: 129 KMIGKHKNIINLLG--ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 125 HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184
+ + L + Q+ G+ YL S IHRDL N+ V + +KI D GL
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGL------ 237
Query: 185 ARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVEC 230
AR H + +++MAPE L++ Y D+++FG+ L E+ T PY
Sbjct: 238 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
Query: 231 TNAAQIYKKVTSG 243
+++K + G
Sbjct: 298 PV-EELFKLLKEG 309
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLK 85
Y +G GA+ V A D+ G +VA IK + ++ +R Y E+ LLK ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVA---IKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 86 HKNIIKFYN---SWVDTEN-EHINFITEIFTSGTLRQYRKK---HKHVDLRALKKWSRQI 138
H+N+I + N + + L++ + + + Q+
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKI-----QYLVYQM 135
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIE----- 193
L+GL Y+HS V+HRDLK N+ VN + E+KI D GL AR A + +
Sbjct: 136 LKGLKYIHSAG--VVHRDLKPGNLAVNED-CELKILDFGL------ARHADAEMTGYVVT 186
Query: 194 --FMAPE--LYEEEYNELVDIYAFGMCLLELVT 222
+ APE L YN+ VDI++ G + E++T
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 53/257 (20%), Positives = 95/257 (36%), Gaps = 56/257 (21%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLR---NSEDLERLYSEVHLLKTL 84
Y +G GAF +V++A G+ V + +L+ +++ E L+
Sbjct: 50 EYVRDIGEGAFGRVFQA--RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKH--------------------- 123
+ NI+K V + + + E G L ++ +
Sbjct: 108 DNPNIVKLLG--VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 124 ---KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180
+ +RQ+ G++YL +HRDL N V N VKI D GL
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGL-- 220
Query: 181 ILAQARSAHSV------------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYP 226
+R+ +S I +M PE ++ Y D++A+G+ L E+ ++ P
Sbjct: 221 ----SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 227 YVECTNAAQIYKKVTSG 243
Y + ++ V G
Sbjct: 277 YYGMAH-EEVIYYVRDG 292
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 42/208 (20%), Positives = 84/208 (40%), Gaps = 38/208 (18%)
Query: 17 EFVEIDPSARYGRY---KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER 73
++I +A Y +VLG G KV + F++ + A +K++ + R
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKMLQ---DCPKARR 59
Query: 74 LYSEVHLLKTL-KHKNIIKFYNSWVDT--ENEHINFITEIFTSGTL--RQYRKKHKHVDL 128
EV L + +I++ + + + + + + E G L R + +
Sbjct: 60 ---EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 116
Query: 129 RALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQG-EVKIGDLGLAAILAQAR 186
R + + I E + YLHS + + HRD+K +N+ + + +K+ D G
Sbjct: 117 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF-------- 166
Query: 187 SAHSVIEFMAPELYEEEYNELVDIYAFG 214
A E E+Y++ D+++ G
Sbjct: 167 ---------AKETTGEKYDKSCDMWSLG 185
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 6e-22
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 48/241 (19%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLK 85
RY+ ++G G++ V A+D+LE VA IK ++ + + D +R+ E+ +L L
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVA---IKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 86 HKNIIKFYNSWVDTENEHIN---FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGL 142
H +++K + + + E + + EI S ++ + ++ +K +L G+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------------------AI 181
Y+HS ++HRDLK N VN + VK+ D GLA
Sbjct: 170 KYVHSAG--ILHRDLKPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 182 LAQARSAHSVIEFM----------APE--LYEEEYNELVDIYAFGMCLL-ELVTFEYPYV 228
L ++ + APE L +E Y E +D+++ G C+ EL+ V
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLNMIKENV 285
Query: 229 E 229
Sbjct: 286 A 286
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 51/248 (20%), Positives = 86/248 (34%), Gaps = 72/248 (29%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH 86
+Y + LG G+F V FD G A +K + +D E+ ++K L H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFA---LKKV-----LQDPRYKNRELDIMKVLDH 59
Query: 87 KNIIK----FYNSWVDTENEHINFITEIFTSGT--------------------------- 115
NIIK FY + + G
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 116 --------LRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167
L+ + + + + + + + Q+ + ++HS + HRD+K N+ VN
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSK 177
Query: 168 QGEVKIGDLGLAAILAQARSAHSVIEFM----------APELY--EEEYNELVDIYAFGM 215
+K+ D G A L + E APEL EY +D+++ G
Sbjct: 178 DNTLKLCDFGSAKKLIPS-------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG- 229
Query: 216 CLL-ELVT 222
C+ EL+
Sbjct: 230 CVFGELIL 237
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 53/234 (22%), Positives = 100/234 (42%), Gaps = 57/234 (24%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLK 85
+Y+ + LG+GA+ V+++ D G VA +K + D +NS D +R + E+ +L L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVA---VKKIFDAFQNSTDAQRTFREIMILTELS 66
Query: 86 -HKNIIKFYNSWVDTENEHINFITE--------IFTSGTLRQYRKKHKHVDLRALKKWSR 136
H+NI+ N + + + + + + L + H +
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANIL-----EPVHK-----QYVVY 116
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA---------------AI 181
Q+++ + YLHS ++HRD+K NI +N VK+ D GL+ +I
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 182 LAQARSAHSVIEFM----------APE--LYEEEYNELVDIYAFGMCLL-ELVT 222
+ + APE L +Y + +D+++ G C+L E++
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 32 EVLGRGAFKKVYRAFDELEGIE-VAWNQIKVIDLLRNSEDLE----RLYSEVHLLKTLK- 85
+G GA+ KV++A D G VA +K + + E + R EV +L+ L+
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIR---EVAVLRHLET 70
Query: 86 --HKNIIKFYNSWVDTENEHINFITEIF--TSGTLRQY--RKKHKHVDLRALKKWSRQIL 139
H N+++ ++ + + +T +F L Y + V +K Q+L
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIE--FMA 196
GL +LHSH V+HRDLK NI V + G++K+ D GLA Q V+ + A
Sbjct: 131 RGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 187
Query: 197 PE-LYEEEYNELVDIYAFGMCLLELVT 222
PE L + Y VD+++ G E+
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 49/223 (21%)
Query: 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLK 82
A Y R + +G GA+ V A D G +VA IK + ++ +R Y E+ LLK
Sbjct: 24 RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVA---IKKLYRPFQSELFAKRAYRELRLLK 79
Query: 83 TLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR------ 136
++H+N+I + V T +E ++ T+ + DL L K +
Sbjct: 80 HMRHENVIGLLD--VFTPDETLDDFTDFYLVMPFMGT-------DLGKLMKHEKLGEDRI 130
Query: 137 -----QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
Q+L+GL Y+H+ +IHRDLK N+ VN + E+KI D GL AR A S
Sbjct: 131 QFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNED-CELKILDFGL------ARQADS- 180
Query: 192 IEFM----------APE--LYEEEYNELVDIYAFGMCLLELVT 222
M APE L Y + VDI++ G + E++T
Sbjct: 181 --EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 67/241 (27%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLK 85
Y ++GRG++ VY A+D+ VA IK V + + D +R+ E+ +L LK
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVA---IKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 86 HKNIIKFYNSWVDTENEHIN---FITEIFTSGTLRQYRKKHKHVDLRALKKWSR------ 136
II+ Y+ + + + + EI S DL+ L K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-------------DLKKLFKTPIFLTEEH 130
Query: 137 ------QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA----------- 179
+L G +++H +IHRDLK N +N + VK+ D GLA
Sbjct: 131 IKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQD-CSVKVCDFGLARTINSEKDTNI 187
Query: 180 -----AILAQARSAHSVIEFM----------APE--LYEEEYNELVDIYAFGMCLL-ELV 221
++ + + APE L +E Y + +DI++ G C+ EL+
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELL 246
Query: 222 T 222
Sbjct: 247 N 247
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 3e-21
Identities = 63/216 (29%), Positives = 95/216 (43%), Gaps = 42/216 (19%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLK 85
RY+ + +G GA V A+D + VA IK + +N +R Y E+ L+K +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 86 HKNIIKFYNSWVDTENEHINFITEI-----FTSGTLRQYRKK---HKHVDLRALKKWSRQ 137
HKNII N V T + + ++ L Q + H+ + Q
Sbjct: 83 HKNIIGLLN--VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERM-----SYLLYQ 135
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM-- 195
+L G+ +LHS +IHRDLK NI V + +KI D GL AR+A + M
Sbjct: 136 MLCGIKHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL------ARTAGT-SFMMTP 185
Query: 196 --------APE-LYEEEYNELVDIYAFGMCLLELVT 222
APE + Y E VDI++ G + E++
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-LERLYSEVHLLKTL 84
RY LG G F V+ A D + VA +K++ R + E E+ LL+ +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVA---MKIV---RGDKVYTEAAEDEIKLLQRV 72
Query: 85 K-----------HKNIIKFYNS--WVDTENEHINFITEIFTSGTLRQYRKKHKHV--DLR 129
+I+K + H+ + E+ L KK++H L
Sbjct: 73 NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV-LGENLLALIKKYEHRGIPLI 131
Query: 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV-----NGNQGEVKIGDLGLAAILAQ 184
+K+ S+Q+L GL Y+H +IH D+K +N+ + N ++KI DLG A +
Sbjct: 132 YVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 185 ARSAHSVIEFM-APE-LYEEEYNELVDIYAFGMCLLELVT 222
+ +PE L + DI++ + EL+T
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 42/216 (19%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI-DLLRNSEDLERLYSEVHLLKTLK 85
RY+ +G GA+ V AFD G+ VA +K + ++ +R Y E+ LLK +K
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVA---VKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 86 HKNIIKFYN---SWVDTEN-EHINFITEIFTS---GTLRQYRKKHKHVDLRALKKWSRQI 138
H+N+I + E + +T + + ++ + HV + QI
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV-----QFLIYQI 141
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM--- 195
L GL Y+HS D +IHRDLK N+ VN + E+KI D GL AR M
Sbjct: 142 LRGLKYIHSAD--IIHRDLKPSNLAVNED-CELKILDFGL------ARHTAD---EMTGY 189
Query: 196 -------APE--LYEEEYNELVDIYAFGMCLLELVT 222
APE L YN+ VDI++ G + EL+T
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 61/231 (26%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVA-------WNQIKVIDLLRNSEDLERLYSEVH 79
Y + G++ V D EGI VA + + +++L +S +R+ E+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHIN---FITEIFTSGTLRQYRKKHKHVDLRALKKWSR 136
LL H NI+ + +V E ++ +TE+ + DL + R
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-------------DLAQVIHDQR 128
Query: 137 -------------QILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
IL GL LH V+HRDL NI + N ++ I D L
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADN-NDITICDFNL----- 180
Query: 184 QARSAHSVIEFM----------APE--LYEEEYNELVDIYAFGMCLLELVT 222
AR + APE + + + +LVD+++ G + E+
Sbjct: 181 -ARED-TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 57/235 (24%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQI 59
+ DD + +++ + RY+ ++G+G+F +V +A+D +E VA I
Sbjct: 28 KERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVA---I 84
Query: 60 KVIDLLRNSED-LERLYSEVHLLKTLKH------KNIIKFYNSWVDTENEHINFITEIFT 112
K+I +N + L + EV LL+ + I+ ++ H+ + E+
Sbjct: 85 KII---KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNHLCLVFEML- 138
Query: 113 SGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQG 169
S L + V L +K+++Q+ L +L + + +IH DLK +NI N +
Sbjct: 139 SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198
Query: 170 EVKIGDLGLAAILAQARSAHSVIEFM-APE-LYEEEYNELVDIYAFGMCLLELVT 222
+KI D G + L Q + F +PE L Y+ +D+++ G L+E+ T
Sbjct: 199 AIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 1e-20
Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK-VIDLLRNSEDLERLYSEVHLLKTLK 85
RY+ + +G GA V A+D + VA IK + +N +R Y E+ L+K +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQ---YRKKHKHVDLRALKKWSRQILEGL 142
HKNII N V T + + +++ L + +D + Q+L G+
Sbjct: 120 HKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFM------- 195
+LHS +IHRDLK NI V + +KI D GL AR+A M
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD-CTLKILDFGL------ARTA-GTSFMMTPYVVTR 227
Query: 196 ---APE-LYEEEYNELVDIYAFGMCLLELVT 222
APE + Y E VDI++ G + E+V
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 29/211 (13%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-LERLYSEVHLLKTL 84
RY+ +V+G+G+F +V +A+D VA +K++ RN + + E+ +L+ L
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVA---LKMV---RNEKRFHRQAAEEIRILEHL 150
Query: 85 KHK------NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV--DLRALKKWSR 136
+ + N+I ++ HI E+ S L + KK+K L ++K++
Sbjct: 151 RKQDKDNTMNVIHMLENFTF--RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAH 207
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNI-FVNGNQGEVKIGDLGLAAILAQARSAHSVIE-- 193
IL+ L LH + +IH DLK +NI + +K+ D G + Q + I+
Sbjct: 208 SILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSR 263
Query: 194 -FMAPE-LYEEEYNELVDIYAFGMCLLELVT 222
+ APE + Y +D+++ G L EL+T
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 54/269 (20%), Positives = 123/269 (45%), Gaps = 25/269 (9%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
+G+G+F KV A +K + ++ ++ E+ +++ L+H ++
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYA---MKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
+ S+ D E+ + + ++ G LR + +++ H +K + +++ L YL +
Sbjct: 79 NLWYSFQDEED--MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR- 135
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPELYEEE---- 203
+IHRD+K DNI ++ G V I D +AA+L + ++ +MAPE++
Sbjct: 136 -IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVEC--TNAAQIYKKVTSGIK--PASLAKVADNGVRA 259
Y+ VD ++ G+ EL+ PY T++ +I + + P++ ++ + ++
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 260 FIEKCIAEVSERL-PAKELLGDPFLQSED 287
+E +R ++ P++ +
Sbjct: 254 LLEP---NPDQRFSQLSDVQNFPYMNDIN 279
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 71/232 (30%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKV--------IDLLRNSEDLERLYSEVHLLKT 83
+G+G F +V++A G +VA ++ + I LR E+ +L+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----------EIKILQL 72
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK---------HVDLRAL--- 131
LKH+N++ + EI + R K H DL L
Sbjct: 73 LKHENVVN---------------LIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN 116
Query: 132 ----------KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-A 180
K+ + +L GL Y+H + ++HRD+K N+ + G +K+ D GLA A
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARA 173
Query: 181 ILAQARSA-----HSVIE--FMAPELY--EEEYNELVDIYAFGMCLL-ELVT 222
S + V+ + PEL E +Y +D++ G C++ E+ T
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 41/286 (14%), Positives = 84/286 (29%), Gaps = 49/286 (17%)
Query: 1 MPQDTTSEQDPDDS-DAEFVEIDPSARY--GRYK--EVLGRGAFKKVYRAFDELEGIEVA 55
+ D E D + S + V++ P AR GRY+ G + ++A D +VA
Sbjct: 1 IAFDALREPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVA 60
Query: 56 WNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTS 113
+ + + + L+ S L + + + + V + E
Sbjct: 61 ---LTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD--VVHTRAGGLVVAEWIRG 115
Query: 114 GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173
G+L++ A+ + + + H V + V+ + G+V +
Sbjct: 116 GSLQEVADTSPSPV-GAI-RAMQSLAAAADAAHRAG--VALSIDHPSRVRVSID-GDVVL 170
Query: 174 GDLGLAAILAQARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNA 233
A + DI G L L+ +P E
Sbjct: 171 AYPATMP-DANPQD---------------------DIRGIGASLYALLVNRWPLPEAGVR 208
Query: 234 AQI---YKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKE 276
+ + + + + I I+ V+ R +
Sbjct: 209 SGLAPAERDTAGQPIEPA-------DIDRDIPFQISAVAARSVQGD 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 62/252 (24%), Positives = 116/252 (46%), Gaps = 25/252 (9%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVID---LLRNSEDLERLYSEVHLLKTLKHKNI 89
+LG G+F V A + E A IK+++ +++ ++ + + E ++ L H
Sbjct: 37 ILGEGSFSTVVLARELATSREYA---IKILEKRHIIKENK-VPYVTRERDVMSRLDHPFF 92
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+K Y ++ D E + F +G L +Y +K D + ++ +I+ L YLH
Sbjct: 93 VKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 150
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS---AHSV---IEFMAPE-LYEE 202
+IHRDLK +NI +N ++I D G A +L+ A+S ++++PE L E+
Sbjct: 151 --IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IK-PASLAKVADNGVRAF 260
+ D++A G + +LV P+ N I++K+ P A + V
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 266
Query: 261 IEKCIAEVSERL 272
+ + ++RL
Sbjct: 267 LVL---DATKRL 275
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 6e-17
Identities = 63/276 (22%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
VLGRG F +V+ + G A K + L+ + + E +L + + I+
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYA---CKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIV 248
Query: 91 KFYNSWVDTENEHINFITEIFTSGTL----RQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
++ +T+ + + I G + + + ++ QI+ GL +LH
Sbjct: 249 SLAYAF-ETK-TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYE 201
+ +I+RDLK +N+ ++ + G V+I DLGLA + A FMAPE L
Sbjct: 307 QRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYV---ECTNAAQIYKKVTSG-IK-PASLAKVADNG 256
EEY+ VD +A G+ L E++ P+ E ++ ++V + P + + +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDF 423
Query: 257 VRAFIEKCIAEVSERL-----PAKELLGDPFLQSED 287
A ++K + +RL L P +
Sbjct: 424 CEALLQK---DPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 57/284 (20%), Positives = 128/284 (45%), Gaps = 25/284 (8%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYGRYK-------EVLGRGAFKKVYRAFDELEGIEV 54
+ + ++ + +F++ + + + LG G+F +V + G
Sbjct: 10 SEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHY 69
Query: 55 AWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSG 114
A + +++ + +E +E +L+ + ++K S+ D N + + E G
Sbjct: 70 AMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGG 126
Query: 115 TLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174
+ + ++ + ++ QI+ YLHS D +I+RDLK +N+ ++ QG +++
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVT 183
Query: 175 DLGLAAILAQARSAHSV---IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVEC 230
D G A + ++ E +APE + + YN+ VD +A G+ + E+ YP
Sbjct: 184 DFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA-GYPPFFA 240
Query: 231 TNAAQIYKKVTSG-IK-PASLAKVADNGVRAFIEKCIAEVSERL 272
QIY+K+ SG ++ P+ + + +R ++ ++++R
Sbjct: 241 DQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV---DLTKRF 281
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 55/274 (20%), Positives = 114/274 (41%), Gaps = 31/274 (11%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
VLG+G F +V G A K + ++ + +E +L+ + + ++
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYA---CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQ--YRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
++ +T+ + + + + G L+ Y ++ +I GL LH
Sbjct: 248 SLAYAY-ETK-DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPE-LYEEEY 204
+++RDLK +NI ++ + G ++I DLGLA + + ++ + +MAPE + E Y
Sbjct: 306 R--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK------PASLAKVADNGVR 258
D +A G L E++ + P+ + ++V +K + A +
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPF-QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421
Query: 259 AFIEKCIAEVSERL-----PAKELLGDPFLQSED 287
+ K + +ERL A+E+ P + +
Sbjct: 422 QLLCK---DPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 61/250 (24%), Positives = 113/250 (45%), Gaps = 19/250 (7%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI---DLLRNSEDLERLYSEVHLLKTLKHKNI 89
VLG+G + KV++ +KV+ ++RN++D +E ++L+ +KH I
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ T + I E + G L ++ + +I L +LH
Sbjct: 84 VDLIYAF-QTG-GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+I+RDLK +NI +N +QG VK+ D GL + H+ IE+MAPE L +
Sbjct: 142 --IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIE 262
N VD ++ G + +++T P+ N + K+ P L + A + ++ ++
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLK 257
Query: 263 KCIAEVSERL 272
+ + RL
Sbjct: 258 R---NAASRL 264
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 58/269 (21%), Positives = 128/269 (47%), Gaps = 26/269 (9%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
+LG+G F KV ++ G A +K++ +++ +++ +E +L+ +H +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYA---MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
++ T + + F+ E G L + + + + + +I+ L YLHS D
Sbjct: 69 ALKYAF-QTH-DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD- 125
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEYN 205
V++RD+K +N+ ++ G +KI D GL ++ + + E++APE L + +Y
Sbjct: 126 -VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 206 ELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IK-PASLAKVADNGVRAFIEK 263
VD + G+ + E++ P+ + ++++ + I+ P +L+ A + + ++K
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 264 CIAEVSERL-----PAKELLGDPFLQSED 287
+ +RL AKE++ F S +
Sbjct: 243 ---DPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 65/291 (22%), Positives = 144/291 (49%), Gaps = 28/291 (9%)
Query: 2 PQDTTSEQDPDDSDAEFVEIDPSARYG------RYKEVLGRGAFKKVYRAFDELEGIEVA 55
P+ + P + ++ + + PS+ + +V+G+G+F KV A + E + A
Sbjct: 8 PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYA 67
Query: 56 WNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNIIKFYNSWVDTENEHINFITEIFT 112
+KV+ + ++ + + SE + LLK +KH ++ + S+ T + + F+ +
Sbjct: 68 ---VKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-QTA-DKLYFVLDYIN 122
Query: 113 SGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172
G L + ++ + + ++ +I L YLHS + +++RDLK +NI ++ +QG +
Sbjct: 123 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIV 179
Query: 173 IGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
+ D GL + + + E++APE L+++ Y+ VD + G L E++ P+
Sbjct: 180 LTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 228 VECTNAAQIYKKVTSG-IK-PASLAKVADNGVRAFIEKCIAEVSERLPAKE 276
N A++Y + + ++ ++ A + + ++K + ++RL AK+
Sbjct: 240 -YSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK---DRTKRLGAKD 286
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 65/308 (21%), Positives = 134/308 (43%), Gaps = 32/308 (10%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSARYGRYK-------EVLGRGAFKKVYRAFDELEGIE 53
D S D+S AE +E+ + R ++LG+G F KV ++ G
Sbjct: 116 AEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRY 175
Query: 54 VAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111
A +K++ +++ +++ +E +L+ +H + S+ T + + F+ E
Sbjct: 176 YA---MKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-QTH-DRLCFVMEYA 230
Query: 112 TSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171
G L + + + + + +I+ L YLHS V++RDLK +N+ ++ G +
Sbjct: 231 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLDK-DGHI 288
Query: 172 KIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYP 226
KI D GL + + + E++APE L + +Y VD + G+ + E++ P
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
Query: 227 YVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIEKCIAEVSERL-----PAKELLG 279
+ + ++++ + P +L A + + ++K + +RL AKE++
Sbjct: 349 F-YNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK---DPKQRLGGGSEDAKEIMQ 404
Query: 280 DPFLQSED 287
F
Sbjct: 405 HRFFAGIV 412
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 47/227 (20%), Positives = 84/227 (37%), Gaps = 43/227 (18%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIE-VAWNQIKVIDLLRNSED-LERLYSEVHLLKT 83
RY+ LG G F KV D G VA +K+I RN E E+++LK
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVA---LKII---RNVGKYREAARLEINVLKK 72
Query: 84 LKHK------NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV--DLRALKKWS 135
+K K + + W + H+ E+ ++ K++ L ++ +
Sbjct: 73 IKEKDKENKFLCVLMSD-WFNFHG-HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF- 194
Q+ L +LH + + H DLK +NI ++ E + + ++ V +F
Sbjct: 130 YQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 195 ------------------MAPE-LYEEEYNELVDIYAFGMCLLELVT 222
PE + E + + D+++ G L E
Sbjct: 188 SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 47/227 (20%), Positives = 88/227 (38%), Gaps = 43/227 (18%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIE-VAWNQIKVIDLLRNSED-LERLYSEVHLLKT 83
RY+ + LG GAF KV D G VA +K++ +N + E SE+ +L+
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVA---VKIV---KNVDRYCEAARSEIQVLEH 67
Query: 84 LKHK------NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV--DLRALKKWS 135
L ++ W + HI + E+ + + K++ + L ++K +
Sbjct: 68 LNTTDPNSTFRCVQMLE-WFEHHG-HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMA 124
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEF- 194
QI + +++LHS+ + H DLK +NI + V++F
Sbjct: 125 YQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 195 ------------------MAPE-LYEEEYNELVDIYAFGMCLLELVT 222
APE + +++ D+++ G L+E
Sbjct: 183 SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 47/231 (20%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-LERLYSEVHLLKTL 84
+ +G G F +V A +KV+ RN + E +LK +
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYA---VKVV---RNIKKYTRSAKIEADILKKI 88
Query: 85 KH-----KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV--DLRALKKWSRQ 137
++ NI+K++ + H+ I E +L + ++ + + +K + +
Sbjct: 89 QNDDINNNNIVKYHG-KFMYYD-HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS------V 191
IL+ L+YL + H DLK +NI ++ E + + + + + +
Sbjct: 146 ILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 192 IEF-------------------MAPE-LYEEEYNELVDIYAFGMCLLELVT 222
I+F APE + ++ D+++FG L EL T
Sbjct: 204 IDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 59/270 (21%), Positives = 123/270 (45%), Gaps = 27/270 (10%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNI 89
VLG+G+F KV + + A +K++ D++ +D+E E L K +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYA---VKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ + T + + F+ E G L + ++ ++ +I GL +L S
Sbjct: 405 TQLHSCF-QTM-DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+I+RDLK DN+ ++ +G +KI D G+ + + + +++APE + + Y
Sbjct: 463 --IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 519
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIE 262
+ VD +AFG+ L E++ + P+ E + ++++ + P S++K A + +
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 578
Query: 263 KCIAEVSERL-----PAKELLGDPFLQSED 287
K +RL +++ F + D
Sbjct: 579 K---HPGKRLGCGPEGERDIKEHAFFRYID 605
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 52/262 (19%), Positives = 120/262 (45%), Gaps = 35/262 (13%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQ----IKVI---DLLRNSEDLERLYSEVHLLKTLK 85
VLG GA+ KV+ I +KV+ +++ ++ E +E +L+ ++
Sbjct: 61 VLGTGAYGKVFLV----RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 86 HKN-IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
++ + ++ ++ I + G L + + + ++ + +I+ L +
Sbjct: 117 QSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 174
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA--AILAQARSAHSV---IEFMAPEL 199
LH +I+RD+K +NI ++ + G V + D GL+ + + A+ IE+MAP++
Sbjct: 175 LHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 200 YEEE---YNELVDIYAFGMCLLELVT----FEYPYVECTNAAQIYKKVTSG-IK-PASLA 250
+++ VD ++ G+ + EL+T F E + A+I +++ P ++
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPF-TVDGEKNSQAEISRRILKSEPPYPQEMS 290
Query: 251 KVADNGVRAFIEKCIAEVSERL 272
+A + ++ + K + +RL
Sbjct: 291 ALAKDLIQRLLMK---DPKKRL 309
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 62/254 (24%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNI 89
+LG+G+F KV+ A + A IK + D++ +D+E E L +H +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFA---IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ T+ E++ F+ E G L + + DL ++ +I+ GL +LHS
Sbjct: 81 THMFCTF-QTK-ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+++RDLK DNI ++ G +KI D G+ + ++ +++APE L ++Y
Sbjct: 139 --IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 195
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIE 262
N VD ++FG+ L E++ + P+ + +++ + P L K A + +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 254
Query: 263 KCIAEVSERLPAKE 276
+ E +RL +
Sbjct: 255 R---EPEKRLGVRG 265
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 61/258 (23%), Positives = 121/258 (46%), Gaps = 29/258 (11%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNI 89
V+GRG++ KV + A +KV+ +L+ + ED++ + +E H + H +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYA---MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ + TE + F+ E G L + ++ + + + +S +I L+YLH
Sbjct: 73 VGLHSCF-QTE-SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+I+RDLK DN+ ++ +G +K+ D G+ L + + ++APE L E+Y
Sbjct: 131 --IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 187
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIY----KKVTSGIK------PASLAKVAD 254
VD +A G+ + E++ P+ ++ + I P SL+ A
Sbjct: 188 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 247
Query: 255 NGVRAFIEKCIAEVSERL 272
+ +++F+ K + ERL
Sbjct: 248 SVLKSFLNK---DPKERL 262
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 62/250 (24%), Positives = 123/250 (49%), Gaps = 26/250 (10%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI---DLLRNSEDLERLYSEVHLLKTLKHKNI 89
LG G+F +V+ G A +KV+ ++R + +E E +L + H I
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYA---MKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFI 68
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHSH 148
I+ + ++ D + I I + G L RK + + A K ++ ++ L YLHS
Sbjct: 69 IRMWGTFQDAQQ--IFMIMDYIEGGELFSLLRKSQRFPNPVA-KFYAAEVCLALEYLHSK 125
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---IEFMAPE-LYEEEY 204
D +I+RDLK +NI ++ G +KI D G A + +++ +++APE + + Y
Sbjct: 126 D--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPY 180
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IK-PASLAKVADNGVRAFIE 262
N+ +D ++FG+ + E++ P+ +N + Y+K+ + ++ P + + + I
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLIT 239
Query: 263 KCIAEVSERL 272
+ ++S+RL
Sbjct: 240 R---DLSQRL 246
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 56/253 (22%), Positives = 111/253 (43%), Gaps = 24/253 (9%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLL---KTLKHK 87
++GRG F +VY G A +K + ++ + +E +L T
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYA---MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 252
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I+ ++ + ++FI ++ G L + +H ++ ++ +I+ GL ++H+
Sbjct: 253 FIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 310
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFMAPE--LYEEE 203
V++RDLK NI ++ G V+I DLGLA ++ + SV +MAPE
Sbjct: 311 RF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVA 367
Query: 204 YNELVDIYAFGMCLLELVTFEYP-YVECT-NAAQIYKKVTSG--IKPASLAKVADNGVRA 259
Y+ D ++ G L +L+ P T + +I + + P S + + +
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
Query: 260 FIEKCIAEVSERL 272
+++ +V+ RL
Sbjct: 428 LLQR---DVNRRL 437
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 59/270 (21%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNI 89
VLG+G+F KV + + A +K++ D++ +D+E E L K +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYA---VKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ + T + + F+ E G L + ++ ++ +I GL +L S
Sbjct: 84 TQLHSCF-QTM-DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+I+RDLK DN+ ++ ++G +KI D G+ + + + +++APE + + Y
Sbjct: 142 --IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY 198
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIE 262
+ VD +AFG+ L E++ + P+ E + ++++ + P S++K A + +
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 257
Query: 263 KCIAEVSERL-----PAKELLGDPFLQSED 287
K +RL +++ F + D
Sbjct: 258 K---HPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 62/254 (24%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNI 89
VLG+G+F KV A + G A +KV+ D++ +D+E +E L H +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYA---VKVLKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ + + T + + F+ E G L + +K + D + ++ +I+ L +LH
Sbjct: 87 TQLFCCF-QTP-DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+I+RDLK DN+ ++ +G K+ D G+ + + + +++APE L E Y
Sbjct: 145 --IIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAFIE 262
VD +A G+ L E++ P+ E N +++ + + + P L + A +++F+
Sbjct: 202 GPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260
Query: 263 KCIAEVSERLPAKE 276
K + RL +
Sbjct: 261 K---NPTMRLGSLT 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 44/255 (17%), Positives = 105/255 (41%), Gaps = 26/255 (10%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI---DLLRNSEDLERLYSEVHLLKTLKHKNI 89
V+GRGAF +V + A +K++ ++++ S+ + E ++ +
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYA---MKLLSKFEMIKRSD-SAFFWEERDIMAFANSPWV 131
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ + ++ D + ++ + E G L + + A + ++ +++ L +HS
Sbjct: 132 VQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTAEVVLALDAIHSMG 188
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEFMAPEL----- 199
IHRD+K DN+ ++ G +K+ D G + + ++++PE+
Sbjct: 189 --FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 200 YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD--NGV 257
+ Y D ++ G+ L E++ + P+ + Y K+ + + D
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304
Query: 258 RAFIEKCIAEVSERL 272
+ I + + RL
Sbjct: 305 KNLICAFLTDREVRL 319
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 50/215 (23%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVH-LLKTLKHKNI 89
V+GRG++ KV + A ++V+ +L+ + ED++ + +E H + H +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYA---MRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ ++ + TE + F+ E G L + ++ + + + +S +I L+YLH
Sbjct: 116 VGLHSCF-QTE-SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEEEY 204
+I+RDLK DN+ ++ +G +K+ D G+ L + + ++APE L E+Y
Sbjct: 174 --IIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 205 NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239
VD +A G+ + E++ P+ ++ +
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER-LYSEVHLLKTLKHKNIIK 91
++G G F KVY+ +G +VA +K S +E+ L +H +++
Sbjct: 46 LIGHGVFGKVYKGVLR-DGAKVA---LKR--RTPESSQGIEEFETEIETLSFCRHPHLVS 99
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQ--YRKKHKHVDLRALKKWSR--QILE----GLS 143
+ D NE I I + +G L++ Y + + W + +I GL
Sbjct: 100 LI-GFCDERNEMI-LIYKYMENGNLKRHLYGSDLPTMSM----SWEQRLEICIGAARGLH 153
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMA 196
YLH+ +IHRD+K NI ++ N KI D G++ + H + + ++
Sbjct: 154 YLHT--RAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTH-LSTVVKGTLGYID 209
Query: 197 PELYEEEY-NELVDIYAFGMCLLELVT 222
PE + + E D+Y+FG+ L E++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLC 236
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLER-LYSEVHLLKTLKHKNIIK 91
+G G F VY+ + + VA ++ + +E+L++ E+ ++ +H+N+++
Sbjct: 38 KMGEGGFGVVYKGY--VNNTTVAVKKLAA-MVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQY---RKKHKHVDLRALKKWSR--QILE----GL 142
+ ++ + +G+L + W +I + G+
Sbjct: 95 LL-GFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLS------WHMRCKIAQGAANGI 146
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFM 195
++LH + IHRD+K NI ++ KI D GLA + + +M
Sbjct: 147 NFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTV-MTSRIVGTTAYM 202
Query: 196 APELYEEEYNELVDIYAFGMCLLELVT 222
APE E DIY+FG+ LLE++T
Sbjct: 203 APEALRGEITPKSDIYSFGVVLLEIIT 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 52/262 (19%), Positives = 110/262 (41%), Gaps = 36/262 (13%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
V+GRGAF +V + A +K++ + + E +L K I
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFA---MKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSR----QILEGLSYLH 146
+ ++ D + ++ + + + G L K + R ++ +R +++ + +H
Sbjct: 138 TLHYAFQD--DNNLYLVMDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVH 192
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEFMAPELYE 201
+HRD+K DNI ++ G +++ D G L + + S ++++PE+ +
Sbjct: 193 QLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 202 EE------YNELVDIYAFGMCLLELVTFEYP-YVECTNAAQIYKKVTSGIK----PASLA 250
Y D ++ G+C+ E++ E P Y E + + Y K+ + + P +
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKERFQFPTQVT 307
Query: 251 KVADNGVRAFIEKCIAEVSERL 272
V++N + I + I RL
Sbjct: 308 DVSENA-KDLIRRLICSREHRL 328
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 11/128 (8%)
Query: 124 KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+ L L +S Q+ +G+ +L S IHRDL NI ++ VKI D GLA +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEKN-VVKICDFGLARDIY 244
Query: 184 ------QARSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQ 235
+ A +++MAPE +++ Y D+++FG+ L E+ + PY +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 236 IYKKVTSG 243
+++ G
Sbjct: 305 FCRRLKEG 312
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 38/175 (21%), Positives = 68/175 (38%), Gaps = 20/175 (11%)
Query: 1 MPQDTTSEQDPDDSDAEFVEIDPSA-RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQI 59
+P D E+ P D+ ++ E + G+ LGRGAF +V A + GI+
Sbjct: 1 LPLDEHCERLPYDAS-KW-EFPRDRLKLGK---PLGRGAFGQVIEA--DAFGIDKTATCR 53
Query: 60 KV-IDLLR---NSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSG 114
V + +L+ + L SE+ +L + H N++ + I E G
Sbjct: 54 TVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL-GACTKPGGPLMVIVEFCKFG 112
Query: 115 TLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169
L Y + ++ + K + +G Y+ + I DLK + +Q
Sbjct: 113 NLSTYLRSKRN-EFVPYKTKGARFRQGKDYVGA-----IPVDLKRRLDSITSSQS 161
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/278 (19%), Positives = 109/278 (39%), Gaps = 33/278 (11%)
Query: 33 VLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNII 90
V+GRGAF +V + G A +K++ + ++ E +L + I
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYA---MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 91 KFYNSWVDTENEHINFITEIFTSGTL-RQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
+ + ++ D ++ + E + G L K + + + + +I+ + +H
Sbjct: 125 QLHFAFQD--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEFMAPEL----- 199
+HRD+K DNI ++ G +++ D G L + S+ ++++PE+
Sbjct: 183 --YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 200 ---YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK----PASLAKV 252
Y D +A G+ E+ + P+ + A+ Y K+ + P V
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLPLVDEGV 298
Query: 253 ADNGVRAFIEKCIAEVSERL---PAKELLGDPFLQSED 287
+ R FI++ + RL A + PF D
Sbjct: 299 PEEA-RDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLD 335
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 60/267 (22%), Positives = 118/267 (44%), Gaps = 30/267 (11%)
Query: 33 VLGRGAFKKVY---RAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHK 87
VLG+G+F KV+ + A +KV+ L+ + + E +L + H
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYA---MKVLKKATLKVRDRVRTK-MERDILVEVNHP 86
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
I+K + ++ TE + I + G L K +K + ++ L +LHS
Sbjct: 87 FIVKLHYAF-QTE-GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSV---IEFMAPE-LYEE 202
+I+RDLK +NI ++ +G +K+ D GL+ + + A+S +E+MAPE +
Sbjct: 145 LG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAF 260
+ + D ++FG+ + E++T P+ + + + + P L+ A + +R
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFLSPEAQSLLRML 260
Query: 261 IEKCIAEVSERL-----PAKELLGDPF 282
++ + RL +E+ F
Sbjct: 261 FKR---NPANRLGAGPDGVEEIKRHSF 284
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 64/228 (28%)
Query: 29 RYKEVLGRGAFKKVYRAFDELE-GIEVAWNQIKVIDLLRNS---EDLERLYSEVHLLKTL 84
K +LGRG F KVY+ L G VA +K L +L+ +EV ++
Sbjct: 33 SNKNILGRGGFGKVYKGR--LADGTLVA---VKR--LKEERTQGGELQFQ-TEVEMISMA 84
Query: 85 KHKNIIKFY-----------------NSWVDTENEHINFITEIFTSGTLRQYRKKHKHVD 127
H+N+++ N V + LR+ + +D
Sbjct: 85 VHRNLLRLRGFCMTPTERLLVYPYMANGSVAS---------------CLRERPESQPPLD 129
Query: 128 LRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186
++ + GL+YLH H DP +IHRD+K NI ++ E +GD GLA L +
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAK-LMDYK 187
Query: 187 SAHSVIEFM------APELYEEEY------NELVDIYAFGMCLLELVT 222
H AP EY +E D++ +G+ LLEL+T
Sbjct: 188 DTHVTTAVRGTIGHIAP-----EYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 68.3 bits (166), Expect = 4e-12
Identities = 102/659 (15%), Positives = 190/659 (28%), Gaps = 182/659 (27%)
Query: 15 DAEFVEIDPSARYGRYKEVLG--RGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLE 72
D E E Y YK++L AF + D + + ++ ++ ++ + + +
Sbjct: 8 DFETGEHQ----YQ-YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVS 62
Query: 73 RLYSEVHLLKTLKHKNIIK-FYNSWVDTENEHINFITEIF------TSGTLRQYRKKHK- 124
L + K + +++ F + + F+ S R Y ++
Sbjct: 63 GTLRLFWTLLS-KQEEMVQKFVE---EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 125 -HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183
+ D + K++ L+ L + N+ ++G G G +A +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQA----LLELRPAKNVLIDGVLG---SGKTWVALDVC 171
Query: 184 QARSAHSVIEFMAPELYEEEYNELVDIY--AFGMC-----LLE-LVTFEYPYVECTNAAQ 235
+ ++F I+ C +LE L Y Q
Sbjct: 172 LSYKVQCKMDF--------------KIFWLNLKNCNSPETVLEMLQKLLY---------Q 208
Query: 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIAEVSERLPAKELLGDPFLQSEDDESVGRSL 295
I TS +D+ + I + L + LL + L
Sbjct: 209 IDPNWTSR---------SDHSSNIKLR--IHSIQAEL--RRLLKSKPYE--------NCL 247
Query: 296 RVKTHYSAETSHQANLDKNAYGSSAETGRDFTVQGQ----RRDIN-TIFLKLRISDSTGH 350
V L N +A+ F + + R T FL + +T H
Sbjct: 248 LV-------------LL-NVQ--NAKAWNAFNLSCKILLTTRFKQVTDFLS---AATTTH 288
Query: 351 FRNIHF--PF-DTEADTAFAVASEMVEELNLTDQD----VSTIS----AMIESEIRSHIP 399
H E + L+ QD V T + ++I IR +
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKY------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLA 342
Query: 400 DWEP-KEIAGDRMYETV-ANLGICSPKTN----DEASVMMSELNRSPSGLQMETLPSGHK 453
W+ K + D++ + ++L + P D SV + L +
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL-------- 394
Query: 454 YWSDSPKETNRNSQGKSATSSRYSLSE--HNERTPGTPDSYRDDDSPNSAASLEQLEDDH 511
W D K K +YSL E E T P Y + LE H
Sbjct: 395 IWFDVIKSDVMVVVNKLH---KYSLVEKQPKESTISIPSIYLE-----LKVKLENEYALH 446
Query: 512 --ISDCVGNIGLKDGSGITNLQLDS----------TTHQLEDKCE----ILLN------- 548
I D D + LD + ++ + L+
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQK 506
Query: 549 --------TESEGVKHVVEKFE-YL--LVKQQNEVDELKRKHELAISDFLKELSPEIHR 596
S + + +++ + Y + + + L AI DFL ++ +
Sbjct: 507 IRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN----AILDFLPKIEENLIC 561
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 8e-08
Identities = 75/570 (13%), Positives = 158/570 (27%), Gaps = 178/570 (31%)
Query: 9 QDPDDSDAEFV-------EIDPSARYGRYKEVLGR-----GAFKK--VYRAFDELEGIEV 54
++ + +F+ + PS Y E R F K V R
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR---------- 133
Query: 55 AWNQIKVIDLLRNSEDLERLYSE----VH---------L-LKTLK-HKNIIKFYNS--WV 97
++ LR + L L + + L +K K W+
Sbjct: 134 ----LQPYLKLRQA--LLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187
Query: 98 DTENEHI---------NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS- 147
+ +N + + +I + T R + + + +++ R++L+ Y +
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247
Query: 148 ------HDPPVIHR-DLKCDNIFVNGNQGEVKI----GDLGLAAILAQARSAHSVIEFMA 196
+ + +L C KI + L+ A + H ++ +
Sbjct: 248 LVLLNVQNAKAWNAFNLSC------------KILLTTRFKQVTDFLSAATTTHISLDHHS 295
Query: 197 PELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTN--------AAQI------------ 236
L +E L L+ + P T A I
Sbjct: 296 MTLTPDEVKSL-----LLKY-LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 237 --YKKVTSGIKPASLAKVADNGVRAFIEKC-IAEVSERLPAKEL----LGDPFLQSED-- 287
K+T+ I+ +SL + R ++ + S +P L
Sbjct: 350 VNCDKLTTIIE-SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVV 408
Query: 288 DESVGRSL-----------------RVKTHYSAETS-HQANLDKNAYGSSAETGRDFTVQ 329
++ SL +K E + H++ +D Y + D
Sbjct: 409 NKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH--Y--NIPKTFDSDDL 464
Query: 330 GQRRDINTIF-------LKLRISDSTGHFRNIHFPFD------TEADTAFAVASEMVEEL 376
+ + + FR + F TA+ + ++ L
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 377 NLTDQDVSTISAMIESEIRSHIPDWEPKEIAGDRMYETVANLGICSPKTNDEASVMMSEL 436
Q + + +I D +PK +R+ + + + + N L
Sbjct: 525 ----QQLKF--------YKPYICDNDPKY---ERLVNAILDF-LPKIEEN---------L 559
Query: 437 NRSPSG--LQMETLPSGHKYWSDSPKETNR 464
S L++ + + ++ K+ R
Sbjct: 560 ICSKYTDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-05
Identities = 59/400 (14%), Positives = 111/400 (27%), Gaps = 111/400 (27%)
Query: 307 HQANLDKNAYGSSAETGRDFTVQGQRRDINTIFLKLRISD--------------STGHFR 352
H ++D ETG Q Q +DI ++F + + S
Sbjct: 3 HHHHMD-------FETGE---HQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID 52
Query: 353 NI----------HFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHIPDWE 402
+I F T + + VEE+ + + + I++E R
Sbjct: 53 HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV--LRINYKFLMSPIKTEQRQPSMMTR 110
Query: 403 PKEIAGDRMYETV---ANLGICSPKTNDEASVMMSELNRSP---------SG---LQMET 447
DR+Y A + + + + EL + SG + ++
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV 170
Query: 448 L--------PSGHKYW-----SDSPKETNRNSQG--KSATSSRYSLSEHNERTPGTPDSY 492
+W +SP+ Q + S S+H+ S
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 493 RDDDS--------PNSAASLEQLEDDHISDCVGNIGLK------DGSGITNLQLDSTTH- 537
+ + N L +++ + N+ K L +TTH
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAF-NLSCKILLTTRFKQVTDFLSAATTTHI 289
Query: 538 QLEDKCEILLNTESEGV--KHVVEKFEYL---------LV------KQQNEVDELKR--- 577
L+ L E + + K++ + + L ++ +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKH 349
Query: 578 ----KHELAISDFLKELSPEIHRKILGMLKL-----KIPA 608
K I L L P +RK+ L + IP
Sbjct: 350 VNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT 389
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 33/174 (18%), Positives = 73/174 (41%), Gaps = 32/174 (18%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
++ + +G G F +Y AF + + A + +KV ++ L+SE+ + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKV-----EYQENGPLFSELKFYQRVA 91
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-------DLRALKKWSR-- 136
K+ I W++ + I + SG + ++ + DL+ + +
Sbjct: 92 KKDCI---KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 137 ----------QILEGLSYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLA 179
++L+ L Y+H ++ +H D+K N+ + N +V + D GL+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 74/368 (20%), Positives = 125/368 (33%), Gaps = 117/368 (31%)
Query: 28 GRYKEV--LGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
GRY + LG G F V+ ++D VA +KV+ E E+ LLK+++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVA---MKVV--KSAEHYTETALDEIRLLKSVR 91
Query: 86 --------HKNIIKFYNS-WVDTEN-EHINFITEIFTSGTLRQYRKKHKH--VDLRALKK 133
+ +++ + + N HI + E L ++ K + + L +KK
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKK 150
Query: 134 WSRQILEGLSYLHSHDPPVIHRDLKCDNIFV----------------------------- 164
+Q+L+GL YLH+ +IH D+K +NI +
Sbjct: 151 IIQQVLQGLDYLHTK-CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 165 -------------------NGNQGEVKIGDLGLAAILAQARSA-HSVIEFMAPE-LYEEE 203
N + +VKI DLG A + + + ++ + E L
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNA---------AQIYK---------------- 238
YN DI++ EL T +Y + + A I +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329
Query: 239 ----------KVTSGIKPASLAKVAD----------NGVRAFIEKCIA-EVSERLPAKEL 277
K + +KP L +V G F+ + +R A E
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 278 LGDPFLQS 285
L P+L S
Sbjct: 390 LRHPWLNS 397
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 31/175 (17%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
+K +G+G F +Y A D V + V+ + D L++E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKV--EPSDNGPLFTELKFYQRAA 91
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV-------DLRAL-----KK 133
I W+ T + + + SG + K ++ + DL+ + K+
Sbjct: 92 KPEQI---QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR 148
Query: 134 WSR--------QILEGLSYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLA 179
+SR +IL+ L Y+H H+ +H D+K N+ +N N +V + D GLA
Sbjct: 149 FSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 39/158 (24%), Positives = 63/158 (39%), Gaps = 17/158 (10%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY+ +G G+F +Y D G EVA I L +L+ E + K ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA------IKLECVKTKHPQLHIESKIYKMMQ 62
Query: 86 H-KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLS 143
I W E ++ N + +L + L+ + + Q++ +
Sbjct: 63 GGVGIPTIR--WCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 144 YLHSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLA 179
Y+HS + IHRD+K DN + V I D GLA
Sbjct: 120 YIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 3e-08
Identities = 52/332 (15%), Positives = 95/332 (28%), Gaps = 74/332 (22%)
Query: 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE------- 69
F P+ + R ++ +G G F +V++ + VA IK+I +
Sbjct: 12 PFSHCLPTEKLQRCEK-IGEGVFGEVFQTIA--DHTPVA---IKIIAIEGPDLVNGSHQK 65
Query: 70 DLERLYSEVHLLKTL---------KHKNIIKFYNSWV----------------------- 97
E + E+ + K L + + I +
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 98 ----DTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVI 153
D + FI F G + + + K L K Q+ L+
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE-ASLRFE 184
Query: 154 HRDLKCDNIFVN----------GNQGEVKIGDLGLAAILAQARSAHSVIE--------FM 195
HRDL N+ + N I GL + + + M
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 196 APELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
+L+ + + DIY + E Y +N ++ +K + +
Sbjct: 245 DEDLFTGDGDYQFDIYR--LMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302
Query: 256 GVRAFIEKCIAEVSERLP----AKELLGDPFL 283
I++ I E + A +LL L
Sbjct: 303 PAMKQIKRKIQEFHRTMLNFSSATDLLCQHSL 334
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 32/160 (20%), Positives = 62/160 (38%), Gaps = 19/160 (11%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
++ + +G G F ++ + VA IK L +L+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IK---LEPMKSRAPQLHLEYRFYKQLG 62
Query: 86 H-KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLS 143
I + Y + ++ N + +L + L+ + + Q++ +
Sbjct: 63 SGDGIPQVY--YFGPCGKY-NAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 144 YLHSHDPPVIHRDLKCDNIFV----NGNQGEVKIGDLGLA 179
Y+HS + +I+RD+K +N + N Q + I D LA
Sbjct: 120 YVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 33/158 (20%), Positives = 63/158 (39%), Gaps = 17/158 (10%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
+++ +G G+F ++Y + EVA I L +L E + + L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA------IKLENVKTKHPQLLYESKIYRILQ 60
Query: 86 -HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLS 143
I W E ++ N + +L + + L+ + + Q++ +
Sbjct: 61 GGTGIPNVR--WFGVEGDY-NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 144 YLHSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLA 179
++HS +HRD+K DN + +V I D GLA
Sbjct: 118 FVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 3e-07
Identities = 25/86 (29%), Positives = 34/86 (39%), Gaps = 9/86 (10%)
Query: 328 VQGQRRD---INTIFLKLRISD----STGHFRN--IHFPFDTEADTAFAVASEMVEELNL 378
V+ D I L LRI D + N I F FD E D VA EMVE +
Sbjct: 13 VELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYV 72
Query: 379 TDQDVSTISAMIESEIRSHIPDWEPK 404
+ D T++ I+ + E +
Sbjct: 73 CEGDHKTMAKAIKDRVSLIKRKREQR 98
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 30/160 (18%), Positives = 58/160 (36%), Gaps = 19/160 (11%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
YK +G G+F ++ + L +VA I D +L E K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA------IKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 86 H-KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLS 143
I Y + E H N + +L + ++ + ++Q+L +
Sbjct: 64 GCTGIPNVY--YFGQEGLH-NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGE----VKIGDLGLA 179
+H +++RD+K DN + + + + D G+
Sbjct: 121 SIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 13/44 (29%), Positives = 27/44 (61%), Gaps = 3/44 (6%)
Query: 137 QILEGLSYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLA 179
++L+ L +LH ++ +H ++ +NIFV+ +Q +V + G A
Sbjct: 167 RLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 613 | |||
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 2v3s_A | 96 | Serine/threonine-protein kinase OSR1; ATP-binding, | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2lru_A | 98 | Serine/threonine-protein kinase WNK1; autoinhibito | 99.03 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.83 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.17 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.11 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.89 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.14 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.56 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.86 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.69 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 95.48 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.38 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 94.84 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 94.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.3 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.36 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 87.03 |
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-62 Score=504.50 Aligned_cols=273 Identities=48% Similarity=0.880 Sum_probs=244.1
Q ss_pred CCCCCCcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcc
Q 035992 11 PDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90 (613)
Q Consensus 11 ~~~~~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIV 90 (613)
.++...+.+...+.|||+++.++||+|+||+||+|.++.++..||+|++.... ......+++.+|+.+|++|+|||||
T Consensus 11 ~~~~~~~~~~~~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~E~~il~~l~HpnIV 88 (290)
T 3fpq_A 11 IEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNIV 88 (290)
T ss_dssp ------CEEEECTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred HHHHhhhhcCcCCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh--CCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 34445667788899999999999999999999999999999999999887543 2456678899999999999999999
Q ss_pred eeeeeeecC--CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 91 KFYNSWVDT--ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 91 kl~~~fv~~--~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
++|++|... ....+|+|||||.||+|.+++.+.+.+++..++.|+.||+.||+|||+++++||||||||+|||+++.+
T Consensus 89 ~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~ 168 (290)
T 3fpq_A 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPT 168 (290)
T ss_dssp CEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTT
T ss_pred cEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCC
Confidence 999998653 345789999999999999999999999999999999999999999999988899999999999998667
Q ss_pred CcEEEeccchhHHHhh--hccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC
Q 035992 169 GEVKIGDLGLAAILAQ--ARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246 (613)
Q Consensus 169 g~VKL~DFGla~~l~~--~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p 246 (613)
|.+||+|||+|+.... .....||+.|||||++.+.|+.++|||||||++|||+||++||.+..+...++..+..+..|
T Consensus 169 g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 169 GSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248 (290)
T ss_dssp SCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred CCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC
Confidence 8999999999986543 23567899999999998889999999999999999999999998888899999999999888
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..++...++++++||.+||+ ||.+|||+.|+|+||||++
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 88888899999999999999 9999999999999999985
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=475.19 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=227.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|+++.+|+.||+|++.+..... ....+.+.+|+.+|++|+|||||++|++|.+ ...+|+|
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~yiv 110 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFG 110 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 688999999999999999999999999999988644322 3446789999999999999999999999865 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
||||.||+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+|.|||+|||+|+.+..
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCC
Confidence 999999999999999999999999999999999999999999 99999999999998 678999999999987642
Q ss_pred ---hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 185 ---ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
..+.+||+.|||||++.+ .|+.++|||||||++|||+||.+||.. .+..+++.+|..+.. .++..+++++++|
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dl 264 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDL 264 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHH
Confidence 234579999999998875 599999999999999999999999965 567778888887643 3566789999999
Q ss_pred HHHHhh-cccCCCCHHH------HhcCCCCCCCCcccccc
Q 035992 261 IEKCIA-EVSERLPAKE------LLGDPFLQSEDDESVGR 293 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~e------LL~HPff~~~~~~~~~~ 293 (613)
|.+||+ ||.+|||++| |++||||++.+|..+..
T Consensus 265 i~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp HHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred HHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 999999 9999999987 68999999998876643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=473.02 Aligned_cols=253 Identities=26% Similarity=0.474 Sum_probs=219.1
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
||..+| ++.+.||+|+||+||+|.++.+|+.||+|++++.+. ...+.+.+|+.+|+.++|||||++|++|.+ .
T Consensus 71 dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~ 143 (346)
T 4fih_A 71 DPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLV--G 143 (346)
T ss_dssp CGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred ChhHhc-EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 344444 777999999999999999999999999999875432 234568899999999999999999999865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+|+|||||.||+|.+++.+ +.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+|.|||+|||+|..
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~ 219 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQ 219 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCcee
Confidence 589999999999999999976 56999999999999999999999999 99999999999998 678999999999987
Q ss_pred Hhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-CcccccccH
Q 035992 182 LAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-ASLAKVADN 255 (613)
Q Consensus 182 l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~ 255 (613)
+.. ....+||+.|||||++.+ .|+.++|||||||++|||++|.+||.+ .+..+++..+..+..+ ......+++
T Consensus 220 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~ 298 (346)
T 4fih_A 220 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSP 298 (346)
T ss_dssp CCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCH
T ss_pred cCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCH
Confidence 643 235679999999998865 599999999999999999999999976 4556666777665433 233456789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
++++||.+||+ ||.+|||+.|+|+||||+..
T Consensus 299 ~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 299 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 99999999999 99999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=454.49 Aligned_cols=251 Identities=25% Similarity=0.503 Sum_probs=208.2
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.+.||+|+||+||+|+++.+|+.||+|++++... ......+++.+|+.+|++++|||||+++++|.+ ...+
T Consensus 13 g~Y-~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 88 (275)
T 3hyh_A 13 GNY-QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL-AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS--KDEI 88 (275)
T ss_dssp -CC-EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred eCe-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc-CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 455 788999999999999999999999999999875433 233456789999999999999999999999864 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+||||+ +|+|.+++.+.+.+++..++.|++||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|.....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC-----
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCC
Confidence 9999998 7899999999999999999999999999999999999 99999999999998 678999999999987654
Q ss_pred h---ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 A---RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ~---~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
. ....||+.|||||++.+. | +.++|||||||++|+|+||+.||.+ .+...+++.+..+.. .++...++++++
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 241 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAG 241 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHH
Confidence 2 356789999999988754 4 6899999999999999999999965 567778888887753 356678999999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||+ ||.+|||++|+|+||||+..
T Consensus 242 li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 242 LIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred HHHHHccCChhHCcCHHHHHcCcccccC
Confidence 9999999 99999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-55 Score=468.18 Aligned_cols=251 Identities=25% Similarity=0.457 Sum_probs=215.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|| ++.+.||+|+||+||+|+++.+|+.||+|++++... .....+++.+|+.+|++|+|||||+++++|.+ +..+|
T Consensus 25 ~Y-~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 25 KY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CE-EEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred ce-EEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 55 778999999999999999999999999999875432 45667889999999999999999999999865 56899
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+|||||.||+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+||||+ .+|.|||+|||+|+.+.
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeec
Confidence 999999999999999754 45799999999999999999999999 99999999999998 67899999999998654
Q ss_pred h----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 184 Q----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 184 ~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
. .....||+.|||||++.+ .|+.++|||||||++|||+||+.||.. .+..+++.++..+..+ .++..++++++
T Consensus 177 ~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~-~~~~~~s~~~~ 254 (350)
T 4b9d_A 177 STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFP-PVSLHYSYDLR 254 (350)
T ss_dssp HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHHH
T ss_pred CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCC-CCCccCCHHHH
Confidence 3 234578999999998875 599999999999999999999999966 5566777777777654 34556789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+||.+||+ ||.+|||+.|+|+||||+..
T Consensus 255 ~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 99999999 99999999999999999864
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=476.33 Aligned_cols=253 Identities=26% Similarity=0.474 Sum_probs=218.8
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
||..+| ++.+.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.++|||||++|++|.+ .
T Consensus 148 dp~~~y-~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~ 220 (423)
T 4fie_A 148 DPRSYL-DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLV--G 220 (423)
T ss_dssp CGGGTE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred ChhHhc-EeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEE--C
Confidence 444444 777999999999999999999999999999875432 334568899999999999999999999875 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+|||||||.||+|.++++. +.+++..++.|++||+.||+|||+++ ||||||||+||||+ .+|.|||+|||+|..
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~ 296 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQ 296 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceE
Confidence 589999999999999999876 56999999999999999999999999 99999999999998 678999999999986
Q ss_pred Hhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-CcccccccH
Q 035992 182 LAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-ASLAKVADN 255 (613)
Q Consensus 182 l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~s~ 255 (613)
+.. ....+||+.|||||++.+ .|+.++|||||||++|||++|++||.+ .+...++..|..+..+ ......+++
T Consensus 297 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~ 375 (423)
T 4fie_A 297 VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSP 375 (423)
T ss_dssp CCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCH
T ss_pred CCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCH
Confidence 643 235678999999998865 599999999999999999999999976 4555666677665433 233456789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
++++||.+||+ ||.+|||+.|||+||||+..
T Consensus 376 ~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 376 SLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 99999999999 99999999999999999865
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=456.27 Aligned_cols=254 Identities=22% Similarity=0.322 Sum_probs=214.8
Q ss_pred eeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
|++.+.||+|+||+||+|++. .+++.||+|++++..... ....++.+|+.+|++++|||||+++++|.+ ...+
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~ 101 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGKL 101 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEEE--TTEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEE
Confidence 588999999999999999884 478899999987644321 223467889999999999999999999865 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+|||||.||+|.+++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 102 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC---
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceeccC
Confidence 999999999999999999999999999999999999999999999 99999999999998 678999999999975432
Q ss_pred ----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.....||+.|||||++.+ .|+.++|||||||++|||+||.+||.+ .+..+++..+..+.. .++..+++++++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 255 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQS 255 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHHHH
Confidence 235678999999998865 599999999999999999999999965 566777777777643 356678999999
Q ss_pred HHHHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 260 FIEKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 260 lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
||.+||+ ||.+||| ++|+++||||+..+|..+
T Consensus 256 li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l 293 (304)
T 3ubd_A 256 LLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKL 293 (304)
T ss_dssp HHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHH
Confidence 9999999 9999998 589999999999877544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=454.01 Aligned_cols=248 Identities=23% Similarity=0.335 Sum_probs=211.7
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
-.++++.++||+|+||+||+|+++.+|+.||+|++++... ..+|+.+|+.|+|||||++|++|.+ ...+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~--~~~~ 125 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVRE--GPWV 125 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEE--TTEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 3467888999999999999999999999999999875322 2369999999999999999999865 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|||||||.||+|.+++++.+.+++..++.|+.||+.||+|||+++ ||||||||+||||+.+...+||+|||+|..+..
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999999999999999999999999999999999999999998 999999999999984433699999999976532
Q ss_pred ---------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-Ccccccc
Q 035992 185 ---------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-ASLAKVA 253 (613)
Q Consensus 185 ---------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-~~l~~~~ 253 (613)
.....||+.|||||++.+ .|+.++|||||||++|||+||.+||.+... ..++.++..+..+ ..++..+
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR-GPLCLKIASEPPPIREIPPSC 282 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC-SCCHHHHHHSCCGGGGSCTTS
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHHcCCCCchhcCccC
Confidence 123468999999998865 599999999999999999999999976443 3444555555433 3456678
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHH-------------hcCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKEL-------------LGDPFLQSE 286 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eL-------------L~HPff~~~ 286 (613)
++.+++||.+||+ ||.+|||+.|| |+|||++..
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999999999 99999999998 679999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=443.24 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=205.9
Q ss_pred Ccc---eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 25 ARY---GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 25 gRy---~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
||| |++.+.||+|+||+||+|+++.+|+.||+|+++... .....+++.+|+.+|++|+|||||++|++|...+.
T Consensus 1 GR~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 77 (299)
T 4g31_A 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNT 77 (299)
T ss_dssp CHHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-
T ss_pred CCcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCc
Confidence 566 688899999999999999999999999999887543 45567789999999999999999999999875432
Q ss_pred ----------CEEEEEEeccCCCCHHHHHHhCCCC---CHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 102 ----------EHINFITEIFTSGTLRQYRKKHKHV---DLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 102 ----------~~l~lV~E~~~gGsL~~~l~~~~~l---se~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
..+|+|||||.+|+|.+++.+.+.+ ++..++.|+.||+.||+|||+++ ||||||||+|||++ .+
T Consensus 78 ~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~ 154 (299)
T 4g31_A 78 TEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MD 154 (299)
T ss_dssp ---------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TT
T ss_pred cccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CC
Confidence 3589999999999999999987654 45678999999999999999998 99999999999998 56
Q ss_pred CcEEEeccchhHHHhhh----------------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC
Q 035992 169 GEVKIGDLGLAAILAQA----------------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT 231 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~----------------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~ 231 (613)
|.+||+|||+|+.+... ....||+.|||||++.+ .|+.++|||||||++|||++ ||....
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 89999999999876432 12368999999998875 59999999999999999996 886544
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
+.......+.....|+.+ ...++.+.+||.+||+ +|.+|||+.|+|+||||+..++
T Consensus 232 ~~~~~~~~~~~~~~p~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 232 ERVRTLTDVRNLKFPPLF-TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHHHHHHTTCCCHHH-HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HHHHHHHHHhcCCCCCCC-cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 444555566666555433 3346778899999999 9999999999999999997654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=445.89 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=212.2
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC----C
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT----E 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~ 100 (613)
.+| ++.++||+|+||+||+|+++.+|+.||+|+++.. .......+++.+|+.+|+.|+|||||+++++|... +
T Consensus 54 ~~Y-~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 54 DEY-EIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNA--FDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp SSE-EEEEEEEECSSCEEEEEEETTTCCEEEEEEETTT--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCe-EEEEEEecccCeEEEEEEECCCCCEEEEEEECcc--ccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 355 7889999999999999999999999999987642 23455677889999999999999999999987543 3
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+|+|||||. |+|.+++.+.+.+++..++.|++||+.||+|||++| ||||||||+|||++ .+|.+||+|||+|.
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceee
Confidence 467999999996 689999999999999999999999999999999999 99999999999998 67899999999997
Q ss_pred HHhh--------hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC--CCC--
Q 035992 181 ILAQ--------ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKP-- 246 (613)
Q Consensus 181 ~l~~--------~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g--~~p-- 246 (613)
.+.. .....||+.|||||++.+ .|+.++|||||||++|||++|.+||.+.....+ +..|... ..+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPA 285 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChH
Confidence 5432 224578999999998754 479999999999999999999999977554444 3343321 111
Q ss_pred ----------------------Cc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 ----------------------AS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 ----------------------~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.. +....++++++||.+||+ ||.+|||+.|+|+||||+...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 00 112357899999999999 999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=421.19 Aligned_cols=245 Identities=26% Similarity=0.408 Sum_probs=207.9
Q ss_pred eeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+.+.+.||+|+||+||+|.+. .+|..||+|+++. .+....+.|.+|+.+|++|+|||||++|++|.+ ..
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~--~~ 88 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE--GD 88 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SS
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC----CChHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CC
Confidence 478899999999999999875 4688999998763 245667889999999999999999999998854 45
Q ss_pred EEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 103 HINFITEIFTSGTLRQYRKKHK-------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~-------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
.+++|||||.+|+|.+++.+++ .+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCC
Confidence 7999999999999999998653 6999999999999999999999998 99999999999998 568
Q ss_pred cEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHH
Q 035992 170 EVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~ 241 (613)
.+||+|||+|+...... ...+|+.|||||++. +.|+.++|||||||++|||+| |+.||.+. +..++...+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHH
Confidence 99999999998765432 234778999999876 459999999999999999999 89999764 5567777888
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
.+..+ ..+..+++++.+||.+||+ +|.+|||+.+| ++||+.
T Consensus 245 ~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 245 QGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred cCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 87654 3456788999999999999 99999999999 456653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=423.02 Aligned_cols=246 Identities=29% Similarity=0.491 Sum_probs=206.9
Q ss_pred ccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 20 ~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
+++++. +++.+.||+|+||+||+|.+. ..||+|+++... .+....+.|.+|+.+|++++|||||++++++..
T Consensus 32 ei~~~~--l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~- 103 (307)
T 3omv_A 32 EIEASE--VMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK- 103 (307)
T ss_dssp BCCTTS--CCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred EEcHHH--eEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence 455432 367899999999999999754 359999876533 356678899999999999999999999997632
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
..+++|||||.+|+|.+++... +.+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+
T Consensus 104 --~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGl 178 (307)
T 3omv_A 104 --DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGL 178 (307)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSS
T ss_pred --CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccC
Confidence 3589999999999999999765 57999999999999999999999998 99999999999998 678999999999
Q ss_pred hHHHhh------hccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc
Q 035992 179 AAILAQ------ARSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248 (613)
Q Consensus 179 a~~l~~------~~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~ 248 (613)
|..... .....||+.|||||++.. .|+.++|||||||++|||+||+.||.+..+...+...+..+..++.
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 976532 234578999999998742 4899999999999999999999999888888888888877765433
Q ss_pred ---ccccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 249 ---LAKVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 249 ---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
++..+++.+.+||.+||+ +|.+|||+.|++
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 345678999999999999 999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=457.69 Aligned_cols=262 Identities=23% Similarity=0.348 Sum_probs=223.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc--ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR--NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~--~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
++---|++.++||+|+||+||+|+++.+|+.||+|++++..... ..........++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-- 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-- 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE--
Confidence 34445788999999999999999999999999999998654322 22223333445677788899999999999865
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+|||||||.||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|+|||+|||+|.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLAC 340 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceee
Confidence 5689999999999999999999999999999999999999999999999 99999999999998 67899999999998
Q ss_pred HHhh--hccCcccccccCccccc-c-ccCccchhhhhhHHHHHHHhcCCCCCCC--CcHHHHHHHHHcCCCCCccccccc
Q 035992 181 ILAQ--ARSAHSVIEFMAPELYE-E-EYNELVDIYAFGMCLLELVTFEYPYVEC--TNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 181 ~l~~--~~~~~gt~~YmAPEvl~-~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.+.. ..+.+||+.|||||++. + .|+.++|||||||++|||++|.+||.+. .+...++..+.... ..++..++
T Consensus 341 ~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S 418 (689)
T 3v5w_A 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFS 418 (689)
T ss_dssp ECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSC
T ss_pred ecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCC
Confidence 7644 34578999999999885 3 5999999999999999999999999653 34556666666553 34566789
Q ss_pred HHHHHHHHHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 255 NGVRAFIEKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
+++++||.+||+ ||.+|++ ++|+++||||+..+|..+
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 999999999999 9999998 899999999999988654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=426.98 Aligned_cols=248 Identities=18% Similarity=0.349 Sum_probs=202.8
Q ss_pred CcceeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTE 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 100 (613)
.+| ++.+.||+|+||+||+|.++ .+++.||+|.+... ....++.+|+++|+.+ +||||++++++|..
T Consensus 21 ~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~------~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-- 91 (361)
T 4f9c_A 21 NVF-KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT------SHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-- 91 (361)
T ss_dssp GTC-EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT------SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--
T ss_pred CcE-EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc------cCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--
Confidence 455 88999999999999999875 46789999876532 2235678999999998 69999999999865
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+|+|||||.+|+|.++++ .+++..++.+++||+.||+|||++| ||||||||+|||++.+.+.+||+|||+|+
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 568999999999999999984 5999999999999999999999999 99999999999998666899999999996
Q ss_pred HHhh--------------------------------hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCC
Q 035992 181 ILAQ--------------------------------ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYP 226 (613)
Q Consensus 181 ~l~~--------------------------------~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~P 226 (613)
.... .....||+.|||||++.+ .|+.++||||+||++|||+||+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 4321 123468999999998754 489999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHc--C-------------------C-------------------CC------------Cccccccc
Q 035992 227 YVECTNAAQIYKKVTS--G-------------------I-------------------KP------------ASLAKVAD 254 (613)
Q Consensus 227 f~~~~~~~~i~~~I~~--g-------------------~-------------------~p------------~~l~~~~s 254 (613)
|....+....+..|.. | . .| .......+
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 9776665444433321 0 0 00 01123457
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++++||.+||+ ||.+|+|++|+|+||||++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 889999999999 99999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=421.68 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=203.3
Q ss_pred cceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
..+.+.++||+|+||+||+|.+. .++..||+|+++. .+....+.|.+|+.+|++++|||||++|++|.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~----~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-- 114 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREAELLTMLQHQHIVRFFGVCTE-- 114 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC----CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc----CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 34577899999999999999864 4689999998763 245667889999999999999999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH---------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~---------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
...+++|||||.+|+|.+++.++ +.+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG 192 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC
Confidence 45799999999999999999764 35899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~ 237 (613)
.++.+||+|||+|+.+... ....+|+.|||||++.+ .|+.++|||||||++|||+| |+.||.+. +..++.
T Consensus 193 -~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~ 270 (329)
T 4aoj_A 193 -QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-SNTEAI 270 (329)
T ss_dssp -TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-CHHHHH
T ss_pred -CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-CHHHHH
Confidence 6789999999999865432 23467889999998765 59999999999999999999 89999775 456677
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+..+..+ ..+..+++++.+||.+||+ +|.+|||+.||+.+
T Consensus 271 ~~i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 778777644 3456789999999999999 99999999999864
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=446.58 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=219.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.. .....+.+.+|+.+|+.|+|||||+++++|.+ ...+|+|
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~~~~~iv 232 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMI 232 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEE
Confidence 47889999999999999999999999999988753 34556788999999999999999999999864 5689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC-CCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~-~g~VKL~DFGla~~l~~~ 185 (613)
||||.||+|.+++.+ .+.+++..++.|++||+.||+|||+++ |+||||||+|||++.+ .|.+||+|||+|..+...
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999999864 468999999999999999999999999 9999999999999743 479999999999876543
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRA 259 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~~ 259 (613)
....||+.|||||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..|..+.. +......+++++++
T Consensus 311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d 389 (573)
T 3uto_A 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389 (573)
T ss_dssp SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 34578999999998865 599999999999999999999999976 455666667766542 33445567999999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
||.+||+ ||.+|||+.|+|+||||+...+
T Consensus 390 li~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999 9999999999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=413.99 Aligned_cols=243 Identities=24% Similarity=0.336 Sum_probs=205.5
Q ss_pred eeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
.++.+.||+|+||+||+|.. ..+++.||+|+++.. ......+.|.+|+.+|++++|||||++++++.. ..
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~---~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~ 102 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK---AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK--DQ 102 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC----CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc---cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE--CC
Confidence 47889999999999999985 347789999987632 233456789999999999999999999998754 45
Q ss_pred EEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC
Q 035992 103 HINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG 166 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~ 166 (613)
.+++|||||.+|+|.+++... ..+++..+..|+.||+.||+|||+++ ||||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~- 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY- 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC-
Confidence 689999999999999999753 35899999999999999999999998 99999999999998
Q ss_pred CCCcEEEeccchhHHHhhh------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHH
Q 035992 167 NQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYK 238 (613)
Q Consensus 167 ~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~ 238 (613)
+++.+||+|||+|+.+... ....+|+.|||||++. +.|+.++|||||||++|||+| |..||.+. +..++..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-~~~~~~~ 258 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQDVVE 258 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-CHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-CHHHHHH
Confidence 6689999999999866432 2346778999999776 469999999999999999998 89999764 5567777
Q ss_pred HHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 239 KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 239 ~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+..+..++ .+..++..+.+||.+||+ +|.+|||+.||+++
T Consensus 259 ~i~~~~~~~-~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 888776543 455678999999999999 99999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=396.71 Aligned_cols=275 Identities=48% Similarity=0.882 Sum_probs=241.0
Q ss_pred CCCCCCCcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc
Q 035992 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI 89 (613)
Q Consensus 10 ~~~~~~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI 89 (613)
+.++.....+..+..++|+++.+.||+|+||+||+|.+..++..||+|.++... ......+.+.+|+.+++.++||||
T Consensus 10 ~~~~l~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i 87 (290)
T 1t4h_A 10 DIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQHPNI 87 (290)
T ss_dssp --------CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHTTCCCTTB
T ss_pred HHHHHhhhhhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh--hCHHHHHHHHHHHHHHHhCCCCCe
Confidence 345666778888999999999999999999999999999999999999887433 245677889999999999999999
Q ss_pred ceeeeeeecC--CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC
Q 035992 90 IKFYNSWVDT--ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN 167 (613)
Q Consensus 90 Vkl~~~fv~~--~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~ 167 (613)
++++++|... ....+++||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++++|+||||||+|||++..
T Consensus 88 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~ 167 (290)
T 1t4h_A 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 167 (290)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST
T ss_pred eeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECC
Confidence 9999988643 34678999999999999999999899999999999999999999999998779999999999999766
Q ss_pred CCcEEEeccchhHHHhhh--ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC
Q 035992 168 QGEVKIGDLGLAAILAQA--RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245 (613)
Q Consensus 168 ~g~VKL~DFGla~~l~~~--~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~ 245 (613)
.+.+||+|||++...... ....+++.|+|||++.+.++.++||||||+++|+|++|..||....+...++..+..+..
T Consensus 168 ~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (290)
T 1t4h_A 168 TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247 (290)
T ss_dssp TSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC
T ss_pred CCCEEEeeCCCcccccccccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC
Confidence 789999999999755432 234578899999999888999999999999999999999999988899999999999888
Q ss_pred CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 246 PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 246 p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..++...++.+.+||.+||. +|.+|||+.++|+||||+..
T Consensus 248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 888888889999999999999 99999999999999999863
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=417.10 Aligned_cols=245 Identities=26% Similarity=0.373 Sum_probs=208.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCC-----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG-----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg-----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~fv~~~~ 101 (613)
+++.+.||+|+||+||+|.+..++ +.||+|.++. .......+.+.+|+.+|+++.| ||||+++++|... +
T Consensus 66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~---~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~-~ 141 (353)
T 4ase_A 66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 141 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-T
T ss_pred eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcc---ccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-C
Confidence 488899999999999999876543 6788777653 2345667889999999999965 8999999987543 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 102 EHINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
..+++|||||.+|+|.+++++. ..+++..+..|+.||+.||+|||+++ ||||||||+|||++
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~ 219 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS 219 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC
Confidence 5689999999999999999763 34899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~ 237 (613)
+++.+||+|||+|+.+... ....+|+.|||||++.+ .|+.++|||||||++|||+| |..||.+....+.+.
T Consensus 220 -~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 220 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp -GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred -CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5689999999999865432 23456789999998764 59999999999999999998 899998877777788
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+..+..+ ..+..+++++.++|.+||+ +|.+|||+.||++|
T Consensus 299 ~~i~~g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 888887655 3456678999999999999 99999999999987
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=396.34 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=191.9
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--CE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--EH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--~~ 103 (613)
|.+.+.++||+|+||+||+|.+ +|+.||+|+++.. .........|+..+.+++|||||++++++..... ..
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 5678899999999999999976 6899999987532 1222233456777778999999999999876543 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC------CCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH------DPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~------~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
+|+|||||.+|+|.+++++. .+++..+..++.|++.||+|||++ .++||||||||+|||++ .++.+||+|||
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFG 153 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCC
Confidence 89999999999999999874 589999999999999999999987 23599999999999998 67899999999
Q ss_pred hhHHHhhh--------ccCcccccccCcccccc-------ccCccchhhhhhHHHHHHHhcCCCCCC----------C--
Q 035992 178 LAAILAQA--------RSAHSVIEFMAPELYEE-------EYNELVDIYAFGMCLLELVTFEYPYVE----------C-- 230 (613)
Q Consensus 178 la~~l~~~--------~~~~gt~~YmAPEvl~~-------~ys~ksDIWSLGviL~EmltG~~Pf~~----------~-- 230 (613)
+|...... ....||+.|||||++.+ .|+.++|||||||++|||+||..||.. .
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99765432 12468899999998754 377899999999999999999766532 1
Q ss_pred --CcHHHHHHHHHcCCCCCccccc-----ccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 231 --TNAAQIYKKVTSGIKPASLAKV-----ADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 231 --~~~~~i~~~I~~g~~p~~l~~~-----~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.....+.+.+......+.++.. ....+.+||.+||+ +|.+|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2344555555544332233322 23468899999999 99999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=390.20 Aligned_cols=255 Identities=29% Similarity=0.506 Sum_probs=219.4
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
++.++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||++++++|.. .
T Consensus 17 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 89 (297)
T 3fxz_A 17 DPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV--G 89 (297)
T ss_dssp CGGGTB-CCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred Chhhce-eeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--C
Confidence 445565 777999999999999999999999999998874332 234668899999999999999999998865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++||||+.+|+|.+++.+. .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~ 165 (297)
T 3fxz_A 90 DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 165 (297)
T ss_dssp TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCcee
Confidence 5799999999999999999875 6999999999999999999999998 99999999999998 668999999999876
Q ss_pred Hhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 182 LAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 182 l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+......+......+...+..
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T 3fxz_A 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (297)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred cCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence 5432 23467889999998765 599999999999999999999999987666666665555555555566778999
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 9999999999 999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=390.33 Aligned_cols=251 Identities=24% Similarity=0.442 Sum_probs=220.0
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.|++.+.||+|+||+||+|.+..+|+.||+|++.... .+....+++.+|+.+|+.++||||+++++++.. ...+++
T Consensus 16 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 91 (328)
T 3fe3_A 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPTSLQKLFREVRIMKILNHPNIVKLFEVIET--EKTLYL 91 (328)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEE
Confidence 3588899999999999999999999999999887543 245677889999999999999999999998754 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSSC
T ss_pred EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCCC
Confidence 9999999999999999899999999999999999999999998 99999999999998 578999999999976543
Q ss_pred -hccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 -ARSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 -~~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.....+++.|+|||++.+. | +.++|||||||++|+|++|..||.+ .+...+...+..+... ++...++.+.+||
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li 245 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLL 245 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHH
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHH
Confidence 2345688899999987654 4 5799999999999999999999965 5666777777776433 3456789999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+||. +|.+|||+.|+++||||+...
T Consensus 246 ~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 246 KRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999 999999999999999998753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=397.86 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=218.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|.++.+|+.||+|++++... ......+.+..|+.+++.+ +||||++++++|.. ...+|+
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~l 101 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRLFF 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEEEE
Confidence 4788999999999999999999999999999875332 1234567788999999988 79999999999854 558999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh---
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA--- 183 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~--- 183 (613)
||||+.||+|..++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecccCC
Confidence 9999999999999999999999999999999999999999998 99999999999998 67899999999987432
Q ss_pred -hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 184 -QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 184 -~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
......||+.|||||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+.. .++...+..+++||
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 255 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDATGIL 255 (353)
T ss_dssp -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence 2234568899999998765 499999999999999999999999965 566777777777643 34556789999999
Q ss_pred HHHhh-cccCCCCH------HHHhcCCCCCCCCccc
Q 035992 262 EKCIA-EVSERLPA------KELLGDPFLQSEDDES 290 (613)
Q Consensus 262 ~~cL~-dP~~Rpta------~eLL~HPff~~~~~~~ 290 (613)
.+||+ +|.+||++ .++++||||+..+|..
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~ 291 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHH
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHH
Confidence 99999 99999998 8999999999987754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=392.28 Aligned_cols=255 Identities=21% Similarity=0.407 Sum_probs=220.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.++.+|+.||+|+++..... .....+.+.+|+.+|+.++||||++++++|.. ...+++|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~~lv 83 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEEEEE
Confidence 47889999999999999999999999999998754321 12345678899999999999999999998864 4589999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.||+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccCCC
Confidence 999999999999999899999999999999999999999998 99999999999998 678999999999875321
Q ss_pred -hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 185 -ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 185 -~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
.....||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+. ..++...++.+++||.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence 234567889999998765 599999999999999999999999966 45666777776653 2345678899999999
Q ss_pred HHhh-cccCCC-----CHHHHhcCCCCCCCCcccc
Q 035992 263 KCIA-EVSERL-----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 263 ~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~~ 291 (613)
+||+ +|.+|| ++.|+++||||+..+|..+
T Consensus 238 ~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~ 272 (337)
T 1o6l_A 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 9999 999999 8999999999999877543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=392.01 Aligned_cols=255 Identities=21% Similarity=0.368 Sum_probs=222.8
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.+.||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+ ...+|+
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 118 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK-LKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYM 118 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEEEE
Confidence 3477899999999999999999999999999987543221 2345678899999999999999999998864 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCB
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceeccCCc
Confidence 9999999999999999899999999999999999999999998 99999999999998 6789999999999765432
Q ss_pred ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 186 RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
....|++.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+.. .++..++..++++|.+|
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~l 272 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence 34568899999998764 599999999999999999999999965 566777788877643 34566889999999999
Q ss_pred hh-cccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 265 IA-EVSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 265 L~-dP~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
|+ +|.+||+ ++++++||||+..+|..
T Consensus 273 L~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~ 304 (350)
T 1rdq_E 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred hhcCHHhccCCccCCHHHHHhCcCcCCCCHHH
Confidence 99 9999998 99999999999987744
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=395.83 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=220.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+|++.+.||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.+|+.++||||++++++|.. ...+
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~ 90 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--RTDV 90 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--CCEE
Confidence 35889999999999999999999999999999886543221 1245778999999999999999999998854 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC---cEEEeccchhHH
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG---EVKIGDLGLAAI 181 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g---~VKL~DFGla~~ 181 (613)
++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999999999899999999999999999999999998 999999999999974332 799999999976
Q ss_pred Hhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccH
Q 035992 182 LAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADN 255 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~ 255 (613)
+... ....|++.|+|||++.. .|+.++|||||||++|+|++|..||.. .+...++..+..+.. +..+....+.
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 247 (361)
T 2yab_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSE 247 (361)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCH
Confidence 5442 34568889999998865 599999999999999999999999976 455666677776543 2233456789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+++||.+||. +|.+|||+.|+|+||||+..++
T Consensus 248 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 248 LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 99999999999 9999999999999999997643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=387.25 Aligned_cols=255 Identities=24% Similarity=0.429 Sum_probs=221.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+.+|+.+++.++||||++++++|.+ ...+++|
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~~~lv 84 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMI 84 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhhCCCCCCceEeEEEEe--CCEEEEE
Confidence 478899999999999999999999999999987543211 2345678899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-hc
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-AR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-~~ 186 (613)
|||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..... ..
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSCBC
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCCccc
Confidence 999999999999999999999999999999999999999998 99999999999998 678999999999976543 23
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...+++.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+.. .++...+.+++++|.+||
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL 238 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI 238 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHh
Confidence 4578899999998765 599999999999999999999999976 455666667766532 345667899999999999
Q ss_pred h-cccCCC-----CHHHHhcCCCCCCCCcccc
Q 035992 266 A-EVSERL-----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 266 ~-dP~~Rp-----ta~eLL~HPff~~~~~~~~ 291 (613)
. +|.+|| +++++++||||+..+|..+
T Consensus 239 ~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 239 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred ccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 9 999999 8999999999999876543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=398.98 Aligned_cols=257 Identities=20% Similarity=0.362 Sum_probs=218.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~ 105 (613)
-|++.++||+|+||+||+|+++.+++.||+|++++... ......+.+..|+.+++++ +||||++++++|.. ...++
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~~ 129 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLF 129 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-C----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEEE
Confidence 45888999999999999999999999999999885433 3345566788999999887 89999999999864 56899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh--
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA-- 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~-- 183 (613)
+||||+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 130 lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCT
T ss_pred EEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccC
Confidence 99999999999999999999999999999999999999999998 99999999999998 67899999999997522
Q ss_pred --hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC--------CcHHHHHHHHHcCCCCCccccc
Q 035992 184 --QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC--------TNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 184 --~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
......||+.|||||++.+ .|+.++|||||||++|||++|..||... .....+++.+..+. ..++..
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~ 284 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRS 284 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTT
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCc
Confidence 2335678899999998765 5999999999999999999999999532 23445666666653 235566
Q ss_pred ccHHHHHHHHHHhh-cccCCCCH------HHHhcCCCCCCCCcccc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPA------KELLGDPFLQSEDDESV 291 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta------~eLL~HPff~~~~~~~~ 291 (613)
++..+++||.+||+ +|.+||++ .|+++||||+..+|..+
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l 330 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 89999999999999 99999984 89999999999877543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=401.05 Aligned_cols=256 Identities=17% Similarity=0.329 Sum_probs=215.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-|++.++||+|+||+||+|.++.+|+.||+|++++..... ....+.+.+|+.+++.++||||++++++|.+ ...+|
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~ 145 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK-RSDSAFFWEERDIMAFANSPWVVQLFYAFQD--DRYLY 145 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-hHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEE
Confidence 34588899999999999999999999999999987533211 1223457889999999999999999999864 56899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+||||+.||+|.+++.+ ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++..+...
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTT
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccC
Confidence 99999999999999876 46999999999999999999999998 99999999999998 6789999999999765432
Q ss_pred -----ccCcccccccCccccccc-----cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccc
Q 035992 186 -----RSAHSVIEFMAPELYEEE-----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVA 253 (613)
Q Consensus 186 -----~~~~gt~~YmAPEvl~~~-----ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~ 253 (613)
....||+.|||||++... |+.++|||||||++|||++|..||.. .+...++.++..+..... ....+
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccc
Confidence 256789999999987532 78999999999999999999999965 556677777765421111 22357
Q ss_pred cHHHHHHHHHHhh-cccC--CCCHHHHhcCCCCCCCCcc
Q 035992 254 DNGVRAFIEKCIA-EVSE--RLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~--Rpta~eLL~HPff~~~~~~ 289 (613)
+.++++||.+||+ +|.+ |++++|+++||||+..+|.
T Consensus 301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 8999999999999 7777 9999999999999998664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=385.80 Aligned_cols=256 Identities=20% Similarity=0.366 Sum_probs=220.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|+++.+|+.||+|++++.. .......+.+.+|+.+++.+ +||||++++++|.. ...+|+
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~l 87 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKEL-VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFF 87 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGG-SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHH-hcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEEEE
Confidence 478899999999999999999999999999987543 23456778899999999988 89999999999854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh---
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA--- 183 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~--- 183 (613)
||||+.+|+|..++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCTT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEeccccccccCCC
Confidence 9999999999999999899999999999999999999999998 99999999999998 67899999999987532
Q ss_pred -hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC--------CcHHHHHHHHHcCCCCCcccccc
Q 035992 184 -QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC--------TNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 184 -~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--------~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
......+++.|+|||++.+ .|+.++|||||||++|||++|..||... .....+++.+..+.. .++...
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~~ 242 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRSL 242 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTTS
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCCC
Confidence 1234568889999998765 5999999999999999999999999542 234456666665532 345678
Q ss_pred cHHHHHHHHHHhh-cccCCCCH------HHHhcCCCCCCCCcccc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPA------KELLGDPFLQSEDDESV 291 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta------~eLL~HPff~~~~~~~~ 291 (613)
+..+++||.+||+ +|.+||++ .++++||||+..+|..+
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~ 287 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence 8999999999999 99999995 89999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=392.11 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=221.3
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l 104 (613)
.-|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|+.+++.+ +||||++++++|.+ ...+
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~ 93 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 93 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEE
Confidence 34588899999999999999999999999999987543221 23456778899999877 99999999998865 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh-
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA- 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~- 183 (613)
|+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhccc
Confidence 999999999999999999889999999999999999999999998 99999999999998 67899999999987532
Q ss_pred ---hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 184 ---QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 184 ---~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
......||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+.. .++...+..+++
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 247 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKD 247 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHH
Confidence 1234578899999998765 599999999999999999999999965 556677777776642 345668899999
Q ss_pred HHHHHhh-cccCCCCHH-HHhcCCCCCCCCcccc
Q 035992 260 FIEKCIA-EVSERLPAK-ELLGDPFLQSEDDESV 291 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~-eLL~HPff~~~~~~~~ 291 (613)
||.+||. +|.+||++. ++++||||+..+|..+
T Consensus 248 li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281 (345)
T ss_dssp HHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred HHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence 9999999 999999998 9999999999877543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=403.80 Aligned_cols=260 Identities=18% Similarity=0.328 Sum_probs=217.7
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-|++.++||+|+||+||+|.++.+|+.||+|++++..... ......+..|+.+++.++||||++++++|.+ ...+|
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~~ 150 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-RAETACFREERDVLVNGDSKWITTLHYAFQD--DNNLY 150 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCEEE
Confidence 34588899999999999999999999999999987533211 1223447889999999999999999998864 56899
Q ss_pred EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 106 FITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+||||+.+|+|.+++.+ .+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||++..+..
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCT
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhccc
Confidence 99999999999999988 578999999999999999999999998 99999999999998 678999999999975533
Q ss_pred h-----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---CCCccc
Q 035992 185 A-----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPASLA 250 (613)
Q Consensus 185 ~-----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---~p~~l~ 250 (613)
. ....||+.|||||++. ..|+.++|||||||++|||++|..||.. .+..+++.++.... ..+...
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCccc
Confidence 2 2357899999999875 3589999999999999999999999976 45666666665432 111222
Q ss_pred ccccHHHHHHHHHHhh-cccC--CCCHHHHhcCCCCCCCCccccc
Q 035992 251 KVADNGVRAFIEKCIA-EVSE--RLPAKELLGDPFLQSEDDESVG 292 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~--Rpta~eLL~HPff~~~~~~~~~ 292 (613)
...++++++||.+||. +|.+ |++++|+++||||+..+|..+.
T Consensus 307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 3478999999999998 6666 8999999999999999887653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=372.62 Aligned_cols=252 Identities=22% Similarity=0.394 Sum_probs=208.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.+++.++||||++++++|.. +..+++|
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccC--CcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 478899999999999999999999999999987543 234556778899999999999999999998864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.++.+..+....+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCS
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCccc
Confidence 999987555555555788999999999999999999999998 99999999999998 5689999999999765422
Q ss_pred --ccCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---CC------------
Q 035992 186 --RSAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KP------------ 246 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---~p------------ 246 (613)
....+++.|+|||++.+ . |+.++|||||||++|+|++|..||....+.......+.... ..
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 23456789999998754 3 89999999999999999999998766666666655554311 00
Q ss_pred ------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 ------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 ------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.......+..+++||.+||+ +|.+|||++|+|+||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01122467899999999999 99999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=400.87 Aligned_cols=262 Identities=20% Similarity=0.314 Sum_probs=218.7
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
...|++.++||+|+||+||+|.++.+|+.||+|++++.... .....+.+.+|+.++..++||||++++++|.+ ...+
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~~ 136 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML-KRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENYL 136 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEE
Confidence 34458889999999999999999999999999998753321 12334568899999999999999999998865 5689
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|+||||+.||+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ ..|++||+|||++..+.
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheecc
Confidence 9999999999999999875 47999999999999999999999998 99999999999998 67899999999997654
Q ss_pred hh-----ccCcccccccCccccc--------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---CCC
Q 035992 184 QA-----RSAHSVIEFMAPELYE--------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI---KPA 247 (613)
Q Consensus 184 ~~-----~~~~gt~~YmAPEvl~--------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~---~p~ 247 (613)
.. ....||+.|||||++. ..|+.++|||||||++|||++|..||.. .+...++.++.... ..+
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCC
Confidence 32 2357889999999875 3589999999999999999999999966 45566666665432 222
Q ss_pred cccccccHHHHHHHHHHhhcccCC---CCHHHHhcCCCCCCCCcccccc
Q 035992 248 SLAKVADNGVRAFIEKCIAEVSER---LPAKELLGDPFLQSEDDESVGR 293 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~dP~~R---pta~eLL~HPff~~~~~~~~~~ 293 (613)
.+...+++++++||.+||.+|.+| ++++|+++||||+..+|..+..
T Consensus 293 ~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~ 341 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341 (412)
T ss_dssp ----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTSGGGTTCCSTTSTT
T ss_pred ccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 234567899999999999988887 5899999999999998876643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=377.35 Aligned_cols=253 Identities=23% Similarity=0.446 Sum_probs=208.9
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC----------------------hHHHHHHHHHHHHHHh
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN----------------------SEDLERLYSEVHLLKT 83 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~----------------------~~~~~~l~~Ei~iLk~ 83 (613)
+| ++.+.||+|+||+||+|.+..+|+.||+|++........ ....+.+.+|+.+|+.
T Consensus 14 ~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 14 QY-TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TE-EEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred ce-EEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 44 888999999999999999999999999999875442211 1234678999999999
Q ss_pred CCCCCcceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEE
Q 035992 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIF 163 (613)
Q Consensus 84 L~HpNIVkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NIL 163 (613)
++||||+++++++.......+++||||+.+++|.+++. .+.+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil 169 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLL 169 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEE
Confidence 99999999999987766778999999999999987653 467999999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeccchhHHHhhh----ccCcccccccCccccccc----cCccchhhhhhHHHHHHHhcCCCCCCCCcHHH
Q 035992 164 VNGNQGEVKIGDLGLAAILAQA----RSAHSVIEFMAPELYEEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235 (613)
Q Consensus 164 l~~~~g~VKL~DFGla~~l~~~----~~~~gt~~YmAPEvl~~~----ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~ 235 (613)
++ .++.+||+|||++...... ....+++.|+|||++.+. ++.++|||||||++|+|++|..||.. .....
T Consensus 170 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~ 247 (298)
T 2zv2_A 170 VG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMC 247 (298)
T ss_dssp EC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHH
T ss_pred EC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHH
Confidence 98 5689999999999765432 235678899999988643 47889999999999999999999966 44555
Q ss_pred HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 236 i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+...+.....+.......+..+++||.+||. +|.+|||+.|+|+||||+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 6666665544333344678899999999999 999999999999999985
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=380.22 Aligned_cols=257 Identities=25% Similarity=0.366 Sum_probs=208.8
Q ss_pred cceeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
..|++.++||+|+||+||+|++. .+|+.||+|+++.............+.+|+.+|+.++||||++++++|.. ..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~ 94 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--GG 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--SS
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--CC
Confidence 34588899999999999999985 68999999998765444445566778899999999999999999998854 45
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKES 171 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC---
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCccccc
Confidence 79999999999999999999899999999999999999999999998 99999999999998 6789999999998754
Q ss_pred hh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 183 AQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 183 ~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.. .++...+..+
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~ 248 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQEA 248 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCHHH
T ss_pred ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHH
Confidence 32 224567889999998754 589999999999999999999999976 445555666665532 3455678999
Q ss_pred HHHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 258 RAFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
++||.+||. +|.+|| ++.++++||||+..++..
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 999999999 999999 899999999999887643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=380.28 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=216.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+|++.+.||+|+||+||+|.+..+|..||+|+++....... ....+.+.+|+.+|+.++||||++++++|.. ...
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 88 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTD 88 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 345888999999999999999999999999999886543221 1246778999999999999999999998854 568
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC----cEEEeccchh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG----EVKIGDLGLA 179 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g----~VKL~DFGla 179 (613)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+ .+||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEECCCC
Confidence 9999999999999999998889999999999999999999999998 99999999999997 344 7999999999
Q ss_pred HHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccc
Q 035992 180 AILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVA 253 (613)
Q Consensus 180 ~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~ 253 (613)
...... ....+++.|+|||++.. .|+.++|||||||++|+|++|..||.... .......+..... +.......
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHTCCCCCHHHHTTS
T ss_pred eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHhcCCCcCccccccC
Confidence 765432 24467889999998864 58999999999999999999999997644 4445555554332 22334567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 8899999999999 999999999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=387.28 Aligned_cols=259 Identities=20% Similarity=0.378 Sum_probs=211.7
Q ss_pred CCCcceeEeeeeccc--CceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 23 PSARYGRYKEVLGRG--AFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 23 p~gRy~r~~e~LG~G--afGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
|.+.-|++.++||+| +||+||+|.+..+|+.||+|+++... ......+.+.+|+.+++.++||||++++++|..
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 97 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-- 97 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--
Confidence 444455899999999 99999999999999999999987543 245667888999999999999999999999865
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++||||+.+|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~ 174 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRS 174 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGG
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEccccc
Confidence 55899999999999999999876 77999999999999999999999998 99999999999998 678999999998
Q ss_pred hHHHhh-----------hccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 179 AAILAQ-----------ARSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 179 a~~l~~-----------~~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
+..... .....+++.|+|||++.+ .|+.++|||||||++|+|++|..||.+......+...+....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 254 (389)
T 3gni_B 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 254 (389)
T ss_dssp CEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred ceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 754321 112356778999998765 589999999999999999999999977555444433222110
Q ss_pred -------------------------------------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 245 -------------------------------------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 245 -------------------------------------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
....++..+++.+++||.+||+ +|.+|||+.|+|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0111344568889999999999 99999999999999
Q ss_pred CCCCCCCc
Q 035992 281 PFLQSEDD 288 (613)
Q Consensus 281 Pff~~~~~ 288 (613)
|||+...+
T Consensus 335 p~f~~~~~ 342 (389)
T 3gni_B 335 SFFKQIKR 342 (389)
T ss_dssp GGGGGC--
T ss_pred HHHHHHhh
Confidence 99987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=387.37 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=220.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|.++.+|+.||+|+++...... ....+.+..|+.++..+ +||||++++++|.. ...+|+
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~~l 98 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 98 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-chHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEEEE
Confidence 578899999999999999999999999999987543222 23456788999999988 89999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh---
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA--- 183 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~--- 183 (613)
||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++....
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccccCC
Confidence 9999999999999999889999999999999999999999998 99999999999998 67899999999987532
Q ss_pred -hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 184 -QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 184 -~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
......|++.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...+++.+..+.. .++...+..+++||
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 252 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAIC 252 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHH
Confidence 1234578899999998764 599999999999999999999999965 566777777776643 34567889999999
Q ss_pred HHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 262 EKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 262 ~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
.+||. +|.+||+ +.++++||||+..+|..+
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 99999 9999994 799999999999877543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=381.57 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=214.4
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~~y-~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 80 (323)
T 3tki_A 7 EDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQ 80 (323)
T ss_dssp TCE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred hhc-eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc---ccchHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeE
Confidence 344 88899999999999999999999999999886433 22334678899999999999999999998754 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
++||||+.+|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+|||++..+..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRY 157 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceecc
Confidence 999999999999999988888999999999999999999999998 99999999999998 568999999999975532
Q ss_pred h------ccCcccccccCccccccc--cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 185 A------RSAHSVIEFMAPELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 185 ~------~~~~gt~~YmAPEvl~~~--ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
. ....+++.|+|||++.+. ++.++|||||||++|+|++|..||.........+................+..
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 237 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHH
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHH
Confidence 1 245678899999987653 47789999999999999999999977666555555555554444445667899
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+.+||.+||. +|.+|||+.|+++||||+...
T Consensus 238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 238 PLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 9999999999 999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=379.49 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=215.4
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.++| ++.+.||+|+||+||+|.+..+|+.||+|.++.. ......+.+|+.+|+.++||||++++++|.+ ...
T Consensus 4 ~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 75 (321)
T 1tki_A 4 YEKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFES--MEE 75 (321)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTE
T ss_pred hhce-EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCE
Confidence 3455 7889999999999999999999999999987632 3456678899999999999999999998855 458
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC-CCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~-~g~VKL~DFGla~~ 181 (613)
+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.. .+.+||+|||++..
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 99999999999999999775 47999999999999999999999998 9999999999999842 68999999999976
Q ss_pred Hhhh---ccCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC--cccccccH
Q 035992 182 LAQA---RSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--SLAKVADN 255 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~ 255 (613)
+... ....+++.|+|||++.+. ++.++|||||||++|+|++|..||... +...+...+..+.... ......+.
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~ 232 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE-TNQQIIENIMNAEYTFDEEAFKEISI 232 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred CCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC-CHHHHHHHHHcCCCCCChhhhccCCH
Confidence 5432 234577899999988654 899999999999999999999999764 4556666666654332 22345789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
++++||.+||. +|.+|||+.|+|+||||+..
T Consensus 233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 99999999999 99999999999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=395.56 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=216.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 13 Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~~lv 88 (444)
T 3soa_A 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISE--EGHHYLI 88 (444)
T ss_dssp EEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--CCEEEEE
Confidence 5888999999999999999999999999998875432 24556788999999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.||+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .++.+||+|||++......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999999999999999999999999999999999998 999999999999974 3578999999999765432
Q ss_pred ----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--CcccccccHHHH
Q 035992 186 ----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKVADNGVR 258 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~l~ 258 (613)
....|++.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+... .......++.++
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 245 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 23468889999998875 599999999999999999999999966 4566677777766432 223346789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+||.+||+ +|.+|||+.|+|+||||+.
T Consensus 246 ~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 246 DLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred HHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 99999999 9999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=396.14 Aligned_cols=254 Identities=21% Similarity=0.390 Sum_probs=209.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.+..+|+.||+|+++.... ........+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv 226 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFV 226 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEEEEE
Confidence 5888999999999999999999999999999874322 234556778899999999999999999998865 4579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
|||+.+|+|..++.+.+.+++..++.++.||+.||+|||+ ++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC--
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccCCC
Confidence 9999999999999998999999999999999999999998 87 99999999999998 568999999999875322
Q ss_pred --hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 --ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.....||+.|||||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..... .++...++.+.+||
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li 380 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAKSLL 380 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHH
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHH
Confidence 234568899999998764 599999999999999999999999966 455666666665532 34566789999999
Q ss_pred HHHhh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 262 EKCIA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 262 ~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
.+||+ +|.+|| +++|+++||||+..++..
T Consensus 381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~ 415 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQH 415 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHH
Confidence 99999 999999 999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=385.09 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=217.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.... .....+.+.+|+.+++.++||||++++++|.+ ...+++|
T Consensus 31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv 106 (362)
T 2bdw_A 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYLV 106 (362)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEEE
Confidence 5788999999999999999999999999998875332 45667889999999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999999998889999999999999999999999998 9999999999999732 346999999999766543
Q ss_pred c---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHHH
Q 035992 186 R---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRA 259 (613)
Q Consensus 186 ~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~~ 259 (613)
. ...+++.|+|||++.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. +......+++.+++
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 2 3467889999998865 599999999999999999999999976 455666677766643 22233457899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
||.+||. +|.+||++.++|+||||+.
T Consensus 264 li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 264 LIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp HHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred HHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 9999999 9999999999999999975
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=391.41 Aligned_cols=257 Identities=21% Similarity=0.413 Sum_probs=220.9
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.|++.++||+|+||+||+|.+..+|+.||+|+++...... ....+.+.+|+.+|+.++||||++++++|.+ ...+++
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~l 92 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-RNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EEDMFM 92 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEE
Confidence 3578899999999999999999999999999987543222 2345778899999999999999999998865 457999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 93 VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp EECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeeccCCC
Confidence 9999999999999999999999999999999999999999998 99999999999998 6789999999999765432
Q ss_pred --ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCC--CCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 186 --RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVE--CTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~--~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
....||+.|+|||++. ..|+.++|||||||++|||++|..||.. ......++..+.... ..++..++..+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~ 247 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEM 247 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCHHH
Confidence 3457888999999875 2489999999999999999999999964 234555666655543 23456678999
Q ss_pred HHHHHHHhh-cccCCCC-HHHHhcCCCCCCCCcccc
Q 035992 258 RAFIEKCIA-EVSERLP-AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpt-a~eLL~HPff~~~~~~~~ 291 (613)
.+||.+||. +|.+||+ +.++++||||+..+|..+
T Consensus 248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence 999999999 9999998 999999999999887544
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=378.42 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=204.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.+..+|+.||+|+++... ......+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 111 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLHLI 111 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEEEE
Confidence 477899999999999999999999999999876432 223445677899999999999999999998864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe----CCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~----~~~g~VKL~DFGla~~l~ 183 (613)
|||+.+ +|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||++....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 999985 99999999999999999999999999999999998 99999999999995 234569999999998765
Q ss_pred hh----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC----------
Q 035992 184 QA----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA---------- 247 (613)
Q Consensus 184 ~~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~---------- 247 (613)
.. ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+...+.....+.
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence 32 23356789999998764 489999999999999999999999977665555544433211110
Q ss_pred -----------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcc
Q 035992 248 -----------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 248 -----------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
.+....+..+.+||.+||+ +|.+|||+.|+|+||||+..++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 0112267899999999999 99999999999999999987653
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=384.30 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=202.4
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l 104 (613)
+| ++.+.||+|+||+||+|.+..+|+.||+|++... ........++.+|+.+++.+. ||||++++++|...+...+
T Consensus 10 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 10 KY-ELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA--FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp TE-EEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ce-EEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc--ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 44 7889999999999999999999999999987532 345667788999999999997 9999999999877666789
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+||||+. |+|..++.. +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+..
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~ 161 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVN 161 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSS
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCcccccccc
Confidence 99999998 589998877 57999999999999999999999998 99999999999998 568999999999865421
Q ss_pred -------------------------hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHH
Q 035992 185 -------------------------ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY 237 (613)
Q Consensus 185 -------------------------~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~ 237 (613)
.....+|+.|+|||++.+ .|+.++|||||||++|||++|..||.+.....++.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 241 (388)
T 3oz6_A 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241 (388)
T ss_dssp CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 123467889999998754 58999999999999999999999997765554443
Q ss_pred HHHHcCCCCCc--------------------------------c------------cccccHHHHHHHHHHhh-cccCCC
Q 035992 238 KKVTSGIKPAS--------------------------------L------------AKVADNGVRAFIEKCIA-EVSERL 272 (613)
Q Consensus 238 ~~I~~g~~p~~--------------------------------l------------~~~~s~~l~~lI~~cL~-dP~~Rp 272 (613)
..+.....|.. + ....++.+.+||.+||+ +|.+||
T Consensus 242 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~ 321 (388)
T 3oz6_A 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI 321 (388)
T ss_dssp HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCC
Confidence 33211111100 0 11457889999999999 999999
Q ss_pred CHHHHhcCCCCCCCC
Q 035992 273 PAKELLGDPFLQSED 287 (613)
Q Consensus 273 ta~eLL~HPff~~~~ 287 (613)
|+.|+|+||||+...
T Consensus 322 t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 322 SANDALKHPFVSIFH 336 (388)
T ss_dssp CHHHHTTSTTTTTTC
T ss_pred CHHHHhCCHHHHHhc
Confidence 999999999998653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=388.54 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=212.5
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHH-HHhCCCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL-LKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~i-Lk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
-|++.++||+|+||+||+|+++.+++.||+|++++.... .......+..|..+ ++.++||||++++++|.. ...+|
T Consensus 39 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~~~ 115 (373)
T 2r5t_A 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLY 115 (373)
T ss_dssp GEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEEC--SSEEE
T ss_pred heEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCEEE
Confidence 458889999999999999999999999999998865433 23445667777776 577899999999999865 56899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ- 184 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~- 184 (613)
+||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccC
Confidence 99999999999999999899999999999999999999999998 99999999999998 678999999999986432
Q ss_pred ---hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 185 ---ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
.....||+.|+|||++.+ .|+.++|||||||++|||++|..||.. .+...++..+..+. ..++..++..+++|
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~l 269 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHL 269 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHHHHH
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHHHHH
Confidence 234568889999998765 599999999999999999999999965 56677777777663 23455678999999
Q ss_pred HHHHhh-cccCCCCH----HHHhcCCCCCCCCcccc
Q 035992 261 IEKCIA-EVSERLPA----KELLGDPFLQSEDDESV 291 (613)
Q Consensus 261 I~~cL~-dP~~Rpta----~eLL~HPff~~~~~~~~ 291 (613)
|.+||+ +|.+||++ .++++||||+..+|..+
T Consensus 270 i~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 270 LEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp HHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 999999 99999986 69999999999887543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=384.26 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=219.6
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
.+|..+| +..+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||++++++|..
T Consensus 50 ~~~~~~y-~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-- 125 (348)
T 1u5q_A 50 DDPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-- 125 (348)
T ss_dssp SCHHHHE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred cchhhhe-eeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--
Confidence 3455555 777999999999999999999999999998874322 234556789999999999999999999998865
Q ss_pred CCEEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRK-KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
...+++||||+. |+|.+++. ..+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 126 ~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a 201 (348)
T 1u5q_A 126 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSA 201 (348)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTC
T ss_pred CCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCc
Confidence 458999999997 57777765 4578999999999999999999999998 99999999999998 6789999999999
Q ss_pred HHHhhhccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 180 AILAQARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 180 ~~l~~~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
..........+++.|+|||++. +.|+.++|||||||++|||++|..||........++ .+..+..+......++.
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 280 (348)
T 1u5q_A 202 SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSE 280 (348)
T ss_dssp BSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-HHHHSCCCCCCCTTSCH
T ss_pred eecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCCCCCCH
Confidence 8777666778899999999873 458999999999999999999999997766555554 44445455555567889
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+++||.+||+ +|.+|||+.++++||||....
T Consensus 281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99999999999 999999999999999997653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=387.98 Aligned_cols=255 Identities=20% Similarity=0.400 Sum_probs=218.0
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC--CCCcceeeeeeecC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK--HKNIIKFYNSWVDT 99 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~fv~~ 99 (613)
...++.|++.+.||+|+||+||+|.+.. ++.||+|++.... ......+.+.+|+.+|+.+. ||||+++++++..
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~- 127 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT- 127 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc--ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-
Confidence 3456778999999999999999999865 9999999887543 24567788999999999996 5999999998765
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
...+++||| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 128 -~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a 201 (390)
T 2zmd_A 128 -DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIA 201 (390)
T ss_dssp -SSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSS
T ss_pred -CCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCcc
Confidence 457999999 678899999999999999999999999999999999998 99999999999995 479999999999
Q ss_pred HHHhhh------ccCcccccccCcccccc------------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH
Q 035992 180 AILAQA------RSAHSVIEFMAPELYEE------------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 180 ~~l~~~------~~~~gt~~YmAPEvl~~------------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~ 241 (613)
..+... ....+++.|||||++.. .|+.++|||||||++|||++|..||....+.......+.
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 281 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh
Confidence 765332 24568899999998753 588999999999999999999999987766666666666
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.......++...+..+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 282 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 6655555666778899999999999 99999999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=372.35 Aligned_cols=248 Identities=23% Similarity=0.406 Sum_probs=206.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC------
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN------ 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~------ 101 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+.+.+|+.+|++++||||++++++|.....
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 477899999999999999999999999999887533 34567889999999999999999999999865432
Q ss_pred -------------------------------------------------CEEEEEEeccCCCCHHHHHHhCCC---CCHH
Q 035992 102 -------------------------------------------------EHINFITEIFTSGTLRQYRKKHKH---VDLR 129 (613)
Q Consensus 102 -------------------------------------------------~~l~lV~E~~~gGsL~~~l~~~~~---lse~ 129 (613)
..++++|||+.+|+|.+++.+... .++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 248999999999999999988654 5666
Q ss_pred HHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----------------ccCccccc
Q 035992 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----------------RSAHSVIE 193 (613)
Q Consensus 130 ~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----------------~~~~gt~~ 193 (613)
.++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...... ....+++.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999998 99999999999998 5689999999998765432 22457889
Q ss_pred ccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCC
Q 035992 194 FMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSER 271 (613)
Q Consensus 194 YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~R 271 (613)
|+|||++.+ .|+.++|||||||++|+|++|..|+. ....+...+.....+. .....++.+++||.+||+ +|.+|
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R 317 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTER 317 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCCcC
Confidence 999998765 58999999999999999999877762 3344555555554443 333456788999999999 99999
Q ss_pred CCHHHHhcCCCCCC
Q 035992 272 LPAKELLGDPFLQS 285 (613)
Q Consensus 272 pta~eLL~HPff~~ 285 (613)
||+.|+|+||||++
T Consensus 318 ps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 318 PEATDIIENAIFEN 331 (332)
T ss_dssp CCHHHHHHSTTCCC
T ss_pred CCHHHHhhchhhhc
Confidence 99999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=381.35 Aligned_cols=254 Identities=23% Similarity=0.402 Sum_probs=212.6
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN-SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~-~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.|++.+.||+|+||+||+|.++.+|+.||+|+++....... ....+.+.+|+.+++.++||||++++++|.. ...+|
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 102 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGMLY 102 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEE
Confidence 35888999999999999999999999999999875443221 1235678999999999999999999998865 56899
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEeccchh
Q 035992 106 FITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLA 179 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DFGla 179 (613)
+||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998877543 35899999999999999999999998 9999999999999732 345999999999
Q ss_pred HHHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--cccc
Q 035992 180 AILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKV 252 (613)
Q Consensus 180 ~~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~ 252 (613)
...... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||.. ....++..+..+..... ....
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~--~~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG--TKERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp EECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS--SHHHHHHHHHHTCCCCCHHHHTT
T ss_pred eEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC--cHHHHHHHHHcCCCCCCcccccc
Confidence 765442 23467889999998765 599999999999999999999999966 34556666666543322 2245
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
++..+++||.+||. +|.+|||+.++|+||||+..
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 78899999999999 99999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=378.00 Aligned_cols=255 Identities=20% Similarity=0.394 Sum_probs=217.1
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CCcceeeeeeecC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH--KNIIKFYNSWVDT 99 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fv~~ 99 (613)
...++.|++.+.||+|+||+||+|.+ .+++.||+|+++... ......+.+.+|+.+|+.++| |||+++++++..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~- 80 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT- 80 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-
Confidence 44577789999999999999999987 468999999887543 345667889999999999976 999999998864
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
...+++||| +.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++
T Consensus 81 -~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a 154 (343)
T 3dbq_A 81 -DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIA 154 (343)
T ss_dssp -SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSS
T ss_pred -CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccc
Confidence 568999999 568899999999999999999999999999999999998 99999999999997 478999999999
Q ss_pred HHHhhh------ccCcccccccCccccc------------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH
Q 035992 180 AILAQA------RSAHSVIEFMAPELYE------------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 180 ~~l~~~------~~~~gt~~YmAPEvl~------------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~ 241 (613)
..+... ....+++.|+|||++. ..|+.++|||||||++|+|++|..||....+.......+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 765322 2346788999999874 3588999999999999999999999987766666666666
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.......++...+..+.+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 6655666677778899999999999 99999999999999999854
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=361.02 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=218.3
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 79 (284)
T 3kk8_A 5 SDNY-DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESF 79 (284)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhh-hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc--CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc--CCE
Confidence 4455 88899999999999999999999999999887543 245667889999999999999999999998754 567
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~ 181 (613)
.++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++. ..+.+||+|||++..
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 8999999999999999998899999999999999999999999998 999999999999973 234599999999976
Q ss_pred Hhhhc---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccH
Q 035992 182 LAQAR---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADN 255 (613)
Q Consensus 182 l~~~~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~ 255 (613)
..... ...+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..+.. +.......++
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCH
Confidence 54332 3467889999998765 489999999999999999999999976 445556666665543 2222346789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+.+||.+||+ +|.+|||+.|+|+||||+....
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 99999999999 9999999999999999987643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=378.10 Aligned_cols=252 Identities=23% Similarity=0.363 Sum_probs=205.3
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..|++.+.||+|+||+||+|.+..+++.||+|+++.. ...+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~ 124 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT------VDKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEIS 124 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc------hhHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEE
Confidence 3468889999999999999999999999999988742 234567889999999999999999998854 56799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~l~ 183 (613)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999999999999889999999999999999999999998 999999999999972 36799999999998765
Q ss_pred hh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--CcccccccHHH
Q 035992 184 QA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKVADNGV 257 (613)
Q Consensus 184 ~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~l 257 (613)
.. ....+++.|+|||++.+ .|+.++|||||||++|||++|..||........++..+..+... ..+....+..+
T Consensus 203 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 282 (349)
T 2w4o_A 203 HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNA 282 (349)
T ss_dssp ----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHH
Confidence 42 24467889999998765 58999999999999999999999998877777777777765432 22334578899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
++||.+||. +|.+|||+.|+|+||||+...
T Consensus 283 ~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 283 KDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999 999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=396.01 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=220.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+|+.++||||++++++|.. ...+++|
T Consensus 28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 104 (484)
T 3nyv_A 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFED--KGYFYLV 104 (484)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEEEEE
Confidence 47889999999999999999999999999988754322 23456788999999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 999999999999999999999999999999999999999998 99999999999995 25678999999999876432
Q ss_pred ---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccccHHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVADNGVRAF 260 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~l~~l 260 (613)
....+++.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...+...+..+..... ....+++.+++|
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 261 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred cccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence 23467889999999988899999999999999999999999966 455666777776654332 335678999999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|.+||+ +|.+|||+.|+|+||||+..
T Consensus 262 i~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 262 IRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp HHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred HHHHCCCChhHCcCHHHHhhChhhccc
Confidence 999999 99999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=370.07 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=206.8
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 103 (613)
.+|.-..++||+|+||+||+|.+..+|+.||+|+++... ....+.+.+|+.+++++ +||||++++++|.. ...
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCE
Confidence 455333588999999999999999999999999886432 23456788999999985 79999999998865 468
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC--CcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~--g~VKL~DFGla~~ 181 (613)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+. +.+||+|||++..
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 9999999999999999999889999999999999999999999998 99999999999997332 2399999999865
Q ss_pred Hhhh-----------ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCc------------
Q 035992 182 LAQA-----------RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTN------------ 232 (613)
Q Consensus 182 l~~~-----------~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~------------ 232 (613)
.... ....+++.|+|||++. ..|+.++|||||||++|+|++|..||.....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 4321 1234788999999875 3489999999999999999999999965432
Q ss_pred --HHHHHHHHHcCCCCCc--ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 233 --AAQIYKKVTSGIKPAS--LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 233 --~~~i~~~I~~g~~p~~--l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
...++..+..+..... .....+..+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 3445666666543221 223568899999999999 999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=365.86 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=207.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|..||+|.+.... .....+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 98 (285)
T 3is5_A 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR---SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED--YHNMYIV 98 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG---CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eeecceeccCCCeEEEEEEEccCCceEEEEEeeccc---cchhHHHHHHHHHHHHhCCCchHHhHHHheec--CCeEEEE
Confidence 488899999999999999999999999999877533 23346778999999999999999999998854 5679999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHH
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAI 181 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~ 181 (613)
|||+.+|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999998754 377999999999999999999999998 999999999999952 357899999999976
Q ss_pred Hhhh---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-CCcccccccHHH
Q 035992 182 LAQA---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADNGV 257 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~l 257 (613)
.... ....+++.|+|||++.+.++.++||||||+++|+|++|..||... ....+...+..... ........++.+
T Consensus 177 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (285)
T 3is5_A 177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGT-SLEEVQQKATYKEPNYAVECRPLTPQA 255 (285)
T ss_dssp ----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCC--CCCCHHH
T ss_pred cCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCC-CHHHHHhhhccCCcccccccCcCCHHH
Confidence 5432 345678899999999888999999999999999999999999764 44445444443332 222223468899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
.+||.+||+ +|.+|||+.|+|+||||+.
T Consensus 256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999999 9999999999999999975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=387.27 Aligned_cols=251 Identities=27% Similarity=0.461 Sum_probs=210.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ........+.+|+.+++.++||||++++++|.. ...+
T Consensus 9 ~~Y-~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 9 GPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CCE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHc-cchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 455 788999999999999999999999999998874322 112234578899999999999999999998854 4579
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
++||||+ +|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTT
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccC
Confidence 9999999 7899999998899999999999999999999999998 99999999999998 668999999999986654
Q ss_pred h---ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 A---RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ~---~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
. ....+++.|+|||++.+. | +.++|||||||++|+|++|..||..... ..+++.+..+ ...++...++.+++
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~~~ 237 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPGAQS 237 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHHHHH
Confidence 3 345678899999988754 4 7899999999999999999999965332 2222222222 22345567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||. +|.+|||+.|+++||||+..
T Consensus 238 li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 238 LIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 9999999 99999999999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=375.09 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=204.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----CCCcceeeeeeecCCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-----HKNIIKFYNSWVDTEN 101 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-----HpNIVkl~~~fv~~~~ 101 (613)
.|++.++||+|+||+||+|.+..+|+.||+|+++. .......+..|+.+++.+. ||||++++++|.. .
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~ 108 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--Y 108 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--T
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--C
Confidence 34888999999999999999999999999998763 3455667788999999996 9999999999865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-------------
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG------------- 166 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~------------- 166 (613)
..+++||||+ +++|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcc
Confidence 5899999999 999999998764 5999999999999999999999998 999999999999963
Q ss_pred -----------CCCcEEEeccchhHHHhh-hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH
Q 035992 167 -----------NQGEVKIGDLGLAAILAQ-ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA 233 (613)
Q Consensus 167 -----------~~g~VKL~DFGla~~l~~-~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~ 233 (613)
..+.+||+|||++..... .....+++.|+|||++.+ .|+.++|||||||++|+|++|..||......
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence 367899999999976543 234567889999998764 5999999999999999999999999765443
Q ss_pred HHHHHHHHcCCC--CC------------------------------------------cccccccHHHHHHHHHHhh-cc
Q 035992 234 AQIYKKVTSGIK--PA------------------------------------------SLAKVADNGVRAFIEKCIA-EV 268 (613)
Q Consensus 234 ~~i~~~I~~g~~--p~------------------------------------------~l~~~~s~~l~~lI~~cL~-dP 268 (613)
. ....+..... |. .+....++.+.+||.+||+ +|
T Consensus 266 ~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 266 E-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp H-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred H-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 3 3333322111 10 0111224778899999999 99
Q ss_pred cCCCCHHHHhcCCCCC
Q 035992 269 SERLPAKELLGDPFLQ 284 (613)
Q Consensus 269 ~~Rpta~eLL~HPff~ 284 (613)
.+|||+.|+|+||||+
T Consensus 345 ~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred hhCCCHHHHhcCcccC
Confidence 9999999999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=362.62 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=215.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..|++.+.||+|+||+||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFED--NTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeEE
Confidence 345888999999999999999999999999998774332 335678899999999999999999998854 56799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFGla~~l~ 183 (613)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|||++....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999999999999899999999999999999999999998 99999999999992 256799999999987654
Q ss_pred hh---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccccHHHH
Q 035992 184 QA---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVADNGVR 258 (613)
Q Consensus 184 ~~---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~l~ 258 (613)
.. ....+++.|+|||++.+.++.++||||||+++|+|++|..||.... ...+...+..+..... .....++.+.
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T 3f3z_A 161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPT-DSEVMLKIREGTFTFPEKDWLNVSPQAE 239 (277)
T ss_dssp TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred CccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCC-HHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence 32 2446778999999998889999999999999999999999997644 4555556665543322 2235788999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+||.+||+ +|.+|||+.++|+||||+..
T Consensus 240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 99999999 99999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=372.52 Aligned_cols=254 Identities=23% Similarity=0.407 Sum_probs=203.6
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
..+| ++.+.||+|+||+||+|.+. +|+.||+|+++... ........+.+|+.+++.++||||++++++|.. ...
T Consensus 20 ~~~y-~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 93 (311)
T 3niz_A 20 MEKY-QKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA--EDEGIPSTAIREISLLKELHHPNIVSLIDVIHS--ERC 93 (311)
T ss_dssp SCEE-EEEEEEEECSSCEEEEEEET-TSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC--SSC
T ss_pred Hhhh-HhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc--ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc--CCE
Confidence 3455 78899999999999999985 58999999886432 223445778899999999999999999998754 567
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAF 169 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEET
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCceec
Confidence 9999999985 777777665 56999999999999999999999998 99999999999998 5689999999999765
Q ss_pred hhh----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH--cCCCCCcc-----
Q 035992 183 AQA----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT--SGIKPASL----- 249 (613)
Q Consensus 183 ~~~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~--~g~~p~~l----- 249 (613)
... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+..... ....+..+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 170 GIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp TSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred CCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 422 23456789999998754 489999999999999999999999976555444332221 11111111
Q ss_pred --------------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 250 --------------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 250 --------------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
....++++.+||.+||+ +|.+|||+.|+|+||||+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 12356789999999999 999999999999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=366.23 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=203.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+ .+|+.||+|+++.... .....+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 4 y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred chhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 37789999999999999998 6899999998865432 12234667899999999999999999998864 4579999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV 154 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC--
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCccc
Confidence 999986 899888765 67999999999999999999999998 99999999999998 6789999999999876432
Q ss_pred ---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--CCCC------------
Q 035992 186 ---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS--GIKP------------ 246 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~--g~~p------------ 246 (613)
....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+...+.. ....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 23456789999998754 4899999999999999999999999776555444333221 0000
Q ss_pred ------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 ------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 ------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..+....+..+.+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 01123467899999999999 99999999999999999863
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.95 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=213.2
Q ss_pred ccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 20 ~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
..++..+| ++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||++++++|..
T Consensus 14 ~~~~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 87 (302)
T 2j7t_A 14 DLDPNEVW-EIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYH- 87 (302)
T ss_dssp SSCGGGTE-EEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred ccCCccce-eecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-
Confidence 34677776 8889999999999999999999999999987643 23446778899999999999999999998865
Q ss_pred CCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 100 ENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++||||+.+++|.+++.+ .+.+++..++.++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||+
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~ 163 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGV 163 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHH
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCC
Confidence 4578999999999999998876 567999999999999999999999998 99999999999998 568999999999
Q ss_pred hHHHhh----hccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-CC
Q 035992 179 AAILAQ----ARSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PA 247 (613)
Q Consensus 179 a~~l~~----~~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p~ 247 (613)
+..... .....+++.|+|||++. ..++.++||||||+++|+|++|..||........ ...+..+.. ..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~ 242 (302)
T 2j7t_A 164 SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSDPPTL 242 (302)
T ss_dssp HHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCC
T ss_pred CccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhccCCccc
Confidence 865432 22346788999999873 3488999999999999999999999977554444 444444433 33
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
..+..++..+.++|.+||. +|.+|||+.++++||||+....
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 3456678999999999999 9999999999999999997643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=368.40 Aligned_cols=259 Identities=26% Similarity=0.414 Sum_probs=202.9
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-ChHHHHHHHHHHHHHHhC---CCCCcceeeeeeecC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVDT 99 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~~ 99 (613)
.+|| ++.+.||+|+||+||+|.+..+|+.||+|+++...... .......+.+|+.+++.+ +||||++++++|...
T Consensus 8 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRY-EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CC-EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3465 88899999999999999999999999999988654221 111123455677776666 599999999998764
Q ss_pred CC---CEEEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 100 EN---EHINFITEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 100 ~~---~~l~lV~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
.. ..++++|||+. |+|.+++.+... +++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEe
Confidence 32 25899999997 599999988754 999999999999999999999999 99999999999998 66899999
Q ss_pred ccchhHHHhhh---ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCCC-C-
Q 035992 175 DLGLAAILAQA---RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIKP-A- 247 (613)
Q Consensus 175 DFGla~~l~~~---~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~p-~- 247 (613)
|||++...... ....+++.|+|||++. ..|+.++|||||||++|+|++|..||........+...+.. +..+ .
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred eCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99999766432 2345678999999875 45999999999999999999999999775554443332221 1110 0
Q ss_pred ---------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 248 ---------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 248 ---------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+....+..+.+||.+||+ +|.+|||+.|+|+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 243 WPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp SCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0112467889999999999 999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.19 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=209.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.++..+ +||||++++++|.. ...+++
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~l 88 (289)
T 1x8b_A 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL--AGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHMLI 88 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCC--TTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEEE
T ss_pred hhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccc--cccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 477899999999999999999999999999887532 2345567788999999999 99999999998865 458999
Q ss_pred EEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC----------------
Q 035992 107 ITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG---------------- 166 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~---------------- 166 (613)
||||+.+|+|.+++.+. +.+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999999765 67999999999999999999999998 999999999999972
Q ss_pred --CCCcEEEeccchhHHHhhhccCcccccccCccccccc--cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc
Q 035992 167 --NQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS 242 (613)
Q Consensus 167 --~~g~VKL~DFGla~~l~~~~~~~gt~~YmAPEvl~~~--ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~ 242 (613)
....+||+|||++..........+++.|+|||++.+. ++.++|||||||++|+|++|..|+.... ....+..
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~~~~~~~ 242 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----QWHEIRQ 242 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----HHHHHHT
T ss_pred cCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----HHHHHHc
Confidence 2347999999999887766667789999999988654 5679999999999999999998775432 2344555
Q ss_pred CCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 243 GIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 243 g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..+ .++..++..+.+||.+||. +|.+|||+.++++||||+..
T Consensus 243 ~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 GRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp TCCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCC-CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 5443 4456678999999999999 99999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=393.10 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=219.4
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|| ++.++||+|+||+||+|.+..+|+.||+|+++..... ......+.+|+.+|++++||||++++++|.. ...++
T Consensus 23 ~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 97 (486)
T 3mwu_A 23 RY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFY 97 (486)
T ss_dssp HE-EEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred ce-EEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEc--CCEEE
Confidence 44 7889999999999999999999999999998754322 2345678999999999999999999998754 56899
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~l~ 183 (613)
+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++....
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999999998899999999999999999999999998 999999999999962 45689999999997654
Q ss_pred hh---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--ccccccHHHH
Q 035992 184 QA---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LAKVADNGVR 258 (613)
Q Consensus 184 ~~---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~~~~s~~l~ 258 (613)
.. ....+++.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...++..+..+..+.. ....+++.++
T Consensus 176 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 176 QNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp CC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 32 24568889999999988899999999999999999999999976 455666677776654333 3346789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+||.+||+ +|.+|||+.++|+||||+...
T Consensus 255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred HHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 99999999 999999999999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.87 Aligned_cols=257 Identities=24% Similarity=0.394 Sum_probs=218.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
..|++.+.||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.+++.++||||++++++|.. ...
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 89 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN--RTD 89 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec--CCE
Confidence 456889999999999999999999999999999886543221 1246778999999999999999999998854 568
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC----cEEEeccchh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG----EVKIGDLGLA 179 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g----~VKL~DFGla 179 (613)
+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. .+ .+||+|||++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~-~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLD-KNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESC-TTSSSCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEec-CCCCcCCEEEccCccc
Confidence 9999999999999999999889999999999999999999999998 999999999999984 44 7999999999
Q ss_pred HHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccc
Q 035992 180 AILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVA 253 (613)
Q Consensus 180 ~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~ 253 (613)
...... ....+++.|+|||++.. .++.++||||||+++|+|++|..||... ........+..... +..+....
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccccChhhhccc
Confidence 765432 23457889999998764 5899999999999999999999999764 44555556665532 22334567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
+..+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus 246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 8899999999999 9999999999999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=393.82 Aligned_cols=253 Identities=25% Similarity=0.453 Sum_probs=213.9
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.|++.+.||+|+||+||+|.++.++..||+|+++..... ......+.+|+.+++.++||||++++++|.. ...+++
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 358889999999999999999999999999998754432 2235678899999999999999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~l~~ 184 (613)
|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+||+|||++.....
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 9999999999999998899999999999999999999999998 999999999999973 245699999999976543
Q ss_pred h---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC--cccccccHHHHH
Q 035992 185 A---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--SLAKVADNGVRA 259 (613)
Q Consensus 185 ~---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~~s~~l~~ 259 (613)
. ....+++.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...+...+..+.... ......++.+++
T Consensus 192 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 192 QKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp TBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred CccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 2 24567889999999988899999999999999999999999976 45566677777665432 233457899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||+ +|.+|||+.|+|+||||+..
T Consensus 271 li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 271 LIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred HHHHHCCCChhhCccHHHHhcCcccccC
Confidence 9999999 99999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=367.18 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=205.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|.+..+|+.||+|++.... ...........|+..+..+ +||||++++++|.. +..+++
T Consensus 59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF--RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSC--CSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccc--cChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 577899999999999999999999999999765322 2344455556666666555 99999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||||+ +++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC--
T ss_pred EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecccC
Confidence 99999 66888887654 56999999999999999999999998 99999999999998 5689999999998655332
Q ss_pred ---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....+++.|+|||++.+.++.++|||||||++|||++|..||... .....+..+..+..++...+..+.+||.
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp ----CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHH
Confidence 234578899999999888999999999999999999997776442 2345566666676777788999999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCCCC
Q 035992 263 KCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+||+ +|.+|||+.|+|+||||+.
T Consensus 287 ~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 MMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHcCCChhhCcCHHHHHhCccccC
Confidence 9999 9999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=376.34 Aligned_cols=253 Identities=22% Similarity=0.341 Sum_probs=202.6
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
..|| ++.+.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.+++.++||||++++++|.. ...
T Consensus 19 ~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 90 (361)
T 3uc3_A 19 SDRY-DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-----AIDENVQREIINHRSLRHPNIVRFKEVILT--PTH 90 (361)
T ss_dssp TTTE-EEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-----TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CCcE-EEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-----cccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCE
Confidence 4555 88899999999999999999999999999886432 222567899999999999999999998864 567
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC-CCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~-~g~VKL~DFGla~~l 182 (613)
+++||||+.+|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++...
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999999999998889999999999999999999999998 9999999999999733 235999999998743
Q ss_pred hh---hccCcccccccCcccccc-ccCc-cchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHcCCCCCccccccc
Q 035992 183 AQ---ARSAHSVIEFMAPELYEE-EYNE-LVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 183 ~~---~~~~~gt~~YmAPEvl~~-~ys~-ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.. .....+++.|+|||++.+ .++. ++|||||||++|+|++|..||..... ...+...+.............+
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 32 234567889999998754 4554 48999999999999999999965432 3344455554433333333568
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+.+++||.+||+ +|.+|||+.|+++||||...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 999999999999 99999999999999999653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=374.28 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=209.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.|++.+.||+|+||+||+|.+..++..||+|+++...... .....+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 104 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQYIC 104 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCeEE
Confidence 3488899999999999999999999999999987544321 34567889999999999999999999998854 56899
Q ss_pred EEEeccCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHhhhh
Q 035992 106 FITEIFTSGTLRQYRKK----------------------------------------HKHVDLRALKKWSRQILEGLSYL 145 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~----------------------------------------~~~lse~~i~~i~~QIl~gL~yL 145 (613)
+||||+.+|+|.+++.. ...+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999998852 11246888999999999999999
Q ss_pred hcCCCCEEecCCCCCcEEEeCCCC--cEEEeccchhHHHhh--------hccCcccccccCccccc---cccCccchhhh
Q 035992 146 HSHDPPVIHRDLKCDNIFVNGNQG--EVKIGDLGLAAILAQ--------ARSAHSVIEFMAPELYE---EEYNELVDIYA 212 (613)
Q Consensus 146 Hs~~~~IIHrDLKp~NILl~~~~g--~VKL~DFGla~~l~~--------~~~~~gt~~YmAPEvl~---~~ys~ksDIWS 212 (613)
|+++ |+||||||+|||++. ++ .+||+|||++..+.. .....+++.|+|||++. ..|+.++||||
T Consensus 185 H~~~--ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQG--ICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHTT--EECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHCC--ccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9998 999999999999973 34 899999999975533 12345788999999875 45899999999
Q ss_pred hhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 213 FGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 213 LGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
|||++|+|++|..||........+...+..... +.......++.+++||.+||. +|.+||++.++|+||||+...
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999776555544444433322 222333578999999999999 999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=371.00 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=195.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
+.||+|+||+||+|.+..+|+.||+|++.. .....+.+|+.+++.+. ||||++++++|.+ ...+++||||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e~ 87 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK-------RMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMEL 87 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG-------GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEECC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh-------hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEEc
Confidence 789999999999999999999999998763 23456778999999997 9999999998854 5689999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC--CcEEEeccchhHHHhhh---
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGDLGLAAILAQA--- 185 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~--g~VKL~DFGla~~l~~~--- 185 (613)
+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.+. ..+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 88 LNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 999999999999999999999999999999999999998 99999999999997322 27999999999754322
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC------CcHHHHHHHHHcCCCCC--cccccccH
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC------TNAAQIYKKVTSGIKPA--SLAKVADN 255 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~------~~~~~i~~~I~~g~~p~--~l~~~~s~ 255 (613)
....+++.|+|||++.+ .|+.++|||||||++|+|++|..||... .....+...+..+..+. ......++
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 23456789999998765 5999999999999999999999999653 23456777777765432 22345789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
++++||.+||. +|.+|||+.++++||||+...
T Consensus 246 ~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp HHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred HHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 99999999999 999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=393.78 Aligned_cols=255 Identities=27% Similarity=0.423 Sum_probs=215.8
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC---------hHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN---------SEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~---------~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
.|++.++||+|+||+||+|.++.++..||+|+++....... ....+.+.+|+.+|+.++||||++++++|.
T Consensus 37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35778999999999999999999999999999876443211 123567899999999999999999999885
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC--CcEEEec
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ--GEVKIGD 175 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~--g~VKL~D 175 (613)
. ...+++|||||.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+. ..+||+|
T Consensus 117 ~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 117 D--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred c--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEE
Confidence 4 5689999999999999999998899999999999999999999999998 99999999999998432 2699999
Q ss_pred cchhHHHhhh---ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--cc
Q 035992 176 LGLAAILAQA---RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS--LA 250 (613)
Q Consensus 176 FGla~~l~~~---~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~--l~ 250 (613)
||++...... ....+++.|+|||++.+.|+.++|||||||++|+|++|..||.. .+...+...+..+..... ..
T Consensus 193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp CTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCcccc
Confidence 9999765432 34567889999999988899999999999999999999999966 556677777777654332 23
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..+++.+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 4578999999999999 99999999999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=369.32 Aligned_cols=248 Identities=27% Similarity=0.475 Sum_probs=211.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+...+.||+|+||+||+|.+..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 120 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLV--GEELWVL 120 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CCEEEEE
Confidence 466689999999999999999999999999876432 2345678899999999999999999998865 4579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+ ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~ 196 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVP 196 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSC
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCcc
Confidence 999999999998865 56999999999999999999999998 99999999999998 5689999999998765432
Q ss_pred --ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC-cccccccHHHHHHH
Q 035992 186 --RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA-SLAKVADNGVRAFI 261 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~~s~~l~~lI 261 (613)
....+++.|+|||++.+ .|+.++||||||+++|+|++|..||... +..+....+.....+. ......++.+++||
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 275 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence 23467889999998765 4899999999999999999999999764 4455555666554332 23445788999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+||+ +|.+|||+.++++||||...
T Consensus 276 ~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 276 ERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHccCChhhCcCHHHHhcChhhccC
Confidence 99999 99999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=371.15 Aligned_cols=250 Identities=26% Similarity=0.490 Sum_probs=195.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++... .....+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 81 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHT--ENKLTLV 81 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC--TTEEEEE
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE--CCeEEEE
Confidence 377899999999999999999999999999887543 22334567899999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 108 TEIFTSGTLRQYRKKH------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
|||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCcccee
Confidence 99998 5999988754 35999999999999999999999998 99999999999998 568999999999976
Q ss_pred Hhhh----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--CCCCC------
Q 035992 182 LAQA----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS--GIKPA------ 247 (613)
Q Consensus 182 l~~~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~--g~~p~------ 247 (613)
.... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+ ..+.. +..+.
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL-KLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCTTTCGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCChhHhhhh
Confidence 5432 23456789999998754 4899999999999999999999999765544433 33321 11000
Q ss_pred ------------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 248 ------------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 248 ------------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
......+..+.+||.+||+ +|.+|||+.|+|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0112457889999999999 999999999999999998754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=377.27 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=210.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.... ...+|+.++.++ +||||++++++|.+ ...+|+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--------~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 93 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--------DPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYV 93 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------CCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEE
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------ChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEE
Confidence 4788999999999999999999999999998874321 234688888887 79999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC---CcEEEeccchhHHHh
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAAILA 183 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~---g~VKL~DFGla~~l~ 183 (613)
||||+.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||+.... +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999999999999999999999999999998 99999999999995333 359999999997654
Q ss_pred hh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC--CcHHHHHHHHHcCCCCC--ccccccc
Q 035992 184 QA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC--TNAAQIYKKVTSGIKPA--SLAKVAD 254 (613)
Q Consensus 184 ~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--~~~~~i~~~I~~g~~p~--~l~~~~s 254 (613)
.. ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||... .....++..+..+.... ..+...+
T Consensus 172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s 251 (342)
T 2qr7_A 172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS 251 (342)
T ss_dssp CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence 32 24467889999998865 4999999999999999999999999653 45677888887765432 2335678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..+++||.+||. +|.+|||+.++++||||..
T Consensus 252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 252 DTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 999999999999 9999999999999999965
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=379.80 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=214.1
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
+|++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||++++++|.. ...+++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 125 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVL 125 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEE
Confidence 457889999999999999999999999999987643 23455678999999999999999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-CCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~-~~g~VKL~DFGla~~l~~ 184 (613)
||||+.+|+|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||++..+..
T Consensus 126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999999987654 7999999999999999999999998 999999999999973 356899999999976543
Q ss_pred h---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHH
Q 035992 185 A---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVR 258 (613)
Q Consensus 185 ~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~ 258 (613)
. ....+++.|+|||++.+ .++.++|||||||++|+|++|..||.... .......+..+.. +......+++.++
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 282 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWEFDEDAFSSVSPEAK 282 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCCCccccccCCHHHH
Confidence 2 23467889999998765 48999999999999999999999997644 4445555554432 2233345789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+||.+||. +|.+|||+.|+|+||||+...
T Consensus 283 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 283 DFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 99999999 999999999999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=363.95 Aligned_cols=255 Identities=22% Similarity=0.400 Sum_probs=207.7
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
+| ++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||++++++|.. ...++
T Consensus 4 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (311)
T 4agu_A 4 KY-EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLH 78 (311)
T ss_dssp CE-EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cc-eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEE
Confidence 44 78899999999999999999999999999875432 334556778899999999999999999998864 56799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+||||+.+++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++......
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC--
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCc
Confidence 99999999999999998889999999999999999999999998 99999999999998 6789999999999755422
Q ss_pred ----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--CC-------------
Q 035992 186 ----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS--GI------------- 244 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~--g~------------- 244 (613)
....++..|+|||++.+ .++.++||||||+++|+|++|..||........+...... ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 23457789999998754 5899999999999999999999999776555444322211 00
Q ss_pred ----C---CCc------ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 245 ----K---PAS------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 245 ----~---p~~------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
. +.. .....+..+.+||.+||. +|.+|||++|+|+||||+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 293 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence 0 000 012457789999999999 9999999999999999998643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=388.75 Aligned_cols=258 Identities=23% Similarity=0.403 Sum_probs=196.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC---C
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---N 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---~ 101 (613)
.+| ++.++||+|+||+||+|.++.+|+.||+|++... .......+++.+|+.+|+.++||||++++++|.... .
T Consensus 53 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 53 DRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV--FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp TTE-EECCC-------CEEEEEECC--CEEEEEEECST--TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred CCe-EEeeEeeecCCeEEEEEEECCCCcEEEEEEechh--hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 455 8889999999999999999999999999987532 345567788999999999999999999999886432 2
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+|+||||+ +|+|..++...+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||++..
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBC
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchh
Confidence 5799999987 5699999999899999999999999999999999998 99999999999998 568999999999976
Q ss_pred Hhh-------------------------------hccCcccccccCcccc-c-cccCccchhhhhhHHHHHHHh------
Q 035992 182 LAQ-------------------------------ARSAHSVIEFMAPELY-E-EEYNELVDIYAFGMCLLELVT------ 222 (613)
Q Consensus 182 l~~-------------------------------~~~~~gt~~YmAPEvl-~-~~ys~ksDIWSLGviL~Emlt------ 222 (613)
... .....+|+.|+|||++ . ..|+.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 531 1123457789999975 3 459999999999999999999
Q ss_pred -----cCCCCCCCCc--------------------HHHHHHHHHc--CCCC---------------------------Cc
Q 035992 223 -----FEYPYVECTN--------------------AAQIYKKVTS--GIKP---------------------------AS 248 (613)
Q Consensus 223 -----G~~Pf~~~~~--------------------~~~i~~~I~~--g~~p---------------------------~~ 248 (613)
|.++|.+... ..++ ..+.. |..+ ..
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL-NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHH-HHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHH-HHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 5666643221 1111 11110 0000 11
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCccc
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~~ 290 (613)
.....++.+.+||.+||. ||.+|||++|+|+||||+...+..
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 122348899999999999 999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.08 Aligned_cols=252 Identities=23% Similarity=0.370 Sum_probs=215.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... .....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 478899999999999999999999999999876433 23456788999999999999999999998754 5688999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
|||+.+++|.+++.....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTE
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcc
Confidence 999999999999988888999999999999999999999998 99999999999998 568999999999875432
Q ss_pred ---hccCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 ---ARSAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.....+++.|+|||++.. . ++.++||||||+++|+|++|..||.........+..+.............+..+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 123457789999998865 3 47789999999999999999999977665545555555544333344567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
||.+||. +|.+|||+.|+++||||+...
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9999999 999999999999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=380.79 Aligned_cols=263 Identities=24% Similarity=0.392 Sum_probs=207.8
Q ss_pred ccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 20 ~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
.....++| ++.++||+|+||+||+|.+..+|+.||+|+++.. .......+++.+|+.+|+.++||||+++++++...
T Consensus 21 ~~~i~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~ 97 (432)
T 3n9x_A 21 NVHVPDNY-IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM--FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD 97 (432)
T ss_dssp GCCCCTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEECST--TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cceecCCE-EEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch--hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 34445666 8889999999999999999999999999987632 23556778899999999999999999999988654
Q ss_pred CC---CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 100 EN---EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 100 ~~---~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
.. ..+|+||||+. |+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 98 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DF 173 (432)
T 3n9x_A 98 DLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDF 173 (432)
T ss_dssp CTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCC
T ss_pred CCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccC
Confidence 32 57999999986 599999999889999999999999999999999998 99999999999998 5689999999
Q ss_pred chhHHHhhh--------------------------ccCcccccccCcccc-c-cccCccchhhhhhHHHHHHHhcCCCCC
Q 035992 177 GLAAILAQA--------------------------RSAHSVIEFMAPELY-E-EEYNELVDIYAFGMCLLELVTFEYPYV 228 (613)
Q Consensus 177 Gla~~l~~~--------------------------~~~~gt~~YmAPEvl-~-~~ys~ksDIWSLGviL~EmltG~~Pf~ 228 (613)
|++...... ....+|..|+|||++ . ..|+.++|||||||++|||++|..||.
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 999754321 234567899999975 3 459999999999999999998544432
Q ss_pred C----------CCc------------------HHHHHHH-----------------------HHcCC--CCCc---cccc
Q 035992 229 E----------CTN------------------AAQIYKK-----------------------VTSGI--KPAS---LAKV 252 (613)
Q Consensus 229 ~----------~~~------------------~~~i~~~-----------------------I~~g~--~p~~---l~~~ 252 (613)
. ..+ ..++... +.... .+.. ....
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 1 111 1111111 11100 0111 1134
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
.++.+.+||.+||+ ||.+|||++|+|+||||+...+.
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 68899999999999 99999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=361.61 Aligned_cols=250 Identities=24% Similarity=0.428 Sum_probs=211.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..++..||+|++..... ........+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 87 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLI 87 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCEEEEE
Confidence 4788999999999999999999999999998864322 112234678899999999999999999998854 5679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC-----
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCcccc
Confidence 999999999999999899999999999999999999999998 99999999999998 6789999999988544322
Q ss_pred ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 186 RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+....+..+..... .++...+..+++||.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~ 241 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRL 241 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHH
Confidence 23467789999998765 488999999999999999999999965 455566666665432 34556789999999999
Q ss_pred hh-cccCCCCHHHHhcCCCCCCC
Q 035992 265 IA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|. +|.+|||+.|+|+||||+..
T Consensus 242 l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 242 LKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp CCSSGGGSCCHHHHHHCHHHHHH
T ss_pred hccChhhCCCHHHHhhCccccCC
Confidence 99 99999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.73 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=214.1
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.+.||+|+||+||+|.+..+|..||+|+++.. ......+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 108 (360)
T 3eqc_A 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 108 (360)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEE
Confidence 347889999999999999999999999999987643 245667889999999999999999999998865 567999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||++......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHH
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCcccccc
Confidence 999999999999999988999999999999999999999985 7 99999999999998 5689999999999766442
Q ss_pred --ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH----------------------------
Q 035992 186 --RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAA---------------------------- 234 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~---------------------------- 234 (613)
....+++.|+|||++.+ .|+.++|||||||++|+|++|..||.......
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 34567889999998765 58999999999999999999999996533221
Q ss_pred -------------HHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 235 -------------QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 235 -------------~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+...+.....+......++..+.+||.+||+ +|.+|||+.|+|+||||+....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 12223333333433445578899999999999 9999999999999999987543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=368.95 Aligned_cols=248 Identities=19% Similarity=0.341 Sum_probs=206.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++. ...+.+.+|+.+++.+. ||||+++++++........++
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-------~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-------CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred eEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-------cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 4888999999999999999999999999998763 22356889999999997 999999999987766778999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
||||+.+++|.+++.. +++..++.++.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||++......
T Consensus 111 v~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 9999999999998854 899999999999999999999998 9999999999999855558999999999765432
Q ss_pred --ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-------------CC----
Q 035992 186 --RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-------------GI---- 244 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-------------g~---- 244 (613)
....++..|+|||++.+ .++.++|||||||++|+|++|..||....+.......+.. ..
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 23456778999998754 4899999999999999999999999665544333222211 10
Q ss_pred ------------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ------------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ------------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+.......++.+++||.+||+ +|.+|||++|+|+||||+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0011122368899999999999 999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=365.74 Aligned_cols=262 Identities=26% Similarity=0.390 Sum_probs=221.2
Q ss_pred CcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeee
Q 035992 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNS 95 (613)
Q Consensus 16 ~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 95 (613)
.+...-....+.|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+.+|+.+++.++||||++++++
T Consensus 31 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 109 (335)
T 2owb_A 31 PEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109 (335)
T ss_dssp CSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhh-hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 333333344455688899999999999999999999999999887433 2345677889999999999999999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
|.. ...+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|
T Consensus 110 ~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~D 184 (335)
T 2owb_A 110 FED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGD 184 (335)
T ss_dssp EEC--SSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECC
T ss_pred Eec--CCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEee
Confidence 854 5689999999999999999998889999999999999999999999998 99999999999998 568999999
Q ss_pred cchhHHHhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 176 LGLAAILAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 176 FGla~~l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
||++..... .....++..|+|||++.+ .++.++||||||+++|+|++|..||... .....+..+..+.. .++
T Consensus 185 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~ 261 (335)
T 2owb_A 185 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEY--SIP 261 (335)
T ss_dssp CTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCC--CCC
T ss_pred ccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHhcCCC--CCC
Confidence 999976532 223457789999998765 4899999999999999999999999664 44455555554432 245
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..++..+.+||.+||+ +|.+||++.|+|+||||...
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 5678899999999999 99999999999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=355.85 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=218.4
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
...+.|++.+.||+|+||+||+|.+..+++.||+|++.... .......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL-LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--ND 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG-CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhh-ccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CC
Confidence 44455688899999999999999999999999999887433 2345677889999999999999999999998854 56
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCceec
Confidence 89999999999999999999889999999999999999999999998 99999999999998 5689999999998765
Q ss_pred hh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 183 AQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 183 ~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.. .....+++.|+|||++.+ .++.++||||||+++|+|++|..||... .....+..+..+.. .++...+..+
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~ 242 (294)
T 2rku_A 166 EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEY--SIPKHINPVA 242 (294)
T ss_dssp CSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHH
T ss_pred ccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhccC--CCccccCHHH
Confidence 32 223456778999998765 4899999999999999999999999664 44455555555432 3455678899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.++|.+||+ +|.+|||+.++++||||...
T Consensus 243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 243 ASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 999999999 99999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=398.58 Aligned_cols=260 Identities=20% Similarity=0.351 Sum_probs=222.3
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
....|++.++||+|+||+||+|.++.+|+.||+|++++..... ......+.+|+.+|+.++||||++++++|.+ ...
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 258 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDA 258 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCE
Confidence 3445688899999999999999999999999999987543221 2335668899999999999999999998854 568
Q ss_pred EEEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+++||||+.||+|.+++.+.+. +++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEeccccee
Confidence 9999999999999999987654 999999999999999999999998 99999999999998 678999999999976
Q ss_pred Hhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC---cHHHHHHHHHcCCCCCccccccc
Q 035992 182 LAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT---NAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
+... ....||+.|||||++.+ .|+.++|||||||++|||++|..||.... ....+...+... +..++..++
T Consensus 336 ~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s 413 (576)
T 2acx_A 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFS 413 (576)
T ss_dssp CCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSC
T ss_pred cccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCC
Confidence 5432 34578899999998765 59999999999999999999999996643 456666666654 334556789
Q ss_pred HHHHHHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCcccc
Q 035992 255 NGVRAFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~~ 291 (613)
+.+++||.+||+ +|.+|| ++.|+++||||+..+|..+
T Consensus 414 ~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l 456 (576)
T 2acx_A 414 PQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456 (576)
T ss_dssp HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred HHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence 999999999999 999999 7999999999999877544
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=362.47 Aligned_cols=261 Identities=26% Similarity=0.488 Sum_probs=209.6
Q ss_pred cccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeee
Q 035992 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSW 96 (613)
Q Consensus 17 ~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 96 (613)
+.....+..+| ++.+.||+|+||+||+|.+..+|+.||+|.+... ...+.+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~~~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 93 (314)
T 3com_A 21 DSLTKQPEEVF-DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE------SDLQEIIKEISIMQQCDSPHVVKYYGSY 93 (314)
T ss_dssp ---------CE-EEEEECC----CEEEEEEETTTCCEEEEEEEETT------SCCHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhhhhcchhhh-hhheeeccCCCeEEEEEEECCCCCEEEEEecCch------HHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 33444555666 7789999999999999999999999999987642 2345688999999999999999999988
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRK-KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
.. ...+++||||+.+++|.+++. ....+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|
T Consensus 94 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~d 168 (314)
T 3com_A 94 FK--NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLAD 168 (314)
T ss_dssp EE--TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECC
T ss_pred Ee--CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEee
Confidence 65 457999999999999999987 4578999999999999999999999998 99999999999998 568999999
Q ss_pred cchhHHHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 176 LGLAAILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 176 FGla~~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
||++...... ....+++.|+|||++.. .++.++||||||+++|+|++|..||........+.............+
T Consensus 169 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp CTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred cccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 9998765432 23457789999998765 589999999999999999999999977655444443333332233345
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcc
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
..++..+.+||.+||. +|.+|||+.++++||||+.....
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 5678999999999999 99999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=364.81 Aligned_cols=256 Identities=25% Similarity=0.482 Sum_probs=212.8
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTE 100 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 100 (613)
++.++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ...+.+.+|+.+++.+ +||||++++++|....
T Consensus 21 ~~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 21 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCTTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred CCCCcE-EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 566666 88899999999999999999999999999886432 2346788999999999 8999999999987643
Q ss_pred ----CCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 101 ----NEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 101 ----~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~ 171 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLV 171 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEEC
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEEe
Confidence 46899999999999999999875 57999999999999999999999998 99999999999998 67899999
Q ss_pred ccchhHHHhhh----ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 175 DLGLAAILAQA----RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 175 DFGla~~l~~~----~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
|||++...... ....+++.|+|||++. ..++.++|||||||++|+|++|..||....... ....+....
T Consensus 172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~ 250 (326)
T 2x7f_A 172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLIPRNP 250 (326)
T ss_dssp CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC
T ss_pred eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHhhcCc
Confidence 99998765432 2345788999999874 358899999999999999999999997655444 344455554
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+......++..+++||.+||. +|.+||++.++++||||+...
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 4544556678999999999999 999999999999999998754
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=375.70 Aligned_cols=256 Identities=27% Similarity=0.416 Sum_probs=204.8
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN-- 101 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~-- 101 (613)
.++| ++.+.||+|+||+||+|.+..+|+.||+|++... .......+++.+|+.+|+.++||||++++++|.....
T Consensus 24 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 24 RAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp BSSE-EEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred cceE-EEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcc--ccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 4455 7889999999999999999999999999887532 2345667889999999999999999999998865422
Q ss_pred --CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 102 --EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 102 --~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLA 175 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTC
T ss_pred cCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeecc
Confidence 4579999999 8899999887 67999999999999999999999998 99999999999998 5789999999999
Q ss_pred HHHhhh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCCC---------
Q 035992 180 AILAQA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIKP--------- 246 (613)
Q Consensus 180 ~~l~~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~p--------- 246 (613)
...... ....++..|+|||++.+ .|+.++|||||||++|||++|..||.+.....++...+.. +..+
T Consensus 176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 765432 23467789999998754 5999999999999999999999999775554444332221 1111
Q ss_pred ---------------C---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 ---------------A---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 ---------------~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
. .+....++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 1123457899999999999 999999999999999998653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=376.63 Aligned_cols=249 Identities=24% Similarity=0.345 Sum_probs=202.8
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC-------
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT------- 99 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~------- 99 (613)
-|++.++||+|+||+||+|.+..+|+.||+|++..... ...+|+.+|+.++||||++++++|...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34889999999999999999999999999998864321 123699999999999999999998652
Q ss_pred -----------------------------CCCEEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHhhhhh
Q 035992 100 -----------------------------ENEHINFITEIFTSGTLRQYR----KKHKHVDLRALKKWSRQILEGLSYLH 146 (613)
Q Consensus 100 -----------------------------~~~~l~lV~E~~~gGsL~~~l----~~~~~lse~~i~~i~~QIl~gL~yLH 146 (613)
...++++||||+.+ +|.+++ ...+.+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 33458999999985 666554 45678999999999999999999999
Q ss_pred cCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHH
Q 035992 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELV 221 (613)
Q Consensus 147 s~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~Eml 221 (613)
+++ |+||||||+|||++..++.+||+|||++..+... ....++..|+|||++.+ .|+.++|||||||++|||+
T Consensus 159 ~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 159 SLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp TTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred HCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence 998 9999999999999866789999999999765432 23456778999997754 4899999999999999999
Q ss_pred hcCCCCCCCCcHHHHHHHHHcCCCC--------------------------CcccccccHHHHHHHHHHhh-cccCCCCH
Q 035992 222 TFEYPYVECTNAAQIYKKVTSGIKP--------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPA 274 (613)
Q Consensus 222 tG~~Pf~~~~~~~~i~~~I~~g~~p--------------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta 274 (613)
+|..||.......++...+.....| ..++...++.+.+||.+||. +|.+|||+
T Consensus 237 ~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9999998766665555443311100 01233467889999999999 99999999
Q ss_pred HHHhcCCCCCCC
Q 035992 275 KELLGDPFLQSE 286 (613)
Q Consensus 275 ~eLL~HPff~~~ 286 (613)
.|+|+||||+..
T Consensus 317 ~e~l~hp~f~~~ 328 (383)
T 3eb0_A 317 YEAMAHPFFDHL 328 (383)
T ss_dssp HHHHTSGGGHHH
T ss_pred HHHhcCHHHHHH
Confidence 999999999754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=388.82 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=200.3
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
+|| ++.+.||+|+||+||+|.+..+|+.||+|++... .......+++.+|+.+|+.++||||++++++|....
T Consensus 62 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 62 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP--FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp TTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG--GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCe-EEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc--ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 344 7789999999999999999999999999988743 234566788999999999999999999999986532
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+|+||||+.++ |.+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 139 ~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 139 FQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 212 (464)
T ss_dssp CCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-
T ss_pred CCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeee
Confidence 25789999999875 666554 35999999999999999999999998 99999999999998 57899999999998
Q ss_pred HHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCCC---------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIKP--------- 246 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~p--------- 246 (613)
..... ....+|+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++...+.. +..+
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred ecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 76543 23467889999997764 5999999999999999999999999775544444332221 1000
Q ss_pred --------------Ccccc---------------cccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 247 --------------ASLAK---------------VADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 247 --------------~~l~~---------------~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..++. ..++++++||.+||. ||.+|||++|+|+||||+.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 00011 115679999999999 9999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=359.20 Aligned_cols=252 Identities=23% Similarity=0.417 Sum_probs=214.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.+.||+|+||+||+|.+..++..||+|++...... .....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 91 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRIYL 91 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEEEE
Confidence 358889999999999999999999999999988753321 11234678899999999999999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSSSC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcccc
Confidence 9999999999999999889999999999999999999999998 99999999999998 668999999999865433
Q ss_pred hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHH
Q 035992 185 ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~ 263 (613)
.....+++.|+|||++.+ .++.++||||||+++|+|++|..||... ........+..... .++...+..+++||.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVDL--KFPPFLSDGSKDLISK 245 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHHHHH
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhcccc--CCCCcCCHHHHHHHHH
Confidence 224467789999998765 4899999999999999999999999664 44455555555432 3445678999999999
Q ss_pred Hhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 264 CIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 264 cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
||. +|.+||++.++++||||+...
T Consensus 246 ~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 246 LLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999 999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=369.61 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=213.2
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC--
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE-- 102 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~-- 102 (613)
.|| ++.+.||+|+||+||+|.+..+|+.||+|+++.. ..........+.+|+.+++.++||||+++++++......
T Consensus 12 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 12 DRY-ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECTT-TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred CcE-EEEEEEccCCCEEEEEEEECCCCceEEEEEeCcc-ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 455 7889999999999999999999999999988642 334556678899999999999999999999988654432
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
..++||||+.+|+|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC---
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcccc
Confidence 56899999999999999998899999999999999999999999998 99999999999998 5689999999999765
Q ss_pred hhh-------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc-ccccc
Q 035992 183 AQA-------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-LAKVA 253 (613)
Q Consensus 183 ~~~-------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~-l~~~~ 253 (613)
... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.........+..+.....+.. ....+
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence 432 12347889999998765 5899999999999999999999999776655555555555443322 23457
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+..+.+||.+||. +|.+||++.+++.|+|++..
T Consensus 247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 8899999999999 99999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.14 Aligned_cols=254 Identities=25% Similarity=0.432 Sum_probs=215.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||++++++|.......+++|
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEccc--CCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 478899999999999999999999999999887533 245667889999999999999999999999877667789999
Q ss_pred EeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCC---CCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 108 TEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHD---PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~---~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
|||+.+++|.+++.+. ..+++..++.++.||+.||+|||+++ .+|+||||||+|||++ .++.+||+|||++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLAR 164 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCchhe
Confidence 9999999999998754 34999999999999999999999986 3499999999999998 56899999999998
Q ss_pred HHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 181 ILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 181 ~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
..... ....++..|+|||++.+ .++.++||||||+++|+|++|..||... +...+...+..+..+ .++..++.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~ 242 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFR-RIPYRYSD 242 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC-CCCTTSCH
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc-CHHHHHHHHhhcccc-cCCcccCH
Confidence 76432 22356778999998765 5899999999999999999999999664 556666777776543 34556789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+.++|.+||. +|.+||++.|||+|+|+...
T Consensus 243 ~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 243 ELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 99999999999 99999999999999999754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=368.56 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=214.1
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 102 (613)
.++|....+.||+|+||+||+|.+..+|+.||+|+++.... .......+.+|+.+++.+ +||||++++++|.. ..
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~ 102 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TS 102 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SS
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CC
Confidence 44554445999999999999999999999999999875432 233456788999999999 56999999998854 56
Q ss_pred EEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccch
Q 035992 103 HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGL 178 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGl 178 (613)
.+++||||+.+|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 799999999999999998653 67999999999999999999999998 999999999999974 257999999999
Q ss_pred hHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC--CCCccccc
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--KPASLAKV 252 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~--~p~~l~~~ 252 (613)
+...... ....+++.|+|||++.. .++.++||||||+++|+|++|..||..... ...+..+.... .+......
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-QETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCCCCTTTTTT
T ss_pred ccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-hHHHHHHHhcccccCchhhcc
Confidence 9765432 23467889999998764 589999999999999999999999976544 44444444332 23333456
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcccc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~~~ 291 (613)
.+..+++||.+||+ +|.+|||++++|+||||+..++...
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 78899999999999 9999999999999999998766543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=404.14 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=221.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|.++.+|+.||+|++++.... .....+.+..|+.+|..+ +||||++++.+|.+ ...+|+
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~~~l 419 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 419 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCEEEE
Confidence 57789999999999999999999999999998854322 224456788899999988 79999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh---
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA--- 183 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~--- 183 (613)
||||+.+|+|..++.+.+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||++....
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~ 496 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDG 496 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTT
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccccCC
Confidence 9999999999999999899999999999999999999999998 99999999999998 67899999999987532
Q ss_pred -hhccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 184 -QARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 184 -~~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
......||+.|||||++.. .|+.++|||||||++|||++|..||.. .+...++..|..+.. .++..+++++++||
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li 573 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAIC 573 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHH
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHH
Confidence 1234578899999998764 599999999999999999999999966 566778888887643 35567899999999
Q ss_pred HHHhh-cccCCCCH-----HHHhcCCCCCCCCcccc
Q 035992 262 EKCIA-EVSERLPA-----KELLGDPFLQSEDDESV 291 (613)
Q Consensus 262 ~~cL~-dP~~Rpta-----~eLL~HPff~~~~~~~~ 291 (613)
.+||+ +|.+||++ +||++||||+..+|..+
T Consensus 574 ~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 574 KGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 99999 99999997 99999999999887554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=387.29 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=209.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc----ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR----NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~----~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|.+..+++.||+|++....... .......+.+|+.+|++++||||++++++|. ...
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---~~~ 213 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---AED 213 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---SSE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCc
Confidence 478899999999999999999999999999987644321 1223345789999999999999999999874 345
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~ 181 (613)
+++||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||++..
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 8999999999999999998899999999999999999999999998 999999999999973 234699999999987
Q ss_pred Hhhh---ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC--ccccc
Q 035992 182 LAQA---RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--SLAKV 252 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~--~l~~~ 252 (613)
.... ....+++.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+.... .....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 371 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTT
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcc
Confidence 6432 2456788999999874 3588999999999999999999999977665555666666664332 22345
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+..+.+||.+||+ +|.+|||+.|+|+||||+...
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 78899999999999 999999999999999998753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=392.25 Aligned_cols=250 Identities=26% Similarity=0.443 Sum_probs=216.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++..... .....+.+.+|+.+|+.++||||+++++++.. ...+++|
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~~lv 94 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDIFMV 94 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 47889999999999999999999999999998754321 12345678999999999999999999998854 4679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhcccccc
Confidence 999999999999999899999999999999999999999998 99999999999998 5689999999999765432
Q ss_pred -ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....+++.|+|||++.+. | +.++|||||||++|+|++|..||... +...++.++..+... .+...++.+++||.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD-HVPTLFKKICDGIFY--TPQYLNPSVISLLK 248 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS-SSHHHHHHHHTTCCC--CCTTCCHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC-CHHHHHHHHhcCCcC--CCccCCHHHHHHHH
Confidence 345688899999988754 4 78999999999999999999999764 445667777776432 34567899999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 263 KCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+||+ +|.+|||+.++++||||+..
T Consensus 249 ~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 249 HMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999 99999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=361.15 Aligned_cols=255 Identities=22% Similarity=0.424 Sum_probs=214.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.+.||+|+||+||+|.+..++..||+|+++...........+.+.+|+.+++.++||||+++++++.......+
T Consensus 5 ~~y-~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKY-LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCB-CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cce-eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 455 7789999999999999999999999999998765443344567889999999999999999999999876666789
Q ss_pred EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKK--HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
++||||+.++ |.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeecccccccc
Confidence 9999999987 7777765 357999999999999999999999998 99999999999998 5689999999998765
Q ss_pred hhh------ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 183 AQA------RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 183 ~~~------~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...++..+..+.. .++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~ 236 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDC 236 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCcc
Confidence 321 23457789999998764 257899999999999999999999965 556666677766643 345567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..+.+||.+||. +|.+|||+.++++||||+...
T Consensus 237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 8899999999999 999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=356.90 Aligned_cols=248 Identities=30% Similarity=0.506 Sum_probs=206.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEecc
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIF 111 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~~ 111 (613)
.+||+|+||+||+|.+..++..||+|.++.. .....+.+.+|+.+++.++||||++++++|.. ...+++||||+
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 101 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFMEQV 101 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEEECC
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEEEeC
Confidence 4899999999999999999999999988643 23456778999999999999999999998854 45899999999
Q ss_pred CCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh----
Q 035992 112 TSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ---- 184 (613)
Q Consensus 112 ~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~---- 184 (613)
.+++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||+++...+.+||+|||++.....
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 9999999998752 4679999999999999999999998 999999999999986578999999999875532
Q ss_pred hccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 ARSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.....+++.|+|||++.. .++.++||||||+++|+|++|..||.....................++...+..+.+||
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 259 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHH
Confidence 224467789999998754 27899999999999999999999997655544433333222233345667789999999
Q ss_pred HHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 262 EKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+||. +|.+||++.++|.||||+...
T Consensus 260 ~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 260 LKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp HHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred HHHccCChhhCCCHHHHhcChhhhhcc
Confidence 99999 999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=370.54 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=212.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh----HHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS----EDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~----~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 102 (613)
|++.+.||+|+||+||+|.+..+|+.||+|++......... ...+.+.+|+.+++.+ +||||++++++|.. ..
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~ 173 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SS 173 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--SS
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--CC
Confidence 47779999999999999999999999999988754321121 2356788999999999 89999999998854 56
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++||||+.+++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ .+|.+||+|||++..+
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCccccc
Confidence 89999999999999999998889999999999999999999999998 99999999999998 6789999999998765
Q ss_pred hhh---ccCcccccccCcccccc-------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc--c
Q 035992 183 AQA---RSAHSVIEFMAPELYEE-------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL--A 250 (613)
Q Consensus 183 ~~~---~~~~gt~~YmAPEvl~~-------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l--~ 250 (613)
... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||... +...+...+..+...... .
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCccc
Confidence 432 24567889999998752 4888999999999999999999999764 445555666665433222 2
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
...+..+.+||.+||. +|.+|||+.++|+||||+
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 3567889999999999 999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.49 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=208.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc----cChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL----RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~----~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|.+..+|+.||+|++...... ........+.+|+.+++.++||||+++++++... .
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 88 (322)
T 2ycf_A 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE---D 88 (322)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS---S
T ss_pred eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC---c
Confidence 47889999999999999999999999999988654321 1223345688999999999999999999987532 3
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DFGla~~ 181 (613)
+++||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+.+||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999999999999998899999999999999999999999998 9999999999999743 23599999999876
Q ss_pred Hhhh---ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--Cccccc
Q 035992 182 LAQA---RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKV 252 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~ 252 (613)
.... ....+++.|+|||++. ..|+.++|||||||++|+|++|..||........+...+..+... +.....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTT
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhh
Confidence 5322 2335678999999863 458999999999999999999999997765544555556555432 223345
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+..+.+||.+||. +|.+||++.++|+||||+...
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 68899999999999 999999999999999998753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=356.89 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=199.7
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-|++.+.||+|+||+||+|.+..+|+.||+|.++... ......+.+..+...++.++||||++++++|.. ...++
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEE
Confidence 34588899999999999999999999999999876432 122333445555666888999999999998864 45789
Q ss_pred EEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 106 FITEIFTSGTLRQYRK----KHKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~----~~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+||||+.+ +|.+++. ..+.+++..++.++.||+.||.|||++ + |+||||||+|||++ ..+.+||+|||++.
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISG 158 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC----
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCcc
Confidence 99999975 7776654 457899999999999999999999998 8 99999999999998 56899999999998
Q ss_pred HHhhhc---cCcccccccCcccc----c-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 181 ILAQAR---SAHSVIEFMAPELY----E-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 181 ~l~~~~---~~~gt~~YmAPEvl----~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
...... ...+++.|+|||++ . ..++.++||||||+++|+|++|..||..................+......
T Consensus 159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (290)
T 3fme_A 159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence 764432 33677899999985 2 348899999999999999999999998756665555555555555555566
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.++.+.+||.+||+ +|.+|||+.|+++||||+..
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 78999999999999 99999999999999999854
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=374.72 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=207.3
Q ss_pred cceeE--eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 26 RYGRY--KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 26 Ry~r~--~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.++++ .++||+|+||+||+|.+..+|+.||+|+++... ....+.+.+|+.+|+.++||||++++++|.. ...
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~ 160 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFES--KND 160 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCE
Confidence 34566 478999999999999999999999999887532 3556789999999999999999999998854 467
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe-CCCCcEEEeccchhHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN-GNQGEVKIGDLGLAAI 181 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~-~~~g~VKL~DFGla~~ 181 (613)
+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+. ...+.+||+|||++..
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~ 238 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARR 238 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEE
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCcee
Confidence 99999999999999888654 56999999999999999999999998 99999999999984 3557899999999976
Q ss_pred Hhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccH
Q 035992 182 LAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADN 255 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~ 255 (613)
+... ....+++.|+|||++.. .++.++|||||||++|||++|..||..... ...+..+..... +......+++
T Consensus 239 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp CCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred cCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCCCChhhhccCCH
Confidence 5432 23457889999998764 489999999999999999999999976544 444445544432 2223345789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 99999999999 999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=353.61 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=215.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-----ChHHHHHHHHHHHHHHhCC-CCCcceeeeeeec
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-----NSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVD 98 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-----~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~ 98 (613)
.+| ++.+.||+|+||+||+|.++.+|+.||+|+++...... .....+.+.+|+.+++++. ||||++++++|..
T Consensus 17 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 17 ENY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hcc-ceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 344 77899999999999999999999999999887543111 1234567889999999995 9999999998854
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||+
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~ 170 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGF 170 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTT
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecccc
Confidence 5689999999999999999999889999999999999999999999998 99999999999998 678999999999
Q ss_pred hHHHhhh---ccCcccccccCccccc-------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC-
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYE-------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA- 247 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~-------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~- 247 (613)
+...... ....+++.|+|||++. ..++.++||||||+++|+|++|..||... +...+...+..+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 171 SCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCC
T ss_pred hhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc-cHHHHHHHHhcCCcccC
Confidence 8765432 2345778999999874 24788999999999999999999999764 4455555665554322
Q ss_pred -cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcc
Q 035992 248 -SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 248 -~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
.....++..+.+||.+||. +|.+|||+.++|+||||+....+
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 2224578899999999999 99999999999999999976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=360.16 Aligned_cols=251 Identities=23% Similarity=0.396 Sum_probs=211.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.|++.+.||+|+||+||+|.+..+|+.||+|+++... ....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYES--TTHYYL 83 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhccc--CCEEEE
Confidence 3488899999999999999999999999999887432 2234568899999999999999999998754 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFGla~~l~~ 184 (613)
||||+.+++|.+++...+.+++..++.++.||+.||.|||+++ |+||||||+||++. ...+.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 9999999999999998889999999999999999999999998 99999999999993 2567999999999865432
Q ss_pred h--ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--CcccccccHHHHH
Q 035992 185 A--RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKVADNGVRA 259 (613)
Q Consensus 185 ~--~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~l~~ 259 (613)
. ....+++.|+|||++.+ .++.++||||||+++|+|++|..||... ....+...+..+..+ ..+....+..+.+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE-TESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 2 12346779999998765 4899999999999999999999999764 455666677666432 2334567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||. +|.+|||+.++|+||||+..
T Consensus 241 li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 241 FICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 9999999 99999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=363.06 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=207.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+..|++.++||+|+||+||+|.+..+|+.||+|+++.... ....+.+.+|+.+++.++||||+++++++.......+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 3445889999999999999999999999999998864332 2335677899999999999999999999887766789
Q ss_pred EEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEE----eCCCCcEEEeccc
Q 035992 105 NFITEIFTSGTLRQYRKKHKH---VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV----NGNQGEVKIGDLG 177 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~---lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl----~~~~g~VKL~DFG 177 (613)
++||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||+|||+ + ..+.+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccCC
Confidence 999999999999999987543 999999999999999999999998 9999999999998 4 45679999999
Q ss_pred hhHHHhhhc---cCcccccccCccccc---------cccCccchhhhhhHHHHHHHhcCCCCCCCCc---HHHHHHHHHc
Q 035992 178 LAAILAQAR---SAHSVIEFMAPELYE---------EEYNELVDIYAFGMCLLELVTFEYPYVECTN---AAQIYKKVTS 242 (613)
Q Consensus 178 la~~l~~~~---~~~gt~~YmAPEvl~---------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---~~~i~~~I~~ 242 (613)
++..+.... ...+++.|+|||++. ..|+.++|||||||++|||++|..||..... ...+...+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 997654432 345788999999874 4589999999999999999999999964332 2333344443
Q ss_pred CCCC-----------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 243 GIKP-----------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 243 g~~p-----------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
+..+ ..+....+..+.+||.+||+ ||.+|||++|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 3221 12234456789999999999 9999999999999973
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=356.25 Aligned_cols=251 Identities=25% Similarity=0.443 Sum_probs=191.0
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.+.||+|+||+||+|.+..+|+.||+|++...... .....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 88 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYVYL 88 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeEEE
Confidence 358889999999999999999999999999988643221 12235678999999999999999999998854 568999
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||||+.+++|.+++... +.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeeccCC
Confidence 99999999999999876 67999999999999999999999998 99999999999998 5689999999998754321
Q ss_pred ----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 186 ----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||........ ...+... ...++...+..+++|
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVLA--DYEMPSFLSIEAKDL 242 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCSS--CCCCCTTSCHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhhc--ccCCccccCHHHHHH
Confidence 23457789999998765 488999999999999999999999966443222 2222221 123445678899999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|.+||. +|.+|||+.++++||||+..
T Consensus 243 i~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 243 IHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHcccCHhhCCCHHHHhcCccccCC
Confidence 999999 99999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=367.96 Aligned_cols=258 Identities=22% Similarity=0.387 Sum_probs=205.9
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC-
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE- 100 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~- 100 (613)
+.-++| ++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 14 DEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp CBGGGE-EEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccccce-eEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 334565 777999999999999999999999999998764432 2233456778999999999999999999886543
Q ss_pred -----CCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 101 -----NEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 101 -----~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
...+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~ 166 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLA 166 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEEC
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEc
Confidence 4578999999986 66666654 467999999999999999999999998 99999999999998 56899999
Q ss_pred ccchhHHHhh--------hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH---
Q 035992 175 DLGLAAILAQ--------ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT--- 241 (613)
Q Consensus 175 DFGla~~l~~--------~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~--- 241 (613)
|||++..+.. .....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+ ..+.
T Consensus 167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~ 245 (351)
T 3mi9_A 167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLC 245 (351)
T ss_dssp CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH
T ss_pred cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHh
Confidence 9999976532 123356789999998754 4899999999999999999999999775544333 3332
Q ss_pred cCCCCCccccc---------------------------ccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 242 SGIKPASLAKV---------------------------ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 242 ~g~~p~~l~~~---------------------------~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
....+..++.. .++.+.+||.+||+ ||.+|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 22222111111 26779999999999 999999999999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=353.89 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=213.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.+++.++||||++++++|.. ...++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 84 (283)
T 3bhy_A 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTDVV 84 (283)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCeEE
Confidence 5888999999999999999999999999999886543221 1246788999999999999999999998854 56799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC----cEEEeccchhHH
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG----EVKIGDLGLAAI 181 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g----~VKL~DFGla~~ 181 (613)
+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++. .+ .+||+|||++..
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~-~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLD-KNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESC-SSSSSCCEEECCCTTCEE
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEec-CCCCCCceEEEeccccee
Confidence 99999999999999998889999999999999999999999998 999999999999973 34 799999999875
Q ss_pred Hhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccH
Q 035992 182 LAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADN 255 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~ 255 (613)
.... ....+++.|+|||++.. .++.++||||||+++|+|++|..||... ........+..... +.......+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE-TKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCc-chHHHHHHhHhcccCCcchhcccCCH
Confidence 5332 23457789999998764 5899999999999999999999999764 44555555555432 2223356788
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+.+||.+||. +|.+||++.++++||||+...
T Consensus 241 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99999999999 999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=392.18 Aligned_cols=258 Identities=23% Similarity=0.360 Sum_probs=220.2
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..|++.++||+|+||+||+|+++.+|+.||+|++++..... ....+.+..|+.+|+.++||||++++++|.. ...+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~l~ 261 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK-RKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTDLC 261 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh-hHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCEEE
Confidence 44577899999999999999999999999999987543221 2345678899999999999999999998854 46799
Q ss_pred EEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 106 FITEIFTSGTLRQYRKKH----KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~----~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+||||+.||+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeee
Confidence 999999999999999864 36999999999999999999999998 99999999999998 678999999999976
Q ss_pred Hhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC---cHHHHHHHHHcCCCCCcccccc
Q 035992 182 LAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT---NAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 182 l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
+... ....||+.|||||++.+ .|+.++|||||||++|||++|..||.... ....+++.+..+.. .++..+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~ 416 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKF 416 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTS
T ss_pred ccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCccc
Confidence 5432 23478899999998765 59999999999999999999999996643 45667777766532 345677
Q ss_pred cHHHHHHHHHHhh-cccCCCC-----HHHHhcCCCCCCCCcccc
Q 035992 254 DNGVRAFIEKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~~ 291 (613)
+..+++||.+||+ +|.+||+ +.++++||||+..+|..+
T Consensus 417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l 460 (543)
T 3c4z_A 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460 (543)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence 8999999999999 9999996 589999999999877544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=353.91 Aligned_cols=250 Identities=25% Similarity=0.446 Sum_probs=208.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|++..... ......+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 89 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDFFMV 89 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeEEEE
Confidence 4788999999999999999999999999998874322 122345678999999999999999999998754 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC---
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCCCcc
Confidence 999999999999999889999999999999999999999998 99999999999998 5689999999999765432
Q ss_pred -ccCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....+++.|+|||++.+. + +.++||||||+++|+|++|..||.. .....+++.+..+..+ ++...+..+.++|.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~ 243 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLM 243 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHH
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHH
Confidence 234567799999988754 3 6899999999999999999999966 4556666777665432 34567889999999
Q ss_pred HHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 263 KCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+||+ +|.+|||+.++++||||+..
T Consensus 244 ~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 244 HMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHccCChhhCCCHHHHHhChhhccC
Confidence 9999 99999999999999999764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.37 Aligned_cols=251 Identities=31% Similarity=0.493 Sum_probs=204.8
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-|++.+.||+|+||+||+|.+ +|..||+|++.... ......+.+.+|+.++++++||||++++++|.. ...++
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ--PPNLS 110 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC--CSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--TTCCE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCceE
Confidence 3458889999999999999976 68899999876433 245667889999999999999999999998854 45689
Q ss_pred EEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 106 FITEIFTSGTLRQYRKKHKH---VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~---lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+||||+.+|+|.+++.+.+. +++..++.++.||+.||+|||+++++|+||||||+|||++ .++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCccc
Confidence 99999999999999987654 9999999999999999999999987799999999999998 6689999999999765
Q ss_pred hhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 183 AQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 183 ~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||... +..+....+........++..+++.+
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 268 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEIPRNLNPQV 268 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-CHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred cccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 432 24567889999998765 4899999999999999999999999764 44555555554444555667789999
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc--CCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG--DPFLQ 284 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~--HPff~ 284 (613)
.+||.+||. +|.+|||+.++++ .++++
T Consensus 269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 999999999 9999999999987 44544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=371.27 Aligned_cols=258 Identities=21% Similarity=0.343 Sum_probs=214.5
Q ss_pred ceeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~ 102 (613)
-|++.++||+|+||+||+|.+. .+|+.||+|+++...........+.+.+|+.+|+.+ +||||++++++|.. ..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~ 132 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--ET 132 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TT
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--Cc
Confidence 3588899999999999999984 589999999987654333333445677899999999 69999999998855 45
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEEC
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCeec
Confidence 79999999999999999998889999999999999999999999998 99999999999998 5689999999998754
Q ss_pred hh-----hccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCC---CcHHHHHHHHHcCCCCCcccc
Q 035992 183 AQ-----ARSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVEC---TNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 183 ~~-----~~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~---~~~~~i~~~I~~g~~p~~l~~ 251 (613)
.. .....+++.|+|||++.+ .++.++|||||||++|||++|..||... .....+...+..... .++.
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 287 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQ 287 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCT
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCc
Confidence 22 223467889999998863 3789999999999999999999999643 234555555554432 3455
Q ss_pred cccHHHHHHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCcccc
Q 035992 252 VADNGVRAFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDESV 291 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~~ 291 (613)
.++..+++||.+||. +|.+|| ++.|+++||||+..++..+
T Consensus 288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l 333 (355)
T 1vzo_A 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 333 (355)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHH
T ss_pred ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHh
Confidence 678899999999999 999999 9999999999998766443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=365.13 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=209.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.++||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 25 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 25 EKY-ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp GGE-EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred hhh-eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEE
Confidence 355 78899999999999999999999999999876432 344556778899999999999999999998854 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
++||||+.+++|..++...+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+..
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC-----
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeecC
Confidence 999999999999999888889999999999999999999999998 99999999999998 568999999999976543
Q ss_pred h----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCCC-----------
Q 035992 185 A----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIKP----------- 246 (613)
Q Consensus 185 ~----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~p----------- 246 (613)
. ....++..|+|||++.+ .++.++|||||||++|+|++|..||........+...+.. +..+
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2 23457789999998765 4899999999999999999999999876665555443321 1000
Q ss_pred -------C---------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 -------A---------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 -------~---------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+ ......+..+.+||.+||+ +|.+|||+.|+|+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0 0112357889999999999 99999999999999999865
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=367.08 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=199.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... .......+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH---EEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc---ccccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEE
Confidence 478899999999999999999999999999876432 12222245579999999999999999998854 4578999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC----
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccCCc
Confidence 999974 888888765 45999999999999999999999998 99999999999998 5689999999998654322
Q ss_pred ---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc---CCCCCcc--------
Q 035992 186 ---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---GIKPASL-------- 249 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---g~~p~~l-------- 249 (613)
....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+ ..+.. ...+..+
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL-HFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCChHhchhhhcchh
Confidence 23356789999998754 4899999999999999999999999775544433 33322 1111111
Q ss_pred -----------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 250 -----------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 250 -----------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
....++.+.+||.+||+ +|.+|||++|+|+||||.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 12357889999999999 9999999999999999987643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=378.03 Aligned_cols=250 Identities=20% Similarity=0.333 Sum_probs=200.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHH-hCCCCCcceeeeeeec--CCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLK-TLKHKNIIKFYNSWVD--TENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk-~L~HpNIVkl~~~fv~--~~~~ 102 (613)
.|+...++||+|+||+||+|.++.+|+.||+|+++.. ..+.+|+.++. ..+||||++++++|.. ....
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 4544458999999999999999999999999987621 24667888874 5589999999998753 2346
Q ss_pred EEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEeccch
Q 035992 103 HINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGL 178 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DFGl 178 (613)
.+|+||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+|||++.. ++.+||+|||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 7999999999999999998754 5999999999999999999999998 9999999999999842 67899999999
Q ss_pred hHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH---HHHHHHHcCCC--CCcc
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAA---QIYKKVTSGIK--PASL 249 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~---~i~~~I~~g~~--p~~l 249 (613)
+...... ....+++.|+|||++.. .|+.++|||||||++|+|++|..||....... .+...+..+.. +...
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 290 (400)
T 1nxk_A 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290 (400)
T ss_dssp CEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTT
T ss_pred ccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcc
Confidence 9754322 24567889999998864 59999999999999999999999996543211 13344444432 2222
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...++.++++||.+||. +|.+|||+.|+|+||||...
T Consensus 291 ~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 34578999999999999 99999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=369.52 Aligned_cols=245 Identities=25% Similarity=0.412 Sum_probs=206.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC----hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN----SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~----~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.+++.++||||++++++|.. ...
T Consensus 26 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~~~ 103 (335)
T 3dls_A 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--QGF 103 (335)
T ss_dssp EEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred eEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--CCE
Confidence 4788999999999999999999999999999886442211 1234467789999999999999999998854 568
Q ss_pred EEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSG-TLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gG-sL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++||||+.+| +|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccceEC
Confidence 99999999777 99999999999999999999999999999999998 99999999999998 5689999999999765
Q ss_pred hhhc---cCcccccccCccccccc-c-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 183 AQAR---SAHSVIEFMAPELYEEE-Y-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 183 ~~~~---~~~gt~~YmAPEvl~~~-y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.... ...+++.|+|||++.+. + +.++|||||||++|+|++|..||..... .... ....+..++..+
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~--~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------TVEA--AIHPPYLVSKEL 251 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GTTT--CCCCSSCCCHHH
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-------HHhh--ccCCCcccCHHH
Confidence 4432 34578899999987653 4 7899999999999999999999965221 1111 122344578999
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+||.+||+ +|.+|||+.++++||||+..
T Consensus 252 ~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 999999999 99999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=375.79 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=201.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC----CCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT----ENE 102 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~~~ 102 (613)
.|++.++||+|+||+||+|.+..+|+.||+|++..... ...+|+.+|+.++||||++++++|... ...
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 45778999999999999999999999999998864321 123699999999999999999988542 233
Q ss_pred EEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 103 HINFITEIFTSGTLRQYR----KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l----~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
++++||||+.+ +|..++ .....+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchh
Confidence 57899999986 555444 34578999999999999999999999998 999999999999986667899999999
Q ss_pred hHHHhhh---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---------
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--------- 244 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~--------- 244 (613)
+..+... ....++..|+|||++.+ .|+.++|||||||++|||++|+.||.+.....++.+.+....
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9765332 23456789999998753 589999999999999999999999987665555544433100
Q ss_pred ---------CCC--------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 245 ---------KPA--------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 245 ---------~p~--------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.|. .+....++++.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 000 0123457899999999999 99999999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=368.34 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=200.3
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC--------CCCcceeeeee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK--------HKNIIKFYNSW 96 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~--------HpNIVkl~~~f 96 (613)
+|| ++.++||+|+||+||+|++..+|+.||+|+++. .....+.+.+|+.+++.+. |+||++++++|
T Consensus 37 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 37 GRY-HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred CeE-EEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 454 888999999999999999999999999998762 3456678899999999985 78899999988
Q ss_pred ecC--CCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCC---
Q 035992 97 VDT--ENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQ--- 168 (613)
Q Consensus 97 v~~--~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~--- 168 (613)
... ....+++||||+ +++|.+++.+. +.+++..++.++.||+.||.|||++ + |+||||||+|||++.+.
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCCHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEeccchhh
Confidence 632 456799999999 55666666544 5699999999999999999999998 8 99999999999997332
Q ss_pred ---------------------------------------------CcEEEeccchhHHHhhh-ccCcccccccCcccccc
Q 035992 169 ---------------------------------------------GEVKIGDLGLAAILAQA-RSAHSVIEFMAPELYEE 202 (613)
Q Consensus 169 ---------------------------------------------g~VKL~DFGla~~l~~~-~~~~gt~~YmAPEvl~~ 202 (613)
..+||+|||++...... ....++..|+|||++.+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHT
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcC
Confidence 27999999999766442 34567889999998765
Q ss_pred -ccCccchhhhhhHHHHHHHhcCCCCCCCCc-----HHHHHHHHHc--CCCCC---------------------------
Q 035992 203 -EYNELVDIYAFGMCLLELVTFEYPYVECTN-----AAQIYKKVTS--GIKPA--------------------------- 247 (613)
Q Consensus 203 -~ys~ksDIWSLGviL~EmltG~~Pf~~~~~-----~~~i~~~I~~--g~~p~--------------------------- 247 (613)
.|+.++|||||||++|||++|..||..... .......+.. +..|.
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 499999999999999999999999965432 1111111111 11110
Q ss_pred -----------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 248 -----------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 248 -----------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
.++...+..+.+||.+||+ +|.+|||+.|+|+||||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 1123345678999999999 9999999999999999963
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.46 Aligned_cols=254 Identities=25% Similarity=0.415 Sum_probs=208.9
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+|| ++.+.||+|+||+||+|.+..++..||+|.+.... .......+.+.+|+.+++.++||||+++++++. ....
T Consensus 10 ~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~ 85 (294)
T 4eqm_A 10 NERY-KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDC 85 (294)
T ss_dssp ETTE-EEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCS-SCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSE
T ss_pred hccE-EEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCc-cccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCe
Confidence 3455 88899999999999999999999999999886533 234566788999999999999999999999874 3568
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC-
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccccc
Confidence 9999999999999999999999999999999999999999999998 99999999999998 56899999999997654
Q ss_pred hh-----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--CcccccccH
Q 035992 184 QA-----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKVADN 255 (613)
Q Consensus 184 ~~-----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~ 255 (613)
.. ....+++.|+|||++.+ .++.++||||||+++|+|++|..||..........+.+...... ......++.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQ 242 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCH
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCH
Confidence 32 23457889999998765 48899999999999999999999997755555444444433222 123345788
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
.+.++|.+||. +|.+||+..+.+.+.|.+
T Consensus 243 ~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 243 SLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred HHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 99999999999 999999666666565544
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=353.17 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=217.9
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
..+|| ++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 20 ~~~~y-~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 94 (287)
T 2wei_A 20 FAERY-NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILED--SS 94 (287)
T ss_dssp HHHHE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SS
T ss_pred Hhhcc-eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CC
Confidence 34455 788999999999999999999999999998875432 23456778999999999999999999998754 56
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEeccchhH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDLGLAA 180 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DFGla~ 180 (613)
.+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ ++||||||+||+++.+ .+.+||+|||++.
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred eEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 89999999999999999988889999999999999999999999998 9999999999999743 3479999999998
Q ss_pred HHhhhc---cCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc--ccccH
Q 035992 181 ILAQAR---SAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA--KVADN 255 (613)
Q Consensus 181 ~l~~~~---~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~--~~~s~ 255 (613)
...... ...+++.|+|||++.+.++.++||||||+++|+|++|..||.. .+...+...+..+..+...+ ..++.
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp TBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred eecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 654322 2245678999999888899999999999999999999999976 45556666776665433332 45788
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+.+||.+||. +|.+|||+.++|+||||+..
T Consensus 252 ~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 99999999999 99999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=355.78 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=190.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
...|++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||++++++|.. ...+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV--KDEL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEES--SSCE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh---cchhHHHHHHHHHHHhhcCCCCEeeEEEEEee--cCCc
Confidence 344588899999999999999999999999988765432 23456678899999999999999999998865 3468
Q ss_pred EEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 105 NFITEIFTSGTLRQYRKK--------HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~--------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
++||||+.+++|.+++.. .+.+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+||
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~df 165 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADF 165 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCC
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEec
Confidence 999999999999999874 456999999999999999999999998 99999999999998 5689999999
Q ss_pred chhHHHhhh---------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC
Q 035992 177 GLAAILAQA---------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245 (613)
Q Consensus 177 Gla~~l~~~---------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~ 245 (613)
|++...... ....+++.|+|||++.. .++.++||||||+++|+|++|..||........+...+.....
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 999765422 23356778999998764 5899999999999999999999999776655444433332211
Q ss_pred C-------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 246 P-------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 246 p-------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
. .......+..++++|.+||. +|.+||++.++++||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 1 12234567899999999999 9999999999999999987543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=362.80 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=209.5
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC-
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE- 100 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~- 100 (613)
+..+|| ++.++||+|+||+||+|.+..++..||+|++.. .......+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 99 (364)
T 3qyz_A 24 DVGPRY-TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP---FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 99 (364)
T ss_dssp CCTTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred cccccE-EEEEEeecCCCeEEEEEEECCCCeEEEEEEecc---ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence 344566 888999999999999999999999999888763 234566788999999999999999999999875432
Q ss_pred --CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 101 --NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 101 --~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++||||+.+ +|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 100 ~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 100 EQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGL 174 (364)
T ss_dssp TTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred cccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcc
Confidence 2468999999975 89998876 56999999999999999999999998 99999999999998 678999999999
Q ss_pred hHHHhhh-------ccCcccccccCccccc-c-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC---
Q 035992 179 AAILAQA-------RSAHSVIEFMAPELYE-E-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--- 246 (613)
Q Consensus 179 a~~l~~~-------~~~~gt~~YmAPEvl~-~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--- 246 (613)
+...... ....+++.|+|||++. . .++.++|||||||++|+|++|..||........+...+.....|
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9765432 2336788999999764 3 48999999999999999999999997755444433222110000
Q ss_pred -------------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 -------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 -------------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..+....+..+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence 01113457889999999999 99999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=350.33 Aligned_cols=249 Identities=31% Similarity=0.497 Sum_probs=207.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC--------
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT-------- 99 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~-------- 99 (613)
|++.+.||+|+||+||+|.+..+|+.||+|.++. .....+.+.+|+.+++.++||||++++++|...
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4778999999999999999999999999998864 245667899999999999999999999988653
Q ss_pred ---CCCEEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 100 ---ENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 100 ---~~~~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
....+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEee
Confidence 2467899999999999999998654 6889999999999999999999998 99999999999998 668999999
Q ss_pred cchhHHHhh------------------hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH
Q 035992 176 LGLAAILAQ------------------ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235 (613)
Q Consensus 176 FGla~~l~~------------------~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~ 235 (613)
||++..... .....++..|+|||++.+ .++.++|||||||++|+|++ ||....+...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999875431 123346778999998764 48999999999999999998 7755445555
Q ss_pred HHHHHHcCC--CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 236 IYKKVTSGI--KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 236 i~~~I~~g~--~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+...+.... .|..++...+..++++|.+||. +|.+|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 666665542 3444556667889999999999 999999999999999998653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.80 Aligned_cols=256 Identities=25% Similarity=0.402 Sum_probs=204.0
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec---
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD--- 98 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~--- 98 (613)
+..+|| ++.+.||+|+||+||+|.+..+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 8 DLGSRY-MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp EETTTE-EEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred ccCCce-eEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 345666 7889999999999999999999999999987643 35667889999999999999999999998643
Q ss_pred ---------CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 99 ---------TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 99 ---------~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
.....+++||||+. |+|.+++.+ +.+++..++.++.||+.||+|||+++ |+||||||+|||++.+++
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDL 158 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTT
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCC
Confidence 23468899999998 599998865 67999999999999999999999998 999999999999986677
Q ss_pred cEEEeccchhHHHhhh-------ccCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHH
Q 035992 170 EVKIGDLGLAAILAQA-------RSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~-------~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I 240 (613)
.+||+|||++...... ....++..|+|||++. ..++.++||||||+++|+|++|..||........+ ..+
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-~~~ 237 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM-QLI 237 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH-HHH
Confidence 9999999998765321 1223466899999764 45899999999999999999999999775544433 333
Q ss_pred HcCCCC----------------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 241 TSGIKP----------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 241 ~~g~~p----------------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
...... ..+....+..+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 221100 01123468899999999999 999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.74 Aligned_cols=255 Identities=28% Similarity=0.421 Sum_probs=192.4
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC----C
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT----E 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~ 100 (613)
+|| ++.+.||+|+||+||+|.+..+|+.||+|++... .......+++.+|+.+|+.++||||++++++|... .
T Consensus 29 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 29 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP--FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp TTE-EEEEECC----CCEEEEEETTTTEEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred Cce-EEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcc--ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 565 7789999999999999999999999999887532 23456678899999999999999999999988543 1
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...++++||++ +++|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLAR 180 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC-----
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeeccccc
Confidence 25689999998 7899988876 67999999999999999999999998 99999999999998 57899999999998
Q ss_pred HHhhh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCC-----------
Q 035992 181 ILAQA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIK----------- 245 (613)
Q Consensus 181 ~l~~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~----------- 245 (613)
..... ....++..|+|||++.+ .|+.++|||||||++|||++|..||.+.....++...+.. +..
T Consensus 181 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 181 HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred cccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 75432 33467889999998754 5899999999999999999999999775544443322211 100
Q ss_pred -------------CCcc---cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 246 -------------PASL---AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 246 -------------p~~l---~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
...+ ....++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0011 12347889999999999 999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=364.32 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=202.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC-hHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN-SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~-~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++....... ......+.+|+.+++.++||||++++++|.. ...+++
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 89 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISL 89 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEE
T ss_pred cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--CCceEE
Confidence 3667999999999999999999999999998875432211 1223467899999999999999999998854 557899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 107 ITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||||+.+ +|..++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+...
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccceeccCC
Confidence 9999986 888888765 46999999999999999999999998 99999999999998 5689999999999876432
Q ss_pred ----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCC-CCc---------
Q 035992 186 ----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIK-PAS--------- 248 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~-p~~--------- 248 (613)
....+++.|+|||++.+ .|+.++|||||||++|+|++|..||........+...+.. +.. +..
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 245 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 245 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence 23456789999998753 4899999999999999999999999775554444333221 110 000
Q ss_pred --------------ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 249 --------------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 249 --------------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+....+..+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 113456889999999999 999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=378.82 Aligned_cols=249 Identities=18% Similarity=0.173 Sum_probs=196.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHH---HHHHhCCCCCcceee-------e
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEV---HLLKTLKHKNIIKFY-------N 94 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei---~iLk~L~HpNIVkl~-------~ 94 (613)
.+.|++.+.||+|+||+||+|.+..+|+.||+|+++.... ......+.+.+|+ .+|+.++||||++++ +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 4556888999999999999999999999999999885432 3345678899999 455566899999998 4
Q ss_pred eeecCCC----------C-----EEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHhhhhhcCCCCE
Q 035992 95 SWVDTEN----------E-----HINFITEIFTSGTLRQYRKKHKHVDL-------RALKKWSRQILEGLSYLHSHDPPV 152 (613)
Q Consensus 95 ~fv~~~~----------~-----~l~lV~E~~~gGsL~~~l~~~~~lse-------~~i~~i~~QIl~gL~yLHs~~~~I 152 (613)
++..... . ..+++|||+ +|+|.+++.+.+.+++ ..+..|+.||+.||+|||+++ |
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--i 227 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--L 227 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--e
Confidence 4332211 1 378999999 6799999987666666 888889999999999999998 9
Q ss_pred EecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-ccCcccccccCcccccc------------ccCccchhhhhhHHHHH
Q 035992 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-RSAHSVIEFMAPELYEE------------EYNELVDIYAFGMCLLE 219 (613)
Q Consensus 153 IHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~gt~~YmAPEvl~~------------~ys~ksDIWSLGviL~E 219 (613)
+||||||+|||++ .+|.+||+|||++...... ....+ +.|+|||++.. .|+.++|||||||++||
T Consensus 228 vHrDikp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 228 VHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp ECSCCCGGGEEEC-TTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEc-CCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 9999999999998 5689999999999764432 24456 89999998754 58999999999999999
Q ss_pred HHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 220 LVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 220 mltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
|++|..||..... ......+... ...+++.+.+||.+||. +|.+|||+.++++||||+..
T Consensus 306 lltg~~Pf~~~~~-~~~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 306 IWCADLPITKDAA-LGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHSSCCC-------CCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHCCCCCccccc-ccchhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999965332 1112222211 23567899999999999 99999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=356.05 Aligned_cols=262 Identities=20% Similarity=0.401 Sum_probs=217.5
Q ss_pred CCcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC--CCCccee
Q 035992 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK--HKNIIKF 92 (613)
Q Consensus 15 ~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~--HpNIVkl 92 (613)
+.-+-.+...++.|++.+.||+|+||+||+|.+. +|+.||+|++.... ......+.+.+|+.+++++. ||||+++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~ 93 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc--ccccchHHHHHHHHHHHhccccCCceEEE
Confidence 3444555566777799999999999999999885 58899999887533 24566788999999999997 5999999
Q ss_pred eeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 93 ~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
++++.. ...++++|| +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+|
T Consensus 94 ~~~~~~--~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~k 166 (313)
T 3cek_A 94 YDYEIT--DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLK 166 (313)
T ss_dssp EEEEEC--SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEE
T ss_pred EEEeec--CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEE
Confidence 998764 457999999 678899999999999999999999999999999999998 99999999999997 47999
Q ss_pred EeccchhHHHhhh------ccCcccccccCcccccc------------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHH
Q 035992 173 IGDLGLAAILAQA------RSAHSVIEFMAPELYEE------------EYNELVDIYAFGMCLLELVTFEYPYVECTNAA 234 (613)
Q Consensus 173 L~DFGla~~l~~~------~~~~gt~~YmAPEvl~~------------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~ 234 (613)
|+|||++..+... ....+++.|+|||++.. .++.++||||||+++|+|++|..||....+..
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 246 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence 9999999765432 23457889999998753 58889999999999999999999998776666
Q ss_pred HHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 235 ~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.....+........++...+..+.+||.+||. +|.+||++.|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 247 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 55566665555555666778899999999999 99999999999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=372.18 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=201.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC------CCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL------KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L------~HpNIVkl~~~fv~~~~ 101 (613)
|++.++||+|+||+||+|.+..+++.||+|+++. .......+..|+.+++.+ +|+||++++++|.. .
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~ 171 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--R 171 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--T
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--C
Confidence 4788999999999999999999999999998763 234556778888888887 57799999998865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc--EEEeccc
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE--VKIGDLG 177 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~--VKL~DFG 177 (613)
..+++||||+. ++|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..+. +||+|||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL~DFG 247 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKVIDFG 247 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEECCCT
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEEeecc
Confidence 68999999996 68999888764 4999999999999999999999998 99999999999998 4455 9999999
Q ss_pred hhHHHhhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCCCCc------
Q 035992 178 LAAILAQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIKPAS------ 248 (613)
Q Consensus 178 la~~l~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~p~~------ 248 (613)
++...... ....+++.|+|||++.+ .|+.++|||||||++|||++|..||........+...+.. +..+..
T Consensus 248 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 248 SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred cceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 99655432 34567889999998765 5999999999999999999999999776555444333221 110000
Q ss_pred -------------------------------------------------ccccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 249 -------------------------------------------------LAKVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 249 -------------------------------------------------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
+....++.+.+||.+||+ ||.+|||+.|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 111236789999999999 999999999999
Q ss_pred cCCCCCCC
Q 035992 279 GDPFLQSE 286 (613)
Q Consensus 279 ~HPff~~~ 286 (613)
+||||+..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.05 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=200.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----CCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE----NEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----~~~ 103 (613)
|++.++||+|+||+||+|.+..++. ||+|.+...... ..+|+.+|+.++||||++++++|.... ...
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 4778999999999999999887776 888876533221 236999999999999999999986532 235
Q ss_pred EEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 104 INFITEIFTSGTLRQY---RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~---l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+++||||+.++.+... ....+.+++..++.|+.||+.||+|||+++ |+||||||+|||++...+.+||+|||++.
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 8899999988654433 334678999999999999999999999998 99999999999998667899999999997
Q ss_pred HHhhh---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-----------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI----------- 244 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~----------- 244 (613)
.+... ....+++.|+|||++.+ .|+.++|||||||++|||++|..||.+.....++...+....
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 65332 23456789999998754 489999999999999999999999987665555544333100
Q ss_pred -----------CCC----cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 245 -----------KPA----SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 245 -----------~p~----~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+. .+....++++.+||.+||. +|.+|||+.|+|+||||+...+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011 1223367899999999999 9999999999999999997644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=365.60 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=199.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC----
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE---- 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~---- 100 (613)
++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||++++++|....
T Consensus 25 ~~y-~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 25 KRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhe-eEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 344 78899999999999999999999999999887432 34566778899999999999999999999886433
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+++||||+.+ +|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 175 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC--
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeeccc
Confidence 2378999999975 7888876 45999999999999999999999998 99999999999998 56899999999998
Q ss_pred HHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc--------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-------- 248 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~-------- 248 (613)
..... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||....... .+..+......+.
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHHhh
Confidence 76542 23467789999998765 58999999999999999999999997755444 3344433211100
Q ss_pred --------------------------------ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 249 --------------------------------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 249 --------------------------------l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.....+..+++||.+||. ||.+|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 001125689999999999 99999999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=372.94 Aligned_cols=258 Identities=14% Similarity=0.173 Sum_probs=190.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC--CCCCcceeeeee-------
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL--KHKNIIKFYNSW------- 96 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~f------- 96 (613)
+-|++.+.||+|+||+||+|.+..+|+.||+|+++.... ......+.+.+|+.+++.| +||||++++..|
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 446788999999999999999999999999999886432 2345667788885555544 699988866433
Q ss_pred ecCCC---------------CEEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHhhhhhcCCCCEEe
Q 035992 97 VDTEN---------------EHINFITEIFTSGTLRQYRKKH-KHVDLRAL------KKWSRQILEGLSYLHSHDPPVIH 154 (613)
Q Consensus 97 v~~~~---------------~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i------~~i~~QIl~gL~yLHs~~~~IIH 154 (613)
..... ..+++||||+. |+|.+++... ..+++... ..++.||+.||+|||+++ |+|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--ivH 217 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG--LVH 217 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--EEE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--Ccc
Confidence 22111 45899999999 8999999864 34455555 567799999999999998 999
Q ss_pred cCCCCCcEEEeCCCCcEEEeccchhHHHhhhc-cCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCC
Q 035992 155 RDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-SAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVEC 230 (613)
Q Consensus 155 rDLKp~NILl~~~~g~VKL~DFGla~~l~~~~-~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~ 230 (613)
|||||+|||++ .+|.+||+|||++....... ...+++.|+|||++.+ .|+.++|||||||++|||++|..||...
T Consensus 218 rDikp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 218 GHFTPDNLFIM-PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TTCSGGGEEEC-TTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred CcCCHHHEEEC-CCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999998 67899999999998765543 4456689999998864 5899999999999999999999999764
Q ss_pred CcHHH-HHHH---HHcCCCCC--cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 231 TNAAQ-IYKK---VTSGIKPA--SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 231 ~~~~~-i~~~---I~~g~~p~--~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
..... .+.. ........ ......++.+.+||.+||. +|.+|||+.++|+||||+...+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 361 (371)
T 3q60_A 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN 361 (371)
T ss_dssp CTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred CcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence 32110 0000 00111111 1123568999999999999 9999999999999999987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.41 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=207.5
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC---C
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT---E 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~---~ 100 (613)
.++| ++.+.||+|+||+||+|.+..+|+.||+|+++. .........+.+|+.+++.++||||+++++++... .
T Consensus 10 ~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 10 SSDF-QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP---FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccce-EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc---cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 3444 888999999999999999999999999998753 23456677888999999999999999999976542 1
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+++||||+. |+|.+++.. +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCE
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEeccccc
Confidence 357899999997 589998877 57999999999999999999999998 99999999999998 56899999999987
Q ss_pred HHhhh--------------ccCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 181 ILAQA--------------RSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 181 ~l~~~--------------~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
..... ....+++.|+|||++. ..++.++|||||||++|+|++|..||........+........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 54321 1235678999999764 4589999999999999999999999977554443322211100
Q ss_pred CC-----------------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 245 KP-----------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 245 ~p-----------------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+ .......++.+.+||.+||. +|.+|||+.|+|+||||+....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00 01123467889999999999 9999999999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=358.44 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecc-------ccChHHHHHHHHHHHHHHhCCCCCcceeeeee
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-------LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSW 96 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~-------~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 96 (613)
.++| ++.+.||+|+||+||+|.+.. |..||+|.+..... .......+.+.+|+.+++.++||||++++++|
T Consensus 21 ~~~y-~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 21 QSPY-TVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TCSC-EEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ccce-EEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 4555 888999999999999998865 99999998865332 22345568899999999999999999999988
Q ss_pred ecC---CCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 97 VDT---ENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 97 v~~---~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
... ....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~k 174 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDIT 174 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEE
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEE
Confidence 653 3457899999998 5787777654 47999999999999999999999998 99999999999998 568999
Q ss_pred EeccchhHHHhhh---ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC-
Q 035992 173 IGDLGLAAILAQA---RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP- 246 (613)
Q Consensus 173 L~DFGla~~l~~~---~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p- 246 (613)
|+|||++...... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.....+
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 254 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 9999999754432 23456778999998754 58999999999999999999999997755444333222111000
Q ss_pred ----------------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 ----------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 ----------------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence 01122357889999999999 99999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=350.53 Aligned_cols=259 Identities=27% Similarity=0.487 Sum_probs=218.9
Q ss_pred CcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeee
Q 035992 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNS 95 (613)
Q Consensus 16 ~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 95 (613)
..-...+|..+| ++.+.||+|+||+||+|.+..+|+.||+|++.... .....+.+.+|+.+++.++||||++++++
T Consensus 13 ~~~~~~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 88 (303)
T 3a7i_A 13 MQNLKADPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGS 88 (303)
T ss_dssp CTTCEECGGGTE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT---CSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hhcCCCChHHHH-HHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 334455677776 77899999999999999999999999999876433 23456789999999999999999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
|.. ...+++||||+.+++|.+++.+ +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|
T Consensus 89 ~~~--~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~D 162 (303)
T 3a7i_A 89 YLK--DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLAD 162 (303)
T ss_dssp EEE--TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECC
T ss_pred Eec--CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEee
Confidence 865 4579999999999999999865 57999999999999999999999998 99999999999998 568999999
Q ss_pred cchhHHHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 176 LGLAAILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 176 FGla~~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
||++...... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... .......+..+. +..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~-~~~~~ 240 (303)
T 3a7i_A 163 FGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNN-PPTLE 240 (303)
T ss_dssp CTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSC-CCCCC
T ss_pred cccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC-HHHHHHHhhcCC-CCCCc
Confidence 9999765432 23457789999998765 58999999999999999999999997644 444444555443 33455
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..++..+.+||.+||. +|.+|||+.++++||||...
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 6678999999999999 99999999999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=361.95 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=191.0
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC-----
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE----- 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~----- 100 (613)
+| ++.+.||+|+||+||+|.+..+|+.||+|++.... ....+...++..++.++||||++++++|....
T Consensus 24 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 24 RF-QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp TE-EEC----------CEEEEETTTCCEEEEEEEECCT-----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-----cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 44 78899999999999999999999999999876432 22235667888889999999999999986532
Q ss_pred CCEEEEEEeccCCCCHH---HHHHhCCCCCHHHHHHHHHHHHHHhhhhh--cCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 101 NEHINFITEIFTSGTLR---QYRKKHKHVDLRALKKWSRQILEGLSYLH--SHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~---~~l~~~~~lse~~i~~i~~QIl~gL~yLH--s~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
...+++||||+.++.+. .+......+++..++.++.||+.||.||| +++ |+||||||+|||++..++.+||+|
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECC
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEee
Confidence 23488999999875333 23345678999999999999999999999 777 999999999999985578999999
Q ss_pred cchhHHHhhhc---cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC---
Q 035992 176 LGLAAILAQAR---SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--- 247 (613)
Q Consensus 176 FGla~~l~~~~---~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~--- 247 (613)
||++..+.... ...+++.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.....+.
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 99998664432 3456789999998743 389999999999999999999999977554444433322110000
Q ss_pred --------------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 248 --------------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 248 --------------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
......+..+.+||.+||+ +|.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 0011146789999999999 999999999999999998764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.09 Aligned_cols=252 Identities=26% Similarity=0.360 Sum_probs=202.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC----E
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE----H 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~----~ 103 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... ........+.+|+.+++.++||||++++++|...... .
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 477899999999999999999999999999876422 3455678889999999999999999999988654321 2
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+++||||+. ++|.+++. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHAD 195 (371)
T ss_dssp CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC----
T ss_pred EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccc
Confidence 489999997 58887773 45999999999999999999999998 99999999999998 67899999999998665
Q ss_pred hh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--------------
Q 035992 184 QA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-------------- 246 (613)
Q Consensus 184 ~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p-------------- 246 (613)
.. ....+++.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.....+
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 43 34567889999998764 58999999999999999999999997755444443332211100
Q ss_pred --------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 --------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 --------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..+....++.+++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 01122457899999999999 999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=354.81 Aligned_cols=260 Identities=23% Similarity=0.383 Sum_probs=192.8
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCc---EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGI---EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~---~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
+.++| ++.+.||+|+||+||+|.+..++. .||+|+++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 21 PEQQF-TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp C---C-EEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ChhHe-EEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34455 888999999999999999888775 899888764321 345678899999999999999999999998654
Q ss_pred CCC----EEEEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 100 ENE----HINFITEIFTSGTLRQYRKKHK------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 100 ~~~----~l~lV~E~~~gGsL~~~l~~~~------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
... ..++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCC
Confidence 322 2489999999999999986543 6999999999999999999999998 99999999999998 568
Q ss_pred cEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHH
Q 035992 170 EVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~ 241 (613)
.+||+|||++....... ...+++.|+|||++.+ .|+.++|||||||++|+|++ |..||.... ...++..+.
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-~~~~~~~~~ 253 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-NAEIYNYLI 253 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-hHHHHHHHh
Confidence 99999999998654322 2334568999998765 48999999999999999999 899997644 445555666
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCC-------HHHHhcCCCCCCCCccc
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLP-------AKELLGDPFLQSEDDES 290 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpt-------a~eLL~HPff~~~~~~~ 290 (613)
.+..+ ..+...+..+.+||.+||. +|.+||| +++++.|||+......+
T Consensus 254 ~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~p 309 (323)
T 3qup_A 254 GGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDP 309 (323)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----------
T ss_pred cCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 55433 3345678899999999999 9999999 78889999998764433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=352.02 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=202.8
Q ss_pred CcceeEeeeecccCceEEEEEEE-cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC------Ccceeeeeee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFD-ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK------NIIKFYNSWV 97 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~-~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp------NIVkl~~~fv 97 (613)
+|| ++.+.||+|+||+||+|.+ ..+|+.||+|+++. .....+.+.+|+.+++.++|+ +|++++++|.
T Consensus 14 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 14 ARY-EIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred Cce-EEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 355 8889999999999999998 66899999998753 245567788999999998765 4999999875
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--------
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN-------- 167 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~-------- 167 (613)
. ...+++||||+ +++|.+++...+ .+++..++.++.||+.||+|||+++ |+||||||+|||++..
T Consensus 88 ~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 88 H--HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp E--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC-
T ss_pred c--CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCC
Confidence 4 45899999999 889999998775 6899999999999999999999998 9999999999999742
Q ss_pred ----------CCcEEEeccchhHHHhhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH
Q 035992 168 ----------QGEVKIGDLGLAAILAQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235 (613)
Q Consensus 168 ----------~g~VKL~DFGla~~l~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~ 235 (613)
.+.+||+|||++...... ....+++.|+|||++.+ .|+.++|||||||++|||++|..||........
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 567999999998765432 34567889999998765 589999999999999999999999976544332
Q ss_pred HHHHHHc--CCCCCc----------------------------------------ccccccHHHHHHHHHHhh-cccCCC
Q 035992 236 IYKKVTS--GIKPAS----------------------------------------LAKVADNGVRAFIEKCIA-EVSERL 272 (613)
Q Consensus 236 i~~~I~~--g~~p~~----------------------------------------l~~~~s~~l~~lI~~cL~-dP~~Rp 272 (613)
+ ..+.. +..|.. .....+..+.+||.+||. +|.+||
T Consensus 243 ~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 243 L-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp H-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred H-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 2 22211 111110 011235678999999999 999999
Q ss_pred CHHHHhcCCCCCCC
Q 035992 273 PAKELLGDPFLQSE 286 (613)
Q Consensus 273 ta~eLL~HPff~~~ 286 (613)
|+.|+|+||||+..
T Consensus 322 t~~ell~hp~f~~~ 335 (339)
T 1z57_A 322 TLREALKHPFFDLL 335 (339)
T ss_dssp CHHHHTTSGGGGGG
T ss_pred CHHHHhcCHHHHHH
Confidence 99999999999864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=355.62 Aligned_cols=239 Identities=24% Similarity=0.402 Sum_probs=199.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.+..+|+.||+|.+.. ......+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 85 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK--DKRLNFI 85 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec--CCeeEEE
Confidence 4788999999999999999999999999887643 346777889999999999999999999998865 5679999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|.+++.. .+.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC---
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceeccccc
Confidence 999999999999987 567999999999999999999999998 99999999999998 67899999999986543211
Q ss_pred ------------------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH----HHHHHHcC
Q 035992 187 ------------------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ----IYKKVTSG 243 (613)
Q Consensus 187 ------------------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~----i~~~I~~g 243 (613)
...+++.|+|||++.+ .++.++||||||+++|+|++|..||........ ........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 3457889999998765 489999999999999999999999855322110 00111111
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+..+++.+.++|.+||. +|.+|||+.++++
T Consensus 243 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 ----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1234467789999999999 9999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.64 Aligned_cols=245 Identities=17% Similarity=0.289 Sum_probs=206.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+. |..||+|+++... ......+.+.+|+.+++.++||||++++++|.......+++|
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred hHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 478899999999999999874 8899999877532 245667789999999999999999999999877655788999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++++++||||||+|||++ .++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeeecc-
Confidence 99999999999998875 48999999999999999999999888899999999999998 668999998888754332
Q ss_pred ccCcccccccCccccccc-c---CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 186 RSAHSVIEFMAPELYEEE-Y---NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~~-y---s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
....+++.|+|||++.+. + +.++||||||+++|+|++|..||...............+. ...++...++.+.++|
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li 244 (271)
T 3kmu_A 166 PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL-RPTIPPGISPHVSKLM 244 (271)
T ss_dssp TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC-CCCCCTTCCHHHHHHH
T ss_pred cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC-CCCCCCCCCHHHHHHH
Confidence 345678899999987643 3 3479999999999999999999977655544444444443 4455667899999999
Q ss_pred HHHhh-cccCCCCHHHHhc
Q 035992 262 EKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~eLL~ 279 (613)
.+||. +|.+|||+.++++
T Consensus 245 ~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 245 KICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 99999 9999999999985
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=343.47 Aligned_cols=251 Identities=23% Similarity=0.392 Sum_probs=206.2
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHH---HHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL---ERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~---~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
..++| ++.+.||+|+||+||+|.+..+++.||+|++............ +.+.+|+.+++.++||||++++++|..
T Consensus 17 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 94 (287)
T 4f0f_A 17 ADNEI-EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN- 94 (287)
T ss_dssp CSTTE-EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT-
T ss_pred hhccc-eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC-
Confidence 34555 8889999999999999999999999999988654433332222 678999999999999999999998743
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc-----EEE
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE-----VKI 173 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~-----VKL 173 (613)
.. ++||||+.+|+|.+++.+. ..+++..++.++.||+.||+|||+++++|+||||||+|||++ ..+. +||
T Consensus 95 -~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~~kl 170 (287)
T 4f0f_A 95 -PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVCAKV 170 (287)
T ss_dssp -TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCCEEE
T ss_pred -CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCceeEEe
Confidence 22 6899999999999887655 579999999999999999999999987799999999999997 3444 999
Q ss_pred eccchhHHHhhh-ccCcccccccCccccc---cccCccchhhhhhHHHHHHHhcCCCCCCCCcH-HHHHHHHHcCCCCCc
Q 035992 174 GDLGLAAILAQA-RSAHSVIEFMAPELYE---EEYNELVDIYAFGMCLLELVTFEYPYVECTNA-AQIYKKVTSGIKPAS 248 (613)
Q Consensus 174 ~DFGla~~l~~~-~~~~gt~~YmAPEvl~---~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~-~~i~~~I~~g~~p~~ 248 (613)
+|||++...... ....+++.|+|||++. ..++.++||||||+++|+|++|..||...... ......+........
T Consensus 171 ~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 171 ADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999998754332 2456788999999873 34789999999999999999999999765433 333444444444555
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++..+++.+.++|.+||+ +|.+|||+.++++
T Consensus 251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 667789999999999999 9999999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.14 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=187.4
Q ss_pred eeeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
.++||+|+||+||+|.++ .+++.||+|+++... ....+.+|+.+|+.++||||++++++|.......+++||
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG------ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS------CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC------CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 568999999999999966 578999998875322 123577899999999999999999999877778999999
Q ss_pred eccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe---CCCCcEEEecc
Q 035992 109 EIFTSGTLRQYRKKH---------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN---GNQGEVKIGDL 176 (613)
Q Consensus 109 E~~~gGsL~~~l~~~---------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~---~~~g~VKL~DF 176 (613)
||+.+ +|.+++... ..+++..++.|+.||+.||.|||+++ |+||||||+|||+. ...+.+||+||
T Consensus 100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 99975 787776532 24999999999999999999999998 99999999999993 25679999999
Q ss_pred chhHHHhhh-------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCc---------HHHHHH
Q 035992 177 GLAAILAQA-------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTN---------AAQIYK 238 (613)
Q Consensus 177 Gla~~l~~~-------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~---------~~~i~~ 238 (613)
|++..+... ....+++.|+|||++.+ .|+.++|||||||++|+|++|..||..... ..++..
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 999765432 23456889999998764 489999999999999999999999965332 122222
Q ss_pred HHHc-CCCC-Ccccc---------------------------------cccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 239 KVTS-GIKP-ASLAK---------------------------------VADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 239 ~I~~-g~~p-~~l~~---------------------------------~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
.+.. +..+ ..+.. ..+..+.+||.+||. ||.+|||++|+|+|||
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 2111 1111 00100 116788999999999 9999999999999999
Q ss_pred CCCCC
Q 035992 283 LQSED 287 (613)
Q Consensus 283 f~~~~ 287 (613)
|+...
T Consensus 337 f~~~~ 341 (405)
T 3rgf_A 337 FLEDP 341 (405)
T ss_dssp GTSSS
T ss_pred hccCC
Confidence 98764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=359.91 Aligned_cols=256 Identities=20% Similarity=0.393 Sum_probs=214.1
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh-------------HHHHHHHHHHHHHHhCCCCCcceee
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-------------EDLERLYSEVHLLKTLKHKNIIKFY 93 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~-------------~~~~~l~~Ei~iLk~L~HpNIVkl~ 93 (613)
.|++.+.||+|+||+||+|.+ +|+.||+|++......... ...+.+.+|+.+++.++||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 347889999999999999998 9999999998754322110 1237889999999999999999999
Q ss_pred eeeecCCCCEEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEE
Q 035992 94 NSWVDTENEHINFITEIFTSGTLRQY------RKK--HKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFV 164 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL~~~------l~~--~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl 164 (613)
+++.. ...+++||||+.+|+|.++ +.+ ...+++..++.++.||+.||.|||+ ++ |+||||||+|||+
T Consensus 110 ~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM 185 (348)
T ss_dssp EEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE
T ss_pred EEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE
Confidence 98865 4689999999999999998 666 5789999999999999999999999 88 9999999999999
Q ss_pred eCCCCcEEEeccchhHHHhh--hccCcccccccCccccccc--cCc-cchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHH
Q 035992 165 NGNQGEVKIGDLGLAAILAQ--ARSAHSVIEFMAPELYEEE--YNE-LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKK 239 (613)
Q Consensus 165 ~~~~g~VKL~DFGla~~l~~--~~~~~gt~~YmAPEvl~~~--ys~-ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~ 239 (613)
+ .++.+||+|||++..... .....++..|+|||++.+. ++. ++||||||+++|+|++|..||........+...
T Consensus 186 ~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 186 D-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp C-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred c-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 8 568999999999976533 2345677899999988654 555 999999999999999999999876665677777
Q ss_pred HHcCCCCCcc-----------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCcc
Q 035992 240 VTSGIKPASL-----------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289 (613)
Q Consensus 240 I~~g~~p~~l-----------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~~ 289 (613)
+..+...... ....+..+.+||.+||. +|.+|||+.|+++||||+.....
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~ 332 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIE 332 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHH
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHH
Confidence 7766432221 15578999999999999 99999999999999999986543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.20 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=202.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----------CCCcceee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-----------HKNIIKFY 93 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpNIVkl~ 93 (613)
++| ++.+.||+|+||+||+|.+..+|+.||+|+++. .....+.+.+|+.+++.+. ||||++++
T Consensus 19 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 19 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CeE-EEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 444 888999999999999999999999999998763 3345677889999999886 89999999
Q ss_pred eeeecCC--CCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeC--
Q 035992 94 NSWVDTE--NEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNG-- 166 (613)
Q Consensus 94 ~~fv~~~--~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~-- 166 (613)
++|.... ...++++||++ +++|.+++.+. +.+++..++.++.||+.||.|||++ + |+||||||+|||++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccC
Confidence 9986542 33789999999 88999999874 4599999999999999999999998 8 999999999999952
Q ss_pred ---CCCcEEEeccchhHHHhhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc-----HHHH
Q 035992 167 ---NQGEVKIGDLGLAAILAQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN-----AAQI 236 (613)
Q Consensus 167 ---~~g~VKL~DFGla~~l~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~-----~~~i 236 (613)
..+.+||+|||++...... ....+++.|+|||++.+ .|+.++|||||||++|||++|..||..... ....
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 3347999999999766543 34567889999998765 489999999999999999999999965331 1111
Q ss_pred HHHHHc--CCCCC--------------------------------------cccccccHHHHHHHHHHhh-cccCCCCHH
Q 035992 237 YKKVTS--GIKPA--------------------------------------SLAKVADNGVRAFIEKCIA-EVSERLPAK 275 (613)
Q Consensus 237 ~~~I~~--g~~p~--------------------------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~ 275 (613)
...+.. +..|. .++...+..+.+||.+||+ +|.+|||+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 111111 11110 1223456789999999999 999999999
Q ss_pred HHhcCCCCCCC
Q 035992 276 ELLGDPFLQSE 286 (613)
Q Consensus 276 eLL~HPff~~~ 286 (613)
|+|+||||+..
T Consensus 330 ell~hp~f~~~ 340 (373)
T 1q8y_A 330 GLVNHPWLKDT 340 (373)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhhChhhhcc
Confidence 99999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=348.68 Aligned_cols=248 Identities=28% Similarity=0.473 Sum_probs=202.3
Q ss_pred CCcceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
..+.|++.+.||+|+||+||+|. +..+|+.||+|.++. ......+.+.+|+.+++.++||||++++++|...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc----CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 44666999999999999999998 677899999988763 2456678899999999999999999999998765
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
....+++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcc
Confidence 5567899999999999999998764 5999999999999999999999998 99999999999998 568999999999
Q ss_pred hHHHhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH---------------HH
Q 035992 179 AAILAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA---------------AQ 235 (613)
Q Consensus 179 a~~l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~---------------~~ 235 (613)
+....... ...++..|+|||++.+ .++.++||||||+++|+|+||..||...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 98764321 2335567999998764 5899999999999999999999998542111 02
Q ss_pred HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 236 i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+...+..+.. ...+..+++.+.+||.+||. +|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 241 LIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2223333322 23455678999999999999 9999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=360.34 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=200.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CC-----CcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HK-----NIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-Hp-----NIVkl~~~fv~~~~ 101 (613)
|++.++||+|+||+||+|.+..+|+.||+|+++. .......+..|+.+++.+. |+ +|++++++|.. .
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~ 128 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--R 128 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--T
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--C
Confidence 4788999999999999999999999999998763 2345667788999998885 55 49999998865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-CCCcEEEeccch
Q 035992 102 EHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGL 178 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~-~~g~VKL~DFGl 178 (613)
..+++||||+. |+|.+++... +.+++..++.++.||+.||.|||++..+|+||||||+|||++. ..+.+||+|||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 68999999996 5999998876 4699999999999999999999965445999999999999952 467899999999
Q ss_pred hHHHhhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCCCCccc-----
Q 035992 179 AAILAQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIKPASLA----- 250 (613)
Q Consensus 179 a~~l~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~p~~l~----- 250 (613)
+...... ....+++.|+|||++.+ .|+.++|||||||++|||+||..||........+...+.. +..+..+.
T Consensus 208 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 287 (382)
T 2vx3_A 208 SCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPK 287 (382)
T ss_dssp CEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTT
T ss_pred ceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHH
Confidence 9766432 34567889999998765 5999999999999999999999999775544443332221 11110000
Q ss_pred -------------------------------------------------------ccccHHHHHHHHHHhh-cccCCCCH
Q 035992 251 -------------------------------------------------------KVADNGVRAFIEKCIA-EVSERLPA 274 (613)
Q Consensus 251 -------------------------------------------------------~~~s~~l~~lI~~cL~-dP~~Rpta 274 (613)
....+.+++||.+||+ ||.+|||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta 367 (382)
T 2vx3_A 288 ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367 (382)
T ss_dssp HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCH
T ss_pred HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCH
Confidence 0001478999999999 99999999
Q ss_pred HHHhcCCCCCCC
Q 035992 275 KELLGDPFLQSE 286 (613)
Q Consensus 275 ~eLL~HPff~~~ 286 (613)
+|+|+||||+..
T Consensus 368 ~e~L~hp~f~~~ 379 (382)
T 2vx3_A 368 YYALQHSFFKKT 379 (382)
T ss_dssp HHHTTSGGGCC-
T ss_pred HHHhcCcccccC
Confidence 999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=349.74 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=204.1
Q ss_pred ceeEeeeecccCceEEEEEEEc-CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCCcceeeeeeec---C
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDE-LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVD---T 99 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~-~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~---~ 99 (613)
.|++.+.||+|+||+||+|.+. .+|+.||+|+++..... ......+.+|+.+++.+ +||||++++++|.. .
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc--ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 3488899999999999999995 78899999998765422 11223455677777665 89999999998762 2
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
....+++||||+. |+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~Dfg 165 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFG 165 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCC
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEecCc
Confidence 3567899999998 59999998754 4999999999999999999999998 99999999999998 57899999999
Q ss_pred hhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCC-------
Q 035992 178 LAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIK------- 245 (613)
Q Consensus 178 la~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~------- 245 (613)
++...... ....++..|+|||++.+ .++.++||||||+++|+|++|..||........+...+.. +..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 166 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred ccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 98765432 23456789999998764 5899999999999999999999999775554444333221 000
Q ss_pred ----------------CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 246 ----------------PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 246 ----------------p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
...+....+..+++||.+||. +|.+|||+.++|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 011224467889999999999 999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=357.82 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=209.2
Q ss_pred CCCcceeEeeeecccCceEEEEEE-----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAF-----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSW 96 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~-----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 96 (613)
+..+| ++.+.||+|+||+||+|. +..+++.||+|+++. .......+.+.+|+.+++++ +||||++++++|
T Consensus 20 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 20 PRDRL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE---GATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp CGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccce-eeceeecCCCCceEEEEEeccccccccceEEEEEEecC---cCCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 34454 889999999999999998 566789999888753 23455677899999999999 799999999987
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhCCC---------------------------------------------------
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKHKH--------------------------------------------------- 125 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~~~--------------------------------------------------- 125 (613)
... +..+++||||+.+|+|.+++.....
T Consensus 96 ~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 96 TKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp CST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 653 4468899999999999999987643
Q ss_pred ---------------CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-----
Q 035992 126 ---------------VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----- 185 (613)
Q Consensus 126 ---------------lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----- 185 (613)
+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..+...
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchh
Confidence 899999999999999999999998 99999999999998 5679999999999765321
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....+++.|+|||++.+ .|+.++|||||||++|||+| |..||........+...+..+..+ ..+...++.+.++|.
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTML 330 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHH
Confidence 23345678999997754 58999999999999999998 999998776666666666665433 345667899999999
Q ss_pred HHhh-cccCCCCHHHHhcC
Q 035992 263 KCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~H 280 (613)
+||. +|.+|||+.|+++|
T Consensus 331 ~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCCCHHHHHHH
Confidence 9999 99999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=339.24 Aligned_cols=248 Identities=29% Similarity=0.424 Sum_probs=195.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.++||+|+||+||+|.+. |..||+|+++...........+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 83 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK--EPNLCL 83 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC--C--CEE
T ss_pred heeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec--CCceEE
Confidence 3488899999999999999874 889999988754433333446788999999999999999999998754 457899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCC-CEEecCCCCCcEEEeC-------CCCcEEEeccch
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDP-PVIHRDLKCDNIFVNG-------NQGEVKIGDLGL 178 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~-~IIHrDLKp~NILl~~-------~~g~VKL~DFGl 178 (613)
||||+.+++|.+++. .+.+++..++.++.||+.||.|||+++. +|+||||||+|||++. ..+.+||+|||+
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999999885 4679999999999999999999999873 3899999999999974 267899999999
Q ss_pred hHHHhhh--ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 179 AAILAQA--RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 179 a~~l~~~--~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
+...... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||......... ..+........++...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 241 (271)
T 3dtc_A 163 AREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA-YGVAMNKLALPIPSTCPE 241 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HHHHTSCCCCCCCTTCCH
T ss_pred ccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HhhhcCCCCCCCCcccCH
Confidence 9865442 23467889999998765 4899999999999999999999999775544444 444444444455667889
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+.++|.+||. +|.+|||+.|++++
T Consensus 242 ~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 242 PFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 99999999999 99999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=358.03 Aligned_cols=258 Identities=20% Similarity=0.319 Sum_probs=184.2
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
......++|....++||+|+||+||+|.+..+|+.||+|++... .... ......++.+.||||++++++|..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKAR---QEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHH---HHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHH---HHHHHHHHhcCCCChHHHHHHHhh
Confidence 33344567865577899999999999999999999999987631 2222 223334667799999999998854
Q ss_pred C--CCCEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEE
Q 035992 99 T--ENEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVK 172 (613)
Q Consensus 99 ~--~~~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VK 172 (613)
. ....+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. ..+.+|
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEE
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEE
Confidence 2 2456899999999999999998764 6999999999999999999999998 999999999999973 245699
Q ss_pred EeccchhHHHhhh--ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH---HHHHHHcCC--
Q 035992 173 IGDLGLAAILAQA--RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ---IYKKVTSGI-- 244 (613)
Q Consensus 173 L~DFGla~~l~~~--~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~---i~~~I~~g~-- 244 (613)
|+|||++...... ....+++.|+|||++.. .|+.++||||||+++|+|++|..||........ ....+..+.
T Consensus 172 l~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 172 LTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp ECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred EeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 9999998754432 24456789999998754 589999999999999999999999965433221 112222221
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+......++..+++||.+||. +|.+|||+.|+|+||||+..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 1222234578999999999999 99999999999999999863
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=352.01 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=198.2
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEe-eccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~-~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
...+| ++.++||+|+||+||+|.+..+|+.+++|+..+ ..........+.+.+|+.++++++||||++++++|...
T Consensus 13 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--
T ss_pred CHHHc-ccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--
Confidence 34455 788999999999999999998888765443222 11222334567889999999999999999999998642
Q ss_pred CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++++|+.+|+|.+++.+. +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTHHH
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCccee
Confidence 378899999999999999874 67999999999999999999999998 99999999999998 56899999999998
Q ss_pred HHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 181 ILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 181 ~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
.+.... ...+++.|+|||++.+ .|+.++|||||||++|||+| |..||... +...+...+..+..+ ..+..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 243 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL-PQPPI 243 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTT
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC-CHHHHHHHHHcCCCC-CCCcc
Confidence 875432 2234568999997764 58999999999999999999 99999654 444555666655433 34456
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+..+.++|.+||+ +|.+||++.+++++
T Consensus 244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 244 CTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp BCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 78899999999999 99999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=350.18 Aligned_cols=250 Identities=21% Similarity=0.295 Sum_probs=209.5
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeee
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNS 95 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 95 (613)
..-....|++.+.||+|+||+||+|.+. .+++.||+|+++.. ......+.+.+|+.+++.++||||++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3333444588899999999999999987 45689998887632 345667889999999999999999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHhhhhhcCCCC
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKH------------------------KHVDLRALKKWSRQILEGLSYLHSHDPP 151 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~------------------------~~lse~~i~~i~~QIl~gL~yLHs~~~~ 151 (613)
|.. ...+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++
T Consensus 119 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~-- 194 (343)
T 1luf_A 119 CAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-- 194 (343)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred Ecc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 754 55789999999999999999874 57999999999999999999999998
Q ss_pred EEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-c
Q 035992 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-F 223 (613)
Q Consensus 152 IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G 223 (613)
|+||||||+|||++ .++.+||+|||++....... ...+++.|+|||++. ..++.++||||||+++|+|++ |
T Consensus 195 ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 195 FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 99999999999998 56799999999998764322 334567899999776 459999999999999999999 9
Q ss_pred CCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 224 EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 224 ~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..||... +...+...+..+..+ .++..++..+.++|.+||. +|.+||++.+++++
T Consensus 274 ~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 274 LQPYYGM-AHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCCC-ChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 9999764 455666667666543 3455678899999999999 99999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.29 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=203.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC---
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--- 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--- 101 (613)
++| ++.+.||+|+||+||+|.+..+|+.||+|++... .......+.+.+|+.+++.++||||++++++|.....
T Consensus 24 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 24 KTY-VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP--FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 100 (353)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEESST--TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred ceE-EEeeeEecCCCeEEEEEEECCCCCEEEEEEeccc--ccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence 454 7789999999999999999999999999987642 2344567788999999999999999999998865432
Q ss_pred -CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 -EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 -~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..++++|||+. ++|.+++. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 101 FYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLAR 174 (353)
T ss_dssp CCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTT
T ss_pred ceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeeccccc
Confidence 24689999997 58877764 35999999999999999999999998 99999999999998 67899999999997
Q ss_pred HHhhh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CC------------
Q 035992 181 ILAQA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GI------------ 244 (613)
Q Consensus 181 ~l~~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~------------ 244 (613)
..... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||........+...+.. +.
T Consensus 175 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp C--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred CCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 65432 23467789999998764 5899999999999999999999999775544333222211 00
Q ss_pred ---------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ---------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ---------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
....+....++.+.+||.+||. +|.+|||+.++|+||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0011223468899999999999 999999999999999998753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.85 Aligned_cols=243 Identities=25% Similarity=0.302 Sum_probs=197.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC--CCE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE--NEH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~--~~~ 103 (613)
.-|++.++||+|+||+||+|.+. ++.||+|+++.. .........|+.++++++||||++++++|.... ...
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 44588899999999999999765 899999987532 234455667999999999999999999987644 346
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC----------CCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH----------DPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~----------~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
+++||||+.+|+|.+++.+. .+++..++.++.||+.||.|||++ + |+||||||+|||++ ..+.+||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~kL 172 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTACI 172 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEEE
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEEE
Confidence 89999999999999999774 599999999999999999999998 7 99999999999998 6789999
Q ss_pred eccchhHHHhhhc------cCcccccccCcccccc------ccCccchhhhhhHHHHHHHhcCCCCCCCC----------
Q 035992 174 GDLGLAAILAQAR------SAHSVIEFMAPELYEE------EYNELVDIYAFGMCLLELVTFEYPYVECT---------- 231 (613)
Q Consensus 174 ~DFGla~~l~~~~------~~~gt~~YmAPEvl~~------~ys~ksDIWSLGviL~EmltG~~Pf~~~~---------- 231 (613)
+|||++..+.... ...+++.|+|||++.+ .++.++|||||||++|||+||..||....
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 9999997654321 2457889999998764 46778999999999999999999996432
Q ss_pred -----cHHHHHHHHHcCCCCCccccc-----ccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 232 -----NAAQIYKKVTSGIKPASLAKV-----ADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 232 -----~~~~i~~~I~~g~~p~~l~~~-----~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
....+...+......+.+... .+..+.+||.+||+ +|.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 334444444444333333322 23569999999999 9999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=346.96 Aligned_cols=263 Identities=21% Similarity=0.355 Sum_probs=205.0
Q ss_pred CCCCCCcccccCCCCcceeEeeeecccCceEEEEEEEcC---CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC
Q 035992 11 PDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK 87 (613)
Q Consensus 11 ~~~~~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~---tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp 87 (613)
.++...++-.+......|++.+.||+|+||+||+|.+.. ++..||+|.++... ......+.+.+|+.++++++||
T Consensus 19 ~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~ 96 (313)
T 3brb_A 19 SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHP 96 (313)
T ss_dssp -----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCT
T ss_pred hHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCC
Confidence 344455566666677778999999999999999998765 56689998876432 2456678899999999999999
Q ss_pred CcceeeeeeecCCCC---EEEEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCC
Q 035992 88 NIIKFYNSWVDTENE---HINFITEIFTSGTLRQYRKK------HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLK 158 (613)
Q Consensus 88 NIVkl~~~fv~~~~~---~l~lV~E~~~gGsL~~~l~~------~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLK 158 (613)
||+++++++...... ..++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+|||||
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dik 174 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLA 174 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCS
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCC
Confidence 999999998764432 46999999999999999843 356999999999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCC
Q 035992 159 CDNIFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVEC 230 (613)
Q Consensus 159 p~NILl~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~ 230 (613)
|+|||++ .++.+||+|||++...... ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...
T Consensus 175 p~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 253 (313)
T 3brb_A 175 ARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253 (313)
T ss_dssp GGGEEEC-TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cceEEEc-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccC
Confidence 9999998 5689999999999765432 22345668999998765 48999999999999999999 88999664
Q ss_pred CcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 231 TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 231 ~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
. ...+...+..+..+ ..+..++..+.++|.+||. +|.+||++.+++.+
T Consensus 254 ~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 254 Q-NHEMYDYLLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C-GGGHHHHHHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C-HHHHHHHHHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4 44555566665433 3455678899999999999 99999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=350.22 Aligned_cols=243 Identities=20% Similarity=0.361 Sum_probs=203.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCc---EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGI---EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~---~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.|++.++||+|+||+||+|.+..+|. .||+|+++. .......+.+.+|+.+++.++||||++++++|.. ...
T Consensus 50 ~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 124 (325)
T 3kul_A 50 RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKA---GYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR--GRL 124 (325)
T ss_dssp GEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECT---TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG--GGC
T ss_pred HeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCC---CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCc
Confidence 34888999999999999999986665 499887753 2345667889999999999999999999998854 457
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++||||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCccccc
Confidence 89999999999999999765 67999999999999999999999998 99999999999998 5789999999999765
Q ss_pred hhhc-------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 183 AQAR-------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 183 ~~~~-------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
.... ...+++.|+|||++. ..|+.++||||||+++|+|++ |..||... ....+...+..+..+ ..+..+
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 279 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-TNRDVISSVEEGYRL-PAPMGC 279 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCCC-CCCCCc
Confidence 4321 122355799999876 459999999999999999999 99999764 455566666666433 344567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+..+.+||.+||. +|.+|||+.++++
T Consensus 280 ~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 280 PHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 8999999999999 9999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=348.62 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=201.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCC-cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC------cceeeeeee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEG-IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN------IIKFYNSWV 97 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg-~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN------IVkl~~~fv 97 (613)
++| ++.+.||+|+||+||+|.+..++ ..||+|+++. .....+.+.+|+.+++.++|++ ++.++++|.
T Consensus 19 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 19 ERY-EIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ccE-EEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 344 78899999999999999998877 7899988753 3455677889999999997665 888888775
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe----------
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN---------- 165 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~---------- 165 (613)
. ...+++||||+ +++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||+.
T Consensus 93 ~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 93 F--HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp E--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECC
T ss_pred e--CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccc
Confidence 4 45899999999 66777777655 46999999999999999999999998 99999999999993
Q ss_pred --------CCCCcEEEeccchhHHHhhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH
Q 035992 166 --------GNQGEVKIGDLGLAAILAQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ 235 (613)
Q Consensus 166 --------~~~g~VKL~DFGla~~l~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~ 235 (613)
...+.+||+|||++...... ....+++.|+|||++.+ .|+.++|||||||++|||++|..||........
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 14678999999999765432 34567889999998754 599999999999999999999999976554433
Q ss_pred HHH--HHHcCCCCCcc----------------------------------------cccccHHHHHHHHHHhh-cccCCC
Q 035992 236 IYK--KVTSGIKPASL----------------------------------------AKVADNGVRAFIEKCIA-EVSERL 272 (613)
Q Consensus 236 i~~--~I~~g~~p~~l----------------------------------------~~~~s~~l~~lI~~cL~-dP~~Rp 272 (613)
+.. .+. +..|..+ ....+..+.+||.+||. +|.+||
T Consensus 248 ~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 248 LVMMEKIL-GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHH-CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHc-CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 221 111 1111100 01124578899999999 999999
Q ss_pred CHHHHhcCCCCCCCCc
Q 035992 273 PAKELLGDPFLQSEDD 288 (613)
Q Consensus 273 ta~eLL~HPff~~~~~ 288 (613)
|+.|+|+||||+....
T Consensus 327 t~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTP 342 (355)
T ss_dssp CHHHHTTSGGGGGCCH
T ss_pred CHHHHhcChhhcCCCh
Confidence 9999999999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=357.62 Aligned_cols=251 Identities=22% Similarity=0.351 Sum_probs=208.3
Q ss_pred cceeEeeeecccCceEEEEEE-----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAF-----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~-----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
..+++.+.||+|+||+||+|. +..++..||+|.++. .........+.+|+.+++.++||||++++++|..
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS---SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc---ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 345888999999999999999 556788999888753 2345666788999999999999999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcE
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK-------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEV 171 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~-------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~V 171 (613)
....++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++. ....+
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceE
Confidence 456789999999999999998653 5999999999999999999999998 999999999999972 23359
Q ss_pred EEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcC
Q 035992 172 KIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 172 KL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g 243 (613)
||+|||++..+.... ...+++.|+|||++. ..|+.++|||||||++|||++ |..||.. .....+...+..+
T Consensus 224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~ 302 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSG 302 (367)
T ss_dssp EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTT
T ss_pred EECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcC
Confidence 999999998764322 234567899999775 459999999999999999998 9999966 5566677777776
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..+ ..+..++..+.+||.+||+ +|.+||++.+++++.++..
T Consensus 303 ~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 303 GRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC-CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 543 3355678899999999999 9999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=357.58 Aligned_cols=245 Identities=28% Similarity=0.450 Sum_probs=205.4
Q ss_pred cceeEeeeecccCceEEEEEEEc-------CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeee
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDE-------LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWV 97 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~-------~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv 97 (613)
..|++.+.||+|+||+||+|.+. .++..||+|+++.. ......+.+.+|+.+|+.+ +||||++++++|.
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 34588899999999999999875 35668998877532 3456678899999999999 8999999999875
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDN 161 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~N 161 (613)
. ...+|+||||+.+|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 158 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~N 233 (370)
T 2psq_A 158 Q--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARN 233 (370)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGG
T ss_pred c--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhh
Confidence 4 457899999999999999998754 4899999999999999999999998 9999999999
Q ss_pred EEEeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcH
Q 035992 162 IFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNA 233 (613)
Q Consensus 162 ILl~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~ 233 (613)
||++ .+|.+||+|||++..+... ....+++.|+|||++.+ .|+.++|||||||++|||+| |..||... +.
T Consensus 234 Ill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~-~~ 311 (370)
T 2psq_A 234 VLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PV 311 (370)
T ss_dssp EEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CG
T ss_pred EEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-CH
Confidence 9998 6789999999999755432 12334568999997754 59999999999999999999 99999664 45
Q ss_pred HHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 234 AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 234 ~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..++..+..+..+ ..+..++..+.++|.+||. +|.+||++.|++++
T Consensus 312 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 312 EELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5666677766543 3455678899999999999 99999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=344.65 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=208.4
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSW 96 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~f 96 (613)
+...+.|++.+.||+|+||+||+|.+. .++..||+|+++. .......+.+.+|+.+++.++||||++++++|
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE---NASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCT---TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccC---CCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 334566789999999999999999883 4568999887653 23456778899999999999999999999987
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHhhhhhcCCCCE
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKHKH------------------------VDLRALKKWSRQILEGLSYLHSHDPPV 152 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~~~------------------------lse~~i~~i~~QIl~gL~yLHs~~~~I 152 (613)
.. ...+++||||+.+|+|.+++...+. +++..++.++.||+.||.|||+++ |
T Consensus 96 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i 171 (314)
T 2ivs_A 96 SQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--L 171 (314)
T ss_dssp CS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred ec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--C
Confidence 54 4568999999999999999987643 899999999999999999999998 9
Q ss_pred EecCCCCCcEEEeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cC
Q 035992 153 IHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FE 224 (613)
Q Consensus 153 IHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~ 224 (613)
+||||||+|||++ .++.+||+|||++...... ....+++.|+|||++.+ .++.++||||||+++|+|++ |.
T Consensus 172 vH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 172 VHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp ECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred cccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999998 6789999999998765332 12344568999997764 58999999999999999999 99
Q ss_pred CCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 225 YPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 225 ~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.||... +...+...+..+..+ ..+..+++.+.++|.+||. +|.+||++.+++++
T Consensus 251 ~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 251 NPYPGI-PPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCC-CHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999664 445566666666433 3455678999999999999 99999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.30 Aligned_cols=242 Identities=19% Similarity=0.352 Sum_probs=201.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCCC-------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEG-------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg-------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
.|++.+.||+|+||+||+|.+..++ ..||+|.++.. .....+.+.+|+.+++.++||||++++++|..
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC- 83 (289)
T ss_dssp GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-
T ss_pred HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-
Confidence 4488899999999999999998887 46998877532 23456788999999999999999999998854
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc--------
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHKH-VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE-------- 170 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~~-lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~-------- 170 (613)
....++||||+.+|+|.+++.+.+. +++..++.++.||+.||.|||+++ |+||||||+|||++. ++.
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~-~~~~~~~~~~~ 159 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIR-EEDRKTGNPPF 159 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEE-CCBGGGTBCCE
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEec-CCcccccccce
Confidence 4567899999999999999988765 999999999999999999999998 999999999999983 444
Q ss_pred EEEeccchhHHHhhhccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc
Q 035992 171 VKIGDLGLAAILAQARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248 (613)
Q Consensus 171 VKL~DFGla~~l~~~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~ 248 (613)
+||+|||++..........+++.|+|||++.+ .++.++||||||+++|+|++|..|+....+............ .
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~---~ 236 (289)
T 4fvq_A 160 IKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH---Q 236 (289)
T ss_dssp EEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---C
T ss_pred eeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccC---C
Confidence 99999999976655555567789999998764 489999999999999999996655545555555544444332 2
Q ss_pred ccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 249 l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
++...+..+.+||.+||+ +|.+|||+.++++|
T Consensus 237 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 237 LPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 334457789999999999 99999999999976
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=338.87 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=204.5
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
+.........|++.+.||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.+++.++||||++++++|.
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 89 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-----CCHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence 3333444555688999999999999999776 67789998876322 12356889999999999999999999874
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
. ...+++||||+.+++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 90 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Df 164 (283)
T 3gen_A 90 K--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDF 164 (283)
T ss_dssp S--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECST
T ss_pred c--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccc
Confidence 3 5578999999999999999987 567999999999999999999999998 99999999999998 6789999999
Q ss_pred chhHHHhh-----hccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcc
Q 035992 177 GLAAILAQ-----ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASL 249 (613)
Q Consensus 177 Gla~~l~~-----~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l 249 (613)
|++..... .....+++.|+|||++. ..++.++||||||+++|+|+| |..||... +.......+..+..+ ..
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~ 242 (283)
T 3gen_A 165 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YR 242 (283)
T ss_dssp TGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC-CC
T ss_pred cccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-ChhHHHHHHhcccCC-CC
Confidence 99976532 12334556899999876 458999999999999999998 99999664 455666667666433 33
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+...++.+.++|.+||. +|.+|||+.++++|
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 45678899999999999 99999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.40 Aligned_cols=240 Identities=20% Similarity=0.409 Sum_probs=202.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.++++++||||+++++++.. ...+++|
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLV 83 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSEEEE
T ss_pred ceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-----cCHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCceEEE
Confidence 478899999999999999987 57789988876322 223568899999999999999999998754 4568999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
|||+.+++|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEeccccccccccccc
Confidence 9999999999999764 56999999999999999999999998 99999999999997 567999999999976532
Q ss_pred ---hccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 ---ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.....+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+...+..+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQ 238 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHH
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHH
Confidence 22334556899999876 459999999999999999999 9999965 5556666777766433 345567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcC
Q 035992 260 FIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+|.+||. +|.+||++.++++|
T Consensus 239 li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 239 IMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHHH
Confidence 9999999 99999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=344.55 Aligned_cols=250 Identities=23% Similarity=0.426 Sum_probs=193.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHH-HHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED-LERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~-~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... .... .+.+..+..+++.++||||++++++|.. ...+++
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~l 101 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG---NKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVFI 101 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTS---CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccc---cchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEEE
Confidence 466799999999999999999999999999876432 2233 3444555567888899999999998865 458999
Q ss_pred EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+|||++.....
T Consensus 102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC-----
T ss_pred EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhccC
Confidence 99999 5566666554 57899999999999999999999995 8 99999999999998 668999999999976543
Q ss_pred h---ccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc-ccccc
Q 035992 185 A---RSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL-AKVAD 254 (613)
Q Consensus 185 ~---~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l-~~~~s 254 (613)
. ....+++.|+|||++. ..++.++||||||+++|+|++|..||............+..+..+... ...++
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCC
T ss_pred CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCC
Confidence 2 2345778999999873 348899999999999999999999998877766666666665443221 23468
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
..+.+||.+||. +|.+||++.++++||||+..
T Consensus 258 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 899999999999 99999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.50 Aligned_cols=250 Identities=26% Similarity=0.451 Sum_probs=203.4
Q ss_pred CCCcceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
...++|++.+.||+|+||+||+|. +..+|+.||+|+++... .....+.+.+|+.+++.++||||++++++|..
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 345778999999999999999998 67899999999876432 23445778999999999999999999999887
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 99 TENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
.....+++||||+.+|+|.+++.+ .+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg 171 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFG 171 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCT
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECccc
Confidence 666779999999999999999954 467999999999999999999999998 99999999999998 56899999999
Q ss_pred hhHHHhhh-------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCC--------------CCcHHH
Q 035992 178 LAAILAQA-------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVE--------------CTNAAQ 235 (613)
Q Consensus 178 la~~l~~~-------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~--------------~~~~~~ 235 (613)
++...... ....++..|+|||++.+ .++.++||||||+++|+|++|..||.. ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 99765432 13345667999998754 588999999999999999999987632 122333
Q ss_pred HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 236 i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+...+..+.. ...+..+++.+.+||.+||. +|.+|||+.++++
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 4444444433 23455678999999999999 9999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.42 Aligned_cols=249 Identities=27% Similarity=0.406 Sum_probs=208.8
Q ss_pred CCCCcceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNS 95 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (613)
-+.++| ++.+.||+|+||+||+|.+ ..+++.||+|+++.. ......+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 20 FPRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp CCGGGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cChhhh-hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 344555 8889999999999999985 567889998887632 3445678899999999999 99999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCC
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKHK------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL 157 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~~------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDL 157 (613)
|.. ...+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||
T Consensus 96 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl 171 (313)
T 1t46_A 96 CTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDL 171 (313)
T ss_dssp ECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCC
T ss_pred Eec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCC
Confidence 854 456899999999999999998764 4899999999999999999999998 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCC
Q 035992 158 KCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVE 229 (613)
Q Consensus 158 Kp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~ 229 (613)
||+|||++ .++.+||+|||++....... ...+++.|+|||++. ..++.++||||||+++|+|+| |..||..
T Consensus 172 kp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 172 AARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp SGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999998 57899999999997664322 233456899999775 458999999999999999999 9999987
Q ss_pred CCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 230 CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 230 ~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
......+...+..+..+ ..+...+..+.++|.+||. +|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 251 MPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 66666666666655433 3345678899999999999 99999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.25 Aligned_cols=242 Identities=24% Similarity=0.401 Sum_probs=201.8
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-|++.+.||+|+||+||+|.+. ++..||+|+++... ...+.+.+|+.+++.++||||++++++|. ....++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~ 79 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-----MSEDEFFQEAQTMMKLSHPKLVKFYGVCS--KEYPIY 79 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-----BCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEE
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-----CcHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCceE
Confidence 34588899999999999999776 67789999876432 22356889999999999999999999874 355789
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 106 FITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+||||+.+++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceecch
Confidence 9999999999999998764 5999999999999999999999998 99999999999998 678999999999875543
Q ss_pred hc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 185 AR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 185 ~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.. ...+++.|+|||++.. .++.++||||||+++|+|++ |..||.... .......+..+..+ ..+...++.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l 234 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKVSQGHRL-YRPHLASDTI 234 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHTTCCC-CCCTTSCHHH
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-hHHHHHHHHcCCCC-CCCCcChHHH
Confidence 21 2334557999998765 58999999999999999999 999996644 44555556655432 3345578899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.++|.+||+ +|.+|||+.+++++
T Consensus 235 ~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 235 YQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999 99999999999976
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=344.27 Aligned_cols=255 Identities=23% Similarity=0.393 Sum_probs=206.2
Q ss_pred CcccccCCCCcceeEeeeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCccee
Q 035992 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKF 92 (613)
Q Consensus 16 ~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl 92 (613)
.+...++|....|++.++||+|+||+||+|.+..++ ..||+|.++ ........+.+.+|+.++++++||||+++
T Consensus 15 ~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 91 (298)
T 3f66_A 15 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVLSL 91 (298)
T ss_dssp HGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEET---TCCSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred hhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecc---cCCCHHHHHHHHHHHHHHHhCCCCCEeee
Confidence 345667888888999999999999999999876544 357766654 33456677889999999999999999999
Q ss_pred eeeeecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcE
Q 035992 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171 (613)
Q Consensus 93 ~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~V 171 (613)
++++... +...++||||+.+|+|.+++.+. ..+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+
T Consensus 92 ~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~ 167 (298)
T 3f66_A 92 LGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTV 167 (298)
T ss_dssp CEEECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCE
T ss_pred eeEEEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCE
Confidence 9986543 45688999999999999999864 56899999999999999999999998 99999999999998 67899
Q ss_pred EEeccchhHHHhhh--------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhc-CCCCCCCCcHHHHHHHHH
Q 035992 172 KIGDLGLAAILAQA--------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVT 241 (613)
Q Consensus 172 KL~DFGla~~l~~~--------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG-~~Pf~~~~~~~~i~~~I~ 241 (613)
||+|||++...... ....+++.|+|||.+.+ .++.++||||||+++|+|++| .+||.. .+...+...+.
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~ 246 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLL 246 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHH
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHh
Confidence 99999999754321 12345568999998764 589999999999999999995 555544 44444555555
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+ ..+...+..+.++|.+||. +|.+|||+.++++
T Consensus 247 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 247 QGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 55433 3345678899999999999 9999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=349.41 Aligned_cols=253 Identities=23% Similarity=0.419 Sum_probs=187.5
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHH-HHHhCCCCCcceeeeeeecCCCCEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH-LLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~-iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
.-|++.+.||+|+||+||+|.++.+|+.||+|+++.. ........+..|+. +++.++||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~ 96 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDC 96 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECC---CCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecc---cCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCce
Confidence 3347789999999999999999999999999988743 23445556666666 7777899999999998865 4579
Q ss_pred EEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHhhhhhcC-CCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 105 NFITEIFTSGTLRQYRKK-----HKHVDLRALKKWSRQILEGLSYLHSH-DPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~-----~~~lse~~i~~i~~QIl~gL~yLHs~-~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
++||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ + |+||||||+|||++ .++.+||+|||+
T Consensus 97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~ 172 (327)
T 3aln_A 97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGI 172 (327)
T ss_dssp EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSS
T ss_pred EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCC
Confidence 999999986 78777663 57899999999999999999999998 8 99999999999998 678999999999
Q ss_pred hHHHhhh---ccCcccccccCccccc-----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC---
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYE-----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA--- 247 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~-----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~--- 247 (613)
+...... ....++..|+|||++. ..++.++||||||+++|+|++|..||............+..+..+.
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 8765432 2235778999999873 3489999999999999999999999976544333333333332221
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.....++..+.+||.+||. +|.+||++.++++||||....
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 1223578899999999999 999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.78 Aligned_cols=244 Identities=24% Similarity=0.419 Sum_probs=193.9
Q ss_pred cceeEeeeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
..|++.+.||+|+||+||+|.+..+ +..||+|.++ ........+.+.+|+.+++.++||||+++++++. ..
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~---~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~ 88 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---EN 88 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT---TTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SS
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecc---ccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc---cC
Confidence 3448889999999999999998754 4568876654 2334566788999999999999999999999873 34
Q ss_pred EEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECccccccc
Confidence 5789999999999999998764 6999999999999999999999998 99999999999998 568999999999987
Q ss_pred Hhhhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 182 LAQAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 182 l~~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
..... ...+++.|+|||++.. .++.++||||||+++|||++ |..||..... ..+...+..+..+ .++..++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-~~~~~~i~~~~~~-~~~~~~~ 243 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERL-PMPPNCP 243 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCCC-CCCTTCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-HHHHHHHHcCCCC-CCCCCCC
Confidence 64422 2234568999998764 58999999999999999997 9999976544 4455566655433 3455678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+.++|.+||. +|.+|||+.+++++
T Consensus 244 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 244 PTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999 99999999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=348.06 Aligned_cols=246 Identities=27% Similarity=0.401 Sum_probs=204.2
Q ss_pred ceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTE 100 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~ 100 (613)
-|++.+.||+|+||+||+|.+ ..++..||+|+++... .....+.+.+|+.+++++ +||||++++++|..
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 348889999999999999997 3467789999876322 334567899999999999 89999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCC
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK-----------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDL 157 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~-----------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDL 157 (613)
...+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Di 198 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDL 198 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTC
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCC
Confidence 456899999999999999998753 3799999999999999999999998 999999
Q ss_pred CCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCC
Q 035992 158 KCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVE 229 (613)
Q Consensus 158 Kp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~ 229 (613)
||+|||++ .++.+||+|||++....... ...+++.|+|||++. ..++.++||||||+++|+|+| |..||..
T Consensus 199 kp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 199 AARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp SGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 99999998 66899999999997664322 223456899999775 458999999999999999998 9999987
Q ss_pred CCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCC
Q 035992 230 CTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDP 281 (613)
Q Consensus 230 ~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HP 281 (613)
......+...+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++|.
T Consensus 278 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 76666666666665433 3455678999999999999 999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=347.75 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=208.4
Q ss_pred CCCcceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
...+.|++.+.||+|+||+||+|. +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 344566999999999999999998 5778999999887632 35667789999999999999999999999887
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
.....+++||||+.+++|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg 172 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFG 172 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGG
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccc
Confidence 7778899999999999999999874 56999999999999999999999998 99999999999998 56899999999
Q ss_pred hhHHHhhh-------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc--------------HHH
Q 035992 178 LAAILAQA-------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN--------------AAQ 235 (613)
Q Consensus 178 la~~l~~~-------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--------------~~~ 235 (613)
++...... ....++..|+|||++.+ .++.++||||||+++|+|++|..||..... ...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 173 LAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp GCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred cceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 99765432 12345667999998765 489999999999999999999999854221 123
Q ss_pred HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 236 i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+...+..+.. ...+..+++.+.+||.+||. +|.+|||+.+++++
T Consensus 253 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 253 LLELLEEGQR-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcccC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3344444433 33456678999999999999 99999999999654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=345.70 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=209.6
Q ss_pred CCCCcceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNS 95 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (613)
......|++.+.||+|+||+||+|.+ ..+++.||+|+++.. ......+.+.+|+.+++.+ +||||++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 33344458999999999999999985 467799998887632 3455667899999999999 79999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCC
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKHKH----------------VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKC 159 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~----------------lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp 159 (613)
|... +..+++||||+.+|+|.+++..... +++..++.++.||+.||.|||+++ |+||||||
T Consensus 100 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp 176 (316)
T 2xir_A 100 CTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAA 176 (316)
T ss_dssp ECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred EecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCcc
Confidence 7543 4568999999999999999987654 899999999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCC
Q 035992 160 DNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECT 231 (613)
Q Consensus 160 ~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~ 231 (613)
+|||++ ..+.+||+|||++..+.... ...+++.|+|||++.+ .++.++||||||+++|+|+| |..||....
T Consensus 177 ~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 177 RNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999998 56899999999997654321 2345568999998754 58999999999999999998 999998776
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
....+...+..+..+ ..+...++.+.++|.+||. +|.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 666666666666433 3445678999999999999 99999999999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.59 Aligned_cols=244 Identities=28% Similarity=0.467 Sum_probs=198.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
...|++.+.||+|+||+||+|.+. ..||+|+++... ......+.+.+|+.+++.++||||+++++++. ...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~ 94 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQL 94 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCcc
Confidence 334488999999999999999754 359988876432 34567788999999999999999999999642 3458
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++||||+.+++|.+++... ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccceeccccc
Confidence 8999999999999998644 57999999999999999999999998 99999999999998 56899999999997654
Q ss_pred hh------ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcc---c
Q 035992 184 QA------RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL---A 250 (613)
Q Consensus 184 ~~------~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l---~ 250 (613)
.. ....+++.|+|||++. ..++.++||||||+++|+|++|..||....+...+...+..+..+..+ .
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVR 251 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcc
Confidence 21 2345778999999874 348889999999999999999999998888888888888776554433 3
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+++.+.+||.+||. +|.+|||+.++++
T Consensus 252 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 252 SNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4567899999999999 9999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.54 Aligned_cols=249 Identities=21% Similarity=0.337 Sum_probs=207.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCC--CCCcceeeeeeecCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLK--HKNIIKFYNSWVDTEN 101 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~fv~~~~ 101 (613)
.-|++.++||+|+||+||+|.+..+|+.||+|+++....... ....+.+.+|+.+++.+. ||||++++++|.. .
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~--~ 120 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER--P 120 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--S
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--C
Confidence 334889999999999999999999999999999875432210 012345678999999996 5999999998854 4
Q ss_pred CEEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTS-GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~g-GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++|||++.+ ++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+.+||+|||++.
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 679999999986 899999999899999999999999999999999998 99999999999998667899999999987
Q ss_pred HHhhh--ccCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 181 ILAQA--RSAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 181 ~l~~~--~~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
..... ....+++.|+|||++.. . ++.++||||||+++|||++|..||... .. +..+. ..++..++..
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~~--~~~~~~~~~~ 269 (320)
T 3a99_A 199 LLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRGQ--VFFRQRVSSE 269 (320)
T ss_dssp ECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHCC--CCCSSCCCHH
T ss_pred ccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh---hh----hhccc--ccccccCCHH
Confidence 65432 23457889999998764 3 468899999999999999999999542 11 22221 2234567889
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+.+||.+||. +|.+|||+.++++||||+...
T Consensus 270 ~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 270 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 9999999999 999999999999999999763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=342.52 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=200.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+++.||+|+++... .......+.+.+|+.+++.++||||+++++++.. ...++++
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 112 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETL-SSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQLYVD 112 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGG-GGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccc-ccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeEEEE
Confidence 478899999999999999999999999998876432 2345566889999999999999999999998865 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
|||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC---------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCcccccccc
Confidence 999999999999999889999999999999999999999998 99999999999998 5689999999998765432
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC-CCcccccccHHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADNGVRAF 260 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~-p~~l~~~~s~~l~~l 260 (613)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .+...+...+..... +...+..++..+.++
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 268 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGIPVAFDAV 268 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS-CHHHHHHHHHHSCCCCGGGTSTTCCTHHHHH
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC-chHHHHHHHhccCCCCccccCCCCCHHHHHH
Confidence 23457789999998764 589999999999999999999999965 334445455554432 233455678899999
Q ss_pred HHHHhh-cccCCC-CHHHHhc
Q 035992 261 IEKCIA-EVSERL-PAKELLG 279 (613)
Q Consensus 261 I~~cL~-dP~~Rp-ta~eLL~ 279 (613)
|.+||. +|.+|| ++++++.
T Consensus 269 i~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 269 IARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHhccCCHHHHHHhHHHHHH
Confidence 999999 999999 7888875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=338.58 Aligned_cols=247 Identities=30% Similarity=0.513 Sum_probs=200.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++... .......+.+.+|+.+++.++||||++++++|.. ...+++|
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 110 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFD-LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIV 110 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTS-SCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhh-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--CCcEEEE
Confidence 588899999999999999999999999999887432 2345677889999999999999999999998865 4589999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceeeec
Confidence 999999999998864 467999999999999999999999998 99999999999998 67899999999987664
Q ss_pred hh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC-cHHHHHHHHHcCCCCCcccccccHHH
Q 035992 184 QA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT-NAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 184 ~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~-~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
.. ....++..|+|||++.+ .++.++||||||+++|+|++|..||.... +...+...+..+..+......++..+
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 267 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHH
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHH
Confidence 32 23356778999998764 58999999999999999999999996533 45566667777665555556678999
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.++|.+||. +|.+||++.+++++
T Consensus 268 ~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 268 RQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999 99999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.47 Aligned_cols=248 Identities=24% Similarity=0.430 Sum_probs=199.7
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEe-eccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~-~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
...+| ++.++||+|+||+||+|.+..+++.||+|++.+ ..........+.+.+|+.+++.++||||++++++|...
T Consensus 13 ~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTE-EEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHc-eEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 34455 888999999999999999999998876664322 22223344567889999999999999999999988643
Q ss_pred CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++++|+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC--
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCccee
Confidence 378999999999999998874 57999999999999999999999998 99999999999998 56899999999998
Q ss_pred HHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 181 ILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 181 ~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
...... ...+++.|+|||++.+ .|+.++|||||||++|+|++ |..||... +...+...+..+..+ ..+..
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~ 243 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL-PQPPI 243 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTT
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcc
Confidence 764321 2234568999997764 58999999999999999999 99999664 444555566655433 34556
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+..+.+||.+||. +|.+||++.|+++
T Consensus 244 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 244 CTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78899999999999 9999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=343.72 Aligned_cols=247 Identities=20% Similarity=0.278 Sum_probs=198.9
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC--CCCE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT--ENEH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~--~~~~ 103 (613)
..|++.+.||+|+||+||+|.+..+|+.||+|++.. ......+.+.+|+.+++.++||||+++++++... ....
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC----HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE----SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec----CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 344888999999999999999999999999998864 2356678899999999999999999999988643 3457
Q ss_pred EEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 104 INFITEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+++||||+.+|+|.+++.+ ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcc
Confidence 8999999999999999876 467999999999999999999999998 99999999999997 5689999999986
Q ss_pred HHHhh-------------hccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCc-HHHHHHHHH
Q 035992 180 AILAQ-------------ARSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTN-AAQIYKKVT 241 (613)
Q Consensus 180 ~~l~~-------------~~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~-~~~i~~~I~ 241 (613)
..... .....+++.|+|||++.. .++.++||||||+++|+|++|..||..... ...+...+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 261 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh
Confidence 54321 112345788999998753 378999999999999999999999943110 011222223
Q ss_pred cCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 242 ~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
... ........+..+.++|.+||+ +|.+||++.+++++
T Consensus 262 ~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 262 NQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 322 222234568899999999999 99999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=348.88 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=200.1
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhC----CCCCcceeeeeeec
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTL----KHKNIIKFYNSWVD 98 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L----~HpNIVkl~~~fv~ 98 (613)
++| ++.+.||+|+||+||+|.+..+|+.||+|+++....... ......+.+|+.+++++ +||||++++++|..
T Consensus 31 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 31 AEY-RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp --C-EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hce-EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 444 888999999999999999999999999998865432211 12334566799999998 89999999998754
Q ss_pred CCCCEEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 99 TENEHINFITEI-FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 99 ~~~~~l~lV~E~-~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
....++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+||+++..++.+||+|||
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcc
Confidence 4568899999 789999999999889999999999999999999999998 99999999999998567899999999
Q ss_pred hhHHHhhh--ccCcccccccCcccccc-cc-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 178 LAAILAQA--RSAHSVIEFMAPELYEE-EY-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 178 la~~l~~~--~~~~gt~~YmAPEvl~~-~y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
++...... ....++..|+|||++.. .+ +.++||||||+++|+|++|..||... ..+ ... ...++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~----~~~--~~~~~~~~ 256 (312)
T 2iwi_A 186 SGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEI----LEA--ELHFPAHV 256 (312)
T ss_dssp SCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHH----HHT--CCCCCTTS
T ss_pred hhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHH----hhh--ccCCcccC
Confidence 98765432 23456789999998764 34 45899999999999999999999542 222 222 12344567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
+..+++||.+||. +|.+|||+.|+++||||+...
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 8899999999999 999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=359.54 Aligned_cols=250 Identities=21% Similarity=0.353 Sum_probs=204.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+..|++.++||+|+||+||+|.+..+|+.||+|+++.... ....+.+.+|+.+++.++||||+++++++.......+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 4456899999999999999999999999999998864332 2335677899999999999999999999887666689
Q ss_pred EEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEE----eCCCCcEEEeccc
Q 035992 105 NFITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV----NGNQGEVKIGDLG 177 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl----~~~~g~VKL~DFG 177 (613)
++||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||+ + ..+.+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecCC
Confidence 99999999999999997653 3999999999999999999999998 9999999999998 4 45679999999
Q ss_pred hhHHHhhh---ccCcccccccCccccc---------cccCccchhhhhhHHHHHHHhcCCCCCCCC---cHHHHHHHHHc
Q 035992 178 LAAILAQA---RSAHSVIEFMAPELYE---------EEYNELVDIYAFGMCLLELVTFEYPYVECT---NAAQIYKKVTS 242 (613)
Q Consensus 178 la~~l~~~---~~~~gt~~YmAPEvl~---------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~---~~~~i~~~I~~ 242 (613)
++...... ....+++.|+|||++. ..|+.++|||||||++|||++|..||.... ....+...+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99765432 2345788999999875 358889999999999999999999996422 22334444444
Q ss_pred CCCCC-----------------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 243 GIKPA-----------------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 243 g~~p~-----------------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+..+. .+....+..+.++|.+||. ||.+||++.+++++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 43221 1223456788999999999 99999999998653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=343.14 Aligned_cols=247 Identities=28% Similarity=0.449 Sum_probs=205.6
Q ss_pred CCcceeEeeeecccCceEEEEEEEc-------CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeee
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDE-------LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNS 95 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~-------~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~ 95 (613)
....|++.+.||+|+||+||+|.+. .++..||+|+++. .......+.+.+|+.+++.+ +||||++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCT---TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeecc---CCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 3445588999999999999999976 4678899887653 23456678899999999999 89999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCC
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKC 159 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp 159 (613)
|.. ...+++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||
T Consensus 110 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp 185 (334)
T 2pvf_A 110 CTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAA 185 (334)
T ss_dssp ECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSG
T ss_pred Ecc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCcc
Confidence 754 457899999999999999998754 3899999999999999999999998 99999999
Q ss_pred CcEEEeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCC
Q 035992 160 DNIFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECT 231 (613)
Q Consensus 160 ~NILl~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~ 231 (613)
+|||++ .++.+||+|||++...... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .
T Consensus 186 ~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~ 263 (334)
T 2pvf_A 186 RNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-I 263 (334)
T ss_dssp GGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT-C
T ss_pred ceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc-C
Confidence 999998 6789999999999765432 12234568999997754 58999999999999999999 9999966 4
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+...+...+..+..+ ..+..++..+.++|.+||. +|.+||++.+++++
T Consensus 264 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 566667777766533 3445678899999999999 99999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=336.49 Aligned_cols=251 Identities=20% Similarity=0.350 Sum_probs=206.5
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCc---EEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGI---EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~---~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
++.....++..++||+|+||+||+|.+..++. .||+|.++ ........+.+.+|+.+++.++||||++++++|.
T Consensus 16 i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~---~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 92 (298)
T 3pls_A 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNHPNVLALIGIML 92 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEET---TCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred ccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecc---ccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 44444445667999999999999999766555 78877664 3345567788999999999999999999999886
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
.. +...+++|||+.+|+|.+++.. .+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 93 ~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Df 168 (298)
T 3pls_A 93 PP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADF 168 (298)
T ss_dssp CS-SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCT
T ss_pred cC-CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcC
Confidence 53 3445899999999999999987 467999999999999999999999998 99999999999998 6789999999
Q ss_pred chhHHHhhh--------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 177 GLAAILAQA--------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 177 Gla~~l~~~--------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
|++...... ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||....+...+...+..+..+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~- 247 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL- 247 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-
Confidence 999754321 12345678999998765 58999999999999999999776665666666676677666533
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+...+..+.++|.+||. +|.+|||+.++++
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 3455678899999999999 9999999999886
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=336.93 Aligned_cols=245 Identities=25% Similarity=0.397 Sum_probs=207.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
....-|++.+.||+|+||+||+|.+..++..||+|.++. .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 82 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EP 82 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS-----CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc-----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CC
Confidence 344556889999999999999999999999999998763 33456788999999999999999999998754 55
Q ss_pred EEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 103 HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
.+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+||+++ .++.+||+|||++.
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSR 159 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGG
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCccce
Confidence 789999999999999999874 45999999999999999999999998 99999999999997 56799999999998
Q ss_pred HHhhhc-----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 181 ILAQAR-----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 181 ~l~~~~-----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
...... ...+++.|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+.....+ ..+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~ 237 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGC 237 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTC
T ss_pred eccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCC
Confidence 664322 223456799999876 458999999999999999999 9999965 4445556666655433 344567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++.+.+||.+||. +|.+|||+.++++
T Consensus 238 ~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 238 PEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 8999999999999 9999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.06 Aligned_cols=247 Identities=19% Similarity=0.333 Sum_probs=206.6
Q ss_pred CCcceeEeeeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
.++|+...+.||+|+||+||+|.+. .++..||+|+++.. ......+.+.+|+.+++.++||||+++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ---A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE---S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec---C
Confidence 4567666679999999999999854 57888998887642 34567788999999999999999999999873 3
Q ss_pred CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~ 158 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSK 158 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECccccee
Confidence 4589999999999999998754 56999999999999999999999998 99999999999998 56899999999997
Q ss_pred HHhhhc-------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 181 ILAQAR-------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 181 ~l~~~~-------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
...... ...+++.|+|||++. ..++.++||||||+++|+|++ |..||..... ..+...+..+..+ .++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i~~~~~~-~~~~ 236 (287)
T 1u59_A 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRM-ECPP 236 (287)
T ss_dssp ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHTTCCC-CCCT
T ss_pred eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHhcCCcC-CCCC
Confidence 654321 223467899999876 458999999999999999998 9999976544 4555666666543 3456
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcCC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGDP 281 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HP 281 (613)
.+++.+.++|.+||. +|.+||++.+++++.
T Consensus 237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 678999999999999 999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.29 Aligned_cols=244 Identities=20% Similarity=0.338 Sum_probs=203.2
Q ss_pred CcceeEee-eecccCceEEEEEE--EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 25 ARYGRYKE-VLGRGAFKKVYRAF--DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 25 gRy~r~~e-~LG~GafGtVYka~--~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
.+| ++.+ .||+|+||+||+|. +..+++.||+|+++... ......+.+.+|+.+++.++||||+++++++. .
T Consensus 16 ~~y-~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~ 89 (291)
T 1xbb_A 16 KLL-TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICE---A 89 (291)
T ss_dssp GGE-EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---S
T ss_pred hhh-hhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---C
Confidence 455 5655 99999999999994 46678999999876432 23455778999999999999999999999872 3
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKA 166 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEE
T ss_pred CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCccee
Confidence 468899999999999999999989999999999999999999999998 99999999999998 568999999999876
Q ss_pred Hhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 182 LAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 182 l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
..... ...+++.|+|||++.. .++.++||||||+++|+|++ |..||.. .....+...+..+..+ .++..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~ 244 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAG 244 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTT
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCC
Confidence 54321 1234568999998764 58999999999999999999 9999976 4556666677766543 34556
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++..+.++|.+||. +|.+||++.++++
T Consensus 245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 245 CPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78999999999999 9999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=343.56 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=187.3
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeec---
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVD--- 98 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~--- 98 (613)
..+.-|++.++||+|+||+||+|.+..+|+.||+|.+... .....+.+.+|+.+++++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 3344558999999999999999999999999999987542 3566678899999999996 9999999998752
Q ss_pred ---CCCCEEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 99 ---TENEHINFITEIFTSGTLRQYRKK---HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 99 ---~~~~~l~lV~E~~~gGsL~~~l~~---~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
.....++++|||+. |+|.+++.. .+.+++..++.++.||+.||.|||+++++|+||||||+|||++ .++.+|
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~k 178 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIK 178 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEE
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEE
Confidence 34456899999996 689888765 5679999999999999999999999887799999999999998 668999
Q ss_pred EeccchhHHHhhh----------------ccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCc
Q 035992 173 IGDLGLAAILAQA----------------RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTN 232 (613)
Q Consensus 173 L~DFGla~~l~~~----------------~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~ 232 (613)
|+|||++...... ....+++.|+|||++. ..++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999998754321 1334778899999873 3488999999999999999999999965332
Q ss_pred HHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCC
Q 035992 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDP 281 (613)
Q Consensus 233 ~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HP 281 (613)
. . +..+..........+..+.+||.+||+ +|.+||++.|+++|-
T Consensus 259 ~-~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 259 L-R----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp ------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred H-H----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 2 1 122222222344556779999999999 999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=353.90 Aligned_cols=244 Identities=22% Similarity=0.361 Sum_probs=205.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
..+++.+.||+|+||+||+|.+..+|..||+|.++. .......+.+.+|+.+|+.++||||+++++++.. ...++
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~ 188 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE---TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIY 188 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT---TSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS--SSSCE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc---cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec--CCCcE
Confidence 345888999999999999999999999999887653 2234566778999999999999999999998754 45689
Q ss_pred EEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 106 FITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+||||+.+|+|.+++.+.+ .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTT
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCC
Confidence 9999999999999998654 6999999999999999999999998 99999999999998 668999999999875432
Q ss_pred hc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 185 AR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 185 ~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.. ...+++.|+|||++. +.|+.++|||||||++|||++ |..||.... ..++...+..+..+ ..+..++..
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 343 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-NQQTREFVEKGGRL-PCPELCPDA 343 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC-HHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHH
Confidence 21 122355799999876 459999999999999999998 999997644 45555666665433 345567889
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhc
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+.++|.+||. +|.+|||+.++++
T Consensus 344 l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 344 VFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999 9999999999975
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=336.74 Aligned_cols=239 Identities=28% Similarity=0.433 Sum_probs=190.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh--CCCCCcceeeeeeecC--CCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT--LKHKNIIKFYNSWVDT--ENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~--L~HpNIVkl~~~fv~~--~~~~ 103 (613)
|++.+.||+|+||+||+|.+ +|+.||+|++.. .....+..|.+++.. ++||||+++++++... ....
T Consensus 10 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-------GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred EEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-------ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 48889999999999999977 699999988652 233455667777766 7999999999987643 2356
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhh--------cCCCCEEecCCCCCcEEEeCCCCcEEEec
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH--------SHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLH--------s~~~~IIHrDLKp~NILl~~~~g~VKL~D 175 (613)
+++||||+.+|+|.+++++ ..+++..++.++.||+.||+||| +++ |+||||||+|||++ .++.+||+|
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~D 156 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCCIAD 156 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECC
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCEEEee
Confidence 8999999999999999954 57999999999999999999999 777 99999999999998 668999999
Q ss_pred cchhHHHhhhc--------cCcccccccCcccccc-------ccCccchhhhhhHHHHHHHhc----------CCCCCCC
Q 035992 176 LGLAAILAQAR--------SAHSVIEFMAPELYEE-------EYNELVDIYAFGMCLLELVTF----------EYPYVEC 230 (613)
Q Consensus 176 FGla~~l~~~~--------~~~gt~~YmAPEvl~~-------~ys~ksDIWSLGviL~EmltG----------~~Pf~~~ 230 (613)
||++....... ...+++.|+|||++.+ .++.++|||||||++|||+|| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99986543321 2367889999998764 355799999999999999999 8888553
Q ss_pred C----cHHHHHHHHHcCCCCCccc-----ccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 231 T----NAAQIYKKVTSGIKPASLA-----KVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 231 ~----~~~~i~~~I~~g~~p~~l~-----~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
. ....+...+........++ ...+..+.+||.+||+ +|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2 2233333333222222222 2345789999999999 9999999999985
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=351.26 Aligned_cols=244 Identities=28% Similarity=0.434 Sum_probs=206.5
Q ss_pred ceeEeeeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeec
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVD 98 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~ 98 (613)
.+++.+.||+|+||+||+|.+.. .+..||+|+++.. ........+.+|+.+++.+ +||||++++++|..
T Consensus 70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 34888999999999999999754 3367998877532 3456778899999999999 99999999998854
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcE
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI 162 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NI 162 (613)
...+++||||+.+|+|.+++...+ .+++..++.|+.||+.||.|||+++ |+||||||+||
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 222 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNV 222 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceE
Confidence 456899999999999999998764 4999999999999999999999998 99999999999
Q ss_pred EEeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHH
Q 035992 163 FVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAA 234 (613)
Q Consensus 163 Ll~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~ 234 (613)
|++ .++.+||+|||++...... ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.. .+..
T Consensus 223 ll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~ 300 (382)
T 3tt0_A 223 LVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVE 300 (382)
T ss_dssp EEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHH
T ss_pred EEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHH
Confidence 998 5689999999999765432 22345678999997765 58999999999999999999 9999965 5566
Q ss_pred HHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 235 QIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 235 ~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+...+..+..+ ..+..++..+.+||.+||+ +|.+|||+.+++++
T Consensus 301 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 301 ELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 777777776544 3345678999999999999 99999999999975
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=345.07 Aligned_cols=240 Identities=17% Similarity=0.209 Sum_probs=197.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l~ 105 (613)
-|++.+.||+|+||+||+|.+..+|+.||+|++..... .+.+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 81 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR------APQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNA 81 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS------SCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEE
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc------hHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccE
Confidence 34888999999999999999999999999998764321 23578899999999 99999999998765 56899
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc-----EEEeccchh
Q 035992 106 FITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE-----VKIGDLGLA 179 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~-----VKL~DFGla 179 (613)
+||||+ +++|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+. +||+|||++
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCCTTC
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEcccc
Confidence 999999 99999999874 68999999999999999999999998 99999999999997 4455 999999999
Q ss_pred HHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCC--CcHHHHHHHHHcCCC
Q 035992 180 AILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVEC--TNAAQIYKKVTSGIK 245 (613)
Q Consensus 180 ~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~--~~~~~i~~~I~~g~~ 245 (613)
..+... ....+++.|+|||++.+ .++.++|||||||++|||++|..||... ......+..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 765322 24467889999998765 4899999999999999999999999764 334455555543322
Q ss_pred CCc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 246 PAS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 246 p~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+.. +....+ .+.++|.+||. +|.+||++.+|++
T Consensus 238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 111 112233 89999999999 9999999888765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.64 Aligned_cols=240 Identities=28% Similarity=0.493 Sum_probs=203.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec---------
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD--------- 98 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~--------- 98 (613)
|++.+.||+|+||+||+|.+..+|+.||+|.++... +.+.+|+.+++.++||||++++++|..
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp EEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 478899999999999999999999999999887432 246789999999999999999998753
Q ss_pred -----CCCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcE
Q 035992 99 -----TENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEV 171 (613)
Q Consensus 99 -----~~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~V 171 (613)
.....+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCE
Confidence 2245689999999999999999764 67999999999999999999999998 99999999999998 56899
Q ss_pred EEeccchhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC
Q 035992 172 KIGDLGLAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247 (613)
Q Consensus 172 KL~DFGla~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~ 247 (613)
||+|||++...... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.. .......+..+..
T Consensus 162 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~~-- 236 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGII-- 236 (284)
T ss_dssp EECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTCC--
T ss_pred EECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhcccc--
Confidence 99999998765432 23457789999998765 489999999999999999999999843 3344555555433
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
+..++..++++|.+||. +|.+|||+.|+++|.+.-.
T Consensus 237 --~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 237 --SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 34567889999999999 9999999999999977643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=334.22 Aligned_cols=242 Identities=15% Similarity=0.216 Sum_probs=199.3
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l 104 (613)
..|++.+.||+|+||+||+|.+..+|+.||+|++.... ..+.+.+|+.+++.+ +|+||+++++++.. ....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~ 81 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHN 81 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC------ccHHHHHHHHHHHHHhcCCCCCeEEeecCC--Ccee
Confidence 33488899999999999999999999999999876432 223577899999999 79999999998743 5689
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc-----EEEeccch
Q 035992 105 NFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE-----VKIGDLGL 178 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~-----VKL~DFGl 178 (613)
++||||+ +++|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ ..+. +||+|||+
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCCTT
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEECcc
Confidence 9999999 999999998764 5999999999999999999999998 99999999999997 3344 99999999
Q ss_pred hHHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcCC
Q 035992 179 AAILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSGI 244 (613)
Q Consensus 179 a~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g~ 244 (613)
+...... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.... .....+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 9765432 23357789999998765 58999999999999999999999997643 3444444444332
Q ss_pred C---CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 245 K---PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 245 ~---p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
. ...+...+++.+.++|.+||. +|.+||++.+|++
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1 122233568899999999999 9999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=343.22 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=205.6
Q ss_pred CCCcceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
..+||+++.+.||+|+||+||+|. +..+|+.||+|+++.. ......+.+.+|+.+++.++||||++++++|..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence 357999999999999999998774 4568899999887632 345667889999999999999999999999987
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
.....+++||||+.+|+|.+++.+.+ +++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGL 180 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGGSC-CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGG
T ss_pred CCCceEEEEEecccCCcHHHHHhhCC-CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCccc
Confidence 76778999999999999999997754 999999999999999999999998 99999999999998 568999999999
Q ss_pred hHHHhhh-------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH--------------HHH
Q 035992 179 AAILAQA-------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA--------------AQI 236 (613)
Q Consensus 179 a~~l~~~-------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~--------------~~i 236 (613)
+...... ....++..|+|||++.+ .++.++||||||+++|+|++|..||...... ..+
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 260 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence 9765432 12345667999998765 5889999999999999999999999642211 112
Q ss_pred HHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 237 YKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 237 ~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
...+..+. ....+..++..+.+||.+||. +|.+|||+.++++
T Consensus 261 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 261 TELLERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 23333333 334456678999999999999 9999999999984
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=352.08 Aligned_cols=261 Identities=16% Similarity=0.185 Sum_probs=197.6
Q ss_pred CCcccccCCCCcceeEeeeecccCceEEEEEEEcC---CCcEEEEEEEEeeccccCh--H-----HHHHHHHHHHHHHhC
Q 035992 15 DAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVIDLLRNS--E-----DLERLYSEVHLLKTL 84 (613)
Q Consensus 15 ~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~---tg~~VAiK~vk~~~~~~~~--~-----~~~~l~~Ei~iLk~L 84 (613)
....+..+..+.-|++.+.||+|+||+||+|.+.. ++..||+|++......... . ....+.+|+.+++.+
T Consensus 26 ~~g~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l 105 (345)
T 2v62_A 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105 (345)
T ss_dssp CTTCEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC
T ss_pred CCCCeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc
Confidence 33444445555566899999999999999999987 8889998887643211000 0 112356788999999
Q ss_pred CCCCcceeeeeeecC--CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcE
Q 035992 85 KHKNIIKFYNSWVDT--ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNI 162 (613)
Q Consensus 85 ~HpNIVkl~~~fv~~--~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NI 162 (613)
+||||+++++++... ....+++||||+ +++|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 106 ~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NI 182 (345)
T 2v62_A 106 DYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANL 182 (345)
T ss_dssp SCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGE
T ss_pred cccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHE
Confidence 999999999998762 256899999999 9999999988889999999999999999999999998 99999999999
Q ss_pred EEeCCCC--cEEEeccchhHHHhhh-----------ccCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCC
Q 035992 163 FVNGNQG--EVKIGDLGLAAILAQA-----------RSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYV 228 (613)
Q Consensus 163 Ll~~~~g--~VKL~DFGla~~l~~~-----------~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~ 228 (613)
|++. ++ .+||+|||++..+... ....+++.|+|||++.+. ++.++|||||||++|||++|..||.
T Consensus 183 ll~~-~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 183 LLGY-KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEES-SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEcc-CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9983 44 9999999999765322 234577899999987654 8999999999999999999999995
Q ss_pred CC-CcHHHHHHHHH--cCCCCCccc-----ccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 229 EC-TNAAQIYKKVT--SGIKPASLA-----KVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 229 ~~-~~~~~i~~~I~--~g~~p~~l~-----~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.. .+...+..... ....+..+. ...+..+.++|.+||. +|.+||++.+|++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 43 23332221111 111121111 1567899999999999 9999999999886
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=328.66 Aligned_cols=241 Identities=21% Similarity=0.410 Sum_probs=203.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.|++.+.||+|+||+||+|.+. ++..||+|.++... ...+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 80 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICL 80 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT-----BCHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSSCEE
T ss_pred heeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc--CCCeEE
Confidence 4588899999999999999986 67889998876432 123578899999999999999999998854 456899
Q ss_pred EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-
Q 035992 107 ITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~- 184 (613)
+|||+.+++|.+++.+. +.+++..+..++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp EECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCH
T ss_pred EEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccccc
Confidence 99999999999999875 56999999999999999999999998 99999999999997 567999999999976532
Q ss_pred ----hccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 185 ----ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 185 ----~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
.....++..|+|||++. ..++.++||||||+++|+|++ |..||.. .+...+...+..+..+ ..+...+..+.
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~ 235 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVY 235 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHH
Confidence 12334566899999876 458999999999999999999 8999966 4556666677766433 34456789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhcC
Q 035992 259 AFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
++|.+||. +|.+||++.+++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999 99999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.29 Aligned_cols=246 Identities=27% Similarity=0.435 Sum_probs=205.3
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCc-----EEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGI-----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDT 99 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~-----~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~ 99 (613)
..|++.+.||+|+||+||+|.+..++. .||+|.++. .......+.+.+|+.+++.+ +||||++++++|..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKS---TAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECT---TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccc---ccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 335888999999999999999987665 799887653 23456678899999999999 89999999998754
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKH--------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~--------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
...+++||||+.+|+|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++
T Consensus 122 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 -GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT 198 (333)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE
T ss_pred -CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC
Confidence 45689999999999999998753 45899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~ 237 (613)
.++.+||+|||++....... ...+++.|+|||++.+ .++.++||||||+++|+|+| |..||........+.
T Consensus 199 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 199 -NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp -GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred -CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 56899999999997654321 2334568999997754 58999999999999999999 999998766666666
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+..+..+ ..+...+..+.++|.+||+ +|.+|||+.+++++
T Consensus 278 ~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 278 KLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 666555433 3345568899999999999 99999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.33 Aligned_cols=260 Identities=19% Similarity=0.234 Sum_probs=196.9
Q ss_pred CcccccCCCCcceeEeeeecccCceEEEEEEEcCC-----CcEEEEEEEEeeccccChHHH--------HHHHHHHHHHH
Q 035992 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELE-----GIEVAWNQIKVIDLLRNSEDL--------ERLYSEVHLLK 82 (613)
Q Consensus 16 ~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~t-----g~~VAiK~vk~~~~~~~~~~~--------~~l~~Ei~iLk 82 (613)
.+.+..+..+.-|++.+.||+|+||+||+|.+..+ ++.||+|++...... ...+. ..+..|+..++
T Consensus 25 ~g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~e~~~~~~~~~~~~~~e~~~~~ 103 (364)
T 3op5_A 25 VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGP-LFTELKFYQRAAKPEQIQKWIRTR 103 (364)
T ss_dssp TTCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHH-HHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchh-HHHHHHHHHhhhhhHHHHHHHHHh
Confidence 33344444455568999999999999999998765 588999987643210 00011 12345666778
Q ss_pred hCCCCCcceeeeeeecCCC--CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCC
Q 035992 83 TLKHKNIIKFYNSWVDTEN--EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKC 159 (613)
Q Consensus 83 ~L~HpNIVkl~~~fv~~~~--~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp 159 (613)
.++||||+++++++..... ..+++||||+ +++|.+++... +.+++..++.|+.||+.||+|||+++ |+||||||
T Consensus 104 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp 180 (364)
T 3op5_A 104 KLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKA 180 (364)
T ss_dssp TCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCG
T ss_pred hccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCH
Confidence 8899999999999876433 5689999999 99999999876 67999999999999999999999998 99999999
Q ss_pred CcEEEe-CCCCcEEEeccchhHHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCC
Q 035992 160 DNIFVN-GNQGEVKIGDLGLAAILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYP 226 (613)
Q Consensus 160 ~NILl~-~~~g~VKL~DFGla~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~P 226 (613)
+|||++ ...+.+||+|||++..+... ....+|+.|||||++.+ .|+.++|||||||++|||+||..|
T Consensus 181 ~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 181 SNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp GGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999997 24579999999999765432 12337889999998765 499999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHcCC---CCCc-----ccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 227 YVECTNAAQIYKKVTSGI---KPAS-----LAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 227 f~~~~~~~~i~~~I~~g~---~p~~-----l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
|................. .+.. .....+..+.+||..||. +|.+||++.+|++
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 975333222221111110 0000 013457899999999999 9999999998875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=342.61 Aligned_cols=253 Identities=24% Similarity=0.409 Sum_probs=205.4
Q ss_pred CcccccCCCCcceeEeeeecccCceEEEEEEEcCCCcEE--EEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCccee
Q 035992 16 AEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEV--AWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKF 92 (613)
Q Consensus 16 ~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~V--AiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl 92 (613)
..|..++. ++| ++.+.||+|+||+||+|.+..+|..+ |+|.++.. ......+.+.+|+.+++++ +||||+++
T Consensus 17 ~~~p~~~~-~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 91 (327)
T 1fvr_A 17 TIYPVLDW-NDI-KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINL 91 (327)
T ss_dssp CCSSBCCG-GGC-EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred cccccccH-HHc-cceeeeecCCCceEEEEEEccCCcccceeeeeeccc---cchHHHHHHHHHHHHHHhccCCCchhhh
Confidence 33444332 344 88899999999999999999999866 87776632 2345567789999999999 89999999
Q ss_pred eeeeecCCCCEEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecC
Q 035992 93 YNSWVDTENEHINFITEIFTSGTLRQYRKKHK----------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRD 156 (613)
Q Consensus 93 ~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~----------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrD 156 (613)
+++|.. ...+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+|||
T Consensus 92 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~d 167 (327)
T 1fvr_A 92 LGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRD 167 (327)
T ss_dssp EEEEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred ceeeee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCC
Confidence 998854 568999999999999999998764 7999999999999999999999998 99999
Q ss_pred CCCCcEEEeCCCCcEEEeccchhHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCC
Q 035992 157 LKCDNIFVNGNQGEVKIGDLGLAAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECT 231 (613)
Q Consensus 157 LKp~NILl~~~~g~VKL~DFGla~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~ 231 (613)
|||+|||++ .++.+||+|||++...... ....+++.|+|||++.. .++.++||||||+++|+|++ |..||.. .
T Consensus 168 lkp~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~-~ 245 (327)
T 1fvr_A 168 LAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-M 245 (327)
T ss_dssp CSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-C
T ss_pred CccceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC-C
Confidence 999999998 5679999999998643221 12334568999998765 48999999999999999998 9999966 4
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+...++..+..+..+ ..+...+..+.+||.+||. +|.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 246 TCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CHHHHHHHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 566677777766433 3345678899999999999 99999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=340.57 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=204.7
Q ss_pred cceeEeeeecccCceEEEEEE-----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAF-----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~-----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
..|++.+.||+|+||+||+|. +..++..||+|.+.. .........+.+|+.+++.++||||+++++++..
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE---VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS---SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc---ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 344888999999999999998 567889999888752 2345667789999999999999999999998754
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcE
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK-------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEV 171 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~-------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~V 171 (613)
...+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++. ....+
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceE
Confidence 456789999999999999998763 4899999999999999999999998 999999999999972 34469
Q ss_pred EEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcC
Q 035992 172 KIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 172 KL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g 243 (613)
||+|||++....... ...+++.|+|||++. ..++.++||||||+++|+|+| |..||.. .....+...+..+
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~ 261 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSG 261 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcC
Confidence 999999998664321 234567899999875 458999999999999999998 9999966 4556666677666
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
..+ ..+..++..+.++|.+||. +|.+||++.+++++.|+-.
T Consensus 262 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 262 GRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 443 3455678899999999999 9999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.41 Aligned_cols=245 Identities=21% Similarity=0.372 Sum_probs=205.0
Q ss_pred cceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
..|++.+.||+|+||+||+|.+. .++..||+|.+.. .........+.+|+.+++.++||||+++++++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT---TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc---ccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--
Confidence 44588899999999999999887 4678999887652 2345566789999999999999999999998744
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCc
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH----------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGE 170 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~ 170 (613)
....++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CCCe
Confidence 45789999999999999998753 45799999999999999999999998 99999999999998 5689
Q ss_pred EEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHc
Q 035992 171 VKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTS 242 (613)
Q Consensus 171 VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~ 242 (613)
+||+|||++....... ...+++.|+|||++.+ .++.++||||||+++|+|++ |..||.. .+..++...+..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~ 255 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVME 255 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHT
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHc
Confidence 9999999997654321 2344668999998764 58999999999999999999 8999966 455666666666
Q ss_pred CCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 243 GIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 243 g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+..+ ..+...+..+.++|.+||. +|.+|||+.+++++
T Consensus 256 ~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 256 GGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp TCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5433 3345678899999999999 99999999999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=350.24 Aligned_cols=246 Identities=23% Similarity=0.394 Sum_probs=199.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEe-eccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKV-IDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~-~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.|++.++||+|+||+||+|.+..+|..+|+|++.+ ............+.+|+.+++.++||||+++++++. ...++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~~~~ 90 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GSSLQ 90 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---BSSEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCccE
Confidence 35888999999999999999999988755443322 111122233456778999999999999999999874 34588
Q ss_pred EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 106 FITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
+||||+.+|+|.+++... +.+++..++.|+.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++..+..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcccccCc
Confidence 999999999999999875 57999999999999999999999998 99999999999997 578999999999987643
Q ss_pred h------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 185 A------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 185 ~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
. ....++..|+|||++. ..|+.++|||||||++|+|+| |..||.... ...+...+..+..+ ..+...+..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~ 245 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGERL-AQPQICTID 245 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-TTHHHHHHHTTCBC-CCCTTBCTT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-HHHHHHHHHcCCCC-CCCCcCcHH
Confidence 2 1234556899999876 459999999999999999999 999997644 44555556655432 334457788
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.++|.+||. +|.+||++.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999 99999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=338.37 Aligned_cols=240 Identities=28% Similarity=0.465 Sum_probs=193.2
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-+++.+.||+|+||+||+|.+. ++.||+|++. .....+.+.+|+.++++++||||+++++++.+ ..+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~----~~~ 75 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIE------SESERKAFIVELRQLSRVNHPNIVKLYGACLN----PVC 75 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECS------STTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT----TTE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEec------ChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC----CcE
Confidence 34578899999999999999764 7889988764 23456788999999999999999999997642 378
Q ss_pred EEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhc---CCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 106 FITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHS---HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs---~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+||||+.+|+|.+++...+ .+++..+..|+.||+.||.|||+ ++ |+||||||+|||++.+...+||+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl~Dfg~~ 153 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKICDFGTA 153 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEEcccccc
Confidence 9999999999999998765 47899999999999999999999 66 9999999999999844334899999999
Q ss_pred HHHhhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc-HHHHHHHHHcCCCCCcccccccHH
Q 035992 180 AILAQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN-AAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 180 ~~l~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~-~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
...... ....+++.|+|||++.+ .++.++||||||+++|+|++|..||..... ...+...+..+..+ .+....+..
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (307)
T 2eva_A 154 CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKP 232 (307)
T ss_dssp -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHH
T ss_pred cccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHH
Confidence 765432 23457889999998765 589999999999999999999999976433 33444455555443 344567889
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.++|.+||. +|.+|||+.+++++
T Consensus 233 l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 233 IESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHHH
Confidence 9999999999 99999999999873
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=332.77 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=196.2
Q ss_pred CCcceeEeeeecccCceEEEEEEEcC-CC--cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDEL-EG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~-tg--~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
....|++.+.||+|+||+||+|.+.. ++ ..||+|+++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence 34455889999999999999998643 33 3689888764322 2346678899999999999999999999987543
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
..++||||+.+++|.+++.+. +.+++..+..++.||+.||.|||+++ ++||||||+|||++ .++.+||+|||++
T Consensus 94 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 --PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLM 168 (291)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTC
T ss_pred --CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEcccccc
Confidence 378999999999999998764 67999999999999999999999998 99999999999998 5679999999998
Q ss_pred HHHhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 180 AILAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 180 ~~l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
....... ...++..|+|||++.. .++.++||||||+++|+|++ |..||... +...+...+.........+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRP 247 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC-CHHHHHHHHHccCCCCCCC
Confidence 7653321 2334568999998764 48999999999999999999 99999764 4555666666554444455
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..++..+.++|.+||. +|.+||++.++++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 6678999999999999 9999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=361.44 Aligned_cols=242 Identities=25% Similarity=0.389 Sum_probs=205.0
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-+++.+.||+|+||+||+|.++.++..||+|.++.. ....+.+.+|+.+|++++||||+++++++.. ...++
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~ 292 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR--EPPFY 292 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-----ccchHHHHHHHHHHHhcCCCCEeeEEEEEec--CCcEE
Confidence 3458889999999999999999999999999987632 2235678999999999999999999998754 45689
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+||||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCT
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceecc
Confidence 999999999999999874 45999999999999999999999998 99999999999997 56899999999997654
Q ss_pred hhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 QAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
... ...+++.|+|||++.. .|+.++|||||||++|||+| |..||... +..+++..+..+... ..+..++..
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~ 447 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM-ERPEGCPEK 447 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 321 2234568999998764 59999999999999999999 99999664 445566667666543 345567899
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhc
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+.+||.+||+ +|.+|||+.+|++
T Consensus 448 l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 448 VYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHH
Confidence 9999999999 9999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.38 Aligned_cols=243 Identities=23% Similarity=0.397 Sum_probs=194.1
Q ss_pred ceeEeeeecccCceEEEEEEEc---CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDE---LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~---~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+++.++||+|+||+||+|.+. .++..||+|.++. .......+.+.+|+.+|++++||||+++++++.. ...
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKV---GYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCT---TCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecC---ccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCc
Confidence 3477899999999999999887 5677899887753 2345667889999999999999999999998754 457
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++||||+.+|+|.+++.+.+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCcccccc
Confidence 899999999999999998764 6999999999999999999999998 99999999999998 5689999999999876
Q ss_pred hhhcc-------CcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 183 AQARS-------AHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 183 ~~~~~-------~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
..... ..+++.|+|||++.. .|+.++||||||+++|||++ |..||... ....+...+..+..++ .+..+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~ 275 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEGYRLP-PPMDC 275 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-CHHHHHHHHHTTEECC-CCTTC
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCccc
Confidence 43221 123457999998764 59999999999999999998 99999764 4555666666654322 23456
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+..+.++|.+||+ +|.+||++.++++
T Consensus 276 ~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 276 PAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 7899999999999 9999999999876
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=344.85 Aligned_cols=252 Identities=17% Similarity=0.254 Sum_probs=201.9
Q ss_pred CCCcccccCCCCcceeEeeeecccCceEEEEEEEcCC--------CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC
Q 035992 14 SDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELE--------GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85 (613)
Q Consensus 14 ~~~~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~t--------g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~ 85 (613)
.....+..++.+..|++.+.||+|+||+||+|.+..+ ++.||+|+++.. +.+.+|+.+++.++
T Consensus 30 l~~g~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~ 100 (352)
T 2jii_A 30 LPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAA 100 (352)
T ss_dssp CCTTCEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHC
T ss_pred CCCCceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhc
Confidence 3444555566677779999999999999999999884 889999987632 35788999999999
Q ss_pred CCCcce---------------eeeeeecCCCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcC
Q 035992 86 HKNIIK---------------FYNSWVDTENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSH 148 (613)
Q Consensus 86 HpNIVk---------------l~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~ 148 (613)
||||++ +++++.. .+..+++||||+ +++|.+++.+. +.+++..++.++.||+.||.|||++
T Consensus 101 h~niv~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 178 (352)
T 2jii_A 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN 178 (352)
T ss_dssp CHHHHHHHHHHTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccchhhhhhhhccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999998 4555443 356899999999 99999999986 7899999999999999999999999
Q ss_pred CCCEEecCCCCCcEEEeCCCC--cEEEeccchhHHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhh
Q 035992 149 DPPVIHRDLKCDNIFVNGNQG--EVKIGDLGLAAILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFG 214 (613)
Q Consensus 149 ~~~IIHrDLKp~NILl~~~~g--~VKL~DFGla~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLG 214 (613)
+ |+||||||+|||++ .++ .+||+|||++..+... ....+++.|+|||++.+ .++.++||||||
T Consensus 179 ~--ivH~Dikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 179 E--YVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp T--CBCSCCCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred C--ccCCCCCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 8 99999999999998 455 8999999999765432 12357789999998765 589999999999
Q ss_pred HHHHHHHhcCCCCCCCC-cHHHHHHHHH---cCCCCC----cccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 215 MCLLELVTFEYPYVECT-NAAQIYKKVT---SGIKPA----SLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 215 viL~EmltG~~Pf~~~~-~~~~i~~~I~---~g~~p~----~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
|++|+|++|..||.... +...+..... ....+. ......+..+.+||.+||. +|.+||++.++++
T Consensus 256 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99999999999997654 4444433332 221110 0112458999999999999 9999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=349.08 Aligned_cols=254 Identities=22% Similarity=0.381 Sum_probs=200.0
Q ss_pred ccccCCCCcceeEeeeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeee
Q 035992 18 FVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYN 94 (613)
Q Consensus 18 ~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~ 94 (613)
.+.+.+....+++.++||+|+||+||+|.+..++ ..||+|.++. .......+.+.+|+.++++++||||+++++
T Consensus 81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~il~~l~hpnIv~~~~ 157 (373)
T 3c1x_A 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157 (373)
T ss_dssp TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS---CSCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC---CCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4456677777788999999999999999876543 4578776543 334567788999999999999999999999
Q ss_pred eeecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 95 SWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 95 ~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
++... ....++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||
T Consensus 158 ~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL 233 (373)
T 3c1x_A 158 ICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKV 233 (373)
T ss_dssp EECCC-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEE
T ss_pred EEEcC-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEE
Confidence 86543 34678999999999999999865 45899999999999999999999998 99999999999998 6689999
Q ss_pred eccchhHHHhhh--------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcC
Q 035992 174 GDLGLAAILAQA--------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 174 ~DFGla~~l~~~--------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g 243 (613)
+|||++..+... ....+++.|+|||++.+ .|+.++|||||||++|||+| |.+||..... ..+...+..+
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-~~~~~~~~~~ 312 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 312 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-SCHHHHHHTT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-HHHHHHHHcC
Confidence 999999765322 12234568999998764 58999999999999999999 6777765433 3344455555
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+ ..+..++..+.++|.+||. +|.+||++.+++++
T Consensus 313 ~~~-~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 RRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 433 3345678899999999999 99999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.26 Aligned_cols=246 Identities=20% Similarity=0.260 Sum_probs=198.3
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
..++| ++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+|+.+++.++|++++..+..+.. ...
T Consensus 7 ~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~ 78 (296)
T 3uzp_A 7 VGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGD 78 (296)
T ss_dssp ETTTE-EEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS------CCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETT
T ss_pred eccEE-EEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc------hhHHHHHHHHHHHhhcCCCCCccccccC-CCC
Confidence 34565 888999999999999999999999999998764321 2357899999999999998877766543 456
Q ss_pred EEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccchh
Q 035992 103 HINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLA 179 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFGla 179 (613)
..++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 889999999 9999999974 467999999999999999999999998 99999999999994 35679999999999
Q ss_pred HHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc--HHHHHHHHHcCC-
Q 035992 180 AILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGI- 244 (613)
Q Consensus 180 ~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--~~~i~~~I~~g~- 244 (613)
...... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 765432 23457789999998765 589999999999999999999999975332 112222222211
Q ss_pred --CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 245 --KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 245 --~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
....+...+++.+.+||.+||+ +|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 1112334568899999999999 9999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=356.21 Aligned_cols=240 Identities=22% Similarity=0.398 Sum_probs=200.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-+++.+.||+|+||+||+|.+. |..||+|+++.. ...+.+.+|+.+|++++||||+++++++... ...++
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC------TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc------hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 34578899999999999999774 789999987632 2346789999999999999999999987653 34689
Q ss_pred EEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+||||+.+|+|.+++.+.+. +++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccccc
Confidence 99999999999999987654 799999999999999999999998 99999999999998 56899999999987543
Q ss_pred hh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 184 QA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 184 ~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
.. ....+++.|+|||++.. .|+.++|||||||++|||+| |..||..... .++...+..+..+ ..+..+++.+.++
T Consensus 341 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~~~~~i~~~~~~-~~p~~~~~~l~~l 418 (450)
T 1k9a_A 341 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKGYKM-DAPDGCPPAVYDV 418 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-TTHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC-CCCCcCCHHHHHH
Confidence 22 22345678999998764 59999999999999999998 9999976543 4455667776543 3456678999999
Q ss_pred HHHHhh-cccCCCCHHHHhc
Q 035992 261 IEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~ 279 (613)
|.+||. +|.+|||+.+|+.
T Consensus 419 i~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 419 MKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHH
Confidence 999999 9999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=336.77 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=199.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
...+.||+|+||+||+|.+ ++..||+|++............+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 109 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLCLVY 109 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceEEEE
Confidence 3458999999999999975 6889999988754433445667889999999999999999999998754 45789999
Q ss_pred eccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 109 EIFTSGTLRQYRKK---HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 109 E~~~gGsL~~~l~~---~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccc
Confidence 99999999999874 356999999999999999999999998 99999999999998 6789999999998755331
Q ss_pred ------ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHH---HHHHHHHcCC---------CCC
Q 035992 186 ------RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAA---QIYKKVTSGI---------KPA 247 (613)
Q Consensus 186 ------~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~---~i~~~I~~g~---------~p~ 247 (613)
....+++.|+|||++.+.++.++||||||+++|+|++|..||....... .+...+.... ...
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMN 266 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCS
T ss_pred cccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccc
Confidence 2345788999999988889999999999999999999999996543321 2222222211 111
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+...+..+.++|.+||. +|.+|||+.+++++
T Consensus 267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1233446789999999999 99999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=336.68 Aligned_cols=245 Identities=23% Similarity=0.409 Sum_probs=198.8
Q ss_pred cceeEeeeecccCceEEEEEEEcCCC----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
..+++.++||+|+||+||+|.+..++ ..||+|.++. .........+.+|+.+++.++||||+++++++.. .
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 118 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK--Y 118 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT---TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--S
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCC---CCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec--C
Confidence 33477899999999999999887654 4599887653 2245566789999999999999999999998743 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 EHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+++||||+.+|+|.+++... +.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCCcch
Confidence 6799999999999999999865 67999999999999999999999998 99999999999998 57899999999998
Q ss_pred HHhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 181 ILAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 181 ~l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
...... ...+++.|+|||++.. .++.++||||||+++|||++ |..||... ....+...+..+..+. .+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~ 273 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRLP-TPM 273 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCC-CCT
T ss_pred hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHCCCcCC-Ccc
Confidence 764321 1233568999998764 58999999999999999999 99999764 4556666777664433 344
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.++..+.++|.+||+ +|.+||++.+++++
T Consensus 274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 274 DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 578899999999999 99999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=328.58 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=194.9
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
....++| ++.+.||+|+||+||+|.+..+|+.||+|++.... ....+.+|+.+++.++|++++..+..+.. .
T Consensus 5 ~~~~~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~ 76 (296)
T 4hgt_A 5 LRVGNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT------KHPQLHIESKIYKMMQGGVGIPTIRWCGA-E 76 (296)
T ss_dssp ------C-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---------CCCHHHHHHHHHHHTTSTTCCCEEEEEE-E
T ss_pred cccCCce-EEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc------cchHHHHHHHHHHHhcCCCCCCeeeeecC-C
Confidence 3455666 88899999999999999999999999999765432 22357889999999999998888776543 4
Q ss_pred CCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccc
Q 035992 101 NEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLG 177 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFG 177 (613)
....+++|||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ ...+.+||+|||
T Consensus 77 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 77 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 56889999999 9999999985 467999999999999999999999998 99999999999993 256799999999
Q ss_pred hhHHHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH--HHHHHHHHcC
Q 035992 178 LAAILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA--AQIYKKVTSG 243 (613)
Q Consensus 178 la~~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~--~~i~~~I~~g 243 (613)
++...... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||...... ...+..+...
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 99765432 13457789999998765 5899999999999999999999999654321 1122222221
Q ss_pred C---CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 244 I---KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 244 ~---~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
. ....+...+++.+.+||.+||+ +|.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 1 1112224467899999999999 9999999999876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.69 Aligned_cols=239 Identities=26% Similarity=0.438 Sum_probs=201.3
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.+++.+.||+|+||+||+|.+. ++..||+|.++... ...+.+.+|+.+|+.++||||+++++++. ...+++
T Consensus 189 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~l 259 (454)
T 1qcf_A 189 SLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIYI 259 (454)
T ss_dssp GEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCEE
T ss_pred HeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccEE
Confidence 3488899999999999999875 57789999876422 23578899999999999999999999864 346899
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIED 336 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCC
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCC
Confidence 99999999999999754 36899999999999999999999998 99999999999998 578999999999986532
Q ss_pred h-----ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 185 A-----RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 185 ~-----~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
. ....+++.|+|||++. +.|+.++|||||||++|||+| |..||.+.. ..++...+..+...+ .+..+++.+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~~-~~~~~~~~l 414 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRMP-RPENCPEEL 414 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHHTCCCC-CCTTSCHHH
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCCC-CCCCCCHHH
Confidence 1 2234456899999876 459999999999999999999 999997644 455666676665433 345678999
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+||.+||. +|.+|||+.+|+.
T Consensus 415 ~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 415 YNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhHCcCHHHHHH
Confidence 999999999 9999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=337.97 Aligned_cols=250 Identities=28% Similarity=0.461 Sum_probs=203.2
Q ss_pred CCCCcceeEeeeecccCceEEEEEE----EcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~----~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
....+.+++.+.||+|+||+||+|. +..+|+.||+|+++. ......+.+.+|+.+++.++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS----CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 3455667999999999999999998 567899999988764 23566788999999999999999999999887
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
......+++||||+.+++|.+++.+. ..+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+||
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Df 189 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 189 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecC
Confidence 66556789999999999999999876 46999999999999999999999998 99999999999998 5689999999
Q ss_pred chhHHHhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcH---------------
Q 035992 177 GLAAILAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNA--------------- 233 (613)
Q Consensus 177 Gla~~l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~--------------- 233 (613)
|++....... ...++..|+|||++.+ .++.++||||||+++|+|+||..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 9997654321 2334567999998764 5899999999999999999999998532110
Q ss_pred HHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 234 AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 234 ~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+...+..+..+ ..+..++..+.++|.+||. +|.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 270 FHLIELLKNNGRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhcCCCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122333333322 2345678999999999999 9999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=328.57 Aligned_cols=242 Identities=25% Similarity=0.448 Sum_probs=201.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+..+| ++.+.||+|+||+||+|.+. ++..||+|.++... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 11 ~~~~y-~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~ 80 (279)
T 1qpc_A 11 PRETL-KLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT---QE 80 (279)
T ss_dssp CGGGE-EEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC---SS
T ss_pred CHHhh-hheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-----ccHHHHHHHHHHHHhCCCcCcceEEEEEc---CC
Confidence 33455 88899999999999999875 56789988875322 23467889999999999999999999864 23
Q ss_pred EEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 103 HINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ ..+.+||+|||++.
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~ 157 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLAR 157 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCE
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCcccc
Confidence 5889999999999999987543 7999999999999999999999998 99999999999998 67899999999997
Q ss_pred HHhhhc-----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 181 ILAQAR-----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 181 ~l~~~~-----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
...... ...++..|+|||++. ..++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~ 235 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRM-VRPDNC 235 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-CHHHHHHHHhcccCC-CCcccc
Confidence 654321 223456899999876 458999999999999999999 99999764 455566667666433 334567
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+..+.++|.+||. +|.+|||+.++++
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8899999999999 9999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=333.31 Aligned_cols=241 Identities=24% Similarity=0.414 Sum_probs=188.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC--CCCCcceeeeeeecCCC--C
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL--KHKNIIKFYNSWVDTEN--E 102 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L--~HpNIVkl~~~fv~~~~--~ 102 (613)
.|++.+.||+|+||+||+|.+. |+.||+|++... .......|.+++..+ +||||+++++++..... .
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 3488999999999999999875 899999987532 223344555565554 99999999998876533 6
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC--------CCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH--------DPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~--------~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
.+++||||+.+|+|.+++++. .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl~ 184 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCIA 184 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEEC
T ss_pred ceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEEEE
Confidence 799999999999999999764 699999999999999999999998 6 99999999999998 56899999
Q ss_pred ccchhHHHhhh--------ccCcccccccCccccccc-cCc------cchhhhhhHHHHHHHhc----------CCCCCC
Q 035992 175 DLGLAAILAQA--------RSAHSVIEFMAPELYEEE-YNE------LVDIYAFGMCLLELVTF----------EYPYVE 229 (613)
Q Consensus 175 DFGla~~l~~~--------~~~~gt~~YmAPEvl~~~-ys~------ksDIWSLGviL~EmltG----------~~Pf~~ 229 (613)
|||++..+... ....+++.|+|||++.+. +.. ++|||||||++|||+|| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99998654321 134678899999988654 333 48999999999999999 778754
Q ss_pred CC----cHHHHHHHHHcCCCCCcccc-----cccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 230 CT----NAAQIYKKVTSGIKPASLAK-----VADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 230 ~~----~~~~i~~~I~~g~~p~~l~~-----~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.. ....+...+........++. .++..+.+||.+||+ +|.+|||+.++++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 32 22333333333322222222 456779999999999 99999999999875
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=325.66 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=199.5
Q ss_pred cceeEeeeecccCceEEEEEEEcC---CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~---tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
..|++.+.||+|+||+||+|.+.. ++..||+|.++. .......+.+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 85 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKK---DCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---E 85 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCT---TSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---S
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccc---ccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---C
Confidence 445888999999999999998654 345689877653 2345667889999999999999999999998743 3
Q ss_pred EEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..++||||+.+++|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCCCcc
Confidence 468999999999999999765 45999999999999999999999998 99999999999998 568999999999976
Q ss_pred Hhhh-----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 182 LAQA-----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 182 l~~~-----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.... ....+++.|+|||++.. .++.++||||||+++|+|++ |..||...... .+...+..+..+ ..+...+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~ 240 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGVLEKGDRL-PKPDLCP 240 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHHHHHTCCC-CCCTTCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHHHhcCCCC-CCCCCCC
Confidence 5432 23345668999998764 58999999999999999998 99999764443 344455544332 2345578
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+.++|.+||. +|.+||++.+++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 241 PVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 899999999999 99999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.53 Aligned_cols=245 Identities=20% Similarity=0.330 Sum_probs=196.4
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.+.||+|+||+||+|.+. +|+.||+|.+... .....+.+.+|+.+++.++||||++++++|.. ...+++
T Consensus 40 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 40 NFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--TTCCEE
T ss_pred ccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCeEEE
Confidence 3477899999999999999864 7899998876532 33567789999999999999999999998743 557899
Q ss_pred EEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 107 ITEIFTSGTLRQYRKKHK----HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~----~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeeccccccc
Confidence 999999999999987653 5999999999999999999999998 99999999999998 6789999999998754
Q ss_pred hhh------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHH-----H-HHHHHHcCC-----
Q 035992 183 AQA------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAA-----Q-IYKKVTSGI----- 244 (613)
Q Consensus 183 ~~~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~-----~-i~~~I~~g~----- 244 (613)
... ....+++.|+|||++. ..++.++||||||+++|||++|..||....... . .......+.
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 321 1234678999999875 469999999999999999999999996533211 1 111111111
Q ss_pred ---CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCC
Q 035992 245 ---KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDP 281 (613)
Q Consensus 245 ---~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HP 281 (613)
....+....+..+.++|.+||+ +|.+|||+.|++++.
T Consensus 270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 1112233456789999999999 999999999999763
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.38 Aligned_cols=235 Identities=20% Similarity=0.337 Sum_probs=188.5
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHH-HhCCCCCcceeeeeeec--CC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL-KTLKHKNIIKFYNSWVD--TE 100 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iL-k~L~HpNIVkl~~~fv~--~~ 100 (613)
.++|+...++||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++ +.++||||++++++|.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 356766668999999999999999999999999987631 3466788887 66699999999998754 33
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--CCcEEEecc
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--QGEVKIGDL 176 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~g~VKL~DF 176 (613)
...+++||||+.+|+|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.. .+.+||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 567999999999999999998864 6999999999999999999999998 9999999999999842 678999999
Q ss_pred chhHHHhhhccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH----cCCC--CCccc
Q 035992 177 GLAAILAQARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT----SGIK--PASLA 250 (613)
Q Consensus 177 Gla~~l~~~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~----~g~~--p~~l~ 250 (613)
|++... ....|+.++|||||||++|+|++|..||....... ....+. .+.. +....
T Consensus 165 g~a~~~-----------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 226 (299)
T 3m2w_A 165 GFAKET-----------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQYEFPNPEW 226 (299)
T ss_dssp TTCEEC-----------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHH
T ss_pred cccccc-----------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh-hhHHHHHHHhhccccCCchhc
Confidence 987432 22457889999999999999999999996533221 111111 1111 11112
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..++..+++||.+||. +|.+|||+.|+|+||||+...
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 4578899999999999 999999999999999998653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=352.27 Aligned_cols=246 Identities=23% Similarity=0.336 Sum_probs=190.1
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~ 103 (613)
+.++...++||+|+||+||.+ ...+|+.||+|++... ..+.+.+|+.+|+.+ +||||+++++++.. ...
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~ 83 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETT--DRF 83 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCe
Confidence 355578899999999999875 5678999999987632 234678899999876 89999999998754 568
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCC-------HHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC----------
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVD-------LRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG---------- 166 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~ls-------e~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~---------- 166 (613)
+++||||+. |+|.+++...+... +..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccccc
Confidence 999999996 59999998765432 3345679999999999999998 999999999999973
Q ss_pred --CCCcEEEeccchhHHHhhh--------ccCcccccccCcccccc--------ccCccchhhhhhHHHHHHHh-cCCCC
Q 035992 167 --NQGEVKIGDLGLAAILAQA--------RSAHSVIEFMAPELYEE--------EYNELVDIYAFGMCLLELVT-FEYPY 227 (613)
Q Consensus 167 --~~g~VKL~DFGla~~l~~~--------~~~~gt~~YmAPEvl~~--------~ys~ksDIWSLGviL~Emlt-G~~Pf 227 (613)
..+.+||+|||++..+... ....+++.|+|||++.+ .++.++|||||||++|||+| |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 2348999999999765432 13467889999998743 48899999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHcCC-CCCcc----cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 228 VECTNAAQIYKKVTSGI-KPASL----AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 228 ~~~~~~~~i~~~I~~g~-~p~~l----~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
........ .+..+. ....+ ....+.++++||.+||+ +|.+|||+.++++||||...
T Consensus 241 ~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 241 GDKYSRES---NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp CSTTTHHH---HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CCchhhHH---HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 66544332 222222 11111 22346789999999999 99999999999999999764
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=358.08 Aligned_cols=247 Identities=26% Similarity=0.311 Sum_probs=190.6
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l 104 (613)
.-++..++||+|+||+||. ....+|+.||+|.+..... ..+.+|+.+|+.+ +||||+++++++.+ ...+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-------~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~ 93 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-------SFADREVQLLRESDEHPNVIRYFCTEKD--RQFQ 93 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-------EECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-------HHHHHHHHHHHhccCCCCcCeEEEEEec--CCEE
Confidence 3357789999999999763 4567899999998753221 2346799999999 79999999998754 5689
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC--C--CcEEEeccchh
Q 035992 105 NFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN--Q--GEVKIGDLGLA 179 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~--~--g~VKL~DFGla 179 (613)
|+||||+. |+|.+++.... .+.+..+..++.||+.||.|||+++ |+||||||+|||++.. . ..+||+|||++
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 99999996 59999998764 4666677899999999999999998 9999999999999521 2 25789999998
Q ss_pred HHHhhh-------ccCcccccccCccccc----cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCC-
Q 035992 180 AILAQA-------RSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKP- 246 (613)
Q Consensus 180 ~~l~~~-------~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p- 246 (613)
..+... ....+++.|+|||++. ..++.++|||||||++|||++ |..||...... +.. .+......
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-~~~-~~~~~~~~~ 248 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-QAN-ILLGACSLD 248 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-HHH-HHTTCCCCT
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-HHH-HHhccCCcc
Confidence 755321 2345788999999885 347789999999999999999 99999654332 222 22222111
Q ss_pred -CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 247 -ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 247 -~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.......+..+++||.+||+ +|.+|||+.++++||||....
T Consensus 249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 11223446678999999999 999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.50 Aligned_cols=241 Identities=22% Similarity=0.401 Sum_probs=194.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
..-|++.+.||+|+||+||+|.+ +|..||+|+++. ....+.+.+|+.+++.++||||+++++++... ...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 90 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 90 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC------CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecc------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCce
Confidence 34458889999999999999976 488999887653 23456789999999999999999999986543 3468
Q ss_pred EEEEeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKKHKH--VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~--lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
++||||+.+++|.+++.+.+. +++..++.++.||+.||.|||+++ ++||||||+||+++ .++.+||+|||++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC----
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeeccccccc
Confidence 999999999999999987643 899999999999999999999998 99999999999998 5689999999999765
Q ss_pred hhh-ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 183 AQA-RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 183 ~~~-~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
... ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||... +...+...+..+..+ ..+...++.+.+
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 245 (278)
T 1byg_A 168 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKM-DAPDGCPPAVYE 245 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCCC-CCCTTCCHHHHH
T ss_pred cccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCCC-CCcccCCHHHHH
Confidence 443 23345678999998764 58999999999999999998 99999664 345556666665433 345567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhc
Q 035992 260 FIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+|.+||. +|.+||++.++++
T Consensus 246 li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 246 VMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCChhhCCCHHHHHH
Confidence 9999999 9999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=332.45 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=188.0
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHH--HHHHHhCCCCCcceeeeeee---cCCC
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSE--VHLLKTLKHKNIIKFYNSWV---DTEN 101 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~E--i~iLk~L~HpNIVkl~~~fv---~~~~ 101 (613)
-|++.+.||+|+||+||+|.+ +|+.||+|+++... ...+..| +..+..++||||+++++.+. ....
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred HhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 348889999999999999965 78999999876321 2233334 44455689999999997543 2334
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC---------CCCEEecCCCCCcEEEeCCCCcEE
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH---------DPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~---------~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
..+++||||+.+|+|.+++...+ .++..+..++.||+.||.|||++ + |+||||||+|||++ .++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCcEE
Confidence 57889999999999999997754 58999999999999999999998 7 99999999999998 568999
Q ss_pred EeccchhHHHhh------------hccCcccccccCcccccc--------ccCccchhhhhhHHHHHHHhcCCCCCCCCc
Q 035992 173 IGDLGLAAILAQ------------ARSAHSVIEFMAPELYEE--------EYNELVDIYAFGMCLLELVTFEYPYVECTN 232 (613)
Q Consensus 173 L~DFGla~~l~~------------~~~~~gt~~YmAPEvl~~--------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~ 232 (613)
|+|||++..+.. .....+++.|+|||++.+ .++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999965432 113457889999998764 467899999999999999999877643221
Q ss_pred -----------------HHHHHHHHHcCCCCCccccc------ccHHHHHHHHHHhh-cccCCCCHHHH------hcCCC
Q 035992 233 -----------------AAQIYKKVTSGIKPASLAKV------ADNGVRAFIEKCIA-EVSERLPAKEL------LGDPF 282 (613)
Q Consensus 233 -----------------~~~i~~~I~~g~~p~~l~~~------~s~~l~~lI~~cL~-dP~~Rpta~eL------L~HPf 282 (613)
...+...+........++.. .++.+.+||.+||. +|.+|||+.|+ +.++|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 12222223322222233322 34579999999999 99999999999 55777
Q ss_pred CCCC
Q 035992 283 LQSE 286 (613)
Q Consensus 283 f~~~ 286 (613)
-++.
T Consensus 321 ~~~~ 324 (336)
T 3g2f_A 321 ERNK 324 (336)
T ss_dssp CC--
T ss_pred Hhcc
Confidence 7654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=364.29 Aligned_cols=238 Identities=20% Similarity=0.347 Sum_probs=201.1
Q ss_pred eeecccCceEEEEEEE--cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFKKVYRAFD--ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafGtVYka~~--~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+.||+|+||+||+|.+ +.+++.||+|+++... ......+.+.+|+.+|+.++||||+++++++.. ..+++|||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~lv~E 449 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVME 449 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG--GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEEEEEE
Confidence 5899999999999954 4677899999876432 234556789999999999999999999998742 34889999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc---
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR--- 186 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~--- 186 (613)
|+.+|+|.+++...+.+++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||++..+....
T Consensus 450 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 450 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-----
T ss_pred ccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCcccc
Confidence 9999999999999999999999999999999999999998 99999999999998 56799999999998764321
Q ss_pred ----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 187 ----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 187 ----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
...+++.|+|||++.. .|+.++|||||||++|||++ |..||.. .+...+...+..+..+ ..+..++..+.+|
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~l 604 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDL 604 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHH
Confidence 2234568999998865 59999999999999999998 9999966 4556677777777543 3455678999999
Q ss_pred HHHHhh-cccCCCCHHHHhc
Q 035992 261 IEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~ 279 (613)
|.+||. +|.+||++.+|++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 999999 9999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.11 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=196.0
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
+.....-|++.++||+|+||+||+|.+ .+|..||+|+++.... ......+.+|+.+++.++||||++++++|..
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 98 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT---QGGELQFQTEVEMISMAVHRNLLRLRGFCMT-- 98 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECC--
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC---chHHHHHHHHHHHHHhccCCCccceEEEEec--
Confidence 333344457889999999999999974 4689999998764332 1222368899999999999999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHhhhhhcC---CCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK----HVDLRALKKWSRQILEGLSYLHSH---DPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~----~lse~~i~~i~~QIl~gL~yLHs~---~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
....++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ + |+||||||+|||++ .++.+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl 175 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVV 175 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEe
Confidence 456789999999999999998654 499999999999999999999998 7 99999999999998 6689999
Q ss_pred eccchhHHHhhh-----ccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCC----CcHHHHHHHHHcC
Q 035992 174 GDLGLAAILAQA-----RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVEC----TNAAQIYKKVTSG 243 (613)
Q Consensus 174 ~DFGla~~l~~~-----~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~----~~~~~i~~~I~~g 243 (613)
+|||++...... ....+++.|+|||++. ..++.++||||||+++|+|++|..||... .....+...+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999765322 2334788999999875 45899999999999999999999999420 0000011111111
Q ss_pred C------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCC
Q 035992 244 I------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPF 282 (613)
Q Consensus 244 ~------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPf 282 (613)
. ....+....+..+.++|.+||+ +|.+|||+.++++|-.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0 1112223345789999999999 9999999999998754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=332.30 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=196.7
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh--CCCCCcceeeeeeecCCC--
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT--LKHKNIIKFYNSWVDTEN-- 101 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~--L~HpNIVkl~~~fv~~~~-- 101 (613)
+.|++.+.||+|+||+||+|.+ +|+.||+|+++. .....+.+|+.+++. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-------~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-------GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-------hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 3458899999999999999987 599999998752 234567789999888 789999999999865442
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhh--------cCCCCEEecCCCCCcEEEeCCCCcEEE
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH--------SHDPPVIHRDLKCDNIFVNGNQGEVKI 173 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLH--------s~~~~IIHrDLKp~NILl~~~~g~VKL 173 (613)
..+++||||+.+|+|.+++.+ ..+++..++.++.||+.||.||| +++ |+||||||+|||++ .++.+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL 188 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCI 188 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEE
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEE
Confidence 278999999999999999987 46999999999999999999999 777 99999999999998 5689999
Q ss_pred eccchhHHHhhh--------ccCcccccccCccccccc-------cCccchhhhhhHHHHHHHhc----------CCCCC
Q 035992 174 GDLGLAAILAQA--------RSAHSVIEFMAPELYEEE-------YNELVDIYAFGMCLLELVTF----------EYPYV 228 (613)
Q Consensus 174 ~DFGla~~l~~~--------~~~~gt~~YmAPEvl~~~-------ys~ksDIWSLGviL~EmltG----------~~Pf~ 228 (613)
+|||++...... ....+++.|+|||++.+. ++.++|||||||++|||+|| ..||.
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~ 268 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence 999998765432 233578899999987653 34789999999999999999 78996
Q ss_pred CCC----cHHHHHHHHHcCCCCCcccc-----cccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 229 ECT----NAAQIYKKVTSGIKPASLAK-----VADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 229 ~~~----~~~~i~~~I~~g~~p~~l~~-----~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
... ....+...+........++. .....+.++|.+||+ +|.+|||+.++++|
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 542 34555555554433333332 234678999999998 99999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=341.76 Aligned_cols=240 Identities=19% Similarity=0.267 Sum_probs=187.2
Q ss_pred CCCCcceeEeeeecccCceEEEEE-----EEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCCcceee
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK---HKNIIKFY 93 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka-----~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~ 93 (613)
...+..|++.++||+|+||+||+| .+..+++.||+|+++.. ....+..|+.+++.++ |+||++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 344566789999999999999999 47889999999887532 2345777888888886 99999999
Q ss_pred eeeecCCCCEEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCC-
Q 035992 94 NSWVDTENEHINFITEIFTSGTLRQYRKK-----HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGN- 167 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL~~~l~~-----~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~- 167 (613)
+++.. ....++||||+.+|+|.+++.. .+.+++..++.|+.||+.||+|||+++ |+||||||+|||++..
T Consensus 134 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 134 SAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGF 209 (365)
T ss_dssp EEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGG
T ss_pred eeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccc
Confidence 98865 4568999999999999999974 467999999999999999999999998 9999999999999731
Q ss_pred ---------CCcEEEeccchhHHHhh------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC
Q 035992 168 ---------QGEVKIGDLGLAAILAQ------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT 231 (613)
Q Consensus 168 ---------~g~VKL~DFGla~~l~~------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~ 231 (613)
.+.+||+|||++..+.. .....||+.|||||++.+ .|+.++|||||||++|||+||+.||....
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 68999999999965431 234567889999998765 48999999999999999999999995432
Q ss_pred cHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 232 ~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..... ...... ....+..+.+++..||+ +|.+|++..+.+.
T Consensus 290 ~~~~~----~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 290 GGECK----PEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp TTEEE----ECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred CCcee----echhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 21000 000000 11236778999999999 8888866444333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=350.09 Aligned_cols=239 Identities=26% Similarity=0.409 Sum_probs=196.9
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-+++.+.||+|+||+||+|.+.. +..||+|.++... ...+.+.+|+.+|++++||||+++++++.. ..+++
T Consensus 185 ~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp GEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 34888999999999999998874 4679988876322 224578999999999999999999998743 45889
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||||+.+|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIED 332 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC----
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccceecCC
Confidence 99999999999999743 56999999999999999999999998 99999999999997 567999999999976543
Q ss_pred h-----ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 185 A-----RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 185 ~-----~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
. ....+++.|+|||++. +.|+.++||||||+++|||++ |..||.+. ...++...+..+..++ .+..++..+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l 410 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRMP-CPPECPESL 410 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCCC-CCTTSCHHH
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHH
Confidence 2 1233456899999775 459999999999999999999 99999764 4556666777665432 345678899
Q ss_pred HHHHHHHhh-cccCCCCHHHHhc
Q 035992 258 RAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+||.+||. +|.+|||+.+|+.
T Consensus 411 ~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 411 HDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 999999999 9999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=359.96 Aligned_cols=241 Identities=19% Similarity=0.343 Sum_probs=198.8
Q ss_pred ceeEeeeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+......||+|+||+||+|.+. .++..||+|+++.. ......+.+.+|+.+|+.++||||+++++++.. ..+
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~ 410 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 410 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC---CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCe
Confidence 3333458999999999999876 35678998887643 233456789999999999999999999998754 358
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++||||+.+|+|.+++... +.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+.
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCccccc
Confidence 9999999999999998754 56999999999999999999999998 99999999999998 56899999999997653
Q ss_pred hhc-------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 184 QAR-------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 184 ~~~-------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
... ...+++.|+|||++. ..|+.++|||||||++|||++ |..||..... .++...+..+..+ .++..++
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~i~~~~~~-~~p~~~~ 565 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRM-ECPPECP 565 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHHHHTTCCC-CCCTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHcCCCC-CCCCcCC
Confidence 221 122346899999876 469999999999999999998 9999977554 4566677777543 3455678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
+.+.++|.+||. +|.+||++.+|+
T Consensus 566 ~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 566 PELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999999999999 999999999885
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=341.91 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=193.4
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc----cChHHHHHHHHHHHHHHhCC---------CCCc
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL----RNSEDLERLYSEVHLLKTLK---------HKNI 89 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~----~~~~~~~~l~~Ei~iLk~L~---------HpNI 89 (613)
+.++| ++.+.||+|+||+||+|++ +|+.||+|+++..... ......+.+.+|+.+|+.++ ||||
T Consensus 18 ~~~~y-~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 18 PTEKL-QRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp CHHHH-HTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred ccccc-hheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 34455 7779999999999999987 7899999999865421 12334577889999998886 6666
Q ss_pred ceeeeeee-----------------cC-----------CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHH
Q 035992 90 IKFYNSWV-----------------DT-----------ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141 (613)
Q Consensus 90 Vkl~~~fv-----------------~~-----------~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~g 141 (613)
+++++.+. .. ....+|+||||+.+|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 66555432 20 25689999999999976666644 678999999999999999
Q ss_pred hhhhh-cCCCCEEecCCCCCcEEEeCCCC--------------------cEEEeccchhHHHhhhccCcccccccCcccc
Q 035992 142 LSYLH-SHDPPVIHRDLKCDNIFVNGNQG--------------------EVKIGDLGLAAILAQARSAHSVIEFMAPELY 200 (613)
Q Consensus 142 L~yLH-s~~~~IIHrDLKp~NILl~~~~g--------------------~VKL~DFGla~~l~~~~~~~gt~~YmAPEvl 200 (613)
|+||| +++ |+||||||+|||++. .+ .+||+|||+|...... ...+|+.|||||++
T Consensus 174 L~~lH~~~~--ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~ 249 (336)
T 2vuw_A 174 LAVAEASLR--FEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLF 249 (336)
T ss_dssp HHHHHHHHC--CBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGG
T ss_pred HHHHHHhCC--EeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhh
Confidence 99999 898 999999999999984 44 8999999999866543 44788899999999
Q ss_pred ccccCccchhhhhhHH-HHHHHhcCCCCCCCCcHHHHHHHHHcC-----CCCCcccccccHHHHHHHHHHhhcccCCCCH
Q 035992 201 EEEYNELVDIYAFGMC-LLELVTFEYPYVECTNAAQIYKKVTSG-----IKPASLAKVADNGVRAFIEKCIAEVSERLPA 274 (613)
Q Consensus 201 ~~~ys~ksDIWSLGvi-L~EmltG~~Pf~~~~~~~~i~~~I~~g-----~~p~~l~~~~s~~l~~lI~~cL~dP~~Rpta 274 (613)
.+..+.++||||||++ .+++++|..||........+...+... ..+.......++++++||.+||+.+ |+
T Consensus 250 ~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----sa 325 (336)
T 2vuw_A 250 TGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----SA 325 (336)
T ss_dssp CCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----SH
T ss_pred cCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----CH
Confidence 8777899999998777 778899999994422112333344322 1122234457889999999999922 99
Q ss_pred HHHh-cCCCCC
Q 035992 275 KELL-GDPFLQ 284 (613)
Q Consensus 275 ~eLL-~HPff~ 284 (613)
+|+| +||||+
T Consensus 326 ~e~l~~Hp~f~ 336 (336)
T 2vuw_A 326 TDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHCGGGC
T ss_pred HHHHhcCCCcC
Confidence 9999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.98 Aligned_cols=241 Identities=27% Similarity=0.454 Sum_probs=198.5
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
-|++.+.||+|+||+||+|.+.. .||+|+++.... .....+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~i 106 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLAI 106 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEEE
T ss_pred HeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceEE
Confidence 34788999999999999998753 499888765322 22334567789999999999999999998865 456899
Q ss_pred EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-
Q 035992 107 ITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~- 184 (613)
+|||+.+++|.+++.+.+ .+++..++.++.||+.||.|||+++ |+||||||+|||++ ++.+||+|||++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCccccccc
Confidence 999999999999998765 7999999999999999999999998 99999999999997 57999999999765421
Q ss_pred --------hccCcccccccCcccccc----------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC
Q 035992 185 --------ARSAHSVIEFMAPELYEE----------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246 (613)
Q Consensus 185 --------~~~~~gt~~YmAPEvl~~----------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p 246 (613)
.....+++.|+|||++.. .|+.++||||||+++|+|++|..||.. .....+...+..+..+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKP 261 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCC
Confidence 122347789999998753 378899999999999999999999966 4556666677777666
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
......++..+.++|.+||. +|.+|||+.++++
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 55555678899999999999 9999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=353.15 Aligned_cols=240 Identities=26% Similarity=0.408 Sum_probs=200.8
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
.-+++.+.||+|+||+||+|.+.. +..||+|+++... ...+.+.+|+.+|+.++||||+++++++.. ..++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~ 337 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIY 337 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCE
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccce
Confidence 335889999999999999998864 4679998876422 224578999999999999999999998743 4689
Q ss_pred EEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 106 FITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
+||||+.+|+|.+++.+. ..+++..+..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+.
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIE 414 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTTCC
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccceecC
Confidence 999999999999999743 56999999999999999999999998 99999999999997 56799999999997653
Q ss_pred h-----hccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 Q-----ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~-----~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
. .....++..|+|||++. ..|+.++|||||||++|||++ |..||... ...++...+..+... ..+..++..
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~ 492 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPES 492 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 2 12234556899999775 459999999999999999999 99999764 455666677766543 234567889
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhc
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+.+||.+||. +|.+|||+.+|+.
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999 9999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=353.34 Aligned_cols=242 Identities=24% Similarity=0.416 Sum_probs=200.2
Q ss_pred ceeEeeeecccCceEEEEEEEcCC---CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELE---GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~t---g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+++.+.||+|+||+||+|.+..+ +..||+|.++. .......+.+.+|+.+|+.++||||+++++++. ...
T Consensus 391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~ 464 (656)
T 2j0j_A 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENP 464 (656)
T ss_dssp GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS---TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---SSS
T ss_pred cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc---cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe---cCc
Confidence 357889999999999999998654 45688766542 334566788999999999999999999999873 235
Q ss_pred EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCeec
Confidence 889999999999999998654 6999999999999999999999998 99999999999998 5689999999999765
Q ss_pred hhhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 183 AQAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 183 ~~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.... ...+++.|||||++.. .|+.++|||||||++|||++ |..||.+. ....+...+..+..+ .++..+++
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~ 619 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNCPP 619 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHHTCCC-CCCTTCCH
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCC-CCCccccH
Confidence 3321 2334568999998764 59999999999999999997 99999764 455566666666433 34556789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
.+.+||.+||. +|.+|||+.+|++
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999 9999999999985
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.84 Aligned_cols=251 Identities=18% Similarity=0.163 Sum_probs=188.5
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CCcceee--------
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNIIKFY-------- 93 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~-------- 93 (613)
...|.+++.++||+|+||+||+|.+..+|+.||+|+++.... ......+.+.+|+.+++.+.| +|+...+
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 344556778999999999999999999999999998763322 222346779999999999987 3221111
Q ss_pred -------------eeeecCC---CCEEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHhhhhhcCCC
Q 035992 94 -------------NSWVDTE---NEHINFITEIFTSGTLRQYRKK-------HKHVDLRALKKWSRQILEGLSYLHSHDP 150 (613)
Q Consensus 94 -------------~~fv~~~---~~~l~lV~E~~~gGsL~~~l~~-------~~~lse~~i~~i~~QIl~gL~yLHs~~~ 150 (613)
.++.... ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||+|||+++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~- 231 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG- 231 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 1111111 22356667765 6799988842 235788899999999999999999998
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-ccCcccccccCcccc----------cc-ccCccchhhhhhHHHH
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-RSAHSVIEFMAPELY----------EE-EYNELVDIYAFGMCLL 218 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~~~~gt~~YmAPEvl----------~~-~ys~ksDIWSLGviL~ 218 (613)
|+||||||+|||++ .++.+||+|||++...... ....+ +.|||||++ .. .|+.++|||||||++|
T Consensus 232 -iiHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp -EECSCCCGGGEEEC-TTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred -cccCCcccceEEEe-cCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 99999999999998 5678999999998765443 23456 899999987 32 3888999999999999
Q ss_pred HHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 219 ELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 219 EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||+||+.||..... ......+... ...++..+++||.+||. +|.+||++.++++||||+..
T Consensus 309 elltg~~Pf~~~~~-~~~~~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 309 WIWCADLPNTDDAA-LGGSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHSSCCCCTTGG-GSCSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHCCCCCCCcch-hhhHHHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 99999999965332 2222222221 12457899999999999 99999999999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.86 Aligned_cols=254 Identities=17% Similarity=0.244 Sum_probs=201.5
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.++||+|+||+||+|.+..+|+.||+|+++.... ...+..|+.+++.+.|++++..+..|. ......
T Consensus 7 ~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~il~~L~~~~~i~~i~~~~-~~~~~~ 78 (483)
T 3sv0_A 7 NKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLLYESKIYRILQGGTGIPNVRWFG-VEGDYN 78 (483)
T ss_dssp TTE-ECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS------SCCHHHHHHHHHHTTTSTTCCCEEEEE-EETTEE
T ss_pred CcE-EEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc------cHHHHHHHHHHHHhcCCCCCCeEEEEE-eeCCEE
Confidence 344 888999999999999999999999999997664322 124778999999998865555444433 245688
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe--CCCCcEEEeccchhHH
Q 035992 105 NFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAI 181 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~--~~~g~VKL~DFGla~~ 181 (613)
++||||+ +++|.+++.. .+.+++..++.|+.||+.||+|||+++ ||||||||+||||+ ...+.+||+|||++..
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 9999999 9999999986 567999999999999999999999998 99999999999994 2567999999999976
Q ss_pred Hhhhc-----------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc--HHHHHHHHHcCCC--
Q 035992 182 LAQAR-----------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGIK-- 245 (613)
Q Consensus 182 l~~~~-----------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--~~~i~~~I~~g~~-- 245 (613)
+.... ...+++.|+|||++.+ .|+.++|||||||++|||++|..||..... ..+.+..+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 54321 4457889999998765 589999999999999999999999976433 3444444433221
Q ss_pred -CCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc----------CCCCCCCCcc
Q 035992 246 -PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG----------DPFLQSEDDE 289 (613)
Q Consensus 246 -p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~----------HPff~~~~~~ 289 (613)
...+...++.++.+||.+||. +|.+||++.+|++ ++|+...+|.
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~ 291 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT 291 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence 122334568899999999999 9999999887643 6676666554
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=364.28 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=204.9
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec----CC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD----TE 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~----~~ 100 (613)
++| ++.++||+|+||+||+|.+..+|+.||+|+++. .......+.+.+|+.+++.++||||+++++++.. ..
T Consensus 14 grY-~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~---~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 14 GPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ---ELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCS---CCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCe-EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecc---cCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 455 778999999999999999999999999887653 2346677889999999999999999999997643 22
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC--cEEEec
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHK---HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG--EVKIGD 175 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~---~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g--~VKL~D 175 (613)
+...++||||+.+|+|.+++...+ .+++..++.++.||+.||.|||+++ |+||||||+|||++.+.+ .+||+|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeEEEcc
Confidence 567899999999999999998764 6999999999999999999999998 999999999999984322 489999
Q ss_pred cchhHHHhhhc---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHH----------
Q 035992 176 LGLAAILAQAR---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT---------- 241 (613)
Q Consensus 176 FGla~~l~~~~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~---------- 241 (613)
||++....... ...+++.|+|||++.+ .|+.++||||||+++|+|++|..||............+.
T Consensus 168 FG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 168 LGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 99998765432 3457789999998764 599999999999999999999999976443332211110
Q ss_pred ---cC--------CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 242 ---SG--------IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 242 ---~g--------~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.+ ..+..+....+..+.+||.+||. +|.+|||+.++++||||+..
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 00 11223344567899999999999 99999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.19 Aligned_cols=224 Identities=16% Similarity=0.142 Sum_probs=181.8
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+|| ++.+.||+|+||+||+|.+..+|+.||+|+++.. ........+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 31 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 106 (286)
T 3uqc_A 31 GRY-RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQ-GVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGG 106 (286)
T ss_dssp TTE-EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTT-CCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEE
T ss_pred CcE-EEEEEEcccCCeEEEEEEecCCCceEEEEEECcc-cccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcE
Confidence 566 7889999999999999999999999999987643 22345667889999999999999999999998865 4679
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
|+||||+.|++|.+++++. .....+..|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~~------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYPA------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSCC-------
T ss_pred EEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEecc-------
Confidence 9999999999999999553 466678899999999999999998 99999999999998 67899998543
Q ss_pred hccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHH---HHHHHcCCC-CCcccccccHHHHHH
Q 035992 185 ARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQI---YKKVTSGIK-PASLAKVADNGVRAF 260 (613)
Q Consensus 185 ~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i---~~~I~~g~~-p~~l~~~~s~~l~~l 260 (613)
|++| ++.++|||||||++|||+||+.||........+ .+.+..... +..+...+++.+++|
T Consensus 175 ---------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 175 ---------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp ---------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred ---------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence 4443 788999999999999999999999764432211 011111111 112334578899999
Q ss_pred HHHHhh-cccCCCCHHHHhcC
Q 035992 261 IEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~H 280 (613)
|.+||+ +|.+| |+.|+++.
T Consensus 240 i~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 240 AARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp HHHHHCTTSSCC-CHHHHHHH
T ss_pred HHHHcccCCccC-CHHHHHHH
Confidence 999999 99999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=357.19 Aligned_cols=242 Identities=20% Similarity=0.266 Sum_probs=200.1
Q ss_pred CcceeEeeeecccCceEEEEEEEcC-CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDEL-EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN-- 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~-tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~-- 101 (613)
++| ++.++||+|+||+||+|.+.. +|+.||+|++.. .........+.+|+.+++.++||||++++++|.....
T Consensus 80 ~~y-~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 80 GQY-EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTE-EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCS---SCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred Cce-EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCc---cCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 455 888999999999999999976 799999887653 2345667788999999999999999999999875432
Q ss_pred -CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 102 -EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 102 -~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
..+|+||||+.|++|.+++.. .+++..++.|+.||+.||.|||+++ ||||||||+|||++. +.+||+|||++.
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~--~~~kl~DFG~a~ 229 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVS 229 (681)
T ss_dssp CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECS--SCEEECCCTTCE
T ss_pred CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeC--CcEEEEecccch
Confidence 127999999999999988765 7999999999999999999999998 999999999999973 489999999998
Q ss_pred HHhhhccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 181 ILAQARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 181 ~l~~~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
.........+|+.|||||++.+.++.++|||||||++|+|++|..||..... ............++.+.+|
T Consensus 230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 230 RINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGRL 300 (681)
T ss_dssp ETTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHHH
T ss_pred hcccCCccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHHH
Confidence 7766666778999999999888889999999999999999999988854210 1111111122346789999
Q ss_pred HHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 261 IEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
|.+||. +|.+||+..+.+.|+|+..
T Consensus 301 i~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhhhccCChhhCCCHHHHHHHHHHHH
Confidence 999999 9999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-31 Score=302.37 Aligned_cols=191 Identities=13% Similarity=0.046 Sum_probs=137.0
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc------cChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCC
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL------RNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~------~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 101 (613)
.+...++.|++|.+..++....|+.||+|++.+.-.. +.....+.+.+|+.+|+++ .|+||++++++|.+ +
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~ 314 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--A 314 (569)
T ss_dssp EEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--S
T ss_pred hhhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--C
Confidence 4445678899999999999999999999998753211 1234567799999999999 79999999998854 5
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+||||||+.|++|.+++.+.+.+++. .++.||+.||+|||++| ||||||||+|||++ .+|.|||+|||+|+.
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~ 388 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVT 388 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEES
T ss_pred CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCee
Confidence 6899999999999999999999999876 47899999999999999 99999999999998 678999999999976
Q ss_pred Hhhh----ccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCC
Q 035992 182 LAQA----RSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPY 227 (613)
Q Consensus 182 l~~~----~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf 227 (613)
.... ....||+.|||||++.+.+..++|+||+|+++++|.++..|+
T Consensus 389 ~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 389 TPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred CCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence 5432 234678899999999988889999999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-26 Score=255.31 Aligned_cols=189 Identities=20% Similarity=0.208 Sum_probs=142.0
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc----ChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR----NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~----~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
+..+++.-.++||+|+||+||+| ...+..+|+|......... .....+++.+|+.+|++++||||+++..++..
T Consensus 333 ~~~~~~~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 410 (540)
T 3en9_A 333 KGKKRKIPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD 410 (540)
T ss_dssp ---------------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred cccccCCCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence 33344344589999999999999 5568889988765422211 11224668999999999999999955544443
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
. ...|+||||+.+++|.+++.+ +..|+.||+.||+|||+++ |+||||||+|||++. .+||+|||+
T Consensus 411 ~--~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 411 L--DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp T--TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS---SEEECCCTT
T ss_pred C--CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC---eEEEEECcc
Confidence 3 346899999999999999876 5689999999999999998 999999999999983 999999999
Q ss_pred hHHHhhh-----------ccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCC
Q 035992 179 AAILAQA-----------RSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYV 228 (613)
Q Consensus 179 a~~l~~~-----------~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~ 228 (613)
+...... ....+|+.|||||++.. .|+..+|+|+..+-.++.+.++.+|.
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9765331 24567889999998874 58899999999999999998888874
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-23 Score=213.26 Aligned_cols=151 Identities=18% Similarity=0.173 Sum_probs=118.2
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc-----Ch---------HHHHHHHHHHHHHHhCCCCCc
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR-----NS---------EDLERLYSEVHLLKTLKHKNI 89 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~-----~~---------~~~~~l~~Ei~iLk~L~HpNI 89 (613)
.+.++++.+.||+|+||.||+|.+ .+|+.||+|+++...... .. .....+.+|+.+|+.++ |
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~- 163 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G- 163 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-
T ss_pred CCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-
Confidence 355667789999999999999999 889999999886432110 00 24567899999999999 4
Q ss_pred ceeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCC
Q 035992 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQG 169 (613)
Q Consensus 90 Vkl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g 169 (613)
+++++++.. ...++||||+.||+|.+ +. ......++.||+.||.|||+++ |+||||||+|||++ +|
T Consensus 164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~ 229 (282)
T 1zar_A 164 LAVPKVYAW---EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EE 229 (282)
T ss_dssp SSSCCEEEE---ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TT
T ss_pred CCcCeEEec---cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CC
Confidence 555554322 34689999999999987 31 1335579999999999999998 99999999999998 68
Q ss_pred cEEEeccchhHHHhhhccCcccccccCccccc
Q 035992 170 EVKIGDLGLAAILAQARSAHSVIEFMAPELYE 201 (613)
Q Consensus 170 ~VKL~DFGla~~l~~~~~~~gt~~YmAPEvl~ 201 (613)
.+||+|||++. .+..++|||++.
T Consensus 230 ~vkl~DFG~a~---------~~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSV---------EVGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCE---------ETTSTTHHHHHH
T ss_pred cEEEEECCCCe---------ECCCCCHHHHHH
Confidence 99999999975 334578999764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=183.18 Aligned_cols=145 Identities=17% Similarity=0.166 Sum_probs=111.0
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcE--EEEEEEEeecccc--------------------ChHHHHHHHHHHHHH
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIE--VAWNQIKVIDLLR--------------------NSEDLERLYSEVHLL 81 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~--VAiK~vk~~~~~~--------------------~~~~~~~l~~Ei~iL 81 (613)
.+.++.+.+.||+|+||.||+|.+..+|+. ||+|+++...... .......+.+|+.+|
T Consensus 45 ~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 124 (258)
T 1zth_A 45 KGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNL 124 (258)
T ss_dssp TTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHH
T ss_pred CCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHH
Confidence 455678899999999999999999889999 9999875432110 011234678999999
Q ss_pred HhCCCCCc--ceeeeeeecCCCCEEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhh-cCCCCEE
Q 035992 82 KTLKHKNI--IKFYNSWVDTENEHINFITEIFTS-G----TLRQYRKKHKHVDLRALKKWSRQILEGLSYLH-SHDPPVI 153 (613)
Q Consensus 82 k~L~HpNI--Vkl~~~fv~~~~~~l~lV~E~~~g-G----sL~~~l~~~~~lse~~i~~i~~QIl~gL~yLH-s~~~~II 153 (613)
+.+.|++| +.++.. ...++||||+.+ | +|.++... .++..+..++.||+.||.||| +++ |+
T Consensus 125 ~~l~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g--iv 193 (258)
T 1zth_A 125 ERAKEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE--LV 193 (258)
T ss_dssp HHHHHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC--EE
T ss_pred HHHHhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC--EE
Confidence 99988864 334432 135789999942 3 77776433 235577899999999999999 888 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 154 HrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
||||||+|||++. .++|+|||+|...
T Consensus 194 HrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 194 HADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp CSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred eCCCCHHHEEEcC---cEEEEECcccccC
Confidence 9999999999973 8999999998643
|
| >2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.1e-15 Score=125.67 Aligned_cols=59 Identities=25% Similarity=0.404 Sum_probs=57.9
Q ss_pred ceEEEEEEecCCCCeeeeEecccCCCCCHHHHHHHHHHhhCCCCccHHHHHHHHHHHHH
Q 035992 337 TIFLKLRISDSTGHFRNIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIR 395 (613)
Q Consensus 337 ~i~L~lri~~~~~~~~~i~F~F~~~~Dta~~Va~Emv~~~~l~~~d~~~ia~~i~~~i~ 395 (613)
+++|+||+||++++++||+|+|.+++|||++||+|||++|+|++.|+++||++|+++|.
T Consensus 2 pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~ 60 (96)
T 2v3s_A 2 PISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE 60 (96)
T ss_dssp CEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred CeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence 68999999999999999999999999999999999999999999999999999999997
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=161.94 Aligned_cols=139 Identities=14% Similarity=0.140 Sum_probs=98.5
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc-----------c--Ch-HH--H--HHHHHHHHHHHhCCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL-----------R--NS-ED--L--ERLYSEVHLLKTLKHK 87 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~-----------~--~~-~~--~--~~l~~Ei~iLk~L~Hp 87 (613)
..|++...||+|+||.||+|.+. +|+.||+|+++..... . .. .. . .....|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34688999999999999999874 7999999987632110 0 00 01 1 1124577777777555
Q ss_pred Ccc--eeeeeeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 88 NII--KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 88 NIV--kl~~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
++. ..+.. . . .++||||+.|++|.++. .......++.||+.+|.|||++| ||||||||.|||++
T Consensus 174 gv~vp~p~~~--~--~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 174 GFPVPEPIAQ--S--R--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG--LIHGDFNEFNILIR 239 (397)
T ss_dssp TCSCCCEEEE--E--T--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred CCCCCeeeec--c--C--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe
Confidence 442 22221 1 1 26899999998886542 22345678899999999999998 99999999999997
Q ss_pred CCCC----------cEEEeccchhH
Q 035992 166 GNQG----------EVKIGDLGLAA 180 (613)
Q Consensus 166 ~~~g----------~VKL~DFGla~ 180 (613)
++| .+.|+||+-+.
T Consensus 240 -~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 240 -EEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp -EEECSSCTTSEEEEEEECCCTTCE
T ss_pred -CCCCcccccccccceEEEEeCCcc
Confidence 333 38999999764
|
| >2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.03 E-value=8.7e-14 Score=118.28 Aligned_cols=64 Identities=34% Similarity=0.429 Sum_probs=59.7
Q ss_pred CcceEEEEEEecCC---CCee---eeEecccCCCCCHHHHHHHHHHhhCCCCccHHHHHHHHHHHHHhhC
Q 035992 335 INTIFLKLRISDST---GHFR---NIHFPFDTEADTAFAVASEMVEELNLTDQDVSTISAMIESEIRSHI 398 (613)
Q Consensus 335 ~~~i~L~lri~~~~---~~~~---~i~F~F~~~~Dta~~Va~Emv~~~~l~~~d~~~ia~~i~~~i~~~~ 398 (613)
..+|+|+|||.|++ |+.+ +|+|+|++++|||.+||+|||++|.|+++|+.+||++|+.-|..+.
T Consensus 23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~ 92 (98)
T 2lru_A 23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK 92 (98)
Confidence 46899999999994 7787 9999999999999999999999999999999999999999988773
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=5.4e-10 Score=111.66 Aligned_cols=139 Identities=18% Similarity=0.081 Sum_probs=102.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
+++...+|.|+++.||++.. .|..+++|....... .....+.+|+.+++.+. +.++.++++++.. ....|+
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~----~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~l 87 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK----GTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNL 87 (263)
T ss_dssp SEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT----TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred ceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC----CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEE
Confidence 36778889899999999964 367888877653111 11235888999999984 6778888887643 467899
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCC-------------------------------------
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD------------------------------------- 149 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~------------------------------------- 149 (613)
|||++.|.+|.+... +......++.+++.+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999987521 12233477889999999999810
Q ss_pred --------------------CCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 150 --------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 150 --------------------~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+.++|+|++|.||+++ +.+.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK-DGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence 2399999999999997 33445799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=107.71 Aligned_cols=133 Identities=16% Similarity=0.047 Sum_probs=90.8
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC--cceeeeeeecCCCCEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN--IIKFYNSWVDTENEHINF 106 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~fv~~~~~~l~l 106 (613)
++..+.+.|..+.||++. ..+|..+++|+.... ....+..|+.+++.+.+.+ +.+++.++.. ....++
T Consensus 23 ~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~ 92 (264)
T 1nd4_A 23 DWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWL 92 (264)
T ss_dssp EEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEE
T ss_pred ceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-------cchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEE
Confidence 443444466679999995 456778887765421 1245778999999886544 4567776543 346889
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCC-------------------------------------
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD------------------------------------- 149 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~------------------------------------- 149 (613)
||||+.|.+|. . ...+ ...++.+++..|..||+..
T Consensus 93 v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 93 LLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp EEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred EEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99999998884 1 1122 1245667777777777642
Q ss_pred -------------------CCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 150 -------------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 150 -------------------~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+.++|+|++|.||+++ +.+.+.|+|||.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~-~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE-NGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE-CCcEEEEEcchhcc
Confidence 1299999999999997 34455699999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.83 E-value=2.5e-09 Score=109.83 Aligned_cols=183 Identities=20% Similarity=0.192 Sum_probs=116.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCC--cceeeeeeecCCC-CEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKN--IIKFYNSWVDTEN-EHINFI 107 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpN--IVkl~~~fv~~~~-~~l~lV 107 (613)
+.++.|.+..||++. ..+++|... .......+.+|+.+|+.+ .+.. +.+++........ ...|+|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~------~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPK------HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEES------SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecC------CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 568999999999872 346655422 234567889999999888 3333 3344443211111 234789
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCC--------------------------------------
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD-------------------------------------- 149 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~-------------------------------------- 149 (613)
|+++.|.+|..... ..++......++.|++..|..||+..
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988765332 24667777777888888877777511
Q ss_pred ------------------CCEEecCCCCCcEEEeCC-CCcEEEeccchhHHHhhhccCcccccc---cCccccc---ccc
Q 035992 150 ------------------PPVIHRDLKCDNIFVNGN-QGEVKIGDLGLAAILAQARSAHSVIEF---MAPELYE---EEY 204 (613)
Q Consensus 150 ------------------~~IIHrDLKp~NILl~~~-~g~VKL~DFGla~~l~~~~~~~gt~~Y---mAPEvl~---~~y 204 (613)
+.++|+|++|.||+++.+ .+.+.|+||+.+..............+ ..|+... ..|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 238999999999999843 446789999987543211000000011 2222211 112
Q ss_pred ------------CccchhhhhhHHHHHHHhcCCCC
Q 035992 205 ------------NELVDIYAFGMCLLELVTFEYPY 227 (613)
Q Consensus 205 ------------s~ksDIWSLGviL~EmltG~~Pf 227 (613)
....+.|++|.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 22358999999999999999887
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.81 E-value=8.9e-09 Score=108.06 Aligned_cols=145 Identities=12% Similarity=0.159 Sum_probs=99.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC--CCCcceeeeeeecCCC-CEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK--HKNIIKFYNSWVDTEN-EHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~fv~~~~-~~l~lV~ 108 (613)
+.|+.|.++.||++... +..+++|..... ..........+.+|+.+++.|. +..+++++.++.+... +..|+||
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p-~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGP-KSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCC-CCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 77899999999998653 456665543200 1111122346788999999997 4567888886543211 4578999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC----------------------------------------
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH---------------------------------------- 148 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~---------------------------------------- 148 (613)
||+.|..+.+. ....++......++.+++..|..||+.
T Consensus 121 e~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99999877431 123467888889999999999999972
Q ss_pred ----------------CCCEEecCCCCCcEEEeCCCCc-EEEeccchhHH
Q 035992 149 ----------------DPPVIHRDLKCDNIFVNGNQGE-VKIGDLGLAAI 181 (613)
Q Consensus 149 ----------------~~~IIHrDLKp~NILl~~~~g~-VKL~DFGla~~ 181 (613)
.+.++|+|+++.|||++.+.+. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 1359999999999999844323 68999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=1.2e-05 Score=82.68 Aligned_cols=136 Identities=22% Similarity=0.176 Sum_probs=87.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC---CcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK---NIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp---NIVkl~~~fv~~~~~~l~lV~ 108 (613)
+.++.|....||+. |..+++|+- ........+.+|+.+|+.|.+. .+.+.+.+.. ...+..++||
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~------~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~ 92 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFP------KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGY 92 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEE------SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEE
T ss_pred eecCCCcceeEEEE-----CCEEEEEec------CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEE
Confidence 56788999999988 456665542 2345567899999999999753 3455555443 2344567999
Q ss_pred eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC----------------------------------------
Q 035992 109 EIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH---------------------------------------- 148 (613)
Q Consensus 109 E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~---------------------------------------- 148 (613)
+++.|..+....- ..++......++.++...|..||+.
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988765211 1223333334444444444444332
Q ss_pred ------------------CCCEEecCCCCCcEEEeC--CCCc-EEEeccchhHH
Q 035992 149 ------------------DPPVIHRDLKCDNIFVNG--NQGE-VKIGDLGLAAI 181 (613)
Q Consensus 149 ------------------~~~IIHrDLKp~NILl~~--~~g~-VKL~DFGla~~ 181 (613)
.+.++|+|+++.||+++. ..+. +.|+||+.+..
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223799999999999984 1345 48999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=4.8e-05 Score=75.74 Aligned_cols=136 Identities=17% Similarity=0.119 Sum_probs=89.8
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEEEe
Q 035992 32 EVLGRGAFK-KVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFITE 109 (613)
Q Consensus 32 e~LG~GafG-tVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV~E 109 (613)
+.+..|..+ +||+......+..+.+|.-. ......+..|..+|+.+. +-.+.+++.++.+ ....++||+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-------~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme 100 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGK-------GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTT 100 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEE-------THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECC-------CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEE
Confidence 344455554 69998777777778776543 234566888999998884 3346677776543 457899999
Q ss_pred ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCC----------------------------------------
Q 035992 110 IFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD---------------------------------------- 149 (613)
Q Consensus 110 ~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~---------------------------------------- 149 (613)
++.|.++.+...... .....+..++...|..||...
T Consensus 101 ~l~G~~~~~~~~~~~----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEYP----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHCG----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCCH----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 999988776543321 122234444444444444311
Q ss_pred ----------------CCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 150 ----------------PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 150 ----------------~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+.++|+|+.+.|||++ +.+.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~-~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD-EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEE-CCeEEEEEECccccc
Confidence 1289999999999998 445567999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=4e-05 Score=81.26 Aligned_cols=79 Identities=16% Similarity=0.167 Sum_probs=48.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeecc-c--cChHHHHHHHHHHHHHHhCCC--C-CcceeeeeeecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-L--RNSEDLERLYSEVHLLKTLKH--K-NIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~-~--~~~~~~~~l~~Ei~iLk~L~H--p-NIVkl~~~fv~~~~~~l~ 105 (613)
+.||.|.++.||++.....++.+++|+...... . ......+++..|..+|+.+.. + .+.+++.+ +.. ..+
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~--~~~ 111 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--MAV 111 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--TTE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCC--ccE
Confidence 789999999999997666678899887542110 0 001123466779999988742 3 34456542 332 346
Q ss_pred EEEeccCCC
Q 035992 106 FITEIFTSG 114 (613)
Q Consensus 106 lV~E~~~gG 114 (613)
+|||++.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 899999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00047 Score=70.44 Aligned_cols=30 Identities=20% Similarity=0.389 Sum_probs=25.4
Q ss_pred CCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 150 ~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+.++|+|+++.||+++ .++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence 4599999999999996 34689999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.00089 Score=69.49 Aligned_cols=84 Identities=5% Similarity=-0.099 Sum_probs=49.5
Q ss_pred eee-cccCceEEEEEEEc--C----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-C--CCcceeeeeeecCC-
Q 035992 32 EVL-GRGAFKKVYRAFDE--L----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-H--KNIIKFYNSWVDTE- 100 (613)
Q Consensus 32 e~L-G~GafGtVYka~~~--~----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-H--pNIVkl~~~fv~~~- 100 (613)
+.| +.|....+|+.... . ++..+++|.......... .....+.+|+.+|+.|. + ..+.+++.+..+..
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~-~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV-FPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS-SSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc-CchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 677 88999999988543 1 155677664322110000 00135677888888874 2 35667777543221
Q ss_pred CCEEEEEEeccCCCCH
Q 035992 101 NEHINFITEIFTSGTL 116 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL 116 (613)
....++|||++.|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 1345789999988653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0024 Score=68.30 Aligned_cols=30 Identities=20% Similarity=0.350 Sum_probs=25.0
Q ss_pred CCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 150 ~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
+.++|+|++|.|||++. ++ ++|+||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECS-SC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeC-CC-CEEEeCccccc
Confidence 34999999999999973 33 99999988754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0057 Score=60.38 Aligned_cols=120 Identities=13% Similarity=0.104 Sum_probs=80.0
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhh-cCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhccCcccc
Q 035992 115 TLRQYRKKH-KHVDLRALKKWSRQILEGLSYLH-SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI 192 (613)
Q Consensus 115 sL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLH-s~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~~~~gt~ 192 (613)
+|.+.++.. .+++|+++|.++.|.+.+|.-+- ...+ ..+=+.|..|++. .+|.|-+.+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~-~dG~V~f~~-~~s~--------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVW-RDGAVTLAP-AADD--------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEE-TTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEe-cCCceeccc-cccc--------cccc
Confidence 688888754 68999999999999999987762 1121 1233446889998 678887764 2211 1223
Q ss_pred cccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh
Q 035992 193 EFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266 (613)
Q Consensus 193 ~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~ 266 (613)
.|.|||......+.+.=|||||+++|.-+-...| ...+...++.+.+||..|..
T Consensus 102 ~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~--------------------e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 102 PPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK--------------------ENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp -----CCSSSSSCHHHHHHHHHHHHHHHHTTTCC--------------------TTEEECCCHHHHHHHHHHTT
T ss_pred CCCChhhccccchHHHHHHHHHHHHHHHhhcCCC--------------------cccchhhCHHHHHHHHHHHh
Confidence 5678987755567788999999999998864333 23355678889999988875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0068 Score=62.76 Aligned_cols=74 Identities=18% Similarity=0.098 Sum_probs=53.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC---CCCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK---HKNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~---HpNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+.|+.|.+..+|+... ++..+++|.... .....+..|...|+.|. ...+++.+.+... ....++||
T Consensus 42 ~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvm 110 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND--EVQTVFVKINER-------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLL 110 (312)
T ss_dssp EEECCSSSSEEEEEES--SSCEEEEEEEEG-------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEE
T ss_pred EEeCCccceeeeEEEE--CCCeEEEEeCCc-------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEE
Confidence 6789999999999864 466777665431 22566788999998883 3567777775432 45789999
Q ss_pred eccCCCCH
Q 035992 109 EIFTSGTL 116 (613)
Q Consensus 109 E~~~gGsL 116 (613)
|++.|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0043 Score=63.01 Aligned_cols=29 Identities=21% Similarity=0.309 Sum_probs=24.2
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.++|+|+.+.||+. .++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil~--~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD--TGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE--CSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE--CCCCEEEEecccccC
Confidence 48999999999995 356789999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.017 Score=59.21 Aligned_cols=31 Identities=23% Similarity=0.322 Sum_probs=25.5
Q ss_pred CEEecCCCCCcEEEeCC---CCcEEEeccchhHH
Q 035992 151 PVIHRDLKCDNIFVNGN---QGEVKIGDLGLAAI 181 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~---~g~VKL~DFGla~~ 181 (613)
.++|+|+.+.|||++.+ .+.+.|+||+.+..
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 49999999999999742 15789999998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.86 E-value=0.13 Score=51.53 Aligned_cols=74 Identities=12% Similarity=-0.012 Sum_probs=48.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC---CCcceeeeeeecCCCCEEEEE
Q 035992 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH---KNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 31 ~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H---pNIVkl~~~fv~~~~~~l~lV 107 (613)
.+.+|.|..+.||+... .+|+.|.+|+-... .......+..|+..|+.|.- -.+.+++.. + . -++|
T Consensus 20 v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~----~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~--~~lv 88 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVEL-ADGTPLFVKALPDD----APALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--D--RTLA 88 (288)
T ss_dssp EEEEEEETTEEEEEEEE-TTSCEEEEEECCTT----CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--T--TEEE
T ss_pred EEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC----CcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--C--ceEE
Confidence 47889999999999964 57888887653211 11222457789999988842 234555552 2 1 2678
Q ss_pred EeccCCCC
Q 035992 108 TEIFTSGT 115 (613)
Q Consensus 108 ~E~~~gGs 115 (613)
||++.++.
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.69 E-value=0.044 Score=55.78 Aligned_cols=77 Identities=9% Similarity=-0.024 Sum_probs=44.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCC--Ccceeeee---eecCCCCEEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHK--NIIKFYNS---WVDTENEHINF 106 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~Hp--NIVkl~~~---fv~~~~~~l~l 106 (613)
+.|+ |....||++.. .+|+.+++|..... . .....+..|..+++.|... .+++++.. .+....+..++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~---~--~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPE---R--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTT---T--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCC---C--CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEE
Confidence 4566 88889998743 35666776765311 0 1234566688888777422 23444432 00011345678
Q ss_pred EEeccCCCC
Q 035992 107 ITEIFTSGT 115 (613)
Q Consensus 107 V~E~~~gGs 115 (613)
+|+++.|..
T Consensus 105 l~~~i~G~~ 113 (328)
T 1zyl_A 105 VFPSVGGRQ 113 (328)
T ss_dssp EEECCCCEE
T ss_pred EEEecCCCC
Confidence 999998743
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.53 E-value=0.039 Score=59.44 Aligned_cols=71 Identities=14% Similarity=0.128 Sum_probs=45.5
Q ss_pred eeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCE
Q 035992 32 EVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEH 103 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~ 103 (613)
+.|+.|....||++.... ++..+.+|+... ... .+.+..|..+++.|...++ .++++.+ . +
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~---~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~--~-~-- 147 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PET---ESHLVAESVIFTLLSERHLGPKLYGIF--S-G-- 147 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCC---HHHHHHHHHHHHHHHHTTSSSCEEEEE--T-T--
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC---CCc---HHHHHHHHHHHHHHHhCCCCCcEEEEe--C-C--
Confidence 678889999999997542 256777665421 011 1345579999888853333 5667654 2 2
Q ss_pred EEEEEeccCCC
Q 035992 104 INFITEIFTSG 114 (613)
Q Consensus 104 l~lV~E~~~gG 114 (613)
.+|++|+.|.
T Consensus 148 -g~v~e~l~G~ 157 (429)
T 1nw1_A 148 -GRLEEYIPSR 157 (429)
T ss_dssp -EEEECCCCEE
T ss_pred -CEEEEEeCCc
Confidence 2789999763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.48 E-value=0.05 Score=55.17 Aligned_cols=76 Identities=7% Similarity=-0.036 Sum_probs=40.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC--cceeeee----eecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN--IIKFYNS----WVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN--IVkl~~~----fv~~~~~~l~ 105 (613)
+.|+.|....||+.... +| .+++|+.... ...+.+..|+.+++.|...+ +.+++.. .+....+..+
T Consensus 28 ~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~------~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT-KD-PLILTLYEKR------VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEECC---EEEEEEEES-SC-CEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred eccCCCcccceEEEEeC-Cc-cEEEEEeCCC------CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 66788888999998643 34 5666665421 12234556777777763222 3333321 0001124578
Q ss_pred EEEeccCCCC
Q 035992 106 FITEIFTSGT 115 (613)
Q Consensus 106 lV~E~~~gGs 115 (613)
+++++++|..
T Consensus 100 ~l~~~l~G~~ 109 (322)
T 2ppq_A 100 ALISFLEGMW 109 (322)
T ss_dssp EEEECCCCBC
T ss_pred EEEEeCCCcC
Confidence 8999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.099 Score=56.90 Aligned_cols=73 Identities=19% Similarity=0.139 Sum_probs=44.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~l~lV~E~ 110 (613)
+.|+.|-...+|++.....+..+.+|+.... . .... ....|..+++.|...++ .++++.+ . + .+||+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~-~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~--~-~---G~v~e~ 182 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPK-T---DEII-NREREKKISCILYNKNIAKKIYVFF--T-N---GRIEEF 182 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC--C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEE--T-T---EEEEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCC-h---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEe--C-C---eEEEEe
Confidence 6788899999999976544577877654211 0 0101 12578999998865555 5677655 2 2 249999
Q ss_pred cCCCC
Q 035992 111 FTSGT 115 (613)
Q Consensus 111 ~~gGs 115 (613)
+.|.+
T Consensus 183 I~G~~ 187 (458)
T 2qg7_A 183 MDGYA 187 (458)
T ss_dssp CCSEE
T ss_pred eCCcc
Confidence 98743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=94.84 E-value=0.037 Score=58.84 Aligned_cols=139 Identities=16% Similarity=0.196 Sum_probs=79.5
Q ss_pred eeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC-cceeeeeeecCCCCE
Q 035992 32 EVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN-IIKFYNSWVDTENEH 103 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~~~~ 103 (613)
+.|..|-...+|++.... ++..+.+++.-. . ......+.+|..+++.|.-.+ ..+++..+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~--~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~--- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA--I---LQGVDSLVLESVMFAILAERSLGPQLYGVF--PE--- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC--c---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---
Confidence 567778889999987542 346777654311 1 112345568999998884222 35666654 22
Q ss_pred EEEEEeccCCCCHH-----------H---HHH---hC-----CCC--CHHHHHHHHHHHHHH------------------
Q 035992 104 INFITEIFTSGTLR-----------Q---YRK---KH-----KHV--DLRALKKWSRQILEG------------------ 141 (613)
Q Consensus 104 l~lV~E~~~gGsL~-----------~---~l~---~~-----~~l--se~~i~~i~~QIl~g------------------ 141 (613)
.+||||+.|..|. . .+. .. +.. -...+..|+.++-..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 2899999885432 1 111 11 111 246677777665332
Q ss_pred -hhh----hhc--CCCCEEecCCCCCcEEEeCC---CCcEEEeccchhHH
Q 035992 142 -LSY----LHS--HDPPVIHRDLKCDNIFVNGN---QGEVKIGDLGLAAI 181 (613)
Q Consensus 142 -L~y----LHs--~~~~IIHrDLKp~NILl~~~---~g~VKL~DFGla~~ 181 (613)
+.. |.. ....++|+|+.+.||+++.+ .+.+.|+||..+..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 222 12249999999999999854 36899999998753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=94.75 E-value=0.035 Score=57.92 Aligned_cols=73 Identities=14% Similarity=0.140 Sum_probs=40.5
Q ss_pred eeecccCceEEEEEEEcC--------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC-cceeeeeeecCCCC
Q 035992 32 EVLGRGAFKKVYRAFDEL--------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN-IIKFYNSWVDTENE 102 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~--------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~~~ 102 (613)
+.|+.|....+|++.... .+..+.+|+... ..........|..+++.+...+ +.+++..+ . .
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~-----~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGK-----HVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCT-----TGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCC-----CccceecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 677888889999997543 125676554321 1111112357888888775333 44666543 1 2
Q ss_pred EEEEEEeccCCCC
Q 035992 103 HINFITEIFTSGT 115 (613)
Q Consensus 103 ~l~lV~E~~~gGs 115 (613)
++||+|+.|..
T Consensus 110 --~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 --GRIEEWLYGDP 120 (369)
T ss_dssp --EEEEECCCSEE
T ss_pred --cEEEEEecCCc
Confidence 57999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.30 E-value=0.16 Score=52.59 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=24.8
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
.++|+|+.+.||+++ .++.+.|+||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~-~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG-NEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEEC-GGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEe-CCCeEEEEECCCCe
Confidence 499999999999997 44679999998764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=87.03 E-value=1.9 Score=46.36 Aligned_cols=73 Identities=11% Similarity=0.082 Sum_probs=43.6
Q ss_pred eeecccCceEEEEEEEcCC-------CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCC-cceeeeeeecCCCCE
Q 035992 32 EVLGRGAFKKVYRAFDELE-------GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN-IIKFYNSWVDTENEH 103 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~t-------g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpN-IVkl~~~fv~~~~~~ 103 (613)
+.|..|-...+|+...... +..+.+++... .. ...-...+|..+++.+.-.+ ..++++.+ . .
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~----~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~- 145 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGK----HV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--E- 145 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCC----CC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--T-
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCC----Cc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--C-
Confidence 6677788899999976521 56777554321 11 11112346888888774222 35566533 2 1
Q ss_pred EEEEEeccCCCC
Q 035992 104 INFITEIFTSGT 115 (613)
Q Consensus 104 l~lV~E~~~gGs 115 (613)
++||+|+.|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 67899999865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 613 | ||||
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-54 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-51 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-14 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-72
Identities = 128/272 (47%), Positives = 176/272 (64%), Gaps = 9/272 (3%)
Query: 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE-DLERLYSE 77
V + R+ ++ +GRG+FK VY+ D +EVA + + ++ + +R E
Sbjct: 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVA---WCELQDRKLTKSERQRFKEE 58
Query: 78 VHLLKTLKHKNIIKFYNSWVDT--ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
+LK L+H NI++FY+SW T + I +TE+ TSGTL+ Y K+ K + ++ L+ W
Sbjct: 59 AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC 118
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IE 193
RQIL+GL +LH+ PP+IHRDLKCDNIF+ G G VKIGDLGLA + + + + E
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE 178
Query: 194 FMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253
FMAPE+YEE+Y+E VD+YAFGMC+LE+ T EYPY EC NAAQIY++VTSG+KPAS KVA
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 254 DNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
V+ IE CI ER K+LL F Q
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 4e-55
Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 20/266 (7%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE-DLERLYSEVHLLKTLKHKNII 90
+G G++ + + + +G + K +D +E + + L SEV+LL+ LKH NI+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILV---WKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQY----RKKHKHVDLRALKKWSRQILEGLSYLH 146
++Y+ +D N + + E G L K+ +++D + + Q+ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 147 SH---DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ----ARSAHSVIEFMAPEL 199
V+HRDLK N+F++G VK+GD GLA IL A++ +M+PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185
Query: 200 YE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258
YNE DI++ G L EL P+ + ++ K+ G K + + +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREG-KFRRIPYRYSDELN 243
Query: 259 AFIEKCIA-EVSERLPAKELLGDPFL 283
I + + + R +E+L +P +
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 4e-55
Identities = 78/289 (26%), Positives = 132/289 (45%), Gaps = 18/289 (6%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL--LRN 67
DPD ++ F + DP + +E +G G+F VY A D VA IK + ++
Sbjct: 1 DPDVAEL-FFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVA---IKKMSYSGKQS 55
Query: 68 SEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVD 127
+E + + EV L+ L+H N I++ ++ + E K +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHKKPLQ 113
Query: 128 LRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187
+ + L+GL+YLHSH +IHRD+K NI ++ G VK+GD G A+I+A A S
Sbjct: 114 EVEIAAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEP-GLVKLGDFGSASIMAPANS 170
Query: 188 AHSVIEFMAPELY----EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243
+MAPE+ E +Y+ VD+++ G+ +EL + P + +Y +
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQN 229
Query: 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291
PA + R F++ C+ +R ++ LL F+ E +V
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-54
Identities = 83/291 (28%), Positives = 139/291 (47%), Gaps = 25/291 (8%)
Query: 14 SDAEFVE--------IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL 65
SD E +E DP +Y E +G+GA VY A D G EVA I+ ++L
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVA---IRQMNL- 55
Query: 66 RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH 125
+ E + +E+ +++ K+ NI+ + +S++ + + + E G+L +
Sbjct: 56 QQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCM 113
Query: 126 VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185
D + R+ L+ L +LHS+ VIHRD+K DNI + + G VK+ D G A +
Sbjct: 114 -DEGQIAAVCRECLQALEFLHSN--QVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPE 169
Query: 186 RSAHSVI----EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
+S S + +MAPE + + Y VDI++ G+ +E++ E PY+ +Y
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 241 TSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
T+G + R F+ +C+ +V +R AKELL FL+ S
Sbjct: 230 TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-54
Identities = 68/284 (23%), Positives = 131/284 (46%), Gaps = 22/284 (7%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
+++P + LG GAF KVY+A ++ + A KVID ++ E+LE E+
Sbjct: 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAA---AKVIDT-KSEEELEDYMVEID 61
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQI 138
+L + H NI+K +++ ++ + E G + + + + ++ +Q
Sbjct: 62 ILASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 119
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS----VIEF 194
L+ L+YLH + +IHRDLK NI + G++K+ D G++A + +
Sbjct: 120 LDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 195 MAPELY------EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS 248
MAPE+ + Y+ D+++ G+ L+E+ E P+ E + K S +
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 249 LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291
+ + F++KC+ V R +LL PF+ + ++ +
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 6e-52
Identities = 68/305 (22%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
LG G V++ + G+ +A K+I L ++ E+ +L I+
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMA---RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
FY ++ + I+ E G+L Q KK + + L K S +++GL+YL
Sbjct: 69 FYGAFYS--DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHK 125
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFMAPE-LYEEEYNELV 208
++HRD+K NI VN GE+K+ D G++ L + + V +M+PE L Y+
Sbjct: 126 IMHRDVKPSNILVNSR-GEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 209 DIYAFGMCLLELVTFEYPY----------------------------------------- 227
DI++ G+ L+E+ YP
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 228 VECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286
++ + + P + V + F+ KC+ +ER K+L+ F++
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 287 DDESV 291
D E V
Sbjct: 305 DAEEV 309
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-51
Identities = 64/260 (24%), Positives = 119/260 (45%), Gaps = 17/260 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEVHLLKTLKHKNI 89
LG+G F VY A ++ +A +KV+ L + +L EV + L+H NI
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILA---LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ Y + D + I E GT+ + +K D + + ++ LSY HS
Sbjct: 69 LRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK- 125
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFMAPE-LYEEEYNE 206
VIHRD+K +N+ + GE+KI D G + +R ++++ PE + ++E
Sbjct: 126 -RVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 207 LVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA 266
VD+++ G+ E + + P+ E + YK+++ + G R I + +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EFTFPDFVTEGARDLISRLLK 240
Query: 267 -EVSERLPAKELLGDPFLQS 285
S+R +E+L P++ +
Sbjct: 241 HNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-51
Identities = 60/262 (22%), Positives = 118/262 (45%), Gaps = 17/262 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
+ LG GA+ +V A + + VA +K++D+ R + E + E+ + K L H+N++K
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVA---VKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPP 151
FY E E + G L + + +++ Q++ G+ YLH
Sbjct: 68 FYG--HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG-- 123
Query: 152 VIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------IEFMAPELYEEE-- 203
+ HRD+K +N+ ++ +KI D GLA + + + ++APEL +
Sbjct: 124 ITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEK 263
+ E VD+++ G+ L ++ E P+ + +++ Q Y + K D+ A + K
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 264 CIA-EVSERLPAKELLGDPFLQ 284
+ S R+ ++ D +
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-49
Identities = 76/275 (27%), Positives = 133/275 (48%), Gaps = 30/275 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEV 78
EI + + +G G+F VY+ + G +VA +K++++ + + L+ +EV
Sbjct: 4 EIPDG-QI-TVGQRIGSGSFGTVYKG--KWHG-DVA---VKMLNVTAPTPQQLQAFKNEV 55
Query: 79 HLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQ 137
+L+ +H NI+ F + +T+ +L + ++ L +RQ
Sbjct: 56 GVLRKTRHVNILLFMGYS---TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQ 112
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------ 191
+G+ YLH+ +IHRDLK +NIF++ + VKIGD GLA + ++ +H
Sbjct: 113 TAQGMDYLHAK--SIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 192 IEFMAPELYEEE----YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247
I +MAPE+ + Y+ D+YAFG+ L EL+T + PY N QI V G
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 248 SLAKVADN---GVRAFIEKCIA-EVSERLPAKELL 278
L+KV N ++ + +C+ + ER ++L
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (436), Expect = 5e-49
Identities = 65/305 (21%), Positives = 123/305 (40%), Gaps = 18/305 (5%)
Query: 19 VEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
VEI Y E LG GAF V+R + G A K + + + D E +
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFA---AKFV-MTPHESDKETVRK 72
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWS 135
E+ + L+H ++ ++++ D + + I E + G L + +H + ++
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 130
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILAQARSAHSVI-- 192
RQ+ +GL ++H ++ +H DLK +NI + E+K+ D GL A L +S
Sbjct: 131 RQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 193 -EFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASL 249
EF APE+ E + D+++ G+ L++ P+ + + + S
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA 248
Query: 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGRSLRVKTHYSAETSHQ 308
+ FI K + + + R+ + L P+L + + + S +
Sbjct: 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIK 308
Query: 309 ANLDK 313
D
Sbjct: 309 TKYDA 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 170 bits (431), Expect = 3e-48
Identities = 64/278 (23%), Positives = 112/278 (40%), Gaps = 18/278 (6%)
Query: 19 VEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
VE+ + Y Y E LG GAF V+R ++ G K I+ D + +
Sbjct: 20 VEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFV---AKFINT-PYPLDKYTVKN 75
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWS 135
E+ ++ L H +I ++++ D + I E + G L + + + +
Sbjct: 76 EISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ-GEVKIGDLGLAAILAQARSAHSVI-- 192
RQ EGL ++H H ++H D+K +NI + VKI D GLA L
Sbjct: 134 RQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 193 -EFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASL 249
EF APE+ + E D++A G+ L++ P+ + + +
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 251
Query: 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286
+ FI+ + E +RL + L P+L+ +
Sbjct: 252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (420), Expect = 4e-47
Identities = 57/277 (20%), Positives = 116/277 (41%), Gaps = 16/277 (5%)
Query: 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLL 81
D Y +++VLG GAF +V A D+ VA IK I + +E+ +L
Sbjct: 6 DIRDIY-DFRDVLGTGAFSEVILAEDKRTQKLVA---IKCIAKKALEGKEGSMENEIAVL 61
Query: 82 KTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
+KH NI+ + + H+ I ++ + G L + R + Q+L+
Sbjct: 62 HKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILAQARSAHSVI---EFMA 196
+ YLH ++HRDLK +N+ ++ I D GL+ + + ++A
Sbjct: 120 VKYLHDL--GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 197 P-ELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVAD 254
P L ++ Y++ VD ++ G+ L+ P+ + +A + + + + +
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
+ + FI + + +R ++ L P++ +
Sbjct: 238 DSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 164 bits (415), Expect = 2e-46
Identities = 58/298 (19%), Positives = 118/298 (39%), Gaps = 21/298 (7%)
Query: 4 DTTSEQDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVID 63
D + +DP+++ EF + + + ++V+G G F +V +L G + IK +
Sbjct: 5 DPFTFEDPNEAVREFAKEIDISCV-KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 64 LLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKK 122
+ SE ++ H N+I V T++ + ITE +G+L + R+
Sbjct: 64 SGYTEKQRRDFLSEASIMGQFDHPNVIHLE--GVVTKSTPVMIITEFMENGSLDSFLRQN 121
Query: 123 HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182
+ L R I G+ YL +HRDL NI VN N K+ D GL+ L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADM--NYVHRDLAARNILVNSN-LVCKVSDFGLSRFL 178
Query: 183 AQARSAHSV---------IEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTN 232
S + I + APE + ++ D++++G+ + E++++
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG--DPFLQSED 287
+ + + + + C + + R +++ D +++ +
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSA-LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-45
Identities = 65/267 (24%), Positives = 124/267 (46%), Gaps = 21/267 (7%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL--LRNSEDLERLYSEVHLLKTLKH 86
++ ++LG G+F V A + E A IK+++ + + + E ++ L H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYA---IKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
+K Y ++ D +E + F +G L +Y +K D + ++ +I+ L YLH
Sbjct: 68 PFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI------LAQARSAHSVIEFMAPE-L 199
+IHRDLK +NI +N + ++I D G A + A+A S ++++PE L
Sbjct: 126 GK--GIIHRDLKPENILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 200 YEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259
E+ + D++A G + +LV P+ N I++K+ + R
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDFPEKFFPKARD 239
Query: 260 FIEKCIA-EVSERLPAKELLGDPFLQS 285
+EK + + ++RL +E+ G L++
Sbjct: 240 LVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-45
Identities = 54/264 (20%), Positives = 112/264 (42%), Gaps = 20/264 (7%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
++ + + +G+G F V + G +VA +K I +N + +E
Sbjct: 3 ALNMK-EL-KLLQTIGKGEFGDVMLG--DYRGNKVA---VKCI---KNDATAQAFLAEAS 52
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWSRQ 137
++ L+H N+++ V+ + + +TE G+L Y + + L K+S
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLD 111
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR-SAHSVIEFMA 196
+ E + YL + +HRDL N+ V+ + K+ D GL + + + +++ A
Sbjct: 112 VCEAMEYLEGN--NFVHRDLAARNVLVSED-NVAKVSDFGLTKEASSTQDTGKLPVKWTA 168
Query: 197 PE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255
PE L E++++ D+++FG+ L E+ +F + +V G K +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 256 GVRAFIEKCIA-EVSERLPAKELL 278
V ++ C + + R +L
Sbjct: 229 -VYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 19/268 (7%)
Query: 27 YGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL 84
Y +Y E LGRG F V+R + K + + D + E+ +L
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYM---AKFVKV--KGTDQVLVKKEISILNIA 58
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLS 143
+H+NI+ + S+ E + I E + + + ++ R + + Q+ E L
Sbjct: 59 RHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 144 YLHSHDPPVIHRDLKCDNIFV-NGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPEL 199
+LHSH + H D++ +NI +KI + G A L + + E+ APE+
Sbjct: 117 FLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
Query: 200 YEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADNGV 257
++ + + D+++ G + L++ P++ TN I + + K
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 258 RAFIEKCIA-EVSERLPAKELLGDPFLQ 284
F+++ + E R+ A E L P+L+
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLK 262
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (396), Expect = 4e-44
Identities = 64/281 (22%), Positives = 119/281 (42%), Gaps = 31/281 (11%)
Query: 27 YGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS--------EDLERLYS 76
Y Y+ E+LGRG V R + E A +K+ID+ E E
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYA---VKIIDVTGGGSFSAEEVQELREATLK 58
Query: 77 EVHLLKTLK-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWS 135
EV +L+ + H NII+ +++ N + ++ G L Y + + + +K
Sbjct: 59 EVDILRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 116
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI--- 192
R +LE + LH + ++HRDLK +NI ++ + +K+ D G + L V
Sbjct: 117 RALLEVICALHKLN--IVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTP 173
Query: 193 EFMAPELYEEE-------YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK 245
++APE+ E Y + VD+++ G+ + L+ P+ + ++ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 246 PAS-LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
S + V+ + + + + +R A+E L PF Q
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 62/276 (22%), Positives = 118/276 (42%), Gaps = 17/276 (6%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK--VIDLLRNSEDLERLYSEVHLLKTL 84
Y E LG G F V + ++ G++ A IK R E + EV +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
+H N+I + + + + I E+ G L + + + + ++ +QIL G+ Y
Sbjct: 71 QHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 145 LHSHDPPVIHRDLKCDNIFV---NGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAPE 198
LHS + H DLK +NI + N + +KI D GLA + ++ EF+APE
Sbjct: 129 LHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 199 LYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADNG 256
+ E D+++ G+ L++ P++ T + +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESV 291
+ FI + + + +R+ ++ L P+++ +D +
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 4e-43
Identities = 58/266 (21%), Positives = 107/266 (40%), Gaps = 22/266 (8%)
Query: 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
IDPS + + +G G F V+ + L +VA IK I + E E +
Sbjct: 2 IDPS-EL-TFVQEIGSGQFGLVHLGYW-LNKDKVA---IKTIR--EGAMSEEDFIEEAEV 53
Query: 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQIL 139
+ L H +++ Y ++ I + E G L Y R + L +
Sbjct: 54 MMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEF 194
EG++YL VIHRDL N V N +K+ D G+ + + S +++
Sbjct: 112 EGMAYLEEA--CVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168
Query: 195 MAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253
+PE Y+ D+++FG+ + E+ + E + +++ + +++G + ++A
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLA 227
Query: 254 DNGVRAFIEKCIA-EVSERLPAKELL 278
V + C +R LL
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 27/279 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
E+ + E LG G F +V+ + +VA +K + + S + +E +
Sbjct: 9 EVPRE-TL-KLVERLGAGQFGEVWMGYYN-GHTKVA---VKSLK--QGSMSPDAFLAEAN 60
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL--RALKKWSRQ 137
L+K L+H+ +++ Y E I ITE +G+L + K + L L + Q
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----I 192
I EG++++ IHRDL+ NI V+ + KI D GLA ++ I
Sbjct: 118 IAEGMAFIEER--NYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 193 EFMAP-ELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251
++ AP + + D+++FG+ L E+VT ++ + + G +
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234
Query: 252 VADNGVRAFIEKCIA-EVSERLPAKEL---LGDPFLQSE 286
+ + + C +R L L D F +E
Sbjct: 235 CPEE-LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 23/287 (8%)
Query: 7 SEQDPDD-SDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFD---ELEGIEVAWNQIKVI 62
S +P+ + V I PS+ + EV+GRG F VY + + I A +K +
Sbjct: 7 SALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCA---VKSL 63
Query: 63 DLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK 122
+ + + ++ + +E ++K H N++ + +E + + G LR + +
Sbjct: 64 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL-VVLPYMKHGDLRNFIRN 122
Query: 123 HKH-VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
H ++ L + Q+ +G+ +HRDL N ++ VK+ D GLA
Sbjct: 123 ETHNPTVKDLIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARD 179
Query: 182 LAQARSAHSV--------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTN 232
+ +++MA E L +++ D+++FG+ L EL+T P N
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239
Query: 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278
I + G + D + + KC + R EL+
Sbjct: 240 TFDITVYLLQGRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 4e-42
Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 22/278 (7%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE 69
DP + + E++ + K LG G + +VY + + VA +K + ++
Sbjct: 3 DPSSPNYDKWEMERT-DI-TMKHKLGGGQYGEVYEGVWKKYSLTVA---VKTLK--EDTM 55
Query: 70 DLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVD 127
++E E ++K +KH N+++ T ITE T G L Y + V
Sbjct: 56 EVEEFLKEAAVMKEIKHPNLVQLLGVC--TREPPFYIITEFMTYGNLLDYLRECNRQEVS 113
Query: 128 LRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187
L + QI + YL IHRDL N V N VK+ D GL+ ++
Sbjct: 114 AVVLLYMATQISSAMEYLEKK--NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTY 170
Query: 188 AHSV-----IEFMAP-ELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVT 241
I++ AP L +++ D++AFG+ L E+ T+ + +Q+Y+ +
Sbjct: 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 230
Query: 242 SGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278
+ + V + C S+R E+
Sbjct: 231 KDYRMERPEGCPEK-VYELMRACWQWNPSDRPSFAEIH 267
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-41
Identities = 55/272 (20%), Positives = 109/272 (40%), Gaps = 29/272 (10%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-----EDLERLYSEVHL 80
+Y+ +LG G F VY + + VA IK ++ R S + R+ EV L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVA---IKHVEKDRISDWGELPNGTRVPMEVVL 60
Query: 81 LKTLK--HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQI 138
LK + +I+ + W + + + + L + + + + + Q+
Sbjct: 61 LKKVSSGFSGVIRLLD-WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQV 119
Query: 139 LEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFMA 196
LE + + H+ V+HRD+K +NI ++ N+GE+K+ D G A+L +
Sbjct: 120 LEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP 177
Query: 197 PELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254
PE + +++ G+ L ++V + P+ + +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSE------- 230
Query: 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
+ I C+A S+R +E+ P++Q
Sbjct: 231 --CQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 26/279 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVH 79
EI R + LG+G F +V+ VA IK + + E E
Sbjct: 13 EIPRE-SL-RLEVKLGQGCFGEVWMGTWN-GTTRVA---IKTLK--PGTMSPEAFLQEAQ 64
Query: 80 LLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY--RKKHKHVDLRALKKWSRQ 137
++K L+H+ +++ Y E I +TE + G+L + + K++ L L + Q
Sbjct: 65 VMKKLRHEKLVQLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----I 192
I G++Y+ +HRDL+ NI V N K+ D GLA ++ I
Sbjct: 122 IASGMAYVERM--NYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 193 EFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAK 251
++ APE + D+++FG+ L EL T ++ +V G + +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 238
Query: 252 VADNGVRAFIEKCIA-EVSERLPAKELLG--DPFLQSED 287
++ + + +C E ER + L + + S +
Sbjct: 239 CPES-LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-41
Identities = 63/285 (22%), Positives = 116/285 (40%), Gaps = 27/285 (9%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAF----DELEGIEVAWNQIKVIDLLRNSEDLERLY 75
EI PS R K V+G G F +VY+ + + VA IK + +
Sbjct: 3 EIHPS-CVTRQK-VIGAGEFGEVYKGMLKTSSGKKEVPVA---IKTLKAGYTEKQRVDFL 57
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKW 134
E ++ H NII+ ++ + + ITE +G L ++ R+K + L
Sbjct: 58 GEAGIMGQFSHHNIIRLEGVI--SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 115
Query: 135 SRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--- 191
R I G + + +HRDL NI VN N K+ D GL+ +L A
Sbjct: 116 LRGIAAG--MKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 192 ----IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246
I + APE + ++ D+++FG+ + E++T+ + ++ K + G +
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232
Query: 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG--DPFLQSEDD 288
+ + + +C E + R +++ D +++ D
Sbjct: 233 PTPMDCPSA-IYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (377), Expect = 5e-41
Identities = 60/266 (22%), Positives = 124/266 (46%), Gaps = 21/266 (7%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKHKNI 89
LG G+F +V+ G A +KV+ +++ + +E E +L + H I
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYA---MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
I+ + ++ D + I I + G L +K + K ++ ++ L YLHS
Sbjct: 67 IRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK- 123
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-ARSAHSVIEFMAPE-LYEEEYNEL 207
+I+RDLK +NI ++ N G +KI D G A + + +++APE + + YN+
Sbjct: 124 -DIIYRDLKPENILLDKN-GHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 208 VDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA- 266
+D ++FG+ + E++ P+ + +N + Y+K+ + + V+ + + I
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--ELRFPPFFNEDVKDLLSRLITR 238
Query: 267 EVSERLP-----AKELLGDPFLQSED 287
++S+RL +++ P+ +
Sbjct: 239 DLSQRLGNLQNGTEDVKNHPWFKEVV 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-41
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 22/266 (8%)
Query: 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHL 80
IDP + + LG G F V +VA IK+I S + E +
Sbjct: 1 IDPK-DL-TFLKELGTGQFGVVKYGKWR-GQYDVA---IKMIK--EGSMSEDEFIEEAKV 52
Query: 81 LKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQIL 139
+ L H+ +++ Y T+ I ITE +G L Y R+ + L + + +
Sbjct: 53 MMNLSHEKLVQLYGVC--TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110
Query: 140 EGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-----IEF 194
E + YL S +HRDL N VN G VK+ D GL+ + SV + +
Sbjct: 111 EAMEYLESK--QFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167
Query: 195 MAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253
PE+ +++ DI+AFG+ + E+ + E ++ + + G++ +A
Sbjct: 168 SPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-YRPHLA 226
Query: 254 DNGVRAFIEKCIA-EVSERLPAKELL 278
V + C + ER K LL
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 147 bits (371), Expect = 1e-40
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 22/273 (8%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKT 83
RY+ E+LG G +V+ A D +VA +KV+ DL R+ R E
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVA---VKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 84 LKHKNIIKFYNSWVDTENE--HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEG 141
L H I+ Y++ + E TLR + + + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 142 LSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEF 194
L++ H + +IHRD+K NI ++ VK+ D G+A +A + ++ + ++
Sbjct: 124 LNFSHQN--GIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 195 MAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS-LAKV 252
++PE + + D+Y+ G L E++T E P+ + + Y+ V P S +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 253 ADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
+ A + K +A R + ++
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 55/286 (19%), Positives = 115/286 (40%), Gaps = 31/286 (10%)
Query: 19 VEIDPSARYGRYK---EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLY 75
++I +A YK +VLG G KV + F++ + A +K++ D +
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA---LKMLQ------DCPKAR 52
Query: 76 SEVH-LLKTLKHKNIIKFYNSWVD--TENEHINFITEIFTSGTLRQY--RKKHKHVDLRA 130
EV + + +I++ + + + + + + E G L + + R
Sbjct: 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 131 LKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN--GNQGEVKIGDLGLAAILAQARSA 188
+ + I E + YLHS + + HRD+K +N+ +K+ D G A S
Sbjct: 113 ASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
Query: 189 HSV---IEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAA---QIYKKVT 241
+ ++APE+ E+Y++ D+++ G+ + L+ P+ A + ++
Sbjct: 171 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230
Query: 242 SGIK--PASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
G P V+ I + E ++R+ E + P++
Sbjct: 231 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-40
Identities = 70/300 (23%), Positives = 115/300 (38%), Gaps = 44/300 (14%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSED----LERLYSEVHLLKTLKHK 87
+ LG G F VY+A D+ VA IK I L SE E+ LL+ L H
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVA---IKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
NII +++ +I+ + + + + + +K + L+GL YLH
Sbjct: 61 NIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPELY--E 201
H ++HRDLK +N+ ++ N G +K+ D GLA A++ + APEL
Sbjct: 119 H--WILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK----------------------- 238
Y VD++A G L EL+ ++ Q+ +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 239 --KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDESVGRSL 295
K GI + A + + I+ R+ A + L + + + G L
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-40
Identities = 71/273 (26%), Positives = 120/273 (43%), Gaps = 25/273 (9%)
Query: 29 RYKEVLGRGAFKKVYRAFDEL---EGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKT 83
R E LG G+F V R + + + VA +K + D+L E ++ EV+ + +
Sbjct: 11 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVA---VKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 84 LKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGL 142
L H+N+I+ Y + +TE+ G+L +KH+ H L L +++ Q+ EG+
Sbjct: 68 LDHRNLIRLYGVV---LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFM 195
YL S IHRDL N+ + VKIGD GL L Q + + +
Sbjct: 125 GYLESK--RFIHRDLAARNLLLATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 196 APE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254
APE L ++ D + FG+ L E+ T+ N +QI K+ + +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 241
Query: 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286
+ + +C A + +R L D L+++
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFVALR-DFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 62/257 (24%), Positives = 116/257 (45%), Gaps = 17/257 (6%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQ-IKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+VLG GAF VY+ EG +V IK + + + + + E +++ ++ + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHD 149
+ + + IT++ G L Y ++HK ++ + L W QI +G++YL
Sbjct: 75 RLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR- 130
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------IEFMAPE-LYEE 202
++HRDL N+ V VKI D GLA +L + I++MA E +
Sbjct: 131 -RLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262
Y D++++G+ + EL+TF + A++I + G + + V +
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID-VYMIMV 247
Query: 263 KCIA-EVSERLPAKELL 278
KC + R +EL+
Sbjct: 248 KCWMIDADSRPKFRELI 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 7e-40
Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 23/270 (8%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFD---ELEGIEVAWNQIKVIDLLRNSEDLERLYS 76
EI R +G G F V++ E + VA IK + E+
Sbjct: 3 EIQRE-RI-ELGRCIGEGQFGDVHQGIYMSPENPALAVA---IKTCKNCTSDSVREKFLQ 57
Query: 77 EVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWS 135
E ++ H +I+K + + I E+ T G LR + + + +DL +L ++
Sbjct: 58 EALTMRQFDHPHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 136 RQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV---- 191
Q+ L+YL S +HRD+ N+ V+ VK+GD GL+ + + +
Sbjct: 115 YQLSTALAYLESK--RFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKASKGKL 171
Query: 192 -IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASL 249
I++MAPE + + D++ FG+C+ E++ + + ++ +G + +
Sbjct: 172 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-PM 230
Query: 250 AKVADNGVRAFIEKCIA-EVSERLPAKELL 278
+ + + KC A + S R EL
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-40
Identities = 51/267 (19%), Positives = 111/267 (41%), Gaps = 25/267 (9%)
Query: 33 VLGRGAFKKVYRAFDELE--GIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLKHKNI 89
LG G F V + + +++ VA +K++ N L + L +E ++++ L + I
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVA---VKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 90 IKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHD 149
++ E E + E+ G L +Y ++++HV + + + Q+ G+ YL
Sbjct: 71 VRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES- 126
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMAPE-LYE 201
+HRDL N+ + Q KI D GL+ L + + +++ APE +
Sbjct: 127 -NFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261
+++ D+++FG+ + E ++ +++ + G + A + +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE-MYDLM 243
Query: 262 EKCIA-EVSERLPAKEL---LGDPFLQ 284
C +V R + L + +
Sbjct: 244 NLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 47/257 (18%), Positives = 104/257 (40%), Gaps = 22/257 (8%)
Query: 34 LGRGAFKKVYRAFDEL--EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIK 91
LG G F V + + + I+VA IKV+ D E + E ++ L + I++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVA---IKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 92 FYNSWVDTENEHINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQILEGLSYLHSHDP 150
+ E + + E+ G L ++ K + + + + + Q+ G+ YL
Sbjct: 74 LIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK-- 128
Query: 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMAPE-LYEE 202
+HRDL N+ + KI D GL+ L S ++ +++ APE +
Sbjct: 129 NFVHRDLAARNVLLVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262
+++ D++++G+ + E +++ + ++ + G + + + A +
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE-LYALMS 246
Query: 263 KCIA-EVSERLPAKELL 278
C + +R +
Sbjct: 247 DCWIYKWEDRPDFLTVE 263
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 67/305 (21%), Positives = 116/305 (38%), Gaps = 49/305 (16%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY +G GA+ V A+D + + VA IK I + +R E+ +L +
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVA---IKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 86 HKNIIKFYNSWVDTENEHIN--FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
H+NII + E + ++ L + K +H+ + + QIL GL
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV-------IEFMA 196
Y+HS V+HRDLK N+ +N ++KI D GLA + + A
Sbjct: 124 YIHSA--NVLHRDLKPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 197 PELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-------- 246
PE+ Y + +DI++ G L E+++ + Q+ + P
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240
Query: 247 --------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
L AD+ ++K + +R+ ++ L P+L+
Sbjct: 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 286 EDDES 290
D S
Sbjct: 301 YYDPS 305
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 61/273 (22%), Positives = 126/273 (46%), Gaps = 21/273 (7%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLL-KTLKHK 87
++LG+G+F KV+ A + A IK + D++ +D+E E +L +H
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFA---IKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS 147
+ + ++ E++ F+ E G L + + DL ++ +I+ GL +LHS
Sbjct: 64 FLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 148 HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPE-LYEE 202
+++RDLK DNI ++ + G +KI D G+ + + +++APE L +
Sbjct: 122 KG--IVYRDLKLDNILLDKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262
+YN VD ++FG+ L E++ + P+ + +++ + + + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPF--YPRWLEKEAKDLLV 235
Query: 263 KCIA-EVSERLPAK-ELLGDPFLQSEDDESVGR 293
K E +RL + ++ P + + E + R
Sbjct: 236 KLFVREPEKRLGVRGDIRQHPLFREINWEELER 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 53/276 (19%), Positives = 121/276 (43%), Gaps = 24/276 (8%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVI--DLLRNSEDLERLYSEVHLLKTLKH 86
Y ++LG+G F KV ++ G A +K++ +++ +++ +E +L+ +H
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYA---MKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
+ + ++ + F+ E G L + + + + + +I+ L YLH
Sbjct: 65 PFLTALK--YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI----EFMAPELYE- 201
S V++RD+K +N+ ++ + G +KI D GL + E++APE+ E
Sbjct: 123 SR--DVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 179
Query: 202 EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261
+Y VD + G+ + E++ P+ + ++++ + + ++ +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILME--EIRFPRTLSPEAKSLL 236
Query: 262 EKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291
+ + +RL AKE++ F S + + V
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 66/328 (20%), Positives = 120/328 (36%), Gaps = 58/328 (17%)
Query: 5 TTSEQDPDDSDAEFVEIDPSARYGRYKE--VLGRGAFKKVYRAFDELEGIEVAWNQIKVI 62
TT P E+ Y + V+G G+F VY+A G VA IK +
Sbjct: 4 TTVVATPGQGPDRPQEVS-------YTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKV 53
Query: 63 DLLRNSEDLERLYSEVHLLKTLKHKNIIK----FYNSWVDTENEHINFITEIFTSG---T 115
+D E+ +++ L H NI++ FY+S + ++N + +
Sbjct: 54 -----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 116 LRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGD 175
R Y + + + + +K + Q+ L+Y+HS + HRD+K N+ ++ + +K+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 176 LGLAAILAQARSAHSVIE---FMAPELY--EEEYNELVDIYAFGMCLLELVTFEYPYVEC 230
G A L + S I + APEL +Y +D+++ G L EL+ + +
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 231 TNAAQIYKKVTSGIKPAS--------------------------LAKVADNGVRAFIEKC 264
+ Q+ + + P A +
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 265 IA-EVSERLPAKELLGDPFLQSEDDESV 291
+ + RL E F D +V
Sbjct: 287 LEYTPTARLTPLEACAHSFFDELRDPNV 314
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-39
Identities = 73/322 (22%), Positives = 122/322 (37%), Gaps = 60/322 (18%)
Query: 7 SEQDPDDSDAEFVEIDPSA------------RYGRYKEVLGRGAFKKVYRAFD-----EL 49
Q SD E+ +D + +VLG GAF KV A
Sbjct: 7 MVQVTGSSDNEYFYVDFREYEYDLKWEFPRENL-EFGKVLGSGAFGKVMNATAYGISKTG 65
Query: 50 EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHINFIT 108
I+VA +K++ +S + E L SE+ ++ L H+NI+ + T + I I
Sbjct: 66 VSIQVA---VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC--TLSGPIYLIF 120
Query: 109 EIFTSGTLRQYRKKHKH-----------------------VDLRALKKWSRQILEGLSYL 145
E G L Y + + + L ++ Q+ +G+ +L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV------IEFMAPE- 198
+HRDL N+ V VKI D GLA + + +++MAPE
Sbjct: 181 EFK--SCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237
Query: 199 LYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257
L+E Y D++++G+ L E+ + PY A YK + +G K + +
Sbjct: 238 LFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEE-I 296
Query: 258 RAFIEKCIA-EVSERLPAKELL 278
++ C A + +R L
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 141 bits (355), Expect = 1e-37
Identities = 62/271 (22%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID--LLRNSEDLERLYSEV---HLLKTLKH 86
++GRG F +VY G A +K +D ++ + +E L+ T
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYA---MKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 87 KNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLH 146
I+ ++ + ++FI ++ G L + +H ++ ++ +I+ GL ++H
Sbjct: 67 PFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 147 SHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--IEFMAPELYEEE- 203
+ V++RDLK NI ++ G V+I DLGLA ++ + SV +MAPE+ ++
Sbjct: 125 NRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 204 -YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262
Y+ D ++ G L +L+ P+ + + + L +R+ +E
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 263 KCIA-EVSERL-----PAKELLGDPFLQSED 287
+ +V+ RL A+E+ PF +S D
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-37
Identities = 69/289 (23%), Positives = 121/289 (41%), Gaps = 43/289 (14%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLKHKNII 90
E +G G + VY+A ++L G VA +K I L +E + E+ LLK L H NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVA---LKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 91 KFYNSWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHD 149
K + + + E + + L +K + Q+L+GL++ HSH
Sbjct: 65 KLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH- 121
Query: 150 PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHS----VIEFMAPELY--EEE 203
V+HRDLK N+ +N G +K+ D GLA ++ + + APE+ +
Sbjct: 122 -RVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 204 YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP----------------- 246
Y+ VDI++ G E+VT + + Q+++ + P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 247 ---------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
+ + D R+ + + + + ++R+ AK L PF Q
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-37
Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 29/272 (10%)
Query: 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHK 87
++++V+G G F +V +A + +G+ + IK + + +D E+ +L L H
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 88 NIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDL----------------RAL 131
NII + ++ E G L + +K + ++ + L
Sbjct: 72 NIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV 191
++ + G+ YL IHRDL NI V N KI D GL+
Sbjct: 130 LHFAADVARGMDYLSQK--QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMG 186
Query: 192 ---IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA 247
+ +MA E L Y D++++G+ L E+V+ A++Y+K+ G +
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246
Query: 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278
D V + +C + ER ++L
Sbjct: 247 KPLNCDDE-VYDLMRQCWREKPYERPSFAQIL 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 6e-37
Identities = 61/317 (19%), Positives = 118/317 (37%), Gaps = 55/317 (17%)
Query: 19 VEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLY 75
VE +Y+ +G+G F +V++A G +VA +K + + E
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITAL 57
Query: 76 SEVHLLKTLKHKNIIKFYNSWVDTENE------HINFITEIFTSGTLRQYRKKHKHVDLR 129
E+ +L+ LKH+N++ + I + + L
Sbjct: 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 117
Query: 130 ALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH 189
+K+ + +L GL Y+H + ++HRD+K N+ + + G +K+ D GLA + A+++
Sbjct: 118 EIKRVMQMLLNGLYYIHRN--KILHRDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQ 174
Query: 190 SV--------IEFMAPE--LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY-- 237
+ + PE L E +Y +D++ G + E+ T T Q+
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
Query: 238 ---------------------------KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVS 269
K +K A V D I+K + + +
Sbjct: 235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294
Query: 270 ERLPAKELLGDPFLQSE 286
+R+ + + L F S+
Sbjct: 295 QRIDSDDALNHDFFWSD 311
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 136 bits (343), Expect = 1e-36
Identities = 65/292 (22%), Positives = 115/292 (39%), Gaps = 45/292 (15%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLK 85
+Y E +G G + VY+A + G A +K I L + E + E+ +LK LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNY-GETFA---LKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
H NI+K Y+ + + + E + ++ K + Q+L G++Y
Sbjct: 59 HSNIVKLYDVIHT--KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAH----SVIEFMAPELYE 201
H V+HRDLK N+ +N GE+KI D GLA + + + AP++
Sbjct: 117 HDR--RVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 202 EE--YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYK--------------------- 238
Y+ +DI++ G E+V + + A Q+ +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 239 -----KVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
V + S K D + K + + ++R+ AK+ L + +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-36
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 45/293 (15%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDL-ERLYSEVHLLKTLK 85
+Y+ E +G G + V++A + VA +K + L + E + E+ LLK LK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALREICLLKELK 59
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
HKNI++ ++ + + + E + + + +D +K + Q+L+GL +
Sbjct: 60 HKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 146 HSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV----IEFMAPELY- 200
HS V+HRDLK N+ +N N GE+K+ + GLA +S + + P++
Sbjct: 118 HSR--NVLHRDLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 201 -EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--------------- 244
+ Y+ +D+++ G EL P + K++ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 245 ------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284
++ + R ++ + +R+ A+E L P+
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (347), Expect = 1e-36
Identities = 56/273 (20%), Positives = 125/273 (45%), Gaps = 19/273 (6%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL--LRNSEDLERLYSEVHLLKTL 84
++ + LG G+F +V + G A +K++D + + +E +E +L+ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYA---MKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 85 KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSY 144
++K S+ D N ++ + E G + + ++ + ++ QI+ Y
Sbjct: 99 NFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 145 LHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA-AILAQARSAHSVIEFMAPE-LYEE 202
LHS D +I+RDLK +N+ ++ G +++ D G A + + + E +APE + +
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQ-GYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK 213
Query: 203 EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG--IKPASLAKVADNGVRAF 260
YN+ VD +A G+ + E+ P+ QIY+K+ SG P+ + + +R
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272
Query: 261 IEKCIAE--VSERLPAKELLGDPFLQSEDDESV 291
++ + + + + ++ + + D ++
Sbjct: 273 LQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 3e-36
Identities = 52/283 (18%), Positives = 103/283 (36%), Gaps = 34/283 (12%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY+ +G G+F +Y D G EVA IK+ +L+ E + K ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKLE---CVKTKHPQLHIESKIYKMMQ 60
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
I W E ++ + E+ + + L+ + + Q++ + Y+
Sbjct: 61 GGVGIPTIR-WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 146 HSHDPPVIHRDLKCDNIFV--NGNQGEVKIGDLGLAAILAQARSAHSV-----------I 192
HS + IHRD+K DN + V I D GLA AR+ +
Sbjct: 120 HSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 193 EFMAPELYE-EEYNELVDIYAFGMCLLELVT--FEYPYVECTNAAQIYKKVTSG---IKP 246
+ + + E + D+ + G L+ + ++ Q Y++++
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 247 ASLAKVADNGVRAFIEKCIAEVSERLP----AKELLGDPFLQS 285
L K + ++ C + + P ++L + F +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 64/291 (21%), Positives = 114/291 (39%), Gaps = 52/291 (17%)
Query: 31 KEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNII 90
+E +G+G F +V+R + G EVA +K+ E +E++ L+H+NI+
Sbjct: 8 QESIGKGRFGEVWRG--KWRGEEVA---VKIFS--SREERSWFREAEIYQTVMLRHENIL 60
Query: 91 KFYNSWVDTEN--EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS- 147
F + + +++ G+L Y ++ V + + K + GL++LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHME 119
Query: 148 -----HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSV--------IEF 194
P + HRDLK NI V N G I DLGLA A + +
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 195 MAPELYEE-------EYNELVDIYAFGMCLLELVT----------FEYPYVECTNAA--- 234
MAPE+ ++ E + DIYA G+ E+ ++ PY + +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 235 -QIYKKVTSGIKPASLAKVADN-----GVRAFIEKCIA-EVSERLPAKELL 278
++ K V ++ + + + +C + RL A +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-35
Identities = 71/303 (23%), Positives = 121/303 (39%), Gaps = 47/303 (15%)
Query: 9 QDPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVID 63
Q P D EF P R + + LG GAF KV A + VA +K++
Sbjct: 11 QLPYDHKWEF----PRNRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVA---VKMLK 62
Query: 64 LLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKK 122
+ + E L SE+ +L L H NI+ + T ITE G L + ++
Sbjct: 63 PSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC--TIGGPTLVITEYCCYGDLLNFLRR 120
Query: 123 HKH------------------VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFV 164
+ +DL L +S Q+ +G+++L S + IHRDL NI +
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL 178
Query: 165 NGNQGEVKIGDLGLAAILAQARSAHSV------IEFMAPE-LYEEEYNELVDIYAFGMCL 217
KI D GLA + + +++MAPE ++ Y D++++G+ L
Sbjct: 179 THG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 218 LELVTFEYPYVECTNA-AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAK 275
EL + ++ YK + G + S + ++ C + +R K
Sbjct: 238 WELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-MYDIMKTCWDADPLKRPTFK 296
Query: 276 ELL 278
+++
Sbjct: 297 QIV 299
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-35
Identities = 75/299 (25%), Positives = 127/299 (42%), Gaps = 43/299 (14%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE-DLERLYSEVHLLKTLK 85
Y+ + +G GA+ V A D G +VA IK + SE +R Y E+ LLK ++
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVA---IKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 86 HKNIIKFYNSWVDTEN--EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
H+N+I + + E + +F + GT KH+ + ++ Q+L+GL
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI-EFMAPELY-- 200
Y+H+ HRDLK N+ VN + E+KI D GLA + + V + APE+
Sbjct: 136 YIHAAGII--HRDLKPGNLAVNED-CELKILDFGLARQADSEMTGYVVTRWYRAPEVILN 192
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-------------- 246
Y + VDI++ G + E++T + + + Q+ + + P
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 247 --------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
AS+ A +EK + + +R+ A E L P+ +S D
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTE 311
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 5e-35
Identities = 67/288 (23%), Positives = 118/288 (40%), Gaps = 37/288 (12%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQ----IKVIDLLRNSEDLERLY 75
E+ R + LG GAF +V A + +K++ +DL L
Sbjct: 9 ELPRD-RL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 76 SEVHLLKTL-KHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK---------- 124
SE+ ++K + KHKNII + T++ + I E + G LR+Y + +
Sbjct: 67 SEMEMMKMIGKHKNIINLLGAC--TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 125 ------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178
+ + L + Q+ G+ YL S IHRDL N+ V + +KI D GL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASK--KCIHRDLAARNVLVTED-NVMKIADFGL 181
Query: 179 AAILAQARSAHSV------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECT 231
A + +++MAPE L++ Y D+++FG+ L E+ T
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 232 NAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278
+++K + G + + + + + C S+R K+L+
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNE-LYMMMRDCWHAVPSQRPTFKQLV 288
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-35
Identities = 50/278 (17%), Positives = 111/278 (39%), Gaps = 22/278 (7%)
Query: 32 EVLGRGAFKKVYRAFD---ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKN 88
+VLG GA+ KV+ G A +K +++ ++ E +E +L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 89 IIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH 148
+ + TE ++ I + G L + + + ++ + +I+ L +LH
Sbjct: 90 FLVTLHYAFQTET-KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 148
Query: 149 DPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVIEFMAPELYEEE----- 203
+I+RD+K +NI ++ N G V + D GL+ + + E +
Sbjct: 149 --GIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 204 ---YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK-PASLAKVADNGVRA 259
+++ VD ++ G+ + EL+T P+ + +K + +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKD 265
Query: 260 FIEKCIA-EVSERLP-----AKELLGDPFLQSEDDESV 291
I++ + + +RL A E+ F Q + + +
Sbjct: 266 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL 303
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 8e-35
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 46/297 (15%)
Query: 29 RYK--EVLGRGAFKKVYRAFD-ELEGIEVAWNQIKVIDLLRNSEDLE-RLYSEVHLLKTL 84
+Y+ +G GA+ KV++A D + G VA +K + + E + EV +L+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 85 K---HKNIIKFYNSWVDTENE---HINFITEIFTSGTLRQY-RKKHKHVDLRALKKWSRQ 137
+ H N+++ ++ + + + + E + V +K Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 138 ILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EF 194
+L GL +LHSH V+HRDLK NI V + G++K+ D GLA I + + SV+ +
Sbjct: 125 LLRGLDFLHSHR--VVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWY 181
Query: 195 MAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS----- 248
APE L + Y VD+++ G E+ + + ++ Q+ K + P
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 249 -------------------LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285
D + + KC+ ++R+ A L P+ Q
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-34
Identities = 55/306 (17%), Positives = 103/306 (33%), Gaps = 51/306 (16%)
Query: 10 DPDDSDAEFVEIDPSARYGRYKEVLGRGAFKKVYRA-----FDELEGIEVAWNQIKVIDL 64
+P E+ P Y +G GAF +V++A VA +K++
Sbjct: 2 NPKLLSLEY----PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVA---VKMLKE 53
Query: 65 LRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHK 124
+++ E L+ + NI+K + + + E G L ++ +
Sbjct: 54 EASADMQADFQREAALMAEFDNPNIVKLLGVC--AVGKPMCLLFEYMAYGDLNEFLRSMS 111
Query: 125 H------------------------VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160
+ +RQ+ G++YL +HRDL
Sbjct: 112 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATR 169
Query: 161 NIFVNGNQGEVKIGDLGLAAILAQARSAHSV------IEFMAPE-LYEEEYNELVDIYAF 213
N V N VKI D GL+ + A + I +M PE ++ Y D++A+
Sbjct: 170 NCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228
Query: 214 GMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERL 272
G+ L E+ ++ ++ V G A + + C + ++R
Sbjct: 229 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLE-LYNLMRLCWSKLPADRP 287
Query: 273 PAKELL 278
+
Sbjct: 288 SFCSIH 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 2e-34
Identities = 54/331 (16%), Positives = 123/331 (37%), Gaps = 57/331 (17%)
Query: 3 QDTTSEQDPDDSDAEFVEIDPSARYGRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIK 60
D + + + D E ++ + Y+ LGRG + +V+ A + +V +K
Sbjct: 11 TDVNTHRPREYWDYESHVVEWGNQ-DDYQLVRKLGRGKYSEVFEAINITNNEKVV---VK 66
Query: 61 VIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQY 119
++ +++ E+ +L+ L+ NII + D + + E + +Q
Sbjct: 67 ILK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 122
Query: 120 RKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179
+ D+R + +IL+ L Y HS ++HRD+K N+ ++ ++++ D GLA
Sbjct: 123 YQTLTDYDIR---FYMYEILKALDYCHSM--GIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177
Query: 180 AILAQARSAHSVI---EFMAPELYEEE--YNELVDIYAFGMCLLELVTFEYPYVECTNAA 234
+ + + F PEL + Y+ +D+++ G L ++ + P+ +
Sbjct: 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 235 QIYKKVT-----------------------------------SGIKPASLAKVADNGVRA 259
++ + +
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 260 FIEKCIA-EVSERLPAKELLGDPFLQSEDDE 289
F++K + + RL A+E + P+ + +
Sbjct: 298 FLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 127 bits (319), Expect = 2e-33
Identities = 35/262 (13%), Positives = 86/262 (32%), Gaps = 32/262 (12%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
YK +G G+F ++ + L +VA IK ++ L Y LL
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 86 HKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYL 145
+ ++ E H + ++ + ++ + ++Q+L + +
Sbjct: 62 GIPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 146 HSHDPPVIHRDLKCDNIFVN----GNQGEVKIGDLGLAAILAQARSAHSV---------- 191
H +++RD+K DN + N + + D G+ + +
Sbjct: 118 HEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 -IEFMAPELYE-EEYNELVDIYAFGMCLLELVT--FEYPYVECTNAAQIYKKVTSGIKPA 247
+M+ + E + D+ A G + + + ++ Q Y+++ +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 248 SLAKVADN---GVRAFIEKCIA 266
L ++ ++
Sbjct: 236 PLRELCAGFPEEFYKYMHYARN 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-33
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 33/286 (11%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQ--IKVIDLLRNSEDLERLYSE 77
E R + + LGRGAF +V A +K++ + L SE
Sbjct: 9 EFPRD-RL-KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKH------------ 125
+ +L + H + + I E G L Y + ++
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 126 ----VDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181
+ L L +S Q+ +G+ +L S IHRDL NI ++ VKI D GLA
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASR--KCIHRDLAARNILLSEK-NVVKICDFGLARD 183
Query: 182 LAQARSAHSV------IEFMA-PELYEEEYNELVDIYAFGMCLLELVTF-EYPYVECTNA 233
+ + +++MA +++ Y D+++FG+ L E+ + PY
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 234 AQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278
+ +++ G + + + + C E S+R EL+
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELV 288
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 51/279 (18%), Positives = 109/279 (39%), Gaps = 28/279 (10%)
Query: 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQ--IKVIDLLRNSEDLERLYSE 77
E+ + LG+G+F VY + + + IK ++ + + +E
Sbjct: 16 EVARE-KI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 78 VHLLKTLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHV----------D 127
++K ++++ ++ + I E+ T G L+ Y + +
Sbjct: 74 ASVMKEFNCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 128 LRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARS 187
L + + + +I +G++YL+++ +HRDL N V + VKIGD G+ + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDY 188
Query: 188 AHSV------IEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKV 240
+ +M+PE L + + D+++FG+ L E+ T + + Q+ + V
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 241 TSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278
G D + + C R E++
Sbjct: 249 MEGGLLDKPDNCPDM-LFELMRMCWQYNPKMRPSFLEII 286
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 43/299 (14%)
Query: 29 RYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTLK 85
RY+ +G GA+ V AFD G+ VA +K + ++ +R Y E+ LLK +K
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVA---VKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 86 HKNIIKFYNSWVDTE--NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLS 143
H+N+I + + E + G K + + ++ QIL GL
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 144 YLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL-AQARSAHSVIEFMAPELY-- 200
Y+HS D +IHRDLK N+ VN E+KI D GLA + + + APE+
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN 192
Query: 201 EEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP-------------- 246
YN+ VDI++ G + EL+T + + Q+ + P
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 247 --------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDDES 290
A++ A+ +EK + + +R+ A + L + D
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 69/314 (21%), Positives = 119/314 (37%), Gaps = 60/314 (19%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDL-LRNSEDLERLYSEVHLLKTL 84
RY+ + +G GA V A+D + VA IK + +N +R Y E+ L+K +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVA---IKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 85 KHKNIIKFYNSWVD----TENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILE 140
HKNII N + E + + + E+ + + + + H + Q+L
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH---ERMSYLLYQMLC 130
Query: 141 GLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQARSAHSVI---EFMAP 197
G+ +LHS IHRDLK NI V + +KI D GLA + + + AP
Sbjct: 131 GIKHLHSAGI--IHRDLKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 198 E-LYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP---------- 246
E + Y E VDI++ G + E+V + + Q K + P
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 247 -----------------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKE 276
+ K+ + R + K + + ++R+ +
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 277 LLGDPFLQSEDDES 290
L P++ D +
Sbjct: 308 ALQHPYINVWYDPA 321
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (248), Expect = 2e-23
Identities = 50/223 (22%), Positives = 95/223 (42%), Gaps = 29/223 (13%)
Query: 28 GRYK--EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK 85
RY LG G F V+ A D + VA +K++ + E E+ LL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVA---MKIVR--GDKVYTEAAEDEIKLLQRVN 67
Query: 86 H-----------KNIIKFYNSWVDTENEHINFITEIFTSGT---LRQYRKKHKHVDLRAL 131
+I+K + + ++ + G + +H+ + L +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 132 KKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN-----GNQGEVKIGDLGLAAILAQ-A 185
K+ S+Q+L GL Y+H +IH D+K +N+ + N ++KI DLG A +
Sbjct: 128 KQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 186 RSAHSVIEFMAPE-LYEEEYNELVDIYAFGMCLLELVTFEYPY 227
++ E+ +PE L + DI++ + EL+T ++ +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 70.6 bits (172), Expect = 1e-14
Identities = 27/204 (13%), Positives = 59/204 (28%), Gaps = 34/204 (16%)
Query: 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSE---------DLERLYSEVHLLK 82
+++G G V+ + E + E +K + S
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECV---VKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 83 TLKHKNIIKFYNSWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGL 142
+ + + K V K+ V + + ILE +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNA-----VLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 143 SYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-------ARSAHSVIEFM 195
+ + ++H DL N+ V+ + I D + + + R ++I +
Sbjct: 117 AKFYHR--GIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREILERDVRNIITY- 171
Query: 196 APELYEEEYNELVDIYAFGMCLLE 219
+ Y DI + +L+
Sbjct: 172 ----FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 613 | |||
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.7 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.01 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.07 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.55 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.24 |
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=480.27 Aligned_cols=264 Identities=50% Similarity=0.914 Sum_probs=241.5
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
+.+.++|||+++.+.||+|+||+||+|.++.+++.||+|.++.... .....+.+.+|+++|++++|||||++|++|..
T Consensus 2 ~g~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 79 (270)
T d1t4ha_ 2 VGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 79 (270)
T ss_dssp CEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred CCcCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEee
Confidence 4678899999999999999999999999999999999998875432 45667889999999999999999999999865
Q ss_pred C--CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 99 T--ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 99 ~--~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
. .+..+|+||||+.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++++|+||||||+|||+++.++.+||+||
T Consensus 80 ~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DF 159 (270)
T d1t4ha_ 80 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 159 (270)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence 3 34678999999999999999999999999999999999999999999998889999999999999766789999999
Q ss_pred chhHHHhh--hccCcccccccCccccccccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 177 GLAAILAQ--ARSAHSVIEFMAPELYEEEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 177 Gla~~l~~--~~~~~gt~~YmAPEvl~~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
|+|..... .....||+.|||||++.+.|+.++|||||||++|||++|+.||.+..+...+++.+..+..|..++...+
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred CcceeccCCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCC
Confidence 99986543 2356789999999999989999999999999999999999999988899999999999988888888899
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQ 284 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~ 284 (613)
+++++||.+||+ +|.+|||++|||+||||+
T Consensus 240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 999999999999 999999999999999996
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=454.62 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=222.7
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
||..|| ++.+.||+|+||+||+|.++.+|+.||+|++++... ...+.+.+|+.+|++++|||||+++++|.+ .
T Consensus 17 dp~~~Y-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 89 (293)
T d1yhwa1 17 DPKKKY-TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLV--G 89 (293)
T ss_dssp CTTTTB-CSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred Cccccc-EEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEE--C
Confidence 577777 666899999999999999999999999998875432 234678999999999999999999999865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+|+|||||.||+|.+++.+ +.+++..++.|++||+.||+|||++| |+||||||+|||++ .+|.+||+|||+|..
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQ 165 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEE
T ss_pred CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhhee
Confidence 579999999999999998876 56999999999999999999999998 99999999999998 568999999999986
Q ss_pred Hhh----hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 182 LAQ----ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 182 l~~----~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
+.. .....||+.|||||++.+ .|+.++|||||||++|+|+||..||.+......++..+..+..+...+..+++.
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 245 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHH
T ss_pred eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHH
Confidence 543 234568899999998865 499999999999999999999999988776677776666666555667778999
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 9999999999 99999999999999999754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=447.19 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=216.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|+++.+|+.||+|+++... .....+++.+|+.+|++++||||++++++|.+ ...+|+|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~iv 81 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 81 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh---cchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEE
Confidence 478899999999999999999999999999987543 23345678999999999999999999999865 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
||||.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|..+..
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTE
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccCCc
Confidence 999999999999998889999999999999999999999998 99999999999998 568999999999986532
Q ss_pred ---hccCcccccccCcccccc-cc-CccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 185 ---ARSAHSVIEFMAPELYEE-EY-NELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~~-~y-s~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
.....||+.|||||++.+ .| +.++|||||||++|||+||++||....+....+..+............+++++++
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHH
Confidence 234568999999998865 34 6789999999999999999999977666666666666665555555677899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||+ +|.+|||++|+|+||||+..
T Consensus 239 li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 239 LLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9999999 99999999999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=445.76 Aligned_cols=257 Identities=25% Similarity=0.468 Sum_probs=220.0
Q ss_pred ccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC
Q 035992 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT 99 (613)
Q Consensus 20 ~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~ 99 (613)
++||+..| ++.+.||+|+||+||+|+++.+|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+
T Consensus 7 ~~~p~d~Y-~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 80 (288)
T d2jfla1 7 DLNPEDFW-EIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYY- 80 (288)
T ss_dssp SSCGGGTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred CCCcccCe-EEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-
Confidence 46677766 8889999999999999999999999999988743 23456778999999999999999999999865
Q ss_pred CCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 100 ENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++|||||.+|+|.+++.+ .+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+
T Consensus 81 -~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~ 156 (288)
T d2jfla1 81 -ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGV 156 (288)
T ss_dssp -TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTT
T ss_pred -CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechh
Confidence 4589999999999999998765 467999999999999999999999998 99999999999998 578999999999
Q ss_pred hHHHhh----hccCcccccccCccccc------cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC-CCC
Q 035992 179 AAILAQ----ARSAHSVIEFMAPELYE------EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-KPA 247 (613)
Q Consensus 179 a~~l~~----~~~~~gt~~YmAPEvl~------~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-~p~ 247 (613)
|..... .....||+.|||||++. ..|+.++|||||||++|||+||++||.+....+ ++..+..+. ...
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~~~~~~ 235 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKSEPPTL 235 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHSCCCCC
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCCCCC
Confidence 865432 34567899999999873 348999999999999999999999997755544 444555443 333
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..+..+++++++||.+||+ +|.+|||+.|+|+||||+...
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 4556789999999999999 999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=446.86 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=224.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|.++.+|+.||+|++++.... .....+.+.+|+++|++++||||++++++|.+ ...+|+|
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~iv 86 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLYFG 86 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEEEE
Confidence 58899999999999999999999999999998754332 23445779999999999999999999999864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
||||.||+|.+++...+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|..+..
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC----
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCCc
Confidence 999999999999999999999999999999999999999998 99999999999998 678999999999976532
Q ss_pred ---hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHH
Q 035992 185 ---ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAF 260 (613)
Q Consensus 185 ---~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~l 260 (613)
.....||+.|||||++.+ .|+.++|||||||++|||+||..||.. .+...++.++..+.. .++..+++++++|
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~l 240 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDL 240 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHH
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHH
Confidence 224568999999998865 599999999999999999999999965 567777888877642 3566789999999
Q ss_pred HHHHhh-cccCCCCHHH------HhcCCCCCCCCccccccc
Q 035992 261 IEKCIA-EVSERLPAKE------LLGDPFLQSEDDESVGRS 294 (613)
Q Consensus 261 I~~cL~-dP~~Rpta~e------LL~HPff~~~~~~~~~~~ 294 (613)
|.+||+ +|.+|||++| +++||||+..+|..+...
T Consensus 241 i~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 281 (288)
T ss_dssp HHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred HHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC
Confidence 999999 9999999987 589999999888766543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-54 Score=452.30 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=226.2
Q ss_pred CCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC
Q 035992 22 DPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 22 dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~ 101 (613)
||+.+| +..+.||+|+||+||+|+++.+|+.||+|+++.... ......+.+.+|+.+|++++|||||+++++|.+ .
T Consensus 12 dp~~~y-~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 87 (309)
T d1u5ra_ 12 DPEKLF-SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 87 (309)
T ss_dssp CHHHHE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CcHHhc-EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--C
Confidence 577666 666899999999999999999999999999875432 234566789999999999999999999999865 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+|+|||||.+|+|..++...+.+++..++.|+.||+.||.|||++| ||||||||+|||++ .+|.+||+|||+|..
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~ 164 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASI 164 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBS
T ss_pred CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccc
Confidence 689999999999999988888899999999999999999999999998 99999999999998 678999999999998
Q ss_pred HhhhccCcccccccCccccc----cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHH
Q 035992 182 LAQARSAHSVIEFMAPELYE----EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGV 257 (613)
Q Consensus 182 l~~~~~~~gt~~YmAPEvl~----~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l 257 (613)
........||+.|||||++. +.|+.++|||||||++|||++|..||.+.... +....+..+..+...+..+++.+
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~s~~~ 243 (309)
T d1u5ra_ 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPALQSGHWSEYF 243 (309)
T ss_dssp SSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCCCCSCTTSCHHH
T ss_pred cCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCCCCCCCCCCHHH
Confidence 87777888999999999874 34899999999999999999999999775544 44455555555555566789999
Q ss_pred HHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 258 RAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 258 ~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
++||.+||+ +|.+|||+.|+|+||||...
T Consensus 244 ~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999 99999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=440.83 Aligned_cols=249 Identities=24% Similarity=0.429 Sum_probs=219.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|+++.+|+.||+|++.+.... .....+.+.+|+.+|+.++|||||+++++|.+ ...+|+|
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~iv 84 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRVYLI 84 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEEEEE
Confidence 47889999999999999999999999999988754332 22345678899999999999999999999864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh--
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-- 185 (613)
||||.+|+|.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||+|......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCCcc
Confidence 999999999999999999999999999999999999999998 99999999999998 5689999999999765432
Q ss_pred ccCcccccccCccccccc-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHH
Q 035992 186 RSAHSVIEFMAPELYEEE-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKC 264 (613)
Q Consensus 186 ~~~~gt~~YmAPEvl~~~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~c 264 (613)
....||+.|||||++.+. |+.++|||||||++|||++|+.||.. .+..+++..+..+.. .++...++++++||.+|
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~ 238 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRL 238 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHH
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHH
Confidence 345788999999988764 89999999999999999999999965 567777788777643 35667899999999999
Q ss_pred hh-cccCCCCHHHHhcCCCCCC
Q 035992 265 IA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 265 L~-dP~~Rpta~eLL~HPff~~ 285 (613)
|+ +|.+|||++|+|+||||+.
T Consensus 239 L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 239 LKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp TCSSGGGSCCHHHHHTCHHHHH
T ss_pred ccCCHhHCcCHHHHHcCcCcCC
Confidence 99 9999999999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=439.23 Aligned_cols=251 Identities=25% Similarity=0.444 Sum_probs=208.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|+++.+|+.||+|+++.... +....+.+.+|+++|++++|||||+++++|.+..+..+|+|
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 4778999999999999999999999999998875432 45667889999999999999999999999987767789999
Q ss_pred EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHhhhhhcCC---CCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 108 TEIFTSGTLRQYRKK----HKHVDLRALKKWSRQILEGLSYLHSHD---PPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~----~~~lse~~i~~i~~QIl~gL~yLHs~~---~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
||||.+|+|.+++.+ .+.+++..++.|+.||+.||+|||+++ .+||||||||+|||++ .+|.+||+|||+|.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeecccee
Confidence 999999999998864 467999999999999999999999865 2499999999999998 56899999999998
Q ss_pred HHhhh----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccH
Q 035992 181 ILAQA----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADN 255 (613)
Q Consensus 181 ~l~~~----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~ 255 (613)
.+... ....+|+.|||||++.+ .|+.++|||||||++|||+||..||.. .+..+++..+..+..+ .++..+++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~ 240 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSD 240 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCH
Confidence 76542 24567889999998865 599999999999999999999999965 5667788888877654 45567899
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCC
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFL 283 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff 283 (613)
++++||.+||+ +|.+|||+.|||+|||+
T Consensus 241 ~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 241 ELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999 99999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=444.60 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=212.4
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.. ......+++.+|+.+|+.++|||||+++++|.+ ...+|+|
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~---~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~iV 82 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 82 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC---CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh---hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 36679999999999999999999999999988743 234556789999999999999999999999865 4579999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.||+|.+++.+.+.+++..++.++.||+.||.|||+ ++ |+||||||+|||++ .+|.+||+|||+|..+...
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHT
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCCCc
Confidence 9999999999999999999999999999999999999997 57 99999999999998 6789999999999877543
Q ss_pred -ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH----------------------------
Q 035992 186 -RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ---------------------------- 235 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~---------------------------- 235 (613)
....||+.|||||++.+ .|+.++|||||||++|||++|+.||........
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 35678999999998865 599999999999999999999999965432211
Q ss_pred -------------HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 236 -------------IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 236 -------------i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
....+.....+.......+.++++||.+||+ ||.+|||++|+|+||||+..++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~ 306 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 306 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence 1111222222333334568899999999999 9999999999999999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-53 Score=432.93 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=219.8
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeecccc--ChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLR--NSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~--~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+|++.+.||+|+||+||+|+++.+|+.||+|++++..... .....+.+.+|+.+|++++|||||+++++|.+ ...+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~ 88 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN--KTDV 88 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 3488899999999999999999999999999998654332 22346789999999999999999999999864 5689
Q ss_pred EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC---CcEEEeccchhHH
Q 035992 105 NFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ---GEVKIGDLGLAAI 181 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~---g~VKL~DFGla~~ 181 (613)
|+|||||.+|+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++ ..+||+|||+|..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999999999899999999999999999999999998 99999999999997332 2599999999987
Q ss_pred Hhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccH
Q 035992 182 LAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADN 255 (613)
Q Consensus 182 l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~ 255 (613)
.... ....+++.|||||++.+ .|+.++|||||||++|||++|..||.+ .+..+++..+..+.. +...+...++
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 6543 24567889999998875 499999999999999999999999976 456666677776643 3334456789
Q ss_pred HHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 256 GVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 256 ~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+++||.+||. +|.+|||++|+|+||||+..++
T Consensus 246 ~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 99999999999 9999999999999999997644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-53 Score=437.56 Aligned_cols=251 Identities=22% Similarity=0.402 Sum_probs=204.1
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|+++.+|+.||+|++..... ......+.+|+.+|++++|||||+++++|.+ +..+|+|
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 85 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL---EGKEGSMENEIAVLHKIKHPNIVALDDIYES--GGHLYLI 85 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 5888999999999999999999999999999875432 2334568899999999999999999998854 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~~l~~~ 185 (613)
||||.||+|.+++.+.+.+++..++.++.||+.||+|||+++ |+||||||+|||+.. ++|.+||+|||+|......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 999999999999999999999999999999999999999998 999999999999952 4679999999999876543
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC--CcccccccHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP--ASLAKVADNGVRA 259 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p--~~l~~~~s~~l~~ 259 (613)
....||+.|||||++.+ .|+.++|||||||++|||++|.+||.+ .....++..+..+..+ ......+++++++
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 34568899999998875 499999999999999999999999976 4556667777766433 2334567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
||.+||. +|.+|||++|+|+||||++.
T Consensus 243 li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 243 FIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999 99999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=440.43 Aligned_cols=254 Identities=20% Similarity=0.402 Sum_probs=224.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.++||+|+||+||+|+++.+|+.||+|++++..... ....+++.+|+.+|+.++||||++++++|.+ ...+|+|
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~~~iv 83 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFV 83 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-HHHHHHHHHHHHHHHhCCCCCEEEEEeeecc--ccccccc
Confidence 578899999999999999999999999999988543322 3456788999999999999999999999865 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh---
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ--- 184 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~--- 184 (613)
||||.||+|..++.+.+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCc
Confidence 999999999999999999999999999999999999999999 99999999999998 568999999999986533
Q ss_pred -hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 185 -ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 185 -~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
.....||+.|||||++.+ .|+.++|||||||++|||++|.+||.. .+...+++.+..+. ..++..+++++++||.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli~ 237 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEE--IRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCC--CCCCccCCHHHHHHHH
Confidence 234578899999998865 599999999999999999999999966 56677788887764 3456778999999999
Q ss_pred HHhh-cccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 263 KCIA-EVSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 263 ~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
+||+ +|.+|++ +.|+++||||+..++..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~ 271 (337)
T d1o6la_ 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred hhccCCchhhcccccccHHHHHcCcccccCCHHH
Confidence 9999 9999994 99999999999887644
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-52 Score=440.33 Aligned_cols=254 Identities=21% Similarity=0.370 Sum_probs=222.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|+++.+|+.||+|++++.... .....+.+.+|+.+|+.++|||||+++++|.. ...+++|
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~~v 119 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNLYMV 119 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHHcCCCcEeeccccccc--ccccccc
Confidence 36779999999999999999999999999998754322 23446778999999999999999999998864 5679999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh-hc
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-AR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-~~ 186 (613)
|||+.+|+|..++.+.+.+++..++.|+.||+.||.|||+++ ||||||||+|||++ .+|.+||+|||+|..+.. ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCBC
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccccc
Confidence 999999999999999999999999999999999999999999 99999999999998 568999999999987654 33
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...||+.|||||++.+ .|+.++|||||||++|||+||..||.+ .+...++..+..+.. .++..+++++.+||.+||
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 273 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLL 273 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHS
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHh
Confidence 5678999999998865 499999999999999999999999965 567777777777643 345568899999999999
Q ss_pred h-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 266 A-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
+ ||.+|+ |+++|++||||+..++..
T Consensus 274 ~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~ 304 (350)
T d1rdqe_ 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHH
T ss_pred hhCHHhccccccccHHHHHcCccccCCCHHH
Confidence 9 999995 899999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-52 Score=435.49 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=223.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|+++.+|+.||+|+++..... .....+.+.+|+.+|+.++||||++++++|.+ ...+|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 82 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD--AQQIFMI 82 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEee--CCeeeeE
Confidence 68889999999999999999999999999998754322 22346788999999999999999999999864 5689999
Q ss_pred EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-c
Q 035992 108 TEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA-R 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~-~ 186 (613)
||||.||+|..++...+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .+|.+||+|||+|...... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSCBC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccccc
Confidence 999999999999999999999999999999999999999998 99999999999998 5789999999999876543 3
Q ss_pred cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHh
Q 035992 187 SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCI 265 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL 265 (613)
...||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++.++..+.. .++...+++++++|.+||
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHT
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHh
Confidence 5678999999998876 499999999999999999999999966 566677777777643 345667899999999999
Q ss_pred h-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 266 A-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 266 ~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
. +|.+|+ |++++|+||||++.+|..
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~ 267 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred hhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence 8 999996 899999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-51 Score=436.85 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=218.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|++++|||||+++++|.+ ...+|+|
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 101 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMI 101 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 47889999999999999999999999999987643 34566789999999999999999999999865 5689999
Q ss_pred EeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-CCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRK-KHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~-~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~-~~g~VKL~DFGla~~l~~~ 185 (613)
||||.||+|.+++. +.+.+++..++.|+.||+.||+|||++| ||||||||+|||++. .++.+||+|||+|..+...
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999999985 4567999999999999999999999999 999999999999963 3578999999999876543
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRA 259 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~~ 259 (613)
....||+.|||||++.+ .|+.++|||||||++|+|++|..||.+ .+..+++..+..+.. +......+++++++
T Consensus 180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 258 (350)
T d1koaa2 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258 (350)
T ss_dssp SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 24567899999998875 499999999999999999999999965 455666667766543 33344567899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
||.+||. ||.+|||++|+|+||||+....
T Consensus 259 li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999 9999999999999999987644
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-51 Score=436.83 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=216.7
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.++.+|+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+ +..+|+|
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 58889999999999999999999999999988743 23456778899999999999999999999864 5689999
Q ss_pred EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-CCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~-~~g~VKL~DFGla~~l~~~ 185 (613)
||||.||+|.+++.+. .++++..++.|+.||+.||+|||++| ||||||||+|||++. ..|.|||+|||+|..+...
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999999999887655 46999999999999999999999998 999999999999973 4689999999999876543
Q ss_pred ---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHHHHH
Q 035992 186 ---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNGVRA 259 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~l~~ 259 (613)
....+++.|||||++.+ .|+.++|||||||++|+|+||..||.+. +...++..+..+.. +......+++++++
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 261 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 24567889999998865 4999999999999999999999999764 44555566665543 33444568899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
||.+||+ +|.+|||+.|+|+||||+...
T Consensus 262 li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred HHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 9999999 999999999999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3e-51 Score=435.36 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=214.6
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc--cChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL--RNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~--~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|++.++||+|+||+||+|+++.+|+.||+|++.+.... .......+...|+.+++.++|||||+++++|.+ ...+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~~~~ 83 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLS 83 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SSEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CCEEE
Confidence 58889999999999999999999999999998754321 122223334456778888899999999999865 46799
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
+|||||.||+|.+++.+++.+++..++.|+.||+.||+|||+++ ||||||||+|||++ ..|.+||+|||+|..+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSSS
T ss_pred EEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999 99999999999998 6789999999999866543
Q ss_pred --ccCcccccccCccccc-c-ccCccchhhhhhHHHHHHHhcCCCCCCCCc--HHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 186 --RSAHSVIEFMAPELYE-E-EYNELVDIYAFGMCLLELVTFEYPYVECTN--AAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~-~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~--~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
....||+.|||||++. + .|+.++|||||||++|||+||..||..... ...+...+.. .+..++..+++++++
T Consensus 161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPELRS 238 (364)
T ss_dssp CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS--CCCCCCSSSCHHHHH
T ss_pred cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc--CCCCCCCCCCHHHHH
Confidence 3457899999999875 3 489999999999999999999999966433 3333333222 344456678999999
Q ss_pred HHHHHhh-cccCCCC-----HHHHhcCCCCCCCCccc
Q 035992 260 FIEKCIA-EVSERLP-----AKELLGDPFLQSEDDES 290 (613)
Q Consensus 260 lI~~cL~-dP~~Rpt-----a~eLL~HPff~~~~~~~ 290 (613)
||.+||+ +|.+||| |+|+++||||++.+|..
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence 9999999 9999999 89999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-50 Score=415.25 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=217.7
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC-----hHHHHHHHHHHHHHHhCC-CCCcceeeeeeecC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN-----SEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDT 99 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~-----~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~ 99 (613)
+| .+.+.||+|+||+||+|+++.+|+.||+|++++...... ....+.+.+|+.+|++++ ||||++++++|.+
T Consensus 4 ~y-~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 4 NY-EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred cC-EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 44 788999999999999999999999999999886543221 223457889999999997 9999999999854
Q ss_pred CCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 100 ENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 100 ~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
+..+|+|||||.+|+|.++++..+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFS 157 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTC
T ss_pred -CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchhe
Confidence 6789999999999999999999999999999999999999999999998 99999999999998 6789999999999
Q ss_pred HHHhhh---ccCcccccccCcccccc-------ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CC
Q 035992 180 AILAQA---RSAHSVIEFMAPELYEE-------EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PA 247 (613)
Q Consensus 180 ~~l~~~---~~~~gt~~YmAPEvl~~-------~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~ 247 (613)
..+... ....||+.|+|||++.. .|+.++|||||||++|||++|+.||.+ .+...+++.+..+.. +.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCT
T ss_pred eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCC
Confidence 876542 34567889999997742 378899999999999999999999976 455566666666543 33
Q ss_pred cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 248 SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 248 ~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
.....+++++++||.+||+ +|.+|||++|+|+||||+.
T Consensus 237 ~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 3445689999999999999 9999999999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-51 Score=427.07 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=218.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHH-hCCCCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLK-TLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk-~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|.++.+|+.||+|++++..... ....+.+..|+.++. .++|||||+++++|.+ +..+|+
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~yi 80 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLFF 80 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCceeE
Confidence 578899999999999999999999999999987543222 234566677777665 6899999999999865 568999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh--
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ-- 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~-- 184 (613)
||||+.+|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ ..|.+||+|||++.....
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTT
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhccccc
Confidence 9999999999999999999999999999999999999999998 99999999999998 678999999999975432
Q ss_pred --hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHH
Q 035992 185 --ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFI 261 (613)
Q Consensus 185 --~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI 261 (613)
.....||+.|||||++.+ .|+.++|||||||++|||+||+.||.+ .+..+++..+..+. ..++..+++++++||
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~--~~~p~~~s~~~~dli 234 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDN--PFYPRWLEKEAKDLL 234 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCccCCHHHHHHH
Confidence 224568899999998765 599999999999999999999999965 56777777777664 345667899999999
Q ss_pred HHHhh-cccCCCCHH-HHhcCCCCCCCCcc
Q 035992 262 EKCIA-EVSERLPAK-ELLGDPFLQSEDDE 289 (613)
Q Consensus 262 ~~cL~-dP~~Rpta~-eLL~HPff~~~~~~ 289 (613)
.+||. +|.+|||+. +|++||||+..++.
T Consensus 235 ~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 235 VKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 99999 999999995 89999999987654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=421.67 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=203.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeeccccCh-HHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEEEec
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNS-EDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFITEI 110 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~-~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV~E~ 110 (613)
++||+|+||+||+|+++.+|+.||+|+++........ ...+.+.+|+.+|++++|||||+++++|.. +..+|+||||
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~~ivmE~ 81 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNISLVFDF 81 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCCEEEEEC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCceeehhhh
Confidence 7999999999999999999999999998765432222 224578899999999999999999999854 4579999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh----c
Q 035992 111 FTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA----R 186 (613)
Q Consensus 111 ~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~----~ 186 (613)
+.++++..++...+.+++..++.|++||+.||+|||+++ |+||||||+|||++ ..+.+||+|||+|...... .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~ 158 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 158 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCccccc
Confidence 999988888877888999999999999999999999998 99999999999998 6789999999999876542 2
Q ss_pred cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CCC------------------
Q 035992 187 SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GIK------------------ 245 (613)
Q Consensus 187 ~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~~------------------ 245 (613)
...+|+.|||||++.. .|+.++|||||||++|||+||.+||....+.+++...... +..
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 3457889999997753 4899999999999999999999999776555544333221 000
Q ss_pred --C----CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 246 --P----ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 246 --p----~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+ .......++++++||.+||+ ||.+||||+|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0 00112457899999999999 99999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-51 Score=424.18 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=216.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
.|| ++.+.||+|+||+||+|.++.+|+.||+|+++.. ..+...+.+|+++|+.++||||++++++|.+ ...+
T Consensus 5 ~rY-~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~ 76 (321)
T d1tkia_ 5 EKY-MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFES--MEEL 76 (321)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEE
T ss_pred cce-EEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 466 7889999999999999999999999999988643 2445668899999999999999999999865 4689
Q ss_pred EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC-CCCcEEEeccchhHHH
Q 035992 105 NFITEIFTSGTLRQYRKKHK-HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG-NQGEVKIGDLGLAAIL 182 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~~-~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~-~~g~VKL~DFGla~~l 182 (613)
|+|||||.||+|.+++.+.+ .+++..++.|+.||+.||+|||+++ |+||||||+|||++. ..+.+||+|||++...
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99999999999999998765 7999999999999999999999998 999999999999973 3458999999999765
Q ss_pred hhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCC--CCcccccccHH
Q 035992 183 AQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIK--PASLAKVADNG 256 (613)
Q Consensus 183 ~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~--p~~l~~~~s~~ 256 (613)
... ....+++.|+|||.+.+ .|+.++|||||||++|+|++|..||.. .+...++..+..+.. +......++++
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 432 23457789999998765 599999999999999999999999965 556667777776643 22333457899
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++||.+||. ||.+|||+.|+|+||||+..
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999 99999999999999999754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-51 Score=414.05 Aligned_cols=249 Identities=21% Similarity=0.364 Sum_probs=209.6
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccC--hHHHHHHHHHHHHHHhCC--CCCcceeeeeeecC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRN--SEDLERLYSEVHLLKTLK--HKNIIKFYNSWVDT 99 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~--~~~~~~l~~Ei~iLk~L~--HpNIVkl~~~fv~~ 99 (613)
.+|| ++.++||+|+||+||+|+++.+|+.||+|+++....... .....++.+|+.+|++++ |||||+++++|.+
T Consensus 3 ~~~Y-~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~- 80 (273)
T d1xwsa_ 3 ESQY-QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 80 (273)
T ss_dssp TTTE-EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred CCeE-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence 4676 889999999999999999999999999999875432211 112234678999999996 8999999998854
Q ss_pred CCCEEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 100 ENEHINFITEIFTS-GTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 100 ~~~~l~lV~E~~~g-GsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+++||||+.+ +++.+++.+.+.+++..++.|+.||+.||+|||+++ |+||||||+|||++.+.+.+||+|||+
T Consensus 81 -~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 81 -PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred -CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECcccc
Confidence 5689999999976 688899998899999999999999999999999998 999999999999986678999999999
Q ss_pred hHHHhhh--ccCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 179 AAILAQA--RSAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 179 a~~l~~~--~~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
|...... ....||+.|||||++.+ . ++.++|||||||++|||+||+.||... . .+..+. ..++..++
T Consensus 158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~~~--~~~~~~~s 228 (273)
T d1xwsa_ 158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRGQ--VFFRQRVS 228 (273)
T ss_dssp CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHCC--CCCSSCCC
T ss_pred ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---h----HHhhcc--cCCCCCCC
Confidence 9765432 34578899999998764 3 467899999999999999999999642 2 233332 23456678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
+++++||.+||+ +|.+|||++|+|+||||++.
T Consensus 229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 999999999999 99999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=421.28 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=204.8
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHh-CCCCCcceeeeeeec--CCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKT-LKHKNIIKFYNSWVD--TENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~-L~HpNIVkl~~~fv~--~~~~ 102 (613)
.|.-+.++||+|+||+||+|.+..+|+.||+|+++.. ..+.+|+.++.+ ++|||||+++++|.+ ..+.
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 5655567899999999999999999999999987632 346789998755 589999999999864 3356
Q ss_pred EEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccch
Q 035992 103 HINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGL 178 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGl 178 (613)
.+|+|||||.||+|.+++.+. ..+++..++.|+.||+.||+|||+++ |+||||||+|||++. +.+.+||+|||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccccccccccce
Confidence 799999999999999999875 46999999999999999999999998 999999999999974 356799999999
Q ss_pred hHHHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHH---HHHHHHcCC--CCCcc
Q 035992 179 AAILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQ---IYKKVTSGI--KPASL 249 (613)
Q Consensus 179 a~~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~---i~~~I~~g~--~p~~l 249 (613)
|...... ....||+.|||||++.+ .|+.++|||||||++|+|+||.+||.+...... +...+..+. .|...
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcc
Confidence 9765432 34568899999998875 599999999999999999999999965443222 222232222 22223
Q ss_pred cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 250 AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 250 ~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...+++++++||.+||+ +|.+|||+.|+|+||||+..
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 34578999999999999 99999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-49 Score=408.52 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=213.3
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeec
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVD 98 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~ 98 (613)
.+++++ .+++.+.||+|+||+||+|.++.+|+.||+|+++. +....+.+.+|+.+|++++|||||+++++|.+
T Consensus 12 wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 12 WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCT-----TCSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECC-----ccchHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 355543 35888999999999999999999999999998753 22345678999999999999999999998854
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
+..+++|||||.+|+|..++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+||
T Consensus 85 --~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DF 159 (287)
T d1opja_ 85 --EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADF 159 (287)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCC
T ss_pred --CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccc
Confidence 45789999999999999998764 57899999999999999999999998 99999999999998 5689999999
Q ss_pred chhHHHhhhc-----cCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCccc
Q 035992 177 GLAAILAQAR-----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLA 250 (613)
Q Consensus 177 Gla~~l~~~~-----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~ 250 (613)
|+|....... ...+++.|||||++. +.|+.++|||||||++|||++|..||....+..++++.+..+..+ ..+
T Consensus 160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~ 238 (287)
T d1opja_ 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERP 238 (287)
T ss_dssp CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCC
T ss_pred cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCC
Confidence 9998764322 223567899999775 469999999999999999999888887778888888888877654 345
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+++.+++||.+||+ +|.+|||+.||++
T Consensus 239 ~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 6678999999999999 9999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-49 Score=410.37 Aligned_cols=244 Identities=20% Similarity=0.386 Sum_probs=196.7
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcE---EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIE---VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~---VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
.+++.++||+|+||+||+|.++.+|+. ||+|.+ .........+.+.+|+.+|++++|||||+++++|.. ...
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~---~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTL---KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEEC---CSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSS
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEE---CcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee--CCE
Confidence 458999999999999999999887764 565544 333456677889999999999999999999998854 457
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
+++|||||.+|+|.+++.+. +.+++..+..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++..+
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccceEc
Confidence 89999999999999988875 57999999999999999999999998 99999999999998 6789999999999876
Q ss_pred hhhc---------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccc
Q 035992 183 AQAR---------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAK 251 (613)
Q Consensus 183 ~~~~---------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~ 251 (613)
.... ...+++.|||||++.. .|+.++|||||||++|||+| |..||.+. ...++...+..+..++ .+.
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~~-~~~ 256 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-TNQDVINAIEQDYRLP-PPM 256 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCCC-CCT
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCc
Confidence 4321 1235678999998764 59999999999999999998 89999764 4566777787776543 345
Q ss_pred cccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 252 VADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 252 ~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.++..+.+||.+||+ +|.+|||+.||+++
T Consensus 257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 678999999999998 99999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=406.28 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=205.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|++.+.||+|+||+||+|.+..+|+.||+|+++.... .....+.+.+|+.+|++++|||||+++++|.+ +..+|+|
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 3677999999999999999999999999999865332 22335678899999999999999999999865 5689999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||+.++.+...... .+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCS
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccCCc
Confidence 999987655544443 467999999999999999999999998 99999999999998 5679999999999877542
Q ss_pred ---ccCcccccccCcccccc-c-cCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC-------------
Q 035992 186 ---RSAHSVIEFMAPELYEE-E-YNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA------------- 247 (613)
Q Consensus 186 ---~~~~gt~~YmAPEvl~~-~-ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~------------- 247 (613)
....+++.|+|||++.. . ++.++|||||||++|+|++|+.||........+++.+.....+.
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 23467889999997654 3 68899999999999999999999987666666655443211100
Q ss_pred -------------cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 248 -------------SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 248 -------------~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
......++++++||.+||+ +|.+|||+.|||+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 0112346889999999999 999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=404.69 Aligned_cols=244 Identities=28% Similarity=0.461 Sum_probs=206.6
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
++| ++.++||+|+||+||+|... ..||+|+++... .+....+.+.+|+.+|++++|||||++++++. ...+
T Consensus 8 ~~~-~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~---~~~~ 78 (276)
T d1uwha_ 8 GQI-TVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQL 78 (276)
T ss_dssp TCC-CCCSEEEECSSCEEEEEESS---SEEEEEECCCSS--CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSC
T ss_pred ccE-EEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe---ccEE
Confidence 444 67899999999999999643 369999876443 24566788999999999999999999999753 2358
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++|||||.+|+|.+++... +.+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC--
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeecc
Confidence 8999999999999999765 56999999999999999999999998 99999999999998 67899999999997654
Q ss_pred h------hccCcccccccCcccccc----ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCc---cc
Q 035992 184 Q------ARSAHSVIEFMAPELYEE----EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPAS---LA 250 (613)
Q Consensus 184 ~------~~~~~gt~~YmAPEvl~~----~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~---l~ 250 (613)
. .....+|+.|||||++.. .|+.++|||||||++|||+||+.||.+..+...+...+..+..++. ++
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~ 235 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence 2 124567889999998742 4899999999999999999999999988888888888887765543 34
Q ss_pred ccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 251 KVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 251 ~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+++.+++||.+||. +|.+|||++||+++
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4578899999999999 99999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.1e-49 Score=402.02 Aligned_cols=254 Identities=23% Similarity=0.323 Sum_probs=209.5
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN-- 101 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~-- 101 (613)
..|| ++.+.||+|+||+||+|.+..+|+.||+|+++.. ...+....+++.+|+.+|+.++||||+++++++.....
T Consensus 6 ~drY-~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 6 SDRY-ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp TTTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECST-TTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred ccee-EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchh-hccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 3566 7889999999999999999999999999998743 33456677889999999999999999999999876433
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
..+|+||||+.||+|..++...+.+++..++.|+.||+.||+|||+++ |+||||||+|||++ ..+.++|+|||++..
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhh
Confidence 468999999999999999999999999999999999999999999998 99999999999998 568999999998754
Q ss_pred Hhh-------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCC-ccccc
Q 035992 182 LAQ-------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPA-SLAKV 252 (613)
Q Consensus 182 l~~-------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~-~l~~~ 252 (613)
... .....||+.|||||++.+ .|+.++|||||||++|||+||..||......+.+.+.+.....++ .....
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSS
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccC
Confidence 321 224467889999998875 499999999999999999999999977655555555565554433 34456
Q ss_pred ccHHHHHHHHHHhh-cccCCC-CHHHHhcCCCC
Q 035992 253 ADNGVRAFIEKCIA-EVSERL-PAKELLGDPFL 283 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rp-ta~eLL~HPff 283 (613)
+++.+++||.+||+ +|.+|| |+++| .|+|+
T Consensus 241 ~s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 241 LSADLDAVVLKALAKNPENRYQTAAEM-RADLV 272 (277)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence 78999999999999 999999 55555 45554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=402.13 Aligned_cols=249 Identities=20% Similarity=0.350 Sum_probs=207.8
Q ss_pred cceeEe-eeecccCceEEEEEEEc--CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 26 RYGRYK-EVLGRGAFKKVYRAFDE--LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 26 Ry~r~~-e~LG~GafGtVYka~~~--~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
++..++ +.||+|+||+||+|.+. .+++.||+|+++... .++...+.+.+|+.+|++++|||||+++++|.. .
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~ 80 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMIGICEA---E 80 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---S
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh--CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---C
Confidence 445565 57999999999999764 456889999886432 234567889999999999999999999998743 3
Q ss_pred EEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 103 HINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++||||+.+|+|.+++.+.+.+++..+..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+
T Consensus 81 ~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 81 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKAL 157 (277)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEEC
T ss_pred CEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhc
Confidence 47899999999999999999999999999999999999999999998 99999999999998 5689999999999765
Q ss_pred hhh-------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 183 AQA-------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 183 ~~~-------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
... ....+++.|||||++.. .|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ .++..+
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~ 235 (277)
T d1xbba_ 158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-KGSEVTAMLEKGERM-GCPAGC 235 (277)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTC
T ss_pred cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCccc
Confidence 432 12356789999998754 59999999999999999998 89999764 556777888887654 345678
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHH---hcCCCCC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKEL---LGDPFLQ 284 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eL---L~HPff~ 284 (613)
++++++||.+||+ +|.+|||++++ |+|+|++
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 8999999999999 99999999988 5677654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-49 Score=402.36 Aligned_cols=251 Identities=25% Similarity=0.412 Sum_probs=207.0
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|| ++.++||+|+||+||+|.++ +|+.||+|+++.... .....+++.+|+.+|++++||||++++++|.. ...++
T Consensus 3 ~Y-~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~ 76 (286)
T d1ob3a_ 3 KY-HGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLV 76 (286)
T ss_dssp SE-EEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEE
T ss_pred Cc-eeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCcee
Confidence 66 66799999999999999986 889999999875432 23345788999999999999999999999865 45689
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
++|+++.++.+..+....+.+++..++.++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||++......
T Consensus 77 i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIP 153 (286)
T ss_dssp EEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC-
T ss_pred EEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccC
Confidence 99999999888888888899999999999999999999999998 99999999999998 5689999999999887542
Q ss_pred ----ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CC--------------
Q 035992 186 ----RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GI-------------- 244 (613)
Q Consensus 186 ----~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~-------------- 244 (613)
....+++.|+|||.+.+ .++.++|||||||++|||++|++||.+.....++.+.... +.
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence 23356778999998754 4789999999999999999999999776555444433210 00
Q ss_pred -----------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 245 -----------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 245 -----------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
....+....++.+++||.+||+ ||.+|||+.|+|+||||+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0011233467899999999999 9999999999999999974
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=407.28 Aligned_cols=244 Identities=27% Similarity=0.396 Sum_probs=204.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCc-----EEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGI-----EVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~-----~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 101 (613)
+++.++||+|+||+||+|++..+++ .||+|.+... ........+.+|+.+|+++ +|||||+++++|.+ .
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~ 113 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREALMSELKMMTQLGSHENIVNLLGACTL--S 113 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc---cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--C
Confidence 4788999999999999999876553 6887776532 2345567789999999998 89999999998854 4
Q ss_pred CEEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCC
Q 035992 102 EHINFITEIFTSGTLRQYRKKHK-----------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLK 158 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~-----------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLK 158 (613)
..+++|||||.+|+|.+++.+.+ .+++..++.++.||+.||+|||+++ |||||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlK 191 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLA 191 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCS
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCc
Confidence 56899999999999999997643 4899999999999999999999998 9999999
Q ss_pred CCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCC
Q 035992 159 CDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVEC 230 (613)
Q Consensus 159 p~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~ 230 (613)
|+|||++ .++.+||+|||+|+...... ...+|+.|||||++. +.|+.++|||||||++|||+| |..||.+.
T Consensus 192 p~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 192 ARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp GGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 9999998 56899999999998665432 234578999999775 569999999999999999998 89999877
Q ss_pred CcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 231 TNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 231 ~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.....+.+.+..+..+ ..+..+++++++||.+||+ +|.+|||++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 7767777777766544 4556788999999999999 99999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=402.66 Aligned_cols=257 Identities=26% Similarity=0.417 Sum_probs=204.4
Q ss_pred CcceeEeeeecccCceEEEEEEEcCC-CcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC---CCCCcceeeeeeecC-
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELE-GIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL---KHKNIIKFYNSWVDT- 99 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~t-g~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L---~HpNIVkl~~~fv~~- 99 (613)
.|| ++.+.||+|+||+||+|++..+ ++.||+|+++..... ......+.+|+.+|+.| +||||++++++|...
T Consensus 7 ~~Y-~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 7 QQY-ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE--EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GTE-EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT--TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCE-EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc--chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 456 7789999999999999999766 677999998764422 12223455677776665 899999999988642
Q ss_pred --CCCEEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEecc
Q 035992 100 --ENEHINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDL 176 (613)
Q Consensus 100 --~~~~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DF 176 (613)
....++++|||+.++.+...... ...+++..++.++.||+.||+|||+++ |+||||||+|||++ ..+.+||+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~df 160 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADF 160 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecch
Confidence 34578999999999877655543 467999999999999999999999998 99999999999998 6689999999
Q ss_pred chhHHHhh---hccCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CC-------
Q 035992 177 GLAAILAQ---ARSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GI------- 244 (613)
Q Consensus 177 Gla~~l~~---~~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~------- 244 (613)
|++..... .....||+.|||||++. ..|+.++|||||||++|||++|.+||........+...+.. +.
T Consensus 161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 99875432 34567889999999775 45999999999999999999999999775554444333221 00
Q ss_pred ----------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 ----------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 ----------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
....+....++.+++||.+||+ ||.+|||+.|+|+||||+..+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0111234467899999999999 999999999999999999764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=395.71 Aligned_cols=246 Identities=21% Similarity=0.392 Sum_probs=201.2
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
+||+. +++.+.||+|+||+||+|.+. ++..||+|+++.. ....+.+.+|+.++++++||||++++++|..
T Consensus 2 idp~~--~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-- 71 (263)
T d1sm2a_ 2 IDPSE--LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-- 71 (263)
T ss_dssp BCCSC--EEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CChHH--cEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-----cCcHHHHHHHHHHHHhcCCCCcccccceecc--
Confidence 45542 478899999999999999876 6778999987632 2233578999999999999999999998854
Q ss_pred CCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchh
Q 035992 101 NEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLA 179 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla 179 (613)
...+++||||+.+|+|.+++.+. ..+++..+..|+.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMT 148 (263)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC--
T ss_pred CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchh
Confidence 45689999999999999998765 56899999999999999999999998 99999999999998 5689999999999
Q ss_pred HHHhhhc-----cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccc
Q 035992 180 AILAQAR-----SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVA 253 (613)
Q Consensus 180 ~~l~~~~-----~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~ 253 (613)
..+.... ...+++.|||||++.+ .|+.++|||||||++|||+|+..||....+..+++..+..+..+ ..+...
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~ 227 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLA 227 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTS
T ss_pred eeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCcccc
Confidence 8765322 2456778999998864 59999999999999999999655655667778888888887654 345677
Q ss_pred cHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 254 DNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 254 s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
++++.+||.+||+ +|.+|||++|+++|
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 8999999999999 99999999999976
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-48 Score=405.39 Aligned_cols=249 Identities=19% Similarity=0.345 Sum_probs=207.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~l 106 (613)
|++.++||+|+||+||+|+++.+|+.||+|+++.. ..+++.+|+.+|+.+. ||||++++++|.......+++
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 48889999999999999999999999999987632 2456889999999995 999999999988776778999
Q ss_pred EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh-
Q 035992 107 ITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA- 185 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~- 185 (613)
|||||.+++|..+ .+.+++..++.+++||+.||+|||++| |+||||||+|||++.+.+.+||+|||+|......
T Consensus 110 v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 110 VFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred EEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999999765 356999999999999999999999999 9999999999999866667999999999866542
Q ss_pred --ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc---------------CC--
Q 035992 186 --RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS---------------GI-- 244 (613)
Q Consensus 186 --~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~---------------g~-- 244 (613)
....+|+.|+|||++.+ .|+.++|||||||++|||++|..||....+.......+.. ..
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 34457789999997654 4899999999999999999999999776654433222210 00
Q ss_pred ------------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCCc
Q 035992 245 ------------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSEDD 288 (613)
Q Consensus 245 ------------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~~ 288 (613)
.+.......++++++||++||. +|.+|||++|+|+||||+...+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 0111223467899999999999 9999999999999999998654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=399.13 Aligned_cols=245 Identities=24% Similarity=0.412 Sum_probs=208.5
Q ss_pred ceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEE
Q 035992 27 YGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINF 106 (613)
Q Consensus 27 y~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~l 106 (613)
.+++.+.||+|+||+||+|.++ ++..||+|+++.. ....+.+.+|+.+|++++|||||++++++.. ..+++
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~i 84 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred HeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-----cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEE
Confidence 3488999999999999999875 6788999987632 2234678999999999999999999997642 35789
Q ss_pred EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhh
Q 035992 107 ITEIFTSGTLRQYRKKH--KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQ 184 (613)
Q Consensus 107 V~E~~~gGsL~~~l~~~--~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~ 184 (613)
||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+ +++.+||+|||+|..+..
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIED 161 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSS
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEccC
Confidence 99999999999976543 36999999999999999999999998 99999999999998 678999999999987643
Q ss_pred h-----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHH
Q 035992 185 A-----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVR 258 (613)
Q Consensus 185 ~-----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~ 258 (613)
. ....+++.|||||++.. .|+.++|||||||++|||+||..||....+..++...+..+..+. .+..+++++.
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~ 240 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELY 240 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHH
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHHH
Confidence 2 23456778999998764 599999999999999999997777667777888888888876553 4556789999
Q ss_pred HHHHHHhh-cccCCCCHHHHhc--CCCCC
Q 035992 259 AFIEKCIA-EVSERLPAKELLG--DPFLQ 284 (613)
Q Consensus 259 ~lI~~cL~-dP~~Rpta~eLL~--HPff~ 284 (613)
+||.+||+ +|.+|||+.+|++ |+||.
T Consensus 241 ~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 99999999 9999999999998 78875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=391.62 Aligned_cols=252 Identities=22% Similarity=0.408 Sum_probs=214.8
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~ 105 (613)
|| ++.++||+|+||+||+|.++.+|+.||+|+++... .......++.+|+.+|+.++||||++++++|.+ ...++
T Consensus 3 ry-~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~ 77 (292)
T d1unla_ 3 KY-EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLT 77 (292)
T ss_dssp SE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEE
T ss_pred CC-EeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcCcCCEEeecccccc--cccee
Confidence 54 78899999999999999999999999999987543 234567889999999999999999999998865 55789
Q ss_pred EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 106 FITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 106 lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
++++++.+++|..++..++.+++..++.++.|++.||+|||+++ |+||||||+|||++ ..+.+||+|||.+......
T Consensus 78 iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 78 LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIP 154 (292)
T ss_dssp EEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSC
T ss_pred EEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccCC
Confidence 99999999999999999999999999999999999999999998 99999999999998 5679999999999876442
Q ss_pred c----cCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC---------------
Q 035992 186 R----SAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI--------------- 244 (613)
Q Consensus 186 ~----~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~--------------- 244 (613)
. ...++..|+|||++.. .++.++|||||||++|||++|..||....+..+.+.++....
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 2345568999997754 378999999999999999999999877777777666654210
Q ss_pred ------------CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCC
Q 035992 245 ------------KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQS 285 (613)
Q Consensus 245 ------------~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~ 285 (613)
.........++.+++||.+||+ ||.+||||+|+|+||||+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1112233457899999999999 9999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=404.11 Aligned_cols=250 Identities=21% Similarity=0.324 Sum_probs=202.3
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC----CCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT----ENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~~~~ 103 (613)
|+..++||+|+||+||+|+++.+|+.||+|+++..... +.+|+.+|++++||||++++++|... +..+
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 45668999999999999999999999999998754321 23699999999999999999998643 3456
Q ss_pred EEEEEeccCCCCHHH---HHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 104 INFITEIFTSGTLRQ---YRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 104 l~lV~E~~~gGsL~~---~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
+++|||||.++.+.. +......+++..++.|++||+.||+|||++| |+||||||+|||++.+...+||+|||++.
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchh
Confidence 899999998775433 3345668999999999999999999999998 99999999999998655689999999997
Q ss_pred HHhhh---ccCcccccccCccccc--cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-C-----------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYE--EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-G----------- 243 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~--~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g----------- 243 (613)
.+... ....++..|+|||++. ..|+.++|||||||++|||++|.+||.......++...+.. +
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp ECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred hccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 65432 2446778999999764 35899999999999999999999999776655554433221 0
Q ss_pred ------CCC--------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 244 ------IKP--------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 244 ------~~p--------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
..+ .......++++.+||.+||+ ||.+|||+.|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 000 01123467899999999999 999999999999999998753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=400.53 Aligned_cols=259 Identities=22% Similarity=0.374 Sum_probs=206.7
Q ss_pred cCCCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC
Q 035992 21 IDPSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE 100 (613)
Q Consensus 21 ~dp~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~ 100 (613)
.++-+|| ++.+.||+|+||+||+|+++.+|+.||+|++..... ......++.+|+.+|++++||||++++++|....
T Consensus 6 ~~~~~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 6 CDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp SCBGGGE-EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CCccCCE-EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 4556788 777999999999999999999999999998875432 2344567889999999999999999999875432
Q ss_pred ------CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 101 ------NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 101 ------~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
...+|++|||+.++.+..+......+++..++.+++||+.||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~ 159 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLA 159 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEEC
T ss_pred ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEee
Confidence 3468999999998888777777788999999999999999999999998 99999999999998 56899999
Q ss_pred ccchhHHHhh--------hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--
Q 035992 175 DLGLAAILAQ--------ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-- 242 (613)
Q Consensus 175 DFGla~~l~~--------~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-- 242 (613)
|||++..... .....+|+.|+|||++.. .|+.++|||||||++|||++|++||.+..+...+ ..+..
T Consensus 160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~i~~~~ 238 (318)
T d3blha1 160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL-ALISQLC 238 (318)
T ss_dssp CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHH
T ss_pred ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH-HHHHHhc
Confidence 9999965432 123457889999997753 5899999999999999999999999765443332 22221
Q ss_pred -CCCCCcc---------------------------cccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 243 -GIKPASL---------------------------AKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 243 -g~~p~~l---------------------------~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...+... ....++.+.+||.+||+ ||.+|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 1111100 01236788999999999 99999999999999999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=403.48 Aligned_cols=257 Identities=27% Similarity=0.403 Sum_probs=204.3
Q ss_pred CCCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCC--
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTE-- 100 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~-- 100 (613)
...|| ++.+.||+|+||+||+|.++.+|+.||+|+++.. ..+....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y-~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~--~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 16 VRAVY-RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP--FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp CBSSE-EEEEEC------CEEEEEETTTCCEEEEEECSST--TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred cCCcE-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh--hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 45677 6779999999999999999999999999987642 234566788999999999999999999999986543
Q ss_pred --CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccch
Q 035992 101 --NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGL 178 (613)
Q Consensus 101 --~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGl 178 (613)
...+|+||||+ +++|..+.+. +.+++..++.+++||+.||+|||++| |+||||||+|||++ .++.+||+|||+
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGL 167 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTT
T ss_pred cccceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccc
Confidence 23689999999 5677776654 67999999999999999999999999 99999999999998 678999999999
Q ss_pred hHHHhhh-ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc-CC----------
Q 035992 179 AAILAQA-RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-GI---------- 244 (613)
Q Consensus 179 a~~l~~~-~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-g~---------- 244 (613)
|...... ....+++.|+|||++.+ .++.++|||||||++|+|++|.+||........+...... +.
T Consensus 168 a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 168 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp CEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred eeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 9766543 34567889999998754 4789999999999999999999999775544443322211 00
Q ss_pred --------------CC---CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 --------------KP---ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 --------------~p---~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.. .......++.+.+||.+||. ||.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00 11223457899999999999 999999999999999998754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=400.51 Aligned_cols=256 Identities=24% Similarity=0.369 Sum_probs=204.1
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN-- 101 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~-- 101 (613)
+.|| ++.+.||+|+||+||+|.++.+|+.||+|++++. ......+++.+|+.+|++++||||+++++++.....
T Consensus 7 ~~rY-~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 7 GPRY-TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CTTE-EEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCCe-EEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh---cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 4566 7889999999999999999999999999987643 345667889999999999999999999998864321
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
...+++++++.+|+|.+++..+ ++++..++.++.||+.||+|||+++ ||||||||+|||++ +.|.+||+|||++..
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARV 158 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEE
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceee
Confidence 2234455667799999999764 6999999999999999999999998 99999999999998 678999999999976
Q ss_pred Hhhh-------ccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC--------
Q 035992 182 LAQA-------RSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI-------- 244 (613)
Q Consensus 182 l~~~-------~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~-------- 244 (613)
.... ....+++.|+|||++.. .|+.++||||+||++|+|++|..||............+....
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 5332 23457789999998743 478999999999999999999999976554443332221100
Q ss_pred -----------------CCC---cccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCCC
Q 035992 245 -----------------KPA---SLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSED 287 (613)
Q Consensus 245 -----------------~p~---~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~~ 287 (613)
.+. ......++.+++||.+||+ ||.+|||+.|+|+||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 000 1122457789999999999 999999999999999998653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=388.41 Aligned_cols=249 Identities=22% Similarity=0.402 Sum_probs=206.1
Q ss_pred ccCCCCcceeEeeeecccCceEEEEEEEcCCC----cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeee
Q 035992 20 EIDPSARYGRYKEVLGRGAFKKVYRAFDELEG----IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNS 95 (613)
Q Consensus 20 ~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg----~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~ 95 (613)
|++|+. ++..++||+|+||+||+|.++.++ ..||+|.++. .........+.+|+.+|++++|||||+++++
T Consensus 3 ei~~~~--~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~ 77 (283)
T d1mqba_ 3 EIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA---GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 77 (283)
T ss_dssp BCCTTT--EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT---TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCCHHH--eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc---ccChHHHHHHHHHHHHHHhcCCCCEeeeeEE
Confidence 567764 467899999999999999987665 4789887653 3345666789999999999999999999998
Q ss_pred eecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 96 WVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 96 fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
+.. ...+++||||+.+|++.+++... +.+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+
T Consensus 78 ~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~ 152 (283)
T d1mqba_ 78 ISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVS 152 (283)
T ss_dssp ECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEEC
T ss_pred Eec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEc
Confidence 854 45689999999999999987655 67999999999999999999999998 99999999999998 67899999
Q ss_pred ccchhHHHhhhc-------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCC
Q 035992 175 DLGLAAILAQAR-------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKP 246 (613)
Q Consensus 175 DFGla~~l~~~~-------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p 246 (613)
|||+++.+.... ...+|+.|||||++.+ .|+.++|||||||++|||++|..||....+..+++..+..+..+
T Consensus 153 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 153 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred ccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 999998764321 2346778999998765 59999999999999999999877776777888888888888665
Q ss_pred CcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 247 ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 247 ~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
+ .+..++..+.++|.+||. +|.+|||+.|+++
T Consensus 233 ~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 P-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp C-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 4 345678999999999998 9999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=393.70 Aligned_cols=246 Identities=19% Similarity=0.370 Sum_probs=207.1
Q ss_pred eeEeee-ecccCceEEEEEEEcC--CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEV-LGRGAFKKVYRAFDEL--EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~-LG~GafGtVYka~~~~--tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
+.+.++ ||+|+||+||+|.++. ++..||+|+++.. ......+++.+|+.+|++++|||||++++++.. ..+
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 455664 9999999999998754 4568999887632 345677889999999999999999999998743 358
Q ss_pred EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
|+||||+++|+|.+++... +.+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||++..+.
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECT
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhccc
Confidence 9999999999999997654 67999999999999999999999998 99999999999998 57899999999998664
Q ss_pred hh-------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 184 QA-------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 184 ~~-------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.. ....+++.|||||++. +.|+.++|||||||++|||+| |..||.+... .++...+..+..+. ++..++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~~i~~~~~~~-~p~~~~ 238 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKRME-CPPECP 238 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHTTCCCC-CCTTCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCC-CCCcCC
Confidence 32 1334677999999876 459999999999999999998 8999977554 56677788876553 456688
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHH---hcCCCCC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKEL---LGDPFLQ 284 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eL---L~HPff~ 284 (613)
+++.+||.+||. +|.+|||+.++ |+|+|+.
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999 99999998877 6778764
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=400.33 Aligned_cols=256 Identities=21% Similarity=0.352 Sum_probs=214.1
Q ss_pred eeEeeeecccCceEEEEEEE---cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFD---ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~---~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~fv~~~~~~ 103 (613)
|++.+.||+|+||+||+|++ +.+|+.||+|++++.....+....+.+.+|+.+|++++| |||++++++|.+ ...
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~~~ 103 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--ETK 103 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--TTE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--CCc
Confidence 58889999999999999987 447899999998766544444456778899999999976 899999998855 458
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++++|||+.+|+|.+++...+.+++..++.++.||+.||+|||+++ |+||||||+|||++ .+|.+||+|||++..+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECC
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchhhhc
Confidence 9999999999999999999999999999999999999999999999 99999999999998 56899999999987543
Q ss_pred h-----hccCcccccccCcccccc---ccCccchhhhhhHHHHHHHhcCCCCCCCC---cHHHHHHHHHcCCCCCccccc
Q 035992 184 Q-----ARSAHSVIEFMAPELYEE---EYNELVDIYAFGMCLLELVTFEYPYVECT---NAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 184 ~-----~~~~~gt~~YmAPEvl~~---~ys~ksDIWSLGviL~EmltG~~Pf~~~~---~~~~i~~~I~~g~~p~~l~~~ 252 (613)
. .....+++.|+|||.+.. .++.++|||||||++|+|++|..||.... ....+.+...... ..++..
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~--~~~~~~ 258 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE--PPYPQE 258 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC--CCCCTT
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC--CCCccc
Confidence 2 234567789999998753 37889999999999999999999996543 3444444444442 234556
Q ss_pred ccHHHHHHHHHHhh-cccCCC-----CHHHHhcCCCCCCCCccc
Q 035992 253 ADNGVRAFIEKCIA-EVSERL-----PAKELLGDPFLQSEDDES 290 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rp-----ta~eLL~HPff~~~~~~~ 290 (613)
.++++++||.+||. +|.+|| |++|+|+||||+..++..
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~ 302 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 302 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHH
Confidence 89999999999999 999999 589999999999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=387.19 Aligned_cols=240 Identities=25% Similarity=0.423 Sum_probs=206.5
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.++||+|+||+||+|+++ +++.||+|+++... ...+.+.+|+.++++++||||++++++|.. ...+++|
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~--~~~~~iv 77 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK--QRPIFII 77 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECC--SSSEEEE
T ss_pred CEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEee--CCceEEE
Confidence 467799999999999999985 78899999887532 223568999999999999999999998754 4579999
Q ss_pred EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc
Q 035992 108 TEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR 186 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~ 186 (613)
|||+.+|+|..++.. ...+++..++.|+.||++||+|||+++ |+||||||+|||++ +++.+||+|||++..+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSS
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCC
Confidence 999999999998665 467999999999999999999999998 99999999999998 67899999999997654322
Q ss_pred -----cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 187 -----SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 187 -----~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
...+++.|||||++. ..|+.++|||||||++|||+| |+.||.... ..++..++.++..+ ..+...++.+.+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~ 232 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRL-YRPHLASEKVYT 232 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHHHHTTCCC-CCCTTCCHHHHH
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHHHHhCCCC-CCcccccHHHHH
Confidence 244677899999876 459999999999999999998 899997654 56777888887654 456778899999
Q ss_pred HHHHHhh-cccCCCCHHHHhcC
Q 035992 260 FIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~H 280 (613)
||.+||+ +|.+|||+.++++|
T Consensus 233 li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 233 IMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCCHhHCcCHHHHHHH
Confidence 9999999 99999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=385.92 Aligned_cols=242 Identities=23% Similarity=0.410 Sum_probs=195.9
Q ss_pred eeEeeeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l 104 (613)
|++.++||+|+||+||+|.+..++ ..||+|.++ ........+.+.+|+.+|++++||||++++++|. ...+
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~---~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~---~~~~ 82 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT---ENPV 82 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT---TTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---SSSC
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEec---cccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe---cCeE
Confidence 488899999999999999987654 456766543 3345666788999999999999999999999874 2468
Q ss_pred EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHh
Q 035992 105 NFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILA 183 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~ 183 (613)
++||||+.+|+|.+++.+ .+.+++..++.++.||+.||.|||+++ |+||||||+||+++ ..+.+||+|||+|..+.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC--------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhheecc
Confidence 999999999999998765 457999999999999999999999998 99999999999998 56899999999998764
Q ss_pred hh-----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHH
Q 035992 184 QA-----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNG 256 (613)
Q Consensus 184 ~~-----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~ 256 (613)
.. ....+++.|||||++.. .|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+ .++..+++.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~ 237 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPT 237 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTCCHH
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHH
Confidence 32 23356779999998864 69999999999999999998 8889866 4456677778877654 355678899
Q ss_pred HHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 257 VRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 257 l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+||.+||. +|.+|||+.||++|
T Consensus 238 ~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 238 LYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999 99999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=396.83 Aligned_cols=254 Identities=28% Similarity=0.393 Sum_probs=204.1
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC---CC
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT---EN 101 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~---~~ 101 (613)
.|| ++.++||+|+||+||+|+++.+|+.||+|+++... .+....+++.+|+.+|++++|||||+++++|... +.
T Consensus 18 ~rY-~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 18 ERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp TTE-EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCe-EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 466 77899999999999999999999999999876432 3456677899999999999999999999988543 22
Q ss_pred CEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 102 EHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
...+++++++.+|+|.+++.. +++++..++.+++||+.||+|||++| |+||||||+|||++ .+|.+|++|||++..
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARH 170 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----C
T ss_pred CceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcc
Confidence 345667788899999998855 57999999999999999999999998 99999999999998 678999999999976
Q ss_pred Hhh-hccCcccccccCcccccc--ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC-CCC-----------
Q 035992 182 LAQ-ARSAHSVIEFMAPELYEE--EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG-IKP----------- 246 (613)
Q Consensus 182 l~~-~~~~~gt~~YmAPEvl~~--~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g-~~p----------- 246 (613)
... .....++..|+|||++.+ .++.++|||||||++|+|++|.+||.+...... ...+... ..+
T Consensus 171 ~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp CTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTTCCCH
T ss_pred cCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhccch
Confidence 644 335567889999997554 368999999999999999999999976544333 3332211 000
Q ss_pred --------------Cc---ccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 247 --------------AS---LAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 247 --------------~~---l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
.. .....++++++||.+||. ||.+|||++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 112357889999999999 99999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=386.14 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=206.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.+.||+|+||+||+|.+..+ ..||+|+++... ...+.+.+|+.+|++++|||||++|++|.+ ..+++|
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv 89 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 89 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred EEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEE
Confidence 58999999999999999998755 579999876322 234678999999999999999999998742 347899
Q ss_pred EeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKK--HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~--~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|..++.. .+.+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||++..+...
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC-----
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhccCC
Confidence 999999999988754 467999999999999999999999998 99999999999998 5689999999999765432
Q ss_pred -----ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHH
Q 035992 186 -----RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRA 259 (613)
Q Consensus 186 -----~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~ 259 (613)
....+++.|||||.+.. .|+.++|||||||++|||+||..||.......+++..+..+..++ .+..+++++++
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~ 245 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHD 245 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHH
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHH
Confidence 22456789999997764 599999999999999999998777777778888888888776544 46678899999
Q ss_pred HHHHHhh-cccCCCCHHHHhc--CCCCCCC
Q 035992 260 FIEKCIA-EVSERLPAKELLG--DPFLQSE 286 (613)
Q Consensus 260 lI~~cL~-dP~~Rpta~eLL~--HPff~~~ 286 (613)
||.+||+ +|.+||++.+++. ++||...
T Consensus 246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999 9999999999988 8888754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=389.44 Aligned_cols=242 Identities=25% Similarity=0.447 Sum_probs=198.8
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcE----EEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIE----VAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~----VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
|++.++||+|+||+||+|.+..+|+. ||+|.++. ..+....+.+.+|+.+|++++|||||+++++|.. ..
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~---~~ 84 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT---ST 84 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc---ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CC
Confidence 58889999999999999999988875 55554432 2234456789999999999999999999999864 24
Q ss_pred EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHH
Q 035992 104 INFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAIL 182 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l 182 (613)
.+++++++.+|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|..+
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceec
Confidence 77899999999999877664 67999999999999999999999998 99999999999998 5679999999999986
Q ss_pred hhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccccc
Q 035992 183 AQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVAD 254 (613)
Q Consensus 183 ~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s 254 (613)
.... ...+|+.|||||++. +.|+.++|||||||++|||+| |..||.+ .+..++...+..+..++ .+..++
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~~-~p~~~~ 239 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLP-QPPICT 239 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCCC-CCTTBC
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCcccC
Confidence 5422 224678999999775 459999999999999999998 7888865 44566777787776553 455678
Q ss_pred HHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 255 NGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 255 ~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
+.+.++|.+||. +|.+|||+.||+.|
T Consensus 240 ~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 240 IDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 999999999999 99999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=385.93 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=198.5
Q ss_pred eeEeeeecccCceEEEEEEEcC-----CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCC
Q 035992 28 GRYKEVLGRGAFKKVYRAFDEL-----EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTEN 101 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~-----tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~ 101 (613)
|++.++||+|+||+||+|.+.. +++.||+|+++.. ......+.+.+|+.++.++ +|+||+.+++++.. .+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~ 90 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-PG 90 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TT
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-CC
Confidence 4888999999999999998754 4578998887632 2345667788888888777 68999999998654 34
Q ss_pred CEEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEe
Q 035992 102 EHINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVN 165 (613)
Q Consensus 102 ~~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~ 165 (613)
..+++|||||.+|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||++
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~ 168 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS 168 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeEC
Confidence 5789999999999999999754 24899999999999999999999998 99999999999998
Q ss_pred CCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhc-CCCCCCCCcHHHHH
Q 035992 166 GNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTF-EYPYVECTNAAQIY 237 (613)
Q Consensus 166 ~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG-~~Pf~~~~~~~~i~ 237 (613)
.++.+||+|||+|+..... ....||+.|||||++.+ .|+.++|||||||++|||+|| .+||........+.
T Consensus 169 -~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 169 -EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp -GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred -CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 5689999999999865432 23467889999998765 599999999999999999987 56787766677777
Q ss_pred HHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 238 KKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 238 ~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+..+..+ ..+...++++++||.+||+ +|.+|||+.|+++|
T Consensus 248 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 248 RRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 778877655 3456678999999999999 99999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=386.16 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=203.0
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcE--EEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeecCCCCEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIE--VAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVDTENEHI 104 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~--VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~~~~~~l 104 (613)
+++.++||+|+||+||+|.++.+|.. ||+|.++. .......+.+.+|+.+|+++ +|||||+++++|.. +..+
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~ 86 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 86 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC---C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEE
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc---ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCee
Confidence 47789999999999999999999875 45555432 22345567899999999999 79999999999865 5689
Q ss_pred EEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCC
Q 035992 105 NFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQ 168 (613)
Q Consensus 105 ~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~ 168 (613)
++||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+++ |+||||||+|||++ ..
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~-~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-EN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-CC
Confidence 9999999999999999754 57999999999999999999999998 99999999999998 56
Q ss_pred CcEEEeccchhHHHhhhc---cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcCC
Q 035992 169 GEVKIGDLGLAAILAQAR---SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSGI 244 (613)
Q Consensus 169 g~VKL~DFGla~~l~~~~---~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g~ 244 (613)
+.+||+|||++....... ...++..|+|||.+.+ .|+.++|||||||++|||++|..|+....+..+++..+..+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 799999999997654322 3356779999998754 599999999999999999997654435577888888888886
Q ss_pred CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 245 KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 245 ~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.+. .+..+++++++||.+||. +|.+|||+.|++++
T Consensus 244 ~~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 244 RLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCC-CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC-CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 653 455678999999999999 99999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=391.54 Aligned_cols=252 Identities=26% Similarity=0.379 Sum_probs=197.0
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecC----C
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDT----E 100 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~----~ 100 (613)
.|| ++.++||+|+||+||+|.++.+|+.||+|+++... .+.....++.+|+.+|++++||||++++++|... .
T Consensus 17 ~~Y-~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 17 KRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp TTE-EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred CCe-EEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh--cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 354 88899999999999999999999999999987432 3456677899999999999999999999998654 3
Q ss_pred CCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 101 NEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 101 ~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
...+|+|||||.++.+.. + .+.+++..++.+++||+.||.|||++| |+||||||+|||++ .++.+|++|||++.
T Consensus 94 ~~~~~iv~Ey~~~~l~~~-~--~~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQV-I--QMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLAR 167 (355)
T ss_dssp CCEEEEEEECCSEEHHHH-H--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC--
T ss_pred CceeEEEEeccchHHHHh-h--hcCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhh
Confidence 468999999997765543 3 457999999999999999999999998 99999999999998 56799999999987
Q ss_pred HHhhh---ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHc--------------
Q 035992 181 ILAQA---RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTS-------------- 242 (613)
Q Consensus 181 ~l~~~---~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~-------------- 242 (613)
..... ....+|+.|+|||++.+ .|+.++||||+||++|+|++|.+||......... .++..
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~-~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW-NKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHTTSC
T ss_pred ccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH-HHHHHhccCCCHHHHHHhh
Confidence 65442 34457789999998764 5999999999999999999999999765443332 22211
Q ss_pred --------CCCC------------------CcccccccHHHHHHHHHHhh-cccCCCCHHHHhcCCCCCCC
Q 035992 243 --------GIKP------------------ASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGDPFLQSE 286 (613)
Q Consensus 243 --------g~~p------------------~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~HPff~~~ 286 (613)
...+ .......++++.+||.+||. ||.+||||+|+|+||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 00112346789999999999 99999999999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=377.18 Aligned_cols=246 Identities=28% Similarity=0.438 Sum_probs=193.6
Q ss_pred cceeEeeeecccCceEEEEEEEcC-CC--cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCC
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDEL-EG--IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENE 102 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~-tg--~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~ 102 (613)
+-|++.+.||+|+||+||+|.+.. ++ ..||+|+++.... ......+.+.+|+.+|++++||||+++|+++.+ .
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 346899999999999999998653 33 4789888775432 344667889999999999999999999998853 3
Q ss_pred EEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHH
Q 035992 103 HINFITEIFTSGTLRQYRKK-HKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAI 181 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~-~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~ 181 (613)
.+++||||+.+|+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRA 160 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEE
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhh
Confidence 57899999999999987654 467999999999999999999999998 99999999999998 467999999999986
Q ss_pred Hhhh-------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCccccc
Q 035992 182 LAQA-------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKV 252 (613)
Q Consensus 182 l~~~-------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~ 252 (613)
+... ....++..|||||++.+ .|+.++|||||||++|||+| |..||.+. +..++...+.........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CHHHHHHHHHhCCCCCCCccc
Confidence 5332 12345668999998765 48999999999999999998 89999764 455555566544433345566
Q ss_pred ccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 253 ADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 253 ~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++..+++||.+||. +|.+|||+.+|++
T Consensus 240 ~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 240 CPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78999999999999 9999999999863
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-45 Score=377.28 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=207.5
Q ss_pred CCCcceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeee
Q 035992 23 PSARYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWV 97 (613)
Q Consensus 23 p~gRy~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv 97 (613)
|...| .+.+.||+|+||+||+|+++ .++..||+|.++. .......+++.+|+.+|++++||||++++++|.
T Consensus 11 p~~~~-~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~---~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 11 PRNNI-EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE---EASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp CGGGC-EEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT---TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CHHHc-EEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh---hcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 44454 88899999999999999875 3568999887652 334566788999999999999999999999885
Q ss_pred cCCCCEEEEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEE
Q 035992 98 DTENEHINFITEIFTSGTLRQYRKKHK------------------------HVDLRALKKWSRQILEGLSYLHSHDPPVI 153 (613)
Q Consensus 98 ~~~~~~l~lV~E~~~gGsL~~~l~~~~------------------------~lse~~i~~i~~QIl~gL~yLHs~~~~II 153 (613)
. ...++++|||+.+|+|.+++.... .+++..+..++.||+.||+|||+++ ||
T Consensus 87 ~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--iv 162 (301)
T d1lufa_ 87 V--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FV 162 (301)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CC
T ss_pred c--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eE
Confidence 4 456889999999999999986532 4899999999999999999999998 99
Q ss_pred ecCCCCCcEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCC-
Q 035992 154 HRDLKCDNIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEY- 225 (613)
Q Consensus 154 HrDLKp~NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~- 225 (613)
||||||+|||++ .++.+||+|||+|..+.... ...+++.|||||++.. .|+.++|||||||++|||++|..
T Consensus 163 HrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 163 HRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999998 56899999999998764432 3456678999998765 59999999999999999999964
Q ss_pred CCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 226 PYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 226 Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
||.. .+..++...+..+..+ ..+..+++++.+||.+||+ +|.+|||+.||++
T Consensus 242 p~~~-~~~~e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 242 PYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5644 6677788888888754 3456678999999999999 9999999999964
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=378.10 Aligned_cols=239 Identities=22% Similarity=0.400 Sum_probs=197.2
Q ss_pred eeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCEEEEE
Q 035992 28 GRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 28 ~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~l~lV 107 (613)
+++.++||+|+||+||+|.+ .|..||+|+++. ....+.+.+|+.++++++||||++++++|.+.. ..+++|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~------~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~~lv 79 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN------DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-GGLYIV 79 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEE--TTEEEEEEECCC------CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEEE
T ss_pred eEEeEEEecCCCeEEEEEEE--CCeEEEEEEECc------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC-CcEEEE
Confidence 57889999999999999987 478999988753 234567899999999999999999999886543 457999
Q ss_pred EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEeccchhHHHhhh
Q 035992 108 TEIFTSGTLRQYRKKHK--HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILAQA 185 (613)
Q Consensus 108 ~E~~~gGsL~~~l~~~~--~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~DFGla~~l~~~ 185 (613)
|||+.+|+|.+++.+.+ .+++..+..|+.||+.||.|||+++ |+||||||+|||++ .+|.+||+|||++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCCC
Confidence 99999999999987643 5999999999999999999999998 99999999999998 6789999999999876543
Q ss_pred -ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCcHHHHHHHHHcCCCCCcccccccHHHHHHHH
Q 035992 186 -RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTNAAQIYKKVTSGIKPASLAKVADNGVRAFIE 262 (613)
Q Consensus 186 -~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~ 262 (613)
....++..|||||++. +.|+.++|||||||++|||+| |.+||.. .+..+++..+..+..++ ++...++.+++||.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~ 234 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMK 234 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHH
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHH
Confidence 3445677999999775 569999999999999999998 6777754 56677888888887664 45567899999999
Q ss_pred HHhh-cccCCCCHHHHhcC
Q 035992 263 KCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 263 ~cL~-dP~~Rpta~eLL~H 280 (613)
+||. +|.+|||+.+|+++
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHH
Confidence 9999 99999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-45 Score=379.81 Aligned_cols=256 Identities=22% Similarity=0.370 Sum_probs=210.6
Q ss_pred cccccCCCCcceeEeeeecccCceEEEEEEEcCCC---cEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceee
Q 035992 17 EFVEIDPSARYGRYKEVLGRGAFKKVYRAFDELEG---IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93 (613)
Q Consensus 17 ~~v~~dp~gRy~r~~e~LG~GafGtVYka~~~~tg---~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~ 93 (613)
+.+.+++......|.++||+|+||+||+|.+..++ ..||+|.++. ..+....+++.+|+.+|++++||||++++
T Consensus 18 ~~~~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~E~~~l~~l~HpnIv~~~ 94 (311)
T d1r0pa_ 18 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR---ITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred hceEeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc---ccCHHHHHHHHHHHHHHHhCCCCCEeEEe
Confidence 34555666565667899999999999999986644 3688887653 34567788999999999999999999999
Q ss_pred eeeecCCCCEEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEE
Q 035992 94 NSWVDTENEHINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVK 172 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VK 172 (613)
+++... ...+++|||||.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++ +.+.+|
T Consensus 95 g~~~~~-~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~k 170 (311)
T d1r0pa_ 95 GICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVK 170 (311)
T ss_dssp EEEEET-TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEE
T ss_pred EEEEec-CCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEE
Confidence 987653 35789999999999999988754 46888999999999999999999998 99999999999998 568999
Q ss_pred EeccchhHHHhhhc--------cCcccccccCccccc-cccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHHHHHHcC
Q 035992 173 IGDLGLAAILAQAR--------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIYKKVTSG 243 (613)
Q Consensus 173 L~DFGla~~l~~~~--------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~~~I~~g 243 (613)
|+|||++..+.... ...+++.|+|||.+. +.|+.++|||||||++|||+||..||....+..++...+..+
T Consensus 171 L~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g 250 (311)
T d1r0pa_ 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250 (311)
T ss_dssp ECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT
T ss_pred EecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC
Confidence 99999998654321 234677999999776 469999999999999999999988887777777778888888
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
..+. .+..+++.+.+||.+||. +|.+||++.|+++|
T Consensus 251 ~~~~-~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 251 RRLL-QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCC-CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6554 456678899999999999 99999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=370.60 Aligned_cols=244 Identities=28% Similarity=0.437 Sum_probs=201.8
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCC-------cEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEG-------IEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSW 96 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg-------~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~f 96 (613)
.+| ++.+.||+|+||.||+|++..++ ..||+|+++. .........+.+|...++++ +|||||+++++|
T Consensus 13 ~~~-~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~---~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 13 DRL-VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS---DATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp GGE-EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT---TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHe-EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc---ccChHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 355 77899999999999999876654 4789777653 33456678889999999888 799999999988
Q ss_pred ecCCCCEEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCC
Q 035992 97 VDTENEHINFITEIFTSGTLRQYRKKH----------------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160 (613)
Q Consensus 97 v~~~~~~l~lV~E~~~gGsL~~~l~~~----------------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~ 160 (613)
.+ +..+++||||+.+|+|.+++... ..+++..++.|+.||+.||+|||+++ ||||||||+
T Consensus 89 ~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~ 164 (299)
T d1fgka_ 89 TQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAAR 164 (299)
T ss_dssp CS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred cc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeeccc
Confidence 64 45799999999999999999755 35899999999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHHhhhc------cCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCc
Q 035992 161 NIFVNGNQGEVKIGDLGLAAILAQAR------SAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTN 232 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l~~~~------~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~ 232 (613)
|||++ .++.+||+|||++....... ...+++.|||||.+. +.|+.++|||||||++|||++ |.+||.+ .+
T Consensus 165 NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~ 242 (299)
T d1fgka_ 165 NVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VP 242 (299)
T ss_dssp GEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CC
T ss_pred ceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC-CC
Confidence 99998 67899999999998765432 245677999999775 469999999999999999998 6777754 66
Q ss_pred HHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 233 ~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
..+++..+..+..+ ..+..+++.+++||.+||+ +|.+|||+.|+++
T Consensus 243 ~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 77888888887655 4456788999999999999 9999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-44 Score=370.07 Aligned_cols=245 Identities=27% Similarity=0.413 Sum_probs=205.9
Q ss_pred CcceeEeeeecccCceEEEEEEE-----cCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhC-CCCCcceeeeeeec
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFD-----ELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTL-KHKNIIKFYNSWVD 98 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~-----~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L-~HpNIVkl~~~fv~ 98 (613)
.+| .+.++||+|+||.||+|.+ ..+++.||+|+++. .........+.+|+.+++++ +|||||+++++|..
T Consensus 23 ~~~-~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~---~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 23 NRL-SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP---SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp GGE-EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECT---TCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHe-EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECc---ccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence 355 7789999999999999976 35678999888763 23456777899999999999 69999999998854
Q ss_pred CCCCEEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCC
Q 035992 99 TENEHINFITEIFTSGTLRQYRKKHK------------------HVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCD 160 (613)
Q Consensus 99 ~~~~~l~lV~E~~~gGsL~~~l~~~~------------------~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~ 160 (613)
...+++|||||.+|+|.+++.+.. .+++..+..|+.||+.||+|||+++ ++||||||+
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~ 174 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAAR 174 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccccc
Confidence 456899999999999999987653 5899999999999999999999998 999999999
Q ss_pred cEEEeCCCCcEEEeccchhHHHhhh------ccCcccccccCccccc-cccCccchhhhhhHHHHHHHh-cCCCCCCCCc
Q 035992 161 NIFVNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYE-EEYNELVDIYAFGMCLLELVT-FEYPYVECTN 232 (613)
Q Consensus 161 NILl~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~-~~ys~ksDIWSLGviL~Emlt-G~~Pf~~~~~ 232 (613)
|||++ ..+.+||+|||++...... ....+++.|||||++. +.|+.++|||||||++|||+| |.+||.....
T Consensus 175 NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 175 NILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 99998 5789999999999876432 2345678999999776 458999999999999999999 5666656555
Q ss_pred HHHHHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 233 AAQIYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 233 ~~~i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
...+.+.+..+..+ ..+...+..+.+||.+||+ +|.+|||+.+|++
T Consensus 254 ~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 56666666666544 3456678999999999999 9999999999985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=366.88 Aligned_cols=249 Identities=20% Similarity=0.378 Sum_probs=208.1
Q ss_pred cccCCCCcceeEeeeecccCceEEEEEEEc-----CCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceee
Q 035992 19 VEIDPSARYGRYKEVLGRGAFKKVYRAFDE-----LEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFY 93 (613)
Q Consensus 19 v~~dp~gRy~r~~e~LG~GafGtVYka~~~-----~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~ 93 (613)
.++++. +| .+.+.||+|+||+||+|.+. .++..||+|+++. .........+.+|+.++++++||||++++
T Consensus 15 ~ei~~~-~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~---~~~~~~~~~~~~E~~il~~l~h~nIv~~~ 89 (308)
T d1p4oa_ 15 WEVARE-KI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE---AASMRERIEFLNEASVMKEFNCHHVVRLL 89 (308)
T ss_dssp TBCCGG-GE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT---TSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred eeecHH-He-EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECc---ccChHHHHHHHHHHHHHHHcCCCCEeeee
Confidence 356653 44 68899999999999999875 3467899887652 23456677899999999999999999999
Q ss_pred eeeecCCCCEEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEE
Q 035992 94 NSWVDTENEHINFITEIFTSGTLRQYRKKH----------KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIF 163 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL~~~l~~~----------~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NIL 163 (613)
++|.. ...+++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiL 165 (308)
T d1p4oa_ 90 GVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCM 165 (308)
T ss_dssp EEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEE
T ss_pred eEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCcee
Confidence 98754 45689999999999999987643 34789999999999999999999998 999999999999
Q ss_pred EeCCCCcEEEeccchhHHHhhh------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcC-CCCCCCCcHHH
Q 035992 164 VNGNQGEVKIGDLGLAAILAQA------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFE-YPYVECTNAAQ 235 (613)
Q Consensus 164 l~~~~g~VKL~DFGla~~l~~~------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~-~Pf~~~~~~~~ 235 (613)
++ .++++||+|||++..+... ....+++.|||||.+.+ .|+.++||||||+++|||+||. +||. ..+..+
T Consensus 166 ld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~-~~~~~~ 243 (308)
T d1p4oa_ 166 VA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQ 243 (308)
T ss_dssp EC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSCHHH
T ss_pred ec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC-CCCHHH
Confidence 98 6689999999999866432 23356789999998764 5899999999999999999985 6664 466777
Q ss_pred HHHHHHcCCCCCcccccccHHHHHHHHHHhh-cccCCCCHHHHhc
Q 035992 236 IYKKVTSGIKPASLAKVADNGVRAFIEKCIA-EVSERLPAKELLG 279 (613)
Q Consensus 236 i~~~I~~g~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL~ 279 (613)
++..+.++..+. .+..+++.+.++|.+||+ +|.+|||+.+|++
T Consensus 244 ~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 244 VLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCC-CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 788888876543 445678999999999999 9999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-43 Score=363.00 Aligned_cols=250 Identities=20% Similarity=0.262 Sum_probs=193.9
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCCCE
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTENEH 103 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~~~ 103 (613)
++|| ++.+.||+|+||+||+|++..+|+.||+|++..... ...+..|+++++.++|+|++..+..+.. .+..
T Consensus 6 g~rY-~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~~~~E~~i~~~l~~~~~i~~~~~~~~-~~~~ 77 (299)
T d1ckia_ 6 GNRY-RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK------HPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDY 77 (299)
T ss_dssp TTTE-EEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT------SCCHHHHHHHHHHSTTSTTCCCEEEEEE-ETTE
T ss_pred CCEE-EEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc------CHHHHHHHHHHHHccCCCcccEEEEEEe-cCCE
Confidence 4566 889999999999999999999999999998764321 2347889999999988877666655443 3567
Q ss_pred EEEEEeccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC--CCCcEEEeccchhH
Q 035992 104 INFITEIFTSGTLRQYR-KKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG--NQGEVKIGDLGLAA 180 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l-~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~--~~g~VKL~DFGla~ 180 (613)
.++||||+.+ +|..++ ...+.+++..+..++.||+.||+|||+++ ||||||||+|||++. ....+||+|||+|.
T Consensus 78 ~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 78 NVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcce
Confidence 8899999855 555544 55678999999999999999999999999 999999999999862 34579999999998
Q ss_pred HHhhh-----------ccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCcHHHHH--HHHHcC---
Q 035992 181 ILAQA-----------RSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTNAAQIY--KKVTSG--- 243 (613)
Q Consensus 181 ~l~~~-----------~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~~~~i~--~~I~~g--- 243 (613)
.+... ....||+.|||||++.+ .|+.++|||||||++|||+||..||.......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 76432 23467889999998765 49999999999999999999999997654332221 111111
Q ss_pred CCCCcccccccHHHHHHHHHHhh-cccCCCCHH---HHhcCCCCC
Q 035992 244 IKPASLAKVADNGVRAFIEKCIA-EVSERLPAK---ELLGDPFLQ 284 (613)
Q Consensus 244 ~~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~---eLL~HPff~ 284 (613)
..+..+...+++++.+||.+||+ +|.+||++. ++|+|+|.+
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 11223345678899999999999 999999976 557777654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=362.86 Aligned_cols=246 Identities=25% Similarity=0.327 Sum_probs=190.1
Q ss_pred cceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCcceeeeeeecCCC--CE
Q 035992 26 RYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNIIKFYNSWVDTEN--EH 103 (613)
Q Consensus 26 Ry~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNIVkl~~~fv~~~~--~~ 103 (613)
|-+.+.+.||+|+||+||+|++ +|+.||+|+++.. .........|+..++.++||||+++++++..... ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 4567889999999999999975 6899999987521 1222223345556677899999999999876543 36
Q ss_pred EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcC------CCCEEecCCCCCcEEEeCCCCcEEEeccc
Q 035992 104 INFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSH------DPPVIHRDLKCDNIFVNGNQGEVKIGDLG 177 (613)
Q Consensus 104 l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~------~~~IIHrDLKp~NILl~~~~g~VKL~DFG 177 (613)
+|+|||||.+|+|.+++++. .+++..+..++.|++.||.|||+. .++|+||||||+||||+ .++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~-~~~~~Kl~DFG 153 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLG 153 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC-TTSCEEECCCT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc-CCCCeEEEecC
Confidence 89999999999999999875 689999999999999999999974 23499999999999998 67899999999
Q ss_pred hhHHHhhh--------ccCcccccccCcccccc-------ccCccchhhhhhHHHHHHHhcCCCCCCC------------
Q 035992 178 LAAILAQA--------RSAHSVIEFMAPELYEE-------EYNELVDIYAFGMCLLELVTFEYPYVEC------------ 230 (613)
Q Consensus 178 la~~l~~~--------~~~~gt~~YmAPEvl~~-------~ys~ksDIWSLGviL~EmltG~~Pf~~~------------ 230 (613)
++...... ....||+.|||||++.. .|+.++|||||||++|||+||..||...
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 98765332 23467899999998764 2677999999999999999998876321
Q ss_pred --CcHHHHHHHHHcCCCCCccccc-----ccHHHHHHHHHHhh-cccCCCCHHHHhcC
Q 035992 231 --TNAAQIYKKVTSGIKPASLAKV-----ADNGVRAFIEKCIA-EVSERLPAKELLGD 280 (613)
Q Consensus 231 --~~~~~i~~~I~~g~~p~~l~~~-----~s~~l~~lI~~cL~-dP~~Rpta~eLL~H 280 (613)
.....+...+......+.++.. ....+.+++.+||+ +|.+|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 2334444444443332222222 23458899999999 99999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-41 Score=348.06 Aligned_cols=243 Identities=15% Similarity=0.232 Sum_probs=196.6
Q ss_pred CCcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC-CCcceeeeeeecCCCC
Q 035992 24 SARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH-KNIIKFYNSWVDTENE 102 (613)
Q Consensus 24 ~gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H-pNIVkl~~~fv~~~~~ 102 (613)
.+|| ++.++||+|+||+||+|++..+|+.||+|++.... ....+.+|+++++.+.| +||+.+++++.. +.
T Consensus 4 g~~Y-~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~ 74 (293)
T d1csna_ 4 GVHY-KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS------DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GL 74 (293)
T ss_dssp TTTE-EEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT------TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TT
T ss_pred CCce-EEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc------CcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CC
Confidence 3566 89999999999999999999999999999876432 12346789999999975 899999998754 56
Q ss_pred EEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeC----CCCcEEEeccc
Q 035992 103 HINFITEIFTSGTLRQYRKKH-KHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNG----NQGEVKIGDLG 177 (613)
Q Consensus 103 ~l~lV~E~~~gGsL~~~l~~~-~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~----~~g~VKL~DFG 177 (613)
..++||||+ +++|.+++... ..+++..+..++.|++.||+|||++| ||||||||+|||++. ..+.+||+|||
T Consensus 75 ~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 75 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence 889999998 78999988765 47999999999999999999999999 999999999999963 35789999999
Q ss_pred hhHHHhh-----------hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCC--cHHHHHHHHHcC
Q 035992 178 LAAILAQ-----------ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECT--NAAQIYKKVTSG 243 (613)
Q Consensus 178 la~~l~~-----------~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~--~~~~i~~~I~~g 243 (613)
+|..+.. .....||+.|||||++.+ .|+.++|||||||++|||+||..||.... .....+..+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9986532 123468899999998765 49999999999999999999999996433 344444444332
Q ss_pred C---CCCcccccccHHHHHHHHHHhh-cccCCCCHHHHh
Q 035992 244 I---KPASLAKVADNGVRAFIEKCIA-EVSERLPAKELL 278 (613)
Q Consensus 244 ~---~p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~eLL 278 (613)
. .+..+...+++++.+++..|+. +|.+||+.+.|.
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1 2222334567899999999999 999999976654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-41 Score=354.93 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=194.2
Q ss_pred CcceeEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-----------CCCcceee
Q 035992 25 ARYGRYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-----------HKNIIKFY 93 (613)
Q Consensus 25 gRy~r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-----------HpNIVkl~ 93 (613)
+|| ++.++||+|+||+||+|+++.+|+.||+|+++. .....+.+.+|+.+++.++ |+||++++
T Consensus 13 ~rY-~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~-----~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 13 ARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TTE-EEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CcE-EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec-----cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 676 889999999999999999999999999998863 2344567788999888875 57899999
Q ss_pred eeeecCCCCEEEEEEeccCCCCH-HHH--HHhCCCCCHHHHHHHHHHHHHHhhhhhc-CCCCEEecCCCCCcEEEeCCC-
Q 035992 94 NSWVDTENEHINFITEIFTSGTL-RQY--RKKHKHVDLRALKKWSRQILEGLSYLHS-HDPPVIHRDLKCDNIFVNGNQ- 168 (613)
Q Consensus 94 ~~fv~~~~~~l~lV~E~~~gGsL-~~~--l~~~~~lse~~i~~i~~QIl~gL~yLHs-~~~~IIHrDLKp~NILl~~~~- 168 (613)
++|........++++.++..+.. ..+ ......+++..++.++.||+.||+|||+ +| |+||||||+|||++.+.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEET
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCc
Confidence 98876656667777777666543 222 2344679999999999999999999998 76 99999999999997322
Q ss_pred ----CcEEEeccchhHHHhh-hccCcccccccCcccccc-ccCccchhhhhhHHHHHHHhcCCCCCCCCc------HHHH
Q 035992 169 ----GEVKIGDLGLAAILAQ-ARSAHSVIEFMAPELYEE-EYNELVDIYAFGMCLLELVTFEYPYVECTN------AAQI 236 (613)
Q Consensus 169 ----g~VKL~DFGla~~l~~-~~~~~gt~~YmAPEvl~~-~ys~ksDIWSLGviL~EmltG~~Pf~~~~~------~~~i 236 (613)
..++|+|||.+..... .....+++.|+|||++.. .|+.++|||||||++++|++|+.||..... ...+
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 1499999999876543 334568889999997754 599999999999999999999999954321 1111
Q ss_pred HHHHH-cCCC--------------------------------------CCcccccccHHHHHHHHHHhh-cccCCCCHHH
Q 035992 237 YKKVT-SGIK--------------------------------------PASLAKVADNGVRAFIEKCIA-EVSERLPAKE 276 (613)
Q Consensus 237 ~~~I~-~g~~--------------------------------------p~~l~~~~s~~l~~lI~~cL~-dP~~Rpta~e 276 (613)
...+. -+.. ...+....++.+.+||.+||. ||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 11110 0000 011123346789999999999 9999999999
Q ss_pred HhcCCCCCCC
Q 035992 277 LLGDPFLQSE 286 (613)
Q Consensus 277 LL~HPff~~~ 286 (613)
+|+||||+..
T Consensus 325 ~L~Hp~f~~~ 334 (362)
T d1q8ya_ 325 LVNHPWLKDT 334 (362)
T ss_dssp HHTCGGGTTC
T ss_pred HhcCcccCCC
Confidence 9999999954
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.1e-23 Score=199.51 Aligned_cols=167 Identities=17% Similarity=0.185 Sum_probs=123.2
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccc----c----------ChHHHHHHHHHHHHHHhCCCCCcceeee
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLL----R----------NSEDLERLYSEVHLLKTLKHKNIIKFYN 94 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~----~----------~~~~~~~l~~Ei~iLk~L~HpNIVkl~~ 94 (613)
-+.++||+|+||+||+|.+. +|+.||+|+++..... . ..........|+..+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 46799999999999999875 7999999986532110 0 0112334567899999999999999887
Q ss_pred eeecCCCCEEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHhhhhhcCCCCEEecCCCCCcEEEeCCCCcEEEe
Q 035992 95 SWVDTENEHINFITEIFTSGTLRQYRKKHKHVDLRALKKWSRQILEGLSYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIG 174 (613)
Q Consensus 95 ~fv~~~~~~l~lV~E~~~gGsL~~~l~~~~~lse~~i~~i~~QIl~gL~yLHs~~~~IIHrDLKp~NILl~~~~g~VKL~ 174 (613)
+. . .+++|||+.++.+. .++...+..++.||+.+|.|||+++ |+||||||+|||++ + +.++|+
T Consensus 82 ~~----~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~li 144 (191)
T d1zara2 82 WE----G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWII 144 (191)
T ss_dssp EE----T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEEC
T ss_pred ec----C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEE
Confidence 53 1 26899999986553 3566667889999999999999998 99999999999998 3 469999
Q ss_pred ccchhHHHhhhccCcccccccC------ccccccccCccchhhhhhHHH
Q 035992 175 DLGLAAILAQARSAHSVIEFMA------PELYEEEYNELVDIYAFGMCL 217 (613)
Q Consensus 175 DFGla~~l~~~~~~~gt~~YmA------PEvl~~~ys~ksDIWSLGviL 217 (613)
|||+|........ ..|.. .+.+...|+.++|+||+.--+
T Consensus 145 DFG~a~~~~~~~~----~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW----REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH----HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc----HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999865432211 11111 133456799999999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.70 E-value=4.7e-05 Score=73.04 Aligned_cols=82 Identities=11% Similarity=-0.036 Sum_probs=50.1
Q ss_pred eEeeeecccCceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCC-CCCcceeeeeeecCCCCEEEEE
Q 035992 29 RYKEVLGRGAFKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLK-HKNIIKFYNSWVDTENEHINFI 107 (613)
Q Consensus 29 r~~e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~-HpNIVkl~~~fv~~~~~~l~lV 107 (613)
|..+..+.++.+.||+.. .++..+.+|...... ......+.+|..++..+. +--+.+++.+.. .+...++|
T Consensus 17 ~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~----~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~lv 88 (263)
T d1j7la_ 17 RCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRY----KGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSNLL 88 (263)
T ss_dssp EEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGG----TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEE
T ss_pred EEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCc----ccchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCceEEE
Confidence 444554445567899873 455556655543221 112234677888887774 433566666443 34678899
Q ss_pred EeccCCCCHHH
Q 035992 108 TEIFTSGTLRQ 118 (613)
Q Consensus 108 ~E~~~gGsL~~ 118 (613)
|+++.|.++..
T Consensus 89 ~~~l~G~~~~~ 99 (263)
T d1j7la_ 89 MSEADGVLCSE 99 (263)
T ss_dssp EECCSSEEHHH
T ss_pred EEecccccccc
Confidence 99999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=7.7e-05 Score=77.14 Aligned_cols=80 Identities=18% Similarity=0.190 Sum_probs=49.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEEEeec-c--ccChHHHHHHHHHHHHHHhCC-C--CCcceeeeeeecCCCCEEE
Q 035992 32 EVLGRGAFKKVYRAFDELEGIEVAWNQIKVID-L--LRNSEDLERLYSEVHLLKTLK-H--KNIIKFYNSWVDTENEHIN 105 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~tg~~VAiK~vk~~~-~--~~~~~~~~~l~~Ei~iLk~L~-H--pNIVkl~~~fv~~~~~~l~ 105 (613)
+.||.|....||++.+..+|+.+.+|+-...- . ...+...++...|..+|+.+. + ..+.++|.+ +.. ..+
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~--~~~ 107 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTE--MAV 107 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETT--TTE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCC--CCE
Confidence 57899999999999887788889888643211 1 011223456677888887763 2 345566653 333 345
Q ss_pred EEEeccCCCC
Q 035992 106 FITEIFTSGT 115 (613)
Q Consensus 106 lV~E~~~gGs 115 (613)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 7999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.01 E-value=0.00033 Score=66.50 Aligned_cols=75 Identities=13% Similarity=-0.051 Sum_probs=46.0
Q ss_pred eeecccC-ceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCC--CCcceeeeeeecCCCCEEEEEE
Q 035992 32 EVLGRGA-FKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKH--KNIIKFYNSWVDTENEHINFIT 108 (613)
Q Consensus 32 e~LG~Ga-fGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~H--pNIVkl~~~fv~~~~~~l~lV~ 108 (613)
+.+..|. -+.||+... ..+..+.+|..... ....+..|..+++.+.. -.+.+++.+.. +....++||
T Consensus 16 ~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~ 85 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-------ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLL 85 (255)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEE
T ss_pred EEcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-------CHhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEE
Confidence 3445555 468998864 35555666653321 22346778888877743 33566676543 345688999
Q ss_pred eccCCCCH
Q 035992 109 EIFTSGTL 116 (613)
Q Consensus 109 E~~~gGsL 116 (613)
+++.|.++
T Consensus 86 ~~i~G~~~ 93 (255)
T d1nd4a_ 86 GEVPGQDL 93 (255)
T ss_dssp ECCSSEET
T ss_pred Eeeecccc
Confidence 99987654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.07 E-value=0.02 Score=56.54 Aligned_cols=70 Identities=9% Similarity=-0.010 Sum_probs=39.3
Q ss_pred ceEEEEEEEcCCCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc--ceeee---eeecCCCCEEEEEEeccCC
Q 035992 39 FKKVYRAFDELEGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI--IKFYN---SWVDTENEHINFITEIFTS 113 (613)
Q Consensus 39 fGtVYka~~~~tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI--Vkl~~---~fv~~~~~~l~lV~E~~~g 113 (613)
--.||++.. .+|..|++|+.. ... ...+.+..|...|..|...+| +.... --........+.+++++.|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~r---p~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYR---PER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEEC---TTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeC---CCC--CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 468999964 578888877643 111 123456778888877742222 11111 0011124467788998876
Q ss_pred C
Q 035992 114 G 114 (613)
Q Consensus 114 G 114 (613)
.
T Consensus 109 ~ 109 (325)
T d1zyla1 109 R 109 (325)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.55 E-value=0.039 Score=55.82 Aligned_cols=72 Identities=14% Similarity=0.161 Sum_probs=45.5
Q ss_pred eeecccCceEEEEEEEcC-------CCcEEEEEEEEeeccccChHHHHHHHHHHHHHHhCCCCCc-ceeeeeeecCCCCE
Q 035992 32 EVLGRGAFKKVYRAFDEL-------EGIEVAWNQIKVIDLLRNSEDLERLYSEVHLLKTLKHKNI-IKFYNSWVDTENEH 103 (613)
Q Consensus 32 e~LG~GafGtVYka~~~~-------tg~~VAiK~vk~~~~~~~~~~~~~l~~Ei~iLk~L~HpNI-Vkl~~~fv~~~~~~ 103 (613)
+.|+.|-.-.+|++.... ....|.+++.- ..... ....+|..+++.+.-.++ .+++++| .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-----~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~--~~--- 116 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-----NPETE-SHLVAESVIFTLLSERHLGPKLYGIF--SG--- 116 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-----SCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEE--TT---
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-----Ccchh-hHHHHHHHHHHHHHhCCCCCeEEEEc--CC---
Confidence 678889999999997653 23456544322 11122 235579999998853344 5677765 22
Q ss_pred EEEEEeccCCCC
Q 035992 104 INFITEIFTSGT 115 (613)
Q Consensus 104 l~lV~E~~~gGs 115 (613)
++|++|+.|..
T Consensus 117 -g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 -GRLEEYIPSRP 127 (395)
T ss_dssp -EEEECCCCEEE
T ss_pred -ceEEEEecccc
Confidence 46899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.24 E-value=0.093 Score=50.77 Aligned_cols=29 Identities=38% Similarity=0.433 Sum_probs=24.3
Q ss_pred CEEecCCCCCcEEEeCCCCcEEEeccchhH
Q 035992 151 PVIHRDLKCDNIFVNGNQGEVKIGDLGLAA 180 (613)
Q Consensus 151 ~IIHrDLKp~NILl~~~~g~VKL~DFGla~ 180 (613)
++||+|+.++||++++ ++..-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred ccccCCcchhhhhccc-ccceeEecccccc
Confidence 4999999999999984 4455899999874
|